Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.5976886355054448,-2.1124639068912594,0.0,0.10005814422549945,0.087,17/35,7.04%,KSR1;PDE7B;RAPGEF3;IRAG1;PDE4D;APOE;ADGRG6;RAPGEF2;RIMS2;CAP2;GUCY1B1;NUDT4;ADCY1;AHR;AKAP6;HTR2C;PDE2A
prerank,vasculature development (GO:0001944),-0.7396957496682733,-2.0943103956712004,0.0,0.06177058903717058,0.101,14/16,21.09%,CDH5;ERRFI1;PDGFRB;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18;ACVRL1;APLNR;ACVR2B;STRA6;STK11;FOXF1
prerank,B cell receptor signaling pathway (GO:0050853),-0.6243229455258953,-2.0841861719204706,0.0,0.04696606769768342,0.117,11/32,11.76%,BCL2;TEC;PRKCB;RFTN1;BMX;NFATC2;CD38;VAV3;SYK;PIK3CD;SH2B2
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6099834396598077,-2.062292699507654,0.0,0.04900807064106095,0.159,14/30,9.28%,TJP1;GJB6;OCLN;PECAM1;CDH5;LAMA2;CLDN5;ESAM;JAM2;LSR;F11R;SLC1A1;CLDN1;MFSD2A
prerank,collagen fibril organization (GO:0030199),0.7261751592749719,2.0524496393314897,0.0,0.000995036977769947,0.001,30/88,4.96%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;COL11A1;DDR2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;P4HB;SERPINH1;COL5A2;COL15A1;COL27A1;COL16A1;LOXL1;CYP1B1;TLL1;TGFB2;PLOD1;P3H1;PLOD3
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.7145619281722158,-1.9558545372357503,0.003424657534246575,0.1627476345871899,0.505,5/15,11.88%,PLTP;APOE;ABCG1;ABCA5;SCARB1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6495947372491122,-1.9432444644687663,0.008888888888888889,0.1562132251683818,0.563,6/19,6.32%,TJP1;ROCK2;OCLN;CLDN5;PRKCH;F11R
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5164065328529309,-1.9123270595806587,0.0,0.19428199432706303,0.726,18/46,14.80%,ATP1A2;GRM7;GRM5;NRXN1;SHANK3;GRM3;GRM8;GRM1;CACNG7;OPHN1;CACNG8;CDH2;HOMER1;CACNG3;CACNG4;DGKZ;RELN;TPRG1L
prerank,positive regulation of blood coagulation (GO:0030194),0.8280301382650113,1.86874762082693,0.0,0.16219102737650137,0.247,3/17,1.07%,THBS1;ST3GAL4;F3
prerank,bicarbonate transport (GO:0015701),0.7777619912737028,1.8625084866808308,0.0,0.1290231281175031,0.283,7/25,7.29%,SLC4A10;SLC26A7;SLC4A4;SLC26A6;SLC4A8;SLC4A11;SLC4A2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6610005849387172,1.8416364962002651,0.0,0.1636835828431563,0.421,11/79,2.20%,BMPER;THBS1;SLIT2;HTRA3;FGF2;SKIL;NEDD4;CRIM1;SMAD9;EMILIN1;SMAD6
prerank,melanocyte differentiation (GO:0030318),-0.7332612867308789,-1.8350599841152175,0.00974025974025974,0.3748351652937396,0.93,4/11,4.52%,LRMDA;KIT;ENPP1;MITF
prerank,muscle tissue morphogenesis (GO:0060415),-0.6439005961649615,-1.8338797038799226,0.007547169811320755,0.33670359644136316,0.931,8/16,15.96%,TGFBR3;MYLK;NOTCH1;TBX1;PROX1;HEY2;EFEMP2;BMP2
prerank,response to glucocorticoid (GO:0051384),0.7523002489421553,1.8293937219253391,0.0,0.17452948590084869,0.504,3/26,1.24%,SLIT3;SLIT2;ADAM9
prerank,negative regulation of heart contraction (GO:0045822),-0.7130216946843078,-1.828297624498365,0.003215434083601286,0.3192671601970783,0.94,2/11,1.29%,ATP1A2;PDE4D
prerank,negative regulation of leukocyte activation (GO:0002695),-0.6584141710121468,-1.8274929697814986,0.0038314176245210726,0.29209923921859626,0.942,12/15,25.05%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CD300A;CD84;HAVCR2;GPER1;MILR1;CD300LF;GRN
prerank,response to ketone (GO:1901654),0.7646091932361806,1.8228432486157151,0.0,0.16766373075423607,0.546,5/24,4.20%,THBS1;SLIT3;SLIT2;TGFB3;TGFB2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.7030155017720419,1.804250192599736,0.001148105625717566,0.2234568755791938,0.695,10/40,7.04%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC38A6;ABCC1;SLC7A10;SLC38A3
prerank,external encapsulating structure organization (GO:0045229),0.6099327863359177,1.803712188502973,0.0,0.19726608084289202,0.697,36/205,3.24%,THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;DDR2;FGF2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;TGFBI;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.7015263009412163,1.799618568736669,0.0,0.18872534678369993,0.726,11/39,6.39%,SLIT2;LRP6;SIX1;PKD1;VEGFA;FGF2;GLI2;LRP5;PKHD1;SEMA3E;TGFBR2
prerank,extracellular matrix organization (GO:0030198),0.6047452211086111,1.7995501049552303,0.0,0.17025082689643792,0.726,58/276,6.99%,COL12A1;PLOD2;THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;BMP1;MFAP5;ELN;COL11A1;ITGA11;GAS6;DDR2;FGF2;COL3A1;COL1A2;GSN;COL1A1;COL5A3;COL14A1;P4HB;HTRA1;TGFBI;SERPINH1;TIMP2;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC;CYP1B1;TLL1;TGFB2;ADAMTS10;PLOD1;P3H1;PLOD3;MMP28;ADAM10;P4HA1;MMP14;LOX;QSOX1
prerank,extracellular structure organization (GO:0043062),0.608229729449154,1.7977730427360543,0.0,0.15956774807147148,0.734,36/204,3.24%,THBS1;COL6A3;COL6A2;SMOC2;COL6A1;ADAMTSL3;SH3PXD2A;ADAMTS3;ADAMTS17;ADAMTS2;SMOC1;COL8A2;COL8A1;MFAP5;ELN;COL11A1;ITGA11;DDR2;FGF2;COL3A1;COL1A2;COL1A1;COL5A3;COL14A1;TGFBI;ADAMTSL1;COL5A2;BGN;VIT;COL15A1;COL27A1;COL16A1;LOXL1;DMP1;COMP;SPARC
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6931417355529841,-1.7957040372649171,0.007272727272727273,0.358031182738862,0.984,7/12,21.69%,IL34;LYN;BST2;CSF1;PTK2;MAPK3;CSF1R
prerank,cellular response to zinc ion (GO:0071294),-0.6569838132969601,-1.7870003416107827,0.00392156862745098,0.3591569023102111,0.99,12/15,18.03%,GLRA2;MT1H;MT1M;MT1X;MT1B;MT1A;MT1E;MT1F;MT1G;GLRA1;ATP13A2;MT3
prerank,regulation of cell junction assembly (GO:1901888),-0.5432594783738186,-1.774275679731877,0.0,0.3753638981987213,0.997,7/27,6.32%,TJP1;ROCK2;OCLN;CLDN5;RAPGEF2;PRKCH;F11R
prerank,B cell homeostasis (GO:0001782),-0.6942106504502393,-1.7721285306438859,0.010380622837370242,0.35646564714893914,0.998,3/10,3.05%,LYN;DOCK11;DOCK10
prerank,cAMP-mediated signaling (GO:0019933),-0.5531061582022403,-1.7663533510494207,0.0,0.35275600846847,0.998,12/24,7.04%,KSR1;PDE7B;RAPGEF3;PDE4D;ADGRG6;RAPGEF2;RIMS2;CAP2;ADCY1;AHR;AKAP6;PDE2A
prerank,negative regulation of interleukin-12 production (GO:0032695),0.8188532674560662,1.7656233699937265,0.0013605442176870747,0.27056713820527806,0.91,3/14,7.14%,THBS1;CMKLR1;IRAK3
prerank,positive regulation of coagulation (GO:0050820),0.8788451533721975,1.7628810584642425,0.0,0.2425758003663449,0.918,2/10,0.30%,THBS1;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.8788451533721975,1.7628810584642425,0.0,0.2425758003663449,0.918,2/10,0.30%,THBS1;ST3GAL4
prerank,positive regulation of macrophage activation (GO:0043032),0.7896031103272931,1.7606817830155137,0.0013315579227696406,0.23529307734333343,0.922,3/17,1.30%,THBS1;LBP;IL33
prerank,protein hydroxylation (GO:0018126),0.8086923617102351,1.7480743320321084,0.004076086956521739,0.27742874736448336,0.955,6/15,7.70%,PLOD2;P3H3;PLOD1;P3H1;PLOD3;P3H2
prerank,motor neuron axon guidance (GO:0008045),0.7921999161228257,1.7471274550796572,0.0,0.26555780989072053,0.959,4/15,2.66%,SLIT2;SLIT1;NTN1;TMEFF1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7575981055070815,1.7445122215839095,0.0013123359580052493,0.2618052848176927,0.962,5/20,8.27%,THBS1;SMOC2;FGF2;SULF1;NOG
prerank,regulation of cellular pH (GO:0030641),0.7107046069656254,1.7422348925261621,0.00245398773006135,0.25755746614066316,0.968,9/29,7.29%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6588280006170639,1.740899856855673,0.0,0.2506498147002496,0.97,11/51,8.27%,BMPER;HTRA3;CHRDL1;FSTL1;SKIL;CRIM1;SMAD9;SMAD6;SMAD4;SKI;NOG
prerank,mesonephros development (GO:0001823),-0.6788239663921992,-1.7402599390662543,0.016286644951140065,0.4124245356521637,0.999,4/11,2.44%,OSR1;ZBTB16;BMP7;FGF1
prerank,cellular response to type I interferon (GO:0071357),-0.4940027956506307,-1.7328991848415793,0.0,0.3915809328524245,0.999,23/41,21.26%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;IFITM3;OAS2;PSMB8;IRF9;IFI27;MYD88;IRF8;ISG15;IRF7;ADAR
prerank,type I interferon signaling pathway (GO:0060337),-0.4940027956506307,-1.7328991848415793,0.0,0.3915809328524245,0.999,23/41,21.26%,IFNAR2;STAT1;SAMHD1;IFITM1;BST2;SP100;IFIT3;IP6K2;IFIT2;RNASEL;IFIT1;EGR1;RSAD2;IFITM3;OAS2;PSMB8;IRF9;IFI27;MYD88;IRF8;ISG15;IRF7;ADAR
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.6847265853340738,-1.7311073881984238,0.013559322033898305,0.37685164320032494,0.999,3/12,2.53%,ROCK2;APOE;PICALM
prerank,establishment of endothelial barrier (GO:0061028),-0.539351697969808,-1.7284155437828983,0.005747126436781609,0.36722019598406086,0.999,11/29,11.60%,TJP1;RAPGEF3;PDE4D;PECAM1;PPP1R16B;RAPGEF2;F11R;PDE2A;ROBO4;SOX18;RAP2B
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7807975413281666,1.7274874800216673,0.006793478260869565,0.2969000810812613,0.98,5/16,6.30%,ESR1;DDX5;DDX17;RBFOX2;SAFB
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.7687072437579207,1.7271413783238858,0.0013297872340425532,0.2853042388987648,0.98,3/18,1.72%,IRS1;KCNB1;CCN3
prerank,positive regulation of leukocyte activation (GO:0002696),0.760825711234764,1.7241462800469158,0.0026490066225165563,0.28592171243832953,0.982,3/18,1.30%,THBS1;LBP;IL33
prerank,Rap protein signal transduction (GO:0032486),-0.7022200297817773,-1.7219845806131344,0.009146341463414634,0.3695561235935307,1.0,4/10,11.65%,RAPGEF3;RAPGEF2;RAP2B;PLK2
prerank,cardiac muscle cell contraction (GO:0086003),0.7629296870764214,1.7185835124787734,0.005221932114882507,0.30037678766430276,0.99,5/19,3.61%,KCNJ2;CACNA1G;CACNA1C;GSN;CAMK2D
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.8166724173860989,1.7173733898675667,0.005738880918220947,0.2938145187959099,0.991,2/11,1.72%,SLIT2;CCN3
prerank,regulation of fibrinolysis (GO:0051917),0.8004146112541866,1.7172549703496602,0.004160887656033287,0.2827818549516207,0.991,2/13,3.77%,THBS1;FAP
prerank,endoderm formation (GO:0001706),0.6712608838174458,1.7163255585671515,0.0011655011655011655,0.2765465733772475,0.992,4/35,0.88%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,embryonic digestive tract development (GO:0048566),0.7592542968430442,1.7152722772197555,0.0013351134846461949,0.2706855949883459,0.993,6/18,4.20%,PKDCC;ID2;PCSK5;RARB;GLI2;TGFB2
prerank,Golgi to endosome transport (GO:0006895),0.784387315720271,1.7142302114092047,0.004076086956521739,0.2658464311641914,0.993,6/16,7.32%,VPS13A;VPS13C;DOP1B;AP2A1;GBF1;MON2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6787107546400396,1.7137362526957276,0.0023584905660377358,0.2590744611120352,0.993,11/35,11.55%,ESR1;PMEPA1;NEDD4;DDX5;DDX17;ZMIZ1;RBFOX2;PLPP1;SAFB;UBR5;RNF14
prerank,endodermal cell differentiation (GO:0035987),0.6807622223528572,1.7123304094291918,0.003658536585365854,0.2567195402646463,0.993,4/31,0.88%,COL12A1;COL6A1;COL8A1;COL11A1
prerank,regulation of acrosome reaction (GO:0060046),-0.700333851208485,-1.7119639648384526,0.030821917808219176,0.3808779403082455,1.0,1/10,0.15%,PLCB1
prerank,regulation of intracellular pH (GO:0051453),0.6769335703747956,1.7077268577433031,0.0035587188612099642,0.2675716623034498,0.994,13/34,15.01%,SLC4A10;SLC4A4;SLC26A6;SLC4A8;TM9SF4;SLC9A8;SLC9A4;SLC9A1;SLC4A2;TMEM165;CHP1;SLC4A3;SLC4A5
prerank,ion homeostasis (GO:0050801),0.6974114296509608,1.7064770446898532,0.0024271844660194173,0.26410693600869595,0.994,12/30,15.01%,SLC4A10;SLC4A4;FHL1;HCN4;SLC4A8;CAMK2D;SLC4A11;SLC4A2;AP3D1;SLC4A3;WNK1;SLC4A5
prerank,organic cation transport (GO:0015695),0.7346197103808242,1.6971247022518396,0.00788436268068331,0.29318471892056847,0.997,1/19,0.01%,SLC47A1
prerank,carbohydrate transport (GO:0008643),0.8213326125804828,1.6959007653438591,0.007132667617689016,0.29032336048533425,0.997,3/11,2.99%,SLC23A1;SLC23A2;SLC26A6
prerank,response to zinc ion (GO:0010043),-0.5118838328103313,-1.6919121824146388,0.0,0.4251194877744116,1.0,14/25,18.03%,PAM;GLRA2;CRIP1;MT1H;MT1M;MT1X;MT1B;MT1A;MT1E;MT1F;MT1G;GLRA1;ATP13A2;MT3
prerank,regulation of mononuclear cell migration (GO:0071675),0.7154061412017378,1.690477037656732,0.0062266500622665,0.30696890764202867,1.0,3/23,0.51%,THBS1;SLIT2;CMKLR1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.8018562423299238,1.6882158944909025,0.0110803324099723,0.3083538915435192,1.0,2/13,0.95%,CACNA1G;KCNB1
prerank,regulation of muscle cell differentiation (GO:0051147),0.6789365043959696,1.6868034385774742,0.004895960832313341,0.30696890764202867,1.0,11/31,13.64%,BOC;CDON;ID2;HDAC9;FGFR2;ABL1;MAPK12;SRF;MEF2A;PTBP1;RBM4
prerank,response to prostaglandin E (GO:0034695),-0.6835732021748566,-1.6864483896594447,0.016233766233766232,0.42567593357648187,1.0,3/10,12.39%,TGFBR3;GNG2;SFRP1
prerank,regulation of fibroblast migration (GO:0010762),0.7315933535903024,1.6860568023106624,0.007853403141361256,0.3018533970255447,1.0,4/20,2.21%,THBS1;DDR2;FGF2;PRKCE
prerank,heart trabecula morphogenesis (GO:0061384),-0.5651042113412676,-1.685705117478129,0.021367521367521368,0.41193482453904595,1.0,9/18,7.38%,TGFBR3;ENG;TEK;ADGRG6;BMP7;RBP4;NOTCH1;S1PR1;RBPJ
prerank,transition metal ion transport (GO:0000041),-0.4914212300133425,-1.6854640632435152,0.0,0.3972452022255751,1.0,6/35,6.30%,CP;SLC30A10;TRPC3;TFRC;SLC39A8;TRPC6
prerank,negative regulation of insulin secretion (GO:0046676),0.7631252002481609,1.6840077035416234,0.006622516556291391,0.3035360300687223,1.0,3/17,1.72%,IRS1;KCNB1;CCN3
prerank,lipoprotein catabolic process (GO:0042159),-0.66785224663026,-1.6835923418842174,0.022950819672131147,0.3878347018886341,1.0,4/11,15.58%,APOE;NOTUM;ABHD17C;LYPLA1
prerank,embryonic skeletal system development (GO:0048706),0.6612201091217271,1.6832457326488703,0.007067137809187279,0.29940905353043507,1.0,12/35,8.27%,SIX1;XYLT1;WNT9A;PCSK5;HOXA3;COL1A1;DEAF1;HOXB3;KIAA1217;SULF1;HOXA9;NOG
prerank,digestive tract development (GO:0048565),0.6716768197406905,1.6800573647145618,0.0024390243902439024,0.3067793767891201,1.0,12/32,9.71%,PKD1;PKDCC;PCSK5;RARB;GLI2;COBL;CLMP;TGFB2;AGR2;EPHB3;CCDC39;FGFR2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.5475762070051629,-1.678933571927208,0.015706806282722512,0.38657228134974797,1.0,5/22,8.99%,SORBS1;APOE;PPARA;PPARD;ZBTB20
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.7504181327502546,1.6738590988928146,0.01637107776261937,0.3280613775312683,1.0,7/15,12.84%,SIX1;VEGFA;SIX4;SOX9;NOG;BMP4;SMO
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6565338210804084,-1.6690226914490973,0.006711409395973154,0.4014918120504139,1.0,2/12,0.54%,IGF1R;INSR
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.7209178472580349,1.6689948641952175,0.010269576379974325,0.3430616125629567,1.0,4/20,1.34%,THBS1;PDCD4;GSN;SFRP4
prerank,skeletal system development (GO:0001501),0.5775708978748666,1.6664473746497988,0.0,0.3473121291073901,1.0,34/148,9.71%,MYOC;GNAS;EXT1;PKD1;XYLT1;CMKLR1;CDH11;PKDCC;GDF10;BMP1;ALPL;PCSK5;COL1A2;COL1A1;NPR3;PAPSS2;GLI2;COMP;DEAF1;TLL1;HES5;TGFB2;P3H1;KIAA1217;SLC10A7;SULF1;MMP14;FGFR1;SOX9;NOG;HAPLN4;SH3PXD2B;EVC;FGFR2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.7286632888914195,1.663333249429762,0.014341590612777053,0.3542764265633954,1.0,8/18,15.53%,NUP93;ENY2;NXF1;ZC3H11A;PABPN1;SARNP;DDX19A;THOC2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5965738670618166,-1.6620686594680734,0.026923076923076925,0.4097180099292999,1.0,6/15,8.00%,GRM7;GRM5;GRM3;GRM8;GRM1;HOMER1
prerank,regulation of BMP signaling pathway (GO:0030510),0.6043816315690111,1.6605317134173705,0.001076426264800861,0.3606903189418422,1.0,18/73,11.75%,BMPER;HTRA3;FSTL1;ZNF423;FOXD1;SKIL;SFRP4;CRIM1;SMAD9;SMAD6;HES5;SMAD4;SULF1;SKI;NOG;BMP4;BMPR1A;SMAD7
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7239735238276008,1.6576073652481742,0.013458950201884253,0.3676868932230323,1.0,4/17,6.57%,SLIT2;FSTL1;SFRP4;SULF1
prerank,negative regulation of coagulation (GO:0050819),-0.6092412678005451,-1.6556604187326152,0.019011406844106463,0.4160580997131737,1.0,6/14,13.04%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,response to estradiol (GO:0032355),0.6597849381578866,1.6521293095296692,0.0024183796856106408,0.38871424139739436,1.0,8/31,9.84%,ESR1;EGFR;CYP19A1;STAT3;NRIP1;SOCS2;ANXA1;FOXA1
prerank,transepithelial transport (GO:0070633),0.7521769954352718,1.6514614112774735,0.00860832137733142,0.38444248673119663,1.0,5/15,3.97%,SLC23A1;SLC23A2;SLC12A2;SLC26A6;ABCC1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6778893634567291,-1.6493523066466713,0.01238390092879257,0.42325151917279913,1.0,3/10,7.82%,TGFA;ADRA2A;HBEGF
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5906909748022369,1.6482887260599766,0.0010626992561105207,0.3932737325668396,1.0,43/80,24.01%,ARFGAP1;ARFGAP3;KDELR3;PLPP3;SCYL1;ARCN1;COPA;COPB1;COPG1;TMEM115;COPE;ARFGAP2;GBF1;KLC2;KDELR1;ARF4;COPZ2;ERGIC1;NSF;SCFD1;KDELR2;ATP9A;TMED9;RER1;ZW10;PICK1;LMAN2;ERGIC2;SEC22B;RINT1;COPB2;KLC1;NAPA;GOLPH3;BNIP1;TMED2;RAB1A;UVRAG;RAB1B;COPZ1;USE1;ARF5;TMED7
prerank,regulation of interleukin-1 production (GO:0032652),0.7540629312664824,1.6467981327260992,0.008185538881309686,0.3930778768721202,1.0,5/15,13.07%,FOXP1;GAS6;HMGB1;ANXA1;F2R
prerank,cell-cell junction organization (GO:0045216),-0.40598273382556915,-1.6458863649898976,0.0,0.42032228233022684,1.0,25/79,9.52%,TJP1;SDK1;TLN2;CADM1;CDH8;CDH13;OCLN;CDH5;CLDN5;CADM2;LIMS2;PKP4;SMAD3;CDH4;ARVCF;GJC1;CXADR;CDH1;CDH6;CDH2;CLDN1;NECTIN2;CDH7;CDH19;CDH20
prerank,regulation of cilium movement (GO:0003352),0.802049327400945,1.6422140061758381,0.014749262536873156,0.4097862662978232,1.0,5/10,11.53%,CFAP298;CFAP206;ODAD2;CCDC39;CFAP43
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.7534842377938177,1.6421110832342218,0.00945945945945946,0.4027688566684352,1.0,3/15,1.13%,THBS1;SMOC2;FGF2
prerank,positive regulation of wound healing (GO:0090303),0.648844520506783,1.6418699759096427,0.004667444574095682,0.39649509826920293,1.0,5/36,2.22%,THBS1;SMOC2;ST3GAL4;PRKCE;PLPP3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5754169276781708,1.6414265864670583,0.001040582726326743,0.3915648192699343,1.0,32/104,17.10%,BMPER;HTRA3;HTRA4;PMEPA1;SKIL;CRIM1;CCN3;SMAD9;EMILIN1;SMAD6;LDLRAD4;SPRED2;ACVR1;BCL9L;SMAD4;TGFBR2;SKI;NOG;BMPR1A;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;LRP2;NBL1;STUB1;CD109;IL17RD;RPS27A;UBC;SLC2A10
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5948236490578392,-1.6411873183394727,0.023890784982935155,0.4225195804554326,1.0,5/15,11.89%,ATP1A2;ADRA2A;PACSIN3;NOS1;SLC30A1
prerank,nucleotide biosynthetic process (GO:0009165),0.7178836398328527,1.640830672762708,0.015915119363395226,0.3876280016031872,1.0,2/18,0.29%,PRPS2;ME1
prerank,cell differentiation in spinal cord (GO:0021515),-0.6719291695065572,-1.63990939263638,0.034482758620689655,0.41495201478551086,1.0,3/10,3.71%,SOX13;MDGA2;SOX6
prerank,peptide cross-linking (GO:0018149),0.6885801087148193,1.638823189961327,0.0075282308657465494,0.3908608183540121,1.0,4/25,2.73%,THBS1;COL3A1;TGM5;TGM6
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.48302092487218506,-1.6370153949974682,0.011627906976744186,0.41303648724966235,1.0,13/30,17.42%,BCL2L1;NOS3;FAS;DDX3X;RFFL;ARHGEF2;FAIM;SERPINE1;FAIM2;GPX1;TNFAIP3;ICAM1;BRCA1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.7274185427688018,1.6365562867672732,0.011936339522546418,0.39511400534227653,1.0,8/18,16.21%,ESR1;EGFR;DDX5;NCOR2;BMP4;TERT;IL6;ZC3H10
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.640887698067704,-1.6337811936250484,0.030612244897959183,0.41194722536663736,1.0,5/12,20.77%,GCNT2;BMP7;CD44;THY1;AGER
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6971470710213372,-1.6328400794351081,0.028662420382165606,0.4037929922904509,1.0,2/10,2.11%,LYN;KIT
prerank,apoptotic cell clearance (GO:0043277),0.6606095586481201,1.6323490774396938,0.014475271411338963,0.4104195854308441,1.0,8/30,9.72%,THBS1;RHOBTB1;GAS6;LRP1;HMGB1;RARA;ANXA1;ITGAV
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7132503669838175,1.6310231372267316,0.0,0.41018360398365716,1.0,10/19,12.12%,SLIT3;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;MDM4;BMPR1A;HEY1
prerank,negative regulation of protein catabolic process (GO:0042177),0.6278118436456485,1.6300133876751925,0.00580046403712297,0.4085429242921253,1.0,15/40,16.82%,EGFR;TIMP2;PTPN3;TIMP3;RILP;SNRNP70;RIC1;IRAK3;MDM4;CST3;CDK5RAP3;RGP1;NELL1;SIRT2;AZIN1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7161794040897427,1.629644860343915,0.010498687664041995,0.40376389364620513,1.0,4/19,1.99%,SLC26A2;PAPSS2;SULT1C2;SULT1C4
prerank,response to hexose (GO:0009746),0.6867500297564455,1.627741998907852,0.0036719706242350062,0.4070945035301296,1.0,2/25,1.27%,THBS1;TCF7L2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.6480671086894604,1.6256681989814703,0.012004801920768308,0.4104297909383084,1.0,5/33,1.13%,BMPER;THBS1;RHOJ;VEGFA;FGF2
prerank,axon extension (GO:0048675),0.6929734013573571,1.6256004540465834,0.011450381679389313,0.40440714987425846,1.0,5/23,1.38%,SLIT3;SLIT2;SLIT1;MAP1B;ULK2
prerank,organic anion transport (GO:0015711),0.5901161907691921,1.6243956795304446,0.0,0.4044454032180443,1.0,11/76,7.29%,SLC4A10;SLC26A7;SLC4A4;SLC23A1;SLCO3A1;SLCO2A1;SLC26A6;SLC4A8;LRRC8D;SLC4A11;SLC4A2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6861900527538778,1.6225500380013727,0.010012515644555695,0.4074822752935252,1.0,2/21,0.51%,THBS1;CMKLR1
prerank,myoblast differentiation (GO:0045445),0.7597721984851149,1.6220617515304423,0.015214384508990318,0.40369659645930284,1.0,7/14,11.43%,TCF7L2;DDX5;DDX17;SDC1;MBNL1;JAG1;MAPK12
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.5972126310502857,-1.6194458424833633,0.027888446215139442,0.4298671446177643,1.0,12/14,40.32%,CSF1;TYROBP;POU4F1;CCR1;ATP6AP1;TRAF6;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,response to alcohol (GO:0097305),0.6463663279238888,1.6194261438151059,0.008526187576126675,0.41041010888819873,1.0,7/27,12.61%,SLIT3;SLIT2;GRIN3A;TGFBR2;CHRNB2;SOD1;TGFBR1
prerank,regulation of sensory perception of pain (GO:0051930),0.7772525856483761,1.618742391289476,0.01702127659574468,0.4079791754909989,1.0,7/11,16.95%,MGLL;TMEM100;CCN3;SCN11A;VIP;F2R;ACP3
prerank,positive regulation of chemotaxis (GO:0050921),0.6153094704715887,1.6176619553376885,0.009324009324009324,0.40770258168321116,1.0,6/43,1.89%,THBS1;SMOC2;VEGFA;F3;FGF2;NTRK3
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7280925317867192,1.6175912183569692,0.015089163237311385,0.40241748896852253,1.0,4/15,1.89%,PGF;VEGFA;F3;NTRK3
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6605090527325214,-1.617252287438093,0.022435897435897436,0.42583232111897473,1.0,5/10,10.96%,LRCH1;RIPOR2;APOD;CD200;PADI2
prerank,negative regulation of hemostasis (GO:1900047),-0.6328931752413616,-1.6165414011680361,0.027303754266211604,0.41751667324415764,1.0,6/12,13.04%,VTN;APOE;TFPI;EDN1;SERPINE1;CD34
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.7269129677000141,1.6158458116093224,0.014627659574468085,0.40510106796317824,1.0,6/17,15.34%,CACNA1G;KCNB1;SLC4A8;RAB3D;NLGN1;STX1A
prerank,amino acid transmembrane transport (GO:0003333),0.6214360210718026,1.615160250212724,0.002257336343115124,0.40297670883712494,1.0,8/45,7.04%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SFXN3;LRRC8D;SLC7A10;SLC38A3
prerank,membrane repolarization during action potential (GO:0086011),0.7480124806648517,1.6142285877445037,0.012195121951219513,0.4020342167944969,1.0,4/13,6.99%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,detection of mechanical stimulus (GO:0050982),0.7073765753150127,1.6116679917101342,0.016304347826086956,0.40963217088739673,1.0,5/19,10.81%,PIEZO2;PKD1;LHFPL5;JUP;CSRP3
prerank,neutral amino acid transport (GO:0015804),0.6636052664518779,1.6114884544684331,0.00853658536585366,0.40512037568000264,1.0,8/28,9.01%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6726549420001147,-1.6084372068898976,0.0438871473354232,0.428868106549827,1.0,4/10,8.24%,SLC1A3;SLC25A13;SLC1A1;SLC1A2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.7438679840657879,1.608029880625931,0.0228494623655914,0.41627812804173103,1.0,2/14,1.29%,THBS1;PDCD4
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5498900761025509,1.607975148784356,0.0,0.4112985347612076,1.0,91/173,24.31%,GAS6;ARFGAP1;ARFGAP3;SEC31A;KDELR3;SEC24D;STX5;ATL2;SEC13;ARCN1;SEC23A;LMAN2L;RAB2A;COPA;COPB1;DYNC1H1;GOPC;COPG1;NRBP2;GOLGB1;TMEM115;ATL3;CNIH2;COPE;ARFGAP2;PROZ;ANK2;GBF1;KDELR1;ARF4;COPZ2;ERGIC1;BET1;DCTN2;NSF;SCFD1;KDELR2;HYOU1;SPAST;TRAPPC12;TRAPPC6A;BCAP31;TMED9;USO1;NRBP1;ZW10;DYNC1LI2;SEC24C;TRIP11;SEC24B;PREB;LMAN2;ERGIC2;SEC16A;SEC22B;BCAP29;MIA3;COPB2;CNIH1;COG6;DCTN5;SEC16B;SPTBN1;YIF1A;SEC24A;IER3IP1;NAPA;TMED2;COG2;TRAPPC3;ACTR10;CTSZ;TRAPPC11;COG8;DYNC1I2;TRAPPC6B;DCTN1;MIA2;CAPZA1;COG5;RAB1A;LMAN1;KLHL12;ACTR1A;VAMP4;RAB1B;COPZ1;USE1;PGAP1;TMED7;BET1L
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.49827026784258216,-1.6077198044751726,0.020833333333333332,0.42155758491295187,1.0,6/29,6.42%,TGFBR3;ENG;NOTCH1;TPM1;PROX1;S1PR1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.7446944843855204,1.6071126978645414,0.012096774193548387,0.4098692439912874,1.0,2/14,0.51%,THBS1;CMKLR1
prerank,endoderm development (GO:0007492),-0.5919106199330902,-1.6045569735950587,0.02880658436213992,0.4215374742779034,1.0,9/13,33.62%,SOX17;SOX7;LHX1;DUSP4;TBX20;DUSP5;DUSP2;GATA4;LAMC1
prerank,amino sugar biosynthetic process (GO:0046349),0.7675875980571358,1.6043338359724566,0.023088023088023088,0.4177699154958992,1.0,6/12,8.39%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2;NANP
prerank,monosaccharide transmembrane transport (GO:0015749),0.7209188050760008,1.602740645061668,0.020435967302452316,0.42045707089575396,1.0,3/16,2.03%,SLC23A1;SLC23A2;SLC5A2
prerank,dopaminergic neuron differentiation (GO:0071542),0.697887733669848,1.6021029388733343,0.018229166666666668,0.41828274669088805,1.0,4/19,13.60%,LRP6;VEGFA;FOXA1;MANF
prerank,O-glycan processing (GO:0016266),0.6036893494058924,1.600616114791018,0.01220865704772475,0.42078357842283226,1.0,10/54,9.01%,ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;B3GNT7;MUC13;ST3GAL2;B4GALT5
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5940272999793473,1.5993759682326516,0.00995575221238938,0.42165270442872294,1.0,19/56,14.52%,BMPER;GDF10;PMEPA1;EMILIN1;INHBC;SMAD6;TGFB3;LDLRAD4;TGFB2;ACVR1;SMAD4;NOG;BMP4;BMPR1A;SMAD7;TGFBR1;INHBA;DAB2;BMP5
prerank,neuron remodeling (GO:0016322),-0.6575713578462742,-1.5993408156941917,0.03819444444444445,0.4276220511642574,1.0,8/10,16.32%,APP;EPHA8;ANKS1A;ADGRB3;CX3CL1;C1QA;SCARF1;C3
prerank,anterior/posterior pattern specification (GO:0009952),0.6017838647185321,1.5979800367893582,0.004415011037527594,0.4231537713049712,1.0,17/53,13.92%,HOXA5;PCSK5;HOXA3;HOXB6;LRP5;HOXC6;HOXB3;HES5;BHLHE40;SKI;HEYL;HOXA9;HOXA6;HEY1;TGFBR1;HOXB4;HOXA4
prerank,cellular response to estradiol stimulus (GO:0071392),0.7069062762029585,1.597172881065895,0.011612903225806452,0.4225854201158662,1.0,2/18,0.31%,ESR1;EGFR
prerank,spliceosomal complex assembly (GO:0000245),0.6114689831224467,1.5944841148570323,0.01021566401816118,0.4304597046977359,1.0,20/46,17.74%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;CELF3;LUC7L;LUC7L3;SF3B1;SF3A1;RBM5;CRNKL1;ZRSR2;SRPK1;YTHDC1;NCBP1;SMN1;SRSF10
prerank,atrioventricular valve development (GO:0003171),0.7270503057664104,1.59297697571816,0.017543859649122806,0.43310642852399894,1.0,7/14,11.28%,SLIT3;TGFB2;ACVR1;TGFBR2;HEYL;MDM4;BMPR1A
prerank,cGMP-mediated signaling (GO:0019934),-0.5997482416581592,-1.5920570164898904,0.05818181818181818,0.4396388890220707,1.0,6/13,8.11%,IRAG1;APOE;GUCY1B1;HTR2C;PDE2A;KCNC2
prerank,negative regulation of macroautophagy (GO:0016242),0.6673142056453273,1.5911547917372666,0.016352201257861635,0.43723674318776773,1.0,19/26,24.51%,TMEM39A;LZTS1;NRBP2;QSOX1;CLEC16A;SCFD1;SMG1;PHF23;USP36;SEC22B;AKT1;CHMP4A;CHMP4B;LRRK2;RUBCN;TSC2;MTM1;SMCR8;PINK1
prerank,androgen receptor signaling pathway (GO:0030521),0.7842554349840738,1.5901892899190466,0.01282051282051282,0.4372430423946266,1.0,6/11,11.55%,PMEPA1;DDX5;DDX17;ZMIZ1;PLPP1;RNF14
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6284246723710845,-1.5891509709670266,0.05136986301369863,0.43834996517837854,1.0,3/10,9.13%,ATP1A2;ADRA2A;SESTD1
prerank,engulfment of apoptotic cell (GO:0043652),0.7336489051177022,1.5887661234088482,0.024489795918367346,0.4395495604381178,1.0,2/15,0.83%,THBS1;RHOBTB1
prerank,negative regulation of cellular protein localization (GO:1903828),-0.47164745414617204,-1.5887332674158505,0.018518518518518517,0.4305292328170074,1.0,6/34,2.53%,ROCK2;MFHAS1;NEDD4L;ACTN2;RIPOR2;PICALM
prerank,positive regulation of macrophage migration (GO:1905523),0.698552981334164,1.586898872482425,0.01297016861219196,0.44404054407972054,1.0,2/19,0.51%,THBS1;CMKLR1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4758271229014171,-1.586869856210573,0.018867924528301886,0.4272278558134488,1.0,15/32,16.32%,SORBS1;APOE;PPARA;PRKAA2;PRKAG2;ADIPOR1;ZBTB20;MID1IP1;ASXL3;CEACAM1;GPER1;CREBL2;AVIL;STAR;C3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7205276836252081,1.5865839340917232,0.020463847203274217,0.44086422559278776,1.0,3/16,1.13%,THBS1;VEGFA;FGF2
prerank,actomyosin structure organization (GO:0031032),-0.39647454917301755,-1.585729705021822,0.0,0.4219538827212589,1.0,19/75,8.20%,TJP1;SORBS1;FRMD5;ROCK2;PHACTR1;FAM171A1;ACTN2;EPB41L3;EPB41;TPM1;PGM5;MYH10;TMOD3;TMOD1;F11R;MYH9;TNFAIP1;FRMD3;LMOD1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.6424077747473463,1.5845078407310136,0.013268998793727383,0.4461289749705631,1.0,15/29,20.54%,GOLGA5;COPA;COPB1;TRAPPC10;COPG1;COPE;COPZ2;NSF;COPB2;COG6;NAPA;COG2;TRAPPC3;COG8;COG5
prerank,retinoic acid metabolic process (GO:0042573),-0.5848385719390718,-1.5826992045438328,0.02867383512544803,0.42149689601428497,1.0,6/14,20.85%,ALDH1A2;CYP26B1;ADH1A;ALDH1A3;CYP2S1;BCO2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.6774873035155561,1.5814315608352856,0.01403061224489796,0.4570912648706295,1.0,6/23,12.78%,SLC12A7;SLC12A2;SLC9A1;SLC12A4;SLC26A4;SCNN1A
prerank,bone development (GO:0060348),0.6217734120607052,1.5797778297657377,0.008045977011494253,0.4606208931990961,1.0,12/39,11.15%,MYOC;GNAS;LRP6;SFRP4;LRP5;P3H1;SLC10A7;SULF1;SKI;SH3PXD2B;FGFR2;IFITM5
prerank,sprouting angiogenesis (GO:0002040),0.5877562611830652,1.578985736035197,0.012542759407069556,0.4600789662365588,1.0,9/51,4.73%,BMPER;THBS1;SLIT2;PGF;VEGFA;FGF2;RSPO3;SEMA3E;RAMP2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7476385145083805,1.5769134574853265,0.024320457796852647,0.4661350226061093,1.0,6/12,12.84%,SIX1;VEGFA;SIX4;SOX9;NOG;SMO
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.649645003625323,1.576421805892667,0.025,0.4639532316249516,1.0,5/25,6.70%,THBS1;EGFR;GLMN;ILK;FZD7
prerank,mesonephric tubule development (GO:0072164),0.7197422811618347,1.5762787382115402,0.02699055330634278,0.4599704758708899,1.0,3/15,0.46%,SLIT2;SIX1;PKD1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.557771451045791,-1.5732524519323274,0.0392156862745098,0.4388765193964822,1.0,7/15,10.23%,PPARA;LPGAT1;NR1H3;PPARGC1A;PPARD;SLC45A3;MID1IP1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.7223751309741043,1.5720771489815022,0.02826379542395693,0.4760720608204173,1.0,3/15,2.87%,PIEZO2;COL11A1;LHFPL5
prerank,endothelial cell development (GO:0001885),-0.5062410100234097,-1.5718453941201904,0.0213903743315508,0.4345684782461979,1.0,9/25,7.31%,COL22A1;RAPGEF3;PDE4D;PECAM1;COL18A1;PPP1R16B;RAPGEF2;PDE2A;ROBO4
prerank,response to organic cyclic compound (GO:0014070),0.5782940672159451,1.5710617221531962,0.009060022650056626,0.47646006207659225,1.0,10/52,9.84%,ESR1;ALPL;IGFBP5;CYP19A1;CYP1B1;STAT3;CHRNB2;SOCS2;ANXA1;FOXA1
prerank,xenobiotic transport (GO:0042908),0.7045443093025282,1.5707108525313644,0.02459016393442623,0.473599695247913,1.0,2/16,3.97%,SLC47A1;ABCC1
prerank,supramolecular fiber organization (GO:0097435),0.5262807649551012,1.5701520967059803,0.0,0.47201362597364377,1.0,66/333,10.64%,COL12A1;PLOD2;COL6A3;COL6A2;COL6A1;ADAMTS3;ADAMTS2;COL8A2;COL8A1;BMP1;RHOBTB1;COL11A1;MAP7D3;DDR2;FGF13;COL3A1;COL1A2;LTBP2;LTBP3;GSN;COL1A1;COL5A3;COL14A1;P4HB;TGFBI;SERPINH1;EMILIN1;COL5A2;STMND1;COL15A1;RND3;COL27A1;COL16A1;LOXL1;PPP1R9B;CYP1B1;TLL1;ARHGAP17;TGFB2;CORO6;SNCAIP;PLOD1;P3H1;DYNC1H1;PLOD3;CLIP4;TUBGCP3;FAT1;TLE6;MYO1E;CDC42EP2;ADAM10;GGA2;P4HA1;LOX;P3H2;IAPP;ELMO3;CST3;DLG1;RHOA;BACE1;SPAST;RIPK3;CKAP5;COL25A1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.7222786017678217,1.5691933522640513,0.03221288515406162,0.4725030732756169,1.0,12/14,26.67%,SEC31A;SEC24D;SEC13;SEC23A;SEC24C;SEC24B;MIA3;SEC24A;SEC23B;RAB1A;TBC1D20;SAR1A
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5905929223643042,1.568844649054679,0.0033632286995515697,0.4695376805378686,1.0,5/51,0.97%,THBS1;PGF;CMKLR1;VEGFA;GAS6
prerank,acidic amino acid transport (GO:0015800),-0.5554463807416378,-1.568474945310485,0.0321285140562249,0.4360418830635912,1.0,6/17,8.24%,SLC6A13;SLC1A3;SLC6A1;SLC25A13;SLC1A1;SLC1A2
prerank,"phagocytosis, engulfment (GO:0006911)",0.6182853522809373,1.567499588459438,0.009708737864077669,0.47159275478527946,1.0,3/36,1.30%,THBS1;RHOBTB1;GSN
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7280484583398406,1.5666189082655817,0.018030513176144243,0.47185558064921584,1.0,3/14,6.57%,THBS1;FGF2;SULF1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.685715969184205,1.5663274361751496,0.022486772486772486,0.4692361315438547,1.0,5/17,9.70%,TMEM100;FGF2;SFRP4;SOX9;BMP4
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.7145009257150592,1.565724060263403,0.02606310013717421,0.46802274990107856,1.0,9/16,15.34%,SRSF6;DDX5;DDX17;SRSF1;CELF4;SFPQ;HNRNPM;RBM17;SCNM1
prerank,hemidesmosome assembly (GO:0031581),-0.6170015943996222,-1.5642967226364082,0.05263157894736842,0.4401427951435463,1.0,4/11,11.06%,ITGA6;DST;ITGB4;LAMC2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6557434855289307,1.5638660272413618,0.0241423125794155,0.4730124011935243,1.0,9/23,12.84%,SIX1;VEGFA;FGF2;SIX4;LBX2;SOX9;NOG;BMP4;SMO
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7360186583623745,1.5620614143205018,0.01675977653631285,0.4776526629077419,1.0,6/14,15.27%,ME1;AK5;AK3;NMNAT3;AK1;NMNAT2
prerank,protein trimerization (GO:0070206),0.7065358979070714,1.5615578536041645,0.021709633649932156,0.4720764227119936,1.0,4/14,11.93%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,protein homotrimerization (GO:0070207),0.7065358979070714,1.5615578536041645,0.021709633649932156,0.4720764227119936,1.0,4/14,11.93%,SCARA5;SLC1A5;DISP1;CLYBL
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6326872970888532,1.5614519186652076,0.02364066193853428,0.46862839817143065,1.0,9/32,9.70%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;MEOX2;FOXC2;RHOA;ANXA1
prerank,skeletal system morphogenesis (GO:0048705),0.6095224856007637,1.5611234425890177,0.009184845005740528,0.4663181768701531,1.0,15/42,14.51%,LRP6;SIX1;HOXA3;SFRP4;LRP5;HOXB3;FGFR1;SKI;HOXA9;FGFR2;IFITM5;TGFBR1;HOXB4;HOXA4;FUZ
prerank,response to glucose (GO:0009749),0.6063933924283418,1.5591134933714308,0.005656108597285068,0.47238335312718815,1.0,7/46,5.38%,THBS1;SLC39A14;KCNB1;GAS6;TCF7L2;UNC13B;ADCY8
prerank,sulfate transport (GO:0008272),0.7193490731582899,1.5590439799407427,0.02435723951285521,0.4687785041770515,1.0,3/14,2.99%,SLC26A7;SLC26A2;SLC26A6
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.7338608724939245,1.5583362233569555,0.034532374100719423,0.4680456580723496,1.0,5/13,7.90%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5349191176509405,1.5574441992078643,0.0,0.46857270008082974,1.0,45/136,19.92%,ESR1;PKD1;CMKLR1;ID2;GAS6;TCF7L2;SFRP4;PTGIS;GLIS2;CYP1B1;HDAC4;PKHD1;ANXA4;TAX1BP1;BHLHE40;IRAK3;HEYL;DAP;CDK5RAP3;WWP2;ITCH;CHUK;IRAK1;COMMD7;SMAD7;RNF2;CHP1;TRAF3;USP7;MAP3K10;ID1;ARRB1;OTULIN;SUMO1;MDFI;UFL1;RWDD3;MEN1;ACOD1;SUFU;LRRC14;ERBIN;ZNF431;NFKBIA;EIF2AK4
prerank,negative regulation of protein processing (GO:0010955),0.7405725846706921,1.5555842600732412,0.03202328966521106,0.473945011216505,1.0,2/12,3.37%,THBS1;GAS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6776850251833214,1.5552774768294453,0.02857142857142857,0.4677231016226302,1.0,5/17,8.51%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,cellular response to interleukin-7 (GO:0098761),0.6776850251833214,1.5552774768294453,0.02857142857142857,0.4677231016226302,1.0,5/17,8.51%,IRS1;STAT5A;STAT3;BRWD1;SOCS2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6502572586792423,1.5552383933675091,0.007416563658838072,0.4641215731787107,1.0,9/27,15.25%,EGFR;DDX5;STAT3;PUM1;BMP4;AGO2;EIF4G1;LIMD1;IL6
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.7555449689489584,1.5541860466289663,0.029411764705882353,0.465732150154165,1.0,5/11,7.90%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2
prerank,regulation of protein acetylation (GO:1901983),-0.6123040304058798,-1.553122592038093,0.05319148936170213,0.46265696512717963,1.0,5/12,14.06%,RAPGEF3;DDX3X;FAM161A;TERF2IP;SIRT1
prerank,positive regulation of dendrite extension (GO:1903861),-0.5330453105223819,-1.5511071351691645,0.04946996466431095,0.46041885331068577,1.0,5/17,14.66%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5457047188697799,-1.551100972773711,0.04032258064516129,0.4526151439325386,1.0,3/17,3.56%,ATP1A2;BMP7;TFPI
prerank,regulation of cardiac conduction (GO:1903779),-0.41944587209294476,-1.5508602487636636,0.017699115044247787,0.4455310088625895,1.0,16/54,13.08%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;ATP2A3;NPR1;ITPR2;NOS1;ACE2;FXYD1
prerank,mRNA splice site selection (GO:0006376),0.6341790462252964,1.550357458776506,0.01920768307322929,0.4798177138976128,1.0,12/30,9.69%,SRSF6;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;CELF3;LUC7L;LUC7L3;PSIP1;SF3A1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5322575027839519,-1.5502637558329315,0.05042016806722689,0.4398507815493308,1.0,8/17,7.38%,MAML2;MAML3;STAT1;NOTCH1;PLXND1;NOTCH3;NOTCH4;RBPJ
prerank,regulation of dendrite extension (GO:1903859),-0.525056627272326,-1.5489107189325089,0.04316546762589928,0.4365769357409835,1.0,5/18,14.66%,NEDD4L;RIMS2;RIMS1;SYT3;SYT2
prerank,regulation of blood coagulation (GO:0030193),0.6257049806814645,1.5486475212175983,0.01726263871763255,0.4850072487458816,1.0,4/27,3.77%,THBS1;ST3GAL4;EPHB2;FAP
prerank,cellular response to fatty acid (GO:0071398),0.7388118697255246,1.5486379798689995,0.0221606648199446,0.481322348539118,1.0,2/12,0.49%,IRS1;PID1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.7513631998211218,1.5472961204797255,0.02844950213371266,0.4839297777916114,1.0,5/11,11.28%,ZFPM2;TGFB2;JAG1;BMP4;BMPR1A
prerank,lipid phosphorylation (GO:0046834),-0.6270332365649984,-1.544584357791625,0.0547945205479452,0.44113746125981446,1.0,7/10,14.58%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,spinal cord development (GO:0021510),0.7307692021836082,1.5443229131044354,0.028735632183908046,0.49426200423045363,1.0,3/12,2.48%,PKD1;VIT;GLI2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.7230578473435225,1.5426325885435286,0.04084507042253521,0.49873797029381933,1.0,6/13,16.91%,TMEM30B;TM9SF4;EDEM2;BCAP31;SEC16A;SEC16B
prerank,purine nucleotide metabolic process (GO:0006163),0.6456056013617246,1.5422807324258843,0.031525851197982346,0.49669424183622374,1.0,3/24,4.54%,PRPS2;FHIT;XDH
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.6915648519419689,1.5409277207418943,0.024226110363391656,0.4993832618877571,1.0,6/17,14.43%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PLA2G5;PLA2G12A
prerank,peptidyl-lysine modification (GO:0018205),0.5457383890084613,1.5385433118130751,0.005263157894736842,0.5073298461437198,1.0,48/99,26.59%,PLOD2;NUP93;LOXL1;P3H3;HDAC9;HDAC4;TOPORS;EEF1AKMT3;PLOD1;TRIM28;RAE1;PLOD3;SEH1L;SIRT5;LOX;TRPM4;NUP37;EEF1AKMT2;SENP5;VIPAS39;RANBP2;PIAS4;GCSH;NUP88;STX1A;SIRT2;HDAC6;LIPT1;SUMO1;USPL1;POM121;NUP210;SAE1;NUP62;SENP1;LOXL2;SUMO2;NDC1;SENP7;NUP35;SENP6;KAT2B;SENP3;P3H4;NUP85;NUP160;TPR;ESCO1
prerank,RNA 3'-end processing (GO:0031123),0.5676223669419389,1.5383051659746996,0.004287245444801715,0.5048178477364975,1.0,31/69,22.02%,SRSF6;SRSF1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;SRRM1;U2AF1;CHTOP;PABPN1;SUPV3L1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;TUT7;NCBP1;SRSF7;CPSF7;NCBP2;CSTF2;CSTF2T;TENT2;SRSF4
prerank,negative regulation of leukocyte migration (GO:0002686),0.7589380116261836,1.537840740341083,0.04380664652567976,0.5034598691000636,1.0,2/10,1.77%,SLIT2;EMILIN1
prerank,bone morphogenesis (GO:0060349),0.7140573953445868,1.5374388781068735,0.03430079155672823,0.5018064539906152,1.0,6/14,11.15%,LRP6;SFRP4;LRP5;SKI;FGFR2;IFITM5
prerank,purine nucleotide biosynthetic process (GO:0006164),0.7351938028936513,1.5374079619072347,0.03488372093023256,0.4983855925370302,1.0,2/12,5.19%,PRPS2;ADA
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6292876009666721,1.5369374498498347,0.026054590570719603,0.49706684089506376,1.0,2/27,0.11%,SLC47A1;SLC38A1
prerank,regulation of interleukin-12 production (GO:0032655),0.5901597151250132,1.5369367349730136,0.011428571428571429,0.4935663701845351,1.0,5/47,7.14%,THBS1;FOXP1;CMKLR1;HMGB1;IRAK3
prerank,mRNA export from nucleus (GO:0006406),0.5484718819525786,1.5362312435867331,0.003092783505154639,0.4936496737825952,1.0,49/102,27.01%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;ENY2;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;PABPN1;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;DDX19A;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.649024116520724,1.5350846030006644,0.027096774193548386,0.49568734444671625,1.0,2/24,0.24%,BOC;CDON
prerank,organic acid transport (GO:0015849),0.5466875000818286,1.5343336541046995,0.003131524008350731,0.49553527725341817,1.0,15/94,7.48%,SLC38A2;SLC38A1;SLC26A7;SLC23A1;SLC23A2;SLC5A6;SLC16A1;SLC26A6;SLC1A5;RXRA;LRRC8D;SLC25A32;SLC7A10;SLC38A3;SLC43A1
prerank,response to progesterone (GO:0032570),0.6810340677798201,1.5343094216989754,0.026525198938992044,0.4922502451602052,1.0,4/18,9.66%,THBS1;TGFB3;TGFB2;CATSPER3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5841875988142138,1.5342790421006336,0.013605442176870748,0.4890708280124776,1.0,16/49,15.82%,PMEPA1;SMAD6;ANKRD27;LDLRAD4;DACT1;PRRT2;HMGB1;TMC8;PEX5;RAF1;IAPP;IMPACT;LCMT1;HSPA5;TFIP11;HDAC6
prerank,regulation of mast cell activation (GO:0033003),-0.6171592920216589,-1.5342303610895145,0.05828220858895705,0.4619234001991927,1.0,5/10,22.28%,LYN;NECTIN2;CD84;MILR1;CD300LF
prerank,regulation of T cell migration (GO:2000404),-0.5251335207238633,-1.5334559656262396,0.05263157894736842,0.45663898128406505,1.0,5/18,3.54%,LRCH1;RIPOR2;APOD;APP;CXCL12
prerank,response to acidic pH (GO:0010447),0.7156665677488003,1.528048103841532,0.02861035422343324,0.5154762170445919,1.0,6/13,15.52%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.6725254914158859,1.5277765704217554,0.03201024327784891,0.5133322309209415,1.0,2/19,0.51%,THBS1;CMKLR1
prerank,RNA export from nucleus (GO:0006405),0.5465979177399416,1.5276547912579364,0.003105590062111801,0.510580007613167,1.0,48/100,27.33%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;HNRNPA1;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E;XPO5
prerank,positive regulation of potassium ion transport (GO:0043268),0.5932025861501748,1.5274305623884572,0.03305785123966942,0.5083452819609736,1.0,8/38,8.78%,KCNJ2;KCNJ15;FHL1;DRD1;KCNN1;KCNE5;ANK2;DLG1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.6163666470781988,1.5271821042330587,0.03262233375156838,0.506198877256835,1.0,15/27,23.44%,MORF4L2;MRGBP;TRRAP;ATAT1;SGF29;MORF4L1;KAT6B;TAF6;KAT2A;CREBBP;BRD8;KAT7;KAT8;TAF6L;KAT2B
prerank,cellular component maintenance (GO:0043954),-0.5990832086586338,-1.5252011782422783,0.056338028169014086,0.4726618025148284,1.0,4/12,9.00%,IGF1R;INSR;ITGA3;CLDN1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.49289066346715144,-1.525134078991914,0.046511627906976744,0.4658204923370495,1.0,8/23,13.95%,EFNB2;AKAP6;PIEZO1;PROX1;NIBAN2;EDN1;MYOCD;IGF1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.5492323930395991,1.5249686358635064,0.00522466039707419,0.513536633174172,1.0,46/96,27.01%,SRSF6;NUP93;SRSF1;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,negative regulation of vascular permeability (GO:0043116),0.7284820895205055,1.524253793145916,0.027548209366391185,0.5137686057621904,1.0,5/12,8.40%,SLIT2;VEGFA;PDE3A;RAMP2;DDAH1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.669804949127399,1.5240944346489869,0.03768506056527591,0.5113334538924633,1.0,6/19,8.42%,UAP1L1;PGM3;GFPT1;GNPDA1;GFPT2;PMM2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5848574954856585,1.5225127701755343,0.019767441860465116,0.5156460215184491,1.0,8/46,6.18%,THBS1;FOXP1;ID2;IGFBP5;ELN;TCF7L2;HES5;PRKDC
prerank,actin filament depolymerization (GO:0030042),0.7409330858876926,1.522118596969072,0.02912621359223301,0.5142820099435818,1.0,2/11,1.30%,MICAL2;GSN
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6400692285883934,1.522010356929694,0.03293807641633729,0.5083512499448463,1.0,12/23,19.01%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2;HIPK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6400692285883934,1.522010356929694,0.03293807641633729,0.5083512499448463,1.0,12/23,19.01%,THBS1;SMAD4;GIPC1;TGFB1I1;DAB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2;HIPK2
prerank,regulation of endothelial cell migration (GO:0010594),0.5418620622844749,1.5212716257844965,0.010649627263045794,0.5088556914504399,1.0,12/85,5.88%,BMPER;THBS1;SLIT2;SMOC2;FOXP1;RHOJ;VEGFA;FGF2;SPARC;PRKCA;BCAS3;FOXC2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6909906503854087,1.5207492674123195,0.030013642564802184,0.5080745333447938,1.0,3/15,1.13%,BMPER;VEGFA;FGF2
prerank,cell junction organization (GO:0034330),-0.38597594653406503,-1.5199369788328114,0.015625,0.47320415267269517,1.0,22/71,10.24%,TJP1;SDK1;OCLN;GRM5;PPFIA2;SLC6A1;PPFIBP1;APP;LIMS2;SMAD3;PPFIBP2;CXADR;PAK3;OPHN1;RAB8B;SLC8A3;CDC42;CLDN1;FLNC;ELFN1;RAB39B;APBB2
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.690210385727239,1.5194049854020422,0.033738191632928474,0.5116639836985796,1.0,3/16,1.17%,SIX1;FGF2;FOXD1
prerank,fatty acid transport (GO:0015908),-0.5351434148474703,-1.5176128539235383,0.05652173913043478,0.47275327563745667,1.0,5/17,9.28%,APOE;ACSL1;PPARD;SLC27A4;MFSD2A
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.592514707581694,1.5174421885887697,0.030624263839811542,0.517724454507173,1.0,9/38,8.87%,KCNJ2;CACNA1G;CACNA1C;HCN4;CAMK2D;KCNE5;ANK2;JUP;TRPM4
prerank,sensory perception of chemical stimulus (GO:0007606),0.6953207221618914,1.5158411924210977,0.04107648725212465,0.5219575678267866,1.0,1/15,0.25%,GNAS
prerank,regulation of RNA splicing (GO:0043484),0.5560146249971476,1.5137842424301697,0.014115092290988056,0.5291003595066778,1.0,31/69,20.91%,SLC38A2;CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;RBM39;FASTK;SNRNP70;FUS;HNRNPL;HNRNPH2;MBNL2;METTL16;KHDRBS1;CLK4;PTBP1;U2AF2;SRPK1;HNRNPK;YTHDC1;SRSF3;SRSF10;RBM22;CLK2;BRDT;LARP7;TRA2B;HNRNPH3;AFF2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7218837791180304,1.5133888359933083,0.040502793296089384,0.5278611225082956,1.0,6/12,8.71%,NFIB;GLI2;EPHB2;EPHB6;CHRNB2;TSKU
prerank,carboxylic acid transport (GO:0046942),0.5728612597416898,1.5122263949074877,0.014722536806342015,0.5305989996668822,1.0,8/55,3.81%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;SLC1A5
prerank,positive regulation of protein acetylation (GO:1901985),-0.5927206309980763,-1.510563598419485,0.05555555555555555,0.4856174714057986,1.0,6/12,12.75%,RAPGEF3;PRKAA2;DDX3X;PRKAA1;FAM161A;TERF2IP
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6889303626743709,1.5104276578188278,0.05874499332443257,0.5361057859693259,1.0,4/14,6.05%,EHHADH;ACOXL;ACOX3;ECI2
prerank,actin filament-based transport (GO:0099515),-0.4995687247800311,-1.5101016873205857,0.04285714285714286,0.4800863962299941,1.0,7/21,14.71%,MYO1B;SYNE2;MYO6;ACTN4;MYO1D;SUN2;MYO5C
prerank,primary neural tube formation (GO:0014020),0.6095833863620962,1.5094014087069167,0.02650602409638554,0.5378910838942547,1.0,10/30,16.73%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,circulatory system development (GO:0072359),0.5227135811750168,1.5089374863225058,0.004145077720207254,0.5369395126807416,1.0,39/118,16.86%,MICAL2;PKD1;CACNA1C;ID2;ZFPM2;PCSK5;PLCE1;COL3A1;NTRK3;ECE1;GLI2;PDLIM7;NXN;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;FOXL1;SH3PXD2B;ALPK3;TAB2;POU6F1;ZDHHC16;WDR11;SRF;HEY1;KAT2A;TGFBR1;MEF2A;TCF25;AKAP13;CRB2;DNAAF4;MTHFD1;KDM6B;NF1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6872417481145763,1.5084159106477757,0.04229195088676671,0.5363773013852524,1.0,3/15,1.13%,SMOC2;VEGFA;FGF2
prerank,nucleotide metabolic process (GO:0009117),0.64103309222967,1.5075154299045137,0.03409090909090909,0.5375629421415058,1.0,7/23,15.27%,ME1;AK5;FHIT;REXO2;NMNAT3;AK1;NMNAT2
prerank,neural tube closure (GO:0001843),0.6034527531413273,1.5075064533898064,0.01701093560145808,0.5344901518508995,1.0,11/34,16.73%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;DVL1;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,potassium ion export across plasma membrane (GO:0097623),0.7065244352633195,1.5074247030183625,0.04306864064602961,0.5318015157914725,1.0,3/13,6.99%,KCNK5;KCNE5;KCNIP2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6983598199724799,1.5070490247187525,0.0620782726045884,0.5306333195051572,1.0,3/14,9.03%,THBS1;MEOX2;RHOA
prerank,negative chemotaxis (GO:0050919),0.6022031318844483,1.506938660012506,0.03743961352657005,0.5281554512857424,1.0,8/33,9.72%,SLIT3;SLIT2;SLIT1;NTN1;SEMA3E;SEMA4B;RHOA;ITGAV
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6082625433005264,1.5066969327171535,0.028708133971291867,0.5262508843278108,1.0,12/31,14.51%,SIX1;HOXA3;TWIST1;HOXB3;TGFBR2;HOXA9;NOG;FGFR2;TGFBR1;HOXB4;HOXA4;FUZ
prerank,thymus development (GO:0048538),0.7089653750940944,1.505877799878612,0.03581267217630854,0.5270006519229437,1.0,5/13,12.61%,SIX1;EPHB3;RIPK3;SOD1;TGFBR1
prerank,response to hydrogen peroxide (GO:0042542),0.5861078751412836,1.505786683461843,0.016260162601626018,0.524495664600714,1.0,18/45,17.54%,PRKCD;ADAM9;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;RIPK3;ABL1;SOD1;STK25;PRDX3;RHOB;CAT;IL6;HDAC6;HMOX1
prerank,mRNA transport (GO:0051028),0.5382747870185538,1.5054129511816845,0.004149377593360996,0.5233618103909429,1.0,47/101,27.01%,SRSF6;NUP93;SRSF1;ARC;SRSF5;SEC13;RAE1;SRSF2;CASC3;SEH1L;HNRNPA2B1;SMG6;SRSF11;SYMPK;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;CHTOP;NUP37;RANBP2;U2AF2;CPSF4;NUP88;YTHDC1;SARNP;THOC2;SRSF3;FYTTD1;NCBP1;SRSF7;POM121;NUP210;NCBP2;GLE1;NUP62;UPF1;SRSF4;NDC1;NUP35;UPF3B;DDX39B;NUP85;NUP160;TPR;EIF4E
prerank,ureteric bud development (GO:0001657),0.6765904772117826,1.5049081114022074,0.0374331550802139,0.5228836856553079,1.0,3/17,1.32%,SLIT2;SIX1;GPC3
prerank,positive regulation of response to wounding (GO:1903036),-0.47772949354571337,-1.5046479651236788,0.03626943005181347,0.48784017540329244,1.0,7/24,9.00%,PTN;MYLK;VTN;OCLN;ADRA2A;HBEGF;CLDN1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7155490001428058,1.503578080799639,0.061170212765957445,0.5257403618478771,1.0,2/13,5.58%,SLC4A10;RAB3GAP1
prerank,positive regulation of cell cycle (GO:0045787),0.5525544796431864,1.5024941323105623,0.02305159165751921,0.527891584829361,1.0,12/62,9.84%,SMOC2;EGFR;LRP6;PKD1;TGFB2;PRKCA;USP2;RARA;PKN2;FGFR2;CDC25B;FOXA1
prerank,tube closure (GO:0060606),0.6053053887747327,1.5024906244342229,0.030193236714975844,0.5250334244441772,1.0,10/31,16.73%,LRP6;PRICKLE1;DEAF1;COBL;TGFB2;SKI;LMO4;LRP2;FUZ;MTHFD1
prerank,peptidyl-threonine modification (GO:0018210),0.5467112076180161,1.5000519139206874,0.020856201975850714,0.5331246769543629,1.0,34/66,24.66%,PRKCD;CIT;GALNT13;ACVR1B;CAMK2D;CSNK2A2;CSNK2A1;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;GALNT1;GALNT3;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;GALNT2;TAF1;TBK1;ROCK1;LMTK2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6554099649130831,1.4998701176698899,0.037760416666666664,0.5310983120541237,1.0,2/20,1.56%,PLOD2;GCLC
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.6001803492487259,-1.4966256859191818,0.06542056074766354,0.5047803303386218,1.0,3/11,2.53%,NEDD4L;ACTN2;PICALM
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.4899087431286026,-1.4955173547950449,0.043478260869565216,0.5011461547929661,1.0,9/22,19.07%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NR1H4;NOD2;MYD88;TGFB1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.572191973199608,1.4948085796744721,0.018411967779056387,0.5523838700496041,1.0,8/47,12.20%,THBS1;PID1;PRKCD;XDH;TGFBR2;AKR1C1;SOD1;DHRS4
prerank,histone modification (GO:0016570),0.5199644635438209,1.4939256304764665,0.006191950464396285,0.553769834628266,1.0,38/109,19.39%,PRMT8;PRKCD;EYA2;PRDM5;HDAC9;HDAC4;BAZ2A;UBE2B;MORF4L2;MIDEAS;MRGBP;TRRAP;SGF29;EHMT1;RPS6KA4;HUWE1;NSD1;RCOR3;ENY2;CARM1;MORF4L1;MIER2;MAP3K12;KAT6B;TAF6;KDM4A;KAT2A;HDAC1;USP36;SIRT2;HDAC6;CREBBP;SIN3B;MTA3;UFL1;CDK2;BRD8;NTMT1
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.5985247236715323,1.4933865162077227,0.038929440389294405,0.5532668833696612,1.0,13/33,20.37%,ESR1;DDX5;CARM1;AXIN1;RNF14;RUNX1;UBA5;HDAC6;DNAAF4;UFL1;SAFB2;CBFB;CALR
prerank,embryonic eye morphogenesis (GO:0048048),0.7216627440728985,1.492533317179911,0.05635838150289017,0.5543927077196137,1.0,2/11,0.73%,LRP6;MFAP5
prerank,chordate embryonic development (GO:0043009),0.5652073089000476,1.4924998050268448,0.018140589569160998,0.5516568358639541,1.0,19/55,9.71%,PKD1;XYLT1;VEGFA;PCSK5;COL1A1;TGFB3;DEAF1;MBNL1;HES5;SIX4;DACT1;KIAA1217;DVL1;ADAM10;SULF1;FGFR1;NOG;FUT8;FGFR2
prerank,response to cholesterol (GO:0070723),0.650430464104387,1.4921226243133514,0.03655352480417755,0.5504731130456678,1.0,7/17,13.94%,LRP6;GRAMD1A;OSBPL7;TGFBR2;TGFBR1;SMO;GRAMD1C
prerank,protein localization to nucleus (GO:0034504),0.5318640598121755,1.487745307777859,0.006276150627615063,0.5694808004689782,1.0,53/102,30.28%,SIX1;COL1A1;NUP93;PRICKLE1;SEC13;TOPORS;IPO5;LMNA;SIX4;STAT3;MORC3;RRS1;IPO4;DVL1;HIKESHI;E2F3;BMP4;WRN;INTS13;CNEP1R1;IPO13;TNPO2;YWHAE;ARL2;NUP88;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;CALR;NUP62;PPP1R10;TBRG1;PAF1;TSC2;IPO8;HNRNPU;NUTF2;NUP85;TPR;XPA;RPAIN;NOP53;TAF3;TOR1AIP1;TOR1AIP2;RPF2;NUP50;ZBTB7A;PIKFYVE;FAM53C
prerank,protein localization to cilium (GO:0061512),0.5882617850414592,1.4870736606430905,0.03345280764635603,0.5696997022259861,1.0,9/32,11.96%,ZNF423;EHD1;MAPK15;CSNK1D;BBS9;TMEM107;IFT20;TCTN1;INVS
prerank,peptidyl-serine modification (GO:0018209),0.5096673455628631,1.4868803161340065,0.003048780487804878,0.5677068664707458,1.0,76/166,24.66%,PKD1;PRKCD;GAS6;ULK2;GALNT13;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A2;CSNK2A1;MORC3;POGLUT3;PRKCA;DYRK4;PRKDC;POGLUT1;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;MAP3K12;ATM;MAPK12;PDPK1;UHMK1;CSNK1E;TGFBR1;MAP3K10;DMPK;WNK1;NDNF;LATS2;CAMK4;GALNT1;TLK2;GALNT3;PARP1;MKNK2;VRK2;MAST2;AKT1;HIPK2;CDK2;IKBKE;NTMT1;CDK5;SGK3;MAPK9;PRKACA;VRK3;LRRK2;CSNK1G3;MAST4;CAMK1;STK38;EIF2AK3;PRKCI;TOP1;HIPK4;GALNT2;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.5726297707498075,1.4867100547920096,0.03161592505854801,0.5656328313887459,1.0,6/43,4.11%,THBS1;FOXP1;ID2;IGFBP5;FGF2;HES5
prerank,cation transport (GO:0006812),0.5124090736479296,1.4865755076459632,0.002036659877800407,0.5634081202301966,1.0,22/166,9.66%,SLC47A1;PIEZO2;SLC4A4;KCNJ2;SLC23A1;KCNJ15;KCNK5;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC5A2;HCN4;SLC9B2;KCNN1;SLC4A11;SCN11A;KCNIP2;TRPM7;TRPM4;KCNK6;CATSPER3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.718285476062059,1.4861271841731822,0.05357142857142857,0.5627034618074683,1.0,1/11,0.08%,THBS1
prerank,myelination in peripheral nervous system (GO:0022011),0.6888103890220757,1.4854826093094022,0.053691275167785234,0.5629259195694392,1.0,7/13,16.86%,MYOC;LGI4;SKI;SOD1;NCMAP;SIRT2;NF1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.6329959973072792,1.4854573096034627,0.054292929292929296,0.5602605455182574,1.0,3/20,1.02%,SLIT2;IGFBP5;LRP1
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.552287755089569,1.4852478268319338,0.02346368715083799,0.5584583157324762,1.0,30/59,24.66%,PRKCD;CIT;ACVR1B;CAMK2D;CSNK2A2;CSNK2A1;PRKCA;DYRK4;ACVR1;PRKDC;TGFBR2;STK39;CDK10;MAPK8;MAP3K12;PDPK1;TGFBR1;MAP3K10;WNK1;CDC42BPB;CAD;AKT1;HIPK2;CDK5;LRRK2;HIPK4;TAF1;TBK1;ROCK1;LMTK2
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.5876773649742199,-1.4839933262021148,0.06291390728476821,0.5266461724500233,1.0,5/11,15.34%,ADIPOR1;SH2B3;CAV1;PTPRT;SOCS3
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6460437868101641,1.483866740471666,0.04697986577181208,0.5622402257707128,1.0,2/20,0.46%,EGFR;PKD1
prerank,peroxisomal membrane transport (GO:0015919),0.6236268638032492,1.4833516385917231,0.040892193308550186,0.561828267940844,1.0,14/27,22.68%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5808835362527239,1.481285024653897,0.030338389731621937,0.5689172696722111,1.0,17/39,20.71%,LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;MON1A;RAB3D;ABCA1;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;MIA2;RCN3
prerank,iron ion transmembrane transport (GO:0034755),0.728194886705678,1.4804881899546907,0.055800293685756244,0.5701270652286838,1.0,2/10,0.72%,SCARA5;SLC39A14
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.7274931834606836,1.479965879888628,0.044797687861271675,0.5698712019433038,1.0,4/11,15.25%,EGFR;DDX5;BMP4;IL6
prerank,cell-cell junction maintenance (GO:0045217),-0.5884381898096984,-1.4792163464414496,0.08012820512820513,0.5339703354633359,1.0,1/11,0.05%,TJP1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6853679821677904,1.4789159849289737,0.04951856946354883,0.5720212817277579,1.0,6/13,15.73%,XPO1;LTV1;RRS1;ABCE1;NUP88;EIF6
prerank,chloride transport (GO:0006821),0.5351454986971748,1.4785828426233059,0.029157667386609073,0.5709790073014894,1.0,9/74,5.17%,SLC4A10;SLC26A7;SLC12A7;SLC12A2;SLC26A6;CLIC3;SLC4A8;CLIC4;GABRA3
prerank,response to fatty acid (GO:0070542),0.6616706355587267,1.4785702807660546,0.05548216644649934,0.5683232254083929,1.0,3/17,7.68%,IRS1;PID1;SOX9
prerank,positive regulation of locomotion (GO:0040017),0.6116146156762835,1.4784510621637061,0.04130162703379224,0.5662565909635859,1.0,3/27,3.00%,THBS1;NTN1;TWIST1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6481883648680428,1.4784414193740503,0.04774193548387097,0.5636153527732369,1.0,14/18,26.51%,EHMT1;ASH1L;EEF1AKMT2;KMT2D;SETD4;KMT2B;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SMYD2;EHMT2;SETD7
prerank,action potential (GO:0001508),0.5649074630162412,1.4767465195510587,0.035046728971962614,0.5691001348659614,1.0,6/44,6.62%,KCNJ2;CACNA1G;KCNB1;DMD;KCNE5;SCN11A
prerank,response to estrogen (GO:0043627),0.5848480997597449,1.476121514109983,0.05250596658711217,0.5694087426450753,1.0,9/31,17.75%,ESR1;BCAS3;RARA;SRA1;SFR1;SERPINB9;KMT2D;CYP27B1;CITED2
prerank,cell junction assembly (GO:0034329),-0.3465432266352789,-1.4760229824051088,0.0,0.5362246690271929,1.0,34/100,12.86%,TJP1;SDK1;TLN2;ADGRL3;CDH8;GPM6A;CDH5;ITGA6;NRXN1;SHANK3;CLDN5;DNM3;SPOCK2;LIMS2;PKP4;PLXND1;ARVCF;GJC1;CDH1;OPHN1;CDH6;CDH2;DNER;CDC42;FLNC;CDH7;CDH19;CDH20;SLITRK1;FN1;CTNND1;SDK2;FBLIM1;PKP2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.44509002361369465,-1.475625110940137,0.05913978494623656,0.5305280724044339,1.0,6/28,6.05%,ARHGAP28;ARHGAP18;ESAM;CXCL12;PLEKHG2;PAK3
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7235734278028125,1.475607959987957,0.05106382978723404,0.5690960554073593,1.0,3/11,7.70%,P4HB;P4HA1;P3H2
prerank,osteoclast differentiation (GO:0030316),0.6251031276831813,1.4754701291619432,0.0451693851944793,0.5671479369340379,1.0,5/22,9.20%,FOXP1;GAB2;ANXA2;GLO1;SBNO2
prerank,serine family amino acid metabolic process (GO:0009069),0.673737560724188,1.4751809376367728,0.051351351351351354,0.5658075081371109,1.0,9/16,20.13%,GCLC;SRR;GLYAT;MTHFD1;SHMT2;SHMT1;DAO;SARS1;SEPHS2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5614591275559906,1.4747487235877776,0.02619589977220957,0.565281882698265,1.0,18/46,18.32%,PRKCD;GAS6;TCF7L2;NEDD4;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;ANP32B;UBR5;XPO4;KHDRBS1;YWHAE;CPSF6;RBM22;NCBP2
prerank,nucleosome assembly (GO:0006334),0.5852301512118502,1.4743603010553097,0.04232164449818621,0.5645967614781254,1.0,16/31,27.86%,CHAF1B;IPO4;NAA60;SOX9;ANP32B;SPTY2D1;CABIN1;KAT6B;BRD2;NAP1L3;NAP1L2;UBN1;H3-3A;DAXX;CHAF1A;HIRA
prerank,potassium ion import across plasma membrane (GO:1990573),0.5725999495373754,1.4742619200437552,0.03318077803203661,0.5624594182149545,1.0,6/41,2.89%,KCNJ2;KCNJ15;SLC12A7;ATP1B1;SLC12A2;HCN4
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.619893033456027,1.4739015193293628,0.056580565805658053,0.5614812749741671,1.0,15/23,27.67%,SEC13;VCP;FAF2;SYVN1;TMED9;TECPR2;PREB;SEC16A;NPLOC4;LMAN1;DERL1;HERPUD1;SELENOS;SEC61B;SURF4
prerank,aortic valve morphogenesis (GO:0003180),0.5978336099104256,1.4736967137164205,0.03671970624235006,0.5598276143843323,1.0,11/30,9.70%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5999677051388955,1.4731526921840374,0.0413625304136253,0.5598741394918901,1.0,6/30,7.38%,KCNJ2;CACNA1G;CACNA1C;KCNE5;ANK2;SNTA1
prerank,eye development (GO:0001654),0.5513581094378044,1.4715373815628445,0.03322259136212625,0.5648641978781654,1.0,19/54,17.09%,SMOC1;CACNA1C;CHRDL1;PBX3;COL5A2;HES5;TGFB2;RAB3GAP1;PBX1;MEIS3;SKI;TSKU;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;NIPBL;MAB21L2
prerank,Golgi organization (GO:0007030),0.5173623799582484,1.4701235123782186,0.008359456635318705,0.56919668831933,1.0,61/112,30.16%,STX5;ATL2;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;BCAS3;GOLGB1;ATL3;GBF1;ATP8B2;HUWE1;TJAP1;ARHGAP21;BET1;PLEKHM2;TRAPPC12;TMED9;ZW10;TRIP11;STK25;PI4K2A;LMAN2;SEC16A;SEC22B;STX16;SEC16B;GOLPH3;TMED2;NPLOC4;COG2;BLZF1;SEC23IP;TRAPPC11;OPTN;LRRK2;RAB1A;LMAN1;ATP8B1;VAMP4;GORASP2;DYNC2H1;TMED7;VPS51;TBC1D20;CUL7;VTI1B;GOLGA2;GCC2;CSNK1A1;SURF4;ARL1;UBXN2A;TMED3;PRMT5;STX17;VTI1A
prerank,import into cell (GO:0098657),0.5735570150469279,1.4691958956527031,0.03263403263403263,0.5709345282981241,1.0,7/41,5.43%,SLC47A1;SLC38A1;SLC5A6;SLC39A14;SLC12A7;LRRC8D;LRSAM1
prerank,aortic valve development (GO:0003176),0.587231103019426,1.4685648242968625,0.03540903540903541,0.5712833097945208,1.0,12/34,9.70%,SLIT3;SLIT2;ELN;EMILIN1;SMAD6;TWIST1;TNFRSF1B;JAG1;HEYL;SOX9;NFATC1;BMP4
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6584094088579513,1.4679184346006917,0.0674931129476584,0.5716772359770967,1.0,2/17,0.46%,EGFR;PKD1
prerank,protein O-linked glycosylation (GO:0006493),0.5242910699910095,1.4673705330859443,0.010438413361169102,0.5717229350824402,1.0,18/96,9.92%,PLOD2;ST3GAL4;GXYLT2;GALNT10;GALNT15;GALNT13;MUC1;PGM3;PLOD1;POGLUT3;PLOD3;B3GNT7;POGLUT1;MUC13;ST3GAL2;B4GALT5;OGT;GALNT18
prerank,muscle cell differentiation (GO:0042692),-0.44207912941150806,-1.4667915868288655,0.04093567251461988,0.5498286786082954,1.0,10/32,10.69%,NEBL;WNT5B;MRTFB;SGCZ;TBX18;TBX1;TMEM204;GATA6;CHRNB1;MYOCD
prerank,negative regulation of secretion by cell (GO:1903531),-0.41603162393296284,-1.4666177493799748,0.024096385542168676,0.5434407958247439,1.0,13/38,17.93%,GRM7;APOE;STXBP6;IL1RAPL1;NOTCH1;RHBDF1;TNFRSF1A;SLC30A1;RSAD2;RHBDF2;SNCA;SERGEF;SYT11
prerank,positive regulation of calcium ion transport (GO:0051928),-0.42014470519497404,-1.4661876622880685,0.0392156862745098,0.537992145841338,1.0,9/36,6.59%,MYLK;CACNA1D;CACNB2;TRPC3;CXCL12;PDGFRB;ATP2B1;TRPC6;ORAI1
prerank,regulation of exit from mitosis (GO:0007096),0.5731782597149552,1.465660221419229,0.03751465416178194,0.5770649602912373,1.0,15/38,18.89%,ANAPC5;PPP1R9B;CDC16;CDC14A;UBE2C;ANAPC4;ZW10;ANAPC2;SIRT2;ANAPC1;RPS27A;UBC;ANAPC10;CDC20;CDC27
prerank,muscle organ development (GO:0007517),0.5463307190805137,1.464790261516508,0.032036613272311214,0.5785707400959298,1.0,14/54,13.48%,COL6A3;FHL1;ITGA11;SGCD;MKX;MRAS;DMD;MEF2B;EVC;CTF1;POU6F1;MAPK12;MEF2D;MEF2A
prerank,nuclear export (GO:0051168),0.5316472587937352,1.4646105053517642,0.009584664536741214,0.576832843307822,1.0,41/80,27.33%,PKD1;SRSF6;XPO1;SRSF1;SRSF5;STRADA;RAE1;SRSF2;CASC3;XPO6;SRSF11;NXF1;ZC3H11A;SRRM1;U2AF1;CHTOP;XPO4;CHP1;WASHC4;U2AF2;SARNP;THOC2;SRSF3;NCBP1;SRSF7;POM121;NCBP2;CALR;NUP62;RITA1;CCHCR1;HNRNPA1;SRSF4;DESI1;UPF3B;DDX39B;NUTF2;TPR;XPO7;EIF4E;XPO5
prerank,COPII-coated vesicle budding (GO:0090114),0.53206377446211,1.4643927349628223,0.026172300981461286,0.5754573335402988,1.0,40/68,26.67%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;MIA3;CNIH1;SEC16B;SEC24A;NAPA;TMED2;SEC23B;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2;SAR1A
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5786000975615411,1.4641271555246589,0.033775633293124246,0.5744395448660562,1.0,6/36,9.43%,THBS1;SLIT2;FGF2;HMGB1;JUP;ANGPT4
prerank,miRNA metabolic process (GO:0010586),0.6365061570654011,1.4640898913042641,0.04150943396226415,0.5721505145124963,1.0,8/20,16.62%,DDX17;TENT4B;PRKRA;DIS3L2;DGCR8;AGO2;SND1;TUT7
prerank,cardiac myofibril assembly (GO:0055003),-0.5335834662006332,-1.4634879475953486,0.09025270758122744,0.5388023985900993,1.0,4/15,6.34%,NEBL;PDGFRB;PROX1;PDGFRA
prerank,regulation of autophagosome maturation (GO:1901096),0.6748183571527149,1.4625264711908694,0.061196105702364396,0.5770325289085557,1.0,8/13,24.22%,TMEM39A;CLEC16A;TBC1D25;PHF23;CLN3;RUBCN;UVRAG;SMCR8
prerank,histone methylation (GO:0016571),0.5971107505797218,1.4621333327122996,0.05555555555555555,0.5762992767223949,1.0,15/26,30.14%,PRMT8;EHMT1;NSD1;CARM1;CREBBP;SUV39H2;NTMT1;SUV39H1;FBL;PRMT1;SMYD2;TRMT112;EHMT2;PRMT5;NSD3
prerank,regulation of cellular metabolic process (GO:0031323),0.555179243142634,1.4615561971997038,0.041189931350114416,0.5767519818996335,1.0,13/45,15.73%,PID1;COQ7;NCOR2;CYP1B1;LAMTOR1;PM20D2;RSPO1;ARF4;FOXM1;ARF1;ACACA;STUB1;EIF6
prerank,positive regulation of embryonic development (GO:0040019),-0.5017023851677173,-1.4607419929254057,0.06074766355140187,0.5393840063928816,1.0,5/19,7.94%,PLCB1;WNT4;OSR1;TENM4;NIBAN2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.6075585772972735,1.4606431366816972,0.05419354838709677,0.5783255254662236,1.0,7/23,14.43%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,ventricular septum morphogenesis (GO:0060412),0.6060774925773277,1.460209874811752,0.04271356783919598,0.5778666840062379,1.0,14/27,12.61%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;HEYL;NOG;BMP4;BMPR1A;SMAD7;HEY1;TGFBR1
prerank,ceramide transport (GO:0035627),-0.5601082718614989,-1.459992383952234,0.06506849315068493,0.5350898546208894,1.0,3/12,9.50%,PLTP;CERT1;GLTP
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6611420384291135,1.4599620136119902,0.07569721115537849,0.5765700307813884,1.0,7/15,6.20%,GPC3;SFRP4;RSPO3;TIAM1;CSNK1D;DACT1;LBX2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5908499480062319,1.4598852869839944,0.045838359469240045,0.5744831540410298,1.0,7/33,9.43%,THBS1;FGF2;MEOX2;HMGB1;JUP;RHOA;ANGPT4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6702993036099834,1.4586103059028426,0.0653950953678474,0.5778656689783723,1.0,3/14,1.02%,SLIT2;IGFBP5;LRP1
prerank,limb morphogenesis (GO:0035108),0.6328061492992504,1.4583037342738807,0.06274007682458387,0.5768716641615322,1.0,5/20,7.28%,LRP6;PCSK5;MBNL1;TGFB2;SKI
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.666176281476434,1.4570758532140546,0.04588394062078273,0.579812940571029,1.0,2/14,0.78%,PGF;VEGFA
prerank,muscle contraction (GO:0006936),-0.3412437384768799,-1.4558697432247016,0.0,0.5410707210849486,1.0,29/126,11.62%,SORBS1;ITGA1;ROCK2;MYLK;SLC8A1;SNTB1;ACTN2;TPM1;UTRN;GJC1;TMOD3;MYOF;SMTN;BDKRB2;MYL6;MYL9;TMOD1;DYSF;LMOD1;KCNJ12;DES;MYH11;TPM3;CHRNB1;VIM;ADRA1A;NOS1;ACTA2;TPM2
prerank,heart development (GO:0007507),0.4933150188269605,1.4537420745985594,0.008146639511201629,0.593090775255922,1.0,46/150,16.94%,MICAL2;PKD1;CACNA1C;ID2;ZFPM2;VEGFA;PCSK5;PLCE1;SGCD;COL3A1;GPC3;NTRK3;ECE1;GLI2;PDLIM7;HDAC9;TGFB2;RAMP2;ACVR1;FOXC2;TGFBR2;SOX9;FOXL1;CRELD1;SH3PXD2B;ALPK3;BMP4;TAB2;POU6F1;CSRP3;FLRT2;ZDHHC16;WDR11;SRF;KAT2A;TGFBR1;MEF2D;MEF2A;TCF25;BMP5;AKAP13;DNAAF4;MTHFD1;KDM6B;NF1;NIPBL
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6544678516598332,1.4532376541505998,0.05789473684210526,0.5930460836166517,1.0,8/17,16.85%,SPRED2;CALM2;DGKQ;SMAD7;PPEF2;EIF4G1;SIRT2;CALM3
prerank,chromatin assembly or disassembly (GO:0006333),0.7014395339741829,1.4527356636051234,0.06770098730606489,0.59300981083258,1.0,7/11,26.19%,CHAF1B;M1AP;CDAN1;SUV39H2;NOC2L;TP53;CHAF1A
prerank,histone deubiquitination (GO:0016578),0.633686302573652,1.4510579045203278,0.060927152317880796,0.5984344972110609,1.0,12/18,27.84%,TRRAP;ENY2;KAT2A;USP7;USP36;BRCC3;USP49;ATXN7;TAF10;USP21;USP16;USP22
prerank,myotube cell development (GO:0014904),0.7237752612520809,1.4507340429223428,0.05063291139240506,0.5973378811247947,1.0,3/10,8.10%,SIX1;SKI;SELENON
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5419424888833324,1.4504895522482737,0.03954802259887006,0.5961903357485525,1.0,14/55,16.42%,THBS1;PID1;COQ7;CYP1B1;XDH;TGFBR2;SIRT5;ARF4;AKR1C1;FOXM1;DHRS4;SIRT2;EIF6;AATF
prerank,ventricular septum development (GO:0003281),0.5711465461935787,1.4503877124848104,0.03769140164899882,0.5942630403012994,1.0,15/37,12.61%,SLIT3;SLIT2;ZFPM2;TGFB2;ACVR1;SMAD4;TGFBR2;MATR3;HEYL;MDM4;NOG;BMPR1A;SMAD7;HEY1;TGFBR1
prerank,potassium ion homeostasis (GO:0055075),0.6109173991325979,1.449699992863869,0.06335403726708075,0.594996575671508,1.0,4/23,1.21%,KCNJ2;SLC12A7;ATP1B1;SLC12A2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6547138760052866,1.4493115776740464,0.0726552179656539,0.5942533881151301,1.0,14/16,32.28%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;RBMXL1;TRA2B;CIRBP;TRA2A;RBM3;SF3B4;PRDX6;SNW1;NCL
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.5367840346111881,-1.4491421089796954,0.0859375,0.554427543347274,1.0,5/14,14.06%,RAPGEF2;PRKAR2B;PRKAR1B;PKIG;SIRT1
prerank,nucleosome organization (GO:0034728),0.5381291922660022,1.4490970121111284,0.0319634703196347,0.5929205972299794,1.0,26/55,26.19%,CHAF1B;NAA60;SOX9;SMARCC2;ANP32B;SPTY2D1;KAT6B;ACTR6;ZNHIT1;BRD2;NFE2;VPS72;HMGA1;NAP1L3;NAP1L2;BRDT;BPTF;PAF1;SETD2;SMARCA4;SRCAP;ANP32E;H3-3A;DAXX;ARID1A;CHAF1A
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5124922876533629,1.4475969121073744,0.015957446808510637,0.5975333625211362,1.0,33/95,17.75%,THBS1;HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;DKK3;LDLRAD4;SPRED2;BCL9L;SMAD4;TGFBR2;SKI;GIPC1;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;DAB2;STUB1;CD109;LATS2;IL17RD;CREBBP;RPS27A;UBC;SLC2A10;FLCN;CDKN1C;MEN1;CITED2
prerank,microtubule polymerization (GO:0046785),0.6079131977894054,1.4471871154878533,0.05368289637952559,0.5972087560953001,1.0,10/28,18.76%,MAP7D3;FGF13;TUBG2;CSNK1D;TUBGCP3;CKAP5;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,protein deacetylation (GO:0006476),0.5600410178847277,1.4471745603793558,0.04312354312354312,0.5949469344437398,1.0,15/41,17.05%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;SIRT5;RCOR3;MORF4L1;MIER2;HDAC1;SIRT2;HDAC6;SIN3B;MTA3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.46288603354795343,-1.4465174017233202,0.06726457399103139,0.5557533987734872,1.0,11/22,24.95%,PPM1E;DUSP16;DUSP10;PPP2CB;PPM1G;DUSP6;PPP5C;DUSP4;PPP1CA;PPM1D;PPM1A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7030223319839842,1.445736211874781,0.06536856745479833,0.5991048221968355,1.0,3/11,6.99%,KCNJ2;ATP1B1;KCNIP2
prerank,early endosome to Golgi transport (GO:0034498),0.7084874197475226,1.445113839855257,0.08016877637130802,0.5997691034152712,1.0,5/11,11.72%,STX5;SNX2;TRAPPC10;SNX1;TMED9
prerank,mRNA 3'-end processing (GO:0031124),0.5289116040763943,1.444907808137435,0.0200845665961945,0.5984037572349488,1.0,33/78,22.02%,SRSF6;CPSF4L;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;TENT4B;SRSF11;SYMPK;ZC3H11A;SRRM1;U2AF1;CHTOP;PABPN1;U2AF2;CLP1;CPSF4;SARNP;THOC2;SRSF3;PCF11;RPRD1A;NCBP1;SRSF7;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T;TENT2;PAF1;SRSF4
prerank,regulation of interleukin-17 production (GO:0032660),-0.43405491791876755,-1.4447015397076797,0.03664921465968586,0.554392196837551,1.0,24/31,42.06%,SLC7A5;RFTN1;SPHK1;PRKCQ;ZBTB7B;NR1H4;NOD2;MYD88;TGFB1;LY9;NCKAP1L;SLAMF6;IL18;IL15;IL12A;CARD9;IL23A;FOXP3;TLR4;IL23R;CCL1;IL12B;IL2;OSM
prerank,smooth muscle cell differentiation (GO:0051145),-0.5608401848114396,-1.4446599086232537,0.09505703422053231,0.5483236780034622,1.0,8/12,14.98%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR
prerank,response to UV (GO:0009411),0.515608526076233,1.4445365542980189,0.015822784810126583,0.5978075415179858,1.0,40/95,26.93%,EGFR;PRKCD;NEDD4;SCARA3;UBE2B;ATF4;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;WRN;SDE2;ERCC3;ERCC2;CAT;N4BP1;CREBBP;PARP1;CDC25A;REV1;MEN1;AKT1;USP1;EIF2AK4;NOC2L;CIRBP;EIF2S1;MAP2K7;USP47;TRIAP1;PRIMPOL;SDF4;TAF1;TP53;UVSSA;POLD1;XPA;YY1;ZRANB3
prerank,antibacterial humoral response (GO:0019731),0.6421672758784902,1.4435753819685069,0.06684856753069578,0.6001668073398061,1.0,5/16,18.50%,RNASE7;RNASE3;RNASE6;DEFB1;DMBT1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.5325354604771669,1.4432405360871041,0.038845726970033294,0.5948819184456328,1.0,37/61,26.49%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,vesicle coating (GO:0006901),0.5325354604771669,1.4432405360871041,0.038845726970033294,0.5948819184456328,1.0,37/61,26.49%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,COPII vesicle coating (GO:0048208),0.5325354604771669,1.4432405360871041,0.038845726970033294,0.5948819184456328,1.0,37/61,26.49%,SEC31A;SEC24D;STX5;SEC13;CSNK1D;SEC23A;TRAPPC10;CNIH2;PPP6R1;BET1;PPP6R3;NSF;SCFD1;TRAPPC6A;USO1;SEC24C;SEC24B;PREB;SEC16A;SEC22B;CNIH1;SEC16B;SEC24A;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TRAPPC6B;RAB1A;LMAN1;KLHL12;RAB1B;ANKRD28;TBC1D20;TFG;GOLGA2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6197400644444734,1.4427479028118084,0.056532663316582916,0.5947814830917268,1.0,4/22,6.31%,SLIT2;PRKCD;GSN;PFN2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.4677117963638723,-1.441839378358484,0.059113300492610835,0.5502403820146711,1.0,14/26,22.14%,LYN;ROCK2;EPHA4;PICALM;GRIN2B;AIM2;PSME3;PSME1;GRIN1;PYCARD;PRELID1;AGER;APH1B;MBP
prerank,positive regulation of organelle organization (GO:0010638),0.5753173213710652,1.4416342353887828,0.049586776859504134,0.5976184635025793,1.0,12/32,12.95%,SORBS3;ANXA2;C2CD5;RAB3GAP1;ATL3;AKT2;ANXA1;SYNJ1;PLA2G5;KATNBL1;TMED9;LIG4
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7068853727747192,1.441406773389634,0.08866279069767442,0.5964504116822049,1.0,8/10,26.97%,ATF4;NFE2L2;HSPA5;QRICH1;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5401379666614108,1.4410084079345702,0.035437430786267994,0.5960715379508645,1.0,9/61,6.48%,SMOC2;EGFR;FGF2;EYA2;GNL3;PARP3;TRIM28;ERCC8;HMGB1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.530351031265389,1.440693814055394,0.03314917127071823,0.5953527357325986,1.0,22/65,17.10%,HTRA3;HTRA4;PMEPA1;SKIL;EMILIN1;SMAD6;LDLRAD4;SPRED2;BCL9L;TGFBR2;SKI;PDPK1;SMAD7;CIDEA;TGFB1I1;TGFBR1;STUB1;CD109;IL17RD;RPS27A;UBC;SLC2A10
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.542251368623181,1.4401797784560717,0.036036036036036036,0.593254215753501,1.0,25/51,27.35%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,mitotic nuclear membrane organization (GO:0101024),0.542251368623181,1.4401797784560717,0.036036036036036036,0.593254215753501,1.0,25/51,27.35%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1
prerank,mitochondrion transport along microtubule (GO:0047497),0.6694649545314568,1.4393447578938365,0.08253094910591471,0.5950685609473721,1.0,4/13,9.94%,SYBU;RHOT2;RHOT1;SPAST
prerank,protein targeting to peroxisome (GO:0006625),0.5984569236466637,1.439080964065868,0.06650544135429262,0.5940842855122752,1.0,15/29,22.68%,ABCD3;PEX7;PXMP2;PEX5;PEX16;PEX13;PEX1;PEX10;ALDH3A2;HACL1;PEX6;PEX2;ABCD1;ACBD5;PEX14
prerank,glucan catabolic process (GO:0009251),0.6581257597501047,1.4387668641008786,0.07267833109017496,0.5933532139512092,1.0,5/15,7.75%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6836467770941265,1.4385993104637353,0.06722689075630252,0.5918595310381762,1.0,6/12,16.21%,ESR1;NCOR2;STAT3;TERT;IL6;ZC3H10
prerank,cellular response to hexose stimulus (GO:0071331),0.6131066508164668,1.438429272759424,0.05493133583021224,0.5904843985769815,1.0,6/23,5.38%,SLC39A14;KCNB1;GAS6;UNC13B;SLC26A6;ADCY8
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.507633301283317,-1.4379385110352603,0.05639097744360902,0.5554696797842594,1.0,6/16,12.06%,APOE;NOS3;GUCY1B1;KCNC2;NOS1;DDAH2
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.5739483382713464,-1.4373276274232663,0.0856269113149847,0.5512964033436014,1.0,4/11,11.60%,TJP1;RAPGEF2;F11R;RAP2B
prerank,positive regulation of lipid catabolic process (GO:0050996),0.6261948977657735,1.4363906622933336,0.08181818181818182,0.5977559369513309,1.0,4/19,8.56%,IRS1;PRKCD;TWIST1;AKT2
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5111009721905994,1.4362975533285527,0.020021074815595362,0.5960806462959062,1.0,21/92,12.40%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;ADAM9;PRKCE;SPARC;TGFB2;PRKCA;BCAS3;FOXC2;DOCK5;GFUS;SOX9;ANGPT4;BMP4;ABL1;IQSEC1;PIK3CB;NRP1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.5859357547668778,1.4356638287455417,0.07421383647798742,0.5967840885280018,1.0,12/29,19.65%,ESR1;CARM1;FOXA1;AXIN1;KMT2D;RUNX1;UBA5;DNAAF4;UFL1;VPS11;CNOT9;CBFB
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.557304243774689,1.4356422060401186,0.05710955710955711,0.594812567181084,1.0,7/39,9.03%,THBS1;MYOC;EFNA5;SEMA3E;JAG1;FZD7;RHOA
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5881595704122696,1.4354576276180189,0.05853658536585366,0.593447816241823,1.0,4/27,1.87%,IRS1;PID1;PRKCD;GRB10
prerank,ureteric bud morphogenesis (GO:0060675),0.6489868743917295,1.4352636327992507,0.07816711590296496,0.5922157712958497,1.0,2/16,1.13%,SIX1;FGF2
prerank,regulation of T cell mediated immunity (GO:0002709),0.7109069339435921,1.4352429862507992,0.08792846497764531,0.5902215994300968,1.0,4/10,10.46%,TNFRSF1B;HMGB1;TRPM4;RIPK3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5857122431730274,1.4339788306724393,0.049516908212560384,0.5937717325345863,1.0,4/31,5.58%,CACNA1G;KCNB1;SYT8;RAB3GAP1
prerank,regulation of response to stress (GO:0080134),0.7122136451171659,1.4339709635095257,0.07254623044096728,0.5917130033470138,1.0,2/10,5.38%,SLC38A2;ADCY8
prerank,integrated stress response signaling (GO:0140467),0.6561171427056305,1.4336774052447865,0.09016393442622951,0.590937552878044,1.0,10/14,26.97%,ATF4;NFE2L2;IMPACT;HSPA5;QRICH1;EIF2AK4;EIF2S1;EIF2AK3;HERPUD1;CCL2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.47087600089814835,-1.4335389598935195,0.07818930041152264,0.5559078550584144,1.0,6/22,6.43%,LYN;ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,calcium ion import into cytosol (GO:1902656),-0.5126700007407573,-1.4335187508852791,0.07782101167315175,0.5500482502956487,1.0,5/15,7.35%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,fatty acid beta-oxidation (GO:0006635),0.5454525717276839,1.433442408210915,0.048554913294797684,0.5899912830169618,1.0,30/51,32.95%,ABCD3;EHHADH;ACOXL;ECHDC2;ACOX3;ECI2;ETFDH;ETFB;ETFA;AUH;ACAT1;BDH2;CRAT;SLC27A2;PEX2;ABCD1;ECHDC1;MCAT;HADHA;GCDH;ACOT8;MTLN;ACAT2;SCP2;ECI1;CPT2;ABCD4;MECR;DECR2;CROT
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3956181584648245,-1.4314916103603732,0.04225352112676056,0.5501263403298217,1.0,12/41,10.40%,ITPR1;SLC8A1;SLC24A2;RYR2;CACNA2D1;ITPR3;GRIN2B;HTR2C;TRPV2;SLC8A3;GRIN2A;ITPR2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.5687884186182051,-1.4313770751893455,0.08904109589041095,0.5446404725539782,1.0,6/11,19.07%,EFNB2;FRS2;SOX6;MYOCD;BMP2;TGFB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6928602533317239,1.4304971607551356,0.06847360912981455,0.6011917014719315,1.0,2/12,6.48%,FOXP1;HMGB1
prerank,positive regulation of axonogenesis (GO:0050772),0.5480368444635697,1.4304795298121464,0.046964490263459335,0.5992009745270851,1.0,5/43,2.41%,SLIT2;PLXNA4;NTN1;TIAM1;TIAM2
prerank,histone deacetylation (GO:0016575),0.5508013768171377,1.429267796645496,0.05045871559633028,0.6024829222410011,1.0,17/43,17.32%,PRDM5;HDAC9;HDAC4;BAZ2A;MORF4L2;MIDEAS;RCOR3;MORF4L1;MIER2;SFPQ;HDAC1;PER1;SIRT2;HDAC6;SIN3B;MTA3;SMARCAD1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5467718192297103,1.4287018989307627,0.04756511891279728,0.6028322484670975,1.0,5/44,4.18%,THBS1;VEGFA;GAS6;CSNK2A1;CARD16
prerank,chromatin assembly (GO:0031497),0.551398494634465,1.4278805626402578,0.05790108564535585,0.6046157111749156,1.0,18/38,26.19%,CHAF1B;M1AP;NAA60;EZH1;SOX9;CDAN1;ANP32B;SPTY2D1;KAT6B;BRD2;NAP1L3;NAP1L2;NOC2L;PAF1;TP53;H3-3A;DAXX;CHAF1A
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.5678113480034322,-1.4252161883222583,0.09931506849315068,0.5556458421544171,1.0,7/11,21.60%,MECOM;WNT5A;ETV6;CD34;YJEFN3;WNT2B;WNT10B
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5769439606315862,1.4249675520322742,0.05481120584652863,0.6160361925841163,1.0,5/32,6.53%,THBS1;MYOC;SEMA3E;BCAS3;JAG1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.6418344483674094,1.4244155596185224,0.09318497913769123,0.6163495150776352,1.0,4/15,11.75%,TGFB3;TGFB2;IRAK3;SMAD7
prerank,extracellular matrix assembly (GO:0085029),0.6006848966639702,1.4244088448557781,0.057766367137355584,0.6142975077050754,1.0,6/23,6.99%,GAS6;LTBP3;EMILIN1;NTN4;RAMP2;QSOX1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5081984708183493,1.4243459372266265,0.03276955602536998,0.6124770875995196,1.0,29/86,17.75%,THBS1;GDF10;ZNF423;FOXD1;NUP93;INHBC;ACVR1B;TGFB3;HES5;TGFB2;ACVR1;SMAD4;SULF1;GIPC1;BMP4;SH2B1;BMPR1A;TGFB1I1;TGFBR1;INHBA;DAB2;BMP5;CRB2;CREBBP;SLC2A10;FLCN;CDKN1C;MEN1;CITED2
prerank,cellular polysaccharide catabolic process (GO:0044247),0.6469914951535762,1.423526973887864,0.06382978723404255,0.6142383298075449,1.0,5/16,7.75%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6627097352538482,1.4234434280904928,0.07113543091655267,0.612590022722195,1.0,6/14,20.89%,GAS6;CARD16;PTPN2;TRAIP;CCDC3;GPS2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5392816340216793,1.4230902878251497,0.055304740406320545,0.6120770961356274,1.0,12/48,9.70%,THBS1;RHOJ;VEGFA;FGF2;HDAC9;STAT5A;PRKCA;FOXC2;HMGB1;FGFR1;ANGPT4;ANXA1
prerank,lymphocyte chemotaxis (GO:0048247),0.5639564897934242,1.4215315808191817,0.05308641975308642,0.6170320166501458,1.0,5/34,7.22%,GAS6;SLC12A2;CCL13;CCL15;CXCL16
prerank,stress fiber assembly (GO:0043149),-0.5111154838978623,-1.4211784546171902,0.08300395256916997,0.5563632969009502,1.0,3/15,0.88%,SORBS1;PHACTR1;FAM171A1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.5111154838978623,-1.4211784546171902,0.08300395256916997,0.5563632969009502,1.0,3/15,0.88%,SORBS1;PHACTR1;FAM171A1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.5757254142068325,1.4198078459318562,0.06650544135429262,0.622922801503854,1.0,4/28,1.87%,IRS1;PID1;PRKCD;GRB10
prerank,visual system development (GO:0150063),0.5554071683791012,1.4193671569404311,0.05741626794258373,0.6229424073403119,1.0,14/37,20.04%,SMOC1;CHRDL1;PBX3;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;ATF6
prerank,eye photoreceptor cell development (GO:0042462),0.6295470106039418,1.4190558087729261,0.0886426592797784,0.6222483379372082,1.0,5/15,19.48%,VEGFA;TOPORS;RPGRIP1L;CRB2;MYO7A
prerank,regulation of vasculature development (GO:1901342),0.5873125260176985,1.4185770399991906,0.08292079207920793,0.622390735970621,1.0,3/26,1.92%,BMPER;FGF2;PROK2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6231654255226995,1.4181970547357856,0.06589147286821706,0.6221127269249515,1.0,6/20,11.14%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.5400531626350873,1.4161996808605601,0.046349942062572425,0.6290124634391323,1.0,19/49,23.44%,THBS1;RAB7B;KMT2C;AGO1;PITHD1;WDR5;HDAC1;KMT2D;RUNX1;SCIN;EIF6;NFE2;KMT2B;SETD1A;CBFB;DPY30;KMT2A;PRMT1;KAT2B
prerank,global genome nucleotide-excision repair (GO:0070911),0.5814121716747076,1.4161872326432037,0.06875753920386007,0.6270348279719772,1.0,18/26,34.39%,CHD1L;ERCC4;CUL4A;USP45;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;RNF111;XPA;DDB1;RBX1;ERCC1;RAD23B;CUL4B;CETN2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5160105739378658,1.415651403045395,0.033622559652928416,0.6275269934270642,1.0,10/69,8.14%,THBS1;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;FZD5
prerank,carboxylic acid metabolic process (GO:0019752),0.5654431387430963,1.4151474689176848,0.08082026537997587,0.6278972211431589,1.0,4/33,1.79%,SLC23A1;SLC23A2;PTGIS;PLA2G4A
prerank,tRNA transport (GO:0051031),0.5669202462057941,1.4149033460648472,0.06900584795321638,0.6269436844629475,1.0,18/35,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;YBX1;NUP85;NUP160;TPR
prerank,regulation of autophagosome assembly (GO:2000785),0.5717633320896272,1.412998556430895,0.06428571428571428,0.6336376339112527,1.0,21/33,27.18%,NPRL3;TMEM39A;LRSAM1;RAB3GAP1;IFT20;SCFD1;PIP4K2B;PHF23;SEC22B;IFT88;RAB3GAP2;CHMP4A;CHMP4B;LRRK2;RAB1B;MTM1;NPRL2;SMCR8;PINK1;RAB5A;PIP4K2C
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.5131617274252624,1.4129946942790677,0.03544575725026853,0.6316164115568326,1.0,10/73,8.14%,THBS1;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;FZD5
prerank,regulation of chromosome segregation (GO:0051983),0.6539693444167156,1.412571095877366,0.08575197889182058,0.6315125766812295,1.0,6/16,8.66%,CSNK2A2;CSNK2A1;HORMAD1;PUM1;RMI2;CDC6
prerank,brain morphogenesis (GO:0048854),-0.5357970729423993,-1.4123317247735452,0.11267605633802817,0.5762021805475571,1.0,2/12,4.18%,SHANK3;CTNNA2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5667225480255751,1.4118293275155096,0.06382978723404255,0.6328624709469771,1.0,7/34,12.40%,MYOC;P4HB;ILK;S100A10;DOCK5;ABL1;NRP1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.6450602140844468,1.4117493645196897,0.08190224570673713,0.6311998175376485,1.0,5/15,11.75%,ACVR1B;DACT1;ACVR1;SKI;SMAD7
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5365266132781908,1.411600556024674,0.03910614525139665,0.6298897961074859,1.0,8/53,6.13%,EGFR;PRKCD;EYA2;DDX5;SPRED2;TRIM28;CCAR2;ERCC8
prerank,regulation of tumor necrosis factor production (GO:0032680),0.49261371626455813,1.4114795390560018,0.025,0.6284910133457177,1.0,15/112,8.14%,THBS1;FOXP1;GAS6;LBP;IL33;EPHB2;TWIST1;SPN;STAT3;MAVS;HMGB1;IRAK3;TRIM27;RARA;FZD5
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5022216596852669,-1.411012785276435,0.11149825783972125,0.5745508875732962,1.0,7/16,12.94%,PDGFD;PLAT;PDGFRB;PDGFRA;PDGFC;PIK3C2A;PTPN1
prerank,embryonic limb morphogenesis (GO:0030326),0.5677399564035485,1.4097768039206249,0.07420494699646643,0.6341785518005123,1.0,9/34,8.27%,LRP6;CACNA1C;AFF3;ECE1;TWIST1;MBNL1;TGFB2;SKI;NOG
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.592321965568009,1.4095586006846448,0.08651399491094147,0.6331295909927951,1.0,17/23,34.49%,GPS1;CUL4A;PARP1;RPS27A;UBC;COPS4;COPS7A;COPS3;XPA;DDB1;RBX1;COPS5;RAD23B;CUL4B;COPS2;CETN2;COPS7B
prerank,embryonic appendage morphogenesis (GO:0035113),0.6832186530775873,1.408909909971918,0.0737134909596662,0.6340493414889526,1.0,4/12,7.28%,LRP6;MBNL1;TGFB2;SKI
prerank,catecholamine metabolic process (GO:0006584),0.6564254892368271,1.4086566323801633,0.10054347826086957,0.6332174292725875,1.0,3/14,4.35%,DRD1;LRTOMT;SNCAIP
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6699098258945514,1.4084185387280208,0.08539944903581267,0.6323444590678822,1.0,5/12,14.45%,FOXP1;NCOR2;HEYL;HDAC1;DAB2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.6112570394987373,1.4079120010540345,0.09350649350649351,0.6327053182814404,1.0,4/20,5.28%,PID1;PKDCC;RHOQ;PPFIA1
prerank,intestinal lipid absorption (GO:0098856),0.6851611890787688,1.4072657774114135,0.0893854748603352,0.6336334241394236,1.0,3/11,8.81%,LIMA1;CEL;AKR1C1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6723234215241085,1.4069609095448248,0.08437067773167359,0.6331090645398028,1.0,6/12,17.87%,SEH1L;CENPC;MAD1L1;MIS12;RMDN1;CDT1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.5083543042659738,1.4068865362226317,0.02863202545068929,0.6314772438463384,1.0,42/80,30.16%,SGSM2;STX5;RAB7B;SNX2;ERC1;TRAPPC10;RIC1;GBF1;VPS52;TBC1D23;TRIM27;SNX1;RGP1;VPS26A;TMED9;SNX32;TMEM87B;VPS53;CLTC;TBC1D10A;TBC1D17;SPAG9;STX16;GGA1;PHETA2;EVI5;HEATR5A;DCTN1;LMAN1;VPS51;BET1L;SNX3;RNF126;VTI1B;GCC2;SURF4;CLN5;SNX5;ARL1;ARFRP1;PIKFYVE;VTI1A
prerank,positive regulation of protein maturation (GO:1903319),-0.5771651176938728,-1.406558032781699,0.09570957095709572,0.5818407112240502,1.0,9/11,39.75%,CCBE1;NKD2;SOX4;BAG2;NLRC4;RHBDD1;TFR2;ADAM8;ANGPTL8
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.659692395575923,1.406530164841363,0.0938337801608579,0.6310324292161721,1.0,10/14,25.06%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,endomembrane system organization (GO:0010256),0.47969090079009863,1.4064692317928487,0.0060790273556231,0.6293926449387819,1.0,69/178,24.23%,NUP93;SEC31A;MAPK15;ATL2;SEC61A1;CSNK1D;LMAN2L;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB43;TLCD2;DOP1B;DNAJC13;BCAS3;SMPD4;GOLGB1;LAMTOR1;ATL3;USP50;GBF1;ATP8B2;HUWE1;TJAP1;ARHGAP21;LAPTM4B;PLEKHM2;TRAPPC12;AP3D1;TMED9;ZW10;TRIP11;WASHC4;PI4K2A;DMPK;REEP3;LMAN2;SEC16A;SQSTM1;MIA3;SEC16B;SPTBN1;TLCD1;VPS11;TMEM170A;GOLPH3;BNIP1;TMED2;NPLOC4;COG2;BLZF1;PHETA2;SEC23IP;TRAPPC11;REEP5;OPTN;ARFGEF2;ATL1;LRRK2;RAB1A;LMAN1;ATP8B1;EIF2AK3;GORASP2;DYNC2H1;TMED7;VPS51
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5707082874986396,1.406340784572043,0.056790123456790124,0.6280311572055625,1.0,8/29,14.43%,PLA2G4F;PLA2G4A;LPCAT1;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,peptidyl-serine phosphorylation (GO:0018105),0.483467247305575,1.4060569757118269,0.014300306435137897,0.6273362437128205,1.0,67/153,24.66%,PKD1;PRKCD;GAS6;ULK2;MARK1;PRKCE;CSNK1D;CAMK2D;CSNK2A2;CSNK2A1;MORC3;PRKCA;DYRK4;PRKDC;TGFBR2;TLK1;STK39;RPS6KA4;AKT2;DGKQ;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;MAP3K12;ATM;MAPK12;PDPK1;UHMK1;CSNK1E;TGFBR1;MAP3K10;DMPK;WNK1;LATS2;CAMK4;TLK2;MKNK2;VRK2;MAST2;AKT1;HIPK2;CDK2;IKBKE;CDK5;SGK3;MAPK9;PRKACA;VRK3;LRRK2;CSNK1G3;MAST4;CAMK1;STK38;EIF2AK3;PRKCI;TOP1;HIPK4;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2
prerank,positive regulation of mRNA processing (GO:0050685),0.6051962808371091,1.4055237418380655,0.09067688378033206,0.6277484489996112,1.0,16/21,32.28%,CELF4;THRAP3;CELF3;DAZAP1;NCBP1;NCBP2;RBMXL1;TRA2B;CIRBP;TRA2A;PAF1;RBM3;SF3B4;PRDX6;SNW1;NCL
prerank,positive regulation of catabolic process (GO:0009896),0.5108277574150457,1.4049300521906518,0.04540540540540541,0.6284181431947874,1.0,15/65,11.35%,WWP1;GPC3;NEDD4;STX5;CSNK2A1;ACTN3;RILP;VCP;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1
prerank,DNA duplex unwinding (GO:0032508),0.523228017019809,1.4048573227160381,0.06222222222222222,0.6268703168424385,1.0,33/50,35.18%,CHD1L;MCMDC2;MCM2;ANXA1;WRN;CUL4A;ERCC3;RAD50;ERCC2;SUPV3L1;PARP1;RPS27A;UBC;MCM4;HMGA1;RAD51;TWNK;RECQL5;GTF2H4;MCM7;XPA;RTEL1;DDB1;RBX1;DDX11;SSBP1;BLM;RAD23B;PURA;CUL4B;CETN2;DHX9;MRE11
prerank,water transport (GO:0006833),-0.5516916703282907,-1.4043023220378814,0.1314878892733564,0.5834874721166607,1.0,9/12,44.86%,AQP11;CFTR;AQP1;AQP4;AQP9;PDPN;AQP6;AQP7;SLC5A1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.6999780008009198,1.4039306817307327,0.1038961038961039,0.6289227751433092,1.0,5/10,16.03%,GALNT13;POGLUT3;POGLUT1;GALNT1;GALNT3
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5483269799763134,1.4036563929215435,0.06141367323290846,0.6282770088744206,1.0,16/40,15.98%,TCF7L2;COL1A1;TIAM1;TGFB3;TWIST1;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;JAG1;TGFB1I1;TGFBR1;DAB2;IL6;CRB2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.5728483773036761,1.4034601161095708,0.0665083135391924,0.6255632621042155,1.0,17/32,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,tRNA export from nucleus (GO:0006409),0.5728483773036761,1.4034601161095708,0.0665083135391924,0.6255632621042155,1.0,17/32,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5801933004450742,1.4029206388914095,0.08585858585858586,0.6259046759282109,1.0,13/24,25.83%,FLVCR1;FXN;RSAD1;SUCLA2;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCG2;ABCB10;COX15
prerank,glycogen metabolic process (GO:0005977),0.5782497794447973,1.4027970942600188,0.059186189889025895,0.6245759312081565,1.0,6/27,7.75%,PYGB;PPP1R3C;STBD1;PHKA1;GAA;PHKB
prerank,blood vessel morphogenesis (GO:0048514),-0.35305310964534503,-1.4026349834241256,0.01680672268907563,0.5829722056906013,1.0,18/54,11.48%,FLT1;TGFBR3;EFNB2;ENG;LAMA1;CCBE1;KDR;RASIP1;TBX1;PROX1;SOX17;SLC1A1;CDH2;RBPJ;FLT4;CAV1;SYK;SOX18
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.5852804425930545,1.4023638120201314,0.08917197452229299,0.6247168962103979,1.0,9/25,12.31%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4;AKAP9
prerank,vitamin transport (GO:0051180),0.578586743650243,1.401920223864624,0.08647990255785627,0.6249006788286104,1.0,3/29,5.93%,SLC23A1;SLC5A6;SLC25A32
prerank,chemical homeostasis (GO:0048878),0.5209635311789778,1.4016554131724428,0.053610503282275714,0.6242043921479868,1.0,15/61,15.91%,SLC4A10;SLC4A4;ACOXL;SLC4A8;TLCD2;ACOX3;TENT4B;SLC4A11;SLC4A2;NR1D2;SLC4A3;WNK1;PNPLA3;SLC4A5;THADA
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5479042780834914,-1.4013507997097214,0.10067114093959731,0.5814554762149845,1.0,2/11,1.06%,LYN;MFHAS1
prerank,protein alkylation (GO:0008213),0.5928577935137068,1.4008132723713593,0.09174311926605505,0.6260142088369337,1.0,10/22,23.22%,PRMT8;FAM98A;GSPT1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;SNRPB;PRMT1
prerank,histone H3-K4 methylation (GO:0051568),0.5847625880018836,1.4007585912297111,0.07721046077210461,0.624459249762042,1.0,12/26,22.61%,KMT2C;OGT;WDR5;KMT2D;SETD4;KMT2B;MEN1;WDR82;SETD1A;DPY30;TET2;KMT2A
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5738099091185834,1.4000451263512192,0.0743073047858942,0.6257833566465845,1.0,8/27,8.87%,CACNA1C;FGF13;HCN4;CAMK2D;ANK2;JUP;DLG1;TRPM4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5338938542953413,1.399907703793886,0.05365296803652968,0.6246194082010402,1.0,8/50,9.53%,THBS1;VEGFA;GAS6;NOL3;CSNK2A1;CARD16;RAF1;PAK2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.5141683152911509,-1.3997814181396888,0.10408921933085502,0.5803526478508656,1.0,5/14,7.35%,SLC8A1;SLC24A2;CACNA2D1;TRPV2;SLC8A3
prerank,positive regulation of protein sumoylation (GO:0033235),0.6950049827848763,1.3982858575797559,0.09985315712187959,0.6298898592466393,1.0,6/10,21.21%,GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,skin development (GO:0043588),0.5116292264970616,1.3975063060188457,0.04590163934426229,0.6315576677843961,1.0,10/65,6.78%,PKD1;COL3A1;ADAM9;COL1A2;COL1A1;COL5A3;COL5A2;CLIC4;JAG1;BCR
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.429071343104853,-1.3966109325894354,0.0673076923076923,0.5845662818560506,1.0,9/26,13.58%,TGFA;ERRFI1;CBLB;APP;ADRA2A;HBEGF;SNX6;SOCS5;GPRC5A
prerank,regulation of cholesterol esterification (GO:0010872),-0.5754509849560658,-1.3962326928846627,0.1069182389937107,0.5802786234604479,1.0,4/10,8.10%,APOE;ABCG1;STARD4;AGTR1
prerank,ncRNA export from nucleus (GO:0097064),0.559547073364808,1.3962205707609165,0.08032596041909197,0.6353026806781749,1.0,18/36,26.42%,NUP93;SEC13;RAE1;SEH1L;SSB;NUP37;RANBP2;NUP88;XPOT;POM121;NUP210;NCBP2;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6769122980244341,1.396102938855289,0.0967741935483871,0.6339150961454385,1.0,6/12,11.90%,KDELR3;GPAA1;KDELR1;KDELR2;RER1;HSPA5
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5808900590365229,1.3960187165222404,0.06369426751592357,0.6324760326142144,1.0,10/25,25.11%,LDB1;TCEA2;CCAR2;HMGN1;CCNT2;SETD5;ZMYND11;KAT7;EAF1;DDX39B
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6010747152095585,1.3954461528291133,0.10841836734693877,0.6331620424466381,1.0,4/21,8.76%,SLIT2;EPHB2;TGFB2;LZTR1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.48706700634456296,1.3952295338210767,0.011293634496919919,0.6322644850441139,1.0,36/150,12.81%,SLIT2;RASSF2;LRP6;PID1;PRKCD;PMEPA1;EMILIN1;UBASH3B;NTRK3;SMAD6;PLPP3;EPHB2;TWIST1;LDLRAD4;SPRED2;WWTR1;XDH;CALM2;DVL1;DMD;PRKDC;TRIM27;NOG;IMPACT;AKT1S1;CDK5RAP3;DGKQ;PAK2;PAQR3;NIBAN1;PDPK1;SMAD7;DEPTOR;CHP1;PPEF2;EIF4G1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6218311745355856,1.3951706588169894,0.09517426273458444,0.6307104949318753,1.0,6/16,15.25%,ST3GAL4;NFAT5;RHOA;IRAK1;FUT4;IL6
prerank,monoacylglycerol metabolic process (GO:0046462),0.6602789325722612,1.3943378614253659,0.08689655172413793,0.6325612180449594,1.0,2/13,1.79%,MGLL;PLA2G4A
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.44487014993995044,-1.3942964675776872,0.07009345794392523,0.5805283230218642,1.0,5/25,7.60%,WNT5A;KIT;B2M;SLC7A5;LACC1
prerank,protein methylation (GO:0006479),0.5342960551404778,1.39251710410497,0.07251461988304093,0.6387886547624798,1.0,21/40,31.19%,PRMT8;EEF1AKMT3;FAM98A;EHMT1;NSD1;GSPT1;CARM1;FAM98B;LCMT1;EEF1AKMT2;ETF1;PCMT1;NTMT1;SNRPB;PRMT1;TRMT112;EHMT2;PRMT5;PRMT3;NSD3;EEF2KMT
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4388483268448144,-1.3923646597841501,0.10582010582010581,0.5810148102118358,1.0,10/26,14.89%,NRXN1;SHANK3;APP;RIMS2;RIMS1;SLC8A3;CUX2;RELN;GRIN1;PRKCZ
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3998291515325818,-1.3920271138790912,0.05925925925925926,0.576727858332305,1.0,12/39,14.71%,MYO1B;PPFIA2;DYNC1I1;MYO6;ACTN4;BICDL1;TRAK2;MYO1D;KIF1A;TRAK1;KIF5B;MYO5C
prerank,ERBB2 signaling pathway (GO:0038128),0.5653050068658101,1.3915274931284578,0.07768187422934648,0.641354141397808,1.0,4/31,4.91%,MYOC;EGFR;SHC1;PRKCA
prerank,gastrulation (GO:0007369),0.6333672995227768,1.391027475947394,0.09703504043126684,0.6418681429302627,1.0,2/15,2.63%,GPC3;LRP5
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5757982273455806,1.3898010281473785,0.09034653465346534,0.645331231932699,1.0,7/25,13.08%,SLIT2;PRKCD;LIMK2;PFN2;CDK10;EVI5L;ARHGAP44
prerank,glycogen catabolic process (GO:0005980),0.6371794994710998,1.3897647746751447,0.09878213802435724,0.6437062345636014,1.0,5/15,7.75%,PYGB;STBD1;PHKA1;GAA;PHKB
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6775031338348352,1.389590111480601,0.10292072322670376,0.6427773953137873,1.0,6/11,19.63%,RDX;RAB21;EZR;DAB2;VPS11;PTPN23
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.6568748899590745,1.3894873413494866,0.10612244897959183,0.6414589482229285,1.0,8/13,21.00%,CPSF4L;CPSF4;NCBP1;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.617535218642089,1.389118342133963,0.09881422924901186,0.6413860743329255,1.0,8/18,19.63%,RDX;DNAJC13;RAB21;EZR;CHMP3;DAB2;VPS11;PTPN23
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5605244529551424,1.3890595698667882,0.07393939393939394,0.6398769299237314,1.0,11/31,8.87%,GDF10;TWIST2;CRIM1;SMAD6;LRP5;TWIST1;NBR1;SKI;SOX9;NOG;TRPM4
prerank,cellular response to organic substance (GO:0071310),0.4896366739405372,1.3890377083803842,0.028361344537815126,0.6382319421511399,1.0,25/116,13.71%,SLIT3;SLIT2;PID1;IGFBP5;GHR;DPYSL3;ACVR1B;SHC1;CYP1B1;NFAT5;STAT3;RAMP2;ACVR1;TGFBR2;SOCS2;RHOA;PTPN18;MAPK8;RAMP1;URI1;BMPR1A;TGFBR1;PTPN2;LRP2;CASP1
prerank,intracellular protein transport (GO:0006886),0.4708460722704381,1.3887547601306478,0.0,0.6377644773021561,1.0,116/304,23.73%,PKD1;SGSM2;XPO1;LTBP2;NUP93;ARFGAP3;CTTN;SEC31A;KIF13A;PRICKLE1;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;IPO5;STRADA;RAB43;STAT3;C2CD5;COPA;BAG3;RAB24;STX11;AP2A1;IPO4;RAB21;RIC1;TLK1;GGA2;XPO6;HIKESHI;E2F3;GIPC1;ARF4;COPZ2;AKT2;SNX1;NSF;SCFD1;STX2;VPS26A;ARFIP2;RAB38;XPO4;ARF1;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;IPO13;CHP1;TECPR2;TBC1D9B;NLGN1;TBC1D25;TNPO2;ERP29;PICK1;VIPAS39;PREB;CLTC;SEC16A;RAB23;HPS4;TBCK;NUP88;TBC1D10A;SIL1;STX4;COPB2;STX1A;SCFD2;TBC1D17;HDAC6;STX16;GGA1;BCS1L;SNX13;NAPA;TMED2;POM121;RAB5B;VPS45;AKT1;IPO9;TNPO1;SNX15;SEC23IP;RAB3GAP2;COX18;EVI5;APPL2;APPL1;CALR;TBC1D22B;VPS26C;NUP62;IFT27;PPP1R10;CCHCR1;LAMP2;RAB1A;LMAN1;RAB18;DESI1;CAMSAP3;TSC2;RAB1B;COPZ1;IPO8;RABGAP1;ARF5
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5547038117842549,-1.388565733394179,0.10431654676258993,0.582016419285442,1.0,5/12,15.08%,CDH5;MAP2;EML2;SNCA;TUBB4A
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.48361585961020626,-1.3881072843542128,0.09333333333333334,0.5781850015472219,1.0,4/18,1.91%,ROCK2;TEK;CDH5;RIPOR2
prerank,positive regulation of cytokinesis (GO:0032467),0.559096192203479,1.387089911136173,0.08433734939759036,0.6433238529862414,1.0,11/32,15.12%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;CDC25B;SPAST;OPN1MW;CSPP1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.501589248615887,1.3870256261421055,0.04904051172707889,0.6418285130105466,1.0,26/76,19.73%,CMKLR1;PTGIS;CYP1B1;PKHD1;ANXA4;TAX1BP1;IRAK3;DAP;CDK5RAP3;ITCH;CHUK;NFKBIB;IRAK1;COMMD7;CHP1;TRAF3;USP7;G3BP2;ARRB1;OTULIN;UFL1;RWDD3;ACOD1;LRRC14;ERBIN;NFKBIA
prerank,regulation of actin nucleation (GO:0051125),0.652700662064147,1.3869942872002818,0.10378681626928471,0.6402336843884749,1.0,5/12,14.92%,GSN;ARFIP2;ARF1;PICK1;SCIN
prerank,chondroitin sulfate catabolic process (GO:0030207),0.651986752917945,1.38626622992576,0.10921985815602837,0.6416674306834197,1.0,5/13,16.48%,BGN;ARSB;CSPG4;HEXA;VCAN
prerank,adherens junction organization (GO:0034332),-0.38683592529614685,-1.3860971647307507,0.027522935779816515,0.5787555798421052,1.0,15/48,9.52%,TJP1;CADM1;CDH8;CDH13;CDH5;CADM2;CDH4;PIP5K1C;CDH1;CDH6;CDH2;NECTIN2;CDH7;CDH19;CDH20
prerank,regulation of phospholipase activity (GO:0010517),0.688822499144139,1.3859938600954858,0.10888252148997135,0.6412451607304374,1.0,5/10,11.57%,LRP1;FGFR1;FGFR2;PLA2G5;PDPK1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6125959850385786,1.3856889024809311,0.10519645120405577,0.6408705051702915,1.0,6/19,12.40%,MYOC;VEGFA;COL16A1;S100A10;ABL1;NRP1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5893311955691968,1.38531956209892,0.08611825192802057,0.6408144557905598,1.0,5/21,12.74%,IGFBP5;FGF2;P2RY6;BMPR1A;MEF2D
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.48727833345293303,-1.384490315016711,0.10980392156862745,0.5783129901118529,1.0,6/17,10.26%,PPARA;PRKAA2;PRKAG2;PPARD;ADIPOR1;CAV1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6163743657210721,1.3834899326717927,0.09973404255319149,0.6470287650167746,1.0,8/16,27.05%,HNRNPA2B1;SMG6;ERCC4;ATM;TNKS2;PARP1;SLX4;RTEL1
prerank,protein localization to Golgi apparatus (GO:0034067),0.5720803553838478,1.3834449653199745,0.07816377171215881,0.6454852509542581,1.0,6/27,10.28%,VPS13A;VPS13C;CSNK1D;IFT20;GBF1;PAQR3
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5706474812474172,-1.3833736358138842,0.125,0.5765137620311588,1.0,3/10,2.42%,ENG;ERRFI1;ENPP1
prerank,respiratory tube development (GO:0030323),0.5543678275463986,1.3831279482699383,0.10519645120405577,0.6450320610005235,1.0,7/28,9.71%,VEGFA;PCSK5;FGF2;GLI2;CCDC39;BMP4;FGFR2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.583131296402581,1.382351981356593,0.09275730622617535,0.6467924621611649,1.0,4/22,4.64%,NTRK3;NTRK1;EHD1;KIDINS220
prerank,smooth muscle contraction (GO:0006939),-0.5261915368815595,-1.3821984829097822,0.12267657992565056,0.574675477919592,1.0,9/14,12.54%,ROCK2;MYLK;SLC8A1;SMTN;BDKRB2;MYH11;ADRA1A;ACTA2;PIK3C2A
prerank,regulation of calcium ion transport (GO:0051924),-0.3705527063131239,-1.381472238500341,0.03305785123966942,0.5717954343650904,1.0,15/54,11.56%,MYLK;BCL2;EPB41;CACNA1D;CACNB2;CACNA2D1;ATP2B1;TRPC6;ORAI1;ADRA2A;PLPP4;HOMER1;PACSIN3;CD84;NOS1
prerank,positive regulation of integrin activation (GO:0033625),-0.5492605639394923,-1.3799366235551644,0.1404109589041096,0.5710315373802191,1.0,3/11,11.13%,RASIP1;PIEZO1;PLEK
prerank,dermatan sulfate metabolic process (GO:0030205),0.6405483023709949,1.378979369458544,0.11392405063291139,0.6600770760949518,1.0,3/13,4.30%,DSE;BGN;CSPG4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5848293781425794,1.377764563826586,0.10526315789473684,0.6638729604579333,1.0,5/22,5.51%,ADAM9;TIMP2;PTPN3;TIMP3;TNFRSF1B
prerank,negative regulation of transmembrane transport (GO:0034763),0.6754382482513943,1.3777324548602783,0.11142857142857143,0.6622741522514225,1.0,1/10,0.08%,THBS1
prerank,ether lipid biosynthetic process (GO:0008611),0.6742077046577691,1.377172620801281,0.125,0.6629082215198557,1.0,4/10,17.93%,PLA2G4A;PEX7;FAR1;AGPS
prerank,cellular senescence (GO:0090398),0.5789206192015094,1.3769323722790279,0.08478802992518704,0.6622451718497344,1.0,3/27,0.89%,ID2;PRKCD;ECRG4
prerank,cardiac muscle cell action potential (GO:0086001),0.5677788280084638,1.3767875383573207,0.07980652962515115,0.6611398819170191,1.0,8/30,6.99%,KCNJ2;CACNA1G;CACNA1C;ATP1B1;HCN4;DMD;ANK2;KCNIP2
prerank,protein import into peroxisome matrix (GO:0016558),0.6648685224323586,1.3767151955573087,0.13233287858117326,0.6597301923545192,1.0,9/12,22.68%,PEX7;PEX5;PEX16;PEX13;PEX1;PEX10;PEX6;PEX2;PEX14
prerank,nuclear membrane reassembly (GO:0031468),0.5158398681149255,1.3760198586216874,0.05511811023622047,0.6612613614962352,1.0,26/54,28.51%,NUP93;SEC13;LMNA;SEH1L;SPAST;RCC1;NUP37;CHMP3;REEP3;SIRT2;SUMO1;POM121;CC2D1B;IST1;CHMP4A;CHMP4B;NDC1;NUP35;CHMP2A;PPP2CA;NUP85;BANF1;NUP160;PPP2R1A;AHCTF1;UBXN2A
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6851699037562852,1.375738165604353,0.10057471264367816,0.6607739744237404,1.0,1/10,0.08%,MYOC
prerank,regulation of plasminogen activation (GO:0010755),0.6568596175174207,1.375431778855421,0.12834978843441466,0.6605122136172531,1.0,1/12,0.08%,THBS1
prerank,muscle cell migration (GO:0014812),0.6786945895474014,1.3752743081790217,0.11063218390804598,0.6594793020506797,1.0,2/10,1.72%,SIX1;CCN3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5803981569633564,1.3750268728075425,0.10037641154328733,0.6588930756643302,1.0,12/24,20.37%,SEC31A;SEC24D;SEC13;SEC23A;FCER1G;PDIA3;BCAP31;SEC24C;SEC24B;IDE;SEC24A;CALR
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4818856398276964,1.3745601138692465,0.025906735751295335,0.6592692569337147,1.0,26/108,11.35%,ESR1;TRABD2B;CTNND2;LRP1;GPC3;SFRP4;RSPO3;TIAM1;GRB10;ATP6V1C2;MDFIC;NXN;CSNK2A1;TCF7L1;DACT1;SULF1;FZD7;SKI;RSPO1;DACT3;TSKU;NFATC1;FOXL1;FGFR2;TERT;AXIN1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4379091748771784,-1.3745373719103369,0.07547169811320754,0.5820218889361832,1.0,5/23,5.35%,TGFBR3;ENG;NREP;SMAD3;ITGA3
prerank,icosanoid biosynthetic process (GO:0046456),0.6790989314230015,1.3743174630066486,0.11259259259259259,0.6586560970120501,1.0,3/10,10.33%,PLA2G4A;PLA2G5;FADS1
prerank,ion transport (GO:0006811),0.48493292098198176,1.374124851756352,0.031512605042016806,0.6578207183342066,1.0,15/111,7.65%,PIEZO2;SLC26A7;SLC26A2;SLC12A7;SLC12A2;SLC24A3;HCN4;SLC26A6;KCNN1;SLC9A8;SLC9A4;CHRNB2;SLC9A1;SLC4A2;SLC12A4
prerank,regulation of B cell differentiation (GO:0045577),0.6144543166699763,1.3738755868683905,0.10266159695817491,0.6571789907494813,1.0,5/17,13.03%,ID2;MMP14;IKZF3;CD27;INHBA
prerank,ncRNA metabolic process (GO:0034660),0.5394883366742448,1.3738747507147153,0.08554913294797688,0.6555202846310154,1.0,12/37,23.20%,DDX17;TENT4B;PRKRA;MAEL;DTD1;DGCR8;AGO2;TDRD12;TUT7;TDRKH;ZCCHC8;NIFK
prerank,camera-type eye morphogenesis (GO:0048593),0.6710186431963893,1.373836375854243,0.11874105865522175,0.654043333471396,1.0,3/10,7.28%,LRP6;VEGFA;SKI
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.519222853530394,-1.3728842971091075,0.11524163568773234,0.5815911275714749,1.0,7/13,15.66%,NOS3;ALDH4A1;GLUL;GLS;PRODH;NOS1;GAD1
prerank,endothelial cell proliferation (GO:0001935),0.6231450326943686,1.3727183301421237,0.1094391244870041,0.6574161690708966,1.0,5/17,9.70%,BMPER;PROK2;DLG1;ANGPT4;BMP4
prerank,extracellular matrix disassembly (GO:0022617),0.5180380349042111,1.3724432035502163,0.06152125279642058,0.6569869150836068,1.0,10/53,10.36%,BMP1;GSN;HTRA1;TIMP2;TLL1;ADAM10;MMP14;CAPN2;SH3PXD2B;SCUBE3
prerank,protein import (GO:0017038),0.5003185242540357,1.3718017648717518,0.04394426580921758,0.6581683311680868,1.0,44/84,31.44%,ABCD3;NUP93;PRICKLE1;PXMP2;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;PEX5;PEX16;PEX13;IPO13;TNPO2;ALDH3A2;NUP88;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;CLU;NUP62;PPP1R10;LAMP2;PEX2;ABCD1;ACBD5;PEX14;TSC2;IPO8;NUTF2;NUP85;TPR;RPAIN;FIS1;NUP50;FAM53C;ATAD1;HSP90AA1;NUP188;RANBP6
prerank,histone lysine demethylation (GO:0070076),0.5722863069740532,1.3716003960363548,0.10960591133004927,0.6573313778846046,1.0,9/25,16.74%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;HR;KDM5C;KDM6B
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5783594958095285,1.3709295928117602,0.10012515644555695,0.6586524445594051,1.0,8/24,16.48%,PLA2G4F;PLA2G4A;LPCAT1;LPCAT4;PGS1;PLA2G5;PLA2G12A;PLA2G15
prerank,cellular component disassembly (GO:0022411),0.5185838957070348,1.3707995938266802,0.0718294051627385,0.657558553242365,1.0,10/53,10.36%,BMP1;GSN;HTRA1;TIMP2;TLL1;ADAM10;MMP14;CAPN2;SH3PXD2B;SCUBE3
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5551995415390809,1.3705239886877438,0.09155766944114149,0.6572058748335375,1.0,12/33,15.82%,PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;ANXA1;RIPK3;ABL1;RHOB;IL6;HDAC6
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.4646106378882335,-1.3700310875941366,0.09174311926605505,0.5848664659872242,1.0,10/20,23.25%,WNT4;ASXL3;CEACAM1;GPER1;BMP2;BRCA1;ERLIN2;TRIB3;SIK1;APOC1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36393930624947535,-1.36963637794589,0.10091743119266056,0.5812154637900485,1.0,23/59,13.94%,ROBO1;SDK1;CADM1;CDH13;PECAM1;BSG;ROBO2;CDH4;TENM3;CNTN6;CDH1;DSCAML1;CNTN4;CDH2;ROBO4;NECTIN2;NEXN;PLXNB2;CD84;CEACAM1;SDK2;PTPRT;IGSF21
prerank,triglyceride metabolic process (GO:0006641),-0.3674730616279141,-1.3695728576418096,0.05303030303030303,0.5766846860817586,1.0,19/48,26.80%,APOE;PLAAT3;LPGAT1;GK;MOGAT3;CAV1;LPIN2;LPL;SIRT1;GK5;DGAT2;FABP5;DGAT1;FABP7;FABP3;APOC1;LIPH;LIPC;LPIN1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5266583071349205,1.369568477240539,0.06750572082379863,0.6599533495802847,1.0,9/47,12.40%,MYOC;EFNA5;P4HB;ILK;S100A10;DOCK5;ABL1;RCC2;NRP1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6368706206080151,1.3694822058319691,0.10990502035278155,0.6587095655208517,1.0,3/15,6.99%,KCNJ2;ATP1B1;KCNIP2
prerank,regulation of focal adhesion assembly (GO:0051893),0.513462909383345,1.3685085876191785,0.0859375,0.6612314816880639,1.0,13/54,12.40%,THBS1;MYOC;VEGFA;EFNA5;LDB1;COL16A1;BCAS3;S100A10;SLC9A1;RHOA;ABL1;RCC2;NRP1
prerank,positive regulation of immune system process (GO:0002684),0.6177088501096324,1.3684549142840072,0.10482758620689656,0.6597975293602456,1.0,5/16,14.88%,VEGFA;TGFB2;ANXA1;PIK3CB;MIA3
prerank,protein import into peroxisome membrane (GO:0045046),0.5943779441953158,1.3683326507360971,0.10997442455242967,0.6587096016514609,1.0,10/22,22.68%,ABCD3;PXMP2;PEX5;PEX16;PEX13;ALDH3A2;PEX2;ABCD1;ACBD5;PEX14
prerank,RNA transport (GO:0050658),0.5021006538240418,1.3682507833637014,0.061636556854410204,0.6574445298890937,1.0,36/71,27.33%,SRSF6;SRSF1;ARC;SRSF5;SIDT2;RAE1;SRSF2;CASC3;TGFBR2;HNRNPA2B1;SRSF11;NXF1;ZC3H11A;SRRM1;U2AF1;CKAP5;CHTOP;U2AF2;SARNP;THOC2;SRSF3;NCBP1;SRSF7;POM121;NCBP2;RTRAF;NUP62;ATXN2;HNRNPA1;SRSF4;YBX1;UPF3B;DDX39B;TPR;EIF4E;XPO5
prerank,nucleotide-sugar metabolic process (GO:0009225),0.6603575370711345,1.3680002725010512,0.11624649859943978,0.6568821550929334,1.0,5/12,9.51%,GFPT1;GMDS;GFUS;GFPT2;FUT8
prerank,tRNA methylation (GO:0030488),0.5449538754550884,1.3677203741275046,0.0850546780072904,0.6565258821355199,1.0,19/34,33.88%,TRMT61B;TARBP1;TRMT1;DALRD3;TYW3;THADA;THUMPD3;TRMT44;ALKBH8;TRMT61A;METTL1;NSUN6;MTO1;TRMT112;TRMT1L;METTL6;PRORP;METTL2B;METTL2A
prerank,response to light stimulus (GO:0009416),0.5075348108676694,1.3676541598691265,0.0707070707070707,0.6552342649998055,1.0,26/55,27.17%,UBE2B;CCAR2;ERCC8;ERCC5;ERCC4;MAPK8;ERCC3;OPN1MW;OPN1MW3;ERCC2;FECH;REV1;MEN1;USP1;CIRBP;MAP2K7;DRD2;CRY2;OPN3;PRIMPOL;UVSSA;POLD1;COPS3;ZRANB3;RRH;GPR52
prerank,in utero embryonic development (GO:0001701),0.5722595965011437,1.3675163974603357,0.09068627450980392,0.6542211524954701,1.0,9/25,12.95%,PKD1;VEGFA;TGFB3;MBNL1;ADAM10;FUT8;FGFR2;TGFBR1;LIG4
prerank,cell-substrate junction assembly (GO:0007044),-0.4080003474776791,-1.366355059948958,0.05714285714285714,0.5809089973320425,1.0,9/33,6.90%,SORBS1;ACTN2;ITGA6;DST;PEAK1;THSD1;ITGB4;WHAMM;PTPRK
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6733297486083292,1.3663202613493894,0.13105413105413105,0.6577026180092094,1.0,4/10,8.07%,RARB;RXRA;RXRB;RARA
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5900946204273442,1.365644818583284,0.11067708333333333,0.6589014982819363,1.0,7/22,17.98%,ESR1;MED13;SRF;PSMC5;PSMC4;MED14;MED12
prerank,regulation of protein polymerization (GO:0032271),-0.3933206973131314,-1.3655977709613776,0.05806451612903226,0.5785999133687691,1.0,7/35,6.69%,ARHGAP28;ARHGAP18;MAP2;ESAM;PLEKHG2;PAK3;CAMSAP1
prerank,membrane lipid catabolic process (GO:0046466),0.6761367644911642,1.36547429732028,0.11782032400589101,0.6580160398666164,1.0,2/10,3.46%,PDXDC1;CYP1B1
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6427627980627618,1.3641369401612766,0.1330532212885154,0.6620789928056607,1.0,3/12,4.30%,DSE;BGN;CSPG4
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.6233503892391572,1.3638948128838937,0.10570236439499305,0.6614901087480105,1.0,7/15,16.94%,SIX1;TWIST1;TGFBR2;FGFR2;TGFBR1;MTHFD1;NIPBL
prerank,carbohydrate biosynthetic process (GO:0016051),0.5900827365400645,1.3638292633790865,0.11877394636015326,0.6601939734057828,1.0,6/21,11.14%,ST3GAL4;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;FUT4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5812306820247262,1.3634792427828297,0.0984251968503937,0.6601454372231645,1.0,4/20,7.86%,ADAM9;HM13;ADAM10;MBTPS1
prerank,regulation of membrane depolarization (GO:0003254),0.5884267423472256,1.3630838038902777,0.12057667103538663,0.6604020241818704,1.0,4/18,3.61%,FHL1;PTPN3;HCN4;CAMK2D
prerank,DNA packaging (GO:0006323),0.6057378869970071,1.3627566817118086,0.13956639566395665,0.6602329717331927,1.0,8/16,26.19%,CHAF1B;M1AP;CDAN1;AIFM1;NOC2L;TP53;BANF1;CHAF1A
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.6286428010121153,1.3620594062670357,0.12586445366528354,0.6616995902170147,1.0,7/13,21.88%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6459535696172741,1.3618216258630746,0.11095100864553314,0.6610424903260346,1.0,7/13,25.75%,PKD1;GOPC;MDFI;SUFU;NFKBIA;YWHAB;GET4
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.33654809694095433,-1.3609036140566149,0.07407407407407407,0.5874858546860515,1.0,44/87,23.31%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6166512683911181,1.360878444800657,0.10887096774193548,0.6636522039569209,1.0,6/15,15.25%,LRP1;DDR2;FAP;CST3;DDR1;IL6
prerank,regulation of myotube differentiation (GO:0010830),0.5712211728410246,1.3605128351551412,0.11196911196911197,0.6636639707294666,1.0,8/24,13.87%,CCN3;HDAC9;HDAC4;MMP14;TMEM119;FBXO22;HDAC1;DMPK
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.48117600132696187,-1.3603084057810806,0.14410480349344978,0.5846031082817964,1.0,5/18,8.74%,OCLN;SLC2A1;PRKCB;PRKAG2;BRAF
prerank,lamellipodium assembly (GO:0030032),-0.4184640838214547,-1.3599231133222163,0.07692307692307693,0.5810131553116349,1.0,11/26,8.77%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;SPEF1;ARHGEF6
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.6744474363742315,1.3598193729466708,0.1386861313868613,0.6650319154587268,1.0,1/10,0.33%,LRP6
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4680739646173866,1.359470878659301,0.017311608961303463,0.6649892568608102,1.0,12/150,2.35%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;FGF17;GAB2
prerank,cellular response to hormone stimulus (GO:0032870),0.4925996362733078,1.3593508430997623,0.07081545064377683,0.6640283014656884,1.0,14/69,10.49%,SLIT3;SLIT2;GHR;RDX;STAT3;RAMP2;BCAS3;RARA;SRA1;SOCS2;AKR1C1;SFR1;RAMP1;URI1
prerank,negative regulation of bone mineralization (GO:0030502),-0.5230722505050989,-1.3592070157961063,0.12547528517110265,0.5785622647186531,1.0,5/13,13.26%,ENPP1;SRGN;BCOR;RFLNA;RFLNB
prerank,positive regulation of endothelial cell migration (GO:0010595),0.48645535093259157,1.358921616990637,0.05005324813631523,0.6643931321754432,1.0,20/84,12.40%,THBS1;SMOC2;FOXP1;VEGFA;FGF2;PLPP3;SPARC;STAT5A;PRKCA;BCAS3;FOXC2;HMGB1;FGFR1;GFUS;ANGPT4;BMP4;ABL1;PDPK1;PIK3CB;NRP1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5262011519437354,1.3586065369381513,0.08538011695906433,0.6641929543376447,1.0,18/42,25.81%,VARS1;VARS2;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;NARS2;EPRS1;PPA1;SARS2;SARS1;DARS1;CARS2;TARS2;QARS1;CARS1
prerank,histone lysine methylation (GO:0034968),0.5380286066793181,1.3582914352491688,0.09712230215827339,0.6640535897338686,1.0,15/33,26.40%,PRDM5;WDR5;KMT2D;SETDB1;KMT2B;MEN1;WDR82;SUV39H2;DPY30;SUV39H1;KMT2A;SETDB2;SMYD2;TRMT112;EHMT2
prerank,negative regulation of mRNA processing (GO:0050686),0.6271302797785918,1.3582860481418582,0.11305518169582772,0.6625544487752836,1.0,10/15,25.06%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6260295941493474,1.3580837476247338,0.1225071225071225,0.6620480824304272,1.0,4/14,11.90%,CARD14;TNFSF15;IRAK1;TNFRSF10B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.6411512163437498,1.3578584599001784,0.11944444444444445,0.6615303195587274,1.0,2/13,1.77%,NEDD4;EMILIN1
prerank,regulation of protein metabolic process (GO:0051246),-0.3786300660353719,-1.3577063648754204,0.06153846153846154,0.578385642855142,1.0,10/44,11.43%,ROCK2;NEDD4L;APOE;APP;FAF1;GSAP;KLF2;ACE;MTPN;SPOP
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4213509485198732,-1.3576385814594165,0.07920792079207921,0.574220509509325,1.0,14/26,26.77%,PPARA;SLC30A10;SLC25A33;SLC5A3;TRAP1;ADGRB1;GRIN1;SNCA;ABCD2;ABCB7;SLC18A2;CD36;TLR6;ALOX5
prerank,protein localization to cell-cell junction (GO:0150105),-0.4881488892390826,-1.3576155153451124,0.109375,0.5699644756917625,1.0,5/15,6.32%,TJP1;CDH5;CGNL1;LSR;F11R
prerank,establishment of protein localization to organelle (GO:0072594),0.49919977048838204,1.357271703095841,0.061356297093649086,0.6624549967299547,1.0,32/72,27.27%,NUP93;TSPAN10;PRICKLE1;SEC13;IPO5;STAT3;LRSAM1;IPO4;HIKESHI;E2F3;IPO13;TNPO2;NUP88;POM121;AKT1;IPO9;TNPO1;NEURL1B;APPL2;APPL1;NUP62;LAMP1;PPP1R10;LAMP2;TSC2;IPO8;PINK1;NUTF2;NUP85;TPR;RPAIN;RALA
prerank,metal ion export (GO:0070839),0.5447305238098326,1.3570584968553818,0.11217183770883055,0.6618430394838328,1.0,6/31,6.99%,SLC4A4;KCNK5;ATP1B1;KCNE5;SLC9A1;KCNIP2
prerank,sulfation (GO:0051923),0.6526283374379754,1.3566195087348845,0.1329639889196676,0.6622448159582585,1.0,2/11,1.99%,SULT1C2;SULT1C4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.5870649868162988,1.3565373884276632,0.10606060606060606,0.6610422764959366,1.0,7/20,16.67%,ZC3H7A;PUM1;PRKRA;AGO1;TERT;AGO2;TSN
prerank,reverse cholesterol transport (GO:0043691),-0.5069030678605764,-1.3564344230013314,0.13937282229965156,0.5689644992195187,1.0,4/13,11.88%,APOE;ABCG1;ABCA5;SCARB1
prerank,embryonic organ morphogenesis (GO:0048562),0.5241499707539311,1.3564077374598458,0.06973995271867613,0.6600803936804619,1.0,13/42,17.63%,SIX1;ID2;MFAP5;HOXA3;HOXB3;ACVR1;HOXA9;FGFR2;HOXB4;HOXA4;FUZ;NIPBL;DYNC2I1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6347299437803804,1.3561809730836036,0.1378299120234604,0.6594883969330815,1.0,4/12,14.58%,P4HB;SOAT1;LPCAT3;ACSL3
prerank,cell projection assembly (GO:0030031),0.5780217285789835,1.3561689402028385,0.10445859872611465,0.6580526221084462,1.0,6/22,14.92%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,relaxation of cardiac muscle (GO:0055119),0.6354835163167767,1.3554891901926513,0.14073071718538566,0.6594399802855552,1.0,4/13,3.61%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6449236993129871,1.3547611899802467,0.13611859838274934,0.6608322944728774,1.0,2/12,2.70%,ESR1;NCOR2
prerank,energy reserve metabolic process (GO:0006112),0.5992672007341735,1.354411419627961,0.1152317880794702,0.6608320074139253,1.0,6/19,7.90%,PID1;PPP1R3C;GFPT1;PHKA1;PHKB;GFPT2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.30191686402255447,-1.354307097811147,0.0,0.5702936072160251,1.0,33/138,9.39%,FLT1;IGF1R;PTPRG;MTSS1;INSR;LYN;PTN;TEK;KIT;EPHA4;EPHA7;TIE1;FRS2;IL31RA;KDR;NEDD9;PTPRD;PDGFRB;MPZL1;ROR2;EPHA8;BDKRB2;ERBB4;EPHA6;PDGFRA;MERTK;CSF1;FGFR4;FLT4;LIFR;BMPR2;ANGPTL1;NPR1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4436743348052847,-1.3542136805738594,0.09375,0.5663930590555827,1.0,10/23,16.81%,DYNC1I1;CCDC88A;TUBA1B;KIF1A;CCDC88C;TUBA1A;KIF1C;KIF5B;HOOK2;MAP6D1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.47828624233910294,1.3540971857034838,0.048268625393494226,0.6607625598792045,1.0,18/95,9.68%,ST3GAL4;EXT1;XYLT1;GPC6;GPC3;DSE;BGN;CHST11;SDC1;CHPF2;CSPG4;B3GNT7;SLC10A7;B4GALT1;ST3GAL2;B4GALT5;ABCC5;HS6ST2
prerank,positive regulation of DNA replication (GO:0045740),0.6025680443476338,1.3535980213028649,0.125,0.6615304116704588,1.0,3/16,9.06%,EGFR;GLI2;BRPF3
prerank,negative regulation of locomotion (GO:0040013),-0.5397775404188663,-1.3534451913891097,0.13978494623655913,0.5642709958314978,1.0,5/12,12.01%,FRMD5;FBLN1;SPOCK3;DUSP3;SPINT2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.49871385571816795,1.3531916250270406,0.07166123778501629,0.6617462325753477,1.0,36/69,29.10%,UBXN8;VCP;DNAJB14;EDEM2;FAF2;SYVN1;HSPA5;RNF103-CHMP3;UBQLN1;FBXO17;STUB1;USP19;RNF121;YOD1;TRIM13;UBE4A;DNAJC18;NPLOC4;UBXN4;UBE2G2;ECPAS;DERL1;SGTB;HERPUD1;AMFR;TMEM67;SELENOS;DNAJB12;JKAMP;SEC61B;TMUB2;SEL1L2;FAM8A1;STT3B;UBE4B;TMUB1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.6337765788884852,1.3516970237688244,0.1298342541436464,0.6667656359434783,1.0,10/13,24.51%,TMEM39A;SCFD1;PHF23;SEC22B;CHMP4A;CHMP4B;LRRK2;MTM1;SMCR8;PINK1
prerank,protein K11-linked ubiquitination (GO:0070979),0.5532653755954604,1.3514599462072554,0.1059850374064838,0.6663165617938672,1.0,16/27,31.31%,ANAPC5;CDC16;UBE2B;UBE2C;ANAPC4;ANAPC2;ANAPC1;ANAPC10;CDC27;RNF4;UBE2W;PRKN;UBE2H;ANAPC11;UBE2S;UBE2A
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5110826593138861,-1.3512030190543118,0.14855072463768115,0.5662636930336477,1.0,5/12,19.82%,DOCK11;DOCK10;LFNG;MFNG;DLL1
prerank,regulation of vacuole organization (GO:0044088),0.5874688531829996,1.3511007351528637,0.10911424903722722,0.666290880573421,1.0,12/20,26.20%,NPRL3;ANXA2;IFT20;LAPTM4B;IFT88;ENO2;RAB1B;MTM1;NPRL2;ENO4;SCARB2;RAB5A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6555485288171169,1.3507330627935428,0.13486370157819225,0.6663885919042936,1.0,1/11,0.33%,LRP6
prerank,negative regulation of cell growth (GO:0030308),0.4661617515198893,1.3507310752012558,0.048205128205128206,0.6649197319596433,1.0,28/121,17.28%,SLIT3;SLIT2;FHL1;FGF13;OSGIN2;ULK2;CCN3;ACVR1B;PPP1R9B;PRDM11;PTPRS;TGFB2;CCAR2;SMAD4;DACT3;NDRG3;SERTAD2;DCBLD2;SESN2;INHBA;CGRRF1;RBBP7;SERTAD3;CYP27B1;MINAR1;APBB1;DIP2B;FLCN
prerank,cytosolic transport (GO:0016482),0.4721797008910631,1.3507171780651472,0.03630705394190872,0.6635143272601722,1.0,36/108,20.99%,VPS13A;ANKRD27;VPS13C;STX5;SNX2;DOP1B;ERC1;AP2A1;RILP;RIC1;GBF1;VPS52;MON2;TBC1D23;TRIM27;EEA1;SNX1;RGP1;VPS26A;SNX32;TMEM87B;VPS53;CLTC;TBC1D10A;TBC1D17;SPAG9;STX16;GGA1;CLN3;PHETA2;EVI5;PTPN23;HEATR5A;DCTN1;CORO7;LAMP1
prerank,protein secretion (GO:0009306),0.503705838885278,1.3506018100362096,0.07386990077177508,0.6624890591158608,1.0,21/56,20.71%,PCSK5;LTBP2;NECAB3;ARFGAP3;COPG1;RAB8A;NAGPA;MON1A;ANXA1;VIP;RAB3D;ABCA1;PREB;TMEM167A;MIA3;RAB3B;TANGO6;GOLPH3;STEAP3;MIA2;RCN3
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5774966809370984,1.3501791579834255,0.11741424802110818,0.6627360870688584,1.0,4/22,5.85%,RASSF2;VEGFA;CALM2;TOM1L1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.49217278421999067,-1.3500179768102538,0.12547528517110265,0.5652895846021297,1.0,4/15,1.29%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,B cell proliferation (GO:0042100),-0.4672977837432303,-1.3484983236626953,0.12313432835820895,0.5654014435506209,1.0,5/17,15.05%,BCL2;CD180;CD40;CTPS1;CR2
prerank,metanephros development (GO:0001656),0.5629675328164004,1.3483280109812383,0.1136079900124844,0.6691634562121905,1.0,4/26,4.18%,SIX1;PKD1;FOXD1;SIX4
prerank,regulation of macroautophagy (GO:0016241),0.4735659565584316,1.348165404554761,0.042355371900826444,0.6683498264374379,1.0,55/105,28.60%,NEDD4;ATP6V1C2;EXOC4;SESN3;LZTS1;NRBP2;LAMTOR1;ATP6V0A1;QSOX1;CLEC16A;MAPK8;SMG1;VPS26A;ATP6V0D1;SESN2;SNX32;TBC1D25;PAFAH1B2;ATP6V1B2;UBQLN1;USP36;ATP6V1E1;HDAC6;TRIM13;PRKAG1;CLN3;RB1CC1;AKT1;ATP6V1C1;CDK5;PRKAB1;RHEB;UCHL1;PRKACA;IL4;RUFY4;CAPNS1;LRRK2;TSC2;RPTOR;ATP6V0E1;SMCR8;TBK1;PINK1;ATP6V0B;LAMTOR2;EXOC7;ATG13;GPSM1;ERN1;CAPN1;LAMTOR3;SNX5;ULK1;LARP1
prerank,vesicle transport along actin filament (GO:0030050),-0.4537951987954093,-1.3478036728026395,0.08444444444444445,0.5632452374031154,1.0,4/19,8.29%,MYO1B;MYO6;ACTN4;MYO1D
prerank,positive regulation of protein export from nucleus (GO:0046827),0.611039000752428,1.3476102783169466,0.11978465679676985,0.6692956894982912,1.0,10/15,26.42%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;YWHAE;RBM22;CAMK1;TP53;TPR
prerank,regulation of cell differentiation (GO:0045595),0.46638487719943134,1.3475649552151319,0.0274949083503055,0.6680353800167717,1.0,30/148,13.69%,SIX1;SMOC1;ID2;ZFHX3;DDX5;TIAM1;DDX17;PHLDB1;HES5;ATF4;TCFL5;MBOAT2;FGFR1;RAF1;PA2G4;CDK5RAP3;EDN3;FGFR2;ANP32B;RUNX2;FADS1;SMAD7;SRF;NR1D2;HEY1;TGFBR1;PDCD2;NLGN1;PTBP1;RUNX1
prerank,protein import into nucleus (GO:0006606),0.5010370994726521,1.3475132314963294,0.08360128617363344,0.6667719045288572,1.0,32/66,27.60%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;RGPD1;KPNA2;IPO13;TNPO2;RANBP2;NUP88;KPNA3;POM121;AKT1;IPO9;TNPO1;KPNA4;APPL2;APPL1;NUP62;PPP1R10;TSC2;NUP35;IPO8;NUTF2;NUP85;TPR;RPAIN;KPNA6
prerank,mitotic chromosome condensation (GO:0007076),0.5636239630461611,1.3459263809352628,0.10807453416149068,0.6718717972430048,1.0,6/26,10.77%,SMC4;CSNK2A2;CSNK2A1;KMT5A;MCPH1;PHF8
prerank,regulation of cell projection organization (GO:0031344),-0.5060977446756411,-1.3455221146437604,0.13953488372093023,0.56531125851117,1.0,5/13,12.67%,NTNG1;MACF1;MFSD2A;SEMA4D;ERMN
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3429473710756641,-1.3454093744252194,0.023255813953488372,0.5617078865783139,1.0,11/61,7.85%,ROBO1;AUTS2;LYN;LPAR1;MAP4K4;ARHGEF3;NOTCH1;NET1;F11R;RASGEF1A;PRAG1
prerank,cellular response to light stimulus (GO:0071482),0.49638577160081154,1.3448830415191313,0.08167770419426049,0.6746952459504377,1.0,28/66,28.72%,PRKCD;NEDD4;ATF4;PDE6A;ERCC4;SDE2;OPN1MW;OPN1MW3;N4BP1;CREBBP;PARP1;CDC25A;SAG;EIF2AK4;NOC2L;EIF2S1;GNB1;USP47;TRIAP1;OPN3;TAF1;TP53;POLD1;YY1;RRH;GPR52;PDE6G;ATR
prerank,cellular response to sterol (GO:0036315),0.6255022788017985,1.3448384055605185,0.13802435723951287,0.6734277308019799,1.0,6/13,13.94%,LRP6;GRAMD1A;OSBPL7;RORA;SMO;GRAMD1C
prerank,sulfur compound biosynthetic process (GO:0044272),0.4750169459646465,1.3442666140856603,0.05439330543933055,0.6744018257009768,1.0,26/104,16.63%,SLC26A2;ST3GAL4;DSE;GCLC;GSTT1;BGN;PAPSS2;CHST11;CHPF2;CSPG4;GSTM5;MPST;B3GNT7;SLC10A7;B4GALT1;LIAS;ST3GAL2;B4GALT5;METTL16;MAT2B;GSTO2;SLC35B3;GSTZ1;B4GAT1;VCAN;AKR1A1
prerank,regulation of osteoblast differentiation (GO:0045667),0.48324294186071926,1.3440056242416876,0.056623931623931624,0.6739923539101941,1.0,26/82,15.25%,SMOC1;GDF10;DDR2;TWIST2;CRIM1;DDX5;SMAD6;LRP5;TWIST1;WWTR1;ATF4;ACVR1;NBR1;SKI;SOX9;NOG;TRPM4;BMP4;FGFR2;TMEM119;RUNX2;BMPR1A;NELL1;LIMD1;HGF;IL6
prerank,regulation of metal ion transport (GO:0010959),-0.47546240181987,-1.3439786043049091,0.13513513513513514,0.5616075317328061,1.0,5/16,6.59%,BCL2;EPB41;SLC30A10;CACNA2D1;ORAI1
prerank,cellular response to alkaloid (GO:0071312),-0.46017367943409776,-1.3435631266401895,0.11403508771929824,0.5589595781075719,1.0,3/17,3.25%,SLC8A1;TGM2;RYR2
prerank,negative regulation of macrophage activation (GO:0043031),-0.4771794566235663,-1.3434331435502067,0.14885496183206107,0.5554667595632807,1.0,7/16,17.93%,IL31RA;NR1H3;LRFN5;CD200;ZC3H12A;CX3CL1;SYT11
prerank,protein O-linked mannosylation (GO:0035269),-0.4738409918946709,-1.343313867813192,0.102880658436214,0.5519728432420288,1.0,3/18,2.16%,TMTC2;TMTC4;CRPPA
prerank,photoreceptor cell development (GO:0042461),0.6150357258311154,1.3431241171691548,0.12981455064194009,0.6762778407564194,1.0,2/14,3.66%,VEGFA;TOPORS
prerank,ERAD pathway (GO:0036503),0.48565197409791433,1.3430609294524538,0.0672358591248666,0.675111327943025,1.0,43/83,29.91%,UBXN8;VCP;DNAJB14;FAF2;SYVN1;UGGT2;UGGT1;HSPA5;RNF103-CHMP3;UBQLN1;USP13;FBXO17;STUB1;USP19;RNF121;YOD1;TRIM13;UBE4A;DNAJC18;NPLOC4;UBXN4;ERLEC1;UBE2G2;RCN3;ECPAS;DERL1;SGTB;HERPUD1;AMFR;TMEM67;SELENOS;DNAJB12;GET4;JKAMP;SEC61B;TMUB2;SEL1L2;CCDC47;FAM8A1;STT3B;UBE4B;TMUB1;PRKN
prerank,cellular response to reactive oxygen species (GO:0034614),0.5022138421009665,1.3429857341501545,0.07341490545050056,0.6740028299485454,1.0,16/59,15.82%,EGFR;PRKCD;CYP1B1;MAP3K5;FXN;NFE2L2;IMPACT;MAPK8;ANXA1;CHUK;RIPK3;ABL1;PRDX3;RHOB;IL6;HDAC6
prerank,intracellular protein transmembrane transport (GO:0065002),0.5279322285756343,1.3424182133925644,0.10957324106113034,0.6747620969251861,1.0,18/42,22.68%,PEX7;SEC61A1;C2CD5;TOMM40;PEX5;AKT2;PEX16;PEX1;AIFM1;HSPA5;HSPD1;PEX10;TOMM70;GRPEL1;PEX6;ZFAND2B;PEX2;PEX14
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5486854598104117,1.341696547840914,0.11191335740072202,0.6763737448828111,1.0,8/28,10.64%,PRKCD;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;UBR5
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.39990806209724783,-1.3415987309852255,0.09154929577464789,0.5524376814281419,1.0,11/35,9.41%,TJP1;TEK;RAPGEF3;ESAM;F11R;PDGFRA;BAIAP2;ARHGDIA;IQGAP2;CDC42;ABI3
prerank,regulation of cell morphogenesis (GO:0022604),0.5439191917134444,1.3414005348790459,0.11566265060240964,0.6762267084666179,1.0,10/30,19.43%,EFNA5;FMNL2;ARC;SPARC;BCL9L;MYO9A;PHIP;SH3D19;ZMYM3;ZRANB1
prerank,relaxation of muscle (GO:0090075),0.6355521887432892,1.3413064877068344,0.1404728789986092,0.6751988550930184,1.0,4/13,3.61%,KCNJ2;ATP1B1;GSN;CAMK2D
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5336954492621298,-1.3402218920608895,0.14285714285714285,0.5522247490062165,1.0,1/10,0.70%,ROCK2
prerank,regulation of ion transmembrane transport (GO:0034765),0.5378020416530646,1.340085692082422,0.10778443113772455,0.6787201805456196,1.0,8/33,13.92%,KCNJ2;KCNJ15;NEDD4;KCNE5;WWP2;AKAP9;YWHAE;WNK1
prerank,inorganic anion transport (GO:0015698),0.5058982792191975,1.3394434318475552,0.09318181818181819,0.6800857787515133,1.0,6/53,5.65%,SLC4A10;SLC26A7;SLC26A6;CLIC3;CLIC4;SLC4A11
prerank,T cell differentiation (GO:0030217),-0.37323895158992615,-1.338100243914814,0.061068702290076333,0.554131532067885,1.0,7/40,7.55%,LEPR;CHD7;SOX13;KIT;TCF7;JAG2;RHOH
prerank,ubiquinone metabolic process (GO:0006743),0.6261193988156043,1.3380577374216482,0.1414965986394558,0.6845603557398975,1.0,8/15,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.49716270052561606,1.3376966336973644,0.10933940774487472,0.6847627533747181,1.0,10/54,8.96%,KCNJ2;KCNJ15;FHL1;NEDD4;KCNN1;KCNE5;STK39;KCNIP2;DLG1;WWP2
prerank,histone H4 deacetylation (GO:0070933),0.6537337894325447,1.3376640062074792,0.1457142857142857,0.6834509320176804,1.0,5/10,17.32%,HDAC9;HDAC4;HDAC1;SIRT2;SMARCAD1
prerank,negative regulation of cellular component movement (GO:0051271),-0.4922621490573113,-1.337255576992469,0.10505836575875487,0.5525443593606814,1.0,5/15,7.71%,TGFBR3;FRMD5;FBLN1;SPOCK3;SP100
prerank,synaptic vesicle membrane organization (GO:0048499),0.5918444334618069,1.3366998264876258,0.14206896551724138,0.6860208698323185,1.0,7/17,15.34%,STX11;PRRT2;STX2;AP3D1;SNAP23;STX4;STX1A
prerank,negative regulation of protein modification process (GO:0031400),0.4850361594027541,1.336581988492917,0.06594594594594595,0.6850788132072011,1.0,18/79,11.15%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;WWTR1;XDH;P3H1;DMD;PRKDC;PPP1R8;SNTA1;BEX4;IMPACT;CDK5RAP3;PAQR3;NIBAN1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.44364821243172764,-1.3365424282032385,0.12987012987012986,0.5507093859070755,1.0,8/22,15.97%,APOD;ADRA2A;PRKAA1;ASXL3;CEACAM1;BSCL2;GPER1;PPP2R5A
prerank,neutrophil activation (GO:0042119),0.6439650930541254,1.336479250716103,0.1422475106685633,0.6841096433982659,1.0,2/12,8.57%,PRKCD;FCER1G
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6631980336528489,1.33643045945533,0.13517441860465115,0.682874059679642,1.0,3/10,8.56%,IRS1;PRKCE;AKT2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3552910734196314,-1.3360102694558564,0.0625,0.5485847580595994,1.0,10/57,8.56%,ADCY5;LPAR1;GRM7;GRM8;ADCY1;ADRA2A;PDE2A;HTR4;ADCY4;OPRM1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3819761252591564,-1.3355622485732668,0.06993006993006994,0.5464413136237669,1.0,9/40,10.26%,TCF4;ZEB1;BRINP3;BRINP1;PROX1;GPRC5B;BRINP2;ARHGEF2;MMD
prerank,regulation of peptide hormone secretion (GO:0090276),-0.3304816350349839,-1.3354543240410466,0.022222222222222223,0.543238654001115,1.0,12/67,8.11%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;DPP4;CACNA1D;CACNA1E;ITPR3;ADRA2A;HTR2C;KCNC2
prerank,negative regulation of double-strand break repair (GO:2000780),0.5394412252361299,1.334666646150036,0.13059250302297462,0.6887777807673423,1.0,18/30,32.75%,HELB;TWIST1;RMI2;OTUB1;OGG1;UBR5;OTUB2;TFIP11;MAD2L2;CGAS;FBH1;SHLD3;SHLD1;HSF1;TRIP12;PARPBP;ERCC6;POLQ
prerank,regulation of lipid kinase activity (GO:0043550),-0.536580563782953,-1.3346169774797385,0.11409395973154363,0.5417852681179254,1.0,3/11,4.77%,PIK3R1;WDR91;RB1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6172546680443716,1.3344744602317178,0.13648648648648648,0.688150304588891,1.0,7/14,18.70%,IRS1;ACTN3;AKT2;NNMT;PTPN2;ARPP19;AKT1
prerank,quinone biosynthetic process (GO:1901663),0.6341204667305532,1.3344199530800263,0.14600550964187328,0.6869468583581219,1.0,8/14,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,positive regulation of angiogenesis (GO:0045766),0.4673377550909261,1.3344119925471243,0.047966631908237745,0.6855661458751716,1.0,19/108,10.01%,BMPER;THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;TWIST1;CYP1B1;RAMP2;PRKCA;FOXC2;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,sodium ion homeostasis (GO:0055078),-0.45595269575605507,-1.3341046698329138,0.105,0.5395830198022968,1.0,4/21,1.29%,ATP1A2;ATP1B3;NEDD4L;SLC8A1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.4643967173896952,1.333878096654633,0.05052631578947368,0.6863446333912675,1.0,40/100,25.08%,RNF144A;XPO1;PRICKLE1;FHIT;CSNK1D;GLMN;COP1;VCP;DVL1;CCAR2;GIPC1;OGT;FBXO22;RNF14;SMAD7;CSNK1E;USP7;DAB2;DDA1;STUB1;SIRT2;TLK2;N4BP1;SUMO1;UFL1;ARAF;HECTD1;RYBP;UCHL5;CLU;USP5;LRRK2;DESI1;SUMO2;DET1;TAF1;HERPUD1;CAMLG;RCHY1;BBS7
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5406875603835815,1.3338042932634668,0.1321212121212121,0.6852358849596346,1.0,6/29,8.51%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,endoplasmic reticulum organization (GO:0007029),0.48448351509140264,1.333617618240977,0.07303974221267455,0.6846261375146302,1.0,30/72,22.45%,SEC31A;MAPK15;STX5;ATL2;SEC61A1;LMAN2L;DOP1B;TLE6;SMPD4;ATL3;TRAM2;LPCAT3;ALDH3A2;REEP3;LMAN2;SEC16A;MIA3;STX1A;SEC16B;HMOX1;TMEM170A;BNIP1;TMEM33;REEP5;SHTN1;ATL1;LRRK2;LMAN1;RAB18;EIF2AK3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4802774360120485,1.3334585330807227,0.06019007391763464,0.6839010989475429,1.0,43/84,25.06%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;RBM39;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;PCBP4;DAZAP1;RBM5;METTL16;KHDRBS1;PTBP1;RBM4;U2AF2;SRPK1;HNRNPK;YTHDC1;SRSF3;ZC3H10;NCBP1;SRSF7;SRSF10;LARP7;RBMXL1;TRA2B;CIRBP;TRA2A;SAP18;SFSWAP;HNRNPA1;FXR2;SRSF4;HNRNPU;SF1;RBM24;RBM3;C1QBP
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5790582207977337,1.3333250265176555,0.12915601023017903,0.6830797126517865,1.0,5/21,9.68%,EXT1;XYLT1;HS3ST4;SULF1;HS6ST2
prerank,response to lipid (GO:0033993),0.4612595239264136,1.333308351235078,0.042842215256008356,0.6817479673727739,1.0,24/105,16.58%,ESR1;FOXP1;ALPL;LBP;SMAD6;CYP19A1;RXRA;STAT3;RXRB;IRAK3;SOX9;LIAS;RARA;SOCS2;ANXA1;FOXA1;IRAK1;TAB2;F2R;SRR;PRDX3;CYP27B1;FOXO3;OTUD5
prerank,protein transport (GO:0015031),0.44754570036108315,1.3333011408370676,0.00501002004008016,0.6803953864139376,1.0,133/332,25.72%,SGSM2;LRP1;LTBP2;NECAB3;ARFGAP3;CTTN;SEC31A;ATP6V1C2;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;LMAN2L;RAB34;RAB43;TCIRG1;COPA;RAMP2;RAB24;STX11;AP2A1;RILP;COPG1;LRSAM1;DNM2;SLC10A7;RAB21;ATP6V0A1;RIC1;TLK1;GGA2;RAB8A;HIKESHI;ARF4;GOLGA4;COPZ2;MON1A;SNX1;NSF;SCFD1;STX2;VPS26A;RAMP1;ARFIP2;RAB38;ATP6V0D1;ARF1;RAB3D;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;TBC1D9B;LRP2;TBC1D25;ATP6V1B2;RAB11B;ERP29;ABCA1;PICK1;TOM1;VIPAS39;CHMP3;PREB;CLTC;RAB23;ATP6V1E1;TMEM167A;TBCK;MIA3;TBC1D10A;SIL1;STX4;COPB2;STX1A;RAB3B;SCFD2;TBC1D17;HDAC6;STX16;SCAMP2;GGA1;TANGO6;SPTBN1;SNX13;NAPA;GOLPH3;TMED2;BLZF1;RAB5B;VPS45;SNX15;SEC23IP;RAB3GAP2;ATP6V1C1;NEURL1B;EVI5;STEAP3;SCAMP3;MIA2;CLU;TBC1D22B;RCN3;VPS26C;OPTN;IFT27;LAMP2;RAB1A;RAB18;ZG16;NDC1;VAMP4;RAB1B;SNX4;COPZ1;RABGAP1;ARF5;ATP6V0E1;SCAMP1;TMED7;CHMP2A;LMTK2;AP3B1;ATP6V0B;STX1B;VAMP2;FAM91A1;STX19
prerank,sodium ion transport (GO:0006814),0.47945419842741027,1.332979163173663,0.07255520504731862,0.6804018540603223,1.0,14/85,7.05%,SLC4A4;SLC23A1;SLC5A6;ATP1B1;FGF13;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC9B2;SLC4A8;SLC4A11;SCN11A;SLC6A2
prerank,polyol metabolic process (GO:0019751),-0.36570150129897255,-1.3329339251137873,0.05755395683453238,0.5393149482637535,1.0,11/46,8.83%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;SLC5A3;IP6K2;PLCD1
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5740476696755907,1.3321705856392374,0.13695090439276486,0.6824124407603309,1.0,8/19,19.93%,PLCE1;NFAT5;NFATC1;EDN3;PPP3CC;NFATC3;NMUR1;NFATC4
prerank,regulation of protein sumoylation (GO:0033233),0.6044671167225977,1.3317849179826269,0.12978142076502733,0.6826655810530503,1.0,7/17,21.21%,ZMIZ1;GNL3;HDAC4;PIAS4;RWDD3;SAE1;MUL1
prerank,regulation of macrophage activation (GO:0043030),0.5483937744512748,1.3316279160314857,0.10453400503778337,0.6819587032513288,1.0,4/30,4.67%,THBS1;LBP;IL33;SHPK
prerank,fluid transport (GO:0042044),0.6336121906656877,1.3316273979828461,0.14027777777777778,0.6805893082648803,1.0,2/12,5.65%,SLC26A6;SLC4A11
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5934992576582582,1.3309490205884853,0.13896103896103895,0.682043011554107,1.0,6/18,9.70%,RHOJ;VEGFA;FGF2;HDAC9;FOXC2;ANXA1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.6321208073497218,1.3307848748868776,0.15088757396449703,0.6813893819331265,1.0,8/12,25.72%,STX11;PRRT2;STX2;SNAP23;STX4;STX1A;STX1B;STX19
prerank,regulation of monocyte chemotaxis (GO:0090025),0.5586282514695382,1.3304360835493996,0.13316892725030827,0.681512941295324,1.0,3/24,6.48%,SLIT2;CCN3;HMGB1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5405957353800892,1.330079408088993,0.12073170731707317,0.6815924011909175,1.0,8/30,15.82%,FOXP1;DDX5;NCOR2;HEYL;RNF14;HDAC1;DAB2;HDAC6
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.642340034886494,1.3296844653299233,0.15724137931034482,0.6819603630327599,1.0,4/11,12.82%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5031126076118931,1.3293510115973244,0.09234234234234234,0.6819241116461325,1.0,18/50,19.33%,GPC3;GLIS2;GAS1;RAB34;ARMC9;VCP;TEDC1;ZIC1;EVC;RORA;FGFR2;WDR11;PDCL;SMO;FUZ;CREBBP;SUFU;UCHL5
prerank,regulation of cell-matrix adhesion (GO:0001952),0.48249767608119626,1.3290692183007777,0.08839779005524862,0.6817087001363291,1.0,11/64,9.03%,THBS1;MYOC;EFNA5;LDB1;PKHD1;CD3E;SEMA3E;JAG1;SLC9A1;JUP;RHOA
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4864243004377607,1.3289421696281625,0.08800880088008801,0.6809061636594634,1.0,22/63,21.31%,THBS1;TCF7L2;NOL3;ACVR1;FGFR1;TMC8;PAK2;BMP4;ITGAV;LTBR;MADD;PHIP;TNFRSF10B;DEPTOR;TGFBR1;STX4;BIRC6;BID;ZMYND11;BCL2L12;IL4;SH3RF1
prerank,response to UV-A (GO:0070141),0.6277517078920327,1.3288452473498293,0.14227642276422764,0.6799713737733031,1.0,1/14,0.31%,EGFR
prerank,odontogenesis (GO:0042476),0.5335134028945924,1.328453041354476,0.11479289940828402,0.6803584922844094,1.0,9/35,13.03%,LRP6;COL1A2;GLI2;TGFB3;TGFB2;BMP4;FGFR2;HDAC1;INHBA
prerank,sensory organ development (GO:0007423),0.4975621913222489,1.3284392682579582,0.09886363636363636,0.6790746170508444,1.0,17/51,20.04%,SMOC1;CHRDL1;PBX3;ECE1;SIX4;TGFB2;PBX1;MEIS3;SH3PXD2B;CPAMD8;ZDHHC16;BLOC1S3;SIPA1L3;MAB21L2;HIPK2;MYO7A;ATF6
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5886948211297338,1.3281808756070779,0.1480978260869565,0.6788395899223264,1.0,3/17,1.13%,SLIT2;VEGFA;FGF2
prerank,receptor signaling pathway via STAT (GO:0097696),0.553377887122939,1.327811934353227,0.11845386533665836,0.6789851934492335,1.0,6/25,8.51%,PKD1;GHR;STAT5A;STAT3;SOCS6;SOCS2
prerank,protein modification process (GO:0036211),0.4849710046303162,1.3275743221565675,0.0860566448801743,0.6786327097234788,1.0,31/76,24.13%,PLOD2;ST8SIA2;TGM5;GGCX;PRKDC;LOX;NAGPA;AKT2;WWP2;RIPK3;ABL1;LCMT1;FBXO22;ATG3;UBE2L6;PARP1;LIPT1;GNMT;NTAQ1;ARAF;FBXW2;CSNK1G3;LOXL2;CDKL3;STK38;UBA3;MAN2B1;B4GALT7;FBXO11;PHEX;PHKA2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.547259703523482,1.3273705816350647,0.12015018773466833,0.6781477648203074,1.0,15/26,29.96%,FOXP1;NCOR2;HEYL;HDAC1;DAB2;PER1;VPS11;CNOT9;CALR;CRY2;SMARCA4;NCOR1;KANK2;VPS18;ZBTB7A
prerank,lung development (GO:0030324),0.5200207229122582,1.326960672935122,0.13144963144963145,0.6786171547087104,1.0,7/33,9.71%,PKD1;VEGFA;FGF2;GLI2;CCDC39;BMP4;FGFR2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.4306982532699627,-1.3265756583865793,0.09734513274336283,0.5518673489300393,1.0,8/22,23.89%,GCNT2;BMP7;CD44;THY1;AGER;MAPK7;MBP;MYADM
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6154722701115352,1.3259914642558503,0.14913448735019974,0.681333698504584,1.0,8/13,32.56%,TMEM30B;TM9SF4;SEC16A;SEC16B;SAR1A;GCC2;INSIG1;SAR1B
prerank,inorganic cation import across plasma membrane (GO:0098659),0.48441400036536314,1.3258314932724027,0.0745945945945946,0.6806457884855994,1.0,13/75,8.87%,KCNJ2;KCNJ15;SLC39A14;SLC12A7;ATP1B1;SLC12A2;SLC5A2;HCN4;TRPV3;SLC9A4;SLC9A1;SLC12A4;TRPM4
prerank,cytoplasmic translational initiation (GO:0002183),0.5966923936422528,1.3257998456528886,0.15311653116531165,0.6794447370932988,1.0,13/17,32.20%,EIF4A2;EIF4A1;EIF4G1;DHX29;RBM4;EIF2S2;EIF3D;EIF3A;EIF4B;EIF4H;EIF3M;EIF3I;EIF2D
prerank,secondary palate development (GO:0062009),-0.4982102251375076,-1.3255135461016836,0.12867647058823528,0.5511493569359941,1.0,4/14,2.06%,TGFBR3;LEF1;CHD7;WNT5A
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5661476258646568,1.3250065474303592,0.13308457711442787,0.6800397130095914,1.0,14/21,33.38%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;RPA3;CUL4B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5661476258646568,1.3250065474303592,0.13308457711442787,0.6800397130095914,1.0,14/21,33.38%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;GTF2H4;XPA;DDB1;RBX1;ERCC1;RPA3;CUL4B
prerank,phagolysosome assembly (GO:0001845),0.6284529663379133,1.3239346145400814,0.14756446991404013,0.6829723326821464,1.0,4/12,18.37%,RAB7B;RAB34;PLA2G5;CLN3
prerank,negative regulation of proteolysis (GO:0045861),0.5207769571728736,1.3237549856174986,0.1263408820023838,0.682440668102968,1.0,15/34,24.84%,TIMP2;PTPN3;TIMP3;GAS1;CST3;SERPINE2;CAMK2N1;HDAC6;EFNA1;CLN3;AKT1;CDK5;LRRK2;ROCK1;DNAJC1
prerank,regulation of chromatin organization (GO:1902275),0.608486616942201,1.323711486578833,0.15678524374176547,0.6812896189919988,1.0,10/14,28.54%,TLK1;SETD5;TLK2;MLLT3;SSRP1;SETD1A;HNRNPU;PARG;IGF2;CDK9
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6349211095837639,1.3232874137472392,0.1573816155988858,0.68177155984507,1.0,1/11,0.08%,THBS1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5343154547800754,-1.3230399802122976,0.14381270903010032,0.5542642833979514,1.0,4/11,15.02%,LYN;TNFRSF21;CD300A;TYROBP
prerank,smooth muscle tissue development (GO:0048745),-0.5429321927556748,-1.3229815486754724,0.14915254237288136,0.5509941584098191,1.0,4/10,5.88%,ENG;MYLK;PTCH1;PROX1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.38688596722334634,-1.3229744483853891,0.06976744186046512,0.5476576728386044,1.0,13/40,9.15%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;WNT6;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,regulation of protein localization to membrane (GO:1905475),0.5397667594346067,1.3229654204474544,0.11235955056179775,0.6817788287722427,1.0,12/28,25.97%,GPC6;GSN;GPC3;MMP14;SPTBN1;CLN3;CDK5;APPL1;CRIPT;GPC1;GPC4;VTI1B
prerank,actin filament bundle organization (GO:0061572),-0.3998207660810273,-1.3229463277637246,0.10493827160493827,0.5443805529720086,1.0,12/33,13.26%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1;RFLNA;RFLNB
prerank,positive regulation of ossification (GO:0045778),-0.38338242461641414,-1.3227647191500291,0.0821917808219178,0.5415577442468451,1.0,14/39,9.15%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;WNT5A;OSR1;ZBTB16;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5051106072366077,1.3227616345369242,0.09739524348810873,0.6812932897907017,1.0,8/48,6.89%,MYOC;P4HB;CUX1;FBXW8;ILK;S100A10;PRKDC;DOCK5
prerank,protein homooligomerization (GO:0051260),0.467205289061156,1.3226805334919018,0.06907216494845361,0.6802818111916045,1.0,33/114,21.39%,SCARA5;KCNJ2;PRMT8;MPP2;EHD1;TRMT61B;ARC;ATL2;SLC1A5;ADCY8;ATL3;CRYZ;DISP1;FUS;C9;TRPM4;SPAST;CBR4;CLYBL;LETM1;ACACA;MICU1;G3BP2;PKD2L1;SHMT2;GNMT;ACOT13;SHMT1;TK1;APPL2;IKZF4;PDCD6IP;ATL1
prerank,RNA splicing (GO:0008380),0.47090458835941224,1.3223949793394651,0.07643979057591622,0.6801974598018575,1.0,40/95,25.11%,NOL3;PPP1R9B;MBNL1;SRSF2;SNRNP48;CCAR2;FUS;YJU2;SRSF11;CELF3;LUC7L3;CDK12;SF3B2;SF3B1;SNRNP25;SRRM1;U2AF1;SFPQ;ZRSR2;PTBP1;HNRNPC;SRPK1;SCNM1;NCBP1;WDR83;SRSF7;SRSF10;NCBP2;SYNCRIP;TRA2B;HNRNPH3;DHX8;SNRPB;GEMIN2;SRSF4;DHX16;PPIG;PPP2CA;SNRNP35;DDX39B
prerank,amino acid transport (GO:0006865),0.5069602393309435,1.3216190341186311,0.10136674259681093,0.6822731104562468,1.0,7/49,7.48%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.565516607405326,1.3214798780216293,0.13947696139476962,0.6815401384996562,1.0,7/24,12.40%,MYOC;VEGFA;COL16A1;S100A10;ABL1;IQSEC1;NRP1
prerank,histone mRNA catabolic process (GO:0071044),0.6014268154028297,1.3213591925189796,0.13598901098901098,0.6807517321989193,1.0,8/15,21.97%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;TENT2;UPF1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.6518158273870296,1.3211979557288367,0.14265129682997119,0.6801817930639921,1.0,4/10,16.31%,ESR1;HMGB1;PSMC5;PSMC4
prerank,ubiquinone biosynthetic process (GO:0006744),0.6166967946662154,1.320670952390472,0.14227642276422764,0.6810747557296442,1.0,8/15,20.19%,COQ7;UBIAD1;COQ10B;FDXR;COQ8B;COQ2;COQ9;COQ6
prerank,regulation of protein kinase activity (GO:0045859),0.46295618783454806,1.3203229733288566,0.06528497409326425,0.6811242801864261,1.0,29/106,20.31%,RASSF2;LRP6;PLCE1;GAS6;DDR2;UBASH3B;CAMKK1;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;TAB2;SNX9;PDPK1;SOD1;DEPTOR;CHP1;MAPRE3;CAMK2N1;IQGAP1;GSKIP;NF1;PRKAG1;AKT1;XRCC6;DUSP19;MAP2K3;RTRAF
prerank,protein polymerization (GO:0051258),0.5001473615287203,1.320300000355714,0.09263392857142858,0.6799661585561135,1.0,16/55,20.58%,PSTPIP1;MAP7D3;FGF13;GSN;COBL;CKAP5;UBE2C;TTC17;CHMP3;SPIRE2;MICALL2;WASHC3;TRIM6;CORO7;CHMP4A;CHMP4B
prerank,cellular response to peptide (GO:1901653),-0.3339648876617065,-1.319823564240423,0.045871559633027525,0.5457314372289227,1.0,22/56,18.23%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;ARHGEF2;VIM;GRIN2A;SNX6;CAV1;ITGA4;IGF1;CACNB1;GRIN1;GPER1;ICAM1;NOD2;PTPN22;CACNA1A;XBP1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4082235791330275,-1.3196845736846237,0.10919540229885058,0.5427753871560317,1.0,10/29,11.88%,SORBS1;APOE;PPARA;LPGAT1;NR1H3;SLC45A3;ZBTB20;MFSD2A;MID1IP1;SCARB1
prerank,histone H2A acetylation (GO:0043968),0.584259016484934,1.319278970792459,0.13881401617250674,0.6829022473134211,1.0,5/16,8.86%,MORF4L2;NAA40;TRRAP;ING3;MORF4L1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5068398429366539,1.319047127462349,0.09040178571428571,0.6825582385047444,1.0,17/52,20.76%,ARFGAP1;SEC31A;KDELR3;SHC1;LMNA;GFPT1;ERN2;SYVN1;HYOU1;ATP6V0D1;HSPA5;ADD1;PREB;SSR1;YIF1A;DCTN1;FKBP14
prerank,cellular potassium ion homeostasis (GO:0030007),0.619532844003318,1.3190340783741688,0.14167812929848694,0.6813538867220534,1.0,3/13,1.21%,KCNJ2;ATP1B1;SLC12A2
prerank,electron transport chain (GO:0022900),0.6077000994744943,1.318956874555156,0.14486638537271448,0.6803815019502011,1.0,5/15,10.20%,ETFRF1;ENOX2;ETFDH;ETFB;ETFA
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5606195900845015,1.318933074905919,0.1407035175879397,0.679207810434399,1.0,14/22,34.39%,CHD1L;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;XPA;DDB1;RBX1;RAD23B;CUL4B;CETN2
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5699637683132616,1.3186659164708443,0.13151041666666666,0.6790132336302118,1.0,7/20,12.59%,VEGFA;SMAD9;ATF4;SMAD4;NFE2L2;RUNX2;SESN2
prerank,regulation of protein import into nucleus (GO:0042306),0.517482880822084,1.3176061566267256,0.11764705882352941,0.6819810555661259,1.0,14/36,18.53%,PRKCD;MDFIC;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;BMP4;UBR5;CHP1;RAB23;RBM22;SUFU
prerank,negative regulation of signal transduction (GO:0009968),0.4479669048544343,1.3171038798723147,0.008016032064128256,0.6826155612275921,1.0,36/249,9.40%,THBS1;EGFR;IRS1;PID1;TRABD2B;IGFBP5;NTN1;PRKCD;LRP1;FGF2;GPC3;SFRP4;NEDD4;EMILIN1;UBASH3B;GRB10;NXN;GLIS2;DKK3;LRPAP1;CSNK2A2;CSNK2A1;CARD16;XDH;VCP;DACT1;ACVR1;SULF1;MMP14;IRAK3;NOG;DACT3;TSKU;NFATC1;WWP2;PTPN18
prerank,modulation by symbiont of entry into host (GO:0052372),-0.474718092404379,-1.3170274535261584,0.16342412451361868,0.546308716030041,1.0,7/16,11.22%,TRIM14;FUCA2;NECTIN2;TRIM21;CAV1;EXOC2;TRIM68
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.517510043664724,1.3169302109576624,0.11288483466362599,0.6820547849666806,1.0,18/38,29.91%,ABLIM3;CSNK2A2;HUWE1;FZD5;SREBF1;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;LRRK2;LMAN1;PINK1;ATG13;HTRA2;SREBF2;PRKN
prerank,regulation of mRNA metabolic process (GO:1903311),0.633236714821554,1.316408826045044,0.15873015873015872,0.6829831385135792,1.0,5/11,19.23%,SAFB;SLTM;SRPK1;NCBP1;SAFB2
prerank,positive regulation of protein catabolic process (GO:0045732),0.4686474131562273,1.3162127172457572,0.07415254237288135,0.6825259880251281,1.0,19/84,12.28%,WWP1;ADAM9;GPC3;NEDD4;RDX;STX5;CSNK2A1;RILP;VCP;TNFRSF1B;DACT1;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;SNX9;EZR
prerank,positive regulation of cell division (GO:0051781),0.5126736900566056,1.31532657355363,0.12778429073856976,0.6848004853272928,1.0,13/38,15.40%,CIT;PRKCE;CDC14A;GIPC1;CDC6;RHOA;PKN2;FGFR2;CDC25B;SPAST;OPN1MW;CSPP1;SIRT2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5886634831458866,1.3152232545536033,0.15414012738853503,0.68397059153116,1.0,9/17,26.61%,HM13;VCP;FAF2;SYVN1;NPLOC4;DERL1;HERPUD1;SELENOS;SEC61B
prerank,regulation of RNA metabolic process (GO:0051252),0.4887651846082562,1.314794247890021,0.11025358324145534,0.684400233093073,1.0,24/59,20.91%,CLK1;HNRNPH1;AHNAK;AHNAK2;CLK3;MBNL1;FASTK;TNFRSF1B;SNRNP70;FUS;HNRNPL;HNRNPH2;MBNL2;PCBP4;PCBP2;CLK4;PTBP1;USP36;RC3H2;CLK2;BRDT;TRA2B;HNRNPH3;AFF2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4994355578387131,1.3147252121967556,0.10645526613816535,0.6834381576329942,1.0,5/48,7.14%,SLIT3;SLIT2;GAS6;CARD16;IRAK3
prerank,positive regulation of RNA metabolic process (GO:0051254),0.504417672517449,1.3135221164445428,0.12060889929742388,0.6871110254711178,1.0,3/45,1.56%,SLC38A2;EGFR;DDX5
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5233425024708804,1.3126680798914199,0.12412177985948478,0.689421573240148,1.0,2/33,0.58%,PKD1;ID2
prerank,regulation of nervous system process (GO:0031644),-0.43834798033527744,-1.3122504218984041,0.09623430962343096,0.5550019005808314,1.0,5/18,7.35%,ROCK2;APP;NOS3;HTR2C;SLC8A3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.6133986013251295,1.312015826507125,0.15290933694181327,0.6908729207391683,1.0,8/14,21.00%,CPSF4L;CPSF4;NCBP1;CPSF7;CPSF6;NCBP2;CSTF2;CSTF2T
prerank,microglial cell activation (GO:0001774),-0.41730164414409465,-1.3117855420520472,0.11764705882352941,0.5527942203363396,1.0,10/21,25.05%,APP;CX3CR1;CX3CL1;C1QA;SNCA;TYROBP;ITGAM;AGER;TREM2;GRN
prerank,regulation of heart contraction (GO:0008016),-0.318970675588668,-1.311584303874689,0.014925373134328358,0.5501167870996772,1.0,21/90,11.99%,ATP1A2;ITPR1;ATP1B3;CELF2;SLC8A1;PDE4D;TPM1;RYR2;ITPR3;ABCC9;ATP2B1;SLC8A3;ATP1B2;KCNJ12;ATP2A3;DES;NPR1;TBX2;ITPR2;NOS1;ACE2
prerank,regulation of interleukin-4 production (GO:0032673),-0.4375904308090608,-1.3110750082723104,0.11570247933884298,0.5483905753431606,1.0,7/21,14.89%,LEF1;SLC7A5;SYK;PRKCQ;HAVCR2;LGALS9;PRKCZ
prerank,epithelial tube morphogenesis (GO:0060562),0.5228380840718736,1.3097759718808155,0.13268998793727382,0.6987264815887144,1.0,5/32,5.63%,SLIT2;PKD1;GLI2;PKHD1;ACVR1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4610187758651718,1.3097583140221893,0.08718487394957983,0.6975316979904993,1.0,26/93,21.02%,RASSF2;EGFR;VEGFA;GAS6;NTRK3;DOCK7;DMD;PFN2;RAF1;NSD1;PAQR3;AXIN1;SMAD7;TENM1;AKAP9;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;MLXIPL;TNKS1BP1;MAD2L2;ATP2B4
prerank,sulfur compound transport (GO:0072348),0.5335326595365236,1.309041581751619,0.14407814407814407,0.699100430565229,1.0,4/27,5.41%,SLC26A7;SLC5A6;SLC26A6;LRRC8D
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5984349989994256,1.308506978597777,0.15945945945945947,0.7000335687490871,1.0,6/13,20.79%,UPP2;DCTPP1;OGG1;TDG;SMUG1;NT5C
prerank,import into nucleus (GO:0051170),0.4808689838461543,1.3083290454707746,0.0867237687366167,0.6995163546378622,1.0,32/73,27.22%,NUP93;PRICKLE1;SEC13;IPO5;STAT3;IPO4;HIKESHI;E2F3;IPO13;SNUPN;TNPO2;GEMIN7;NUP88;SMN1;POM121;AKT1;IPO9;TNPO1;APPL2;APPL1;NUP62;PPP1R10;SNRPB;GEMIN2;HNRNPA1;TSC2;IPO8;NUTF2;NUP85;DDX20;TPR;RPAIN
prerank,carnitine shuttle (GO:0006853),-0.5141721395068494,-1.3082709486440651,0.15771812080536912,0.5523558944410135,1.0,5/11,14.39%,PRKAA2;PRKAG2;CPT1A;MID1IP1;ACACB
prerank,renal system development (GO:0072001),0.48662155868028356,1.3080384613788352,0.12134831460674157,0.6993861699449538,1.0,9/52,9.70%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4
prerank,neuron differentiation (GO:0030182),0.44531768814021977,1.3074823639222801,0.04060913705583756,0.7003992305277418,1.0,32/165,16.23%,LRP6;ID2;WNT9A;VEGFA;PBX3;VSX1;LDB1;GLI2;LHX9;TGFB2;NRBP2;FZD7;PBX1;FZD5;MYEF2;FOXA1;RUNX2;CTF1;NEUROD2;SRF;ERCC3;TENM1;TGFBR1;INHBA;MANF;ERCC2;RUNX1;WNK1;ACSL3;EN2;THOC2;ERBB2
prerank,vascular transport (GO:0010232),0.4655162175460633,1.3073278769208698,0.08172043010752689,0.6997775231341754,1.0,13/81,3.97%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC12A2;SLC2A13;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4541801814184285,1.3072727755572084,0.052845528455284556,0.6987483110577609,1.0,44/144,19.02%,PRKCD;KCNB1;GAS6;TMEM30B;TCF7L2;ABLIM3;IPO5;CSNK2A2;C2CD5;TM9SF4;TRIM28;BAG3;MAVS;BCAS3;MIEF2;JUP;HUWE1;FZD5;AKT2;ZIC1;PPP3CC;MAPK8;ANP32B;UBR5;XPO4;TENM1;CHP1;YWHAE;SEC16A;USP36;HPS4;YWHAQ;PCM1;TFDP1;MICALL2;ERBB2;SEC16B;VPS11;E2F1;BID;KIF20B;RBM22;NPEPPS;SAE1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.6259416364258523,1.3072657769853626,0.15760111576011157,0.6975209214167328,1.0,2/12,1.72%,SLIT2;CCN3
prerank,actin filament bundle assembly (GO:0051017),-0.3901378562419131,-1.3069968335582005,0.13095238095238096,0.5524380779027737,1.0,10/33,11.92%,MYO1B;PAWR;SHROOM2;EPS8;PLS3;NEDD9;BAIAP2;SHROOM1;AIF1L;LCP1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3582745537982051,-1.3069850149016276,0.09090909090909091,0.5493337975333018,1.0,19/47,23.25%,ROCK2;WNT4;RAPGEF2;PROX1;C1QTNF3;ZC3H12A;CAV1;PLEK;CEACAM1;CD34;SIRPA;BRCA1;C1QTNF12;GLA;ERLIN2;TRIB3;SIK1;EP300;APOC1
prerank,phagosome maturation (GO:0090382),0.5134144045313939,1.3065968071923613,0.11524609843937575,0.6989737107519493,1.0,9/35,14.53%,ATP6V1C2;RAB34;RAB43;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1
prerank,natural killer cell mediated immunity (GO:0002228),0.6049599120446888,1.3064333219152797,0.17096336499321574,0.6983254193987596,1.0,3/15,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.443995211767114,1.3061986866578335,0.011033099297893681,0.6980651097815662,1.0,106/264,25.89%,SRSF6;DDX5;DDX17;HNRNPH1;SRSF1;PABPC1;SRSF5;CELF4;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;CRNKL1;SNUPN;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;HNRNPC;U2AF2;SRPK1;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;TFIP11;SCNM1;SRSF3;ISY1;PCF11;IK;NCBP1;WDR83;SNRPA;SRSF7;SMN1;SRSF10;CWC25;CPSF7;AQR;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;MTREX;HNRNPH3;TRA2A;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;GEMIN2;HNRNPA1;SRSF4;POLR2B;DHX16;WDR77;RBM19;SF3B6;HNRNPU;YBX1;USP49;SF1;CDK13;SUGP1;UPF3B;SNRNP35;DDX39B;METTL14;POLR2H;DDX20
prerank,chromatin organization (GO:0006325),0.4505357782500136,1.3061001957183824,0.04963805584281282,0.697234364831262,1.0,51/132,26.75%,ESR1;HDAC4;BAZ2A;CHD1L;TCF7L1;PHF1;SAFB;EZH1;TADA2A;BRWD1;SOX9;EHMT1;HMGN1;SMARCC2;CDAN1;FOXA1;SETD5;KDM5B;PBRM1;KDM4A;KAT2A;HDAC1;BAZ2B;SETDB1;HMGN2;SUPV3L1;KDM5C;HMG20A;KDM6B;GATAD1;SMARCAD1;SUV39H2;HCFC1;BRDT;MPND;BPTF;SUV39H1;LOXL2;FAM50A;SETD2;TOP1;TAF6L;KAT2B;SETDB2;SMARCA4;HDAC2;DAXX;CHD1;ARID1A;SETD7;MYSM1
prerank,regulation of leukocyte activation (GO:0002694),-0.4735147471564738,-1.3060373842729434,0.12087912087912088,0.5484982337964386,1.0,5/14,15.51%,LYN;MFHAS1;CD200;CD74;GPER1
prerank,mRNA catabolic process (GO:0006402),0.4990821628211421,1.305650327006512,0.12558139534883722,0.6977964431195721,1.0,13/44,16.63%,DDX5;THRAP3;ZC3H12D;AGO1;DIS3L2;METTL16;LSM2;SUPV3L1;XRN1;EXOSC4;MRTO4;TUT7;CNOT10
prerank,positive regulation of heart contraction (GO:0045823),-0.4338224499436941,-1.3054642929933402,0.13229571984435798,0.5468587713023189,1.0,4/19,10.95%,ATP1A2;RYR2;EDN1;ADRA1A
prerank,autophagy of nucleus (GO:0044804),0.5951966925586077,1.3051410652975615,0.14580467675378267,0.6985772722927808,1.0,8/16,28.38%,ULK2;WIPI2;ATG3;RB1CC1;ATG9A;ATG13;ATG2B;ULK1
prerank,peptidyl-arginine modification (GO:0018195),0.5981324142043783,1.305085550346209,0.15811373092926492,0.6975733838232937,1.0,1/15,0.46%,PRMT8
prerank,response to iron ion (GO:0010039),-0.5016058798780216,-1.305024837146505,0.17582417582417584,0.5448878359723297,1.0,3/12,2.11%,BCL2;BMP6;B2M
prerank,fatty acid oxidation (GO:0019395),0.48732343977445686,1.3046706744210939,0.11659192825112108,0.6980847757041356,1.0,18/57,22.45%,ABCD3;EHHADH;ECHDC2;ECI2;ADIPOR2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;PHYH;SLC27A2;PEX2;ABCD1;ECHDC1;MCAT;HADHA
prerank,response to interleukin-6 (GO:0070741),0.6362237042366945,1.3044852835401897,0.15476190476190477,0.6975871410404724,1.0,3/10,9.20%,PID1;PTGIS;SBNO2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.48084656211644916,1.3041256225188167,0.09375,0.6978218679152541,1.0,22/65,19.01%,VEGFA;P4HB;PTGIS;TWIST1;LMNA;CARD16;MDM4;NDRG1;ANGPT4;RORA;HYOU1;TERT;PICK1;UBQLN1;NDNF;STUB1;SIRT2;PGK1;HMOX1;SUV39H2;NPEPPS;HIPK2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.4449562393546359,-1.3040902691282483,0.1336206896551724,0.5440911138710618,1.0,8/18,14.89%,NRXN1;SHANK3;RIMS2;RIMS1;CUX2;RELN;GRIN1;PRKCZ
prerank,proteolysis (GO:0006508),0.4382521409219123,1.3032815798965598,0.02814070351758794,0.7000892629352699,1.0,71/252,24.74%,ADAMTS3;CAPN5;HTRA3;TRABD2B;BMP1;PCSK5;F3;HTRA4;HTRA1;ECE1;PRSS38;CPZ;FAP;HM13;CPQ;ADAM10;SPG7;MMP14;PM20D2;BACE2;TASP1;CLPP;MBTPS1;CAPN10;XPNPEP1;DDI2;CAPN2;OGT;BACE1;SDE2;FBXO3;LONP1;PSMA6;MMP16;CASP1;NLN;LNPEP;CPXM2;PSEN2;HGF;LAP3;IDE;CAPN15;PSMC4;DPP8;PCSK7;NAPSA;CLN3;SUFU;FBXW2;NPEPPS;CTSZ;LVRN;CPB2;RNPEPL1;CTSB;SENP1;CTSK;DESI2;DESI1;UBA3;CTSO;CAPN6;MMP2;SENP6;AFG3L2;SPPL2A;PHEX;METAP2;ADAMTS9;VASH1
prerank,regulation of protein catabolic process (GO:0042176),0.4566240701826821,1.302538361905113,0.09157127991675339,0.7018945769827843,1.0,18/99,11.36%,EGFR;WWP1;GPC3;NEDD4;STX5;CSNK2A1;RILP;VCP;DACT1;IRAK3;MDM4;HUWE1;WWP2;NSF;ITCH;VIP;AXIN1;CHEK2
prerank,transport across blood-brain barrier (GO:0150104),0.46291264359033824,1.302163945733352,0.08788853161843516,0.7021603894817784,1.0,13/83,3.97%,SLC38A2;SLC38A1;SLC4A4;SLC5A6;SLCO3A1;LRP1;SLC12A2;SLC2A13;SLC24A3;SLC16A1;SLC4A8;SLC1A5;ABCC1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4772420119384545,1.3018305536266108,0.10197368421052631,0.7023147193565099,1.0,23/63,24.64%,PLAGL1;MUC1;CRADD;PRKDC;MDM4;CARM1;PCBP4;ATM;CHEK2;SDE2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;CDK2;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53;RPS27L
prerank,heme biosynthetic process (GO:0006783),0.5484400897415082,1.3013419364285637,0.15394402035623408,0.7030789875854546,1.0,11/22,25.83%,FLVCR1;FXN;NFE2L1;HMBS;ABCB6;FECH;UROS;SLC25A38;ABCG2;ABCB10;COX15
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5047193031706878,1.3011697636255213,0.141852286049238,0.7025632454788231,1.0,5/41,6.98%,KCNJ2;KCNJ15;KCNN1;KCNE5;ANK2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5832249723964296,1.3010406369190173,0.16511318242343542,0.701812125792366,1.0,2/16,4.91%,SLC39A14;PRKCA
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.45203280446376143,1.3009992790631775,0.048205128205128206,0.700753076013489,1.0,34/128,16.53%,TMEM100;GDF10;COL3A1;ADAM9;COL1A2;LTBP2;PDCD4;DDX5;SMAD9;SMAD6;ZMIZ1;ACVR1B;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMP4;RUNX2;BMPR1A;SMAD7;RGMA;TGFB1I1;TGFBR1;ZMIZ2;INHBA;BMP5;ID1;STUB1;RPS27A;UBC
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3650830404165303,-1.3007126319059434,0.13450292397660818,0.5495597143668786,1.0,11/39,8.55%,ROBO1;TSPAN5;MAML2;ROBO2;NOS3;MAML3;NOTCH1;JAG2;NOTCH4;RBPJ;EPN2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.48623711481899234,1.3007024331371844,0.11224489795918367,0.7007046972199589,1.0,5/54,3.15%,EXT1;XYLT1;GPC6;GPC3;SDC1
prerank,regulation of cell killing (GO:0031341),0.5786471715937977,1.3004154982829494,0.17551020408163265,0.7006393878212902,1.0,4/16,9.65%,CFH;TGFB2;FZD7;MAPK8
prerank,glycerolipid catabolic process (GO:0046503),0.5645682930932345,1.3003056359228828,0.15979381443298968,0.6999223228364967,1.0,7/19,16.32%,MGLL;PLA2G4F;PLA2G4A;SMPD4;ABHD6;ENPP6;GDPD3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6442644748484825,1.3002121729672154,0.17062314540059348,0.6990918530836916,1.0,2/10,1.87%,PID1;GRB10
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5079214113707251,-1.2997225134604864,0.17647058823529413,0.5490957196526421,1.0,5/11,14.06%,LYN;RAPGEF2;PIK3CD;LGALS9;SIRT1
prerank,cartilage development (GO:0051216),0.4930194018016729,1.299417687466303,0.1252821670428894,0.7010350178202759,1.0,12/49,13.69%,PKD1;SLC39A14;FGF2;NFIB;CCN3;HES5;SULF1;SOX9;BMP4;RUNX2;TRIP11;RUNX1
prerank,regulation of protein binding (GO:0043393),0.45397292604108086,1.29840519668945,0.07046632124352331,0.7039648895577515,1.0,43/114,25.50%,PRMT8;PKD1;PRKCD;LRP1;TCF7L2;TIAM1;HDAC4;LRPAP1;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;BMP4;GTF2F1;NVL;TERT;CSNK1E;ADD1;USP33;DAB2;MITD1;TFIP11;IDE;STYX;MEN1;AKT1;HIPK2;SNAPIN;CRK;CTSZ;PRKACA;LRRK2;CAMK1;PEX14;DERL1;TAF1;AMFR;ROCK1;PPP2CA;STK3
prerank,regulation of spindle organization (GO:0090224),0.5733193611678603,1.2975810268941839,0.1638709677419355,0.7060795955236501,1.0,8/18,23.14%,PARP3;RAE1;DYNC1H1;CLTC;DCTN1;NUP62;RNF4;SENP6
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.495729266717949,1.297491888261427,0.14269141531322505,0.7052663027896121,1.0,9/39,6.91%,FGF13;FXYD5;NEDD4;PRKCE;PTPN3;CAMK2D;DMD;STK39;SLMAP
prerank,aminoglycan biosynthetic process (GO:0006023),0.49511445365898776,1.2971108649426732,0.13257142857142856,0.7056062303736206,1.0,12/49,16.70%,EXT1;XYLT1;GPC6;GPC3;SDC1;B3GNT7;HS6ST2;HEXA;B3GNT9;B4GAT1;B3GNT6;XYLT2
prerank,cellular response to copper ion (GO:0071280),-0.48098623244107114,-1.2968583144558294,0.14285714285714285,0.5533940174517054,1.0,10/16,18.03%,MT1H;MT1M;MT1X;MT1B;MT1A;MT1E;MT1F;MT1G;SNCA;MT3
prerank,cellular response to pH (GO:0071467),0.5758564419677858,1.2967599762489417,0.16775884665792923,0.7058336964394922,1.0,7/17,20.27%,SLC9A1;IMPACT;RAB11FIP5;CHP1;RAB11B;PKD2L1;HVCN1
prerank,positive regulation of RNA splicing (GO:0033120),0.5372108633344168,1.2967340030847496,0.15166461159062886,0.7047404113671178,1.0,12/29,20.67%,SLC38A2;CELF4;THRAP3;CELF3;DAZAP1;U2AF2;NCBP1;RBM22;RBMXL1;TRA2B;CIRBP;TRA2A
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.44015331246692757,-1.2965763743820014,0.13106796116504854,0.5510618325612011,1.0,11/20,21.24%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4969869940389111,1.2960642074079407,0.1396713615023474,0.7062711959205679,1.0,7/44,6.99%,KCNJ2;KCNJ15;ATP1B1;KCNN1;KCNE5;ANK2;KCNIP2
prerank,regulation of lipase activity (GO:0060191),0.6056324671281954,1.295962358687573,0.16620498614958448,0.7055567259471549,1.0,3/13,9.03%,PCSK5;LMF1;RHOA
prerank,organic substance transport (GO:0071702),0.44733428798405267,1.29593596542903,0.06564102564102564,0.7044627282111412,1.0,23/120,14.88%,SLC47A1;SLC23A1;ABCD3;SLCO2A1;LMAN2L;FLVCR1;RAMP2;RILP;HIKESHI;DISP1;SLC6A2;ATP8A1;RAMP1;RAB38;PCTP;LRP2;ABCA1;PICK1;TOM1;CHMP3;ABCB6;SLC50A1;MIA3
prerank,negative regulation of lipid storage (GO:0010888),-0.44657084386267076,-1.295407730479836,0.12987012987012986,0.5506915709500466,1.0,6/19,6.84%,OSBPL8;PPARA;ABCG1;NR1H3;ABHD5;PPARD
prerank,pulmonary valve development (GO:0003177),0.5687462808265064,1.2952644029198233,0.16102841677943167,0.7059344189548179,1.0,9/18,12.12%,SLIT2;SMAD6;TGFB2;TNFRSF1B;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,response to purine-containing compound (GO:0014074),-0.45032987459599855,-1.294951579201554,0.1568627450980392,0.5488517586917647,1.0,4/17,3.96%,STAT1;RYR2;TRPC3;ABCC9
prerank,chondroitin sulfate metabolic process (GO:0030204),0.5189035486020159,1.2948828162147623,0.15233415233415235,0.7062224863968284,1.0,6/30,4.30%,DSE;BGN;CHST11;ARSB;CHPF2;CSPG4
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5003456285650432,1.2945205341590182,0.12416107382550336,0.7053530937484437,1.0,30/50,30.87%,NUP93;SEC13;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;POLR2I;PUM2;NUP50;POLR2L;NUP188
prerank,regulation of gene silencing by RNA (GO:0060966),0.5003456285650432,1.2945205341590182,0.12416107382550336,0.7053530937484437,1.0,30/50,30.87%,NUP93;SEC13;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;POLR2I;PUM2;NUP50;POLR2L;NUP188
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.6081728250537547,1.29446288797634,0.16331994645247658,0.7043981385919708,1.0,4/13,12.82%,ZMIZ1;ELOF1;SERTAD2;ZMIZ2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4514920390596416,-1.2940423950864561,0.1518987341772152,0.5480472415774558,1.0,9/17,19.82%,OSR1;AJAP1;APOLD1;CAV1;CEACAM1;PRKX;MAFF;DSPP;DLL1
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5551959154631537,1.2939882057252223,0.17035110533159947,0.70513129590171,1.0,11/21,17.10%,NUP93;CCN3;TGFB3;WWTR1;SMAD4;BMP4;SH2B1;BMPR1A;TGFBR1;DAB2;SLC2A10
prerank,regulation of organelle assembly (GO:1902115),0.4710515886667372,1.2937497813510406,0.10845986984815618,0.7049812152966518,1.0,32/72,26.20%,GSN;NPRL3;RDX;MAPK15;TBC1D2B;DYNLT2B;ATXN2L;ALMS1;IFT20;TBC1D24;TRAPPC12;ATG3;SDCCAG8;EZR;TBC1D9B;TBC1D10A;TBC1D17;IFT88;VPS11;EVI5;TBC1D22B;PDCD6IP;RNF4;ATXN2;RAB1B;SENP6;CYLD;RABGAP1;NPRL2;SPICE1;TBC1D20;RAB5A
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.5383776604259027,-1.2928011012536065,0.17406143344709898,0.5479119769353553,1.0,6/10,22.00%,RIF1;JARID2;SIRT1;BRCA1;KDM1A;DNMT3B
prerank,camera-type eye development (GO:0043010),0.5495155670477856,1.2926204946756816,0.16034271725826194,0.7081787261221492,1.0,7/25,8.71%,CACNA1C;VEGFA;CYP1B1;HES5;RAB3GAP1;SKI;TSKU
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5333689618231745,1.292471908830569,0.16020025031289112,0.7075967021568046,1.0,7/25,18.44%,PRPS2;ADA;AMPD3;DGUOK;MTHFD1;SHMT2;SHMT1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6417847965687574,1.292142851214554,0.18,0.7076442694769915,1.0,7/10,26.51%,KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;SETD7
prerank,ribonucleoprotein complex assembly (GO:0022618),0.448739983184301,1.2918260816364513,0.06666666666666667,0.7077969396598843,1.0,37/132,18.09%,SRSF6;RPSA;KHDC4;LUC7L2;SRSF1;NOL3;SRSF5;CELF4;RRS1;PRKDC;RRP7A;CELF3;LUC7L;LUC7L3;NLE1;SF3B1;RBM5;CRNKL1;SNUPN;XAB2;DHX29;ZRSR2;GEMIN7;SRPK1;CLP1;EIF2S2;YTHDC1;EIF6;ISY1;PPAN;EIF3A;NCBP1;BOP1;SMN1;SRSF10;CPSF7;CPSF6
prerank,phagosome-lysosome fusion (GO:0090385),0.6407030785592864,1.291327973544007,0.17058823529411765,0.7086403775445513,1.0,4/10,18.37%,RAB7B;RAB34;PLA2G5;CLN3
prerank,gland development (GO:0048732),0.4825979314041838,1.2911753184194255,0.10508849557522124,0.7080040539914261,1.0,16/59,12.61%,SIX1;IGSF3;GLI2;TGFB3;DKK3;COBL;PRKCSH;EPHB3;SOX9;CDK5RAP3;ANXA1;FGFR2;RIPK3;SOD1;EZR;TGFBR1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5892432216835032,1.2907222030183156,0.1686746987951807,0.7086038003862363,1.0,8/14,23.30%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;CSTF2;RTRAF;TSEN34
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.43974291630727214,1.290010321031482,0.018090452261306532,0.7101574008684122,1.0,94/241,25.11%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;CRNKL1;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;HNRNPC;U2AF2;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;TFIP11;SRSF3;ISY1;PCF11;IK;NCBP1;WDR83;SNRPA;SRSF7;SRSF10;CWC25;CPSF7;AQR;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;MTREX;HNRNPH3;TRA2A;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;HNRNPA1;SRSF4;POLR2B;DHX16;RBM19;SF3B6;HNRNPU;YBX1;USP49;SF1;SUGP1;UPF3B;SNRNP35;DDX39B
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.4204437162628047,-1.2899225367901288,0.13513513513513514,0.5524486899258959,1.0,7/23,9.59%,UACA;BMP7;DDX3X;C1QTNF3;TMSB4X;ADIPOR1;ZC3H12A
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.455283768979533,-1.2898919312139747,0.13777777777777778,0.5496121149715102,1.0,4/17,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,histone H3 deacetylation (GO:0070932),0.5914667260951363,1.2893360543393941,0.15167785234899328,0.7116064038807385,1.0,12/15,33.14%,HDAC9;HDAC4;SFPQ;HDAC1;PER1;SIRT2;SMARCAD1;HDAC2;PER2;ELK4;HDAC3;SIRT7
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.5512900643585475,1.289303646292677,0.16313823163138233,0.7105834281249042,1.0,8/22,17.52%,EDEM3;EDEM2;SYVN1;UGGT2;UGGT1;RPS27A;UBC;TRIM13
prerank,cellular response to amyloid-beta (GO:1904646),-0.36782097627143573,-1.2891676401361911,0.12418300653594772,0.5484336273636008,1.0,13/35,14.19%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;CACNB1;GRIN1
prerank,cellular response to amino acid starvation (GO:0034198),0.4668949105943705,1.2891101902851805,0.10676532769556026,0.71015886656086,1.0,31/71,25.64%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;IMPACT;CASTOR2;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;ATP6V0B;LAMTOR2
prerank,actin polymerization or depolymerization (GO:0008154),0.48848405807414164,1.2890762605637647,0.12141280353200883,0.709115618206636,1.0,12/50,16.87%,PSTPIP1;MICAL2;GSN;VILL;COBL;ABI1;TTC17;SCIN;SPIRE2;MICALL2;WASHC3;WDR1
prerank,calcium ion transmembrane transport (GO:0070588),0.45754505131841716,1.2888930513159953,0.09564293304994687,0.7086056981723459,1.0,17/86,13.04%,CACNA1G;PKD1;CACNA1C;SLC35G1;GAS6;SLC24A3;TRPV3;MCU;SPG7;TRPC4AP;TRPM7;TRPM4;ITGAV;TMEM165;TRPM6;MICU2;LETM1
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6133438631867363,1.2888785402293492,0.18439716312056736,0.7075165936909812,1.0,5/13,15.61%,GLI2;BMP4;SOD1;CLPTM1;CAMK4
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5402361402563804,1.288742910806322,0.1639751552795031,0.7069140058740903,1.0,3/24,2.01%,MAP7D3;FGF13;STMND1
prerank,positive regulation of protein import (GO:1904591),0.5252606305991045,1.2885727446649808,0.13908872901678657,0.7064149715502843,1.0,8/30,10.64%,PRKCD;IPO5;TRIM28;BAG3;MAVS;JUP;ZIC1;UBR5
prerank,membrane depolarization during action potential (GO:0086010),0.539567963848031,1.2885058797705333,0.178168130489335,0.7055198594516213,1.0,4/26,2.89%,KCNJ2;CACNA1G;CACNA1C;HCN4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.5442700816034138,1.2884776551837847,0.17413572343149808,0.7044765353146496,1.0,7/24,17.17%,PID1;RHOQ;GDI1;PPFIA1;CLTC;DAB2;LZTFL1
prerank,protein mannosylation (GO:0035268),-0.41360996140959616,-1.2880206657988214,0.1461187214611872,0.548272444739426,1.0,3/22,2.16%,TMTC2;TMTC4;CRPPA
prerank,positive regulation of lipid transport (GO:0032370),0.6095590293615997,1.2877061461352024,0.15584415584415584,0.7065019325902823,1.0,2/12,2.67%,LRP1;CYP19A1
prerank,regulation of mRNA processing (GO:0050684),0.5161058154248606,1.2875081509012034,0.14757969303423848,0.7061429729100984,1.0,15/32,19.46%,RBM39;SAFB;SLTM;PABPN1;METTL16;KHDRBS1;SRPK1;CPSF4;HNRNPK;YTHDC1;SRSF3;NCBP1;SRSF10;SAFB2;LARP7
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.47874114948439883,1.2864969278687803,0.12319644839067703,0.708979844040151,1.0,19/54,24.29%,PLAGL1;MUC1;CRADD;MDM4;CARM1;PCBP4;ATM;CHEK2;TFDP1;CNOT8;CNOT10;RBL2;E2F1;CNOT9;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53
prerank,visual perception (GO:0007601),0.45755421373608335,1.2852578433646513,0.09247311827956989,0.7126924402800341,1.0,7/84,6.91%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.6312279080840942,1.2848582958848254,0.16544655929721816,0.7131225909527924,1.0,3/10,4.67%,PDE11A;UBE2B;PDE3A
prerank,cation transmembrane transport (GO:0098655),-0.3633751252256075,-1.2847193412193307,0.10344827586206896,0.5533243027793311,1.0,7/44,8.08%,ATP1A2;TRPM3;SLC7A5;ABCC9;SLC6A9;SLC38A5;SLC7A1
prerank,embryonic organ development (GO:0048568),0.4765687365639299,1.2844398890440734,0.1168122270742358,0.7136023110366596,1.0,15/61,12.12%,PKDCC;PCSK5;PBX3;RARB;GLI2;COBL;TGFB2;ATF4;TGFBR2;PBX1;TBC1D23;FGFR2;BMPR1A;ERCC3;HEY1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.43784543816466154,-1.2840053287446074,0.11788617886178862,0.5521766404763234,1.0,2/18,1.08%,ATP1A2;NEDD4L
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4621308446086034,1.2836655841996865,0.09554140127388536,0.7155158313613551,1.0,29/86,24.29%,VEGFA;MUC1;PSMD7;GCN1;ATF4;BAG3;PSMA8;NFE2L2;IMPACT;PSMA4;PSMD12;PSMA6;LIMD1;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;RPS27A;UBC;HIGD1A;HMOX1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;TP53
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.537717819890945,1.2825471050027892,0.16393442622950818,0.7188055082522201,1.0,10/24,25.69%,TENT4B;ERCC4;TEN1;HNRNPC;TNKS2;XRN1;PARP1;HNRNPA1;HNRNPU;SLX4
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.5259695929320204,1.2824261274106552,0.15347137637028013,0.7181346651759478,1.0,8/27,15.24%,ID2;PPP1CC;USP2;PER3;BHLHE40;FBXL12;RBM4;PER1
prerank,sodium ion import across plasma membrane (GO:0098719),0.5762922179162806,1.2823644293161822,0.170439414114514,0.7172413204070033,1.0,6/17,8.87%,SLC12A2;SLC5A2;HCN4;SLC9A4;SLC9A1;TRPM4
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5254485167009911,1.2823136292900736,0.16273584905660377,0.7162923729735514,1.0,5/29,7.83%,SLC4A10;EPHB2;ARC;RAB3GAP1;DLG4
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.49708694897156286,1.281352285922599,0.1490104772991851,0.7190395816364613,1.0,14/43,17.46%,FGF2;NFIB;DDX5;GNL3;KLF5;TGFB2;STAT3;SOX9;BMP4;TERT;SRF;NFATC3;FOXO3;NR3C1
prerank,protein modification by small protein removal (GO:0070646),0.4332662279003602,1.281319960526863,0.026078234704112337,0.7180419846576402,1.0,106/252,26.82%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;OTUB1;USP50;TRRAP;MDM4;GPS1;MBD6;FOXK1;OGT;RHOA;INO80E;RHOT1;PSMA4;USP40;UCHL3;INO80B;WDR48;USP48;USP45;SMAD7;PSMD12;OTUB2;KAT2A;USP34;TRAF3;TGFBR1;USP11;PSMA6;STAM2;SENP5;USP7;USP33;USP36;PSMD1;USP13;PSMC5;USP19;USP35;PSMD11;PSMC4;PSMD14;RPS27A;UBC;OTUD5;CDC25A;POLB;YOD1;USPL1;SENP8;CDC20;USP32;USP10;HCFC1;USP46;ACTR8;USP1;UCHL5;ZRANB1;NFKBIA;TAF9B;OTUD6B;PSMA3;UCHL1;BRCC3;USP5;SMURF2;PSMB1;SENP1;PSMD4;COPS4;USP47;DESI2;DESI1;BIRC3;SENP7;SENP6;PSMA5;CYLD;KAT2B;PSMA7;USP4;USP49;COPS7A;ASXL2;USP14;TP53;SNX3;SENP3;CCP110;SUDS3;PSMC1;COPS3;RIPK1;YY1;ATXN7;TAF10;MYSM1;USP21;USP16
prerank,regulation of axonogenesis (GO:0050770),0.4715819204123824,1.281096212624114,0.14078212290502792,0.7177832067934383,1.0,9/51,9.53%,SLIT2;PLXNA4;TIAM1;TIAM2;GDI1;SIPA1L1;EPHB3;RHOA;PAK2
prerank,regulation of cell cycle (GO:0051726),0.43141225601887123,1.2809897099263285,0.027054108216432865,0.7170198794795306,1.0,71/271,21.16%,THBS1;PLAGL1;LRP6;PKD1;ID2;TCF7L2;PDCD4;TTC28;GADD45G;PPP1R9B;PRDM11;FAP;CSNK2A2;CSNK2A1;TGFB2;STAT3;EIF4G2;CDC14A;NEK7;ADAM10;PUM1;GBF1;CDK10;SOX9;RARA;SRA1;AKT2;CDK5RAP3;BMP4;FGFR2;TBRG4;CDC123;MADD;FOXM1;ABL1;INTS13;ATM;MAPK12;FBXL12;TAF6;MED25;UHMK1;TGFBR1;INHBA;SND1;RHOB;CAMK2N1;ING4;SIRT2;IQGAP1;APBB1;CDC25A;BOP1;E4F1;MEN1;CITED2;DAPK3;KIF20B;HCFC1;UHRF2;BIRC5;HIPK2;MLXIPL;CKS1B;GMNC;CDK5;DLGAP5;CALR;PRKACA;WDR12;TBRG1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5695125632522586,1.280797203744061,0.18413978494623656,0.7165864567057515,1.0,4/17,5.88%,ADAM9;TGFB2;CD3E;FOXC2
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5276681914841477,1.280715506157369,0.1696969696969697,0.7157820402917813,1.0,5/27,11.27%,SMOC2;FGF2;TOM1L1;SMG6;ATM
prerank,cortical cytoskeleton organization (GO:0030865),0.495466495169992,1.2804043433865273,0.14386792452830188,0.7158908348524856,1.0,10/41,14.75%,RHOBTB1;FMNL2;RHOQ;RND3;LLGL1;DLG1;RHOA;EZR;NLGN1;RHOB
prerank,aminoglycan catabolic process (GO:0006026),0.5156790166398151,1.279847568535636,0.18472906403940886,0.717019279247579,1.0,3/28,3.15%,GPC6;GPC3;SDC1
prerank,lysosome organization (GO:0007040),0.49928029643207167,1.2797149213326018,0.15282791817087846,0.7163908088918756,1.0,15/36,22.33%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;TMEM165;ABCA1;HPS4;ACP3;CLN3;SNAPIN;MYO7A;LRRK2;ZKSCAN3
prerank,gas transport (GO:0015669),0.6300087465465377,1.2790546754413008,0.2026431718061674,0.717996916724905,1.0,1/10,1.37%,CYGB
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5736791878546182,1.278930073144378,0.17553191489361702,0.717370434419454,1.0,6/17,8.87%,KCNJ2;CACNA1G;CACNA1C;HCN4;ANK2;TRPM4
prerank,cell-cell junction assembly (GO:0007043),-0.32471318347806866,-1.2788897689269838,0.07228915662650602,0.5620823617414036,1.0,18/63,9.52%,TJP1;TLN2;GJB6;CDH8;CDH5;CLDN5;EPB41L3;PKP4;GJB2;ARVCF;GJC1;GJD3;PIP5K1C;CDH6;CDH2;CDH7;CDH19;CDH20
prerank,positive regulation of cell adhesion (GO:0045785),0.46786546473634083,1.2787494761841711,0.10907127429805616,0.7169535906181028,1.0,19/74,17.75%,ZFHX3;VEGFA;ADAM9;P4HB;VIT;TGFB2;PRKCA;AGR2;FOXC2;TFE3;ITGAV;ATM;SMAD7;ARL2;NDNF;STX4;ERBB2;FLCN;CITED2
prerank,negative regulation of cell junction assembly (GO:1901889),0.5339870326214474,1.2786134538538576,0.1702127659574468,0.7163152046127143,1.0,3/25,5.22%,THBS1;SLIT1;BCAS3
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5622171328257428,1.2783380833601417,0.1959731543624161,0.716241213377386,1.0,3/19,10.69%,LBP;PRKCE;IRAK1
prerank,neural crest cell migration (GO:0001755),-0.37067094091719077,-1.2783032099533307,0.12162162162162163,0.560618818341846,1.0,16/36,21.24%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;SEMA4D;SEMA3G;FN1;SEMA4A;HTR2B;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5026582672421509,1.2782754758967028,0.13879408418657566,0.7153837635339394,1.0,19/41,26.42%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;SCARB2;NUP85;NUP160;TPR
prerank,presynaptic endocytosis (GO:0140238),0.5355630230095436,1.2782335520906607,0.17002518891687657,0.7144688964421241,1.0,10/24,20.59%,STON2;SYT8;CEL;FCHO2;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,negative regulation of organelle assembly (GO:1902116),0.5114146509228907,1.276829131553099,0.160188457008245,0.7190118746274858,1.0,18/35,25.58%,TMEM39A;LIMK2;SMAD4;CDK10;SCFD1;EVI5L;KAT2A;PHF23;SEC22B;CHMP4A;CHMP4B;LRRK2;CDK5RAP2;MTM1;KAT2B;SMCR8;PINK1;CCP110
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4906855006699264,1.2767623609227328,0.14605418138987045,0.7181617965018927,1.0,5/40,3.20%,ESR1;EGFR;FGF2;NTRK3;EDNRA
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.569867259672786,1.2764306833989034,0.21372031662269128,0.7183676360342027,1.0,4/17,8.51%,PCSK5;HDAC9;ANGPTL4;LMF1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5533861519892321,1.2755913832748322,0.16318537859007834,0.7205705703002437,1.0,4/21,11.35%,LRP6;DVL1;FZD5;AXIN1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5634224740503132,1.2748643607623777,0.18766404199475065,0.722214957381174,1.0,5/18,10.59%,PRKDC;TBX21;IKZF3;CRTAM;ABL1
prerank,negative regulation of phosphorylation (GO:0042326),0.4598773995383028,1.2744805128531058,0.12473347547974413,0.7225830337617298,1.0,19/85,13.03%,SLIT2;LRP6;PID1;NTRK3;PLPP3;EPHB2;HDAC4;WWTR1;XDH;ACTN3;PRKDC;IMPACT;CDK5RAP3;BMP4;PAQR3;NIBAN1;GIT1;CHP1;INHBA
prerank,response to molecule of bacterial origin (GO:0002237),0.4584777651424675,1.2744611990977321,0.12269272529858849,0.721563330965361,1.0,18/69,18.91%,FOXP1;LBP;SMAD6;IRAK3;LIAS;FZD5;IRAK1;TAB2;F2R;SRR;PRDX3;CYP27B1;IL6;SIRT2;OTUD5;TRIM6;ACOD1;ERBIN
prerank,DNA modification (GO:0006304),0.5424314273160182,1.2744564846107151,0.17534942820838628,0.7204737162892672,1.0,7/22,16.21%,PARP3;MPG;OGG1;TDG;SMUG1;EXOSC4;PARP1
prerank,regulation of receptor recycling (GO:0001919),0.5676828217279686,1.2744184355476185,0.1891891891891892,0.719516555616933,1.0,6/16,20.95%,ECE1;ANXA2;LAMTOR1;NSF;TRAT1;OPTN
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5684025299847788,1.2742785797725633,0.17473118279569894,0.7189764062498973,1.0,4/17,14.43%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.525256807342716,1.2741849343773903,0.16917293233082706,0.7182531302275286,1.0,9/26,13.55%,FHL1;ATP1B1;NEDD4;STK39;ANK2;DLG1;WWP2;AKAP9;YWHAE
prerank,GTP metabolic process (GO:0046039),0.5714249185326897,1.2741242570258011,0.20272108843537415,0.7174065388296125,1.0,7/15,21.88%,RHOQ;AK3;RAB23;EFL1;ENTPD7;LRRK2;MFN1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.6155777517499808,1.2734440432689802,0.1882183908045977,0.7189904673756263,1.0,2/11,2.26%,GSN;PRR7
prerank,positive regulation of vacuole organization (GO:0044090),0.6319259419562236,1.2734198139292543,0.19407407407407407,0.7179704389416897,1.0,4/10,10.05%,ANXA2;LRSAM1;RAB3GAP1;PIP4K2B
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.43254623220963606,1.2733085854288475,0.047474747474747475,0.7173223078094496,1.0,68/184,25.78%,PKD1;ID2;ANAPC5;PSMD7;PPP1R9B;CSNK1D;CDC16;DYNC1H1;SFI1;PSMA8;ODF2;CDC14A;ALMS1;CDC6;DCTN2;PSMA4;CKAP5;UBE2C;PSMD12;ANAPC4;ERCC3;SDCCAG8;AKAP9;ZW10;CUL1;CEP164;CSNK1E;PSMA6;YWHAE;ERCC2;PSMD1;CEP41;CEP63;PCM1;ANAPC2;SIRT2;PSMC5;HAUS5;ANAPC1;PSMD11;PSMC4;PSMD14;RPS27A;UBC;ANAPC10;E2F1;CDC20;CDC27;CDK2;DYNC1I2;APPL2;APPL1;PSMA3;DCTN1;PRKACA;PSMB1;PSMD4;ACTR1A;CDK5RAP2;NEDD1;PSMA5;PSMA7;PLK4;CNTRL;RIOK2;TUBB4B;CCP110;PSMC1
prerank,protein depolymerization (GO:0051261),0.5277181287126609,1.2731678793648629,0.17783191230207065,0.7168023932457855,1.0,3/27,2.01%,MICAL2;GSN;STMND1
prerank,dendritic spine morphogenesis (GO:0060997),0.5877531672866898,1.2725833823292492,0.1768617021276596,0.7179979719818809,1.0,6/15,11.52%,CTNND2;EPHB2;ARC;EPHB3;DLG4;SHANK1
prerank,response to amino acid starvation (GO:1990928),0.4612881138728583,1.2725480093267503,0.10782241014799154,0.7170290409598189,1.0,31/72,25.64%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;DAP;IMPACT;CASTOR2;MAPK8;ATP6V0D1;SESN2;ATP6V1B2;ATP6V1E1;FLCN;ATF2;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;ATP6V0B;LAMTOR2
prerank,protein targeting to lysosome (GO:0006622),0.54953508963108,1.2724227850897856,0.16861219195849547,0.7164400906602263,1.0,11/20,34.65%,NEDD4;NAGPA;ZFYVE16;CLU;LAMP2;SCARB2;GCC2;GGA3;GNPTAB;M6PR;SNX16
prerank,photoperiodism (GO:0009648),0.5179024552735011,1.2718637917215778,0.15956151035322777,0.7175217622897151,1.0,8/28,15.24%,ID2;PPP1CC;USP2;PER3;BHLHE40;FBXL12;RBM4;PER1
prerank,regulation of angiogenesis (GO:0045765),0.4309013985224479,1.2716356818888108,0.05358948432760364,0.7172724800159442,1.0,29/192,10.01%,BMPER;THBS1;SMOC2;PGF;RHOJ;HOXA5;VEGFA;F3;FGF2;PTGIS;EMILIN1;PROK2;ISM1;TWIST1;SPARC;CYP1B1;TGFB2;SERPINF1;SEMA3E;RAMP2;PRKCA;THBS2;SULF1;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.5904250916575021,1.2714393384285816,0.18218623481781376,0.7169762776542377,1.0,6/14,19.73%,PKD1;NFKBIB;G3BP2;MDFI;SUFU;NFKBIA
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5927704762509831,1.2711689834220352,0.203778677462888,0.7169501711037415,1.0,4/13,11.05%,BLOC1S2;RHOT2;RHOT1;VDAC2
prerank,protein maturation (GO:0051604),0.4511832532704784,1.2700970366196227,0.12179487179487179,0.7200651920474013,1.0,26/95,18.37%,ADAMTS3;PCSK5;F3;ECE1;CPZ;NAA60;ADAM10;NAA40;MMP14;TASP1;LMF1;DDI2;OGT;BACE1;NAA16;SDE2;HSPD1;MMP16;GCSH;CPXM2;MMS19;PSEN2;STUB1;LIPT1;PCSK7;CLN3
prerank,tRNA processing (GO:0008033),0.46736534372994937,1.2699087870643733,0.13777777777777778,0.71973204489369,1.0,24/61,23.80%,TSEN54;SSB;ANKRD16;ELP5;FAM98B;TRMT1;PUS3;TRUB1;CTU2;CLP1;CPSF4;RTCB;RPP40;ELAC2;ADAT1;TRMT6;SARS1;CSTF2;RTRAF;TRMT61A;METTL1;NSUN6;TSEN34;RPP21
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44452390748290604,1.2697677126783906,0.09538461538461539,0.7191452071657689,1.0,10/122,4.20%,THBS1;SMOC2;EGFR;IRS1;FGF2;IL33;LDB1;GLI2;SAMD4A;TGFB2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.47259961484321367,-1.2697547572954193,0.18214285714285713,0.5789911815064458,1.0,6/14,14.06%,WNT5A;KIT;SEMA7A;GPRC5B;CD74;SIRT1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5188947676919162,1.269134897340573,0.17772511848341233,0.7205605369064639,1.0,14/31,24.84%,PEX7;TOMM40;PEX5;PEX16;PEX1;AIFM1;HSPD1;PEX10;TOMM70;GRPEL1;PEX6;PEX2;PEX14;TIMM17B
prerank,positive regulation of bone mineralization (GO:0030501),-0.37671080039903565,-1.2689837259287462,0.10828025477707007,0.577731350518226,1.0,12/35,9.15%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;BMP7;KL;ATP2B1;FBN2;ANO6;BMPR2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5467279807470421,1.2678068246145242,0.17935483870967742,0.7247663330261458,1.0,7/20,6.98%,CACNA1C;ATP1B1;CAMK2D;CALM2;DMD;SLC9A1;ANK2
prerank,negative regulation of endocytosis (GO:0045806),-0.40630261829664405,-1.2668129529428516,0.15765765765765766,0.5802537000238496,1.0,7/24,13.30%,MCTP1;PICALM;NR1H3;PACSIN3;CD300A;CAV1;PRKD1
prerank,pulmonary valve morphogenesis (GO:0003184),0.5659403975274948,1.2667570164295856,0.16983695652173914,0.727743511221532,1.0,8/17,12.12%,SLIT2;SMAD6;TGFB2;JAG1;HEYL;NFATC1;BMP4;HEY1
prerank,cellular response to heat (GO:0034605),0.502479770029293,1.2661315779587867,0.1773049645390071,0.7291825270259511,1.0,9/35,17.54%,THBS1;BAG3;VCP;HIKESHI;RBBP7;YWHAE;STUB1;SUMO1;HMOX1
prerank,negative regulation of DNA replication (GO:0008156),0.5908179669014704,1.2659950937481714,0.1975806451612903,0.7286727807133858,1.0,9/13,30.53%,CDC6;CDAN1;GMNC;PDS5A;GTPBP4;S100A11;WAPL;ATR;RAD17
prerank,cellular response to misfolded protein (GO:0071218),0.5517328798324057,1.2657122304096164,0.18227848101265823,0.7287354368742387,1.0,10/20,25.97%,VCP;DNAJB14;UGGT2;UGGT1;STUB1;DNAJC18;DERL1;DNAJB12;UBE2W;RNF126
prerank,acute inflammatory response (GO:0002526),0.5439314606131167,1.265336425705586,0.16793893129770993,0.7291041864313099,1.0,2/23,1.07%,LBP;F3
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.43997072915266733,1.264949523121438,0.08385093167701864,0.7295318463074613,1.0,20/118,9.71%,BMPER;PID1;EFNA5;FGF2;NEDD4;FMNL2;SRCIN1;PROK2;PHLDB1;ARC;SPARC;SIPA1L1;LZTS1;EPHB3;BCL9L;POGLUT1;CHRNB2;TANC2;PAK2;FGFR2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.36443544015228074,-1.264712604643967,0.1111111111111111,0.5826019101239944,1.0,14/37,10.82%,PLCB1;GRM7;GRM5;GRM3;APP;GRM8;GRID2;GRM1;GRIK2;GRIN2B;GRIA4;HOMER1;GRIN2A;GRIA3
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.36822633329737814,-1.2643993856974423,0.14689265536723164,0.5805669618390267,1.0,10/37,6.79%,ALCAM;CADM1;IL1RAPL1;GRID2;VCAM1;PTPRD;TENM4;TENM3;CXADR;TENM2
prerank,regulation of cell growth (GO:0001558),0.4258701853554371,1.264376283219305,0.048144433299899696,0.7307881782594143,1.0,48/204,17.71%,SLIT3;SLIT2;EGFR;FHL1;PLCE1;OSGIN2;CCN3;ACVR1B;PPP1R9B;PRDM11;CAMK2D;CSNK2A1;TGFB2;EIF4G2;FXN;DCUN1D5;LAMTOR1;CCAR2;SMAD4;ADAM10;MMP14;CXCL16;TMC8;PAK4;DACT3;SOCS2;NDRG3;SERTAD2;DCBLD2;ITCH;URI1;SESN2;TGFBR1;EIF4G1;INHBA;CGRRF1;RBBP7;SUPV3L1;SERTAD3;CYP27B1;EXOSC4;KLHL22;ERBB2;MINAR1;APBB1;NCBP1;FLCN;HDGFL2
prerank,heart morphogenesis (GO:0003007),-0.33220800512524395,-1.2643137664719692,0.11851851851851852,0.5778614349292843,1.0,10/50,5.92%,TGFBR3;ENG;INSR;CHD7;NOS3;TBX3;NOTCH1;RYR2;TBX1;SOX17
prerank,lipoxygenase pathway (GO:0019372),-0.4532753268283687,-1.2642627956452508,0.18518518518518517,0.5751220418619142,1.0,4/14,12.80%,PON2;HPGD;ALOX12;GPX1
prerank,negative regulation of anoikis (GO:2000811),-0.45543458590604863,-1.2640828109533804,0.1797752808988764,0.5726963230311009,1.0,5/14,15.88%,BCL2;NOTCH1;TLE1;CAV1;PTK2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6193430963896357,1.263845752214686,0.19574468085106383,0.7319489090478728,1.0,2/10,1.49%,XYLT1;DSE
prerank,mRNA processing (GO:0006397),0.4283070301134358,1.263658097529849,0.02404809619238477,0.7316115001573137,1.0,111/287,25.90%,SRSF6;DDX5;HNRNPH1;SRSF1;PABPC1;SRSF5;SRSF2;CASC3;SNRNP70;SNRNP48;PRPF40B;FUS;HNRNPA2B1;SRSF11;CHERP;SYMPK;HNRNPL;RAVER2;HNRNPH2;SF3B2;SF3B1;PPIL3;SF3A1;PNN;TBRG4;ZC3H11A;RBM10;SNRNP25;GTF2F1;SRRM1;U2AF1;RBM6;CHTOP;RBM5;PABPN1;SFPQ;CRNKL1;ERCC3;XAB2;CWF19L1;HNRNPM;PCBP2;LSM2;ZRSR2;PTBP1;RALY;GEMIN7;RBM4;ERCC2;HNRNPC;U2AF2;RBM17;CLP1;CPSF4;HNRNPK;YTHDC1;POLR2F;SARNP;TFIP11;THOC2;SRSF3;ISY1;PCF11;RPRD1A;IK;NCBP1;WDR83;SNRPA;SRSF7;SRSF10;CWC25;CPSF7;AQR;CPSF6;U2SURP;RBM22;NCBP2;SYNCRIP;CSTF2;TRA2B;RAMAC;MTREX;HNRNPH3;TRA2A;PRKACA;ZCCHC8;SNRPB2;CSTF2T;DHX8;HNRNPA3;SNRPB;GEMIN2;HNRNPA1;SRSF4;POLR2B;DHX16;RBM19;PRMT9;SF3B6;HNRNPU;YBX1;USP49;SF1;SUGP1;UPF3B;SNRNP35;DDX39B;GTF2H4;METTL14;POLR2H;RNMT
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3690322415572609,-1.263442230374805,0.11235955056179775,0.5714305001401648,1.0,6/34,6.43%,ROCK2;APOE;EPHA4;PICALM;ABCG1;GSAP
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5237045770873533,1.2634384695977043,0.1925925925925926,0.7314045490281621,1.0,6/26,9.84%,SMOC2;PRKCA;USP2;PKN2;CDC25B;FOXA1
prerank,negative regulation of myotube differentiation (GO:0010832),0.6076428830257453,1.2632239684017732,0.19686162624821682,0.7311299295257302,1.0,4/12,12.69%,CCN3;HDAC4;TMEM119;HDAC1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5497577873708832,1.2631935938987893,0.20410783055198972,0.7301627758594951,1.0,2/19,0.50%,EXT1;XYLT1
prerank,positive regulation of neutrophil migration (GO:1902624),-0.44839843504035604,-1.2631020201264807,0.15668202764976957,0.5694847379380926,1.0,4/18,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,regulation of astrocyte differentiation (GO:0048710),0.5997820852144202,1.2620016285202222,0.20266666666666666,0.7337391087036547,1.0,6/12,15.25%,ID2;HES5;NOG;SERPINE2;CLCF1;IL6
prerank,positive regulation of vasculature development (GO:1904018),0.44556602464234063,1.26167292356519,0.1109936575052854,0.7339381177833713,1.0,17/94,10.01%,THBS1;SMOC2;PGF;VEGFA;F3;FGF2;PTGIS;TWIST1;CYP1B1;RAMP2;PRKCA;ANGPTL4;JUP;PAK4;STIM1;ANGPT4;AGGF1
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3435786374506597,-1.261641976067396,0.11023622047244094,0.5702194093025305,1.0,12/47,7.46%,TGFBR3;LEF1;ENG;ROCK2;WNT4;WNT5A;BMP7;TBX3;NOTCH1;NOTCH4;RBPJ;AKNA
prerank,BMP signaling pathway (GO:0030509),0.4658178824599855,1.2616173260349401,0.16703296703296702,0.733062082553044,1.0,15/62,12.49%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;NOG;BMP4;RUNX2;BMPR1A;SMAD7;RGMA
prerank,protein localization to cell junction (GO:1902414),-0.4102199157449379,-1.2613695457484555,0.1509433962264151,0.5680714081997053,1.0,4/22,4.80%,TJP1;CGNL1;HEG1;BSN
prerank,endocardial cushion morphogenesis (GO:0003203),0.5468808835886809,1.2613261523048396,0.20155038759689922,0.733173528955003,1.0,10/18,12.12%,TGFB2;ACVR1;TGFBR2;HEYL;MDM4;SOX9;NOG;BMP4;BMPR1A;HEY1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.3780027204543711,-1.2608115369898296,0.0963855421686747,0.5669454277816405,1.0,6/30,7.85%,ROBO1;LPAR1;ARHGEF3;NET1;F11R;PRAG1
prerank,regulation of histone modification (GO:0031056),0.5894087462776371,1.2607819873103039,0.20495185694635487,0.7342436898785116,1.0,9/13,31.49%,SETD5;NNMT;FLCN;AKAP8;MTHFR;PARG;IGF2;CDK9;UBE2N
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5010853213038629,1.2604734017652537,0.1701093560145808,0.734330100020682,1.0,6/32,13.60%,CCL13;RNASE7;RNASE3;RNASE6;DEFB1;HMGN2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.4900263099956702,1.2600153167938457,0.16647264260768335,0.7350365435742698,1.0,14/36,20.21%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX
prerank,regulation of protein kinase B signaling (GO:0051896),0.4314656324399392,1.2599099538682639,0.055611729019211326,0.7343702663240317,1.0,17/193,4.54%,THBS1;MYOC;ESR1;EGFR;IRS1;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;NTRK3;NTRK1;FGF17;GAB2;PKHD1;PHLPP2;XDH
prerank,protein localization to organelle (GO:0033365),0.43596737406502944,1.2594574838928019,0.0811088295687885,0.7350903679399863,1.0,24/133,13.55%,SIX1;ZNF423;COL1A1;CNTLN;TSPAN10;EHD1;STX5;CSNK1D;TOPORS;LMNA;SIX4;DVL1;BBS9;SSB;IFT20;ANK2;GBF1;TRAM2;BMP4;PAQR3;CSRP3;CNEP1R1;ALDH3A2;YWHAE
prerank,histone H4 acetylation (GO:0043967),0.4723838352821881,1.2592881644359866,0.15582959641255606,0.7346789761426217,1.0,23/47,23.26%,KANSL2;MORF4L2;NAA60;NAA40;TRRAP;ING3;MORF4L1;OGT;ING5;WDR5;PER1;ING4;APBB1;HCFC1;ATF2;BRD8;KANSL1;KAT7;MSL1;KAT8;KMT2A;MEAF6;ZZZ3
prerank,non-motile cilium assembly (GO:1905515),0.504514785263859,1.2581465491879313,0.17114914425427874,0.7382303539247498,1.0,9/30,16.02%,GORAB;CSNK1D;TMEM107;TMEM216;RPGRIP1L;TMEM80;FUZ;PCM1;IFT88
prerank,cellular response to mechanical stimulus (GO:0071260),0.47707540631656103,1.257946809126952,0.16569428238039674,0.7379710277838134,1.0,8/46,13.71%,PIEZO2;CRADD;SLC9A1;SOX9;MAPK8;LTBR;TNFRSF10B;CASP1
prerank,histone acetylation (GO:0016573),0.4516693221897747,1.257525275279784,0.1356297093649085,0.7386078345631907,1.0,30/69,23.44%,MORF4L2;TADA1;NAA60;MRGBP;NAA40;TRRAP;TADA2A;ING3;SGF29;KAT14;MORF4L1;BRPF3;ING5;KAT6B;TAF6;WDR5;KAT2A;PER1;ING4;CREBBP;APBB1;ATF2;BRD8;KAT7;YEATS2;KAT8;TAF6L;MEAF6;ZZZ3;KAT2B
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5177936683288724,1.257406419328235,0.18888888888888888,0.7380814715934294,1.0,12/26,22.61%,KMT5C;OGT;SETD5;KMT2D;SETD4;WDR82;SUV39H2;SETD1A;TET2;SUV39H1;SETD2;KMT2A
prerank,protein deubiquitination (GO:0016579),0.4249364837849903,1.2572162071735435,0.036072144288577156,0.7378021758463413,1.0,113/242,30.65%,ESR1;IL33;PSMD7;USP24;VCP;USP2;PSMA8;SMAD4;OTUB1;USP50;TRRAP;MDM4;MBD6;FOXK1;ENY2;OGT;RHOA;INO80E;RHOT1;PSMA4;USP40;UCHL3;INO80B;WDR48;USP48;USP45;SMAD7;PSMD12;OTUB2;KAT2A;USP34;TRAF3;TGFBR1;USP11;PSMA6;STAM2;USP7;USP33;USP36;PSMD1;USP13;PSMC5;USP19;USP35;PSMD11;PSMC4;PSMD14;RPS27A;UBC;OTUD5;OTULIN;CDC25A;POLB;SHMT2;YOD1;SENP8;CDC20;USP32;USP10;HCFC1;USP46;ACTR8;USP1;UCHL5;ZRANB1;NFKBIA;TAF9B;OTUD6B;PSMA3;UCHL1;BRCC3;USP5;SMURF2;PSMB1;PSMD4;USP47;DESI2;BIRC3;PSMA5;CYLD;KAT2B;PSMA7;USP4;USP49;ASXL2;USP14;TP53;SNX3;CCP110;SUDS3;PSMC1;RIPK1;YY1;ATXN7;TAF10;MYSM1;USP21;USP16;PSMA1;USP22;USP37;USP30;TADA3;NLRP3;FOXO4;ADRM1;PRKN;OTUD3;PSMD2;USP26;SPATA2;KEAP1;COPS5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.6038789984461423,1.257211733488674,0.20229555236728838,0.7367681847749551,1.0,7/11,15.99%,RSPO3;PLEKHA4;CSNK1D;LBX2;CSNK1E;DAB2;MLLT3
prerank,negative regulation of RNA splicing (GO:0033119),0.5532508166725086,1.2563560771118085,0.21045918367346939,0.7391213934133708,1.0,10/19,25.06%,SRSF6;PCBP4;PTBP1;U2AF2;SRSF7;SRSF10;SAP18;SFSWAP;SRSF4;C1QBP
prerank,cellular response to estrogen stimulus (GO:0071391),0.5724575100772843,1.2563298614438196,0.2072678331090175,0.7381789238350996,1.0,5/14,12.63%,BCAS3;RARA;SRA1;SFR1;SERPINB9
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4532452242456218,1.256287337726457,0.1411637931034483,0.7372969953280982,1.0,22/78,19.98%,EGFR;PID1;LRP1;RHOQ;PRKCE;EPHB2;PLS1;PPFIA1;AGR2;MMP14;DLG1;PDPK1;CLTC;SQSTM1;DAB2;STAC3;STX4;SPTBN1;CLN3;AKT1;CDK5;APPL1
prerank,eye morphogenesis (GO:0048592),0.5418793402568989,1.2561187927671877,0.19261213720316622,0.7369150836910214,1.0,5/19,7.28%,MFAP5;VEGFA;COL5A2;STAT3;SKI
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5032766572849452,1.2560299067619418,0.17204301075268819,0.7361781783734613,1.0,8/32,11.12%,PEMT;CSNK2A2;CSNK2A1;LPCAT1;STARD7;GPAT4;LPCAT3;PCTP
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.475451586522218,1.25590065113406,0.16013824884792627,0.7355487611688504,1.0,12/48,15.19%,SLC26A2;AK5;PAPSS2;ADCY2;ADCY8;ADCY9;PANK4;DCAKD;ACAT1;AMPD3;GUCY2D;SLC35B3
prerank,regulation of transferase activity (GO:0051338),0.5531824336644636,1.2555502876431783,0.20647773279352227,0.7358810705188286,1.0,5/17,11.27%,LDB2;LDB1;SMG6;PPP1R3F;ATM
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4624220987137439,1.2554039509880628,0.11572052401746726,0.7353603557826321,1.0,22/74,17.25%,COL1A1;TIAM1;PHLDB1;TGFB3;TWIST1;LDLRAD4;SPRED2;WWTR1;TGFB2;BCL9L;SMAD4;TGFBR2;FOXA1;SMAD7;TGFB1I1;TGFBR1;DAB2;BMP5;IL6;IL17RD;CRB2;EFNA1
prerank,regulation of protein phosphorylation (GO:0001932),0.4223853998950586,1.2552126410340878,0.04522613065326633,0.7350650240927306,1.0,45/256,12.59%,BMPER;SLIT2;PGF;EGFR;LRP6;PID1;SLCO3A1;VEGFA;EFNA5;PLCE1;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;PLPP3;EPHB2;CSNK1D;WWTR1;LIMK2;ATF4;XDH;MAVS;BRD4;ILK;PRKDC;RSPO1;SOX9;NSD1;AKT2;IMPACT;CDK5RAP3;BMP4;TMEM119;PAQR3;MUSK;ABL1;NIBAN1;AXIN1;ROPN1L;SOD1;PHIP;CHP1;SESN2
prerank,protein localization to centrosome (GO:0071539),0.565014329301007,1.255199965030015,0.18120805369127516,0.734070362539791,1.0,5/17,15.08%,CSNK1D;GOLGB1;DCTN2;NUDCD3;PCM1
prerank,cellular protein localization (GO:0034613),0.4224117133197202,1.2549653493089636,0.022110552763819097,0.7339730474466781,1.0,102/285,25.74%,EGFR;SGSM2;CNTLN;ARFGAP3;CTTN;SEC31A;KIF13A;EHD1;TBC1D8B;TBC1D2B;STX5;SEC13;ARCN1;RAB43;PTPRU;TM9SF4;COPA;RAB24;STX11;AP2A1;RIC3;PACS2;DMD;RAB21;LAMTOR1;RIC1;TLK1;GGA2;ANK2;WIPI2;ARF4;COPZ2;SNX1;SH3PXD2B;NSF;SCFD1;STX2;VPS26A;ARFIP2;RAB38;CSRP3;ARF1;SNX9;AP3D1;TMED9;WDR11;USO1;EVI5L;TBC1D9B;TBC1D25;ERP29;PICK1;VIPAS39;CLTC;RAB23;TBCK;TBC1D10A;SIL1;STX4;ID1;COPB2;STX1A;SCFD2;TBC1D17;HDAC6;STX16;GGA1;NIPBL;SNX13;NAPA;TMED2;RAB5B;VPS45;SNX15;SEC23IP;RAB3GAP2;MYO7A;COX18;EVI5;TBC1D22B;TM9SF1;VPS26C;IFT27;FBLN5;LRRK2;RAB1A;RAB18;UNC50;RAB1B;COPZ1;RABGAP1;ARF5;USP4;TMED7;ATG9A;AP3B1;STX1B;PRRT1;LAMTOR2;FAM91A1;STX19;ATG13
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5543938910824832,1.2549084468012823,0.20671834625322996,0.7331652642464553,1.0,5/19,11.94%,GAS6;ZMIZ1;PRKDC;MMP14;CD27
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5123091929904985,1.2548001563891766,0.19315403422982885,0.7325378730735823,1.0,5/27,4.30%,XYLT1;BGN;CHST11;CHPF2;CSPG4
prerank,hepaticobiliary system development (GO:0061008),-0.42617835862778264,-1.254790397582465,0.1638655462184874,0.5796015292273402,1.0,5/20,5.88%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6211205448076391,1.254601323876876,0.2025862068965517,0.7322818989655591,1.0,8/10,33.82%,DGKQ;OGT;USP7;GNMT;SELENOS;ZNF692;SIRT7;SDHAF3
prerank,negative regulation of secretion (GO:0051048),-0.5041727458100461,-1.254200869855435,0.20711974110032363,0.5783049573880591,1.0,5/10,23.36%,NR1H3;CD74;ERBB3;PTGER3;NRG1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.597414934821521,1.2538737364936312,0.21225071225071226,0.7340416928351343,1.0,7/11,24.64%,MUC1;FOXM1;ING4;HIPK2;MAD2L2;TP53;RPS27L
prerank,protein sumoylation (GO:0016925),0.47804953956477614,1.2538487012236683,0.15600448933782268,0.7331302182743913,1.0,22/49,26.42%,NUP93;TOPORS;TRIM28;RAE1;SEH1L;TRPM4;NUP37;RANBP2;PIAS4;NUP88;STX1A;SUMO1;POM121;NUP210;SAE1;NUP62;SUMO2;NDC1;NUP35;NUP85;NUP160;TPR
prerank,estrogen metabolic process (GO:0008210),0.5777257021213773,1.2532532203344686,0.20901639344262296,0.7344147889972181,1.0,2/15,3.46%,CYP19A1;CYP1B1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4585122430983811,1.2531890668111958,0.1539301310043668,0.7336366177223744,1.0,11/68,8.14%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;TCF7L1;DVL1;BCL9L;FZD7;FZD5
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.4194823053878065,-1.2530868748253072,0.1688888888888889,0.5782352315822967,1.0,8/21,18.03%,EPHA7;GRIN2B;AIM2;SOX2;GRIN1;DELE1;PYCARD;MT3
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.46984148623528194,-1.2528954605225286,0.21505376344086022,0.5759411509260218,1.0,3/13,10.00%,GRM3;ADGRV1;EDNRB
prerank,cardiac conduction system development (GO:0003161),0.5311202881705717,1.2526173308386457,0.1782178217821782,0.7347513133020307,1.0,6/24,12.12%,CACNA1G;HCN4;SMAD4;BMP4;BMPR1A;HEY1
prerank,regulation of cellular response to stress (GO:0080135),0.43935103290894983,1.2514656601382717,0.10677618069815195,0.7381493010630735,1.0,54/115,31.19%,SLC38A2;NUP93;SEC13;CAMK2D;ATF4;RAE1;BAG3;ADCY8;CCAR2;SEH1L;HIKESHI;AKT1S1;SMG1;ABL1;ATM;NUP37;DNAJC7;CHORDC1;EIF4G1;YWHAE;MANF;RANBP2;NUP88;USP19;CREBBP;POM121;NUP210;CLN3;ARMT1;NUP62;NEK4;ABCD1;DNAJC2;NDC1;RPTOR;NUP35;FKBP4;AMFR;PINK1;VASH1;NUP85;NUP160;TPR;HSPB8;NEK6;HSF1;BAG1;ATR;DNAJB1;NUP50;PRKN;HSP90AA1;NUP188;HSPH1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4476212373758477,1.2506307553292184,0.15755627009646303,0.7402758574490996,1.0,24/73,24.51%,EGFR;VEGFA;GAS6;NTRK3;DOCK7;PFN2;RAF1;AXIN1;TENM1;AKAP9;EIF4G1;IL6;HDAC6;ARAF;TRIM6;CNOT9;AKT1;TNKS1BP1;MAD2L2;ATP2B4;CAMK1;RPTOR;TBK1;PINK1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4552530532951424,1.2501294900085407,0.13230429988974643,0.741200845764087,1.0,16/70,16.48%,PLA2G4F;PLA2G4A;PEMT;CSNK2A2;CSNK2A1;LPCAT1;MBOAT2;LPCAT4;STARD7;GPAT4;PLA2G5;LPCAT3;PCTP;PLA2G12A;CHKB;PLA2G15
prerank,lytic vacuole organization (GO:0080171),0.4959521731968705,1.2500456676337872,0.1796116504854369,0.7404790695604561,1.0,14/32,22.33%,ARSB;GAA;LAMTOR1;MBTPS1;NAGPA;TMEM106B;ABCA1;HPS4;ACP3;CLN3;SNAPIN;MYO7A;LRRK2;ZKSCAN3
prerank,regulation of trophoblast cell migration (GO:1901163),0.5859190266875229,1.2499188862459736,0.2024623803009576,0.7399155271968706,1.0,7/14,25.38%,VEGFA;ACVR1B;AGO2;CALR;SMURF2;C1QBP;ARHGDIB
prerank,positive regulation of actin filament polymerization (GO:0030838),0.47907786530792346,1.2493853323006956,0.16493656286043828,0.7410219671725268,1.0,10/44,15.30%,GSN;CTTN;PRKCE;CDC42EP2;PFN2;SNX9;TENM1;CDC42EP5;SCIN;SPIRE2
prerank,positive regulation of biosynthetic process (GO:0009891),-0.3485420077316906,-1.248866176810237,0.11594202898550725,0.5833801084995777,1.0,12/40,15.81%,SORBS1;WNT4;APOE;PPARA;SLC5A3;ZBTB20;VIM;MTPN;SUCO;ADGRB1;GRIN1;CREBL2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5361075418267697,1.248823638367147,0.18717948717948718,0.7421581708947698,1.0,7/22,16.85%,ATP1B1;CALM2;SLC9A1;ANK2;P2RY6;STAC3;CALM3
prerank,zinc ion transport (GO:0006829),0.54146588942643,1.2487726762063664,0.20205920205920205,0.7413243873846247,1.0,8/21,17.32%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6;SLC30A9
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.5560560429723707,1.2486028098702382,0.22148541114058357,0.7409835913799828,1.0,12/16,32.97%,MCMDC2;MCM2;WRN;MCM4;HMGA1;RAD51;TWNK;RECQL5;MCM7;SSBP1;BLM;PURA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5301331007166976,1.2483712774053228,0.17888198757763976,0.7408261285450133,1.0,7/24,12.59%,VEGFA;MUC1;GCN1;ATF4;NFE2L2;HSPA5;SESN2
prerank,regulation of anoikis (GO:2000209),-0.41828124673721817,-1.2483569596988249,0.18303571428571427,0.5819756098975133,1.0,8/19,21.48%,BCL2;NOTCH1;TLE1;CAV1;BRMS1;PTK2;SIK1;MCL1
prerank,protein processing (GO:0016485),0.44145756498073496,1.2483203689729347,0.13403141361256546,0.7400261280531925,1.0,20/102,15.15%,ADAMTS3;PCSK5;F3;ECE1;PRSS12;CPZ;HM13;FXN;ADAM10;SPG7;MMP14;DDI2;OGT;BACE1;SDE2;MMP16;SPCS2;CASP1;CPXM2;PSEN2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.5734163735839026,1.2482915429278534,0.2054263565891473,0.7391129240932586,1.0,8/15,26.61%,VCP;FAF2;SYVN1;NPLOC4;DERL1;HERPUD1;SELENOS;SEC61B
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.5532559884062823,1.248020550072489,0.2018111254851229,0.7391104846878557,1.0,7/18,17.52%,EDEM2;SYVN1;UGGT2;UGGT1;RPS27A;UBC;TRIM13
prerank,icosanoid metabolic process (GO:0006690),0.48011322765919673,1.2479825407872767,0.1615566037735849,0.7382456865395567,1.0,7/40,10.33%,MGLL;PTGIS;PLA2G4A;CYP1B1;ABCC1;DAGLA;FADS1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.595489891350468,1.247870409415406,0.2173314993122421,0.7376644444886391,1.0,4/12,6.89%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5190285779467665,1.2475845559497483,0.1962025316455696,0.7377409371124815,1.0,12/25,26.31%,LDB1;BRD4;CDK12;HEXIM1;ZMYND11;LARP7;NELFB;HNRNPU;CDK13;EAF1;RECQL5;NELFA
prerank,cellular defense response (GO:0006968),0.48519803499560077,1.246973804728719,0.18128654970760233,0.7390684342486853,1.0,4/40,4.24%,LSP1;LBP;SPN;TCIRG1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.5594405901066793,1.2467455007377501,0.205607476635514,0.7389597008860804,1.0,9/16,21.66%,ANK2;GBF1;BCAP31;HSPA5;SEC16A;BCAP29;MIA3;SEC16B;LRRK2
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.4841497761141901,-1.2465138791511279,0.19444444444444445,0.5841125675311181,1.0,4/11,13.17%,ENPP3;SLC19A3;ERH;SLC19A2
prerank,regulation of bone mineralization (GO:0030500),-0.3348749890588054,-1.246365218138035,0.10679611650485436,0.5817628570813288,1.0,16/55,6.42%,PTN;WNT4;SLC8A1;ADGRV1;BMP6;OSR1;BMP7;ENPP1;KL;ANKH;SRGN;BCOR;ATP2B1;NOTUM;FBN2;S1PR1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6180308995695437,1.2463360154558678,0.22647058823529412,0.7385202048246572,1.0,1/10,0.75%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6180308995695437,1.2463360154558678,0.22647058823529412,0.7385202048246572,1.0,1/10,0.75%,PRKCD
prerank,nerve growth factor signaling pathway (GO:0038180),0.6026484908840593,1.246268996551999,0.22317596566523606,0.7377917575925165,1.0,2/10,4.64%,NTRK1;KIDINS220
prerank,regulation of gene silencing by miRNA (GO:0060964),0.46632648854541775,1.246227522849112,0.15135135135135136,0.7369875966992097,1.0,32/62,29.94%,NUP93;SEC13;STAT3;RAE1;SEH1L;PUM1;AGO1;NUP37;AGO2;EIF4G1;LIMD1;RANBP2;NUP88;POLR2F;POM121;NUP210;NUP62;POLR2B;NDC1;NUP35;IPO8;H3-3A;NUP85;POLR2H;NUP160;TPR;TNRC6A;FXR1;POLR2I;PUM2;NUP50;POLR2L
prerank,nitrogen compound transport (GO:0071705),0.43196769900621784,1.2461842524537607,0.0849539406345957,0.7361615240534657,1.0,27/141,14.88%,SLC38A2;SLC38A1;SLC23A1;TMEM30B;SLC12A2;LMAN2L;SLC1A5;FLVCR1;ABCC1;RAMP2;RILP;LRRC8D;SLC7A10;HIKESHI;SLC38A3;SLC6A2;SLC43A1;RAMP1;RAB38;SLC25A47;LRP2;SLC1A4;PICK1;TOM1;CHMP3;ABCB6;MIA3
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.4928337004286876,1.2460952492720412,0.1874258600237248,0.7355273271072316,1.0,9/36,13.20%,EGFR;CYGB;NPR3;DNM2;DDAH1;TERT;NOSIP;PIK3CB;S100A1
prerank,endocrine system development (GO:0035270),0.5404766163725426,1.245934874540424,0.1921119592875318,0.735126916793738,1.0,3/21,3.09%,SIX1;GLI2;DKK3
prerank,ear morphogenesis (GO:0042471),0.5415994910630482,1.245655591708774,0.21251629726205998,0.7351871337599735,1.0,6/20,9.71%,SIX1;EPHB2;TWIST1;NOG;ZIC1;FGFR2
prerank,protein glycosylation (GO:0006486),0.4373170782984618,1.244565001267918,0.102880658436214,0.7383413822454075,1.0,23/125,11.18%,PLOD2;ST3GAL4;ST8SIA2;GALNT10;PGM3;GFPT1;PLOD1;PLOD3;B3GNT7;POGLUT1;B4GALT1;GFPT2;PMM2;ST3GAL2;B4GALT5;OGT;MGAT4B;FUT8;DOLPP1;GALNT18;NPC1;FUT4;TMEM165
prerank,negative regulation of telomere maintenance (GO:0032205),0.5718903570017322,1.2440626662175058,0.20656634746922026,0.7392208088602854,1.0,8/15,27.05%,SMG6;ERCC4;ATM;RAD50;TNKS2;PARP1;SLX4;RTEL1
prerank,negative regulation of growth (GO:0045926),0.42966321687639086,1.243882178731571,0.09896907216494845,0.7389463008752513,1.0,26/121,17.28%,SLIT3;SLIT2;FHL1;OSGIN2;CCN3;ACVR1B;PPP1R9B;PRDM11;TGFB2;CCAR2;SMAD4;DACT3;NDRG3;SERTAD2;DCBLD2;ING5;SESN2;INHBA;CGRRF1;RBBP7;SERTAD3;CYP27B1;ING4;MINAR1;APBB1;FLCN
prerank,neuron projection regeneration (GO:0031102),-0.496452225544475,-1.2438722708574277,0.23076923076923078,0.5854808254887731,1.0,2/10,1.81%,PTN;NREP
prerank,protein stabilization (GO:0050821),0.4270545823534437,1.2434165232866572,0.0790273556231003,0.7397854814085884,1.0,51/168,21.48%,RASSF2;PRKCD;ATP1B1;PLPP3;UBE2B;MORC3;P3H1;BAG3;HYPK;USP2;DVL1;RAB21;PER3;PFN2;PRKRA;ANK2;COA8;MDM4;SYVN1;TELO2;CHEK2;NAA16;SMAD7;NCLN;CHP1;PARVA;HSPD1;USP7;IFT46;USP33;SEC16A;USP36;HPS4;USP13;USP19;CREB1;HIP1;SUMO1;EFNA1;PEX6;HCFC1;CCT4;CCT6A;TAF9B;CALR;CLU;LAMP1;CCT8;TBRG1;MUL1;LAMP2
prerank,regulation of epithelial cell migration (GO:0010632),0.46986869002984316,1.2429653721568459,0.1678082191780822,0.7404729098946453,1.0,8/51,7.68%,BMPER;RHOJ;PRKCE;ARSB;TGFB2;PFN2;DOCK5;SOX9
prerank,positive regulation of axon extension (GO:0045773),0.5278496911313741,1.2424684277472646,0.20764331210191084,0.7415205844297553,1.0,4/22,12.40%,NTN1;VEGFA;GOLGA4;NRP1
prerank,artery morphogenesis (GO:0048844),0.49963979601858344,1.2423279474478346,0.19950738916256158,0.7410399325784298,1.0,11/30,13.14%,VEGFA;LRP1;TGFB2;JAG1;NOG;BMP4;BMPR1A;SMAD7;NRP1;TGFBR1;LRP2
prerank,phagosome acidification (GO:0090383),0.5053760668847187,1.2412915452561504,0.19527363184079602,0.7440214375580004,1.0,10/26,25.08%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,regulation of smooth muscle contraction (GO:0006940),0.533964994893452,1.2412803385450721,0.21646746347941567,0.7430807163711067,1.0,3/20,1.92%,PLCE1;CTTN;PROK2
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5193368153530451,-1.240730379677091,0.22295081967213115,0.5908413745845187,1.0,2/10,4.88%,LYN;FAS
prerank,sensory perception of light stimulus (GO:0050953),0.4389719887092292,1.2406640887568623,0.1304812834224599,0.7444453931068375,1.0,7/87,6.91%,SLC4A10;COL11A1;COL1A1;PDE6C;PITPNA;CRYZ;CHRNB2
prerank,sphingoid metabolic process (GO:0046519),0.5901957956539507,1.2405689191257008,0.20684931506849316,0.743816395156855,1.0,3/12,6.19%,PLPP3;KDSR;PLPP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.4129346070703747,1.2405359145896762,0.024,0.7429583214332396,1.0,131/417,22.37%,FOXP2;WWP1;FOXP1;ID2;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;LDB1;PHC2;PRICKLE1;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;RBFOX2;HDAC4;EIF4A2;SIX4;KMT5A;TRIM28;MIDEAS;CCAR2;SMAD4;ERN2;BHLHE40;HEYL;TBX21;SOX9;EHMT1;MAEL;BTAF1;RARA;MBTD1;PA2G4;DAP;RCOR3;FOXK1;SMARCC2;WWP2;EID2B;SBNO2;SPINDOC;ILF3;BMP4;PHC3;TSC22D4;SCMH1;RUNX2;FOXM1;ID4;COMMD7;KAT6B;SFPQ;KDM4A;NR1D2;HEY1;KHDRBS1;HDAC1;NPAS1;NACC1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;HDAC6;FOXN3;NKX6-2;KDM5C;SUMO1;DPF3;NIPBL;L3MBTL3;MTA3;CBX5;CALCA;NR3C1;CDKN1C;MEN1;THAP7;CITED2;HMGA1;E2F1;SUV39H2;BIRC5;ZMYND11;CHD8;CBFA2T2;KLF10;MLXIPL;XRCC6;CDK5;SCML2;CALR;IKZF4;KAT7;SUV39H1;IL4;MPHOSPH8;SMURF2;YEATS2;SAMD11;SAP18;CRY2;USP47;ATP8B1;LOXL2;ZKSCAN3;KAT8
prerank,central nervous system neuron axonogenesis (GO:0021955),0.588565728490005,1.2403232913584046,0.22889842632331903,0.7427728464991837,1.0,4/12,9.01%,EPHB2;EPHB6;CHRNB2;B4GALT5
prerank,autophagy of peroxisome (GO:0030242),0.5893023144226635,1.2397059190844262,0.21309192200557103,0.744071915480551,1.0,6/12,22.03%,NBR1;PEX5;ATM;SQSTM1;RB1CC1;ACBD5
prerank,skeletal muscle tissue development (GO:0007519),0.49833558962201513,1.239259784618281,0.18170878459687123,0.744845245709857,1.0,5/32,10.81%,SIX1;SIX4;SKI;SELENON;CSRP3
prerank,negative regulation of cell projection organization (GO:0031345),-0.3401669723689887,-1.2390498201567166,0.10526315789473684,0.592558484260796,1.0,10/48,7.85%,EFNB2;LPAR1;APOE;EPHA4;RAPGEF2;PTPRO;PTPN9;GRIN2B;DCC;PRAG1
prerank,regulation of filopodium assembly (GO:0051489),0.4859084554633722,1.2390282433707935,0.18405627198124266,0.7447010626772324,1.0,12/38,13.08%,PRKCD;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;GAP43;TENM1;NRP1;MIEN1;NLGN1;ARHGAP44
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5201635501450815,1.2388858056997363,0.20522388059701493,0.7443019858205532,1.0,8/25,15.82%,VCP;CLPP;UGGT2;UGGT1;LONP1;NGLY1;STUB1;HDAC6
prerank,neurogenesis (GO:0022008),0.48142652168647493,1.23881940354534,0.17386363636363636,0.7436008887519694,1.0,10/43,15.84%,SIX1;CIT;SIX4;TGFB2;WDR62;DAGLA;ANXA1;DCHS1;THOC2;CXCR4
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4402651302112176,-1.238655709948018,0.20080321285140562,0.5907978606769263,1.0,4/15,11.93%,OSBPL8;PPARA;ABHD5;LPL
prerank,chromosome organization (GO:0051276),0.4374465871298998,1.2386032751251195,0.12033195020746888,0.7434913699889267,1.0,35/99,26.55%,TCF7L2;LDB1;TCF7L1;RAE1;PHF1;SAFB;EZH1;BRWD1;EHMT1;GPS1;HMGN1;CDAN1;CUL4A;CENPT;ABL1;HDAC1;LIG4;HMGN2;PARP1;RPS27A;UBC;HMG20A;GATAD1;CDT1;MTHFR;SUV39H1;COPS4;FAM50A;COPS7A;SMARCA4;HDAC2;H3-3A;COPS3;SETD7;XPA
prerank,organophosphate ester transport (GO:0015748),0.5123089861524941,1.2385772023407922,0.21520618556701032,0.7426465618792488,1.0,5/24,4.74%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,iron ion transport (GO:0006826),0.4697760244870527,1.2381621868094397,0.17465753424657535,0.7432848486677616,1.0,12/47,15.46%,SCARA5;SLC39A14;ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;IREB2
prerank,cellular response to retinoic acid (GO:0071300),-0.3517578299766173,-1.2379569872735647,0.11643835616438356,0.5898339361694508,1.0,9/42,6.52%,LYN;WNT5B;PTK7;WNT5A;WNT6;BRINP3;TBX1;BRINP1;BRINP2
prerank,regulation of multicellular organismal development (GO:2000026),-0.3914403454888689,-1.237668172776578,0.17535545023696683,0.58785309508913,1.0,7/25,13.72%,INSR;PTN;SOX17;SPAAR;DUSP6;OAS2;RACGAP1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.546514208024163,1.2376639626475046,0.21813403416557162,0.7441699111729905,1.0,7/17,12.12%,ACVR1;JAG1;HEYL;NOG;BMP4;BMPR1A;HEY1
prerank,negative regulation of transferase activity (GO:0051348),0.49955857828800615,1.2376149435081383,0.21631644004944375,0.7434050486500802,1.0,10/28,24.29%,EIF4A2;ERCC4;ABL1;SMAD7;PRDX3;CDKN1C;MEN1;HNRNPU;NPRL2;TP53
prerank,digestive tract morphogenesis (GO:0048546),0.5752537102245912,1.2373137275927262,0.21378340365682139,0.7436010709514617,1.0,4/14,9.71%,ID2;AGR2;EPHB3;FGFR2
prerank,regulation of phosphatase activity (GO:0010921),0.5144839551568712,1.2371763751810412,0.19925742574257427,0.7431160419978363,1.0,11/24,21.95%,PPP6R1;CDK5RAP3;TIPRL;PPP6R3;ZCCHC9;RIPK3;URI1;CHP1;PPP6R2;PPP1R35;PPP1R36
prerank,synaptic vesicle recycling (GO:0036465),0.4961876719299652,1.237171087307416,0.19975786924939468,0.7421727230789371,1.0,11/31,20.59%,STON2;SYT8;CEL;FCHO2;TBC1D24;STON1;SYNJ1;NLGN1;STX1A;CDK5;SYNJ2
prerank,skeletal muscle organ development (GO:0060538),0.5105301199958718,1.2370789517813374,0.20875,0.7415223821895132,1.0,4/26,10.81%,SIX1;SIX4;DISP1;CSRP3
prerank,regulation of integrin activation (GO:0033623),-0.43998072868000543,-1.2369804754437899,0.2047244094488189,0.5869568056907113,1.0,7/15,27.06%,RASIP1;PIEZO1;PLEK;FBLIM1;KIF14;SELP;SRC
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.4158526732639833,1.2364370410076713,0.03507014028056112,0.7429125824645763,1.0,86/327,19.78%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;LDB1;ZMIZ1;PRRX2;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;SBNO1;BAZ2A;STAT3;TCF7L1;MLF2;ATF4;ERC1;CHD3;TCFL5;DNM2;PHF1;DVL1;CCAR2;NFX1;NFXL1;BHLHE40;FZD7;TRRAP;FUS;TBX21;RPS6KA4;NSD1;ESRRB;CARM1;SBNO2;RORA;OGG1;CRABP2;FADS1;ABL1;SPTY2D1;CHEK2;KAT6B;RNF14;SFPQ;NR1D2;TGFBR1;KMT2D;RALY;LIMD1;SERTAD3;USP13;FOXN3;NKX6-2;ZFPL1;CREBBP;APBB1;HMG20A;PRDM2;NFYA;NFKB2;MAGED1;NR3C1;THAP7;SRSF10;HMGA1;DAPK3;E2F1;RYBP;HCFC1;SUFU;BRDT;ATF2;GON4L;ACTR8;GPBP1L1;MLXIPL;TEAD2;ZNF431;WWC2;TCF3
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5985376198311477,1.2363561531987173,0.23472222222222222,0.7422488593788092,1.0,4/10,6.67%,NEDD4;PRKCE;CAMK2D;STK39
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5848214028037824,1.2359620736392325,0.23669467787114845,0.7427880605289748,1.0,3/12,8.56%,IRS1;TWIST1;AKT2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.46665484650521455,1.2359063968416524,0.18335208098987626,0.7420622553342343,1.0,16/52,18.70%,EGFR;LRP1;PRKCE;EPHB2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;ACSL3;STAC3;STX4;CNST;SPTBN1;CLN3;AKT1
prerank,arachidonic acid metabolic process (GO:0019369),0.4901748451202834,1.2357432008338698,0.1908763505402161,0.741734284636924,1.0,6/35,8.00%,MGLL;PTGIS;PLA2G4A;CYP1B1;PTGES2;DAGLA
prerank,cellular response to purine-containing compound (GO:0071415),-0.5095442019271312,-1.2355654443163118,0.25412541254125415,0.5878917357899368,1.0,2/10,3.25%,SLC8A1;RYR2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.4459226250546543,1.2353487994418815,0.1655773420479303,0.7422682445824205,1.0,26/72,23.58%,CARD14;PSMD7;PSMA8;TNFSF15;PSMA4;CHUK;IRAK1;TNFRSF10B;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;NFKB2;AKT1;PSMA3;PSMB1;PSMD4;BIRC3;MAP3K14;ZFP91;PSMA5;PSMA7
prerank,regulation of inclusion body assembly (GO:0090083),0.5955043460483826,1.2351804649603715,0.22330097087378642,0.7419357537881004,1.0,2/11,4.35%,HSPA2;SNCAIP
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5626495669142919,1.2351560690589098,0.20293724966622162,0.7410633323876888,1.0,9/15,26.76%,TSEN54;FAM98B;CLP1;CPSF4;RTCB;CSTF2;RTRAF;TSEN34;ERN1
prerank,potassium ion transmembrane transport (GO:0071805),0.43458417874858596,1.2347160761796352,0.11673553719008264,0.7417562243020382,1.0,17/135,7.65%,KCNJ2;KCNJ15;KCNK5;SLC12A7;KCNB1;ATP1B1;SLC12A2;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;KCNE5;SLC9A1;KCNIP2;KCND1;SLC12A4
prerank,cilium organization (GO:0044782),0.4202379543052355,1.2344091215776871,0.07769929364278506,0.7418990629533451,1.0,79/209,26.29%,PKD1;GSN;CFAP298;EXOC4;EHD1;ABLIM3;PKHD1;DYNLT2B;RILP;ARMC9;MNS1;BBS9;ODF2;CDC14A;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;RFX2;TCTN1;IFT80;IQCB1;TMEM216;CCDC66;ATP6V0D1;CFAP43;PTPDC1;WDR11;CEP164;PARVA;TRAPPC14;OCRL;BBS5;TTC17;IFT46;MARK4;RAB23;FUZ;NUDCD3;CEP41;PCM1;HDAC6;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TMEM237;PTPN23;TTC29;KIF24;RAB1A;TMEM231;TXNDC15;SPAG16;FAM161B;BBIP1;PLK4;CEP89;DYNC2H1;TCTN3;TMEM67;TMEM138;BBS7;CEP20;FBF1;CCP110;EXOC7;INTU;ACTR2
prerank,cellular response to hypoxia (GO:0071456),0.43076576962400553,1.23396950730019,0.1105424769703173,0.7425663087785297,1.0,45/126,24.51%,VEGFA;P4HB;PTGIS;TWIST1;PSMD7;LMNA;CARD16;PSMA8;MDM4;NDRG1;ANGPT4;RORA;PSMA4;HYOU1;TERT;PSMD12;PSMA6;LIMD1;UBQLN1;NDNF;PSMD1;STUB1;SIRT2;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;RPS27A;UBC;HIGD1A;PGK1;HMOX1;SUV39H2;NPEPPS;HIPK2;PSMA3;SUV39H1;PSMB1;PSMD4;PSMA5;PSMA7;TP53;BAD;PINK1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.53891118036174,1.233933759192282,0.22076215505913271,0.7417519608140664,1.0,3/19,4.54%,SMOC2;ADAMTS3;XDH
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4542582297225826,-1.2338126022991034,0.20216606498194944,0.5898166679494872,1.0,4/14,11.94%,MOXD1;ALDH9A1;NOS1;SLC22A2
prerank,acylglycerol catabolic process (GO:0046464),0.5051859042993749,1.2335910274063377,0.19212410501193317,0.7421509217703558,1.0,4/30,14.82%,MGLL;DAGLA;ABHD6;PNPLA3
prerank,monocarboxylic acid transport (GO:0015718),0.4656156122334576,1.2334841307824396,0.19144144144144143,0.7416106563352803,1.0,7/51,3.81%,SLC5A6;SLCO3A1;SLC16A9;SLCO2A1;SLC16A1;SLC26A6;RXRA
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5577686390766953,1.2329533888796806,0.22994652406417113,0.7426683596514431,1.0,3/15,8.56%,IRS1;PRKCE;AKT2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.44049873091370423,1.232568541018493,0.14984059511158343,0.7431238439700728,1.0,29/84,23.58%,ECRG4;ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;PSMA6;PSMD1;ANAPC2;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;RPS27A;UBC;ANAPC10;CDC20B;CDC20;CDC27;CDK2;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6051272837043344,1.2325196008963546,0.22931785195936139,0.7423743202528456,1.0,4/10,12.83%,LRTOMT;CHDH;HNMT;SMOX
prerank,activation of protein kinase B activity (GO:0032148),-0.377446058131263,-1.2320194177864698,0.18421052631578946,0.5917516715449271,1.0,8/29,6.60%,INSR;OSBPL8;WNT5A;FGF1;CCDC88A;RICTOR;PPIA;ADRA2A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5081232244166559,1.2319256093336588,0.21608040201005024,0.7436557103822508,1.0,6/27,11.27%,DDX5;TWIST1;SPRED2;KMT5A;YJU2;ATM
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38716154643239553,-1.231886224530423,0.1712707182320442,0.5895046602946635,1.0,8/27,11.93%,PPARA;PRKCH;ABCG1;NR1H3;AGTR1;CSF1;ABCA5;LPL
prerank,epithelial cell differentiation (GO:0030855),0.4386880657038104,1.2314540783038375,0.16878980891719744,0.74447964002463,1.0,22/88,18.87%,SIX1;VEGFA;FSTL1;ANXA7;ANXA4;JAG1;FZD7;AKT2;AKR1C1;ANXA1;BMP4;FGFR2;EHF;HDAC1;DHRS9;BDH2;DAB2;KDM6B;PGK1;DMBT1;AKT1;CNN3
prerank,negative regulation of cyclase activity (GO:0031280),-0.4621748319225152,-1.231142697553458,0.2015810276679842,0.588777515340524,1.0,3/14,10.00%,GRM3;ADGRV1;EDNRB
prerank,neural tube development (GO:0021915),0.5591215551152102,1.2306103792556482,0.244,0.7465872725384288,1.0,4/15,5.70%,PKD1;HES5;DACT1;DVL1
prerank,gliogenesis (GO:0042063),0.5712805976004973,1.2306064490044208,0.23958333333333334,0.7456619368581987,1.0,4/15,9.70%,NFIB;TGFB2;CD9;ANXA1
prerank,Golgi ribbon formation (GO:0090161),0.5796055426240591,1.230429957269972,0.2220708446866485,0.7453601992298683,1.0,9/13,30.16%,TRIP11;STX16;GOLPH3;OPTN;VAMP4;GOLGA2;GCC2;PRMT5;VTI1A
prerank,positive regulation of neurogenesis (GO:0050769),0.44788537496572484,1.2303547542458941,0.17768147345612134,0.7447183842870152,1.0,8/68,4.55%,SLIT2;PLXNA4;VEGFA;TIAM1;TIAM2;CUX1;FBXW8;SERPINF1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.456186057984384,1.23012383634359,0.1945392491467577,0.7446068692294506,1.0,8/55,6.94%,GPC6;FGF2;GPC3;BGN;SDC1;ARSB;CSPG4;SLC9A1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5910468912550186,1.2299705348747565,0.2257142857142857,0.744255280196173,1.0,5/11,15.81%,PRKCD;CYP1B1;MAP3K5;STK25;GSKIP
prerank,actin filament polymerization (GO:0030041),0.5064523613321248,1.2297234153416436,0.19853836784409257,0.7443088039076978,1.0,7/29,15.63%,PSTPIP1;GSN;COBL;TTC17;SPIRE2;MICALL2;WASHC3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.477648762454838,1.2297225211311917,0.20954598370197905,0.7433795794334062,1.0,9/42,12.40%,MYOC;VEGFA;COL16A1;CD3E;S100A10;GFUS;JUP;ABL1;NRP1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.42628821242439835,-1.2296228782431646,0.20392156862745098,0.5900853483755838,1.0,5/18,6.43%,ROCK2;EPHA4;PICALM;ABCG1;GSAP
prerank,regulation of cellular response to heat (GO:1900034),0.444060384511755,1.2295475171913615,0.15058324496288442,0.7430916298874188,1.0,37/77,31.19%,NUP93;SEC13;CAMK2D;RAE1;BAG3;CCAR2;SEH1L;HIKESHI;AKT1S1;ATM;NUP37;DNAJC7;CHORDC1;YWHAE;RANBP2;NUP88;CREBBP;POM121;NUP210;NUP62;DNAJC2;NDC1;RPTOR;NUP35;FKBP4;NUP85;NUP160;TPR;HSPB8;HSF1;BAG1;ATR;DNAJB1;NUP50;HSP90AA1;NUP188;HSPH1
prerank,regulation of MAPK cascade (GO:0043408),-0.284923541914035,-1.2290502027979717,0.0,0.5890068707435844,1.0,28/157,6.71%,FLT1;IGF1R;TGFBR3;KSR1;INSR;LYN;ROCK2;LPAR1;TEK;PHLPP1;MAP4K4;PELI2;KIT;TNIK;LBH;JCAD;EPHA7;KDR;DAG1;CAV2;FAS;ROR2;TBX1;EPHA8;PAK3;ADRA2A;DUSP3;PAK5
prerank,stress granule assembly (GO:0034063),0.5238731490947628,1.229016021200427,0.23186528497409326,0.7441017869601326,1.0,7/20,21.61%,DYNC1H1;ATXN2L;UBAP2L;PRRC2C;CIRBP;EIF2S1;ATXN2
prerank,T cell migration (GO:0072678),0.567053655422574,1.2288273985236928,0.24755244755244754,0.743817368263024,1.0,2/13,7.22%,SLC12A2;CXCL16
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4293427225314145,1.228566286855062,0.14182194616977226,0.7438834642269131,1.0,28/113,18.14%,ESR1;TRABD2B;VEGFA;MPP7;UNC13B;CHD1L;IL5;VCP;CDC42EP2;USP50;SLF2;ERCC5;ERCC4;CUL4A;SPIDR;ATM;MED25;ERCC3;EIF4G1;ERCC2;ABCA1;STUB1;PSMC5;PARP1;PSMC4;SUMO1;CDT1;BID
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.3943335313099683,-1.2284993236529138,0.2,0.5879156309813062,1.0,9/25,13.58%,ERRFI1;PPARA;CBLB;SLC6A9;CNRIP1;SNX6;SOCS5;ACE2;GPRC5A
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4820924776810426,-1.2282319632652738,0.2236024844720497,0.5860680473545912,1.0,3/10,11.13%,ACTN2;SEMA5A;PLEK
prerank,synaptic membrane adhesion (GO:0099560),0.5702345457963213,1.2282150999127623,0.2302357836338419,0.7442222289006775,1.0,4/14,4.90%,GPC6;PTPRS;PTPRF;LRFN4
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.45664798595886924,1.227904314243828,0.1819184123484013,0.7444837075496966,1.0,9/54,9.43%,THBS1;VEGFA;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;JUP;ANGPT4
prerank,positive regulation of rRNA processing (GO:2000234),0.5923960742328015,1.227584973303934,0.22792022792022792,0.7447383815672963,1.0,9/10,38.90%,RIOK1;WDR75;BUD23;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;WDR43
prerank,substrate-dependent cell migration (GO:0006929),0.5713457075075086,1.2274973014103094,0.22672064777327935,0.744149903943601,1.0,2/14,0.91%,NTN1;ITGA11
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.46781228921889284,1.2270617801909884,0.19582850521436848,0.7448183457600642,1.0,7/41,10.33%,MGLL;PLA2G4A;CYP1B1;ELOVL5;SCD5;DAGLA;FADS1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.430887097064664,1.2270063660256116,0.12670157068062826,0.7441183435853208,1.0,29/110,18.40%,TRABD2B;VEGFA;MPP7;GSN;HJURP;MAPK15;VCP;CDC42EP2;ANKRA2;TMC8;PEX5;RAF1;SLF2;IAPP;IMPACT;SPIDR;LCMT1;HSPA5;NCLN;ABCA1;PREB;FARP2;TFIP11;HDAC6;SUMO1;NAPA;CDT1;BID;HCFC1
prerank,positive regulation of phospholipase activity (GO:0010518),0.5183787183369689,1.2265795943124558,0.2097812097812098,0.7447925303507887,1.0,8/22,11.57%,ESR1;FGF2;NTRK3;FGFR1;ARF4;FGFR2;PLA2G5;PDPK1
prerank,chromatin remodeling (GO:0006338),0.4328032434715537,1.226508086620752,0.1260593220338983,0.7441579251534166,1.0,39/100,26.75%,ESR1;HDAC4;BAZ2A;CHD1L;CHD3;EZH1;TADA2A;SOX9;SMARCC2;FOXA1;INO80B;KDM5B;PBRM1;KDM4A;KAT2A;HDAC1;BAZ2B;HNRNPC;KDM5C;KDM6B;GATAD1;SMARCAD1;SUV39H2;HCFC1;BRDT;CHD8;ACTR8;MPND;BPTF;TOP1;TAF6L;KAT2B;CHD4;SMARCA4;SRCAP;HDAC2;DAXX;ARID1A;MYSM1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5545492605187059,1.226394397663968,0.22994652406417113,0.7436568988307295,1.0,3/15,4.30%,DSE;BGN;CSPG4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5685322744114047,1.2259792321793348,0.22836879432624113,0.7443023102231267,1.0,5/14,13.92%,ATP1B1;DMD;SLC9A1;CHP1;WNK1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5004150833931982,1.2257881813242981,0.2,0.7440754823693077,1.0,17/29,34.39%,CHD1L;ERCC5;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;GTF2H4;XPA;DDB1;RBX1;RAD23B;RPA3;CUL4B;CCNH;CETN2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.4120274982622425,1.2257004231411661,0.04308617234468938,0.7434862709614275,1.0,132/314,30.24%,WWP1;ECRG4;NEDD4;ANAPC5;FBXL7;PSMD7;UBXN8;TOPORS;CDC16;COP1;UBE2B;VCP;DNAJB14;PSMA8;ERCC8;NFE2L2;FAF2;TBX21;HUWE1;SYVN1;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;UBE2C;FBXL12;HSPA5;PSMD12;ANAPC4;CUL1;FBXL19;PSMA6;PCBP2;LTN1;RNF103-CHMP3;UBQLN1;FBXL14;PSMD1;KCTD5;ANAPC2;ARRB1;FBXO17;STUB1;SIRT2;FBXL20;PSMC5;ANAPC1;USP19;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;RPS27A;UBC;RNF121;YOD1;ANAPC10;TRIM13;KCTD17;CDC20B;UBE4A;FBXL18;GID4;DNAJC18;NPLOC4;CDC20;UBR2;CDC27;ZFAND2B;CDK2;FBXW4;UBXN4;UBE2G2;DCAF12;PCNP;RMND5B;PSMA3;UCHL1;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;APPBP2;AREL1;ECPAS;DERL1;RNF216;PSMA5;PSMA7;SGTB;TAF1;HERPUD1;FBXO9;RNF122;AMFR;ANKRD9;TMEM67;SELENOS;DNAJB12;UBE2W;UBR3;PSMC1;RNF126;JKAMP;FBXO38;SEC61B;TMUB2;SEL1L2;PSMA1;DMAC2;DDB1;FAM8A1;STT3B;UBXN2A;UBE4B;FBXL8;RBX1;SPOPL;BTRC;UBR1;TMUB1;ZFAND2A;PRKN;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,regulation of receptor internalization (GO:0002090),0.4834411954377166,1.225619587000471,0.22195704057279236,0.7428620073695408,1.0,9/35,15.61%,VEGFA;SFRP4;LRPAP1;RSPO1;DLG4;ARF1;PICK1;ARRB1;WDR54
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4129412710881258,1.2250886616033179,0.057,0.7438150471810137,1.0,58/308,13.07%,GNAS;SIX1;CMKLR1;BMP1;VEGFA;GAS6;LRP1;LBP;FGF2;FOXD1;IL33;COL1A1;TIAM1;GADD45G;GRB10;GHR;PEMT;ACVR1B;TGFB3;TWIST1;GLMN;WWTR1;LRPAP1;SIX4;TGFB2;DYNC1H1;TLE6;ACVR1;BCL9L;SMAD4;TGFBR2;ALMS1;KMT5C;SOX9;EHMT1;NOG;ESRRB;ADIPOR2;TSKU;TRPM4;B4GALT5;OGT;BMP4;CRTAM;TMEM119;VIP;PLAC8;TERT;BMPR1A;SOD1;KAT2A;TGFB1I1;TGFBR1;AGO2;SMO;NLGN1;INHBA;F2R
prerank,regulation of developmental growth (GO:0048638),0.49720657450805916,1.2250729914759904,0.21437578814627994,0.7429613478881367,1.0,10/29,11.85%,SIX1;CTTN;GHR;STAT5A;SIX4;AGR2;DNM2;MUSK;ABL1;SOD1
prerank,mRNA metabolic process (GO:0016071),0.43625602111462625,1.2246448916919745,0.14,0.7436586408683118,1.0,39/90,29.55%,DDX5;SRSF1;SRSF5;SRSF2;SSB;HNRNPA2B1;SRSF11;ZC3H12D;SF3B2;SF3A1;TBRG4;U2AF1;DIS3L2;SFPQ;METTL16;PCBP2;LSM2;PTBP1;U2AF2;PCF11;CNOT10;NCBP1;SRSF7;CPSF6;NCBP2;PRKACA;SNRPB;GEMIN2;SRSF4;PRMT9;TP53;ERN1;RIDA;SON;LSM5;HSF1;DXO;SF3B4;SNRPF
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4038377129275664,1.2244957529386025,0.0,0.7432962539159671,1.0,457/1646,22.68%,TBX15;FOXP2;PLAGL1;BNC2;ESR1;EGFR;LRP6;SIX1;WWP1;FOXP1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;GAS6;NFIX;FGF2;HOXA3;ZNF423;FOXD1;NFIB;TCF7L2;PDCD4;COL1A1;TWIST2;ELF4;VSX1;DDX5;GCLC;HOXB6;MKX;SMAD9;NFIA;DDX17;ZIM3;ZFHX4;SMAD6;LDB1;ZMIZ1;PHC2;PRRX2;PRICKLE1;JDP2;GLI2;MDFIC;PRDM5;TCF20;DMTF1;LRP5;NCOR2;ACVR1B;GLIS2;TGFB3;TWIST1;JMJD1C;DKK3;APBB3;HOXC6;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;SP140;CUX1;RBFOX2;NFAT5;HDAC4;CAMK2D;STAT5A;SIX5;ELF1;MAP3K5;HOXB3;RXRA;ONECUT2;MEOX2;MED13L;WWTR1;SBNO1;BAZ2A;HES5;TCEA2;KLF5;SIX4;STAT3;ZBTB25;ANXA4;TCF7L1;ZNF250;TARBP1;KMT5A;MLF2;ATF4;CCNL2;ERC1;TRIM28;MAMSTR;ZFP14;NR2F1;CHD3;TCFL5;GMEB1;TADA1;DNM2;PHF1;ACVR1;BRD4;DVL1;FOXC2;ILK;ZNF25;MIDEAS;CCAR2;RXRB;NFX1;LBX2;NFXL1;GPATCH3;SAFB;SMAD4;ERN2;MRGBP;NFE2L2;BHLHE40;HMGB1;PKNOX2;MEF2B;FZD7;ZNF471;TRRAP;RFX7;TADA2A;E2F3;FUS;TASP1;PBX1;TSHZ2;CREG1;MEIS3;BRWD1;MED27;ZNF691;HEYL;TBX21;THRAP3;MDM4;SOX9;EHMT1;RPS6KA4;HOXA9;HOXA6;PURG;MAEL;CCNL1;BTAF1;IKZF3;MED31;RARA;NSD1;FOXJ3;MBTD1;MED13;PA2G4;SRA1;ESRRB;DAP;TFE3;RCOR3;BRD3;FOXK1;ENY2;ZNF76;CDC6;CARM1;DGKQ;NFATC1;FOXL1;SMARCC2;RFX2;SLTM;WWP2;OGT;EID2B;PSIP1;RBBP8;ZIC1;SBNO2;SPINDOC;RORA;OGG1;ILF3;BMP4;SFR1;PHC3;CRABP2;FOXA1;TSC22D4;ING5;ZBTB2;UBP1;SCMH1;CSRNP1;ZFP90;SREBF1;EHF;CHUK;RUNX2;ZNF260;FADS1;KDM2A;URI1;FOXM1;ABL1;ZIC4;SPTY2D1;RFX5;CCNT2;PHF8;POU6F1;PITHD1;SETD5;MAP3K12;ID4;NFE2L1;NRF1;HSF4;AXIN1;CHEK2;MAZ;COMMD7;KAT6B;NEUROD2;KDM5B;RNF14;TAF15;NAA16;SFPQ;FOXO6;SMAD7;PHIP;FOXP4;SRF;KDM4A;NR1D2;HEY1;GLIS1;TENM1;KAT2A;ZNF112;TGFB1I1;KHDRBS1;TGFBR1;FBXL19;HDAC1;MEF2D;ZMIZ2;CDC45;HSPD1;HOXB4;ZNF740;INHBA;BAZ2B;F2R;CD80;MYPOP;MAPRE3;HR;ARID4B;KMT2D;NPAS1;MEF2A;NACC1;MAP3K10;RUNX1;NFATC3;ZBTB9;NDP;HOXA4;ERF;LIMD1;TIAL1;PIAS4;HEXIM1;ZNF148;RING1;HNRNPK;MMS19;SERTAD3;EN2;VDR;BRD2;ZKSCAN1;USP13;MED21;MAFG;YWHAQ;MBD1;L3MBTL2;TFDP1;ID1;PER1;IL6;ARRB1;ING4;GRHL1;SIRT2;BRD9;PSMC5;CAMK4;FOXO3;HDAC6;FOXN3;NKX6-2;NFE2;CREB1;MLLT3;ZFPL1;CREBBP;MED26;ERBB2;KDM5C;AATF;APBB1;HMG20A;KMT2B;SUMO1;HOXA2;DPF3;NIPBL;PRDM2;L3MBTL3;MTA3;NFYA;CBX5;CALCA;NFKB2;KLF3;MAGED1;NR3C1;RFXANK;E4F1;MED14;CDKN1C;MEN1;LCOR;ZKSCAN7;THAP7;HDGFL2;SRSF10;CITED2;HMGA1;ELP4;DAPK3;CDT1;MED12;E2F1;SUV39H2;CC2D1B;RYBP;HCFC1;BIRC5;ZMYND11;SUFU;HOXC5;BRDT;ZBTB32;AKT1;ZSCAN20;ATF2;GON4L;CHD8;ACTR8;GPBP1L1;CBFA2T2;HIPK2;KLF10;CRK;HOXB2;MLXIPL;SAFB2;FOSL2;CC2D1A;QRICH1;TEAD2;XRCC6;IRF3;CBFB;NR3C2;ZNF431;VEZF1;WWC2;TCF3;CDK5;SCML2;NFATC4;BICRAL;MAP2K3;ATF6;MAX;BPTF;CALR;IKZF4;KAT7;MRPL12;ZBTB24;HOMEZ;HOXC8;SUV39H1;MAD2L2;KLF9;NUP62;IL4;ATP2B4;ZKSCAN5;MPHOSPH8;SMURF2;MAP2K7;YEATS2;RNF4;MED20;BCL11B;SMAD5;NEK4;SAMD11;CHD2;SAP18;NFIC;CEBPD;NR2F6;CRY2;ELP3;ZBTB40;DNAJC2;USP47;TGFBRAP1;ATP8B1;LOXL2;ZNF18;ZNF177;SS18L1;ZKSCAN3;KAT8;NR2C2;CDK5RAP2;KDM3B;MNT;KMT2A;TFCP2;PEX14
prerank,regulation of hemopoiesis (GO:1903706),-0.4967356503490188,-1.2244909679122136,0.2202797202797203,0.5927680389752217,1.0,4/10,10.57%,PTN;PRKCB;MAFB;IL17D
prerank,RNA interference (GO:0016246),0.5414186655476912,1.224099302582623,0.2248062015503876,0.7438197622754475,1.0,6/17,16.67%,PRKRA;AGO1;TERT;AGO2;CLP1;TSN
prerank,regulation of cytoplasmic transport (GO:1903649),0.5990712662988549,1.2237753107281508,0.23478260869565218,0.7440932407391279,1.0,5/11,21.66%,DNAJC13;ATP9A;USP7;CHMP3;LRRK2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4611220583399957,1.2233399218976055,0.1877094972067039,0.744821964076347,1.0,17/52,16.21%,SRSF6;DDX5;DDX17;RBFOX2;MBNL1;CELF4;THRAP3;CELF3;HNRNPL;MBNL2;RBM25;RBM5;KHDRBS1;PTBP1;RBM4;YTHDC1;ZC3H10
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.5211803051787003,1.223242246382862,0.23311258278145697,0.7442828407909142,1.0,5/21,9.55%,ADAM9;HM13;ADAM10;BACE2;BACE1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4241717261148058,1.2230524384389097,0.16684266103484688,0.7440843204973822,1.0,20/95,15.40%,LBP;ADAM9;PDCD4;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;FZD5;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CD80;CASP1;IL6;SIRT2
prerank,peroxisome organization (GO:0007031),0.5177142270730832,1.2226672615262102,0.23690773067331672,0.744579681093657,1.0,14/25,25.85%,ABCD3;PEX7;PEX11A;PEX16;PEX1;PEX10;TMEM135;SEC16B;PEX6;PEX2;ABCD1;PEX14;ACOT8;LONP2
prerank,folic acid metabolic process (GO:0046655),0.5321162407118827,1.222617001075672,0.2335958005249344,0.7438879641806085,1.0,9/18,19.88%,SLC25A32;PM20D2;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,renal absorption (GO:0070293),0.5937502620124183,1.2219882279954637,0.2571022727272727,0.7453114685032644,1.0,2/10,6.72%,GSN;MAGED2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.334491817472921,-1.2216898876156268,0.14685314685314685,0.5973993055458958,1.0,10/41,7.82%,IL34;TGFA;GRM5;EPHA4;NEDD9;GPRC5B;ADRA2A;DOCK3;ACE;HBEGF
prerank,cellular iron ion homeostasis (GO:0006879),0.45998089416135196,1.2207059018917037,0.1877094972067039,0.749240093716152,1.0,14/55,15.46%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;ABCB6;FRRS1;IREB2
prerank,telomere maintenance via recombination (GO:0000722),0.5931211866977671,1.2206923663829565,0.24621733149931224,0.7483862071156916,1.0,9/11,31.99%,ERCC4;RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;ERCC1
prerank,RNA stabilization (GO:0043489),0.48973796875704956,1.2206166623459098,0.19497607655502391,0.7477553572668376,1.0,17/33,28.60%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;ZCCHC17;CIRBP;TENT2;SLC11A1;HNRNPU;YBX1;RBM24;DKC1;LARP1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4550693859341653,1.2206163897145714,0.1774370208105148,0.7468599611993447,1.0,20/63,15.96%,TIMP2;PTPN3;TIMP3;STAT3;EIF4G2;RIC1;EIF4G3;DAP;FOXK1;CST3;CDK5RAP3;RGP1;TAB2;KDM4A;NELL1;EIF4G1;HGF;SIRT2;TLK2;KLHL22
prerank,regulation of urine volume (GO:0035809),0.5994131578087539,1.2203975095389694,0.24390243902439024,0.7467091146280024,1.0,1/10,1.86%,NPR3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5819741257722401,1.2203837310617676,0.2557471264367816,0.7458671020387873,1.0,4/12,8.87%,CACNA1C;JUP;DLG1;TRPM4
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5278004756569632,1.2201724313041526,0.22551546391752578,0.7457154244977289,1.0,4/21,11.75%,RASSF2;DMD;PAQR3;SMAD7
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.45150828329218384,-1.2201014032676418,0.22448979591836735,0.5987282970596353,1.0,4/15,8.07%,ALDH4A1;GGT5;GGACT;PRODH
prerank,tRNA modification (GO:0006400),0.44980184813112367,1.21918313358069,0.16964285714285715,0.7484566030818848,1.0,24/62,26.16%,TRMT61B;TARBP1;SSB;ANKRD16;ELP5;TRMT1;PUS3;TRUB1;ALKBH1;TYW3;CTU2;THADA;TPRKB;THUMPD3;TRMT44;TRMT6;ALKBH8;TRMT61A;METTL1;NSUN6;PUS1;MTO1;PUS10;TRMT112
prerank,regulation of ATP metabolic process (GO:1903578),0.4647045309998946,1.2191264812840468,0.1592920353982301,0.7477696958042594,1.0,28/54,31.56%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;SHMT2;PRKAG1;POM121;NUP210;NUP62;ABCD1;NDC1;COX7A2L;NUP35;PINK1;NUP85;NUP160;TPR;SPHK2;FIS1;NUP50;ZBTB7A;NUP188;ATP7A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.43865393382803686,1.2189821714906077,0.17215727948990436,0.7473864888169752,1.0,26/72,24.64%,PLAGL1;MUC1;CRADD;MDM4;NDRG1;CARM1;PCBP4;FOXM1;ATM;CHEK2;SESN2;TFDP1;ING4;CNOT8;CNOT10;RBL2;E2F1;USP10;CNOT9;HIPK2;TNKS1BP1;SFN;TRIAP1;PRMT1;TP53;RPS27L
prerank,tRNA aminoacylation (GO:0043039),0.4823823674281029,1.2183021394779996,0.20588235294117646,0.7490439597888469,1.0,12/37,20.24%,VARS1;WARS2;HARS2;PPA2;YARS1;DARS2;YARS2;EPRS1;PPA1;SARS2;SARS1;DARS1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.44425046270716073,1.218206490253799,0.17576419213973798,0.748469887239293,1.0,22/65,23.58%,FHL1;FBXL7;PSMD7;PSMA8;INTS3;CDK5RAP3;PSMA4;PSMD12;CUL1;PSMA6;ZFYVE19;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;PSMB1;PSMD4;USP47;PSMA5;PSMA7
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.4886686618638256,-1.2176563327986158,0.2222222222222222,0.602421152238331,1.0,5/10,20.60%,SHQ1;PIH1D1;RUVBL1;ZNHIT6;TAF9
prerank,regulation of transmembrane transport (GO:0034762),0.4957691200404401,1.2176442247259782,0.21411483253588517,0.7496417373448319,1.0,3/31,1.36%,KCNJ2;KCNJ15;NEDD4
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.4771367174039674,1.2175966137802818,0.20135746606334842,0.7489339161602987,1.0,18/41,26.42%,NUP93;SEC13;RAE1;SEH1L;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,lamellipodium organization (GO:0097581),-0.3633921113623315,-1.217399390422462,0.15591397849462366,0.6006504269691073,1.0,11/29,8.77%,ABLIM1;CDH13;KIT;CCDC88A;PARVB;PTPRO;S1PR1;WHAMM;SPATA13;SPEF1;ARHGEF6
prerank,regulation of leukocyte migration (GO:0002685),0.5457078063618642,1.2173896274100964,0.25165562913907286,0.7488671845867693,1.0,6/16,23.70%,VEGFA;ANXA1;MIA3;HMOX1;TNFSF18;BST1
prerank,myofibril assembly (GO:0030239),-0.3421939374718002,-1.2172120468545071,0.12307692307692308,0.5985470980500164,1.0,8/42,8.20%,ACTN2;TPM1;PGM5;PDGFRB;TMOD3;TMOD1;PDGFRA;LMOD1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5990949450962779,1.2171661775755789,0.243202416918429,0.7488264864371854,1.0,6/10,17.25%,ANXA2;RIC1;CDK5RAP3;RGP1;NELL1;EFNA1
prerank,cellular glucose homeostasis (GO:0001678),0.4768352118535944,1.216338676154533,0.21205098493626884,0.7509897679411971,1.0,7/41,8.58%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8;LRRC8D;FOXK1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.49046534530403596,-1.2163087751386548,0.23948220064724918,0.5983666700272076,1.0,3/10,8.40%,ACSL1;SLC2A1;SLC27A4
prerank,outflow tract septum morphogenesis (GO:0003148),0.50434047451069,1.2162014641038197,0.20987654320987653,0.7506216329639039,1.0,12/24,13.14%,ZFPM2;SMAD6;TGFB2;ACVR1;SMAD4;TGFBR2;BMP4;FGFR2;BMPR1A;NRP1;PARVA;LRP2
prerank,RNA processing (GO:0006396),0.4172299892035589,1.2158383243551634,0.1,0.7510653965243863,1.0,67/176,25.11%,DDX17;HNRNPH1;TSEN54;SRSF1;NOL3;SRSF5;PPP1R9B;MBNL1;RBM39;DUSP11;M1AP;SRSF2;TENT4B;SNRNP48;CCAR2;FUS;HNRNPA2B1;YJU2;SRSF11;CELF3;LUC7L3;HNRNPL;CDK12;SF3B2;SF3B1;SF3A1;SNRNP25;SRRM1;U2AF1;RBM6;RBM5;PABPN1;SFPQ;ZRSR2;PTBP1;RBM4;HNRNPC;U2AF2;SRPK1;CLP1;HNRNPK;TFIP11;SCNM1;TUT7;NCBP1;SRSF7;CPSF6;NCBP2;SYNCRIP;HNRNPH3;PRKACA;ZCCHC8;TENT2;DHX8;SNRPB;GEMIN2;SRSF4;DHX16;TSEN34;PPIG;PRMT9;HNRNPU;PABPC4;RBM3;PPP2CA;SNRNP35;DDX39B
prerank,regulation of dendrite development (GO:0050773),-0.33869378719310017,-1.215784210026549,0.13095238095238096,0.5972007774819562,1.0,16/37,16.04%,PTN;NEDD4L;CSMD3;BMP7;TNIK;HECW2;CAMK1D;DCC;VLDLR;MFSD2A;ADGRB3;SEMA4D;SARM1;LRP8;RTN4IP1;CDKL5
prerank,sensory perception of sound (GO:0007605),-0.293231794050789,-1.215654022078746,0.1,0.5949769571948996,1.0,14/88,5.37%,USP53;COL4A3;GRM7;EYA1;CEMIP;DCDC2;RIPOR2;ADGRV1;KIT;CACNA1D;CCDC50;CLIC5;WHRN;TBX1
prerank,inorganic cation transmembrane transport (GO:0098662),0.41263904732488665,1.2152014638668542,0.0712136409227683,0.7525406131287181,1.0,39/268,11.80%,SCARA5;SLC4A4;KCNJ2;CACNA1G;KCNK5;PKD1;CACNA1C;SLC39A14;KCNB1;ATP1B1;GAS6;SLC12A2;SLC24A3;HCN4;SLC4A8;SLC39A11;TRPV3;KCNN1;SLC9A8;SLC39A7;SLC4A11;SLC9A4;SCN11A;SLC9A1;SLC6A2;KCND1;TRPC4AP;TRPM7;TRPM4;SLC6A7;KCNK6;ITGAV;SLC30A5;SLC39A13;ATP6V0D1;TMEM165;ABCB8;TRPM6;NNT
prerank,neuromuscular synaptic transmission (GO:0007274),0.5307462259510376,1.215178448359149,0.22845953002610966,0.7517416672841218,1.0,6/18,19.50%,ERC1;CHRNB2;TBC1D24;STAC3;ERC2;KIF1B
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5932922146036704,1.2150980575999955,0.23076923076923078,0.7511641590492788,1.0,8/11,26.42%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1;TPR
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4223499867114919,-1.214908402902762,0.18269230769230768,0.5943789600536594,1.0,4/19,4.57%,RIPOR2;CAMK1D;DNM1L;DAPK2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5612524003675727,1.2147188888080083,0.2457293035479632,0.7516740299970543,1.0,2/15,2.48%,LRP6;GLI2
prerank,regulation of osteoblast proliferation (GO:0033688),0.5431593033230709,1.2147084532633894,0.2457293035479632,0.750834629838067,1.0,5/17,12.41%,NPR3;RHOA;FGFR2;TMEM119;NELL1
prerank,negative regulation of angiogenesis (GO:0016525),0.43515031111584124,1.2146742317678436,0.1713362068965517,0.750085640919581,1.0,11/84,6.57%,THBS1;HOXA5;SLC12A2;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,negative regulation of cellular component organization (GO:0051129),0.4356315415350236,1.2137511255185032,0.19658119658119658,0.7525792467112113,1.0,15/74,11.90%,VEGFA;TMEFF2;RDX;HSPA2;FAP;LRSAM1;DNM2;IRAK3;TMC8;PEX5;RAF1;IAPP;IMPACT;LCMT1;HSPA5
prerank,anterior/posterior axis specification (GO:0009948),-0.42969546967296984,-1.2137396834090708,0.20502092050209206,0.5950001621700345,1.0,2/15,2.98%,WLS;TBX3
prerank,blood vessel endothelial cell migration (GO:0043534),0.5131656508072443,1.2131693771145222,0.22978177150192555,0.7537538629655706,1.0,3/22,1.13%,SLIT2;VEGFA;FGF2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.4780727207164316,1.2128202434534359,0.2141119221411192,0.7541220574738889,1.0,2/33,0.14%,THBS1;SLIT2
prerank,histone H3-K4 trimethylation (GO:0080182),0.5855009351463564,1.2125659864526586,0.2392807745504841,0.7541882193823973,1.0,6/11,22.61%,OGT;KMT2D;WDR82;SETD1A;TET2;KMT2A
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.49711938365353775,1.2124255582867096,0.2170263788968825,0.7538515845559277,1.0,13/29,24.32%,PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;E2F1;GDNF;CIRBP;SLC11A1;HNRNPU;YBX1;RBM24
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5217050312100587,1.2124024451963575,0.22076215505913271,0.7530476829392795,1.0,10/22,27.29%,NEDD4;MVB12B;TOM1L1;RNF115;UBAP1;PTPN23;UBAP1L;MVB12A;RNF126;VPS37B
prerank,regulation of neuron projection development (GO:0010975),-0.2798499833131523,-1.2123153861339142,0.0,0.5960640067177126,1.0,37/163,10.48%,EFNB2;LYN;PTN;LPAR1;CSMD3;APOE;ITGA6;SHANK3;PPFIA2;IL1RAPL1;PTK7;WNT5A;EPHA4;LRRC4C;RAPGEF2;CCDC88A;CHN1;CAMK1D;CTNNA2;SERPINI1;PTPRO;NTNG1;PTPN9;ROR2;TENM3;PAK3;CDH2;DCC;PRAG1;ATP1B2;PAK1;MFSD2A;ABI3;PDLIM5;PLXNB2;KIF1A;BAG5
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.48171206846695175,1.2120290066623514,0.2140309155766944,0.7535246499706617,1.0,6/39,8.18%,THBS1;GAS6;PDCD4;RAMP2;NFE2L2;PAK4
prerank,regulation of DNA replication (GO:0006275),0.45942032354769424,1.2119686793658775,0.21840354767184036,0.7528382899943328,1.0,23/49,30.61%,EGFR;GLI2;SMC3;RBBP6;CDC6;BRPF3;CDAN1;CDT1;GMNC;KAT7;PDS5A;GTPBP4;PPP2CA;S100A11;EHMT2;ESCO1;PPP2R1A;USP37;WAPL;ATR;CTC1;RAD17;GLI1
prerank,protein deneddylation (GO:0000338),0.5914914480964847,1.2115176900927118,0.2633863965267728,0.7535470312483906,1.0,7/10,34.49%,GPS1;COPS4;COPS7A;COPS3;COPS5;COPS2;COPS7B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4419568077865556,1.2109865266414213,0.17703862660944206,0.7537968118292229,1.0,27/78,20.52%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4419568077865556,1.2109865266414213,0.17703862660944206,0.7537968118292229,1.0,27/78,20.52%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.45070071691211,1.210942022861757,0.20469798657718122,0.7530719881237671,1.0,22/55,27.30%,FHL1;FBXL7;PSMD7;PSMA8;PSMA4;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;PSMB1;PSMD4;USP47;PSMA5;PSMA7;PSMC1;ATF5;PSMA1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5299724132116277,1.210817081821796,0.2513157894736842,0.7526480334259251,1.0,6/20,14.06%,ZMIZ1;DCUN1D5;ITCH;DCUN1D2;TGFBR1;UBQLN1
prerank,inorganic anion transmembrane transport (GO:0098661),0.4473263695602584,1.2107641976806012,0.18722466960352424,0.7519468105161127,1.0,7/63,7.65%,SLC26A2;SLC5A6;SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4728490474832273,1.2101019590767654,0.2159904534606205,0.7534934669972886,1.0,16/40,24.51%,PID1;VCP;SLC4A11;AKT2;PPA2;ABL1;SOD1;PRDX3;AKT1;LRRK2;ABCD1;PYCR1;STOML2;RNF122;BAD;PINK1
prerank,icosanoid secretion (GO:0032309),-0.46211414510600113,-1.2100671928813997,0.23553719008264462,0.5993111944695253,1.0,4/12,7.77%,ABCC4;BDKRB2;PNPLA8;ACE
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3470049346739146,-1.2100202726738987,0.16793893129770993,0.5970160841263052,1.0,6/39,3.15%,TJP1;ROCK2;APOE;RAPGEF2;TIE1;NOTCH1
prerank,negative regulation of protein polymerization (GO:0032272),0.5011221145703021,1.209338389691724,0.24019607843137256,0.7553381676221713,1.0,2/27,0.75%,SLIT2;PRKCD
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4311232791382369,-1.2088936350819433,0.203125,0.597480140570195,1.0,6/16,15.34%,PARP14;ADIPOR1;SH2B3;INPP5F;CAV1;SOCS3
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5773747484234781,1.2082405073180182,0.25348189415041783,0.7583379922931145,1.0,2/13,11.85%,PRKCD;SOD1
prerank,regulation of lamellipodium assembly (GO:0010591),0.4777762435306372,1.2081591693678781,0.21983273596176822,0.7577292069994586,1.0,2/34,0.87%,SLIT2;PLCE1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4935179557803663,1.2081237458592924,0.22884386174016685,0.7569943043477674,1.0,14/30,28.39%,ABLIM3;CSNK2A2;HUWE1;FZD5;USP36;HPS4;MICALL2;VPS11;NPEPPS;SAE1;PINK1;ATG13;HTRA2;SREBF2
prerank,glial cell development (GO:0021782),-0.3766340123595239,-1.207912649723683,0.21354166666666666,0.5976481517827231,1.0,12/25,19.95%,CDK6;APP;EIF2B3;CSPG5;NRROS;EIF2B1;SOX11;MT3;MXRA8;MDK;DLL1;SOX4
prerank,nucleoside salvage (GO:0043174),0.5920656358301903,1.2077870728845201,0.2615606936416185,0.7573493676309667,1.0,6/10,26.96%,UCK2;UPP2;TK2;TK1;DCK;UCKL1
prerank,positive regulation of synapse assembly (GO:0051965),-0.37409449949615825,-1.2076943735937138,0.18974358974358974,0.5957195052665042,1.0,12/27,12.95%,NRXN1;IL1RAPL1;GRID2;PTPRD;SRPX2;SEMA4D;CLSTN1;CUX2;IL1RAP;EPHB1;SYNDIG1;VSTM5
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4363520730290847,1.2075019210012428,0.18670886075949367,0.7575116553710044,1.0,29/85,22.71%,PLCE1;ARHGEF28;ARFGAP1;NTRK1;RDX;EPHB2;SHC1;ARHGAP17;TGFB2;EPS8L1;BCR;RAF1;LZTR1;OGT;MADD;FOXM1;SHOC2;ARHGAP44;SQSTM1;AKAP13;LRRC59;FLCN;ERBIN;RASGRF1;MAPKAP1;NUP62;DENND4B;DENND1A;SYNGAP1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.4749041665080791,-1.206999685835767,0.2226148409893993,0.5950845817649694,1.0,6/11,21.80%,CYC1;UQCRC2;UQCR11;UQCRB;UQCRC1;UQCRQ
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5932527198225184,1.2069596280467607,0.26850507982583455,0.7586096112195714,1.0,4/10,28.45%,PDE6A;SAG;GNB1;PDE6G
prerank,cardiolipin metabolic process (GO:0032048),0.5674174440389295,1.2066115768804078,0.2536327608982827,0.7589661547433056,1.0,5/13,15.86%,PLA2G4A;TAMM41;PGS1;PLA2G5;PLSCR3
prerank,myelination (GO:0042552),0.4673665977978493,1.2057454164805936,0.19314285714285714,0.7612293242289226,1.0,18/46,22.79%,MYOC;LGI4;ACER3;MARVELD1;PMP22;HES5;SKI;B4GALT5;PLP1;SIRT2;CXCR4;NF1;SCN8A;ACSBG1;BCAS1;ARHGEF10;ABCD1;GPC1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5303280132078059,1.2055360443540752,0.2513089005235602,0.7611003921247174,1.0,5/18,16.21%,ESR1;NCOR2;TERT;PTBP1;ZC3H10
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5301328124437066,1.2048573114047654,0.2404227212681638,0.7627065731443066,1.0,4/17,6.89%,IGFBP5;DOCK4;DOCK7;DOCK5
prerank,regulation of monooxygenase activity (GO:0032768),0.5146604383617547,1.204781348569452,0.23155216284987276,0.7620945342666151,1.0,8/23,18.74%,EGFR;CYGB;DNM2;DDAH1;NOSIP;VDR;AKT1;GDNF
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5216850370610245,1.2046490187939756,0.2646675358539765,0.7616855935732683,1.0,6/20,17.17%,PID1;RHOQ;PPFIA1;CLTC;DAB2;LZTFL1
prerank,regulation of G0 to G1 transition (GO:0070316),0.466047309035081,1.2046080318750951,0.22157772621809746,0.7609590311793306,1.0,14/38,20.21%,EHMT1;RBBP8;PHC3;RNF2;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX
prerank,histone H3-K36 demethylation (GO:0070544),0.5890634404211551,1.2044581343905494,0.2769010043041607,0.7606017684650751,1.0,4/10,12.08%,RIOX2;KDM2A;PHF8;KDM4A
prerank,cilium assembly (GO:0060271),0.40547665715526554,1.2043927046009457,0.07422266800401203,0.7599926222355037,1.0,104/296,25.71%,PKD1;GSN;CFAP298;EXOC4;EHD1;GORAB;CSNK1D;ABLIM3;PKHD1;CFAP206;DYNC1H1;DYNLT2B;RILP;ARMC9;SFI1;BBS9;ODF2;CDC14A;DNAAF3;TMEM107;ALMS1;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CCDC39;RFX2;TCTN1;IFT80;IQCB1;DCTN2;TMEM216;CKAP5;CCDC66;RPGRIP1L;ATP6V0D1;CFAP43;PTPDC1;WDR11;SDCCAG8;AKAP9;CEP164;CSNK1E;PARVA;TRAPPC14;TRIP11;OCRL;BBS5;TMEM80;YWHAE;IFT46;MARK4;RAB23;FUZ;NUDCD3;CEP41;CEP63;PCM1;HAUS5;HDAC6;LRGUK;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;IFT43;CCDC57;TEKT2;TNPO1;TMEM237;DYNC1I2;PTPN23;DCTN1;KIF24;PRKACA;IFT27;RAB1A;ACTR1A;TMEM231;CDK5RAP2;TXNDC15;SPAG16;NEDD1;NPHP4;BBIP1;PLK4;CEP89;DYNC2H1;TCTN3;CNTRL;TMEM67;TMEM138;BBS7;TUBB4B;CEP20;FBF1;CCP110;EXOC7
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4649057444806996,1.2043693106572042,0.20501138952164008,0.7592188230405991,1.0,4/43,1.87%,IRS1;PID1;PRKCD;GRB10
prerank,defense response to Gram-positive bacterium (GO:0050830),0.46000541703716946,1.204270033229243,0.22984356197352587,0.7587179366238588,1.0,8/40,18.50%,LBP;RNASE7;RNASE3;GBP6;RNASE6;DEFB1;IL6;DMBT1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5014575838076483,1.2039402650912674,0.2534332084893883,0.7590106249575063,1.0,8/24,16.46%,VKORC1L1;TTLL2;GGCX;AGBL5;TPGS1;CEP41;PARP1;TTLL3
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5838321781194843,1.2036945110257073,0.2614942528735632,0.7581511712036106,1.0,4/11,20.59%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5838321781194843,1.2036945110257073,0.2614942528735632,0.7581511712036106,1.0,4/11,20.59%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,positive regulation of reproductive process (GO:2000243),0.479848047904292,1.2035798822616681,0.2285012285012285,0.7576983483256763,1.0,9/31,17.65%,VEGFA;TAC4;ACVR1B;PDE3A;VIP;AGO2;INHBA;SIRT2;LHFPL2
prerank,cellular response to BMP stimulus (GO:0071773),0.4403896157050926,1.2035138811873456,0.20174482006543076,0.7570794001387725,1.0,15/66,12.49%,TMEM100;PDCD4;DDX5;SMAD9;SMAD6;TGFB3;TGFB2;ACVR1;SMAD4;SOX9;BMP4;RUNX2;BMPR1A;SMAD7;RGMA
prerank,mitochondrial gene expression (GO:0140053),0.4713069420448494,1.2034022599247527,0.22916666666666666,0.7566710837731154,1.0,15/42,23.88%,MRPS2;MRPS28;NOA1;MRPS18B;MRPS14;MRPS17;FOXO3;TFB2M;PTCD3;TWNK;MRPL12;MRPL47;MRPS24;MRPS21;MRPS18A
prerank,endocardial cushion development (GO:0003197),0.5064842326218786,1.2033706850411465,0.24744897959183673,0.7559412656300036,1.0,10/21,12.12%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;CRELD1;BMP4;BMPR1A;HEY1
prerank,peptide metabolic process (GO:0006518),0.433208825882055,1.2033169854516594,0.1982851018220793,0.75526860316231,1.0,23/75,19.94%,PCSK5;GSTT1;CPZ;GSTM5;HM13;DMD;CPQ;BACE2;DNPEP;BACE1;SOD1;SPCS2;CARNMT1;NLN;LNPEP;CPXM2;PSEN2;GSR;GSTZ1;IDE;NPEPPS;LVRN;SEC11A
prerank,cellular response to leucine starvation (GO:1990253),0.6016036223471629,1.2023503865277483,0.25675675675675674,0.7579064653653224,1.0,5/10,19.92%,GCN1;SESN3;IMPACT;SESN2;EIF2AK4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5723981142595649,1.2021561825051053,0.262002743484225,0.7577594406366497,1.0,1/13,0.97%,GAS6
prerank,regulation of telomere capping (GO:1904353),0.5080604525639872,1.2020673005286413,0.2593068035943517,0.7572463834383614,1.0,7/23,14.20%,MAPK15;NEK7;SMG6;ATM;RAD50;USP7;TNKS2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3826152568949731,-1.201998433340776,0.19900497512437812,0.6025650868014639,1.0,12/22,28.06%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3826152568949731,-1.201998433340776,0.19900497512437812,0.6025650868014639,1.0,12/22,28.06%,ZDHHC14;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,T-helper cell differentiation (GO:0042093),0.5567180461417579,1.2019396075337652,0.25862068965517243,0.7569025170567591,1.0,3/14,6.48%,FOXP1;TMEM98;HMGB1
prerank,nucleic acid metabolic process (GO:0090304),0.43986581587336443,1.2015535538572675,0.20910075839653305,0.7575577640610254,1.0,32/69,28.86%,HNRNPH1;RBFOX2;DUSP11;HNRNPA2B1;HNRNPL;HNRNPH2;WRN;GTF2F1;KPNA2;RAD50;HNRNPM;PCBP2;PTBP1;HNRNPC;HNRNPK;MMS19;POLR2F;NCBP1;NCBP2;ATXN2;HNRNPA3;HNRNPA1;POLR2B;TOPBP1;HNRNPU;RECQL5;METTL14;POLR2H;POLG;DNASE1L2;POLR2I;DXO
prerank,substantia nigra development (GO:0021762),0.47529890078492165,1.201475473005212,0.2170263788968825,0.7569727261206749,1.0,14/37,16.85%,NDRG2;CALM2;RHOA;RAD1;HSPA5;S100A1;YWHAE;SEC16A;PLP1;ZNF148;YWHAQ;SIRT2;CKB;CALM3
prerank,regulation of postsynapse organization (GO:0099175),-0.367551522589112,-1.2014402729937261,0.20918367346938777,0.6016200727189333,1.0,11/28,10.47%,SHANK3;PPFIA2;IL1RAPL1;WNT5A;EPHA4;ARHGAP22;ABHD17C;HOMER1;ABI3;PDLIM5;KIF1A
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5041814454691378,1.2014313452967196,0.24112607099143207,0.7562876069775845,1.0,8/26,17.96%,ST3GAL4;TKT;ST3GAL2;B4GALT5;GAL3ST4;B3GNT6;RRM2B;GOLPH3
prerank,chromosome condensation (GO:0030261),0.4769437450255518,1.2012079710246675,0.23627684964200477,0.7562721312900168,1.0,10/36,18.12%,SMC4;CSNK2A2;CSNK2A1;KMT5A;ERN2;MCPH1;PHF8;AIFM1;ACIN1;DFFB
prerank,cytoplasmic translation (GO:0002181),-0.2946342445874118,-1.2007538040048844,0.06521739130434782,0.6010362324855115,1.0,47/91,24.27%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;EIF2B3;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;GSPT2;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37;RWDD1;RPL14
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5961558667895356,1.2004876415637606,0.26571428571428574,0.7579817870604558,1.0,4/10,16.67%,PRKRA;TERT;AGO2;TSN
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5479190560060819,1.1999113669097474,0.26104417670682734,0.7591835606186021,1.0,8/16,23.20%,SCD5;CBR4;PPT2;ACAT1;ACACA;HSD17B8;GCDH;PPCS
prerank,cellular response to glucose stimulus (GO:0071333),0.4903234028765063,1.1998889527215306,0.23272727272727273,0.758425522142065,1.0,5/30,5.38%,SLC39A14;KCNB1;GAS6;UNC13B;ADCY8
prerank,neural crest cell development (GO:0014032),-0.3297044979651029,-1.1996397064465127,0.16,0.6014779728628642,1.0,19/44,23.36%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;TBX1;ERBB4;CORO1C;CDH2;SEMA4D;SEMA3G;SEMA4A;SOX11;HTR2B;SEMA4G;SEMA5B;SEMA6D;SEMA3B;NRTN;NRG1
prerank,response to nutrient levels (GO:0031667),0.5425181479836518,1.1995636115766768,0.24178712220762155,0.7587485712206563,1.0,3/17,5.09%,KCNB1;ATF4;MEAK7
prerank,organelle organization (GO:0006996),0.402706941920319,1.1992314381289437,0.05905905905905906,0.7590621523190721,1.0,131/388,24.56%,MICAL2;PLCE1;ABCD3;FMNL2;SEC31A;MARK1;MAPK15;VPS13C;PEX7;ARC;ATL2;CCL13;SEC61A1;CSNK1D;LMAN2L;FGD6;RAB2A;FBXW8;GOLGA8B;GOLGA5;RAB30;RAB34;RAB43;DOP1B;PEX11A;BCAS3;SMPD4;MNS1;RAB3GAP1;MIEF2;GOLGB1;ODF2;ATL3;SIRT5;GBF1;ATP8B2;BRWD1;RHOT2;FAF2;HUWE1;TJAP1;ARHGAP21;PAK4;PALLD;PEX16;PLEKHM2;RHOT1;CENPT;PEX1;RAB38;TRAPPC12;TERT;NRF1;TMED9;PHIP;CIDEA;ZW10;LONP1;LIG4;TRIP11;PEX10;TTC17;PI4K2A;CHMP3;MARK4;NDP;LIMD1;MTFR1;LMAN2;SEC16A;PRDX3;TMEM135;PNPLA3;MIA3;SIPA1L3;STX4;CDC42BPB;PARP1;POLG2;SEC16B;BCS1L;VPS11;GOLPH3;BNIP1;SH3D19;TFB2M;TMED2;NPLOC4;COG2;BLZF1;PEX6;HCFC1;MAST2;ZMYM3;SEC23IP;CLUH;ZFYVE16;ZRANB1;TRAPPC11;TTC29;REEP5;TWNK;NIPSNAP2;FANCG;CHMP4A;CHMP4B;PDCD6IP;OPTN;SNX11;ATL1;ABI2;PEX2;LRRK2;RAB1A;LMAN1;RAB18;ABCD1;MAST4;ATP8B1;EIF2AK3;PRKCI;PEX14;FAM161B;GORASP2;STOML2;VPS13D;DYNC2H1;TMED7;VPS51;PINK1;CHMP2A
prerank,cellular response to fluid shear stress (GO:0071498),-0.46801145210796624,-1.1990158368352404,0.23595505617977527,0.6006120922949164,1.0,3/12,8.78%,MTSS1;KLF2;ASS1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.428169474284699,1.1990049710517736,0.1664899257688229,0.7590229542207421,1.0,20/87,12.82%,GDF10;COL3A1;ADAM9;COL1A2;LTBP2;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;ACVR1;SMAD4;TGFBR2;SKI;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4307533963352227,1.1989268939690585,0.18083961248654468,0.7584683016138382,1.0,30/78,25.08%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;NFE2L2;BCAP31;FBXO22;RNF14;SMAD7;CSNK1E;UBQLN1;DAB2;DDA1;STUB1;SIRT2;SUMO1;CDC20B;HECTD1;CDC20;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;HERPUD1;RCHY1;BBS7
prerank,positive regulation of heart rate (GO:0010460),-0.43329303610579883,-1.1989044658680208,0.20318725099601595,0.5985293374384696,1.0,7/17,18.42%,PDE4D;TPM1;RYR2;EDN1;ADRA1A;SCN3B;KCNQ1
prerank,negative regulation of chemokine production (GO:0032682),-0.44113932501876196,-1.1985902906446135,0.22426470588235295,0.5970088450347589,1.0,5/14,15.59%,APOD;C1QTNF3;LGALS9;SIGIRR;SIRPA
prerank,protein complex oligomerization (GO:0051259),0.4314222326703751,1.1981589590254995,0.18789808917197454,0.7603893652029827,1.0,25/85,21.39%,PRMT8;MPP2;EHD1;TRMT61B;NOL3;ARC;ATL2;ADCY8;LRRC8D;MCU;ATL3;SLC9A1;FUS;C9;SPAST;LETM1;MICU1;G3BP2;SHMT2;CPSF7;CPSF6;TWNK;IKZF4;PDCD6IP;ATL1
prerank,lysosome localization (GO:0032418),0.46883657914563615,1.1974193255107297,0.245260663507109,0.7622266611836327,1.0,14/37,19.02%,RAB34;LAMTOR1;BLOC1S2;FAM98A;KLC2;PLEKHM2;TMEM106B;NDEL1;PLEKHM1;HDAC6;SPAG9;FLCN;SYTL4;SNAPIN
prerank,protein heterotetramerization (GO:0051290),0.5654526075127974,1.1972881175918175,0.26379542395693134,0.7618771697109017,1.0,5/13,18.09%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5033539432000356,1.1972206160267531,0.23927178153446033,0.7612739736809547,1.0,7/21,14.43%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4862102040602277,1.196971100841048,0.25552825552825553,0.7612662925188026,1.0,12/29,17.61%,TCF7L2;TLE2;TCF7L1;BCL9L;TRRAP;PYGO1;TLE3;TERT;HDAC1;KMT2D;CREBBP;MEN1
prerank,regulation of ossification (GO:0030278),0.4729876710401742,1.196901149282353,0.223121387283237,0.7606672484443711,1.0,9/36,9.70%,LRP6;DDR2;SMAD6;TWIST1;TGFB2;ACVR1;NBR1;SOX9;BMP4
prerank,acylglycerol biosynthetic process (GO:0046463),0.511690423332131,1.1967886522602003,0.2540272614622057,0.7602386007279798,1.0,6/23,16.48%,PLCE1;PLA2G4A;GPAT4;AGMO;PNPLA3;PLA2G15
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3991901573360855,-1.1966996461878845,0.196,0.5993948794219207,1.0,5/19,13.12%,SLCO1C1;APP;KLF2;MTPN;PAX8
prerank,regulation of mitochondrion organization (GO:0010821),0.4624680086154698,1.1966895669012718,0.2265193370165746,0.7597957275249115,1.0,21/47,28.51%,PID1;CSNK2A2;MIEF2;RHOT2;FZD5;IAPP;RHOT1;SREBF1;USP36;SQSTM1;HDAC6;PLSCR3;FLCN;GOLPH3;MUL1;LRRK2;PINK1;CYRIB;HTRA2;SREBF2;FIS1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4597146301684576,1.1962624327009022,0.2454337899543379,0.7604829677470585,1.0,10/46,11.85%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.43398669950380137,1.1960444660478156,0.20106382978723406,0.760412444272264,1.0,27/79,20.52%,SEC31A;SEC24D;SEC13;SEC23A;DYNC1H1;AP2A1;RILP;DNM2;KLC2;FCER1G;DCTN2;ARF1;DYNC1LI2;SEC24C;AP2A2;SEC24B;LAG3;CLTC;KLC1;DCTN5;SEC24A;ACTR1B;ACTR10;DYNC1I2;DCTN1;CLTA;CAPZA1
prerank,neural crest cell differentiation (GO:0014033),0.5263995022752215,1.1958010402595614,0.26648721399730824,0.7603992722147919,1.0,1/18,0.33%,LRP6
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5417279903890946,1.1956836851622465,0.260347129506008,0.7599926417036134,1.0,3/16,8.96%,KLRK1;RAET1E;PLEKHM2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5987696398495929,1.1956829265966689,0.2849083215796897,0.7591722926043187,1.0,1/10,1.06%,LBP
prerank,regulation of B cell proliferation (GO:0030888),-0.3263326183668627,-1.1950998103876032,0.15267175572519084,0.6011106895280259,1.0,11/44,12.44%,LYN;BCL2;TFRC;AHR;TNFRSF21;NFATC2;CD38;VAV3;CD300A;CD74;CD40
prerank,urogenital system development (GO:0001655),0.5857630286658597,1.1950793446696466,0.26988636363636365,0.7604276970091747,1.0,4/11,9.70%,EPHB2;EPHB3;SOX9;ANXA1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.4223977330759257,-1.1949435455884634,0.21285140562248997,0.5992105073903092,1.0,5/17,12.44%,BCL2;BCL2L1;DNM1L;BOK;MFF
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.2961348520029886,-1.1948670085783084,0.11538461538461539,0.5970988072331934,1.0,44/91,23.31%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;RPS11;UBA52;RPL18;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,negative regulation of immune effector process (GO:0002698),-0.44774640734814275,-1.1945187638746615,0.2589928057553957,0.5956398357516336,1.0,6/13,19.64%,ENPP3;CD300A;HAVCR2;CD55;CD47;RPS19
prerank,negative regulation of cell differentiation (GO:0045596),0.40965719863834155,1.1942924650924907,0.13617886178861788,0.7625228402712249,1.0,58/181,20.89%,EGFR;GDF10;ID2;WNT9A;ZFPM2;PDCD4;TWIST2;CRIM1;COL5A2;SMAD6;LRP5;TWIST1;LDLRAD4;SPRED2;WWTR1;HES5;XDH;JAG1;NBR1;SKI;SOX9;HOXA9;SRA1;NOG;ESRRB;TSKU;TRPM4;EID2B;IQCB1;RORA;BMP4;ITGAV;FOXA1;ANP32B;SMAD7;HEY1;TGFBR1;PTBP1;ABCA1;LIMD1;BMP5;IL6;SIRT2;IL17RD;NPHP3;TRIO;NEPRO;ANKRD26;EFNA1;MEN1;E2F1;SUFU;NFKBIA;EIF2AK4;CALR;CHRD;MAD2L2;GPS2
prerank,histone H4-K16 acetylation (GO:0043984),0.5187038826485614,1.194104618038512,0.24937343358395989,0.7623979764042121,1.0,11/19,23.19%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;MSL1;KAT8;KMT2A;MEAF6
prerank,inner ear morphogenesis (GO:0042472),0.5110881809330794,1.1940187629293093,0.2532467532467532,0.7618820147256133,1.0,5/22,9.71%,SIX1;EPHB2;SOX9;ZIC1;FGFR2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3119275633512925,-1.1938409755338193,0.12087912087912088,0.5949538007582776,1.0,13/66,6.90%,ROBO1;TGFBR3;MTSS1;MCC;NR2F2;APOE;CDK6;B2M;STAT1;CAV2;DUSP10;AQP11;PTPRK
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.5595666994001841,1.1936763895262836,0.2781546811397558,0.7622604478401438,1.0,3/13,9.70%,ESR1;PLPP1;BMP4
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4348863472379928,-1.193621219464255,0.2139917695473251,0.593248089080082,1.0,4/16,8.28%,MCTP1;RIMS1;MCTP2;SYN1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.464398355888276,1.193572885304046,0.23113207547169812,0.761837757808867,1.0,8/39,8.96%,FHL1;FXYD5;NEDD4;PTPN3;KCNE5;STK39;ANK2;WWP2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.51759145342893,1.193182373844338,0.2669270833333333,0.7623565048565376,1.0,4/20,13.20%,STARD3NL;AKR1C1;FDXR;DHRS9
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5398779244478915,1.192988497692716,0.2862957937584803,0.7614251183170279,1.0,2/16,5.22%,THBS1;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5398779244478915,1.192988497692716,0.2862957937584803,0.7614251183170279,1.0,2/16,5.22%,THBS1;BCAS3
prerank,protein targeting to ER (GO:0045047),-0.2929244130277894,-1.1928921376787518,0.08,0.5926644858555495,1.0,47/99,23.31%,RPS14;RPS15;RPS25;RPL8;RPS8;RPL4;RPS20;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;RPL11;RPL18A;RPS12;RPL12;SPCS3;RPS11;UBA52;RPL18;SEC61G;RPS15A;RPS28;RPL21;RPL7;RPL10;RPL15;SRP68;RPS3;RPS18;RPS19;SGTA;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.5706384267950053,1.1928163077219762,0.28551336146272854,0.7612405752469237,1.0,8/12,28.38%,SEC61A1;HSPA5;CHMP4A;CHMP4B;SGTB;GET3;SEC61B;SEC62
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5555738299447536,1.1926666788482296,0.276797829036635,0.7609787395423415,1.0,4/13,11.57%,FGF2;HMGB1;FGFR1;PDPK1
prerank,microtubule nucleation (GO:0007020),0.5341056208289807,1.1926614197793806,0.2575957727873184,0.7601795480264961,1.0,7/19,18.76%,TUBG2;CSNK1D;TUBGCP3;AKAP9;NDEL1;CCDC57;SLAIN2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.4319161395564841,1.19263779015746,0.22281449893390193,0.759456398102407,1.0,17/68,19.88%,SLC23A1;SLC23A2;SLC5A6;AOX1;ABCC1;SLC25A32;MTRR;MMAB;NNMT;MTHFD2;GSTO2;ALDH1L2;MTHFD1;SHMT2;SHMT1;RFK;MTHFR
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5845877437643487,1.1925727983140082,0.2647482014388489,0.7588652693383537,1.0,6/10,24.64%,MUC1;FOXM1;ING4;HIPK2;TP53;RPS27L
prerank,calcium ion import (GO:0070509),0.48438069180240534,1.1925643224949283,0.2490842490842491,0.7580888964309999,1.0,3/28,5.91%,CACNA1G;CACNA1C;MCU
prerank,regulation of cell death (GO:0010941),0.42627478054531465,1.192303742953198,0.18796198521647306,0.7581970060611726,1.0,14/94,9.70%,SRSF6;LRP1;FGF2;SRGAP2;CCN5;CCN3;ACER3;PRR7;LRPAP1;AGR2;TNFRSF1B;IMPACT;NOA1;BMP4
prerank,regulation of gene expression (GO:0010468),0.39562728531388397,1.1917449682164594,0.007,0.7592904060675633,1.0,213/903,18.89%,SLC38A2;BNC2;ESR1;SIX1;FOXP1;PID1;ID2;ZFHX3;HOXA5;VEGFA;ATP1B1;GAS6;C1D;F3;FGF2;ZNF423;FOXD1;IL33;GSN;SFRP4;SLC24A3;VSX1;AFF3;NFIA;EMILIN1;YBX3;COQ7;CLK1;NTRK3;FGF17;DRD1;HNRNPH1;LDB1;PRRX2;PRDM5;DMTF1;RDX;AHNAK;ACVR1B;AHNAK2;EPHB2;ANXA7;C1QTNF1;TWIST1;JMJD1C;APBB3;PRDM11;CLK3;PRDM10;MBNL1;HDAC4;GLMN;WWTR1;SBNO1;BAZ2A;TGFB2;STAT3;CD3E;TCF7L1;ZC3H7A;MLF2;ATF4;ERC1;XDH;FASTK;RAMP2;CHD3;TCFL5;AGR2;DNM2;PHF1;DVL1;PRDM6;SNRNP70;CCAR2;NFX1;NFXL1;FAM98A;ADAM10;PUM1;NFE2L2;BHLHE40;ANKRA2;FZD7;MATR3;TRRAP;ANK2;FUS;HNRNPDL;TBX21;SOX9;RPS6KA4;TRIM27;NSD1;NOG;ESRRB;BTNL9;TSKU;CARM1;DGKQ;WWP2;HNRNPL;HNRNPH2;SBNO2;MBNL2;EDN3;RORA;OGG1;MAPK8;PCBP4;BMP4;CRABP2;TMEM119;PRDM4;FAM98B;MUSK;FADS1;ABL1;UBR5;AGO1;SPTY2D1;TDG;TERT;ATM;BMPR1A;CHEK2;MAZ;PABPN1;KAT6B;RNF14;SFPQ;FUBP1;METTL16;KDM4A;NR1D2;HEY1;EZR;MARF1;PIK3CB;NELL1;TRAF3;PTRH2;TGFBR1;SERPINB9;HDAC1;AGO2;SMO;VTCN1;INHBA;PCBP2;KMT2D;SETDB1;CLK4;ERP29;PTBP1;RUNX1;TRIM26;LIMD1;USP36;ZNF148;CPSF4;HNRNPK;SERTAD3;VDR;YTHDC1;USP13;CAMK2N1;PER1;IL6;AFF4;UBAP2;HDAC6;FOXN3;NKX6-2;ZFPL1;CREBBP;MED26;ZC3H10;ZNF462;APBB1;HMG20A;FGF5;KDM6B;RBL2;CCN4;SEC16B;PRDM2;NFYA;SLC2A10;FLCN;NFKB2;MAGED1;NR3C1;RFXANK;PRKAG1;THAP7;SRSF10;CITED2;HMGA1;DAPK3;E2F1;TRIM6;RYBP;CLK2;HCFC1;SUFU;BRDT;AKT1;GDNF;ATF2;GON4L;ACTR8;GPBP1L1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.43391853201611585,1.1914731154069145,0.21513513513513513,0.7594477131988357,1.0,12/76,12.28%,RASSF2;EGFR;PDCD4;CCN3;NFAT5;ILK;DLG1;RHOA;IRAK1;C1QTNF4;CD27;EZR
prerank,NAD biosynthetic process (GO:0009435),0.5175008391301502,1.1914385329181474,0.2709677419354839,0.758746823429589,1.0,6/20,15.89%,PTGIS;QPRT;NNMT;NMNAT3;NMNAT2;NAPRT
prerank,triglyceride homeostasis (GO:0070328),-0.36727039866071454,-1.1913741520563221,0.2009132420091324,0.594039305696493,1.0,9/26,14.60%,APOE;NR1H3;PNPLA8;C1QTNF3;SCARB1;LPL;SIRT1;NR1H4;DGAT2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5953909080434081,1.1913548915503076,0.2815829528158295,0.7582814209364053,1.0,4/10,8.69%,EMILIN1;FAP;TNFRSF1B;CST3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5706071654421986,1.1911180099164755,0.2616033755274262,0.7583466368610042,1.0,7/12,26.96%,UCK2;UPP2;CAD;TK2;TK1;DCK;UCKL1
prerank,inositol phosphate catabolic process (GO:0071545),0.5715844556454573,1.1904507439483254,0.26666666666666666,0.7599452919840592,1.0,4/12,20.59%,SYNJ1;INPP5B;OCRL;SYNJ2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5271537419482243,1.188734842060193,0.2693298969072165,0.7650310807184191,1.0,7/18,12.41%,RDX;DACT1;RIC1;CDK5RAP3;RGP1;EZR;NELL1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5188369733585657,1.1884732412981467,0.25129533678756477,0.7651508977760693,1.0,3/18,8.57%,CMKLR1;FPR3;FCER1G
prerank,response to retinoic acid (GO:0032526),-0.30970796438676895,-1.1884417691707936,0.14545454545454545,0.5988668893362544,1.0,11/59,6.52%,LYN;WNT5B;PTK7;WNT5A;WNT6;ACER2;RBP4;BRINP3;TBX1;BRINP1;BRINP2
prerank,myeloid cell development (GO:0061515),0.513819642313639,1.1884357408550104,0.24804177545691905,0.7644809335077173,1.0,2/18,4.03%,FOXP1;ANXA2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.394012636041347,1.188272853109354,0.012,0.7642407692945703,1.0,236/807,22.38%,FOXP2;ESR1;WWP1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;GAS6;NFIX;ZNF423;FOXD1;SKIL;TCF7L2;PDCD4;IL33;RARB;TWIST2;DDX5;GCLC;MUC1;LDB2;LDB1;PHC2;PRICKLE1;JDP2;GLI2;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;CUX1;RBFOX2;HDAC4;RXRA;HES5;SIX4;STAT3;PHF21A;KMT5A;ATF4;TRIM28;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;PRDM6;FOXC2;ZNF25;MIDEAS;CCAR2;NFX1;PER3;SMAD4;ERN2;BHLHE40;HMGB1;EZH1;SKI;HEYL;TBX21;MDM4;SOX9;EHMT1;MAEL;TRIM27;BTAF1;NRIP1;RARA;NSD1;MBTD1;PA2G4;NOG;DAP;RCOR3;FOXK1;IMPACT;DLG1;SMARCC2;WWP2;EID2B;SBNO2;MCPH1;SPINDOC;ILF3;BMP4;FGFR2;PHC3;TSC22D4;ZBTB2;SCMH1;ZFP90;MIER2;RUNX2;KDM2A;URI1;FOXM1;ATN1;POU6F1;CBX2;ID4;HSF4;MAZ;COMMD7;KAT6B;SFPQ;SMAD7;RNF2;MED25;FOXP4;KDM4A;NR1D2;HEY1;GLIS1;EZR;KHDRBS1;HDAC1;MYPOP;NPAS1;MEF2A;NACC1;MAP3K10;RUNX1;ERF;LIMD1;PIAS4;TCF25;FRK;HEXIM1;DAB2;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;FOXO3;HDAC6;FOXN3;NKX6-2;CREB1;VPS72;CREBBP;PARP1;KDM5C;SIN3B;RPS27A;UBC;APBB1;SUMO1;DPF3;NIPBL;PRDM2;L3MBTL3;MDFI;MTA3;CBX5;CALCA;EFNA1;FLCN;NR3C1;E4F1;CDKN1C;MEN1;LCOR;ORC2;THAP7;CITED2;HMGA1;PCGF2;E2F1;SUV39H2;HCFC1;BIRC5;ZMYND11;SUFU;ZBTB32;CHD8;CBFA2T2;SARS1;KLF10;MLXIPL;XRCC6;LARP7;CBFB;ZNF431;WWC2;LEFTY1;TCF3;TAF9B;CDK5;SCML2;NOC2L;MAX;BPTF;CALR;IKZF4;KAT7;SUV39H1;MAD2L2;GPS2;IL4;MPHOSPH8;SMURF2;RITA1;YEATS2;MIER1;SAMD11;SAP18;PEX2;PAF1;NFIC;NR2F6;CRY2;USP47;ATP8B1;LOXL2;ZNF177;ZKSCAN3;KAT8;NR2C2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5947181716918433,1.187558758536582,0.27391304347826084,0.7659744432186476,1.0,1/10,0.78%,VEGFA
prerank,negative regulation of blood coagulation (GO:0030195),-0.34381129807665134,-1.1872473957367877,0.1891891891891892,0.5995593920960774,1.0,10/38,10.56%,VTN;APOE;NOS3;TFPI;PLAT;F8;PDGFRA;A2M;EDN1;SERPINE1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5005228322915278,1.1871533913099965,0.2644526445264453,0.7665892391982622,1.0,6/25,12.19%,HSPA2;DNAJB14;ST13;HSPA14;HSPA5;DNAJC7
prerank,regulation of mRNA stability (GO:0043488),0.4138378910449716,1.1865415305112896,0.16056910569105692,0.7680463859502573,1.0,54/145,25.78%,XPO1;PRKCD;PABPC1;SAMD4A;PSMD7;PRKCA;FTO;PSMA8;PUM1;TENT5A;FUS;THRAP3;PSMA4;PCBP4;TBRG4;VIP;TAF15;METTL16;PSMD12;PSMA6;EIF4G1;PSMD1;XRN1;EXOSC4;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;RC3H2;DIS3;E2F1;AKT1;GDNF;TNPO1;FASTKD3;PSMA3;CIRBP;PSMB1;PSMD4;FXR2;SLC11A1;DCP1A;PSMA5;PSMA7;ZC3H14;HNRNPU;YBX1;RBM24;ROCK1;YWHAB;METTL14;PSMC1
prerank,cell projection organization (GO:0030030),0.47981669039468877,1.186469782376029,0.2506053268765133,0.7675031028218191,1.0,6/30,14.92%,RHOJ;GSN;RHOQ;CYFIP1;PARVA;SCIN
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.45175991049711217,-1.1861978623801952,0.2326388888888889,0.5999291203035246,1.0,4/13,12.41%,NOS3;MTHFD1L;GCH1;SPR
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5284516385118937,1.1860221757920226,0.2743243243243243,0.7682560684155013,1.0,3/17,6.53%,STAT3;GNL1;JAG1
prerank,Golgi localization (GO:0051645),0.5738946615423485,1.1856665210527768,0.26732673267326734,0.7686941678360705,1.0,4/11,12.98%,ARCN1;COPG1;ARHGAP21;STK25
prerank,mitochondrion disassembly (GO:0061726),0.4744623417322881,1.185552991707577,0.2434052757793765,0.7682548457612359,1.0,15/34,29.91%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;ATG2B;AMBRA1;ULK1;FIS1;CISD2;USP30;PRKN
prerank,negative regulation of chemotaxis (GO:0050922),0.4773577985363358,1.1853793378661044,0.2536057692307692,0.7680491008546374,1.0,4/31,6.96%,THBS1;SLIT2;SEMA3E;SEMA4B
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.5666454016682684,1.18507607421882,0.27486187845303867,0.7682972064684757,1.0,6/12,27.45%,GCLC;BDH2;GCLM;CHAC2;HAGH;OPLAH
prerank,regulation of superoxide anion generation (GO:0032928),0.5590128357553259,1.184590730983353,0.27097661623108665,0.7691552918413542,1.0,3/14,16.42%,PRKCD;SOD1;AATF
prerank,neuron fate commitment (GO:0048663),0.5398707677661871,1.1840902748572533,0.27165354330708663,0.7701161686440029,1.0,1/14,0.58%,ID2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.41335188842784143,-1.1839843006429402,0.24786324786324787,0.6034721502977567,1.0,5/17,16.68%,COX8A;COX6C;COX4I1;COX10;COX5B
prerank,regulation of endothelial cell proliferation (GO:0001936),0.41978982258952624,1.1839816891422756,0.20126448893572182,0.7696704113828085,1.0,15/88,12.61%,THBS1;PGF;VEGFA;F3;FGF2;SPARC;STAT5A;XDH;PRKCA;SULF1;BMP4;AGGF1;VIP;NRP1;TGFBR1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3953906443950587,1.1837893843643221,0.11022044088176353,0.7695820573114928,1.0,42/291,12.59%,SLIT2;ESR1;EGFR;IRS1;PID1;WNT9A;IGFBP5;PRKCD;LBP;ADAM9;PDCD4;DRD1;HCN4;SLC26A6;IPO5;CARD16;SHPK;PDE3A;VCP;TNFRSF1B;LAMTOR1;HMGB1;FZD7;TRIM41;SOX9;NRIP1;IMPACT;CAPN2;RHOA;SBNO2;RORA;MAPK8;CHUK;NFKBIB;IRAK1;P2RY6;GIT1;ATM;PABPN1;EZR;AKAP9;SESN2
prerank,endosome organization (GO:0007032),0.4556135999506012,1.183555352765989,0.2364475201845444,0.7696198144636527,1.0,12/41,21.10%,DNAJC13;RILP;LAMTOR1;USP50;LAPTM4B;EEA1;WASHC4;PI4K2A;SQSTM1;VPS11;PHETA2;ARFGEF2
prerank,insulin receptor signaling pathway (GO:0008286),0.4289576803919526,1.1832420210154002,0.2247557003257329,0.7699080570782932,1.0,19/69,15.93%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;TCIRG1;C2CD5;FOXC2;ATP6V0A1;AKT2;ZNF106;ATP6V0D1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4479033538054989,1.1826987379036278,0.23964165733482642,0.7709733974496492,1.0,27/52,28.53%,ABLIM3;CSNK2A2;HUWE1;FZD5;PPP3CC;MAPK8;YWHAE;USP36;HPS4;YWHAQ;TFDP1;MICALL2;VPS11;E2F1;BID;NPEPPS;SAE1;SFN;TP53;BAD;PINK1;YWHAB;ATG13;NMT1;HTRA2;SREBF2;BBC3
prerank,regulation of defense response to virus (GO:0050688),0.5449440036789716,1.1825081296259958,0.2755244755244755,0.7708089448580037,1.0,8/14,27.83%,IFNLR1;ITCH;TRAF3;PCBP2;RNF216;C1QBP;ILRUN;PPM1B
prerank,response to lipopolysaccharide (GO:0032496),0.40194640319463193,1.1822989836973286,0.18051282051282053,0.7707722954589478,1.0,27/138,15.25%,FOXP1;LBP;ADAM9;PDCD4;SMAD6;CARD16;SHPK;TNFRSF1B;HMGB1;IRAK3;TRIM41;LIAS;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;TAB2;GIT1;PABPN1;F2R;CD80;CASP1;SRR;PRDX3;CYP27B1;IL6
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.42703756374504614,1.182092983004657,0.2182410423452769,0.770698754385587,1.0,10/75,6.57%,THBS1;HOXA5;EMILIN1;ISM1;SPARC;TGFB2;SERPINF1;SEMA3E;THBS2;SULF1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.392645490828794,1.181266528019284,0.057,0.7728759949734365,1.0,145/497,22.45%,FOXP2;WWP1;FOXP1;ID2;IGFBP5;ZFPM2;GAS6;ZNF423;FOXD1;TCF7L2;PDCD4;TWIST2;GCLC;LDB1;PHC2;PRICKLE1;MDFIC;PRDM5;NCOR2;GLIS2;TWIST1;DKK3;SAMD4A;DEAF1;SHC1;PRDM11;TLE2;LHX9;HDAC9;RBFOX2;HDAC4;SIX4;KMT5A;TRIM28;MIDEAS;CCAR2;SMAD4;ERN2;BHLHE40;HEYL;TBX21;SOX9;EHMT1;MAEL;BTAF1;RARA;MBTD1;PA2G4;DAP;RCOR3;FOXK1;CDC6;SMARCC2;WWP2;EID2B;CDAN1;SBNO2;SPINDOC;ILF3;BMP4;PHC3;TSC22D4;SCMH1;RUNX2;FOXM1;ID4;COMMD7;KAT6B;SFPQ;KDM4A;NR1D2;HEY1;KHDRBS1;HDAC1;NPAS1;RBM4;NACC1;MAP3K10;LIMD1;PIAS4;HEXIM1;ZNF148;RING1;VDR;YWHAQ;MBD1;L3MBTL2;ID1;PER1;ING4;SIRT2;CNOT8;HDAC6;FOXN3;NKX6-2;KDM5C;CNOT10;SUMO1;DPF3;NIPBL;L3MBTL3;MTA3;CBX5;CALCA;NR3C1;EPRS1;CDKN1C;MEN1;THAP7;CITED2;HMGA1;DAPK3;E2F1;SUV39H2;CNOT9;SHMT1;BIRC5;ZMYND11;CHD8;CBFA2T2;KLF10;MLXIPL;SYNCRIP;XRCC6;GMNC;CDK5;SCML2;CALR;IKZF4;KAT7;SUV39H1;IL4;MPHOSPH8;SMURF2;YEATS2;SAMD11;SAP18;CRY2;FXR2;USP47;ATP8B1;LOXL2;ZKSCAN3;KAT8;EIF2AK3
prerank,glycine metabolic process (GO:0006544),0.561297880559372,1.181114783487438,0.2791946308724832,0.7726231562538121,1.0,5/12,26.94%,GCSH;GLYAT;SHMT2;SHMT1;RIDA
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.4455049625015194,-1.1808914983173682,0.26334519572953735,0.6087758811763102,1.0,2/11,3.01%,NOVA1;NOVA2
prerank,glycolipid biosynthetic process (GO:0009247),0.4546179701453726,1.1808603784373204,0.2505854800936768,0.7726656635496576,1.0,7/38,14.13%,ST3GAL4;ST6GALNAC5;PIGW;ST3GAL2;PIGF;PIGL;PGAP2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.47338768768008077,1.180781156054705,0.25183374083129584,0.7721446041555311,1.0,15/31,27.84%,HSPA2;BAG3;DNAJB14;HSPA14;HSPA5;STUB1;HDAC6;DNAJC18;OPTN;DNAJB12;UBE2W;DAXX;HSPB8;ERN1;HSF1
prerank,protein localization to chromatin (GO:0071168),0.5336072433360755,1.1807774637284556,0.2630890052356021,0.7713630854723689,1.0,2/18,7.50%,ESR1;SGF29
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4686494485292729,-1.1806533021802859,0.23843416370106763,0.6071480619666603,1.0,4/10,3.10%,ATP1A2;NEDD4L;OSR1;HECW2
prerank,aorta development (GO:0035904),-0.4235905063134727,-1.1805294023880741,0.24731182795698925,0.6052116643331201,1.0,8/14,14.98%,ROBO1;ROBO2;PDGFRB;TBX1;PDE2A;TBX2;EFEMP2;APLNR
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5304826886059641,1.1801599275825592,0.27225130890052357,0.7727079565585229,1.0,9/17,30.73%,DHDDS;ALG13;DOLPP1;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5553775092718288,1.1801270970333086,0.29338842975206614,0.7720232956221574,1.0,5/13,13.78%,NFIB;SOX9;BMP4;SRF;NFATC3
prerank,mitochondrion morphogenesis (GO:0070584),0.5714341427626111,1.1800641694508829,0.29651162790697677,0.7714612331732303,1.0,1/11,0.49%,PID1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.45943196260644037,1.1793461525517743,0.26229508196721313,0.7732749789359731,1.0,12/40,24.15%,XPO1;GLMN;CSNK2A2;CSNK2A1;CDK5RAP3;AXIN1;UFL1;ARAF;HIPK2;CLU;DESI1;TAF1
prerank,regulation of cellular protein localization (GO:1903827),0.4453671797118783,1.1792849716572151,0.25057471264367814,0.7727320974310314,1.0,12/45,16.21%,GPC6;GPC3;VCP;DVL1;GBF1;SPIDR;CCDC66;RAB11FIP5;CSNK1E;RAB11B;NDEL1;PARP1
prerank,negative regulation of peptidase activity (GO:0010466),0.4495850168934374,1.1791930627563427,0.2482837528604119,0.7722410910402718,1.0,11/47,18.73%,LRP1;SERPINH1;TIMP2;TIMP3;SERPINF1;CST3;SERPINB9;SERPINE2;CRB2;AKT1;SERPING1
prerank,UV protection (GO:0009650),0.578853128350513,1.1791295982296908,0.2627118644067797,0.771676026827317,1.0,6/10,26.55%,SCARA3;ERCC5;ERCC2;CAT;SDF4;XPA
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5290163251180985,1.1785546341906457,0.27648578811369506,0.7728610277386563,1.0,5/17,14.14%,MPG;ERCC5;OGG1;TDG;SMUG1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.49034792321832477,1.1782139128274396,0.25953259532595324,0.7732783603315655,1.0,7/26,17.34%,EGFR;SOX9;SYAP1;PDPK1;IQGAP1;ERBB2;GAREM1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.43358417878854155,1.17750668647999,0.22965440356744704,0.774972011052257,1.0,13/67,14.32%,MYOC;P4HB;VIT;CD3E;AGR2;ILK;S100A10;DOCK5;JUP;ABL1;NRP1;ARL2;NDNF
prerank,aminoglycan metabolic process (GO:0006022),0.5769053224355978,1.1773297802815113,0.2962962962962963,0.7748307487352446,1.0,1/10,0.50%,XYLT1
prerank,'de novo' posttranslational protein folding (GO:0051084),0.48253985710135533,1.1771444500050678,0.2751196172248804,0.7747089470949172,1.0,7/30,12.19%,HSPA2;DNAJB14;ST13;HSPA14;UGGT1;HSPA5;DNAJC7
prerank,regulation of phospholipase C activity (GO:1900274),0.5347938541577226,1.1769530269953943,0.27125506072874495,0.7745773108380783,1.0,5/15,10.59%,ESR1;FGF2;NTRK3;FGFR1;ABL1
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5486283701665977,1.176825338353061,0.2883008356545961,0.7742334382150495,1.0,5/13,9.70%,PRICKLE1;SOX9;SRA1;EID2B;BMP4
prerank,organelle assembly (GO:0070925),0.3936301501270609,1.1766894005688495,0.08508508508508508,0.7739415722968864,1.0,143/384,28.51%,PKD1;GSN;ULK2;CFAP298;EXOC4;EHD1;CSNK1D;ABLIM3;GOLGA8B;PKHD1;RAB43;DYNC1H1;DYNLT2B;TUBGCP3;RILP;ARMC9;PACS2;ATXN2L;BBS9;CDC14A;NEK7;TMEM107;RAB8A;IFT20;GBF1;WIPI2;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CENPC;RFX2;TCTN1;UBAP2L;IFT80;IQCB1;SH3PXD2B;PRRC2C;CENPT;TMEM216;RAB38;CCDC66;RCC1;ATP6V0D1;TRAPPC6A;CFAP43;PTPDC1;MIS12;WDR11;ATG3;PATL1;ATG16L2;CEP164;PARVA;TRAPPC14;OCRL;DHX29;STAM2;MAPRE3;BBS5;IFT46;CHMP3;LIMD1;UBQLN1;ABCB6;RAB23;HPS4;FUZ;FARP2;NUDCD3;CEP41;CEP63;PCM1;HAUS5;HDAC6;IFT88;NPHP3;INPP5E;TTLL3;LZTFL1;DYNC2I1;CDS1;IST1;IFT43;CCDC57;RB1CC1;TEKT2;TMEM237;VTA1;PTPN23;DLGAP5;CCDC61;KIF24;CIRBP;CHMP4A;CHMP4B;EIF2A;EIF2S1;PDCD6IP;NUP62;ATG16L1;RUFY4;POGZ;ATXN2;RAB1A;MVB12A;TMEM231;TXNDC15;SPAG16;RAB1B;GORASP2;BBIP1;PLK4;SYNPO;CEP89;DYNC2H1;TCTN3;ATG9A;TMEM67;CHMP2A;TMEM138;FITM2;NCOR1;BBS7;CEP20;FBF1;EXOC7;ATG13;INTU;ACTR2;GOLGA2;ATG2B;AMBRA1;NEK6;VPS37B;YTHDF1;E2F4;TTBK2;DYNC2I2;ULK1;IFT140;UBXN2A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.454834105998725,-1.1764883526636818,0.23574144486692014,0.6130798255217996,1.0,1/12,1.21%,IL1R1
prerank,endocytic recycling (GO:0032456),0.4479169637631083,1.1764872266808395,0.24688561721404303,0.7738583491931017,1.0,18/50,25.38%,EHD1;ANKRD27;VPS52;EHD2;VPS26A;VPS53;RAB11B;MICALL2;DENND1B;PTPN23;VPS26C;DENND1A;SNX4;VPS51;SNX3;LMTK2;RAB11FIP4;VPS35L
prerank,regulation of mitotic cell cycle (GO:0007346),0.4016036176884585,1.176322438001128,0.15384615384615385,0.7736377359583917,1.0,74/171,30.21%,SMOC2;TTC28;PTPN3;ANAPC5;PSMD7;GAS1;CDC16;PRKCA;USP2;PSMA8;NEK7;GBF1;CDK10;SRA1;CDK5RAP3;PKN2;PSMA4;CDC25B;FOXA1;INTS13;UBE2C;RCC1;PSMD12;ANAPC4;ERCC3;CUL1;PSMA6;ERCC2;PSMD1;ANAPC2;IQGAP1;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;ANAPC10;CDKN1C;DAPK3;KIF20B;CDC20;CCDC57;HECA;CDC27;CKS1B;DLGAP5;PSMA3;PSMB1;PSMD4;CUL9;RNF20;PSMA5;CYLD;PSMA7;HNRNPU;RPS6KB1;CDK13;PSMC1;CCDC8;CUL7;EIF4E;NEK6;PSMA1;HSF1;USP22;DDB1;CDK9;BTRC;BTG3;PRMT5;ANAPC11;UBE2S;PSMD2;TTLL12
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3921779836804494,1.1761522546366092,0.03303303303303303,0.7734235858772466,1.0,163/572,22.38%,FOXP2;ESR1;FOXP1;KLF12;ID2;ZFHX3;ZFPM2;VEGFA;NFIX;NFIB;SKIL;TCF7L2;IL33;RARB;NEDD4;DDX5;LDB2;LDB1;JDP2;GLI2;PRDM5;NCOR2;GLIS2;TWIST1;DEAF1;HDAC9;CUX1;HDAC4;RXRA;HES5;STAT3;PHF21A;KMT5A;ATF4;BAG3;NR2F1;CHD3;TCFL5;USP2;TLE6;DACT1;PRDM6;FOXC2;ZNF25;NFX1;PER3;SMAD4;BHLHE40;HMGB1;EZH1;SKI;TBX21;MDM4;SOX9;TRIM27;NRIP1;RARA;NSD1;NOG;IMPACT;DLG1;WWP2;MCPH1;BMP4;FGFR2;ZBTB2;ZFP90;MIER2;URI1;FOXM1;ATN1;POU6F1;CBX2;ID4;HSF4;MAZ;SFPQ;SMAD7;RNF2;MED25;FOXP4;SRF;NR1D2;HEY1;GLIS1;EZR;HDAC1;MYPOP;MEF2A;RUNX1;NFATC3;ERF;TCF25;FRK;HEXIM1;DAB2;ZNF148;VDR;ID1;PER1;SIRT2;FOXO3;VPS72;CREBBP;PARP1;SIN3B;RPS27A;UBC;APBB1;SUMO1;NIPBL;PRDM2;MDFI;MTA3;CBX5;EFNA1;FLCN;NR3C1;E4F1;MEN1;LCOR;ORC2;THAP7;CITED2;PCGF2;E2F1;SUV39H2;HCFC1;SUFU;ZBTB32;CHD8;SARS1;KLF10;CC2D1A;LARP7;CBFB;ZNF431;WWC2;LEFTY1;TCF3;TAF9B;NFATC4;NOC2L;MAX;BPTF;CALR;SUV39H1;MAD2L2;GPS2;IL4;SMURF2;RITA1;YEATS2;MIER1;PEX2;PAF1;NFIC;NR2F6;CRY2;LOXL2;ZNF177;ZKSCAN3;NR2C2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.45989554157698775,1.1760794902874856,0.25143513203214696,0.77293029479244,1.0,15/37,24.93%,ENTPD2;SIDT2;ENTPD6;PPP1R8;RNASE3;RNASE6;SUPV3L1;SND1;NCBP1;DFFB;ENTPD7;MTREX;ENTPD5;PABPC4;NUDT18
prerank,lung epithelium development (GO:0060428),0.5835511734917325,1.1753254419849806,0.2780979827089337,0.7748294885386819,1.0,2/10,9.70%,PKD1;BMP4
prerank,Rho protein signal transduction (GO:0007266),-0.31043374972514054,-1.1751501079510653,0.216,0.6143173492555213,1.0,15/53,9.23%,ARHGAP29;ROCK2;ARHGAP6;CDH13;ARHGEF3;EPS8;CDC42EP4;ADRA2A;ARHGDIA;GNA13;CDC42EP3;AGTR1;CDC42;EPS8L2;RHOU
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.46469429348357255,1.174421901166535,0.2693236714975845,0.7771668812363629,1.0,9/33,15.69%,HOXA5;ACVR1B;RAB7B;STAT3;PRKDC;PITHD1;INHBA;SCIN;FOXO3
prerank,mesoderm formation (GO:0001707),-0.4093361840903039,-1.1742628036548644,0.226890756302521,0.6143922429960804,1.0,4/17,9.15%,ITGB4;ITGA3;ITGA8;BMPR2
prerank,proteoglycan metabolic process (GO:0006029),0.49233590998756965,1.1741674104181836,0.25398773006134967,0.7772667413730886,1.0,6/26,11.97%,XYLT1;CHST11;HS3ST4;SULF1;FOXL1;GAL3ST4
prerank,morphogenesis of an epithelium (GO:0002009),0.48702655837906345,1.1736031278934522,0.2657601977750309,0.7784382865588131,1.0,3/25,9.71%,LRP6;SOX9;FGFR2
prerank,peptidyl-lysine methylation (GO:0018022),0.4816321971031743,1.1735786773244175,0.2614213197969543,0.7777460270071948,1.0,12/26,26.51%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SUV39H2;SUV39H1;SETD2;SMYD2;TRMT112;EHMT2;SETD7
prerank,respiratory system development (GO:0060541),0.4616792611547187,1.173515606495774,0.25093167701863356,0.7771806535199431,1.0,7/32,9.71%,VEGFA;FGF2;GLI2;DISP1;CCDC39;BMP4;FGFR2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4473047677577743,1.173419380527315,0.24235560588901472,0.776732830106065,1.0,12/52,15.15%,EGFR;LRP1;PRKCE;EPHB2;EPB41L2;PLS1;AGR2;DLG1;PDPK1;SQSTM1;STAC3;STX4
prerank,sphingosine metabolic process (GO:0006670),0.5247307528990582,1.1731867748524825,0.2774798927613941,0.7768028037703767,1.0,3/17,6.19%,ACER3;PLPP3;PLPP1
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5622247618406522,1.172712802693727,0.27247191011235955,0.777696869993791,1.0,4/12,10.45%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,response to interferon-beta (GO:0035456),-0.37737905215878775,-1.1725179823644103,0.1963470319634703,0.6166408168940448,1.0,7/22,13.59%,IFNAR2;STAT1;IFITM1;BST2;AIM2;IFITM3;NDUFA13
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.45726646783707486,1.1724011796402682,0.2653534183082271,0.7779740757399725,1.0,12/37,19.33%,FHIT;CSNK2A2;CSNK2A1;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;HIPK2;UCHL5
prerank,nucleotide-excision repair (GO:0006289),0.41413842429994674,1.1722314071310478,0.19771071800208118,0.777776005466389,1.0,56/101,34.68%,CHD1L;ERCC8;GPS1;ERCC5;HMGN1;ERCC4;OGG1;CUL4A;USP45;ERCC3;XAB2;LIG4;USP7;ERCC2;MMS19;POLR2F;ISY1;PARP1;RPS27A;UBC;HUS1;POLB;SLC30A9;AQR;COPS4;POLR2B;COPS7A;TP53;UVSSA;POLD1;GTF2H4;SLX4;RNF111;POLR2H;COPS3;XPA;PNKP;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;ERCC1;RAD23B;ERCC6;POLR2K;POLK;RPA3;CUL4B;CCNH;COPS2;CETN2;FAN1;COPS7B;RFC4
prerank,regulation of cytokinesis (GO:0032465),0.42145906193389787,1.1720993627358456,0.22138228941684665,0.7774337767269277,1.0,26/78,25.58%,CIT;PRKCE;KIF13A;CALM2;CDC14A;GIPC1;CDC6;RHOA;PKN2;CDC25B;SPAST;GIT1;ZFYVE19;OPN1MW;CSPP1;CALM3;BIRC6;FLCN;KIF20B;DRD2;SETD2;UVRAG;PLK4;SVIL;RAB11FIP4;CCP110
prerank,negative regulation of protein secretion (GO:0050709),0.4562258661076135,1.172011802609068,0.25381903642773207,0.7769903508192442,1.0,3/38,1.72%,IRS1;KCNB1;CCN3
prerank,regulation of mitochondrial fusion (GO:0010635),0.5683484574202268,1.171456672725726,0.28077455048409405,0.7780704987293947,1.0,2/11,7.87%,PID1;HUWE1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.4148352559286968,1.1713879834069123,0.20104166666666667,0.7775710539944096,1.0,37/107,25.07%,THBS1;P4HB;MAP3K5;ATF4;VCP;AGR2;ERN2;MBTPS1;SYVN1;CDK5RAP3;HYOU1;PDIA3;NIBAN1;BCAP31;AIFM1;TNFRSF10B;HSPA5;UBA5;UBQLN1;SEC16A;USP19;UFL1;TMEM33;QRICH1;ERLEC1;RASGRF1;ATF6;EIF2S1;RCN3;EIF2AK3;DERL1;GORASP2;HERPUD1;CREB3L1;TP53;SELENOS;DNAJB12
prerank,membrane protein proteolysis (GO:0033619),0.4539340623499416,1.1710523122495977,0.2674698795180723,0.7779049195653789,1.0,7/37,9.55%,ADAM9;HM13;ADAM10;BACE2;CLPP;MBTPS1;BACE1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.4597547208696706,1.170633793490267,0.2708333333333333,0.7785701314040376,1.0,7/37,12.74%,IGFBP5;FGF2;PDCD4;TGFB3;P2RY6;BMPR1A;MEF2D
prerank,regulation of cell cycle phase transition (GO:1901987),0.4154302676381028,1.1699613178627029,0.2266526757607555,0.7801276905741878,1.0,39/91,30.19%,ANAPC5;PSMD7;CDC16;PSMA8;PSMA4;UBE2C;PSMD12;ANAPC4;ERCC3;CUL1;PSMA6;ERCC2;PSMD1;ANAPC2;PSMC5;ANAPC1;PSMD11;PSMC4;PSMD14;ANAPC10;CDC20;DBF4;CDC27;PSMA3;ATP2B4;PSMB1;PSMD4;PSMA5;PSMA7;TAF1;TP53;PSMC1;PSMA1;DDB1;BTRC;TRIM39;ANAPC11;UBE2S;PSMD2
prerank,defense response to symbiont (GO:0140546),-0.274940339119953,-1.1696383686153653,0.15384615384615385,0.6216471756226333,1.0,20/92,12.64%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;NLRC5;BST2;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;CD40;RSAD2;IFITM3;OAS2
prerank,response to metal ion (GO:0010038),0.43042066785647415,1.1695528219402196,0.24078091106290672,0.7807244976349625,1.0,8/67,9.75%,THBS1;ADAM9;NEDD4;SEC31A;CALM2;FXN;NDRG1;SLC30A5
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.45194450945198544,1.169382191463324,0.24103139013452915,0.7804989507692442,1.0,19/48,26.42%,NUP93;SEC13;RAE1;SEH1L;NOA1;OGT;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;NUP62;NDC1;NUP35;NUP85;NUP160;TPR
prerank,lipid translocation (GO:0034204),0.5049229023508149,1.1690944193418271,0.29577464788732394,0.7807173958243183,1.0,6/21,13.71%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ATP9A;ABCA1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3953495163046754,-1.1688287083396172,0.25217391304347825,0.6212939812579262,1.0,4/19,3.85%,GRM5;RYR2;KDR;VCAM1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.47688941559288667,-1.1686683635300308,0.2857142857142857,0.6195444197121844,1.0,4/10,17.81%,CX3CR1;CEACAM1;LGALS9;ARRB2
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4292297962489239,1.1678613545962246,0.2265193370165746,0.7840116922548916,1.0,30/66,29.40%,PRKCD;IPO5;WWTR1;LIMK2;TRIM28;BAG3;MAVS;JUP;CDK5RAP3;ZIC1;UBR5;TERT;SESN2;ORMDL3;RBM22;AKT1;CCT4;LARP7;CCT6A;KAT7;CCT8;EIF2AK3;TCP1;EFCAB7;TPR;DKC1;LIF;CCT5;TESK1;MEPCE
prerank,regulation of protein transport (GO:0051223),0.4813327787472645,1.1678406675597426,0.2701005025125628,0.7833095622678512,1.0,13/27,26.37%,P3H1;DISP1;LLGL1;WWP2;SCFD1;CHP1;STXBP5;GAPVD1;NDEL1;DNAJA1;SNX3;DNAJC1;NDFIP1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.27544901909909386,-1.1676819386607136,0.10810810810810811,0.6197515138876779,1.0,26/107,11.55%,ATP1A2;GRM7;GRM5;MCTP1;GRM3;LRRC4C;APP;RIMS2;GRM8;GRID2;NRG3;GRM1;GRIK2;RIMS1;EIF4EBP2;OPHN1;MCTP2;CDH2;SLC8A3;HOMER1;SYN1;LGI1;NMU;CX3CR1;CNTNAP4;CLSTN1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.43192846171883903,1.1676176287726272,0.2249173098125689,0.7832985879635067,1.0,8/66,9.70%,EGFR;PKD1;ID2;FHL1;RDX;DACT1;DLG1;ANXA1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.5765329282859587,1.167562076742181,0.3123209169054441,0.7819730981188052,1.0,2/11,3.64%,SHC1;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.5765329282859587,1.167562076742181,0.3123209169054441,0.7819730981188052,1.0,2/11,3.64%,SHC1;STAT5A
prerank,regulation of synapse assembly (GO:0051963),0.4411200161076262,1.1666195061690194,0.2540045766590389,0.7843749677322148,1.0,11/46,13.02%,SLIT1;GPC6;EPHB2;CLSTN2;LRFN4;EPHB3;CHRNB2;MUSK;SETD5;EIF4G1;NLGN1
prerank,negative regulation of defense response to virus (GO:0050687),0.5670341648776563,1.16637262959086,0.30503597122302156,0.7844468060349625,1.0,6/10,27.83%,ITCH;PCBP2;MUL1;C1QBP;ILRUN;PPM1B
prerank,response to laminar fluid shear stress (GO:0034616),0.5720865078106552,1.1661575058010896,0.3101449275362319,0.7844571658580577,1.0,4/10,13.71%,SMAD6;NFE2L2;SMAD7;ABCA1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.41374245983832303,1.16530208480018,0.23036649214659685,0.7865713812659723,1.0,38/94,25.58%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;CC2D2A;TCTN1;IQCB1;DCTN2;TMEM216;CKAP5;RPGRIP1L;SDCCAG8;AKAP9;CEP164;CSNK1E;YWHAE;MARK4;CEP41;CEP63;PCM1;HAUS5;DYNC1I2;DCTN1;KIF24;PRKACA;ACTR1A;CDK5RAP2;NEDD1;NPHP4;PLK4;CEP89;TCTN3;CNTRL;TMEM67;TUBB4B;FBF1;CCP110
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.40295837753394653,1.1650660350994537,0.1979381443298969,0.7865971369589136,1.0,51/145,25.78%,FHL1;FBXL7;PSMD7;CSNK1D;DYNC1H1;SFI1;PSMA8;BRD4;ODF2;ALMS1;DCTN2;PSMA4;CDC25B;CKAP5;PSMD12;RCC2;SDCCAG8;AKAP9;CUL1;CEP164;CSNK1E;PSMA6;YWHAE;PSMD1;CEP41;CEP63;PCM1;PSMC5;HAUS5;PSMD11;PSMC4;PSMD14;CDC25A;CDK2;DYNC1I2;PSMA3;DCTN1;PRKACA;PSMB1;PSMD4;USP47;ACTR1A;CDK5RAP2;NEDD1;PSMA5;PSMA7;PLK4;CNTRL;TUBB4B;CCP110;PSMC1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.45068158164127015,-1.164597314994209,0.27181208053691275,0.625271403043548,1.0,7/12,20.86%,CNKSR3;GPD1L;NOS1;PKP2;ANK3;SCN3B;SCN5A
prerank,cellular response to interleukin-6 (GO:0071354),0.47872261601797506,1.1645014459273444,0.28553770086526575,0.7877547576320443,1.0,6/26,9.20%,PID1;PTGIS;STAT3;SMAD4;CBL;SBNO2
prerank,kidney development (GO:0001822),0.4250750479894695,1.1638779182114662,0.2508250825082508,0.7890749914093413,1.0,16/65,19.34%,SIX1;PKD1;VEGFA;PCSK5;GLI2;TGFB2;SULF1;PYGO1;BMP4;TGFBR1;IFT88;NPHP3;NF1;NIPBL;GDNF;SULF2
prerank,regulation of mitotic spindle organization (GO:0060236),0.46605020595193286,1.163585839973011,0.26473988439306356,0.7892658498480782,1.0,14/35,27.13%,PARP3;RAE1;DYNC1H1;EML3;CHMP3;CLTC;DCTN1;CHMP4B;PDCD6IP;NUP62;HNRNPU;CHMP2A;TPR;DRG1
prerank,natural killer cell activation (GO:0030101),0.49114225958799007,1.1629330342978816,0.2708333333333333,0.7907359467768293,1.0,3/23,7.12%,ELF4;KLRK1;PBX1
prerank,negative regulation of axonogenesis (GO:0050771),0.4812771775197412,1.1627687453189748,0.2769607843137255,0.790544791411379,1.0,5/27,9.03%,FGF13;ULK2;GDI1;PTPRS;RHOA
prerank,negative regulation of autophagy (GO:0010507),0.4392898002317631,1.1624676636793234,0.2560706401766004,0.7907645807316409,1.0,27/54,27.01%,STAT3;LZTS1;EIF4G2;NRBP2;SNRNP70;QSOX1;EIF4G3;DAP;FOXK1;SMG1;TAB2;KDM4A;EIF4G1;USP36;HGF;SIRT2;TLK2;KLHL22;AKT1;LRRK2;RUBCN;ZKSCAN3;SMCR8;PINK1;MET;GOLGA2;EIF4E
prerank,renal filtration (GO:0097205),0.5681278662159424,1.162178986811629,0.31107954545454547,0.790968501797504,1.0,3/10,6.57%,TBC1D8B;MYO1E;SULF1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.39765456473629573,1.1617878861592976,0.18071065989847715,0.7915490232666388,1.0,21/151,13.07%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;NTRK3;NTRK1;FSHR;CCL13;SHC1;CCL15;PRKCA;HMGB1;ROR1;FGFR2;PLA2G5;MAP3K12;P2RY6;ARHGAP8;NRP1;F2R
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.48936009596308755,1.1617526373674707,0.2844387755102041,0.7908848653734898,1.0,3/24,1.87%,NEDD4;EMILIN1;GRB10
prerank,positive regulation of phospholipid transport (GO:2001140),-0.48538563044518734,-1.1616937299763002,0.28846153846153844,0.6304791939946289,1.0,1/10,1.38%,APOE
prerank,cellular response to interleukin-12 (GO:0071349),0.4448570624194854,1.1615914894960313,0.2835990888382688,0.7906819801990642,1.0,10/48,11.85%,PDCD4;P4HB;ANXA2;PITPNA;IL12RB2;HNRNPA2B1;HNRNPDL;PAK2;ARF1;SOD1
prerank,protein-containing complex disassembly (GO:0032984),0.43526660088453784,1.161402691060177,0.2516930022573363,0.7905794714652543,1.0,21/54,30.24%,LRP6;VCP;DVL1;LIX1L;WIPI2;FZD5;AXIN1;VIPAS39;CHMP3;UBQLN1;CLN3;PYM1;LAMP2;UVRAG;VTI1B;DVL2;VPS16;CSNK1A1;FZD1;STX17;CTNNB1
prerank,myeloid dendritic cell activation (GO:0001773),0.5583884646967597,1.161205494431554,0.2882758620689655,0.7905050139764471,1.0,4/12,20.97%,TGFBR2;HMGB1;CAMK4;IL4
prerank,nuclear pore organization (GO:0006999),0.5463584509584631,1.1611391362004106,0.3,0.7899576497228735,1.0,7/14,27.35%,NUP93;SEH1L;TMEM170A;NDC1;NUP35;TPR;AHCTF1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.47993959993338964,1.1609281754435807,0.29733163913595934,0.7899079000001206,1.0,3/27,1.13%,IRS1;TNFAIP8L3;FGF2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.39323072059974995,-1.1605378306876164,0.2336448598130841,0.6310613061136556,1.0,6/21,4.70%,ROCK2;ENPP1;NOS3;NOTCH1;SRGN;BCOR
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.44578285936051454,-1.1603962441220925,0.26421404682274247,0.629290330146636,1.0,4/12,9.47%,PPARA;ABCG1;NR1H3;ABCA5
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3899724363628316,1.1600862102525293,0.0960960960960961,0.7920513496792333,1.0,90/366,19.78%,BNC2;ESR1;SIX1;ZFHX3;ZNF423;VSX1;NFIA;LDB1;PRRX2;DMTF1;ACVR1B;JMJD1C;APBB3;WWTR1;SBNO1;BAZ2A;STAT3;TCF7L1;MLF2;ATF4;ERC1;CHD3;TCFL5;DNM2;PHF1;DVL1;TOM1L1;CCAR2;NFX1;NFXL1;BHLHE40;FZD7;TRRAP;FUS;TBX21;RPS6KA4;NSD1;CYFIP1;ESRRB;SMC3;RBBP6;CARM1;SBNO2;RORA;OGG1;CRABP2;FADS1;ABL1;SPTY2D1;CHEK2;KAT6B;RNF14;SFPQ;NR1D2;TGFBR1;KMT2D;NOLC1;LIMD1;SERTAD3;USP13;FOXO3;FOXN3;NKX6-2;ZFPL1;CREBBP;APBB1;HMG20A;PRDM2;NFYA;NFKB2;MAGED1;NR3C1;THAP7;SRSF10;HMGA1;DAPK3;E2F1;RYBP;HCFC1;SUFU;BRDT;ATF2;GON4L;ACTR8;GPBP1L1;MLXIPL;TEAD2;ZNF431;WWC2;TCF3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3892194566543324,-1.1599511963713132,0.23728813559322035,0.6283072296944672,1.0,5/20,9.22%,BCL2;BCL2L1;FAS;DCC;BOK
prerank,histone H3 acetylation (GO:0043966),0.4417505710688733,1.1597141500087227,0.27147766323024053,0.7925852234467539,1.0,21/40,27.96%,LDB1;TADA1;NAA60;TADA2A;SGF29;KAT14;BRPF3;ING5;KAT6B;WDR5;KAT2A;PER1;ING4;KAT7;YEATS2;TAF6L;MEAF6;KAT2B;BRD1;TAF10;TAF5L
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.4421107255416062,1.1593694423193004,0.27605956471935855,0.7930119724764574,1.0,8/50,11.94%,EGFR;PDCD4;NFAT5;ILK;RHOA;IRAK1;C1QTNF4;CD27
prerank,membrane repolarization (GO:0086009),0.5169461985674808,1.159317236555411,0.2925877763328999,0.7924065780953633,1.0,4/15,6.99%,KCNJ2;ATP1B1;KCNE5;KCNIP2
prerank,DNA metabolic process (GO:0006259),0.3921768390723231,1.1591160519474735,0.14814814814814814,0.7923194203688364,1.0,119/270,33.14%,TCF7L2;HELB;PARP3;CHD1L;UBE2B;TRIM28;MPG;POLE2;VCP;PRKDC;HMGB1;RMI2;INTS3;TRRAP;KMT5C;MCM2;ERCC5;DCTPP1;CDC6;RBBP8;ERCC4;RAD1;OGG1;WRN;TDG;KPNA2;TERT;ATM;USP45;TDP1;ERCC3;RAD50;LONP1;CSNK1E;CDC45;LIG4;ALKBH1;USP7;SUPV3L1;SMUG1;DCLRE1B;MMS19;ATRIP;UBE2V2;PARP1;RPS27A;UBC;HUS1;MCM4;TSN;SUMO1;POLB;SMARCAD1;MEN1;ORC2;CDT1;DFFB;TOP3B;UHRF2;DBF4;RAD51;CDK2;XRCC6;FANCG;XRCC3;ENDOV;UPF1;TOPBP1;TOP1;PDS5A;TOP1MT;UVRAG;PRIMPOL;ALKBH3;SMC1A;DNMT1;TOP3A;PARG;PRIM1;RECQL5;POLD1;GTF2H4;SLX4;MCM7;POLG;XPA;PARP4;ZRANB3;RTEL1;RPAIN;DNASE1L2;NOP53;PNKP;ADPRS;DDB1;ATR;SMARCAL1;IGHMBP2;MBD4;RAD52;PDS5B;TIMELESS;CTC1;RAD17;HINFP;UBE2A;MSH2;UBE2N;BLM;XRCC1;ERCC1;CHRNA4;CNBP;POLK;POLQ;GLRX2;RPA3;PURA;SIRT7
prerank,GPI anchor biosynthetic process (GO:0006506),0.4602475911302643,1.1585497833257568,0.2919254658385093,0.7934361956101031,1.0,15/30,32.31%,PIGW;GPAA1;PIGF;PIGL;PGAP2;PIGT;DPM3;PIGX;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,positive regulation of DNA repair (GO:0045739),0.4450177931018231,1.1584578761981246,0.275,0.7930016228003514,1.0,11/46,16.88%,EGFR;EYA2;TRIM28;ERCC8;HMGB1;SLF2;SPIDR;FOXM1;SPIRE2;PARP1;FAM168A
prerank,phospholipid transport (GO:0015914),0.4295529289918265,1.1583447198844035,0.2531500572737686,0.7926363729428167,1.0,11/52,11.37%,TNFAIP8L3;TMEM30B;PITPNC1;PRELID3B;ABCC1;PITPNA;PITPNM1;ATP8B2;ATP8A1;PCTP;ATP9A
prerank,telomere capping (GO:0016233),0.5204884236815871,1.1582066857816153,0.2957559681697613,0.7923592547965235,1.0,5/16,15.19%,PRKDC;TEN1;RAD50;DCLRE1B;TFIP11
prerank,actin cytoskeleton reorganization (GO:0031532),-0.2936951663234967,-1.1580839320356047,0.16831683168316833,0.6309718192156618,1.0,21/63,13.74%,AUTS2;PHACTR1;PTK7;KIT;TNIK;NEDD9;PARVB;RICTOR;CXADR;S1PR1;WHAMM;MYH9;SYDE1;GAB1;PAK1;CDC42BPG;PLEK;DTNBP1;PTPN1;THSD7A;FGF7
prerank,negative regulation of catabolic process (GO:0009895),0.43787466351055665,1.1574386480682828,0.27376861397479957,0.7942085126325962,1.0,11/47,16.82%,EGFR;HDAC4;ACTN3;RILP;IRAK3;MDM4;CST3;GIT1;CIDEA;SIRT2;AZIN1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3978131897041852,1.1571861505701275,0.201417004048583,0.7943278697868639,1.0,33/151,17.96%,ST3GAL4;PCSK5;ACER3;GSTT1;PLA2G4A;PEMT;PLPP3;CSNK2A2;CSNK2A1;GSTM5;LPCAT1;KDSR;DMD;ELOVL5;PLPP1;NFS1;NANP;ST3GAL2;B4GALT5;STARD7;GPAT4;LPCAT3;PCTP;GAL3ST4;INHBA;ALDH3A2;GSTO2;CHKB;GSTZ1;B3GNT6;AKR1A1;SLC25A2;GOLPH3
prerank,transferrin transport (GO:0033572),0.45765894520630596,1.1569358412260264,0.29201430274135876,0.7944507902112293,1.0,14/33,25.08%,ATP6V1C2;TCIRG1;DNM2;ATP6V0A1;ATP6V0D1;ATP6V1B2;RAB11B;CLTC;ATP6V1E1;ATP6V1C1;STEAP3;ATP6V0E1;LMTK2;ATP6V0B
prerank,positive regulation of filopodium assembly (GO:0051491),0.4860606643314076,1.1567282870948636,0.29056603773584905,0.7943926469785034,1.0,10/24,15.89%,ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;TENM1;NRP1;MIEN1;NLGN1;PALM
prerank,signal peptide processing (GO:0006465),0.5594567246787308,1.155602768404232,0.31386861313868614,0.7974029602499139,1.0,3/11,13.46%,PCSK5;HM13;SPCS2
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.5479647719891183,1.1555825220595575,0.2972222222222222,0.7967071145170601,1.0,3/13,6.98%,CACNA1C;KCNE5;ANK2
prerank,sodium-independent organic anion transport (GO:0043252),0.5698669260605802,1.155503383166979,0.2997159090909091,0.7962268903073749,1.0,2/10,1.19%,SLCO3A1;SLCO2A1
prerank,activin receptor signaling pathway (GO:0032924),0.5346766143276728,1.1548191673534731,0.3208053691275168,0.7977895243965439,1.0,4/15,13.03%,ACVR1B;ACVR1;TGFBR1;INHBA
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5178771534640219,1.1547974228521833,0.2825520833333333,0.7971056544021443,1.0,7/17,19.17%,PID1;HDAC4;ACTN3;GIT1;PARP1;FLCN;MLXIPL
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.4178417948628336,1.154449411464354,0.2464864864864865,0.7975131945877318,1.0,24/74,23.58%,VEGFA;PSMD7;PSMA8;NFE2L2;PSMA4;PSMD12;PSMA6;LIMD1;PSMD1;SIRT2;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;RPS27A;UBC;HIGD1A;CITED2;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,RNA methylation (GO:0001510),0.42669705181566014,1.1539498371079728,0.2467391304347826,0.7984955434217351,1.0,27/60,33.88%,TRMT61B;TARBP1;METTL16;TYW3;THADA;THUMPD3;TRMT44;TRMT6;ALKBH8;TFB2M;FBL;TRMT61A;METTL1;NSUN6;METTL8;BUD23;MTO1;METTL14;TRMT112;NSUN3;MEPCE;METTL6;RBM15;TGS1;PCIF1;METTL2B;METTL2A
prerank,intracellular pH reduction (GO:0051452),0.4572976707461996,1.1537257346594934,0.2815533980582524,0.7985580472841152,1.0,13/33,28.02%,ATP6V1C2;TCIRG1;ATP6V0A1;RAB38;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;SLC11A1;ATP6V0E1;ATP6V0B;GPR89A;GPR89B
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5664128704040753,1.1535876811105317,0.2925764192139738,0.7982965768398391,1.0,6/10,29.79%,BAG3;IMPACT;SIRT2;CITED2;NCK1;DNAJB1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5815062557071086,1.153551751537657,0.3054393305439331,0.7976642188344807,1.0,4/10,6.03%,PRKCD;RDX;C1QTNF1;CD9
prerank,sphingolipid catabolic process (GO:0030149),0.5254177088586952,1.153371776377255,0.30598052851182195,0.7975043357027842,1.0,4/15,9.61%,ACER3;PDXDC1;SMPD4;SMPDL3A
prerank,homotypic cell-cell adhesion (GO:0034109),0.4451358856590064,1.1532985646749558,0.25295508274231676,0.797046148686191,1.0,4/39,5.92%,GNAS;UBASH3B;PLPP3;ILK
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5553371358797852,1.1530730119784676,0.3146067415730337,0.7970554803030003,1.0,1/12,1.30%,IL33
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.47053282570177124,1.1525818650110253,0.29277566539923955,0.7979729408204284,1.0,11/26,25.06%,CARD16;TRAFD1;IRAK3;ITCH;MAPKBP1;PCBP2;SIRT2;ACOD1;MUL1;C1QBP;ILRUN
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4707609384056443,1.1522190597262618,0.28102189781021897,0.7985311761187939,1.0,5/29,6.33%,SLIT2;PRKCD;LIMA1;PFN2;SMAD4
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4080301821150817,1.152076697209499,0.24474789915966386,0.7982574578859598,1.0,16/98,13.74%,THBS1;PID1;VEGFA;SFRP4;ECE1;ANXA2;XDH;TGFBR2;IFNLR1;AKR1C1;NSF;DHRS4;EIF4G1;INHBA;ACACA;PICK1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.5423023755458253,1.1520063990880856,0.30662983425414364,0.7977326979419533,1.0,8/13,14.45%,NUP93;TGFB3;SMAD4;BMP4;SH2B1;BMPR1A;TGFBR1;DAB2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.5129127670870169,1.1519006751862886,0.3076923076923077,0.7973550571049607,1.0,3/18,9.20%,LBP;FCER1G;SBNO2
prerank,protein kinase A signaling (GO:0010737),0.5528237264031896,1.1516522020892948,0.3128415300546448,0.7974505322178571,1.0,3/12,12.28%,TCP11;RDX;EZR
prerank,female gonad development (GO:0008585),0.4999473190752973,1.1514412043258972,0.3180628272251309,0.797434340302221,1.0,5/19,13.03%,VEGFA;FSHR;CYP19A1;SOD1;INHBA
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5457730687098342,1.1510841301335153,0.2984869325997249,0.7978442252117974,1.0,5/12,16.62%,MCMDC2;MCM2;CDC45;GINS4;MCM4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4968463365528635,1.1509628194875272,0.29934640522875816,0.797508691236967,1.0,3/20,1.21%,KCNJ2;ATP1B1;SLC12A2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4153330945923686,1.1506828361829244,0.2700106723585913,0.797735227538187,1.0,12/80,13.71%,THBS1;VEGFA;GAS6;MAP3K5;CSNK2A1;CARD16;HMGB1;RAF1;BCAP31;F2R;YWHAE;CASP1
prerank,hemopoiesis (GO:0030097),-0.28311719464197843,-1.1506078988897588,0.10606060606060606,0.6480321070948074,1.0,22/87,13.04%,FLT1;TGFBR3;MECOM;TEK;WNT5A;KIT;ZBTB16;SNRK;KDR;MEIS1;NOTCH4;FLT3LG;FLT4;SH2B3;TAL1;HIPK1;PLEK;ETV6;KITLG;SFRP1;PRKX;CD34
prerank,dicarboxylic acid metabolic process (GO:0043648),0.43165795687352965,1.150565710914471,0.2829324169530355,0.7973911630478642,1.0,27/52,33.96%,ME1;GCLC;SLC25A32;MTRR;MTHFD2;MDH1B;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR;GCLM;PHYH;ACOT8;HOGA1;L2HGDH;ACLY;FPGS;MDH2;NIT2;DGLUCY;IDH2;IDH1;SDHA;ALDH18A1;SDHAF3;DHFR
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4645397842764922,1.150285052100033,0.291970802919708,0.7975813220381676,1.0,6/33,5.88%,ADAM9;MUC1;CYP1B1;TGFB2;ADA;FOXC2
prerank,regulation of glucose metabolic process (GO:0010906),0.4619155272995633,1.1501308524965994,0.2801418439716312,0.7973498309079105,1.0,10/34,18.70%,IRS1;AKT2;FOXK1;DGKQ;OGT;RORA;USP7;GNMT;BCKDK;AKT1
prerank,mRNA modification (GO:0016556),0.493621838495075,1.1496900710375106,0.3028720626631854,0.7980695003243727,1.0,10/22,26.90%,TRMT61B;METTL16;PUS3;TRUB1;TRMT6;TRMT61A;PUS1;METTL8;METTL14;DKC1
prerank,amyloid fibril formation (GO:1990000),0.4364711056946083,1.1494360618943351,0.27303370786516856,0.7981459954355887,1.0,15/51,17.16%,GSN;TGFBI;SNCAIP;ADAM10;GGA2;IAPP;CST3;BACE1;RIPK3;UBE2L6;GGA1;RPS27A;UBC;SERF1A;CALCA
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4641887987673842,1.1494096472415372,0.3019559902200489,0.7974917337749584,1.0,6/29,12.60%,TOPORS;DCUN1D5;ABL1;AXIN1;SMAD7;DCUN1D2
prerank,positive regulation of double-strand break repair (GO:2000781),0.43882244352925076,1.1488382609144498,0.29508196721311475,0.7987505158942998,1.0,20/39,30.17%,PARP3;PRKDC;FUS;KMT5C;SLF2;SPIDR;FOXM1;WDR48;MMS19;SPIRE2;PARP1;MAD2L2;SLF1;ACTR2;WAS;SHLD3;PNKP;SHLD1;DDX11;TIMELESS
prerank,regulation of TOR signaling (GO:0032006),0.41939192179122897,1.1488360904079638,0.2652838427947598,0.7980187365439764,1.0,24/67,24.47%,GAS6;NPRL3;SEC13;PKHD1;LAMTOR1;SEH1L;AKT1S1;DGKQ;TELO2;DEPTOR;TMEM127;TBCK;MINAR1;FLCN;ARAF;GOLPH3;UBR2;RHEB;TSC2;RPTOR;NPRL2;SMCR8;FBXO9;FAM83D
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.5339516517988504,1.1485636554740428,0.2948539638386648,0.7982034118460625,1.0,5/14,14.34%,AK5;AK3;DCTPP1;SMPDL3A;AK1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3819020726096471,1.1485438039854834,0.036,0.797538660436856,1.0,200/834,20.42%,PLAGL1;ESR1;EGFR;LRP6;SIX1;MICAL2;PKD1;PID1;ZFHX3;HOXA5;ZFPM2;VEGFA;NFIX;FGF2;NFIB;TCF7L2;IL33;RARB;ELF4;SMAD9;NFIA;GALR1;DDX17;RHOQ;MUC1;LDB2;LDB1;ZMIZ1;GLI2;TCF20;LRP5;GNL3;GLIS2;TGFB3;TWIST1;PRDM10;NFAT5;HDAC4;ELF1;HOXB3;GCN1;RXRA;ONECUT2;MEOX2;WWTR1;KLF5;TGFB2;STAT3;DCAF6;ATF4;NR2F1;MAVS;BCAS3;KMT2C;ACVR1;BRD4;DVL1;FOXC2;BCL9L;RXRB;PRKDC;SMAD4;NFE2L2;HMGB1;JAG1;MEF2B;SLC9A1;E2F3;PBX1;MEIS3;SKI;HEYL;THRAP3;JUP;SOX9;ARF4;RPS6KA4;NRIP1;RARA;FOXJ3;MED13;FZD5;ESRRB;TFE3;ZNF76;NFATC1;OGT;SBNO2;CDK12;RORA;BMP4;FGFR2;FOXA1;UBP1;CSRNP1;PRDM4;SREBF1;EHF;CHUK;RUNX2;GTF2F1;FOXM1;ABL1;AGO1;RFX5;CCNT2;CSRP3;PLAC8;TERT;NRF1;ATM;BMPR1A;KAT6B;PAXBP1;SFPQ;TAF6;SMAD7;MED25;PHIP;SRF;NR1D2;HEY1;GLIS1;KAT2A;SSBP3;RGMA;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HOXB4;INHBA;KMT2D;MEF2A;RUNX1;NFATC3;SQSTM1;DAB2;BMP5;VDR;MED21;TFDP1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;CRTC2;FOXO3;CREB1;CREBBP;PARP1;AATF;ZNF462;RPS27A;UBC;APBB1;KDM6B;DPF3;PRDM2;FLCN;NFKB2;SLC30A9;NR3C1;RFXANK;E4F1;MED14;MEN1;CITED2;HMGA1;ATAD2B;MED12;E2F1;HCFC1;GDNF;ATF2;CCDC62;CHD8;HIPK2;KLF10;HOXB2;MLXIPL;BRD8;FOSL2;XRCC6;LARP7;IRF3;VEZF1;MPND;NFKBIA;TCF3;DLGAP5;ATF6;MAX;BPTF;TET2;RTRAF;KAT7
prerank,limb development (GO:0060173),0.4734113861623884,1.1483143090948518,0.28872366790582404,0.7975886263285924,1.0,3/28,2.65%,SMOC1;PCSK5;COMP
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.4735461845058801,1.1479968591093095,0.29375,0.7978959637295095,1.0,4/24,4.67%,PDE11A;TCP11;UBE2B;PDE3A
prerank,response to organophosphorus (GO:0046683),-0.40158026493994925,-1.1478416065729764,0.2559055118110236,0.6529022755871287,1.0,6/16,13.56%,STAT1;TRPC3;ABCC9;TYMS;RFC3;TRIM16
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5224733728257778,1.1477551197578983,0.32085561497326204,0.7979949404415988,1.0,3/15,5.56%,AK5;ENTPD2;ENTPD6
prerank,mitotic DNA replication (GO:1902969),0.5824790372546813,1.147707985897478,0.3108882521489971,0.7974270238538551,1.0,4/10,16.62%,MCMDC2;MCM2;CDC45;MCM4
prerank,calcium-mediated signaling (GO:0019722),0.40177023543475604,1.147702370636536,0.23529411764705882,0.7967139556744972,1.0,17/93,13.87%,EGFR;CACNA1C;PLCE1;ATP1B1;PPP1R9B;MCU;SLC9A1;ANK2;ACKR4;TRPM4;PPP3CC;RCAN1;BCAP31;PDPK1;DEFB1;STIMATE;DMPK
prerank,intracellular cholesterol transport (GO:0032367),0.5290321160563494,1.1474226800695415,0.30278884462151395,0.7969315056416792,1.0,4/15,13.71%,LRP6;NPC1;OSBP;ABCA1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5523651507236522,1.1473812206825786,0.3278463648834019,0.7963424123565397,1.0,7/12,24.79%,TRIM28;RESF1;SETDB1;MPHOSPH8;TASOR;SETDB2;DNMT1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4175087650423747,1.1472905350333813,0.24437299035369775,0.7958929013124176,1.0,20/68,24.67%,RHOQ;SULT1C2;SULT1C4;ACSF2;ACOT11;AK3;GPAT4;BPNT1;ACAT1;AMPD3;RAB23;GLYAT;EFL1;ACOT13;ACSL6;ENTPD7;LRRK2;MFN1;BAD;ACOT8
prerank,positive regulation of lipid kinase activity (GO:0090218),0.47284839502706866,1.1470890700779948,0.28322981366459626,0.7958065409903824,1.0,3/29,1.13%,IRS1;TNFAIP8L3;FGF2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5258652123908758,1.1462660111553922,0.3062068965517241,0.7977577085941686,1.0,5/15,16.23%,EGFR;MVB12B;PTPN18;WDR54;ERBB2
prerank,negative regulation of kinase activity (GO:0033673),0.42771409271597904,1.1459872243359859,0.27952329360780065,0.7979187894093674,1.0,24/62,25.20%,LRP6;UBASH3B;WWTR1;DVL1;TRIM27;AKT1S1;PAK2;PDPK1;DEPTOR;CHP1;PRDX3;CAMK2N1;GSKIP;NF1;CDKN1C;AKT1;DUSP19;RTRAF;SFN;TSC2;HNRNPU;NPRL2;SMCR8;QARS1
prerank,DNA-dependent DNA replication (GO:0006261),0.3976543658373777,1.1458779692147794,0.22895277207392198,0.7975339401285167,1.0,47/128,27.40%,HELB;REV3L;PSMD7;MCMDC2;POLE2;PSMA8;MCM2;CDC6;PSMA4;WRN;PSMD12;PSMA6;CDC45;GINS4;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;MCM4;POLG2;POLB;ORC2;HMGA1;CDT1;DBF4;RAD51;CDK2;TWNK;PSMA3;PSMB1;PSMD4;TOPBP1;PSMA5;PSMA7;PRIMPOL;PRIM1;RECQL5;POLD1;PSMC1;MCM7;POLG;RPAIN;PSMA1;PNKP
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.37059301028970804,-1.145598735691704,0.242152466367713,0.6565214892764922,1.0,6/24,11.87%,PECAM1;VCAM1;F11R;SYK;SEMA4D;ITGA4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5576186081703977,1.1453610971998294,0.310948905109489,0.798473182597099,1.0,7/11,32.29%,TENT4B;EXOSC4;LARP7;FBL;DKC1;EXOSC2;EXOSC3
prerank,protein localization to microtubule organizing center (GO:1905508),0.5259382351558138,1.1449473920607,0.3183673469387755,0.7992376249311721,1.0,7/15,32.66%,CSNK1D;DCTN2;PCM1;NEDD1;STIL;C2CD3;PIBF1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5348790529964744,1.1449371008930822,0.29850746268656714,0.798556559654498,1.0,3/14,8.56%,IRS1;TWIST1;AKT2
prerank,glycine transport (GO:0015816),-0.4710519643527599,-1.1448159147272214,0.27666666666666667,0.6562382061868093,1.0,3/10,8.57%,SLC6A9;SLC38A5;SLC6A17
prerank,regulation of protein export from nucleus (GO:0046825),0.48012479808898406,1.1445144160616505,0.3161131611316113,0.799223650914599,1.0,7/23,13.55%,GAS6;TCF7L2;BAG3;ANP32B;XPO4;UHMK1;YWHAE
prerank,regulation of intracellular transport (GO:0032386),0.44459942716892464,1.144489214956262,0.30814639905548996,0.7985854083495937,1.0,14/38,21.66%,GAS1;DYNC1H1;DYNLT2B;CAPN10;SCFD1;ATP9A;RAB11B;RBM4;NDEL1;RINT1;GRIPAP1;REEP5;LAMP1;LRRK2
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4874149001973281,1.1441648942199452,0.3042362002567394,0.7989560022204515,1.0,3/23,11.17%,GAS6;CARD16;GIT1
prerank,establishment of epithelial cell polarity (GO:0090162),0.5049334715425805,1.1439744977704949,0.296875,0.7988883965247091,1.0,10/19,26.52%,CYTH3;RHOA;SYNE4;MYO9A;EZR;SIPA1L3;GOLPH3;CAMSAP3;FBF1;PARD3
prerank,Golgi inheritance (GO:0048313),0.5590986763771397,1.1438516463641946,0.3031988873435327,0.79860009440853,1.0,3/11,12.98%,STX5;GBF1;STK25
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5167496808975636,1.1437617442329866,0.3091655266757866,0.7981871465587058,1.0,1/16,0.03%,BOC
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4348075815984223,-1.1435157607391593,0.28,0.6573681386678204,1.0,5/14,13.30%,LIMS2;LOXL3;EMP2;CD63;PRKD1
prerank,dicarboxylic acid transport (GO:0006835),0.4707691186333362,1.1434431573418482,0.3021223470661673,0.79856755627951,1.0,4/28,7.58%,SLC26A7;SLC26A6;SLC25A32;GIPC1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.39632939718612265,1.1431172586971519,0.2657563025210084,0.7989337958340015,1.0,18/101,13.71%,LBP;ADAM9;PDCD4;PRKCE;CARD16;SHPK;TNFRSF1B;HMGB1;TRIM41;RHOA;SBNO2;MAPK8;NFKBIB;IRAK1;GIT1;PABPN1;CD80;CASP1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5005055913184405,1.142924850664182,0.3042362002567394,0.7988656172121646,1.0,7/19,22.54%,DLG2;CLIC4;CRB1;DLG1;CRB2;ERBIN;PRKCI
prerank,positive regulation of vasculogenesis (GO:2001214),0.5603745409874897,1.1421917835037088,0.30758226037195996,0.8006485636060023,1.0,1/10,0.56%,TMEM100
prerank,response to amyloid-beta (GO:1904645),-0.3224024948953796,-1.141927623695756,0.1896551724137931,0.6591432698281358,1.0,13/44,14.19%,IGF1R;GRM5;EPHA4;APP;CACNA2D1;VCAM1;CASP4;GRIN2A;SNX6;ITGA4;IGF1;CACNB1;GRIN1
prerank,platelet aggregation (GO:0070527),0.4526523551816839,1.1418684115113602,0.2889963724304716,0.8010719993330351,1.0,3/33,5.92%,GNAS;UBASH3B;ILK
prerank,positive regulation of fat cell differentiation (GO:0045600),0.43884914624850074,1.1417014815101976,0.29659090909090907,0.8009241610490022,1.0,8/47,9.74%,SIX1;CMKLR1;ID2;LRP5;TFE3;CARM1;TRPM4;SYAP1
prerank,cellular response to lipid (GO:0071396),0.3861698396806235,1.1415513875655308,0.22401614530776992,0.8007103721716361,1.0,28/191,11.42%,ESR1;EGFR;IRS1;PID1;WNT9A;LBP;ADAM9;PDCD4;CARD16;SHPK;ADCY2;ADCY8;TNFRSF1B;HMGB1;FZD7;TRIM41;SOX9;NRIP1;RHOA;SBNO2;RORA;MAPK8;URI1;NFKBIB;IRAK1;GIT1;ATM;PABPN1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.37690921610388795,1.1413435597228854,0.013,0.8006659360045603,1.0,419/1668,21.64%,TBX15;FOXP2;PLAGL1;ESR1;EGFR;LRP6;SIX1;FOXP1;PKD1;PID1;KLF12;ZBTB7C;ID2;PRRX1;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;PBX3;NFIX;FGF2;HOXA3;FOXD1;NFIB;SKIL;TCF7L2;IL33;RARB;TWIST2;ELF4;DDX5;HOXB6;MKX;SMAD9;NFIA;GALR1;DDX17;RHOQ;ZIM3;MUC1;ZFHX4;SMAD6;LDB2;LDB1;ZMIZ1;PRRX2;JDP2;GLI2;PRDM5;TCF20;DMTF1;LRP5;NCOR2;GLIS2;TGFB3;TWIST1;JMJD1C;HOXC6;DEAF1;LHX9;HDAC9;SP140;CUX1;PRDM10;NFAT5;HDAC4;CAMK2D;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;MED13L;WWTR1;HES5;KLF5;SIX4;STAT3;ZBTB25;DCAF6;ANXA4;TCF7L1;ZNF250;PHF21A;TARBP1;KMT5A;ATF4;CCNL2;TRIM28;MAMSTR;ZFP14;NR2F1;MAVS;CHD3;TCFL5;BCAS3;GMEB1;USP2;TLE6;TADA1;KMT2C;DACT1;ACVR1;BRD4;DVL1;PRDM6;FOXC2;ZNF25;MIDEAS;BCL9L;RXRB;NFX1;PRKDC;LBX2;PER3;SAFB;SMAD4;MRGBP;NFE2L2;BHLHE40;HMGB1;PKNOX2;JAG1;MEF2B;ZNF471;SLC9A1;RFX7;EZH1;TADA2A;E2F3;FUS;PBX1;TSHZ2;CREG1;MEIS3;BRWD1;SKI;MED27;ZNF691;HEYL;TBX21;THRAP3;MDM4;JUP;SOX9;ARF4;RPS6KA4;HOXA9;HOXA6;PURG;CCNL1;TRIM27;IKZF3;MED31;NRIP1;RARA;NSD1;FOXJ3;MED13;FZD5;SRA1;NOG;ESRRB;TFE3;RCOR3;BRD3;FOXK1;ENY2;ZNF76;IMPACT;DGKQ;DLG1;NFATC1;FOXL1;SMARCC2;RFX2;SLTM;WWP2;OGT;PSIP1;RBBP8;ZIC1;SBNO2;CDK12;MCPH1;RORA;BMP4;FGFR2;FOXA1;ZBTB2;UBP1;CSRNP1;ZFP90;PRDM4;MIER2;SREBF1;EHF;CHUK;RUNX2;ZNF260;KDM2A;URI1;GTF2F1;FOXM1;ABL1;ZIC4;AGO1;ATN1;RFX5;CCNT2;PHF8;POU6F1;CSRP3;CBX2;PLAC8;ID4;NFE2L1;NRF1;ATM;BMPR1A;HSF4;MAZ;KAT6B;PAXBP1;NEUROD2;KDM5B;RNF14;SFPQ;FOXO6;TAF6;SMAD7;RNF2;MED25;PHIP;FOXP4;SRF;NR1D2;HEY1;GLIS1;EZR;KAT2A;ZNF112;SSBP3;RGMA;FBXL19;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HSPD1;HOXB4;ZNF740;INHBA;BAZ2B;MYPOP;HR;ARID4B;KMT2D;NPAS1;MEF2A;NACC1;RUNX1;NFATC3;ZBTB9;HOXA4;ERF;TIAL1;PIAS4;TCF25;FRK;HEXIM1;SQSTM1;DAB2;BMP5;ZNF148;HNRNPK;EN2;VDR;BRD2;ZKSCAN1;MED21;MAFG;TFDP1;ID1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;BRD9;PSMC5;CRTC2;FOXO3;NKX6-2;NFE2;CREB1;VPS72;CREBBP;MED26;PARP1;ERBB2;RPRD1A;AATF;SIN3B;ZNF462;RPS27A;UBC;APBB1;KDM6B;SUMO1;HOXA2;DPF3;NIPBL;PRDM2;MDFI;MTA3;NFYA;CBX5;EFNA1;FLCN;NFKB2;SLC30A9;KLF3;NR3C1;RFXANK;E4F1;MED14;MEN1;LCOR;ZKSCAN7;ORC2;THAP7;HDGFL2;CITED2;HMGA1;ELP4;PCGF2;ATAD2B;MED12;E2F1;SUV39H2;CC2D1B;HCFC1;SUFU;HOXC5;ZBTB32;ZSCAN20;GDNF;ATF2;CCDC62;CHD8;SARS1;HIPK2;KLF10;CRK;HOXB2;MLXIPL;BRD8;SAFB2;FOSL2;CC2D1A;TEAD2;XRCC6;LARP7;IRF3;CBFB;NR3C2;ZNF431;VEZF1;MPND;NFKBIA;WWC2;LEFTY1;TCF3;TAF9B;NFATC4;NOC2L;ATF6;MAX;BPTF;TET2;RTRAF;CALR;IKZF4;KAT7;ZBTB24;HOMEZ;BCL2L12;HOXC8;SUV39H1;MAD2L2;KLF9;GPS2;IL4;ATP2B4;ZKSCAN5;SMURF2;RITA1;YEATS2;RNF4;MED20;BCL11B;SMAD5;IER2;MIER1;CHD2;SENP1;SAP18;POGZ;PEX2;PAF1;NFIC;CEBPD;NR2F6
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.39235237073513257,1.1413215982277307,0.22120285423037717,0.8000311671893952,1.0,51/152,22.11%,EGFR;GPC3;COL1A1;SFRP4;RSPO3;PLEKHA4;ATP6V1C2;PSMD7;CSNK1D;CSNK2A1;UBE2B;VCP;PSMA8;DACT1;ILK;CCAR2;LBX2;SULF1;SKI;RSPO1;JUP;TRPM4;PSMA4;FGFR2;CSNK1G1;UBR5;TERT;AXIN1;PSMD12;USP34;CSNK1E;PSMA6;WNK1;TNKS2;PSMD1;PSMC5;GSKIP;PSMD11;PSMC4;PSMD14;DAPK3;SULF2;ZRANB1;PSMA3;DEPDC1B;SMURF2;PSMB1;PSMD4;LRRK2;CSNK1G3;USP47
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3823442652390231,1.1409776192208982,0.14014014014014015,0.8004389792627391,1.0,119/341,26.37%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;TOPORS;CDC16;MVB12B;COP1;UBE2B;UBR4;VCP;PSMA8;TOM1L1;UBE2R2;ERCC8;UBE3C;NFE2L2;RNF115;TBX21;TRPC4AP;HUWE1;SYVN1;NTAN1;CBL;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;FBXL4;RNF114;UBE2C;FBXO22;RNF14;PSMD12;ANAPC4;MYLIP;TGFB1I1;FBXL19;PSMA6;PCBP2;USP33;UBQLN1;SQSTM1;FBXL14;RNF11;UBAP1;ATE1;PSMD1;KCTD5;UBE2L6;ANAPC2;ARRB1;STUB1;SIRT2;PSMC5;ANAPC1;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;UBL7;RC3H2;BIRC6;ANAPC10;TRIM13;KCTD17;UBE4A;GID4;NPLOC4;CDC20;RNF7;CDC27;ZFAND2B;ZRANB1;FBXW4;PTPN23;UBE2G2;PCNP;RMND5B;PSMA3;UCHL1;UBAP1L;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;MVB12A;APPBP2;AREL1;TTC3;RNF20;RNF216;PSMA5;RNF146;FBXO11;PSMA7;TAF1;HERPUD1;RNF122;AMFR;ANKRD9;PINK1;RCHY1;UBE2W;UBR3;RNF111;PSMC1;COPS3;RNF126;RNF166;NDFIP1
prerank,oligosaccharide metabolic process (GO:0009311),0.43859582737523245,1.1408334489034198,0.3115124153498871,0.8002174753025035,1.0,9/46,11.97%,ST3GAL4;ST8SIA2;ST6GALNAC5;B4GALT1;ST3GAL2;FUT8;MAN2C1;FUT4;GAL3ST4
prerank,amino acid import across plasma membrane (GO:0089718),0.47997970186540756,1.1407799808998695,0.3240857503152585,0.7996934918753736,1.0,2/24,3.81%,SLC47A1;SLC1A5
prerank,tight junction assembly (GO:0120192),-0.31137592217524873,-1.1407097043284888,0.21818181818181817,0.6600272666286897,1.0,10/49,9.00%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;LSR;F11R;APC;CLDN1
prerank,vasculogenesis (GO:0001570),-0.3378901796569022,-1.1404865011936203,0.2254335260115607,0.6584562666775542,1.0,13/32,15.10%,TGFBR3;ENG;NOTCH1;KDR;RASIP1;PDGFRB;SOX17;SPRED1;CAV1;SOX18;HEY2;APLNR;ITGB8
prerank,regulation of protein targeting to membrane (GO:0090313),0.46817999899320956,1.1404791134264016,0.2980769230769231,0.7999474290640285,1.0,7/28,16.23%,KCNB1;GDI1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.4219280459137685,1.1403678947613778,0.284434490481523,0.7996078027687246,1.0,32/59,33.56%,TCF7L2;TWIST1;TRIM28;MED27;SOX9;MED31;MED13;RUNX2;AGO1;MED25;IL6;MED26;MED14;MED12;CBFB;MED20;BCLAF1;TP53;MED23;CCNC;MED24;TNRC6A;MED8;SETX;MECP2;MED15;CTNNB1;MOV10;NFKB1;MED1;CEBPB;RELA
prerank,gene silencing by miRNA (GO:0035195),0.46043526490781883,1.1398517459116504,0.3150851581508516,0.8005747689822711,1.0,9/32,15.73%,ZC3H7A;PUM1;PRKRA;AGO1;AGO2;RBM4;LIMD1;CNOT8;EIF6
prerank,purine ribonucleotide transport (GO:0015868),-0.4090041778278303,-1.1398035446415415,0.25957446808510637,0.6580612313688589,1.0,2/16,2.40%,ABCC4;LRRC8C
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.4081850150119333,1.1396047814684414,0.26247288503253796,0.8006754551344659,1.0,26/76,25.08%,RNF144A;PRICKLE1;CSNK1D;COP1;VCP;DVL1;CDK5RAP3;AXIN1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;DDA1;STUB1;SIRT2;SUMO1;HECTD1;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;RCHY1;BBS7
prerank,metanephric mesenchyme development (GO:0072075),0.5683774691837415,1.1394889714491838,0.34813753581661894,0.8003422959618536,1.0,2/10,4.18%,SIX1;SIX4
prerank,protein-DNA complex assembly (GO:0065004),0.39895221025305816,1.1393308772859507,0.23357664233576642,0.8001709916853224,1.0,45/116,26.55%,CHAF1B;PSMD7;CHD1L;PSMA8;NAA60;SOX9;MCM2;ERCC5;CDC6;PSMA4;CUL4A;ANP32B;SPTY2D1;KAT6B;PSMD12;ERCC3;PSMA6;ERCC2;BRD2;PSMD1;PSMC5;PSMD11;PARP1;PSMC4;PSMD14;RPS27A;UBC;MCM4;ORC2;NAP1L3;CDT1;NAP1L2;RAD51;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;H3-3A;GTF2H4;DAXX;PSMC1;MCM7;CHAF1A;XPA
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5303982026456178,1.139155225239534,0.32373113854595337,0.8000300912039846,1.0,2/13,1.99%,SULT1C2;SULT1C4
prerank,DNA strand elongation (GO:0022616),0.49995351685101674,1.1388256968055988,0.3320610687022901,0.8003484849381358,1.0,6/18,16.62%,MCMDC2;TERT;RAD50;DCLRE1B;GINS4;MCM4
prerank,protein dephosphorylation (GO:0006470),-0.25844573369063745,-1.1387150900266607,0.14285714285714285,0.6587446676464981,1.0,27/135,10.32%,PTPRG;PTPRB;PPP2R2B;PTPN13;EYA1;PPM1E;PTPN14;PPP1CB;DUSP16;PTPRD;PTPRO;PPP4R1;PTPN9;DUSP10;CTTNBP2NL;PPP2R2C;EYA4;PTPN4;DUSP3;MTMR3;PTPRK;SSH2;PPP2R3A;CTDSP1;PPP2CB;PPM1G;DUSP22
prerank,autophagy of mitochondrion (GO:0000422),0.4482222622052255,1.1386119089846065,0.28150765606595995,0.8003340450212127,1.0,16/38,29.91%,ULK2;WIPI2;ATG3;SQSTM1;RB1CC1;CTSK;ATG9A;PINK1;ATG13;ATG2B;AMBRA1;ULK1;FIS1;CISD2;USP30;PRKN
prerank,fatty acid catabolic process (GO:0009062),0.4184340627300878,1.1385816502281447,0.28230184581976114,0.7997130731398762,1.0,30/67,29.64%,ABCD3;EHHADH;ECHDC2;CEL;ECI2;PEX13;AUH;ACAT1;ALDH3A2;BDH2;HACL1;PLA2G15;MCEE;PHYH;SLC27A2;PCCB;PEX2;ABCD1;ACBD5;ECHDC1;MCAT;HADHA;ACOT8;FAAH;MTLN;ACAT2;ABHD3;SCP2;ECI1;CPT2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.43672932988125024,1.1385605166084152,0.2906574394463668,0.7990711491480061,1.0,18/46,17.43%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;FOXC2;ACOT11;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.3949905171629899,1.1385145805981398,0.23006134969325154,0.7985149713012643,1.0,21/140,13.07%,ESR1;CACNA1C;CMKLR1;PLCE1;PROK2;TAC4;DRD1;C1QTNF1;EDNRA;ADCY8;HMGB1;FPR3;DLG4;GPR20;IAPP;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R
prerank,neuronal action potential (GO:0019228),0.4927917051508715,1.1384045546493968,0.3038961038961039,0.7981667103089201,1.0,2/22,6.62%,CACNA1G;SCN11A
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4139830611939016,1.1383577594340846,0.2535059331175836,0.7976035178067891,1.0,31/77,27.87%,THBS1;TCF7L2;NOL3;CSNK2A2;CSNK2A1;FXN;ACVR1;BMP4;ITGAV;URI1;BCL2L2;MAZ;PHIP;TGFBR1;HGF;SLC35F6;BIRC6;ZMYND11;AKT1;NOC2L;CLU;IL4;SH3RF1;TRIAP1;HERPUD1;PINK1;QARS1;RIPK1;PLAUR;SLC25A5;SCG2
prerank,regulation of receptor binding (GO:1900120),-0.4655975221354133,-1.138142817489115,0.3142857142857143,0.6580644736288614,1.0,3/10,8.72%,B2M;GREM2;ATP2A3
prerank,V(D)J recombination (GO:0033151),0.5555495964487979,1.1377267793319072,0.32558139534883723,0.7989830488637553,1.0,4/11,19.78%,PRKDC;HMGB1;LIG4;TCF3
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.417221740660084,1.1376061365132533,0.2692307692307692,0.7986906255016089,1.0,24/72,22.06%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;NOG;CBL;FGFR2;GTF2F1;FLRT2;SHOC2;HNRNPM;PTBP1;TIAL1;POLR2F;GALNT3;FGF5;NCBP1;NCBP2;FGF18;FGFR3;HNRNPA1;POLR2B
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4154511324993137,1.1375432010832862,0.2809110629067245,0.7981705788877024,1.0,24/71,22.57%,FAP;HM13;VCP;PSMA8;CLPP;SOCS6;DDI2;CAPN2;LONP1;PSMA6;ATE1;NGLY1;STUB1;HDAC6;IDE;RPS27A;UBC;CTSZ;ZRANB1;CHMP4B;PDCD6IP;CTSB;CTSK;CTSO
prerank,mitotic sister chromatid segregation (GO:0000070),0.4019328303200566,1.1369003031180807,0.26343519494204426,0.7996380158727866,1.0,28/98,24.56%,TUBG2;SMC4;CSNK2A2;CSNK2A1;KMT5A;RRS1;SEH1L;DCTN2;MCPH1;EML3;PHF8;DIS3L2;MIS12;ZW10;CHMP3;KLHL22;HASPIN;NIPBL;DLGAP5;CHMP4A;CHMP4B;PDCD6IP;NUP62;POGZ;PDS5A;WRAP73;SMC1A;CHMP2A
prerank,keratinocyte differentiation (GO:0030216),0.46068972987772977,1.1368881491785356,0.2935560859188544,0.7989770288974679,1.0,10/29,26.22%,ADAM9;CLIC4;JAG1;BCR;ANXA1;PIP5K1A;ASAH1;OPN3;KRT10;CERS3
prerank,positive regulation of cell junction assembly (GO:1901890),0.42736121900094565,1.1368182539577074,0.28114663726571115,0.7985053602371636,1.0,7/56,5.98%,MYOC;VEGFA;COL16A1;EPHB2;CLSTN2;EPHB3;S100A10
prerank,activation of protein kinase activity (GO:0032147),0.40236320441996654,1.1368085203931682,0.26708727655099895,0.7978272940141078,1.0,23/106,11.90%,PRKCD;VEGFA;GAS6;CARD14;NTRK3;GHR;PRRC1;STRADA;TGFB2;ADCY2;ADCY8;TOM1L1;TNFSF15;TGFBR2;ADCY9;PAK4;PAK2;RIPK3;ABL1;IRAK1;AXIN1;PDPK1;TNFRSF10B
prerank,body fluid secretion (GO:0007589),0.5147708043581535,1.1368004805568963,0.32171581769436997,0.7971582808773086,1.0,3/15,10.43%,VEGFA;GPAT4;VIP
prerank,regulation of actin filament-based process (GO:0032970),0.414997633844475,1.1366986940613797,0.27085590465872156,0.7967976809356395,1.0,14/70,15.54%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;ARHGAP17;CDK10;RHOA;ABL1;EZR;ARHGAP44;RHOB;IQGAP1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.45599342329739584,-1.1366365712831388,0.29900332225913623,0.6597949743729558,1.0,6/11,20.35%,PPARA;SLC30A10;TRAP1;ABCD2;ABCB7;SLC18A2
prerank,peptidyl-methionine modification (GO:0018206),0.5424101341710221,1.1366176124654872,0.3291316526610644,0.7963522497722896,1.0,8/12,33.33%,NAA60;NAA16;METAP1D;METAP2;NAA15;NAA25;METAP1;NAA20
prerank,negative regulation of bone remodeling (GO:0046851),0.5579362155944052,1.1362626110128637,0.3194244604316547,0.7967902365781232,1.0,4/11,17.16%,UBASH3B;TMEM119;IL6;CALCA
prerank,mitotic metaphase plate congression (GO:0007080),0.4323287610684708,1.1362305841895197,0.2857142857142857,0.796196727535058,1.0,15/51,20.87%,RRS1;SEH1L;CENPC;MAD1L1;DCTN2;EML3;MIS12;ZW10;CHMP3;RMDN1;CDT1;CHMP4A;CHMP4B;PDCD6IP;NUP62
prerank,response to copper ion (GO:0046688),-0.3908384743358184,-1.1361917509861958,0.26576576576576577,0.6587935675363771,1.0,10/20,18.03%,MT1H;MT1M;MT1X;MT1B;MT1A;MT1E;MT1F;MT1G;SNCA;MT3
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.4785988984797806,1.1361363234573594,0.3209580838323353,0.7958069165985545,1.0,7/25,11.28%,ZNF423;FOXD1;HES5;SMAD4;SULF1;BMP4;BMPR1A
prerank,lymphocyte migration (GO:0072676),0.4559419646220951,1.1360892569632348,0.29826732673267325,0.7952535402760899,1.0,4/32,9.77%,CCL13;CCL15;TBX21;CRTAM
prerank,Wnt signaling pathway (GO:0016055),0.4032178950980438,1.1359427751760158,0.27672955974842767,0.7950397548558722,1.0,18/92,12.58%,LRP6;WNT9A;TCF7L2;SFRP4;PLPP3;LRP5;NXN;TCF7L1;DVL1;BCL9L;FZD7;FZD5;VPS26A;CSNK1G1;AXIN1;USP34;CUL1;CSNK1E
prerank,regulation of ion transport (GO:0043269),0.4099836511538004,1.1359220934862744,0.27253218884120173,0.7944272864025825,1.0,5/76,2.09%,KCNJ2;KCNJ15;NEDD4;SYT8;DRD1
prerank,epidermal cell differentiation (GO:0009913),0.44163324982645974,1.1357016151367625,0.2956120092378753,0.7944486175404764,1.0,14/41,26.22%,ADAM9;CLIC4;JAG1;BCR;ANXA1;ERCC3;HDAC1;ERCC2;PIP5K1A;ASAH1;OPN3;HDAC2;KRT10;CERS3
prerank,innate immune response in mucosa (GO:0002227),0.5566013724711929,1.1355740950382203,0.3441011235955056,0.7941460265791866,1.0,3/10,20.97%,RNASE3;DEFB1;IL4
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5086788180308721,1.135177303810745,0.32075471698113206,0.794740360392586,1.0,9/16,31.92%,PIGW;PIGF;PIGL;PIGX;PIGV;PIGQ;PIGB;PIGN;PIGC
prerank,regulation of protein modification process (GO:0031399),-0.31182297653854557,-1.1350903660751446,0.21739130434782608,0.6595128579177432,1.0,14/50,16.19%,LYN;GRM5;CDH5;PPP1R16B;CCDC88A;CORO1C;HSPB1;SPRED1;PLXNB2;FN1;CCDC88C;CADM4;PTK2;PML
prerank,positive regulation of ATP metabolic process (GO:1903580),0.46738286505059135,1.1350517159992692,0.3146341463414634,0.7944596541954274,1.0,4/32,5.17%,SLC4A4;PID1;ACTN3;VCP
prerank,histone H4-K5 acetylation (GO:0043981),0.5155362549197564,1.134729690806006,0.32133333333333336,0.7941396160569669,1.0,9/15,23.19%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.5155362549197564,1.134729690806006,0.32133333333333336,0.7941396160569669,1.0,9/15,23.19%,KANSL2;OGT;WDR5;ING4;HCFC1;KANSL1;KAT7;KAT8;MEAF6
prerank,phosphate ion homeostasis (GO:0055062),0.5604967409697358,1.1343586695358352,0.3338129496402878,0.7946215272898757,1.0,1/10,1.34%,SFRP4
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5481625213665973,1.1337221618933868,0.32409972299168976,0.795930509270119,1.0,8/11,35.58%,ATL2;LPCAT3;BNIP1;ATL1;ARL6IP1;VCPIP1;STX18;MOSPD3
prerank,myeloid cell differentiation (GO:0030099),-0.30666585479134983,-1.13366690313144,0.22580645161290322,0.6609282860065303,1.0,6/47,3.82%,LYN;MFHAS1;KIT;ZBTB16;SNRK;RPS14
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3547154947205102,-1.133621992517508,0.29015544041450775,0.6588650121991593,1.0,6/28,4.15%,PTN;APOE;SHANK3;EPHA4;APP;ADCY1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4070784343254895,1.1333436940342174,0.2883569096844396,0.7964582400143394,1.0,27/76,27.13%,PRICKLE1;GNL3;HDAC4;DCUN1D5;HUWE1;CDK5RAP3;WDR48;AXIN1;SMAD7;DCUN1D2;TANK;PHF23;UBQLN1;PIAS4;STUB1;RWDD3;SAE1;MYCBP2;MUL1;LRRK2;BIRC3;DERL1;PINK1;RCHY1;XIAP;NDFIP1;RIPK2
prerank,receptor clustering (GO:0043113),0.46519299646698437,1.1330402679611635,0.3175591531755915,0.796786395129041,1.0,8/27,13.74%,DLG2;DVL1;DLG4;DLG1;NRXN2;MUSK;NLGN1;PICK1
prerank,zinc ion transmembrane transport (GO:0071577),0.48878460875714536,1.1329548678682753,0.327319587628866,0.7963784466485782,1.0,7/22,16.54%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;SLC39A3;SLC30A6
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.5603235777557485,1.1327459384734924,0.3436185133239832,0.7963532482561813,1.0,1/10,0.33%,LRP6
prerank,nucleosome disassembly (GO:0006337),0.5255649420859572,1.1323892268574367,0.3356164383561644,0.7961752809982322,1.0,7/14,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),0.5255649420859572,1.1323892268574367,0.3356164383561644,0.7961752809982322,1.0,7/14,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,negative regulation of axon extension (GO:0030517),-0.341069863221839,-1.1321166662326283,0.27586206896551724,0.6607452868356485,1.0,15/30,21.24%,SEMA6A;MAP2;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;SEMA4A;MAG;SEMA4G;SEMA5B;MT3;RTN4R;SEMA6D;SEMA3B
prerank,neurotransmitter secretion (GO:0007269),-0.3183149359267218,-1.1320913292210104,0.2421875,0.6586293643921723,1.0,17/44,22.23%,NRXN1;LIN7A;RIMS2;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,positive regulation of telomere maintenance (GO:0032206),0.456008960336253,1.1315741643287152,0.31363088057901084,0.7980761729017323,1.0,12/31,27.40%,GNL3;MAPK15;NEK7;HNRNPA2B1;ATM;RAD50;TNKS2;PPP1R10;MAP2K7;SLX4;RTEL1;PNKP
prerank,sodium ion export across plasma membrane (GO:0036376),0.527993267698341,1.1315418860362043,0.314404432132964,0.7975242766271047,1.0,3/13,6.94%,SLC4A4;ATP1B1;SLC9A1
prerank,P-body assembly (GO:0033962),0.5399802436124451,1.1314358884406384,0.34405594405594403,0.7971878941617292,1.0,4/12,21.61%,DYNC1H1;PATL1;LIMD1;ATXN2
prerank,positive regulation of ERAD pathway (GO:1904294),0.5240403908098036,1.1313517276724472,0.33558863328822736,0.796761553623639,1.0,6/13,25.04%,NFE2L2;BCAP31;UBQLN1;USP13;HERPUD1;RNFT1
prerank,inflammatory response (GO:0006954),0.38090609620140453,1.131240373903388,0.21248741188318226,0.7964357894212908,1.0,20/195,10.27%,THBS1;MGLL;CMKLR1;PROK2;TAC4;CCL13;HDAC9;HDAC4;CCL15;STAT3;ADCY8;NOX4;NFX1;HMGB1;ABCF1;FPR3;LIAS;ANXA1;ITCH;CHUK
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.43472674021958585,-1.1303129188940706,0.3107142857142857,0.6608706398865218,1.0,6/12,23.25%,CEACAM1;SIRT1;BRCA1;ERLIN2;TRIB3;APOC1
prerank,positive regulation of nervous system development (GO:0051962),-0.3080192106547506,-1.1302746954314613,0.20863309352517986,0.6588343490056102,1.0,14/42,12.29%,NRXN1;IL1RAPL1;TGM2;GRID2;PTPRD;OPRM1;FAIM;SRPX2;CX3CR1;CLSTN1;CUX2;IL1RAP;EPHB1;SYNDIG1
prerank,angiogenesis involved in wound healing (GO:0060055),0.5401154828771676,1.1297809509813386,0.32016925246826516,0.8003661358311571,1.0,4/11,14.32%,VEGFA;ADIPOR2;SRF;NDNF
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4569312937015761,1.1295904464163162,0.3089133089133089,0.8003291983347974,1.0,12/30,24.28%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;STYX;RYBP;UCHL5;USP14;CAMLG
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.4422671332252879,1.129547198166794,0.305952380952381,0.799792677578422,1.0,18/36,29.38%,KIF13A;RAB34;NECTIN3;GGA2;GOLGA4;NSF;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;VAMP4;GORASP2;AFDN;VAMP2;GCC2;GGA3;ARFRP1
prerank,regulation of phosphorylation (GO:0042325),0.3963407468182913,1.129332627234472,0.27589743589743587,0.7997605456531172,1.0,29/120,18.15%,THBS1;EGFR;NUP93;LDB2;LDB1;SEC13;GLMN;RAE1;ILK;SEH1L;FZD7;OGT;BMP4;ROPN1L;NUP37;PHIP;NRP1;SESN2;INHBA;RANBP2;KCTD20;NUP88;SIRT2;EIF6;FLCN;CDKN1C;PRKAG1;POM121;NUP210
prerank,kinetochore organization (GO:0051383),0.5282652661742746,1.1289511601729028,0.3364737550471063,0.8002909916467997,1.0,6/13,21.56%,CENPC;CENPT;MIS12;CDT1;DLGAP5;POGZ
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.39343450391192,1.128499819178313,0.2733887733887734,0.8010047671048073,1.0,16/113,10.43%,PGF;EGFR;SRSF6;VEGFA;F3;FGF2;TCF7L2;STAT5A;PKHD1;PRKCA;FZD7;SOX9;BMP4;FGFR2;AGGF1;VIP
prerank,DNA replication (GO:0006260),0.3941563357516367,1.1281987815324677,0.27481713688610243,0.8013126941490788,1.0,43/105,30.56%,HELB;REV3L;POLE2;RMI2;MCM2;CDC6;RBBP8;RAD1;WRN;ING5;ATM;RAD50;CDC45;ING4;ATRIP;HUS1;MCM4;POLG2;POLB;REV1;ORC2;DBF4;CDK2;KAT7;TBRG1;UPF1;TOPBP1;PTMS;TOP1;DONSON;TOP1MT;TOP3A;RECQL5;POLD1;MCM7;POLG;RPAIN;PNKP;ATR;IGHMBP2;TIMELESS;RAD17;RHNO1
prerank,acyl-CoA metabolic process (GO:0006637),0.4456802945714675,1.1281105762529382,0.3093858632676709,0.8009115353607231,1.0,11/35,24.67%,ACSF2;ACOT11;SUCLA2;GPAT4;ACACA;GLYAT;MCEE;ACOT13;ACSL6;HMGCS2;ACOT8
prerank,protein localization to plasma membrane (GO:0072659),0.3921191494432996,1.127202739723862,0.265495867768595,0.8030566603789662,1.0,22/129,7.66%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;TTC7A;EHD1;RDX;RAB34;C2CD5;NECTIN3;RAMP2;PIGW;PACS2;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP
prerank,eye photoreceptor cell differentiation (GO:0001754),0.5213708904824387,1.1271978470915367,0.310192023633678,0.8023873269871848,1.0,2/12,4.21%,VEGFA;STAT3
prerank,regulation of vasoconstriction (GO:0019229),-0.35219737848932053,-1.1270873752600623,0.29064039408866993,0.664853689722926,1.0,10/27,11.99%,ATP2B1;BDKRB2;ACE;AGTR1;BMPR2;TBXA2R;CAV1;ADRA1A;CHRM3;ACE2
prerank,positive regulation of receptor internalization (GO:0002092),0.4790070113252737,1.1268976221987388,0.3155149934810952,0.802694723705115,1.0,2/22,1.34%,VEGFA;SFRP4
prerank,regulation of protein localization to cell periphery (GO:1904375),0.49622012115969155,1.1268301050053784,0.35092348284960423,0.8022270239017792,1.0,6/18,19.98%,MISP;MMP14;SPTBN1;CLN3;CDK5;APPL1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.37899814940691656,1.1267609042035056,0.15815815815815815,0.8017862804563042,1.0,59/348,13.74%,SLC38A2;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;GSN;SFRP4;SLC24A3;EMILIN1;NTRK3;ECE1;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;ANXA2;STAT3;CD3E;ATF4;TRIM28;RAMP2;AGR2;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;NSF;MAPK8;BMP4;ITCH;TMEM119;FAM98B;MUSK;RESF1;UBR5;AGO1;ATM;MAZ;FUBP1;HEY1;EZR;PIK3CB;TGFBR1;SERPINB9;AGO2;SMO;INHBA;SETDB1;ERP29;PICK1
prerank,negative regulation of protein binding (GO:0032091),0.4111130218556069,1.1264577533121505,0.29955947136563876,0.8020251016328594,1.0,22/71,22.68%,PRKCD;LRPAP1;PTPRF;CARD16;DACT1;DVL1;TMC8;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;USP33;DAB2;MITD1;TFIP11;STYX;AKT1;CTSZ;LRRK2;CAMK1;PEX14
prerank,regulation of hippo signaling (GO:0035330),0.5039137497834028,1.1263995927855233,0.3638676844783715,0.801519557615745,1.0,7/17,23.45%,CIT;MOB3B;LIMD1;WWC2;MAP2K3;NEK8;DLG5
prerank,negative regulation of hippo signaling (GO:0035331),0.5397049288649353,1.1263430284308091,0.3506139154160982,0.8010148690030587,1.0,5/12,23.45%,CIT;LIMD1;WWC2;MAP2K3;DLG5
prerank,mesenchyme morphogenesis (GO:0072132),0.4956962857545258,1.1263248188552646,0.3398184176394293,0.8003966422232116,1.0,8/17,12.12%,TGFB2;ACVR1;HEYL;MDM4;SOX9;NOG;BMPR1A;HEY1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4231609076860253,1.1257221487636897,0.3036117381489842,0.8016779297899371,1.0,21/51,30.51%,MAPK15;TENT4B;NEK7;SMG6;ATM;TEN1;HNRNPC;TNKS2;XRN1;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;HNRNPU;PNKP;CCT5;ATR;CTNNB1;CTC1
prerank,proteoglycan biosynthetic process (GO:0030166),0.4584394100305923,1.1255855870484235,0.31167268351383876,0.8014262933181748,1.0,3/31,2.94%,EXT1;XYLT1;CHST11
prerank,RNA catabolic process (GO:0006401),0.42766715107404657,1.1255567176381738,0.3068181818181818,0.8008579446165192,1.0,18/46,28.86%,SIDT2;PPP1R8;RNASE3;ZC3H12D;RNASE6;DIS3L2;METTL16;LSM2;SUPV3L1;SND1;CNOT10;NCBP1;MTREX;PABPC4;ERN1;RIDA;LSM5;DXO
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4463596101543685,1.125060323704738,0.3416370106761566,0.8017801750276694,1.0,9/33,17.46%,FGF2;GNL3;KLF5;TGFB2;STAT3;TERT;SRF;FOXO3;NR3C1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.42013814699084334,-1.12474645712266,0.31343283582089554,0.6687362026373374,1.0,6/14,12.93%,ZEB1;OSR1;NOTCH4;SPRED1;CAV1;SPRY1
prerank,DNA methylation or demethylation (GO:0044728),0.5043727799342607,1.1245121489907248,0.33506493506493507,0.8021094338925754,1.0,8/19,26.54%,BAZ2A;TEX15;EHMT1;MTRR;FOS;DNMT1;EHMT2;DNMT3A
prerank,DNA alkylation (GO:0006305),0.5043727799342607,1.1245121489907248,0.33506493506493507,0.8021094338925754,1.0,8/19,26.54%,BAZ2A;TEX15;EHMT1;MTRR;FOS;DNMT1;EHMT2;DNMT3A
prerank,response to tumor necrosis factor (GO:0034612),0.3956262973441056,1.1240100286636021,0.2965738758029979,0.8030884915994314,1.0,10/91,7.22%,PID1;ADAM9;AFF3;YBX3;CCL13;CCL15;SMPD4;ADAM10;NFE2L2;CXCL16
prerank,cardiac atrium morphogenesis (GO:0003209),-0.4084898310098992,-1.1238084675503157,0.2868525896414343,0.6690842602492918,1.0,7/16,18.01%,ENG;NOTCH1;PROX1;BMPR2;HEY2;BMP2;DLL4
prerank,base conversion or substitution editing (GO:0016553),-0.44687266785711494,-1.1233733300778646,0.2974910394265233,0.6680327545803647,1.0,6/11,41.33%,ADARB2;ADAR;METTL3;APOBEC2;ADAD1;A1CF
prerank,regulation of spindle assembly (GO:0090169),0.4731904890366553,1.1231826132499128,0.32754342431761785,0.8050392201406185,1.0,11/25,27.13%,DYNC1H1;EML3;CHMP3;CHMP4B;PDCD6IP;RNF4;SENP6;HNRNPU;CHMP2A;TPR;DRG1
prerank,negative regulation of binding (GO:0051100),0.4029542642638963,1.1227117979434216,0.29229122055674517,0.8059373791028297,1.0,30/81,25.06%,PRKCD;LRPAP1;CARD16;DACT1;DVL1;TMC8;BTAF1;SYMPK;EFHB;MAPK8;GTF2F1;CSNK1E;SMO;USP33;DAB2;MITD1;TFIP11;STYX;SUMO1;MDFI;E2F1;AKT1;CTSZ;NFKBIA;LRRK2;CAMK1;PEX14;ROCK1;GTPBP4;ILRUN
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.4130737749201741,-1.122681718392081,0.2813688212927757,0.6677414864555204,1.0,6/14,22.20%,PPP2R2B;PPP2R2C;PPP2CB;PPP5C;PPP1R15B;PPP1CA
prerank,autophagosome assembly (GO:0000045),0.4200412809819815,1.122502456820386,0.32915717539863326,0.805943253228341,1.0,21/52,30.06%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RUFY4;RAB1A;RAB1B;ATG9A;ATG13;ATG2B;AMBRA1;ULK1;UBXN2A;STX17;IRGM
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.43639715875436236,1.1221800933530595,0.3176605504587156,0.8062666293138855,1.0,21/39,34.68%,CHD1L;ERCC5;ERCC4;OGG1;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;POLK;RPA3;CUL4B;FAN1;RFC4
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.42384051891961,1.1215658708025493,0.3002257336343115,0.8075403698148628,1.0,6/51,5.52%,DCLK1;SRGAP2;CTTN;ANKRD27;SNX2;DNM2
prerank,N-terminal protein amino acid modification (GO:0031365),0.5154836354990354,1.1214045344181627,0.32205683355886333,0.8073959661543296,1.0,7/14,26.41%,NAA60;NAA40;NAA16;NTMT1;METAP1D;METAP2;NAA15
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.41331894810500996,1.1211439244579573,0.31140350877192985,0.8075876391406972,1.0,22/60,30.44%,SMOC2;FGF2;MAPK15;NEK7;NVL;ATM;TNKS2;HGF;POLG2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;DKC1;PNKP;CCT5;PRKD2;ATR;CTNNB1;HSP90AA1
prerank,nuclear envelope organization (GO:0006998),0.4870543104588172,1.1211368464343765,0.33819628647214856,0.8069334598822046,1.0,5/20,17.76%,NUP93;TMEM43;DMPK;REEP3;TMEM170A
prerank,AMP metabolic process (GO:0046033),0.5210691257213668,1.1210770803241408,0.3477653631284916,0.8064762256489585,1.0,3/13,12.81%,XDH;AK3;AMPD3
prerank,atrial septum development (GO:0003283),0.5269521943573888,1.120656424852985,0.343878954607978,0.8071449744551293,1.0,4/13,16.20%,TGFB2;ANK2;MDM4;NPHP3
prerank,cell differentiation in hindbrain (GO:0021533),-0.44713304581992624,-1.120419435746026,0.2857142857142857,0.6715653438018102,1.0,7/11,24.35%,GRID2;PROX1;OPHN1;FAIM2;LHX1;CBLN1;CEND1
prerank,coenzyme A metabolic process (GO:0015936),0.5217469373102994,1.1198126725207889,0.3554054054054054,0.8092061584811143,1.0,10/14,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;ACLY;PPCDC;CROT;COASY
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5007252104728722,1.1193438554152253,0.3324396782841823,0.8100470207721793,1.0,9/16,32.75%,HELB;RMI2;MAD2L2;CGAS;FBH1;SHLD3;SHLD1;PARPBP;POLQ
prerank,positive regulation of translation (GO:0045727),0.40203559168640246,1.1192444888684963,0.2897489539748954,0.8096879742474746,1.0,32/94,27.86%,THBS1;YBX3;RCC1L;SAMD4A;MPV17L2;PRKDC;RMND1;CDC123;NIBAN1;KHDRBS1;UHMK1;AGO2;IL6;EIF6;ERBB2;EIF3D;FASTKD3;PYM1;CIRBP;FXR2;UPF3A;RPS6KB1;EIF5A2;RPS9;RPS27L;UPF3B;RBM3;C1QBP;METTL14;USP16;FXR1;YTHDF1
prerank,positive regulation of histone deacetylation (GO:0031065),0.5288595981016695,1.1189672077899016,0.34011627906976744,0.8099162984430908,1.0,5/12,27.91%,VEGFA;NIPBL;AKAP8;SAP30BP;PRKD2
prerank,response to X-ray (GO:0010165),0.5204679668556653,1.1189615655127427,0.33426573426573425,0.8092582066009157,1.0,6/14,20.55%,ANXA1;ATM;LIG4;NIPBL;XRCC6;BRCC3
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.44485454660395995,1.118928506462161,0.3345029239766082,0.8086696871076952,1.0,2/35,0.54%,PCDHB16;CDH11
prerank,selective autophagy (GO:0061912),0.42326526852597973,1.1185939400196778,0.3184855233853007,0.8090557456672772,1.0,32/56,33.09%,ULK2;DYNC1H1;STBD1;NBR1;PEX5;LGALS8;ATM;DYNC1LI2;UBA5;UBQLN1;SQSTM1;HDAC6;IFT88;RPS27A;UBC;UFL1;RB1CC1;TEX264;DYNC1I2;ACBD5;ATG13;ATG2B;AMBRA1;UFC1;UBE2V1;ULK1;USP30;PRKN;UBE2N;DYNLL2;MAP1LC3B;UFM1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.500690968796401,1.1184134569393935,0.33112582781456956,0.8089617681025371,1.0,8/16,26.11%,LRP1;LRPAP1;SRF;HDAC1;CLU;IL4;ROCK1;HMGCR
prerank,positive regulation of transport (GO:0051050),0.40201877579256223,1.1181728268607467,0.3029661016949153,0.8090448963321312,1.0,17/85,14.92%,GAS6;LRP1;GPC3;RXRA;ANXA2;C2CD5;DYNC1H1;CAPN10;AKT2;FCER1G;ANXA1;PLA2G5;CHP1;LMAN2;DAB2;ACSL3;SCIN
prerank,protein-containing complex assembly (GO:0065003),0.377532922457046,1.1177760647441097,0.23046092184368738,0.809673101635942,1.0,104/259,27.15%,TCF7L2;TIAM1;SEC31A;SEC24D;COL16A1;STX5;NOL3;FBXL7;SEC13;TLE2;CSNK1D;SEC23A;HES5;CD3E;TCF7L1;TRAPPC10;ADCY8;DNAJB14;DMD;MCU;BCL9L;CNIH2;GPAA1;ADAM10;SPG7;SLC9A1;TRRAP;LLGL1;MDM4;SOX9;DLG4;PPP6R1;PYGO1;BET1;PPP6R3;TLE3;SH3PXD2B;NSF;ST13;SCFD1;CDC123;WIPF1;TERT;TRAPPC6A;AXIN1;SNX9;SHANK1;USO1;ZW10;CUL1;HDAC1;SEC24C;SEC24B;KMT2D;PREB;SEC16A;SEC22B;FARP2;CNIH1;CREBBP;KPNA3;SEC16B;SEC24A;EPRS1;MEN1;NAPA;TMED2;TRAPPC3;SEC23IP;CTSZ;TEAD2;TRAPPC6B;DARS1;CAPZA1;LRRK2;RAB1A;LMAN1;REPS2;KLHL12;KMT2A;PEX14;RAB1B;AFG3L2;NIFK;STOML2;DET1;ANKRD28;TP53;BAD;SMARCA4;DNAJB12;TRADD;AFDN;TBC1D20;VAMP2;TFG;PPID;RIPK1;GOLGA2;PARD3;PPP2R1A;WAS;CAND1;WDCP
prerank,regulation of nervous system development (GO:0051960),0.43693228462638867,1.1177288596126913,0.3301775147928994,0.8091630843238641,1.0,10/37,16.20%,LGI4;DOCK7;HES5;TNFRSF1B;BHLHE40;HEYL;HEY1;SIRT2;NKX6-2;NPHP3
prerank,activation of adenylate cyclase activity (GO:0007190),0.43826573259249235,1.1175217837587428,0.3333333333333333,0.8091284394604455,1.0,9/35,12.88%,DRD1;FSHR;EDNRA;ADCY2;ADCY8;ADCY9;RAF1;CAP1;GLP1R
prerank,positive regulation of intracellular transport (GO:0032388),0.4438540906120083,1.1173098468937894,0.3329479768786127,0.8090987735843258,1.0,14/38,26.42%,NEDD4;EHD1;DYNC1H1;BCAS3;EHD2;CAPN10;TENM1;PCM1;KIF20B;ICE1;PGAP1;TBC1D20;VAMP2;TPR
prerank,cell part morphogenesis (GO:0032990),0.5223675996374992,1.1169811774599272,0.3609550561797753,0.8094773348471531,1.0,1/13,0.49%,PID1
prerank,pharyngeal system development (GO:0060037),0.5053898608005979,1.1168555935703814,0.3436241610738255,0.8091919149786889,1.0,7/15,14.52%,SIX4;TGFB2;NOG;BMP4;BMPR1A;TGFBR1;BMP5
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.474440540894526,1.1167708788719242,0.3290653008962868,0.8088226809910031,1.0,4/21,4.30%,BGN;CHST11;CHPF2;CSPG4
prerank,protein localization to vacuole (GO:0072665),-0.4373682676106005,-1.116661759111529,0.31746031746031744,0.6792414870066622,1.0,7/13,27.45%,LAMTOR5;SH3BP4;ATP13A2;LAMTOR4;LMBRD1;RTN4;MFSD1
prerank,positive regulation of cell differentiation (GO:0045597),0.37934750925099614,1.1166484693683696,0.21809045226130652,0.8085423561747014,1.0,52/237,16.05%,BOC;CDON;CMKLR1;TMEM100;PKDCC;ID2;HOXA5;DDR2;COL1A1;TIAM1;LRP5;TGFB3;TWIST1;WWTR1;TGFB2;ACVR1;BCL9L;SMAD4;TGFBR2;FGFR1;HEYL;SOX9;PA2G4;IMPACT;CARM1;TRPM4;RHOA;EDN3;BMP4;SYAP1;PLA2G5;TMEM119;RUNX2;ABL1;BMPR1A;MAPK12;NEUROD2;SRF;NELL1;TGFB1I1;TGFBR1;HOXB4;MEF2A;RBM4;WDFY2;DAB2;NBL1;HGF;IL6;CRB2;CREB1;SPAG9
prerank,phospholipid metabolic process (GO:0006644),0.4060317750123659,1.116181909886255,0.30944625407166126,0.8093065452395348,1.0,15/71,17.91%,TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;LPCAT1;PLPP1;LPCAT4;PLA2G5;PIP4K2B;FADS1;LGALS13;PNPLA3;PIP5K1A;PLA2G15;AGPAT5
prerank,bile acid and bile salt transport (GO:0015721),-0.35092665913136106,-1.116137560073304,0.2857142857142857,0.6785394843873898,1.0,3/24,2.24%,ABCC4;SLCO2B1;SLCO1C1
prerank,protein export from nucleus (GO:0006611),0.45628703658414543,1.1156836660295157,0.361244019138756,0.8102686511578927,1.0,14/27,27.33%,PKD1;XPO1;STRADA;XPO6;XPO4;CHP1;STYX;CALR;CCHCR1;DESI1;NUTF2;TPR;XPO7;XPO5
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5527108373686975,1.1156822485501103,0.373546511627907,0.8096085745461968,1.0,4/10,9.71%,LRP5;TGFBR2;SOX9;FGFR2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5438800430454289,1.1153103975869771,0.34738372093023256,0.8101589443130708,1.0,6/11,33.37%,IPO4;CABIN1;UBN1;H3-3A;HIRA;HAT1
prerank,polyamine metabolic process (GO:0006595),0.5211857156775187,1.1150329341130454,0.35567715458276333,0.8103656059726004,1.0,5/13,18.58%,SAT2;SMOX;SRM;HDAC6;AOC1
prerank,negative regulation of viral release from host cell (GO:1902187),0.5284754836921891,1.114774916242038,0.3389121338912134,0.810528808692522,1.0,6/13,22.10%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8
prerank,T cell activation (GO:0042110),-0.27972498363501225,-1.1146467570023624,0.18072289156626506,0.6805055329426447,1.0,19/69,20.76%,LEPR;CHD7;KIT;DPP4;CXADR;JAG2;RHOH;CD74;PIK3CD;LCP1;LFNG;CTPS1;CD44;PTPN22;DLL4;MDK;CD276;SOX4;NHEJ1
prerank,cellular response to organonitrogen compound (GO:0071417),0.39077589984955274,1.11393329614046,0.30640083945435465,0.8125468708714558,1.0,15/99,12.59%,SLIT2;IGFBP5;HCN4;SLC26A6;IPO5;PDE3A;LAMTOR1;JUP;SOX9;IMPACT;CAPN2;P2RY6;EZR;AKAP9;SESN2
prerank,glutathione biosynthetic process (GO:0006750),0.5453251900374946,1.1136189517664095,0.35235378031383735,0.8128924129575936,1.0,6/11,32.05%,GCLC;GCLM;CHAC2;HAGH;OPLAH;GSS
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5354070187769118,1.113506847642811,0.3527777777777778,0.8125872897065649,1.0,3/13,8.27%,CHRDL1;FSTL1;NOG
prerank,mRNA stabilization (GO:0048255),0.43272629138023355,1.1126448057521974,0.34418604651162793,0.8147122732460015,1.0,16/40,24.32%,YBX3;PABPC1;TENT5A;FUS;THRAP3;VIP;TAF15;HNRNPC;E2F1;GDNF;SYNCRIP;CIRBP;SLC11A1;HNRNPU;YBX1;RBM24
prerank,oxoacid metabolic process (GO:0043436),0.46070094455360705,1.112641862186118,0.3478802992518703,0.8140585502577989,1.0,9/27,18.59%,SULT1C2;SULT1C4;LIAS;PPA2;BPNT1;LIPT1;GNMT;PPA1;DAO
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5587923719447432,1.1125979216032207,0.3500738552437223,0.8128626955764756,1.0,5/10,20.46%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5587923719447432,1.1125979216032207,0.3500738552437223,0.8128626955764756,1.0,5/10,20.46%,AP2A1;MYLIP;AP2A2;CLTC;CLTA
prerank,smoothened signaling pathway (GO:0007224),0.45353058044064415,1.1124983675024886,0.32595325953259535,0.8125176116818806,1.0,16/32,31.35%,GLI2;HES5;CC2D2A;SMO;MAP3K10;EVC2;PKD2L1;HIPK2;IFT27;TMEM231;TCTN3;GLI3;TTBK2;STIL;GLI1;ULK3
prerank,inositol phosphate metabolic process (GO:0043647),-0.3020920932692663,-1.1124891647040274,0.23741007194244604,0.6839457688698535,1.0,10/46,8.83%,PLCB1;INPP4B;ITPKB;INPP5D;ISYNA1;NUDT4;PLCB4;PLCH1;IP6K2;PLCD1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5501712155302603,1.1124147560208029,0.35389133627019087,0.812143204572685,1.0,5/10,25.70%,HMGB1;RUNX1;CBFB;SH3RF1;SOCS1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.42864521741388223,1.112157641092522,0.33254437869822484,0.8122786248334741,1.0,6/41,12.27%,GAS6;LBP;IRAK3;TRIM27;RARA;CIDEA
prerank,RNA metabolic process (GO:0016070),0.3909554092985706,1.1119207991419373,0.30546955624355004,0.8123501238934808,1.0,52/127,25.89%,DDX17;HNRNPH1;SIDT2;RBFOX2;RBM39;DUSP11;M1AP;FTO;PPP1R8;HNRNPA2B1;RNASE3;HNRNPL;HNRNPH2;RNASE6;TBRG4;GTF2F1;AGO1;RBM6;RBM5;PABPN1;AGO2;HNRNPM;PCBP2;ALKBH1;PTBP1;RBM4;HNRNPC;SUPV3L1;CLP1;SND1;HNRNPK;POLR2F;TFIP11;TP53RK;NCBP1;NCBP2;SYNCRIP;MTREX;HNRNPH3;TENT2;DHX8;ATXN2;HNRNPA3;HNRNPA1;POLR2B;HNRNPU;PABPC4;RBM3;DDX39B;METTL14;POLR2H;DDX20
prerank,ovarian follicle development (GO:0001541),0.518835291065961,1.1118752662709144,0.34708392603129445,0.8118631584808442,1.0,3/13,13.03%,VEGFA;SOD1;INHBA
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3791639056099652,-1.1118464960999672,0.308,0.6836036938218628,1.0,7/18,13.90%,NRXN1;SHANK3;CACNG7;CACNG8;CACNG3;CACNG4;RELN
prerank,iron ion homeostasis (GO:0055072),0.41677640929813703,1.1117382162625793,0.3219026548672566,0.8116474765272333,1.0,15/58,15.46%,SCARA5;NEO1;FLVCR1;HMOX2;FXN;SMAD4;ACO1;ATP6V0D1;SOD1;CUL1;CYBRD1;BDH2;ABCB6;FRRS1;IREB2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4225242281332841,1.1117122200104277,0.3148984198645598,0.8110653390376841,1.0,12/45,14.52%,GDF10;INHBC;TGFB3;TGFB2;ACVR1;SMAD4;BMP4;BMPR1A;TGFBR1;INHBA;DAB2;BMP5
prerank,regulation of hydrolase activity (GO:0051336),0.3999007395104995,1.1115934445497315,0.30202774813233724,0.8107694716629067,1.0,15/71,13.08%,PLXNA4;EFNA5;RDX;VAV2;SIPA1L1;FGD6;RAB3GAP1;EPHB3;CDK5RAP3;ADAP1;WRN;TDG;SOD1;ARHGAP44;OCRL
prerank,neuron development (GO:0048666),0.3846433379097779,1.111452945511906,0.27840327533265097,0.8105367234318062,1.0,31/141,15.53%,MYOC;PBX3;NEDD4;VSX1;LGI4;STMND1;EHD1;GLI2;LRP12;DOCK7;PPP1R9B;TGFB2;BLOC1S2;HMGB1;GPRIN1;PBX1;TBC1D23;TBC1D24;B4GALT5;SRF;TENM1;UHMK1;NLGN1;BLOC1S3;MANF;RUNX1;WNK1;PLP1;IL6;MICALL2;THOC2
prerank,regulation of B cell apoptotic process (GO:0002902),0.5317082846016553,1.1107526869322224,0.37175792507204614,0.8120938122627128,1.0,1/12,0.44%,FOXP1
prerank,modification-dependent protein catabolic process (GO:0019941),0.3801353635607788,1.1105187057593222,0.26720647773279355,0.8121145433852104,1.0,79/193,30.07%,RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;TOPORS;CDC16;UBE2B;UBR4;UBE2R2;UBE3C;TRPC4AP;SYVN1;NTAN1;CBL;RBBP6;ITCH;FBXL4;RNF114;UBE2C;FBXO22;RNF14;ANAPC4;MYLIP;LONP1;USP33;UBQLN1;SQSTM1;FBXL14;RNF11;UBE2L6;ANAPC2;ARRB1;STUB1;ANAPC1;PSMD11;PSMD14;RPS27A;UBC;UBL7;RC3H2;BIRC6;ANAPC10;UBE4A;NPLOC4;CDC20;RNF7;PCYOX1L;CDC27;FBXW4;UBE2G2;SMURF2;AREL1;TTC3;RNF20;RNF146;FBXO11;TAF1;HERPUD1;AMFR;PINK1;RCHY1;UBR3;RNF111;COPS3;RNF126;RNF166;NDFIP1;RNF167;DDB1;UBE4B;RBX1;BTRC;ADRM1;PRKN;UBE2H;TRIP12;ANAPC11;UBE2S
prerank,response to sterol (GO:0036314),0.5382783292098254,1.1104611356339427,0.35893854748603354,0.8116497399901771,1.0,3/11,12.61%,TGFBR2;RORA;TGFBR1
prerank,histone mRNA metabolic process (GO:0008334),0.4562190221041504,1.1104129007334316,0.34572490706319703,0.8111512624332338,1.0,11/27,21.97%,TENT4B;SSB;ATM;XRN1;EXOSC4;TUT7;NCBP1;NCBP2;TENT2;SNRPB;UPF1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.47835384357735583,1.109047877881937,0.35382685069008785,0.8141720234973855,1.0,5/20,16.63%,GSTT1;GSTM5;GSTO2;GSTZ1;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),0.47835384357735583,1.109047877881937,0.35382685069008785,0.8141720234973855,1.0,5/20,16.63%,GSTT1;GSTM5;GSTO2;GSTZ1;AKR1A1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.44343678672770237,-1.1088300433893823,0.3447098976109215,0.6893801936842574,1.0,4/12,13.56%,CYP26B1;CNOT1;KLF2;TRIM16
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.4004490324031602,1.1086705474349288,0.3114406779661017,0.8147372357000978,1.0,10/88,7.68%,TRABD2B;VEGFA;MPP7;EMILIN1;SDC1;PRKCA;VCP;CDC42EP2;PFN2;SLF2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3283759685706624,-1.108539315927198,0.3208955223880597,0.6880436677702274,1.0,12/32,15.08%,CDH5;MAP2;NAV3;CAMSAP1;APC;SPEF1;EML2;ARHGEF2;MID1IP1;CLASP2;SNCA;TUBB4A
prerank,aorta morphogenesis (GO:0035909),-0.38175991107486407,-1.108220054205077,0.321285140562249,0.6867534930036767,1.0,10/17,14.31%,ENG;MYLK;PDGFRB;TBX1;PROX1;RBPJ;TBX2;ACVRL1;HEY2;EFEMP2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.4899298413219303,1.1081000324992762,0.3521505376344086,0.8158768594798484,1.0,9/17,26.14%,EMC2;EMC9;EMC1;CAMLG;EMC8;GET4;EMC4;MMGT1;GET3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.44114195871773143,1.1080850148122865,0.3418803418803419,0.8152741395336124,1.0,8/33,15.57%,GRIK4;ARC;SLC4A8;CEL;BCR;IQSEC2;NLGN1;PSMC5
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.41049934211921807,1.1080441120786308,0.32887402452619846,0.8147401013992281,1.0,30/60,33.56%,TCF7L2;TRIM28;MED27;SOX9;MED31;MED13;RUNX2;AGO1;MED25;SRF;IL6;MED26;MED14;MED12;CBFB;MED20;TP53;MED23;CCNC;MED24;TNRC6A;MED8;MECP2;MED15;CTNNB1;MOV10;NFKB1;MED1;CEBPB;RELA
prerank,regulation of cholesterol storage (GO:0010885),-0.40658510643812085,-1.1077869422933606,0.31679389312977096,0.6857526355142572,1.0,8/15,17.37%,PPARA;ABCG1;NR1H3;PPARD;SCARB1;LPL;MSR1;TTC39B
prerank,protein polyubiquitination (GO:0000209),0.37029675117632216,1.1077497091106723,0.22122122122122123,0.8150347884913635,1.0,118/297,30.24%,WWP1;RNF144A;NEDD4;FBXO10;ANAPC5;FBXL7;PSMD7;FBXW8;TOPORS;CDC16;UBE2B;LRSAM1;PSMA8;UBE2R2;ERCC8;UBE3C;RNF115;HUWE1;TRIM27;SYVN1;RBBP6;WWP2;SHARPIN;PSMA4;ITCH;FBXL4;RNF114;UBR5;UBE2C;FBXO22;RNF14;FBXL12;PSMD12;ANAPC4;MYLIP;TRAF3;CUL1;FBXL19;PSMA6;TNKS2;FBXL14;LNPEP;PSMD1;DDA1;UBE2L6;ANAPC2;FBXO17;STUB1;FBXL20;PSMC5;ANAPC1;PSMD11;UBE2V2;PSMC4;PSMD14;TRAF3IP2;RPS27A;UBC;RC3H2;ANAPC10;UBE4A;FBXL18;TRIM6;HECTD1;TPP2;FBXW2;NPEPPS;UBR2;CDC27;FBXW4;RUSC1;CBFB;UBE2G2;PSMA3;UBOX5;SMURF2;MUL1;RNF4;PSMB1;PSMD4;AREL1;TTC3;RNF20;RNF216;ZFP91;PSMA5;RNF146;FBXO11;PSMA7;TAF1;FBXO9;AMFR;UBE2W;SHPRH;PSMC1;RNF126;RNF166;FBXO38;FBXW10;PSMA1;RNF167;UBE2V1;UBE4B;FBXL8;FBXO41;RBX1;BTRC;RNF135;UBE2Q2;TRAF5;PRKN;UBE2H;BLMH;TRIP12;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.5120327093524067,1.1077212962066842,0.35684647302904565,0.8144588442262929,1.0,6/13,24.32%,TSR1;RRS1;RPP40;ABT1;TBL3;KRI1
prerank,calcium ion transport (GO:0006816),0.38777869672355003,1.1076373123180183,0.29791666666666666,0.8140459506257554,1.0,19/113,11.59%,CACNA1G;PKD1;CACNA1C;GAS6;SLC24A3;GRIN3A;CRACR2A;TRPV3;RAMP2;CHRNB2;ANK2;TRPC4AP;TRPM7;TRPM4;STIM1;ITGAV;RAMP1;TMEM165;TRPM6
prerank,chondrocyte differentiation (GO:0002062),0.4486447689157362,1.107594892311151,0.35106382978723405,0.8135368329836481,1.0,8/32,10.29%,SLC39A14;NFIB;CCN3;HES5;SULF1;SOX9;BMP4;RUNX2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5210955985068337,1.1075611453295267,0.362116991643454,0.8116958690275823,1.0,5/12,19.95%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5210955985068337,1.1075611453295267,0.362116991643454,0.8116958690275823,1.0,5/12,19.95%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5210955985068337,1.1075611453295267,0.362116991643454,0.8116958690275823,1.0,5/12,19.95%,ANAPC5;CDC16;ANAPC4;CDC27;DLGAP5
prerank,bicellular tight junction assembly (GO:0070830),-0.3009886585885309,-1.1068034732272234,0.29508196721311475,0.686440717842309,1.0,9/46,9.00%,PARD6G;OCLN;PECAM1;CDH5;CLDN5;ESAM;F11R;APC;CLDN1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5439328893190453,1.106348438046471,0.3554301833568406,0.8141886115765636,1.0,5/10,19.93%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),0.5439328893190453,1.106348438046471,0.3554301833568406,0.8141886115765636,1.0,5/10,19.93%,NFAT5;NFATC1;PPP3CC;NFATC3;NFATC4
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5502681256793145,1.1062993815370994,0.35311143270622286,0.8136991943779931,1.0,3/10,4.21%,GHR;STAT5A;STAT3
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.40332326312955336,-1.1062759094001569,0.34831460674157305,0.6855977759245242,1.0,8/15,26.04%,DDX3X;GBP5;DHX33;MYD88;TREM2;CPTP;CD36;TLR6
prerank,axon guidance (GO:0007411),0.3736057161833281,1.1061701128548753,0.2613521695257316,0.813465630971658,1.0,25/201,8.25%,SLIT3;SLIT2;SLIT1;PLXNA4;EMB;NTN1;VEGFA;EFNA5;NFIB;GRB10;GAB2;GLI2;TMEFF1;PDLIM7;EPHB2;SHC1;NTN4;SEMA3E;PRKCA;EPHB3;EPHB6;GAP43;SEMA4B;PALLD;CYFIP1
prerank,receptor-mediated endocytosis (GO:0006898),0.38527861811506814,1.1057413962086664,0.2882231404958678,0.8141738171619068,1.0,29/132,16.06%,LRP6;LRP1;NEDD4;CTTN;COLEC11;IGF2R;PDLIM7;SPARC;DNAJC13;RAMP2;AP2A1;DNM2;CD9;CXCL16;FCHO2;FCER1G;SNX1;HYOU1;RAMP1;RABEPK;SNX9;LRP2;AP2A2;SNAP91;CLTC;COLEC12;DAB2;GPR107;PI4KB
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.33739644957927156,-1.1052339715591348,0.3225806451612903,0.6861129889748533,1.0,8/26,12.24%,PRKAA2;PRKAG2;LPGAT1;NR1H3;ADIPOR1;SLC45A3;MID1IP1;CEACAM1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.46875873413886476,1.1052225926208248,0.3501896333754741,0.8151095345337507,1.0,9/25,24.56%,RILP;VCP;LAPTM4B;CHMP3;VTA1;CHMP4A;CHMP4B;MVB12A;CHMP2A
prerank,positive regulation of cellular component movement (GO:0051272),0.46477458513427394,1.1048767590071014,0.35651074589127685,0.815523010514423,1.0,6/24,12.61%,NTN1;VEGFA;TWIST1;AKT2;CCDC25;TGFBR1
prerank,autophagosome organization (GO:1905037),0.41872557268341826,1.1046223859772837,0.3310104529616725,0.8156705415477299,1.0,19/50,28.51%,ULK2;RAB43;PACS2;WIPI2;ATG3;ATG16L2;UBQLN1;RAB23;RB1CC1;ATG16L1;RUFY4;RAB1A;RAB1B;ATG9A;ATG13;ATG2B;AMBRA1;ULK1;UBXN2A
prerank,ribosomal small subunit assembly (GO:0000028),0.5000750783760592,1.104607762132294,0.35216819973718794,0.8150792308544023,1.0,3/16,6.23%,RPSA;PRKDC;RRP7A
prerank,regulation of membrane repolarization (GO:0060306),0.5201869513699194,1.1041774408100111,0.35907859078590787,0.815740117230582,1.0,4/13,13.55%,KCNJ2;KCNE5;AKAP9;YWHAE
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.48667259560057097,1.1040164912643402,0.3577981651376147,0.815580841538438,1.0,1/18,0.08%,MYOC
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.44596369756073423,1.1039808169518965,0.3420074349442379,0.8150451469204697,1.0,16/30,29.38%,KIF13A;RAB34;GGA2;GOLGA4;NSF;SEC16A;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;VAMP4;VAMP2;GCC2;GGA3;ARFRP1
prerank,amino acid import (GO:0043090),0.4764915950258415,1.1039697809071205,0.36607142857142855,0.8144350219158739,1.0,1/21,0.01%,SLC47A1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.43017041725603544,1.1038002065673849,0.35232558139534886,0.814345314050074,1.0,13/39,16.06%,TTC7A;PIK3C2B;SOCS4;SOCS7;SOCS6;SOCS2;SMG1;PIP4K2B;IP6K1;PIK3CB;PI4K2A;TTC7B;PI4KB
prerank,piRNA metabolic process (GO:0034587),0.4812650676077024,1.1037200375743876,0.36895674300254455,0.8139817403097754,1.0,4/19,20.44%,TEX15;MAEL;TDRD12;TDRKH
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5322524810378692,1.1033416659644104,0.3659863945578231,0.8145347667647987,1.0,4/11,12.70%,NECAB3;SOAT1;BACE2;AGO2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.38719552223020937,-1.103085879255375,0.3201754385964912,0.6894882262558796,1.0,6/18,8.60%,IL34;PTN;NOTCH1;TNFRSF21;TENM4;SLC45A3
prerank,ncRNA 3'-end processing (GO:0043628),0.5079167169508612,1.1027150893839086,0.3617021276595745,0.8158271443313992,1.0,8/14,33.17%,INTS14;SSB;ELAC2;TOE1;INTS7;ERI1;INTS6;TRNT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5363811335482197,1.10265726254123,0.3788732394366197,0.814090751057752,1.0,8/11,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5363811335482197,1.10265726254123,0.3788732394366197,0.814090751057752,1.0,8/11,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5363811335482197,1.10265726254123,0.3788732394366197,0.814090751057752,1.0,8/11,33.10%,PANK4;DCAKD;ACAT1;PANK3;PPCS;PANK2;PPCDC;COASY
prerank,regulation of cholesterol transport (GO:0032374),0.479795957301281,1.1025845654487971,0.3660130718954248,0.8136683074045075,1.0,2/20,5.94%,LRP1;LAMTOR1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4626985100478589,1.102182291488678,0.3573200992555831,0.8142688124516687,1.0,3/22,4.54%,VEGFA;GADD45G;XDH
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.42167014005462394,-1.1019659217690376,0.3247232472324723,0.690309055998745,1.0,5/12,26.04%,SLC5A3;ADGRB1;GRIN1;CD36;TLR6
prerank,protein autoubiquitination (GO:0051865),0.4057723175534964,1.1018937521324432,0.3443708609271523,0.8145330689081236,1.0,19/61,25.04%,SH3RF3;UBE2B;LRSAM1;ERCC8;NFX1;RNF115;WWP2;ITCH;RNF11;STUB1;TRIM13;UHRF2;RNF141;SH3RF1;RNF4;RNF146;RNF122;AMFR;RNFT1
prerank,endodermal cell fate commitment (GO:0001711),-0.4437729054990831,-1.101866054693326,0.33653846153846156,0.6884560166682424,1.0,4/10,16.69%,SOX17;LEO1;SOX2;CTR9
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.44945795395028976,1.1015809807363264,0.36101083032490977,0.8149018577701146,1.0,19/32,33.42%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;RRN3;POLR2K;TAF1A;CCNH
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4831781479778158,1.1014374235839886,0.3464566929133858,0.8147442004090968,1.0,2/20,2.21%,LBP;PRKCE
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4489037953398984,1.1013780053388118,0.3501896333754741,0.8142848628065574,1.0,6/27,8.78%,FXYD5;PTPN3;CAMK2D;SLMAP;SNTA1;DLG1
prerank,vitamin D metabolic process (GO:0042359),0.5270257222105537,1.101316984480562,0.37077131258457374,0.8138851834156439,1.0,4/13,14.77%,LRP2;PIAS4;VDR;CYP27B1
prerank,apical protein localization (GO:0045176),-0.4564999678404995,-1.1012644355477064,0.32954545454545453,0.6879446037361859,1.0,6/10,20.25%,SHROOM2;MAL;INSC;VANGL2;SHROOM3;ACTB
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.541343083651141,1.1009368999385647,0.3638968481375358,0.8144331165991979,1.0,4/10,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,generation of neurons (GO:0048699),0.3743733743331169,1.1009220473874834,0.2868686868686869,0.8138364852049051,1.0,35/190,16.33%,SIX1;WNT9A;CIT;FGF13;MAP1B;MARK1;LDB1;LRP12;NAV1;DOCK7;LHX9;HES5;SIX4;TGFB2;NRBP2;BHLHE40;FZD7;FGFR1;HEYL;FZD5;PEX13;MYEF2;RUNX2;CTF1;NEUROD2;HEY1;SDCCAG8;NRP1;RUNX1;NDNF;ACSL3;EN2;THOC2;ERBB2;DNAAF4
prerank,regulation of coagulation (GO:0050818),0.5315479667898872,1.1001047732038243,0.369472182596291,0.8157423015648261,1.0,2/11,13.07%,EPHB2;F2R
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5333069565295391,1.0997788374518906,0.37771345875542695,0.8160872701058455,1.0,6/11,29.23%,STAT3;PUM1;LIMD1;XPO5;FXR1;PUM2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.3205529634589293,-1.099623492780637,0.3246753246753247,0.6902494330036588,1.0,11/34,13.60%,PTPRB;PTPN13;DUSP16;PTPRO;PTPN9;DUSP10;DUSP3;DUSP22;DUSP6;PTPN1;PTPRT
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.46889874117803904,1.0995427423449948,0.35786802030456855,0.8161922142678347,1.0,10/20,25.93%,MCU;SPG7;MICU2;LETM1;MICU1;PMPCA;AFG3L2;SLC8B1;STOML2;PMPCB
prerank,positive regulation of macroautophagy (GO:0016239),0.41773089075904885,1.0994372437258582,0.3416572077185017,0.815892496471193,1.0,23/48,28.60%,SESN3;BAG3;LRSAM1;RAB3GAP1;PIP4K2B;SESN2;PAFAH1B2;TRIM13;RAB3GAP2;OPTN;IL4;RUFY4;TSC2;UVRAG;VPS13D;SMCR8;TBK1;PINK1;GPSM1;HSPB8;PIP4K2C;SLC25A5;LARP1
prerank,nuclear migration (GO:0007097),0.5158347070410615,1.099360667512753,0.3691899070385126,0.8154867975370791,1.0,6/13,20.23%,DOCK7;DYNC1H1;CLMN;TMEM201;PCM1;DCTN1
prerank,cellular response to UV (GO:0034644),0.39841740586344204,1.0992199890773464,0.34371643394199786,0.8152983075794344,1.0,24/76,26.56%,PRKCD;NEDD4;CARD16;ATF4;IMPACT;ERCC4;SDE2;N4BP1;CREBBP;PARP1;CDC25A;EIF2AK4;NOC2L;EIF2S1;USP47;TRIAP1;OPN3;MMP2;TAF1;TP53;POLD1;PPID;XPA;YY1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.43572647928576064,1.0988906602328268,0.34975961538461536,0.8157131387777565,1.0,16/35,30.24%,MAPK15;NEK7;HNRNPA2B1;ATM;TNKS2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;RTEL1;PNKP;CCT5;ATR;CTNNB1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.39556794802132467,-1.0986430453255416,0.31679389312977096,0.6908551102680583,1.0,5/16,20.77%,TNFRSF21;CD274;TYROBP;DLL1;AGER
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.4316477859168231,-1.0984881621564437,0.3296296296296296,0.6891882576718619,1.0,7/11,16.08%,WNT4;FGFR4;EGR1;SIRT1;NR1H4;BMP2;STAR
prerank,proteasomal protein catabolic process (GO:0010498),0.37176825247552586,1.0983829586907632,0.29435483870967744,0.8165921406428817,1.0,77/201,30.24%,WWP1;NEDD4;PSMD7;TOPORS;COP1;UBE2B;VCP;PSMA8;ERCC8;NFE2L2;TBX21;HUWE1;SYVN1;SOCS6;DDI2;WWP2;SHARPIN;PSMA4;ITCH;CUL4A;PSMD12;FBXL19;PSMA6;PCBP2;ATE1;PSMD1;KCTD5;ARRB1;STUB1;SIRT2;PSMC5;PSMD11;KLHL22;PPP2R5C;PSMC4;PSMD14;TRIM13;KCTD17;GID4;ZFAND2B;ERLEC1;PCNP;RMND5B;PSMA3;UCHL1;RCN3;DCAF11;SMURF2;RNF4;PSMB1;PSMD4;KCTD13;APPBP2;AREL1;DERL1;RNF216;PSMA5;PSMA7;RNF122;ANKRD9;DNAJB12;UBE2W;PSMC1;RNF126;PSMA1;CCDC47;DDB1;NR1D1;UBXN2A;UBE4B;RBX1;SPOPL;BTRC;ZFAND2A;PRKN;PSMD2;CTNNB1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.5220866436195537,1.0983415778278178,0.3712660028449502,0.8160810383460418,1.0,5/12,25.00%,TMEFF2;AP2A1;CLTC;SELENOS;HDAC2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.525371003563515,1.0979729354108894,0.36049723756906077,0.8165941920020848,1.0,3/12,8.39%,F3;IFT20;CBL
prerank,DNA geometric change (GO:0032392),0.45599355170647393,1.0978865365496975,0.36721728081321475,0.8162374319496806,1.0,13/24,35.18%,HMGB1;HNRNPA2B1;ANXA1;WRN;RAD50;SUPV3L1;RECQL5;ZRANB3;RTEL1;DDX11;BLM;DHX9;MRE11
prerank,response to calcium ion (GO:0051592),0.38467199631478965,1.0973070659350743,0.3284823284823285,0.8174247951967195,1.0,15/102,13.48%,THBS1;ADAM9;NEDD4;SEC31A;SYT8;CAMK2D;CLIC4;CALM2;ADCY8;KCNIP2;STIM1;NEUROD2;NLGN1;ADD1;MEF2A
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4129105334835833,-1.097251707890008,0.33807829181494664,0.6904476598935798,1.0,4/12,11.13%,PLEKHH2;SEMA5A;MTPN;PLEK
prerank,regulation of cation transmembrane transport (GO:1904062),-0.33887647471347976,-1.097248682927849,0.2903225806451613,0.6883896698684399,1.0,11/29,13.01%,DPP10;CACNA1D;KCNIP3;KCNIP4;KCNIP1;FGF12;KCNN2;HOMER1;DPP6;KCNAB1;CD63
prerank,positive regulation of cell communication (GO:0010647),-0.3298985191804844,-1.0972355711949957,0.27225130890052357,0.6864016649861939,1.0,9/28,11.55%,WLS;RIMS2;GRIK2;RIMS1;HOMER1;LGI1;NMU;EDN1;CLSTN1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.513693233608297,1.097213861482566,0.38337801608579086,0.8170909427146105,1.0,8/13,31.61%,NFE2L2;HGF;LRRK2;PYCR1;MET;GPR37;GPR37L1;NR4A3
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.47870323561904776,1.0968214698770977,0.35316946959896506,0.817678339002512,1.0,6/19,23.74%,TENT4B;TEN1;HNRNPC;XRN1;HNRNPA1;HNRNPU
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.30471392290861765,-1.0966874575823038,0.2635135135135135,0.6858524366705054,1.0,15/38,18.71%,INSR;ROCK2;SMAD3;KLF2;ASS1;ZC3H12A;EDN1;CAV1;CX3CR1;DDAH2;CD34;SIRPA;NOS1AP;CD47;GLA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37896305389756624,1.0966379736811305,0.3052415210688592,0.8175836139805742,1.0,33/129,16.38%,EGFR;GPC3;COL1A1;SFRP4;PLEKHA4;PSMD7;CSNK1D;UBE2B;VCP;PSMA8;DACT1;ILK;CCAR2;RSPO1;JUP;TRPM4;PSMA4;FGFR2;CSNK1G1;UBR5;AXIN1;PSMD12;USP34;CSNK1E;PSMA6;WNK1;TNKS2;PSMD1;PSMC5;GSKIP;PSMD11;PSMC4;PSMD14
prerank,negative regulation of cellular process (GO:0048523),0.36408484338157776,1.0966098250971443,0.174,0.8170324342117612,1.0,97/521,15.40%,SLIT3;SLIT2;PLXNA4;ZBTB7C;SRSF6;FHL1;WNT9A;FGF2;SRGAP2;OSGIN2;PDCD4;SFRP4;CCN5;TGFBI;CCN3;EMILIN1;NTRK1;SMAD6;ACVR1B;VPS13C;EPHB2;TGFB3;P3H3;SPN;PPP1R9B;PRDM11;CYP1B1;SLURP1;GLMN;PKHD1;LMNA;LRPAP1;PTPRU;TGFB2;P3H1;CLMN;AGR2;TMEM98;TNFRSF1B;TMEM115;NOX4;CD9;CCAR2;PLPP1;SMAD4;ADAM10;PRKRA;ABI1;IFNLR1;SKI;TEX15;CDK10;MDM4;RAF1;TES;P3H2;CHERP;DACT3;DDAH1;CDC6;IMPACT;NDRG3;SERTAD2;DCBLD2;BMP4;ING5;ANP32B;LPCAT3;FOXM1;DIS3L2;RBM5;TAF6;PBRM1;TENM1;TGFB1I1;SESN2;PTPN2;PIP4P2;INHBA;F2R;CGRRF1;RBBP7;GSDME;FRK;FUZ;BMP5;TMEM127;SERTAD3;RHOB;VDR;CYP27B1;MIA3;SCIN;CAMK2N1;IL6;ING4;SIRT2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.49223913045586287,1.0964293103159761,0.36970474967907574,0.8169811480727649,1.0,6/17,14.06%,P4HB;NOL3;NFE2L2;SFPQ;SOD1;UBQLN1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3344107249219741,-1.0964082734519263,0.30994152046783624,0.6845754453384936,1.0,11/32,17.93%,MCTP1;RIMS2;RIMS1;MCTP2;SYN1;DTNBP1;SLC30A1;GPER1;PREPL;CAMK2A;SYT11
prerank,lymphocyte mediated immunity (GO:0002449),0.5215690389669629,1.0962269107817957,0.3709449929478138,0.8170185241453566,1.0,2/12,6.53%,GNL1;JAG1
prerank,positive regulation of calcium ion import (GO:0090280),-0.41694644616380533,-1.0961148191225472,0.34448160535117056,0.6832999642711444,1.0,2/12,4.51%,CXCL12;PDGFRB
prerank,termination of RNA polymerase I transcription (GO:0006363),0.44931364198381807,1.0959736317732314,0.364190012180268,0.8171458845823898,1.0,17/30,33.42%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;POLR2K;TAF1A;CCNH
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3788342282215692,1.0959343102938996,0.29625884732052576,0.8166623029963826,1.0,47/166,24.95%,THBS1;SMOC2;EGFR;IRS1;FGF2;AGXT2;LDB1;GLI2;SAMD4A;ELOVL5;PRKDC;GIPC1;DDAH1;AKT2;BRPF3;SREBF1;NNMT;NIBAN1;CNEP1R1;CHP1;PTPN2;ARPP19;HGF;IL6;EIF6;ERBB2;EIF3D;CDT1;AKT1;MLXIPL;EPM2AIP1;APPL1;KAT7;PYM1;CLU;CIRBP;FXR2;LDLR;OPN3;UPF3A;SLC25A37;PRMT1;ABCB10;RPS6KB1;RPS27L;UPF3B;RBM3
prerank,regulation of microtubule polymerization (GO:0031113),-0.29880318058443583,-1.0956217106773134,0.2608695652173913,0.6824674131318234,1.0,11/40,15.08%,OCLN;CDH5;MAP2;NAV3;CAMSAP1;EML2;PAK1;CLIP1;PRUNE1;SNCA;TUBB4A
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.45580855971108986,1.095584274831377,0.3690773067331671,0.8170693572091559,1.0,10/26,21.02%,ACTN3;SLC9A1;CHERP;EFHB;RCAN1;CHP1;STIMATE;PTBP1;HOMER2;ATP2B4
prerank,dopamine metabolic process (GO:0042417),0.49063593469317845,1.095507069216191,0.3740053050397878,0.8166908741361554,1.0,4/18,4.35%,DRD1;LRTOMT;TGFB2;SNCAIP
prerank,negative regulation of metabolic process (GO:0009892),0.41042190553263097,1.0953972059324373,0.3400447427293065,0.8163920858734255,1.0,18/54,17.43%,ZNF423;NPR3;DOCK7;ATF4;ACTN3;FOXC2;ACOT11;PGAM5;TFE3;TLE3;IP6K1;PCTP;ABHD6;CIDEA;LNPEP;ID1;FLCN;ACOT13
prerank,cortical actin cytoskeleton organization (GO:0030866),0.47756387326996713,1.0952109313277212,0.35128205128205126,0.8163468842341662,1.0,4/20,8.78%,FMNL2;RHOQ;LLGL1;DLG1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3642811730265521,1.0950794427884794,0.218,0.8161103399116095,1.0,117/476,19.96%,ESR1;EGFR;LRP6;SIX1;ID2;ZFHX3;HIVEP3;FGF2;ZNF423;NFIB;COL1A1;ELF4;ZMIZ1;GLI2;MDFIC;LRP5;GLIS2;TGFB3;DEAF1;SHC1;PRDM11;HDAC4;ELF1;MAP3K5;RXRA;HES5;SIX4;STAT3;ATF4;TRIM28;DNM2;ACVR1;BRD4;FOXC2;ILK;RXRB;GPATCH3;SMAD4;FZD7;TASP1;TBX21;THRAP3;SOX9;RARA;NSD1;MED13;ESRRB;TFE3;FOXK1;ENY2;NFATC1;SMARCC2;ZIC1;RORA;ILF3;BMP4;SFR1;ING5;ZFP90;EHF;CHUK;RUNX2;FOXM1;PHF8;PITHD1;MAP3K12;AXIN1;CHEK2;MAZ;KAT6B;RNF14;TAF15;NAA16;PHIP;NR1D2;HEY1;KAT2A;TGFB1I1;TGFBR1;HDAC1;INHBA;F2R;CD80;MAPRE3;RUNX1;NDP;MMS19;SERTAD3;IL6;PSMC5;CAMK4;FOXO3;NFE2;CREB1;MLLT3;CREBBP;APBB1;KMT2B;NFYA;MED14;CDKN1C;CITED2;HMGA1;MED12;E2F1;RYBP;HCFC1;AKT1;CHD8;HIPK2;MLXIPL;QRICH1;TEAD2;XRCC6;TCF3;BICRAL;MAP2K3
prerank,transcription by RNA polymerase I (GO:0006360),0.43976760829964523,1.0948743918581958,0.36904761904761907,0.8161276593870851,1.0,20/34,34.00%,ERCC3;ERCC2;POLR2F;POLR1G;CAVIN1;POLR1C;TAF1C;TBP;TAF1;GTF2H4;POLR2H;UBTF;TAF1D;POLR2L;TAF1B;RRN3;POLR2K;TAF1A;CCNH;TCOF1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.5353316203720897,1.0946039179984282,0.3849431818181818,0.8163512406148491,1.0,3/11,10.66%,VCP;UGGT2;UGGT1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4748320085968487,1.0944014482841125,0.3496143958868895,0.8163372790120743,1.0,5/20,6.67%,NEDD4;PRKCE;CAMK2D;GOPC;STK39
prerank,regulation of T cell differentiation (GO:0045580),0.44387779936003385,1.094222369906209,0.3573170731707317,0.8162476128624414,1.0,11/33,20.97%,ZMIZ1;TBX21;CRTAM;ABL1;SOD1;CLPTM1;KAT2A;RUNX1;CAMK4;CBFB;IL4
prerank,adenine nucleotide transport (GO:0051503),-0.3856395299602168,-1.0933210601991192,0.341991341991342,0.6862507193786589,1.0,2/17,2.40%,ABCC4;LRRC8C
prerank,protein localization to chromosome (GO:0034502),0.43593760442620827,1.0931669215296684,0.3467455621301775,0.8188889488307334,1.0,3/34,7.68%,ESR1;PARP3;SLF2
prerank,mucosal immune response (GO:0002385),0.5059583720018881,1.0930838877873235,0.37830319888734354,0.8185192325706607,1.0,4/15,20.97%,IFNLR1;RNASE3;DEFB1;IL4
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5021399022090672,1.093011409349346,0.3828947368421053,0.8181274117723853,1.0,5/15,17.74%,ZC3H12D;ZC3H12C;LACTB2;RPP40;KHNYN
prerank,nucleus organization (GO:0006997),0.4227640051658716,1.092315915250893,0.35714285714285715,0.8195782873833325,1.0,15/47,26.66%,NUP93;SEH1L;CHMP3;DMPK;REEP3;USP36;TMEM170A;CHMP4A;CHMP4B;PDCD6IP;NDC1;NUP35;CHMP2A;TPR;ATXN7
prerank,positive regulation of neuron projection development (GO:0010976),-0.26676567059191403,-1.0920197859300582,0.20588235294117646,0.6875847834939837,1.0,23/85,14.43%,LYN;PTN;APOE;ITGA6;PTK7;WNT5A;BMP7;RAPGEF2;CAMK1D;SERPINI1;ROR2;TENM3;ATP1B2;VLDLR;PLXNB2;CUX2;CX3CL1;STYXL1;PRKD1;LRP8;RELN;SCARF1;RIT2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.39120891977238786,1.0917337197868429,0.3259493670886076,0.8207832959017538,1.0,16/93,13.67%,RASSF2;VEGFA;SH3RF3;GADD45G;MAP3K5;TGFB2;XDH;MID1;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;STK25;MAP3K10
prerank,positive regulation of phosphorylation (GO:0042327),0.3669316626716316,1.0917032068995138,0.2725450901803607,0.8202602402564403,1.0,39/240,12.40%,THBS1;SLC4A4;PGF;EGFR;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;EPHB2;CSNK1D;GLMN;LIMK2;MAVS;EPHB3;EPHB6;ILK;FZD7;FGFR1;RSPO1;SOX9;AKT2;ROR1;BMP4;FGFR2;TMEM119;MUSK;ABL1;LMO4;NIBAN1;AXIN1;DDR1;RAD50;NRP1
prerank,tRNA metabolic process (GO:0006399),0.49018645907023634,1.0912638720177534,0.36473755047106327,0.8210328051077787,1.0,8/17,27.07%,SSB;DTD1;DARS2;YARS2;ADAT1;SARS1;RPP21;POP5
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43057685650806327,-1.0912607925946411,0.33980582524271846,0.6874911921275993,1.0,2/10,2.33%,SHANK3;APP
prerank,regulation of extracellular matrix organization (GO:1903053),0.48978757759616554,1.0911385520193062,0.3629139072847682,0.8207798098559038,1.0,7/15,17.10%,LRP1;DDR2;FAP;RIC1;DDR1;RUNX1;SLC2A10
prerank,regulation of platelet activation (GO:0010543),-0.3589420968005357,-1.0910649109430934,0.35,0.686018012093766,1.0,8/21,11.13%,LYN;APOE;TEC;NOS3;PDGFRA;SYK;PRKCQ;PLEK
prerank,regulation of cilium assembly (GO:1902017),0.39930247337654895,1.0909085516726713,0.34093376764386535,0.8208761745043989,1.0,29/62,30.11%,MAPK15;TBC1D2B;LIMK2;DYNLT2B;IFT20;CDK10;TBC1D24;ATG3;EVI5L;SDCCAG8;TBC1D9B;MARK4;FUZ;TBC1D10A;TBC1D17;IFT88;KCTD17;EVI5;TBC1D22B;CYLD;RABGAP1;ARHGAP35;TBC1D20;CCP110;TAPT1;IFT140;TESK1;TBC1D19;TCHP
prerank,pentose-phosphate shunt (GO:0006098),0.5250401877570167,1.0906562736152616,0.36984352773826457,0.8210280074361703,1.0,4/11,16.24%,SHPK;TKT;DERA;PGD
prerank,melanosome organization (GO:0032438),0.45851397757588047,1.0902117275478376,0.38202247191011235,0.8217300731519733,1.0,8/26,14.45%,KIF13A;BLOC1S2;RAB38;TRAPPC6A;AP3D1;BLOC1S3;ABCB6;HPS4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3922784936061801,1.0900542446790429,0.35200845665961944,0.821567363835465,1.0,16/86,15.25%,EGFR;PRKCD;VEGFA;EFNA5;GHR;CSPG4;IL5;ACVR1;DGKQ;ANGPT4;PAK2;ABL1;NRP1;CD80;HGF;IL6
prerank,platelet degranulation (GO:0002576),0.3775012093342403,1.0897456408965713,0.3448275862068966,0.8218855468485599,1.0,14/118,7.26%,THBS1;VEGFA;GAS6;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;TGFB2;CD9;MAGED2;QSOX1;FAM3C
prerank,positive regulation of apoptotic process (GO:0043065),0.3671933320538692,1.0896952873859118,0.25625625625625625,0.8214112671722504,1.0,66/293,18.27%,SLIT2;RASSF2;HOXA5;SFRP4;PTGIS;TIAM1;GADD45G;PRR7;TIAM2;UNC13B;VAV2;TGFB3;PRDM11;CYP1B1;FAP;MAP3K5;CRADD;TGFB2;ATF4;DNM2;CCAR2;HMGB1;ING3;IAPP;KALRN;BACE1;MAPK8;BMP4;FOXA1;ING5;ABL1;RBM5;ATM;AIFM1;SOD1;TNFRSF10B;ERCC3;PTRH2;TGFBR1;PDCD2;HSPD1;MAP3K10;SOS2;SQSTM1;ARHGEF1;RHOB;SCIN;AKAP13;PSEN2;IL6;SOS1;ING4;SIRT2;LATS2;FOXO3;TRIO;RPS27A;UBC;APBB1;NF1;NGEF;FLCN;DAPK3;E2F1;BID;RYBP
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.4473217468670888,1.0896820010898263,0.36670687575392036,0.8202179585530104,1.0,7/29,18.78%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.4473217468670888,1.0896820010898263,0.36670687575392036,0.8202179585530104,1.0,7/29,18.78%,ACSF2;ACOT11;GPAT4;ACAT1;GLYAT;ACOT13;ACSL6
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4282051469736354,1.0895895447286774,0.3704994192799071,0.8198813138280914,1.0,3/37,2.75%,EFNA5;STMND1;PHLDB1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3686099263113765,-1.089359777935865,0.33195020746887965,0.6885870679033513,1.0,2/19,2.53%,APOE;PICALM
prerank,neuron migration (GO:0001764),0.411619258495791,1.0889030907101482,0.36475869809203143,0.8213948078767522,1.0,11/48,14.32%,VEGFA;FGF13;MAP1B;MARK1;LRP12;NAV1;FGFR1;PEX13;SDCCAG8;NRP1;NDNF
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4231205430297735,1.0888752575181762,0.3611764705882353,0.8208823662653744,1.0,15/40,28.54%,PRKCD;KMT5A;SMG1;ABL1;UBE2V2;ARMT1;USP1;NEK4;FXR2;BCLAF1;SMYD2;PARG;FXR1;UBE2V1;CDK9
prerank,atrial septum morphogenesis (GO:0060413),0.5374460808149943,1.0887772328865952,0.38659058487874465,0.8205929725569936,1.0,2/10,5.63%,TGFB2;ACVR1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4661008650732398,1.0887590888092535,0.3587385019710907,0.8200364331650154,1.0,8/19,19.88%,SLC25A32;MTRR;MTHFD2;ALDH1L2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,inner dynein arm assembly (GO:0036159),0.5306531824269354,1.0884594691016327,0.37752161383285304,0.8203469155424462,1.0,4/10,24.63%,CCDC39;DNAAF4;CFAP73;DNAAF5
prerank,protein localization to cell periphery (GO:1990778),0.37789363222755573,1.0884492992769217,0.3343621399176955,0.8197698100049504,1.0,21/133,7.66%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;TTC7A;EHD1;RDX;RAB34;C2CD5;RAMP2;PIGW;PACS2;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP
prerank,positive regulation of programmed cell death (GO:0043068),0.3666803298627529,1.0881465750289685,0.2865731462925852,0.8200785402033451,1.0,61/272,18.27%,SLIT2;RASSF2;HOXA5;SFRP4;TIAM1;GADD45G;NTRK1;PRR7;TIAM2;UNC13B;VAV2;TGFB3;CYP1B1;MAP3K5;CRADD;ATF4;DNM2;CCAR2;HMGB1;ING3;IAPP;KALRN;MAPK8;BMP4;FOXA1;ING5;ABL1;RBM5;ATM;AIFM1;SOD1;TNFRSF10B;ERCC3;PDCD2;HSPD1;MAP3K10;MARK4;SOS2;SQSTM1;ARHGEF1;RHOB;SCIN;AKAP13;PSEN2;IL6;SOS1;ING4;LATS2;FOXO3;HDAC6;TRIO;RPS27A;UBC;APBB1;NF1;NGEF;FLCN;DAPK3;E2F1;BID;RYBP
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3981664830863964,1.0881345827468758,0.352112676056338,0.8194980383735025,1.0,30/64,29.94%,ELOF1;TCEA2;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;POLR2I;CDK9;MLLT1;ADRM1;POLR2L
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5322360585628797,1.0875732322136162,0.36995827538247567,0.8206582325455813,1.0,7/11,33.43%,ATF4;HSPA5;ATF6;CREB3L1;TP53;ATF6B;CEBPB
prerank,cellular glucan metabolic process (GO:0006073),0.5362043745366034,1.0874837924827059,0.39255014326647564,0.8203267379483041,1.0,3/11,7.75%,PPP1R3C;PHKA1;PHKB
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5218190941714721,1.08738691338718,0.3806179775280899,0.8193977626171967,1.0,5/12,21.02%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5218190941714721,1.08738691338718,0.3806179775280899,0.8193977626171967,1.0,5/12,21.02%,ACTN3;RCAN1;CHP1;HOMER2;ATP2B4
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3617974362741558,-1.08715855337694,0.3008849557522124,0.6923865413702589,1.0,4/18,5.21%,APOE;CTSC;VGLL4;FAF1
prerank,response to interleukin-4 (GO:0070670),-0.4448649831568705,-1.0867225916319654,0.38235294117647056,0.691568138048372,1.0,2/10,3.71%,LEF1;TCF7
prerank,telomere maintenance (GO:0000723),0.4104651447546479,1.0864393735119702,0.35923423423423423,0.8215821910334814,1.0,21/50,28.72%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;TEN1;RAD50;DCLRE1B;PARP1;TPRKB;HUS1;SMC5;RAD51;XRCC6;XRCC3;POLD1;SMC6;RTEL1;NSMCE2;ATR
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.4178591266659431,1.0863259883201632,0.3482758620689655,0.8213087000824253,1.0,21/42,32.75%,HELB;RMI2;FUS;SPIDR;WDR48;MMS19;PARP1;RAD51;MAD2L2;SETD2;ACTR2;CGAS;WAS;FBH1;RTEL1;SHLD3;SHLD1;TIMELESS;PARPBP;ERCC6;POLQ
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5218585342143882,1.0856805323660486,0.3783422459893048,0.8226094890032668,1.0,2/11,4.91%,ID2;PRKCA
prerank,glycoprotein biosynthetic process (GO:0009101),0.3924220502287072,1.0855330590652692,0.35005336179295626,0.8224405377216805,1.0,13/79,13.44%,ST3GAL4;XYLT1;ST8SIA2;CHST11;B3GNT7;PMM2;ST3GAL2;FOXL1;B4GALT5;NPC1;FUT4;GAL3ST4;B3GNT9
prerank,negative regulation of stress fiber assembly (GO:0051497),0.45427453339980434,1.085420708126272,0.3710462287104623,0.8221603752523493,1.0,4/24,5.28%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,striated muscle cell development (GO:0055002),-0.39785768379106745,-1.0853531852317702,0.33739837398373984,0.6931866514698005,1.0,4/14,8.20%,PGM5;TMOD3;TMOD1;LMOD1
prerank,histone H3-K9 demethylation (GO:0033169),0.5280018622469788,1.0844552332014974,0.37926136363636365,0.8244091579903822,1.0,4/11,13.22%,JMJD1C;PHF8;KDM4A;HR
prerank,regulation of mitochondrial translation (GO:0070129),0.4712363382811508,1.083489068247294,0.379746835443038,0.8266907253554036,1.0,6/21,18.98%,RCC1L;MPV17L2;RMND1;ALKBH1;SHMT2;FASTKD3
prerank,protein heterooligomerization (GO:0051291),0.4842820569212726,1.08343659085839,0.37290322580645163,0.8262460049028486,1.0,5/17,18.09%,PKD1;CBR4;HSD17B8;CPSF7;CPSF6
prerank,regulation of telomere maintenance (GO:0032204),0.4569448554234139,1.0831752188080572,0.3844221105527638,0.8264613751107871,1.0,8/26,21.97%,GNL3;SMG6;ERCC4;SMG1;RAD50;USP7;PPP1R10;UPF1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.40649143730586884,1.0831141023208342,0.3589462129527991,0.8260314547275059,1.0,16/56,19.95%,EGFR;RDX;ANAPC5;CDC16;BRD4;ANXA1;CDC25B;UBE2C;ANAPC4;RCC2;EIF4G1;TFDP1;CDC25A;AKT1;CDC27;DLGAP5
prerank,focal adhesion assembly (GO:0048041),-0.3653718048534232,-1.0830800676628358,0.30357142857142855,0.697291346061738,1.0,6/21,6.90%,SORBS1;ACTN2;PEAK1;THSD1;WHAMM;PTPRK
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.46077352349431794,1.0829754241162253,0.38107098381070986,0.8258307192340719,1.0,2/23,5.91%,SLIT2;MCU
prerank,pre-replicative complex assembly (GO:0036388),0.3979479162747248,1.0827625952130278,0.3548034934497817,0.8258946440970837,1.0,25/64,27.30%,PSMD7;PSMA8;MCM2;CDC6;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;MCM4;ORC2;CDT1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;MCM7;PSMA1
prerank,positive regulation of protein kinase activity (GO:0045860),0.37028766017523557,1.0826603757854385,0.34014300306435136,0.8255746956642992,1.0,23/148,11.47%,RASSF2;PRKCD;VEGFA;GAS6;DDR2;SRCIN1;CAMKK1;STRADA;TGFB2;CALM2;TOM1L1;NOX4;TGFBR2;DLG4;PAK4;RHOA;PAK2;SYAP1;RIPK3;TAB2;TELO2;AXIN1;SNX9
prerank,nitric oxide metabolic process (GO:0046209),-0.3975578851393511,-1.0826010656625635,0.3678571428571429,0.6965680440449463,1.0,6/14,12.41%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,macrophage activation involved in immune response (GO:0002281),0.508555454208727,1.0825241048031853,0.4072524407252441,0.8253894057899506,1.0,2/13,9.20%,LBP;SBNO2
prerank,positive regulation of protein modification process (GO:0031401),0.3675738863556496,1.0822951317830374,0.3221884498480243,0.8254674361326626,1.0,45/203,17.28%,PGF;EGFR;TRABD2B;PRKCD;SLCO3A1;VEGFA;EFNA5;GAS6;FGF2;CARD14;NTRK3;NTRK1;FGF17;CSNK1D;LIMK2;CALM2;MAVS;RAB3GAP1;ILK;RSPO1;SOX9;SYMPK;AKT2;BMP4;TMEM119;RAMP1;MUSK;ABL1;NNMT;NIBAN1;AXIN1;CNEP1R1;CHP1;ERP29;PTBP1;WDFY2;DAB2;HGF;ARRB1;NSMF;ERBB2;FGF5;CALM3;EFNA1;FLCN
prerank,rRNA modification (GO:0000154),0.46058824268782295,1.0819844975514443,0.38071065989847713,0.8258023479459498,1.0,14/21,41.21%,TFB2M;TSR3;FBL;BUD23;TRMT112;DKC1;NSUN3;NOP10;THUMPD1;MRM2;ZCCHC4;DIMT1;NSUN4;MTERF4
prerank,filopodium assembly (GO:0046847),0.4995097276642122,1.0819373567149357,0.39295392953929537,0.8253268364077531,1.0,3/16,3.63%,SRGAP2;PPP1R9B;FGD6
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4054651116208839,-1.081929105492577,0.35034013605442177,0.6963055506751309,1.0,5/13,13.58%,ERRFI1;CBLB;SNX6;SOCS5;GPRC5A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5221911205902786,1.0817743685478758,0.3950617283950617,0.8252241572316147,1.0,5/11,20.97%,TBX21;ANXA1;SMAD7;RC3H2;IL4
prerank,regulation of epithelial cell proliferation (GO:0050678),0.38299300985677137,1.0817563623857198,0.3479188900747065,0.8246708668536176,1.0,13/85,9.71%,EGFR;SRSF6;VEGFA;FGF2;TCF7L2;DEAF1;PKHD1;SIX4;TGFB2;PRKDC;SOX9;BMP4;FGFR2
prerank,positive regulation of lyase activity (GO:0051349),0.5049718293244098,1.081628440596274,0.3868421052631579,0.8244673448220108,1.0,3/14,9.17%,CACNA1C;FXN;STIM1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.4476716784942745,1.08153409328761,0.3647342995169082,0.8241481308289654,1.0,4/29,13.03%,THBS1;PAK2;LTBR;INHBA
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.48573140169796264,1.080904873713053,0.38821954484605087,0.8253908271907692,1.0,5/18,12.69%,CCN3;HDAC4;FZD7;TMEM119;HDAC1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4126413221288329,1.0808282498236408,0.36374269005847953,0.8250335260987292,1.0,5/43,8.07%,GAS6;LBP;IRAK3;TRIM27;RARA
prerank,regulation of translation (GO:0006417),0.3705729696050317,1.0807425449693213,0.3181818181818182,0.8246862104367514,1.0,60/173,28.60%,THBS1;IGFBP5;SAMD4A;EIF4A2;EIF4G2;PRKDC;EIF4G3;CYFIP1;GSPT1;IMPACT;ILF3;NIBAN1;EIF4G1;ALKBH1;LTN1;RBM4;NOLC1;ETF1;IL6;FOXO3;CNOT8;EIF6;ERBB2;EIF3D;CNOT10;NCBP1;SHMT2;EPRS1;DAPK3;NCBP2;CNOT9;SHMT1;GLE1;SYNCRIP;EIF2AK4;CALR;PYM1;CIRBP;EIF2A;ATXN2;FXR2;UPF1;SHFL;EIF2AK3;EIF4B;UPF3A;YBX1;RPS6KB1;RPS27L;UPF3B;RBM3;METTL14;MRPL13;RIDA;EIF4E;FXR1;YTHDF1;EIF4H;NSUN3;LARP1
prerank,regulation of glucose import (GO:0046324),0.43636406135864964,1.0806116369309535,0.37605804111245467,0.8244645095346422,1.0,6/30,8.56%,IRS1;PID1;GRB10;RHOQ;CAPN10;AKT2
prerank,protein modification by small protein conjugation (GO:0032446),0.36206191325670517,1.0804045413743275,0.273,0.8245026125791131,1.0,119/361,25.87%,WWP1;RNF144A;NEDD4;NUP93;FBXO10;FBXL7;FBXW8;TOPORS;CDC16;UBE2B;TRIM28;RAE1;VCP;RNF182;DTX3;DCUN1D5;UBE2R2;NFX1;PRKDC;SEH1L;KLHL7;NFE2L2;TRIM41;PEX5;TRPC4AP;HUWE1;TRIM27;SYVN1;CBL;CDK5RAP3;LZTR1;TRPM4;WWP2;PEX13;ITCH;CUL4A;FBXO25;UCHL3;RNF25;UBE2C;NEUROD2;RNF14;NUP37;SDE2;ATG3;MYLIP;CUL1;DCUN1D2;RNF38;DTX2;PEX10;USP7;RNF103-CHMP3;UBA5;TRIM26;RANBP2;PIAS4;NUP88;ARRB1;STX1A;STUB1;UBE2V2;RPS27A;UBC;OTULIN;SUMO1;BIRC6;UFL1;TRIM13;VPS11;TRIM6;POM121;NUP210;UHRF2;RNF7;UBR2;CDC27;ASB5;SAE1;MYCBP2;UBE2G2;PCNP;TRAIP;TRIM47;NUP62;USP5;SMURF2;TRIM43;MUL1;PEX2;PAF1;KCTD13;CUL9;UBA3;SUMO2;NDC1;AREL1;PEX14;DERL1;RNF20;NUP35;FBXO11;DET1;UBE2Z;FBXO9;AMFR;ANKRD9;PINK1;RCHY1;SELENOS;RNF138;UBE2W;RTF1;UVSSA;UBR3;RNF111;SHPRH;NUP85;CUL7
prerank,response to muscle stretch (GO:0035994),0.48825871832485807,1.0803657169664371,0.39335180055401664,0.8240257102050965,1.0,4/15,10.81%,GSN;DMD;SLC9A1;CSRP3
prerank,snRNA metabolic process (GO:0016073),0.47968713830109566,1.0802494091425812,0.387434554973822,0.8237824771779888,1.0,11/17,38.04%,INTS3;INTS4;MTREX;ZCCHC8;INTS9;INTS7;MEPCE;INTS6;INTS10;RBM7;INTS8
prerank,"DNA-templated transcription, termination (GO:0006353)",0.39771267937886073,1.0802268474420984,0.37269772481040087,0.8232495004737285,1.0,37/68,34.59%,SYMPK;MAZ;PABPN1;ERCC3;ERCC2;CLP1;CPSF4;POLR2F;PCF11;NCBP1;SMN1;CPSF7;NCBP2;POLR1G;CAVIN1;CSTF2;POLR3K;CSTF2T;SNRPB;POLR1C;TAF1C;TBP;GTF2H4;POLR2H;UBTF;SETX;TAF1D;SNRPF;PRMT5;POLR2L;TTF2;TAF1B;POLR2K;TAF1A;CCNH;CPSF3;MTERF2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.3815575181159542,1.0799091011413593,0.36663124335812963,0.8236130508327835,1.0,28/85,25.08%,RNF144A;PRICKLE1;CSNK1D;COP1;OSBPL7;VCP;DVL1;FBXO22;RNF14;SMAD7;CSNK1E;DAB2;USP13;DDA1;STUB1;SIRT2;PSMC5;SUMO1;HECTD1;CLU;USP5;LRRK2;SUMO2;DET1;TAF1;RCHY1;RNFT1;BBS7
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4096986714925879,1.079723349886927,0.36848072562358275,0.8235712498299087,1.0,5/49,6.48%,LBP;F3;STAT3;MAVS;HMGB1
prerank,response to steroid hormone (GO:0048545),0.4387745167812168,1.0796893774939538,0.38658536585365855,0.8230801147461689,1.0,5/31,10.49%,THBS1;TGFB3;TGFB2;CATSPER3;URI1
prerank,negative regulation of cell migration (GO:0030336),0.37233639469364305,1.0795539764464264,0.3432682425488181,0.8228709939462372,1.0,18/137,6.57%,SLIT2;IGFBP5;LRP1;FGF2;COL3A1;SRGAP2;SRGAP3;TMEFF2;DPYSL3;MAPK15;LDLRAD4;CYP1B1;SLURP1;CLIC4;PTPRU;PFN2;JAG1;SULF1
prerank,ethanol metabolic process (GO:0006067),-0.41268024408408344,-1.0794883210701363,0.35661764705882354,0.7005868450649867,1.0,5/12,15.15%,ALDH1A1;ACSS2;ALDH2;SULT1A1;ADH1A
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5070713197007412,1.0794786980202185,0.3815789473684211,0.8224750203244883,1.0,3/14,8.35%,RCC1L;MPV17L2;RMND1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.421640849563872,1.079436619386425,0.38953488372093026,0.8219864720852582,1.0,19/36,32.30%,CDC6;TIPRL;RAD1;ATM;CHEK2;CDC45;CEP63;ATRIP;HUS1;CDT1;E2F1;DONSON;ATR;INTS7;TIMELESS;RAD17;RHNO1;HINFP;ERCC6
prerank,I-kappaB phosphorylation (GO:0007252),0.5307214302687817,1.0794147530113394,0.3994252873563218,0.8214567816790723,1.0,2/10,10.27%,ERC1;CHUK
prerank,regulation of cell size (GO:0008361),0.45121925287605075,1.0792785208556985,0.37766624843161856,0.821294147914567,1.0,6/23,12.29%,RDX;VAV2;AKT1S1;RHOA;EZR;DEPTOR
prerank,cAMP metabolic process (GO:0046058),-0.4122022355957549,-1.07910618796476,0.3612167300380228,0.6996116118314298,1.0,4/13,7.53%,ADCY5;PDE4D;ADCY1;ADCY4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.27679794247431283,-1.0788928536563445,0.25333333333333335,0.6982381024973945,1.0,22/72,11.65%,NRXN1;SHANK3;APP;RIMS2;SLC24A2;CACNG7;ADCY1;GRIK2;RIMS1;GRIN2B;CACNG8;SLC8A3;ZDHHC3;LGI1;GRIN2A;NMU;CACNG3;ADRA1A;CACNG4;DTNBP1;CLSTN1;PLK2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.42941904363384487,1.0787853779253447,0.3725728155339806,0.8222327029766814,1.0,3/34,1.13%,IRS1;TNFAIP8L3;FGF2
prerank,monocyte chemotaxis (GO:0002548),-0.3272823829368149,-1.0784219353160642,0.292817679558011,0.6974734278851932,1.0,3/32,4.47%,FLT1;IL6R;PTPRO
prerank,regulation of vasculogenesis (GO:2001212),0.49397362547126805,1.078401353100048,0.3675675675675676,0.8227314211143484,1.0,3/14,12.12%,TMEM100;XDH;HEY1
prerank,positive regulation of secretion by cell (GO:1903532),0.39287747021873975,1.07816462626489,0.3533260632497274,0.8228373029619505,1.0,16/70,17.96%,KCNB1;SLC12A2;ADAM9;UNC13B;TGFB3;APBB3;TGFB2;RAB2B;EDN3;EZR;STXBP5;STX1A;APBB1;SYTL4;IER3IP1;GOLPH3
prerank,regulation of stem cell differentiation (GO:2000736),0.38545792586048994,1.077376981293643,0.3574468085106383,0.824598071629734,1.0,34/89,24.32%,LDB1;PSMD7;HES5;PSMA8;SLC4A11;PRKDC;JAG1;ESRRB;PSMA4;ITCH;ABL1;BMPR1A;PSMD12;PSMA6;HOXB4;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;GDNF;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;NELFB;PSMA5;PSMA7;HNRNPU;RBM24
prerank,negative regulation of cytokine production (GO:0001818),0.3698521345828027,1.0772112850588413,0.3285859613428281,0.8245034454217022,1.0,37/163,19.91%,THBS1;CMKLR1;GAS6;PDCD4;CHID1;HDAC9;ANXA4;TAX1BP1;MAVS;GPATCH3;HMGB1;IRAK3;TBX21;RPS6KA4;TRIM27;RARA;ANXA1;ITCH;MAPKBP1;CIDEA;EZR;INHBA;PCBP2;UBE2L6;IL6;ARRB1;N4BP1;OTUD5;SLC2A10;ACOD1;NPLOC4;ADCY7;SARS1;IKBKE;IRF3;HOMER2;APPL2
prerank,axonemal dynein complex assembly (GO:0070286),0.44170781924833696,1.0769466953241442,0.3774752475247525,0.8246961237183774,1.0,9/27,26.04%,DNAH8;DNAAF3;ODAD2;CCDC39;DNAAF4;CFAP73;TTC12;DNAAF5;DNAL1
prerank,regulation of glycolytic process (GO:0006110),0.39970049730287605,1.0764492421238467,0.36,0.8255722085638786,1.0,27/68,26.42%,SLC4A4;NUP93;SEC13;HDAC4;RAE1;ACTN3;SEH1L;OGT;GIT1;NUP37;RANBP2;NUP88;EIF6;PRKAG1;POM121;NUP210;MLXIPL;NUP62;NDC1;NUP35;PFKFB4;ENTPD5;NCOR1;PFKFB1;NUP85;NUP160;TPR
prerank,mammary gland development (GO:0030879),0.46438385369531276,1.0763419226350024,0.3939393939393939,0.8252792246727239,1.0,3/21,2.90%,VEGFA;GLI2;TGFB3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3896186311652989,1.0761219886324283,0.35223555070883317,0.8253319526541878,1.0,14/75,12.61%,PGF;VEGFA;F3;FGF2;STAT5A;PRKCA;HMGB1;FGFR1;BMP4;AGGF1;VIP;PDPK1;NRP1;TGFBR1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.355953168741426,1.0758136157115175,0.161,0.8256322902315839,1.0,279/1082,22.67%,PLAGL1;ESR1;EGFR;LRP6;SIX1;PKD1;PID1;ID2;ZFHX3;HOXA5;ZFPM2;VEGFA;HIVEP3;NFIX;FGF2;ZNF423;NFIB;TCF7L2;IL33;COL1A1;RARB;ELF4;NFIA;GALR1;DDX17;RHOQ;LDB2;LDB1;ZMIZ1;GLI2;MDFIC;TCF20;LRP5;GLIS2;TGFB3;TWIST1;DEAF1;SHC1;PRDM11;PRDM10;NFAT5;HDAC4;ELF1;ELOF1;MAP3K5;HOXB3;RXRA;ONECUT2;MEOX2;WWTR1;HES5;KLF5;SIX4;STAT3;DCAF6;ATF4;TRIM28;NR2F1;MAVS;BCAS3;DNM2;KMT2C;ACVR1;BRD4;DVL1;FOXC2;ILK;BCL9L;RXRB;PRKDC;GPATCH3;SMAD4;NFE2L2;HMGB1;JAG1;MEF2B;FZD7;SLC9A1;E2F3;TASP1;PBX1;MEIS3;SKI;HEYL;TBX21;THRAP3;JUP;SOX9;ARF4;RPS6KA4;NRIP1;RARA;NSD1;FOXJ3;MED13;FZD5;ESRRB;TFE3;FOXK1;ENY2;ZNF76;NFATC1;HMGN1;SMARCC2;OGT;SERTAD2;ZIC1;SBNO2;RORA;ILF3;BMP4;FGFR2;SFR1;FOXA1;ING5;UBP1;CSRNP1;ZFP90;PRDM4;SREBF1;EHF;CHUK;RUNX2;GTF2F1;FOXM1;ABL1;AGO1;RFX5;CCNT2;PHF8;CSRP3;PITHD1;MAP3K12;PLAC8;NRF1;ATM;BMPR1A;AXIN1;CHEK2;MAZ;KAT6B;PAXBP1;RNF14;TAF15;NAA16;SFPQ;TAF6;SMAD7;MED25;PHIP;SRF;NR1D2;HEY1;GLIS1;KAT2A;SSBP3;RGMA;TGFB1I1;TGFBR1;HDAC1;AGO2;PTOV1;MEF2D;ZMIZ2;HOXB4;INHBA;F2R;CD80;MAPRE3;KMT2D;MEF2A;RUNX1;NFATC3;NDP;SQSTM1;DAB2;BMP5;MMS19;SERTAD3;VDR;MED21;TFDP1;PER1;HGF;IL6;ARRB1;GRHL1;SIRT2;PSMC5;CAMK4;CRTC2;FOXO3;NFE2;CREB1;MLLT3;CREBBP;PARP1;ERBB2;AATF;ZNF462;RPS27A;UBC;APBB1;KMT2B;KDM6B;DPF3;PRDM2;NFYA;FLCN;NFKB2;SLC30A9;NR3C1;RFXANK;E4F1;MED14;CDKN1C;MEN1;CITED2;HMGA1;ATAD2B;MED12;E2F1;RYBP;HCFC1;AKT1;GDNF;ATF2;CCDC62;CHD8;HIPK2;KLF10;HOXB2;MLXIPL;BRD8;FOSL2;QRICH1;TEAD2;XRCC6;IRF3;VEZF1;MPND;NFKBIA;TCF3;BICRAL;MAP2K3;ATF6;MAX;BPTF;TET2;RTRAF;KAT7;MRPL12;BCL2L12;MAD2L2;NUP62;GPS2;IL4;MAP2K7;RNF4;BCL11B;SMAD5;IER2;NEK4;SENP1;POGZ;NFIC;DNAJC2;CAMK1;SS18L1;ZKSCAN3;KAT8;NR2C2;EIF2AK3;CDK5RAP2;TRIAP1;KMT2A;SLC11A1;ICE1;TFCP2
prerank,negative regulation of type I interferon production (GO:0032480),0.41452346794827644,1.075770607875772,0.3684834123222749,0.8251610602049606,1.0,19/40,28.95%,PTPRS;TAX1BP1;MAVS;GPATCH3;ITCH;PCBP2;UBE2L6;OTUD5;ACOD1;NPLOC4;IKBKE;IRF3;RNF216;CYLD;TBK1;ILRUN;YY1;PPM1B;RNF135
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3645966526268484,-1.0755195750827051,0.326271186440678,0.7030771005058619,1.0,8/18,26.51%,PLCB1;OPRM1;CHRM3;RGS8;CHRM2;CHRM1;GNAQ;GNA15
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.533807849051149,1.0753416077704354,0.3954887218045113,0.82586996916783,1.0,1/10,1.30%,IL33
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3429929371342376,-1.0752861132205374,0.3259668508287293,0.7017140058601817,1.0,1/26,0.01%,ATP1A2
prerank,regulation of cell population proliferation (GO:0042127),0.35635918721760346,1.0752427522080825,0.21,0.8255756802141616,1.0,133/691,15.71%,THBS1;PGF;EGFR;SIX1;IRS1;ZBTB7C;ID2;WNT9A;ELN;VEGFA;ECRG4;FGF2;TCF7L2;SFRP4;TIAM1;ACER3;NPR3;NTRK3;PROK2;NTRK1;FGF17;BRICD5;SMAD6;GAB2;LRP5;GNL3;MAPK15;TGFB3;P3H3;PPP1R9B;SHC1;CYP1B1;SLURP1;RBFOX2;HDAC4;STAT5A;GLMN;PKHD1;LMNA;WWTR1;PTPRU;HES5;CSNK2A1;SIX4;TGFB2;STAT3;TCIRG1;P3H1;MEAK7;DNAJA2;CLMN;TCFL5;FXN;TMEM115;NOX4;PRKDC;PLPP1;FAM98A;ADAM10;IL12RB2;TGFBR2;JAG1;PRKRA;ABI1;IFNLR1;FGFR1;MEIS3;SKI;CDK10;MDM4;RAF1;JUP;SOX9;TES;P3H2;RARA;S100B;BEX4;CHERP;DDAH1;AKT2;CDC6;TRPM4;RHOA;EDN3;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;ING5;CDC123;FAM98B;VIP;FOXM1;CTF1;DIS3L2;CHTOP;RBM5;BMPR1A;MAZ;PHIP;PBRM1;TENM1;TGFB1I1;TGFBR1;HDAC1;TRAPPC14;PTPN2;INHBA;F2R;CGRRF1;KMT2D;GSDME;NACC1;RUNX1;SETD4;FRK;FUZ;BMP5;CLCF1;TMEM127;PRDX3;VDR;CYP27B1;SCIN;CAMK2N1;STX4;IL6;ING4;SIRT2;SLC35F6;CNOT8
prerank,regulation of actin filament polymerization (GO:0030833),0.39630250378492127,1.0751568449141156,0.37717391304347825,0.8252311336941272,1.0,6/69,6.31%,SLIT2;PRKCD;CTTN;PRKCE;CDC42EP2;PFN2
prerank,response to peptide (GO:1901652),0.43241265360798786,1.075089861953574,0.3674698795180723,0.8248449971463878,1.0,3/33,4.21%,IRS1;STAT5A;STAT3
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3813027664522345,1.0748304011793266,0.37343096234309625,0.8250303483438414,1.0,41/91,29.88%,STON2;ARFGAP1;GAS1;DNAJC13;RAB21;RAB8A;MBTPS1;STON1;NSF;ITGAV;SCFD1;ABL1;ATP9A;RAB3D;NRP1;STXBP5;RAB11B;USP7;CHMP3;RINT1;STX4;RAB3B;RAB4B;HIP1;RAB5B;RUFY2;ZFYVE16;RAB4A;LRRK2;TSC2;BET1L;VAMP2;RAB5A;LGI3;RALA;FES;ABL2;RAB3A;RAB5C;PACSIN2;RUFY1
prerank,inhibitory synapse assembly (GO:1904862),0.5224046910750689,1.0747460410184027,0.38620689655172413,0.8246983283542828,1.0,2/11,5.23%,FGF13;LGI2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.38238585959946014,-1.0747099482060538,0.37209302325581395,0.7012312258503343,1.0,4/16,10.90%,CECR2;KPNA1;H1-0;KPNB1
prerank,regulation of mRNA catabolic process (GO:0061013),0.37830551286920133,1.0746985337977373,0.35020661157024796,0.8242294141610543,1.0,38/121,24.66%,XPO1;PRKCD;PABPC1;SAMD4A;PSMD7;PRKCA;PSMA8;PUM1;PSMA4;PCBP4;PSMD12;PSMA6;EIF4G1;PSMD1;XRN1;EXOSC4;PSMC5;CNOT8;PSMD11;PSMC4;PSMD14;RPS27A;UBC;RC3H2;DIS3;AKT1;TNPO1;PSMA3;PSMB1;PSMD4;FXR2;UPF1;DCP1A;PSMA5;PSMA7;ZC3H14;RBM24;YWHAB
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3857743729580132,1.0741046654096658,0.35706462212486306,0.825325917537147,1.0,15/78,18.70%,EGFR;PKD1;IPO5;CDC6;CDK5RAP3;CCNT2;MAPRE3;CCNG2;CCNE2;HEXIM1;LATS2;CDC25A;CDKN1C;MEN1;AKT1
prerank,phosphatidylserine metabolic process (GO:0006658),0.42715072987919817,1.0739184214459372,0.37997587454764775,0.8252566612158545,1.0,9/32,17.33%,PLA2G4F;PLA2G4A;MBOAT2;LPCAT4;PLA2G5;LPCAT3;PLA2G12A;PLA2G15;PTDSS1
prerank,regulation of glycogen metabolic process (GO:0070873),0.5166991423831568,1.073915062460863,0.4005524861878453,0.8246853687556321,1.0,4/12,23.12%,PPP1R3C;PPP1R3F;AKT1;PPP1R3B
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3811533482374192,1.0737859447598868,0.3675392670157068,0.8245009826440739,1.0,33/101,25.65%,THBS1;RDX;SAMD4A;DACT1;PRKDC;OGT;NIBAN1;EZR;EIF4G1;INHBA;TBC1D10A;IL6;STUB1;EIF6;ERBB2;EIF3D;PERP;VPS11;IST1;AKT1;NFKBIA;PYM1;CIRBP;FXR2;CYFIP2;UPF3A;RPS6KB1;BAD;RPS27L;UPF3B;RBM3;HDAC2;METTL14
prerank,artery development (GO:0060840),-0.3415686221443647,-1.073772494879665,0.35602094240837695,0.7017778249248859,1.0,11/23,17.44%,ROBO1;ENG;ROBO2;TBX1;PDE2A;BMPR2;ACVRL1;EFEMP2;APLNR;ACVR2B;STRA6
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.32496692087505163,-1.0737192210638713,0.2727272727272727,0.6999418866858379,1.0,7/30,12.39%,FLT1;KIT;KDR;ACE;FLT4;PLEK;SFRP1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3815825506702614,1.0735256721890458,0.3597497393117831,0.8246345903587909,1.0,26/98,18.70%,EGFR;KCNB1;LRP1;PRKCE;EPHB2;PLS1;C2CD5;AGR2;MIEF2;AKT2;DLG1;PPP3CC;MAPK8;PDPK1;CHP1;YWHAE;SQSTM1;STAC3;YWHAQ;TFDP1;STX4;ERBB2;SPTBN1;E2F1;BID;AKT1
prerank,negative regulation of protein metabolic process (GO:0051248),0.40555728663998264,1.0734685771409718,0.3762945914844649,0.8242293837440673,1.0,15/48,24.47%,EGFR;RILP;IRAK3;MDM4;IAPP;ITGAV;SIRT2;VBP1;AZIN1;CLU;MAD2L2;LDLR;PFDN4;SNX3;ROCK1
prerank,organelle disassembly (GO:1903008),0.43627488341673015,1.0733185499212865,0.3859223300970874,0.8240485487294895,1.0,9/33,19.32%,ULK2;STX5;VCP;GBF1;UBA5;KLC1;UFL1;RB1CC1;TEX264
prerank,regulation of interleukin-13 production (GO:0032656),-0.41053490824184635,-1.0732940903819435,0.3709090909090909,0.6990211627055667,1.0,4/13,14.89%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,vasodilation (GO:0042311),-0.4063549828497838,-1.0731701471080055,0.3655913978494624,0.6974173367608439,1.0,5/13,17.49%,NOS3;KLF2;NOS1;GPER1;SOD2
prerank,maintenance of protein localization in organelle (GO:0072595),0.477242428237317,1.0730342279339555,0.3855109961190168,0.8242798568095712,1.0,9/19,28.23%,TOPORS;MORC3;HSPA5;ARL2;AKT1;HNRNPU;PINK1;TAPT1;TAF3
prerank,regulation of neuron differentiation (GO:0045664),0.3892525989640942,1.0729882551428311,0.3700534759358289,0.8238177755119879,1.0,13/76,13.02%,SIX1;ID2;ZFHX3;TIAM1;HES5;FGFR1;HEYL;IMPACT;CDK5RAP3;RHOA;NEUROD2;HEY1;NLGN1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4945047393182832,1.0729044492406206,0.391304347826087,0.8234715430709183,1.0,4/14,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,lipid transport (GO:0006869),0.37655054571483587,1.0723855034208083,0.36477987421383645,0.8244697022789464,1.0,10/97,4.74%,SLCO3A1;TNFAIP8L3;ABCD3;LBP;SLCO2A1;PITPNC1;RXRA;PRELID3B;PITPNA;PITPNM1
prerank,regulation of DNA metabolic process (GO:0051052),0.4157461971495524,1.0721051548794753,0.37528868360277134,0.8247268720748333,1.0,19/44,31.49%,HELB;TOM1L1;SMG6;SMG1;KPNA2;UBE2V2;SMARCAD1;CDT1;WDR70;USP1;KAT7;MPHOSPH8;UPF1;PARG;UBE2V1;CDK9;MPV17;IL7R;UBE2N
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3389343206635679,-1.0719673685832827,0.3333333333333333,0.6985562686187958,1.0,6/24,12.75%,DACH1;NIBAN2;BMPR2;H1-0;ACVRL1;TERF2IP
prerank,endothelial cell migration (GO:0043542),0.420183355892668,1.0716797020960491,0.38552787663107946,0.8253574332659196,1.0,10/37,12.40%,VEGFA;FSTL1;CCN3;CYP1B1;FAP;GIPC1;RHOA;LGALS8;ABL1;NRP1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.450419939523173,1.0716412886410103,0.38978829389788294,0.8248919968749687,1.0,4/24,9.33%,PID1;GFPT1;GFPT2;COQ10B
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.44559721250770445,1.071574030341106,0.3746958637469586,0.8245258075113847,1.0,7/26,15.12%,EGFR;RDX;CDK10;CDC6;ANXA1;EIF4G1;TFDP1
prerank,protein localization to membrane (GO:0072657),0.3648571669796856,1.071474613113295,0.3417593528816987,0.824207987944983,1.0,39/187,14.25%,LRP6;KCNB1;ATP1B1;GAS6;FGF13;DLG2;TTC7A;EHD1;RDX;RAB34;C2CD5;TM9SF4;RAMP2;PIGW;PACS2;DVL1;S100A10;PRAM1;RAB8A;SLMAP;ANK2;EHD2;FCHO2;JUP;DLG4;DLG1;SH3PXD2B;NRXN2;NPC1;RAMP1;RAB38;RAB3D;AP3D1;EZR;NLGN1;RAB11B;PICK1;SEC16A;TTC7B
prerank,lipoprotein transport (GO:0042953),0.5323400560991068,1.0714690940942782,0.409288824383164,0.8236508242299687,1.0,1/10,1.02%,LRP1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.4342235172768663,1.0710888943843564,0.37735849056603776,0.8241984044552839,1.0,6/27,16.72%,AK5;AK6;DTYMK;AK1;GSR;RRM2B
prerank,mRNA methylation (GO:0080009),0.49603653226143923,1.070569506284959,0.39831697054698456,0.8251517936076832,1.0,6/15,25.65%,TRMT61B;METTL16;TRMT6;TRMT61A;METTL8;METTL14
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4690810835187661,1.069298786461558,0.40657894736842104,0.8283296894703656,1.0,4/17,12.31%,KCNE5;ANK2;SNTA1;AKAP9
prerank,embryonic hemopoiesis (GO:0035162),-0.40545714306209835,-1.0690806621827236,0.36042402826855124,0.7042918640792899,1.0,6/12,12.22%,KIT;KDR;FLT3LG;SH2B3;TAL1;KITLG
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4188702551652899,1.0682878777564864,0.39010356731875717,0.830700204690855,1.0,19/37,34.68%,CHD1L;ERCC5;ERCC4;CUL4A;ERCC3;ERCC2;PARP1;RPS27A;UBC;POLD1;GTF2H4;XPA;DDB1;RBX1;ERCC1;POLK;RPA3;CUL4B;RFC4
prerank,cardiac muscle cell development (GO:0055013),-0.35890762231788287,-1.068208617132022,0.3784860557768924,0.7045777306587371,1.0,7/20,9.88%,SORBS2;SLC8A1;PDGFRB;CXADR;PDGFRA;MYH11;PDLIM5
prerank,central nervous system myelination (GO:0022010),0.5167595635856256,1.068132146372618,0.4169014084507042,0.8305657741077671,1.0,4/11,20.48%,HES5;B4GALT5;PLP1;CLU
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.43662531636349244,1.068058435488105,0.39927623642943305,0.830170344276585,1.0,8/29,16.62%,ZC3H7A;PUM1;PRKRA;HNRNPA2B1;AGO1;DGCR8;AGO2;TUT7
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3609502348030254,1.0677910677471498,0.3155778894472362,0.8303716530985128,1.0,68/259,18.93%,PKD1;NTN1;SRGAP2;FXYD5;GSN;CFAP298;EXOC4;EHD1;PMP22;PPP1R9B;ABLIM3;FGD6;PKHD1;DYNLT2B;RILP;ARMC9;BBS9;CDC14A;TMEM107;RAB8A;IFT20;GBF1;CC2D2A;EHD2;ATAT1;ARF4;PDE6D;CYFIP1;RFX2;TCTN1;IFT80;IQCB1;ABLIM2;TMEM216;ARFIP2;CCDC66;ATP6V0D1;CFAP43;PTPDC1;WDR11;EZR;NRP1;CEP164;PARVA;TRAPPC14;OCRL;BBS5;IFT46;EMP3;RAB23;FUZ;NUDCD3;CEP41;PCM1;HDAC6;PIP5K1A;IFT88;NPHP3;INPP5E;EMP1;TTLL3;LZTFL1;DYNC2I1;GOLPH3;IFT43;CCDC57;TEKT2;TMEM237
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.38174700047915017,1.067624922618132,0.38176033934252385,0.8302587144006495,1.0,11/90,9.02%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;ADIPOR2;OGT
prerank,regulation of collagen biosynthetic process (GO:0032965),0.47693087457312555,1.067591044194961,0.39564660691421255,0.8297672053625085,1.0,6/19,15.25%,EMILIN1;TGFB3;BMP4;F2R;RUNX1;IL6
prerank,neuron projection development (GO:0031175),0.3655281985963817,1.0674227187343597,0.36088709677419356,0.8296716078664685,1.0,22/168,7.83%,MYOC;DCLK1;CTNND2;SRGAP2;NEDD4;CTTN;STMND1;EHD1;ANKRD27;LRP12;EPHB2;ARC;DOCK7;PPP1R9B;DNM2;EPHB3;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;DLG4
prerank,methylguanosine-cap decapping (GO:0110156),0.5213500456451191,1.067289995074015,0.4105409153952843,0.8294861305842154,1.0,6/10,36.24%,PNRC2;PATL1;DCP1A;EDC4;DCPS;DCP1B
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4928815140256819,1.0670120285852873,0.4263456090651558,0.82968581894057,1.0,4/13,12.40%,VEGFA;SEMA3E;TGFBR2;NRP1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.40288729914458565,-1.066732199690564,0.39792387543252594,0.7066892372130401,1.0,6/13,12.41%,NOS3;CYB5B;GCH1;NOS1;DDAH2;SPR
prerank,axonal transport (GO:0098930),0.42350290618221326,1.0664908373456112,0.4105263157894737,0.8306517126882652,1.0,12/36,22.20%,DYNC1H1;RAB21;BLOC1S2;SYBU;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;DCTN1;NEFL
prerank,regulation of neuron death (GO:1901214),-0.2655822663577802,-1.0660802576243527,0.2857142857142857,0.7065107622457582,1.0,20/82,15.02%,EFNB2;WNT5A;PICALM;RRAS2;GRID2;GRIN2B;PPARGC1A;LANCL1;DCC;CSF1;CD200;EGR1;FAIM2;EPHB1;SARM1;BTBD10;CD34;C1QA;SNCA;TYROBP
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.31059142715666727,-1.0650720462215069,0.3625,0.7073958756306267,1.0,6/32,8.39%,AUTS2;OCLN;PIK3R1;ENPP2;CORO1C;CDC42
prerank,response to peptide hormone (GO:0043434),0.4141163977448685,1.064993704423718,0.38724373576309795,0.8344669763446342,1.0,7/43,9.70%,IRS1;IGFBP5;STAT5A;STAT3;MEAK7;OGT;ANXA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.45369531991801526,1.0648721526865017,0.41259640102827766,0.8342383063322691,1.0,7/22,25.11%,BRD4;HMGN1;CDK12;CCNT2;KAT7;CDK13;DDX39B
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3746530827502411,-1.0647383649315452,0.3735408560311284,0.7062922944844094,1.0,6/17,11.08%,ROCK2;CDH5;CLDN5;F11R;S1PR3;TNFRSF1A
prerank,positive regulation of gene expression (GO:0010628),0.35786036592985826,1.0646517656143974,0.299,0.8342867027470021,1.0,62/442,13.03%,THBS1;SLC38A2;EGFR;PID1;ID2;HOXA5;VEGFA;GAS6;F3;FGF2;FOXD1;IL33;GSN;SFRP4;SLC24A3;DDX5;EMILIN1;NTRK3;FGF17;DRD1;RDX;EPHB2;C1QTNF1;TWIST1;SAMD4A;GLMN;STAT3;CD3E;ATF4;RAMP2;AGR2;TENT4B;PRKDC;FAM98A;NFE2L2;ANK2;SOX9;NOG;DGKQ;SF3B1;MAPK8;BMP4;CRTAM;TMEM119;FAM98B;MUSK;UBR5;AGO1;NIBAN1;ATM;MAZ;FUBP1;SOD1;HEY1;EZR;KAT2A;PIK3CB;TGFBR1;SERPINB9;AGO2;SMO;INHBA
prerank,macrophage activation (GO:0042116),0.423888083615992,1.064586453591277,0.3872901678657074,0.8338917120216186,1.0,2/34,1.06%,FOXP1;LBP
prerank,leukotriene metabolic process (GO:0006691),0.4611099568121494,1.0644578034364942,0.39765319426336376,0.8337194720389686,1.0,3/19,9.99%,PLA2G4A;ABCC1;PLA2G5
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5330985178106391,1.0642824354291163,0.4192139737991266,0.833664739538333,1.0,2/10,7.90%,GFPT1;GFPT2
prerank,regulation of protein autophosphorylation (GO:0031952),0.4211812425339756,1.0640215039797152,0.3919239904988123,0.8338576291046417,1.0,9/36,16.85%,RASSF2;VEGFA;CALM2;TOM1L1;IMPACT;RAD50;CHP1;PPP2R5C;CALM3
prerank,mitochondrion localization (GO:0051646),0.46770143991281643,1.0636875153643512,0.4191374663072776,0.834225559462206,1.0,7/19,23.26%,MARK1;TLE6;MEF2A;MUL1;LRRK2;MFN1;MTM1
prerank,DNA repair (GO:0006281),0.3585382431737233,1.0633457093544922,0.3153153153153153,0.8346289846437988,1.0,122/284,33.49%,PARP3;CHD1L;UBE2B;TRIM28;MPG;POLE2;FTO;VCP;ERCC8;PRKDC;RMI2;INTS3;TRRAP;KMT5C;HUWE1;ERCC5;FAAP20;RBBP8;ERCC4;RAD1;OGG1;MAPK8;WRN;ABL1;WDR48;TDG;KPNA2;ATM;USP45;CHEK2;PMS2;TDP1;KDM4A;ERCC3;RAD50;CSNK1E;LIG4;ALKBH1;ERCC2;SMUG1;PIAS4;DCLRE1B;MMS19;FANCE;ATRIP;UBE2V2;FAAP24;PARP1;RPS27A;UBC;HUS1;APBB1;SUMO1;POLB;SLC30A9;MEN1;ACTR8;RAD51;USP1;TEX264;TNKS1BP1;TRAIP;FANCG;BRCC3;XRCC3;MAD2L2;APEX2;ENDOV;UPF1;USP47;TOPBP1;SETD2;PDS5A;UVRAG;PRIMPOL;ALKBH3;SMC1A;TP53;RECQL5;POLD1;GTF2H4;SLX4;XPA;PARP4;ZRANB3;FBH1;RPAIN;NOP53;PNKP;ADPRS;UBE2V1;SETX;DDB1;ATR;SMARCAL1;IGHMBP2;MBD4;RAD52;PDS5B;TIMELESS;RAD17;RHNO1;HINFP;TDP2;UBE2A;MSH2;UBE2N;MTA1;BLM;XRCC1;ERCC1;RAD23B;ERCC6;HERC2;CHRNA4;POLK;POLQ;RPA3;VCPIP1;ALKBH5;CUL4B;FANCA
prerank,actin-myosin filament sliding (GO:0033275),-0.3109242552590833,-1.0625422946910932,0.34782608695652173,0.708222762084146,1.0,8/38,11.62%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,muscle filament sliding (GO:0030049),-0.3109242552590833,-1.0625422946910932,0.34782608695652173,0.708222762084146,1.0,8/38,11.62%,ACTN2;TPM1;MYL6;TMOD1;DES;TPM3;VIM;TPM2
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3948813426819016,1.0624144177617894,0.3949394939493949,0.8368551605806495,1.0,20/62,23.44%,THBS1;HOXA5;KMT2C;HOXA9;AGO1;WDR5;HDAC1;KMT2D;RUNX1;EIF6;NFE2;CREBBP;KMT2B;SETD1A;CBFB;DPY30;PAF1;KMT2A;PRMT1;KAT2B
prerank,vascular process in circulatory system (GO:0003018),-0.3972524398919148,-1.0623489472488192,0.3665480427046263,0.7049454021791931,1.0,6/13,11.99%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.3972524398919148,-1.0623489472488192,0.3665480427046263,0.7049454021791931,1.0,6/13,11.99%,ROCK2;NOS3;ACE;AGTR1;NPR1;ACE2
prerank,defense response to virus (GO:0051607),-0.25810645713427705,-1.0622739574797133,0.28205128205128205,0.7032625377586738,1.0,27/100,18.43%,SERINC3;BCL2;BCL2L1;IFNAR2;STAT1;AGBL4;ABCC9;SAMHD1;IFITM1;NLRC5;BST2;IFIT3;IFIT2;RNASEL;IFIT1;PQBP1;CD40;RSAD2;IFITM3;OAS2;IFI27;MLKL;SERINC5;PYCARD;MYD88;PHB2;ZBP1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.44850458047116687,1.0621935823836761,0.40648379052369077,0.8369305114967722,1.0,3/23,5.17%,GPC3;GLIS2;VCP
prerank,phospholipid dephosphorylation (GO:0046839),0.41822732327926965,1.0621335261275544,0.41920374707259955,0.8365220592279845,1.0,9/37,13.08%,PLPP3;PLPP5;PLPP1;MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL
prerank,regulation of cellular respiration (GO:0043457),0.4595563898785146,1.061722590834896,0.4,0.8371382126098357,1.0,7/17,20.97%,ACTN3;VCP;IFNLR1;NOA1;IDE;SHMT2;IL4
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3659679735640941,1.0616299458842362,0.3522842639593909,0.8368260983045253,1.0,24/142,15.84%,ESR1;CACNA1C;CMKLR1;SLC35G1;PLCE1;PROK2;TAC4;C1QTNF1;EDNRA;ADCY8;HMGB1;FPR3;DLG4;IAPP;ACKR4;TRPM4;ABL1;BCAP31;GLP1R;F2R;YWHAE;PTGDR;CALB2;CXCR4
prerank,epiboly involved in wound healing (GO:0090505),0.4742466149980161,1.0613362771119568,0.3949930458970793,0.8370702030100905,1.0,4/16,17.44%,TMEFF2;RHOA;DDR1;CD151
prerank,sulfur amino acid metabolic process (GO:0000096),0.44648921581601386,1.0613310948211658,0.4049689440993789,0.8365036070956636,1.0,4/24,7.73%,GCLC;MPST;NOX4;MTRR
prerank,positive regulation of cartilage development (GO:0061036),0.4831386691408622,1.0613003519837985,0.40498034076015726,0.8360052788737282,1.0,4/17,9.70%,PKDCC;BMP1;SOX9;BMP4
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5046690850539437,1.0612925095713317,0.41168289290681503,0.8354429556175837,1.0,3/13,11.27%,DDX5;SPRED2;ATM
prerank,cellular response to starvation (GO:0009267),0.36485355070217834,1.0609860122010661,0.3800813008130081,0.8357519809864351,1.0,52/147,26.40%,NPRL3;ATP6V1C2;SEC13;MAP3K5;GCN1;SESN3;TCIRG1;ATF4;LAMTOR1;SEH1L;WIPI2;DAP;CLEC16A;IMPACT;CASTOR2;MAPK8;WRN;SREBF1;FADS1;ATP6V0D1;HSPA5;SESN2;ATP6V1B2;USP33;PICK1;ATP6V1E1;VPS41;FOXO3;FLCN;SIK2;PRKAG1;AOC1;ATF2;KLF10;KPTN;ATP6V1C1;RHEB;EIF2AK4;EIF2S1;LAMP2;LRRK2;HNRNPA1;EIF2AK3;RPTOR;NPRL2;ATP6V0E1;TP53;ATP6V0B;STK24;LAMTOR2;NIM1K;EHMT2
prerank,sodium ion transmembrane transport (GO:0035725),0.3854714566055023,1.060976618437944,0.3925133689839572,0.8352009170528499,1.0,13/84,9.01%,SLC4A4;ATP1B1;SLC12A2;SLC24A3;SLC5A2;HCN4;SLC4A8;SLC9A4;SCN11A;SLC9A1;SLC6A2;TRPM4;SLC6A7
prerank,cellular response to glucagon stimulus (GO:0071377),-0.38090136047655165,-1.060956749898046,0.3686274509803922,0.7048449626421032,1.0,6/17,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,regulation of apoptotic process (GO:0042981),0.3526687395455049,1.060704097505636,0.251,0.8354210978514424,1.0,165/676,20.48%,THBS1;SLIT2;RASSF2;EGFR;HOXA5;VEGFA;FSTL1;GAS6;SFRP4;GCLC;TIAM1;GADD45G;CARD14;PROK2;NTRK1;SMAD6;PRR7;TIAM2;FBXO10;UNC13B;VAV2;COMP;TGFB3;NOL3;SHC1;GAS1;CYP1B1;TOPORS;MAP3K5;PKHD1;CRADD;SIX4;CD3E;ANXA4;ATF4;ERC1;ACTN3;BAG3;TAX1BP1;HYPK;VCP;DNM2;FXN;CCAR2;GLO1;PRKDC;ADAM10;HMGB1;ANGPTL4;ING3;RAF1;SOX9;ARF4;NDRG1;IKZF3;ERCC5;PA2G4;SRA1;IAPP;CBL;SOCS2;AKT2;AKT1S1;KALRN;RBM25;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;WRN;ITCH;FOXA1;ING5;ANP32B;MADD;VIP;RIPK3;ABL1;IRAK1;RBM5;LCMT1;BCL2L2;ATM;AIFM1;NAA16;SOD1;PHIP;TNFRSF10B;HSPA5;CD27;ERCC3;CIDEA;MIEN1;SERPINB9;HDAC1;PDCD2;VTCN1;HSPD1;LRP2;MAP3K10;CASP1;SUPV3L1;SOS2;USP36;SQSTM1;ARHGEF1;DAB2;PRDX3;HNRNPK;RHOB;SCIN;CAT;AKAP13;PSEN2;HGF;IL6;SOS1;ING4;TOMM70;LATS2;FOXO3;PLSCR3;NSMF;CREBBP;TRIO;AATF;HIP1;RPS27A;UBC;HIGD1A;APBB1;NF1;PERP;NGEF;BIRC6;FLCN;MAGED1;PRLR;IER3IP1;CITED2;DAPK3;ARAF;GOLPH3;BNIP1;E2F1;BID;RYBP;CLN3;BIRC5;AKT1;GDNF;DNAJA1;PRDX2;QRICH1;IRF3;NFKBIA;STEAP3;TAF9B;CDK5;ATF6;RTKN;CALR;TNFSF18;CLU
prerank,regulation of signal transduction (GO:0009966),0.3607006297714996,1.0606359234847214,0.35577889447236183,0.8350494426249071,1.0,52/190,21.70%,ESR1;MGLL;IGFBP5;PLCE1;RSPO3;UBASH3B;MDFIC;GAS1;ELF1;WWTR1;CD3E;TCF7L1;ACVR1;ILK;SULF1;LLGL1;SOCS2;CASTOR2;DGKQ;FOXL1;OGT;ZIC1;SHARPIN;RORA;FGFR2;IRAK1;GIT1;AXIN1;GRK6;WDR11;NCLN;PTPN2;CD80;SRMS;RUNX1;USP33;FUZ;GSKIP;CREBBP;SIK2;IGFBP6;GDNF;DHRS3;TMEM237;ZFAND2B;CRK;CBFB;CLU;GRK4;NUP62;LRRK2;MTCH1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5145778791962833,1.0604569880223884,0.39917127071823205,0.8349868914303841,1.0,4/10,16.62%,DIS3L2;RPS27A;UBC;TUT7
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.40638240768769396,1.060167464953903,0.3915525114155251,0.8352485672281985,1.0,23/48,33.07%,ZMIZ1;ELOF1;SERTAD2;SF3B1;KAT2A;ZMIZ2;POLR2F;HMGA1;ATAD2B;POLR1G;POLR1C;TAF1C;TBP;KAT2B;POLR2H;ARID1A;SPHK2;TAF1D;POLR2L;TAF1B;ERCC6;POLR2K;TAF1A
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5277813917266803,1.0597175245897972,0.4051724137931034,0.8359420014440292,1.0,6/10,31.55%,NFE2L2;LRRK2;PYCR1;RIPK1;GPR37;GPR37L1
prerank,negative regulation of cell cycle process (GO:0010948),0.3907653803805617,1.0590766535276277,0.40863787375415284,0.837205225186014,1.0,27/61,32.08%,TOM1L1;EHMT1;RBBP8;BMP4;PHC3;RNF2;ZFYVE19;RBBP7;RING1;L3MBTL2;TFDP1;CBX5;PCGF2;E2F1;RYBP;RAD51;MAX;PPP1R10;CHMP2A;CCP110;EHMT2;E2F8;WAPL;FOXO4;SUZ12;CHMP4C;MGA
prerank,dorsal/ventral pattern formation (GO:0009953),0.4572594116589419,1.0588062955138335,0.41309823677581864,0.8373820880384958,1.0,7/20,19.61%,GLI2;ACVR1;NOG;BMPR1A;NBL1;MDFI;AIDA
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.45961791968923255,1.0587148213051778,0.41590612777053454,0.8370748575489678,1.0,8/21,28.13%,TWIST1;MED13;SRF;MED14;MED12;BCLAF1;MED24;SETX
prerank,striated muscle tissue development (GO:0014706),0.4287678747325638,1.0580785675216293,0.39298669891172916,0.8383688495281234,1.0,3/29,4.18%,SIX1;SGCD;SIX4
prerank,cellular response to acid chemical (GO:0071229),0.4255510825754756,1.058067473388929,0.4024691358024691,0.8378259125517359,1.0,6/27,15.93%,VEGFA;IPO5;LAMTOR1;CAPN2;SESN2;NSMF
prerank,positive regulation of stem cell proliferation (GO:2000648),0.46976248080063143,1.0579253739583756,0.41688311688311686,0.8376526814553528,1.0,5/17,23.74%,LTBP3;TERT;PDCD2;KAT7;HNRNPU
prerank,regulation of proteolysis (GO:0030162),0.39844866888613195,1.0579177556665806,0.39211136890951276,0.8371021188360301,1.0,21/48,28.94%,CST3;OGT;ITCH;TRAF3;SERPINE2;TBC1D10A;CAMK2N1;STUB1;HDAC6;PERP;IST1;CLN3;AKT1;CDK5;CYFIP2;BAD;DNAJC1;HDAC2;PLAUR;SPOPL;BTRC
prerank,keratan sulfate metabolic process (GO:0042339),0.42551593851066083,1.057871481300256,0.39434889434889436,0.8366592372096905,1.0,9/31,18.01%,ST3GAL4;B3GNT7;B4GALT1;ST3GAL2;B4GALT5;HEXA;B4GAT1;CHST5;GLB1
prerank,regulation of axon extension (GO:0030516),0.4178424271835206,1.0573140739983367,0.40665873959571935,0.8376931825108721,1.0,6/37,10.59%,NTN1;CTTN;PTPRS;DNM2;GOLGA4;ABL1
prerank,regulation of insulin secretion (GO:0050796),0.373432713412151,1.057212074202203,0.39125910509885536,0.8374565831154568,1.0,11/101,7.97%,IRS1;CACNA1C;EFNA5;KCNB1;TCF7L2;CCN3;LRP5;PRKCA;MCU;AACS;CAPN10
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5196930788932995,1.0565126255339619,0.42075736325385693,0.8389473485829544,1.0,5/12,13.64%,NEDD4;BMP4;KHDRBS1;UHMK1;RBM4
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.46778531312394384,1.0560334911746712,0.40664961636828645,0.8397765697252986,1.0,7/18,24.29%,MORC3;SKI;MED25;NF1;PEX2;B4GALT7;TP53
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.43543827284491365,1.055893799171448,0.4161640530759952,0.8396075863910882,1.0,7/28,21.23%,EGFR;MMP14;WWP2;HEY1;ARRB1;AKT1;RITA1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3212391548693685,-1.0558764429138912,0.35,0.7166968708249347,1.0,8/29,12.94%,IFNAR2;WNT5A;SAMHD1;USP18;NLRC5;RNASEL;CACTIN;PTPN1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.3269173170428254,-1.055741193356701,0.34946236559139787,0.71516684517718,1.0,13/28,17.63%,PRKAA2;PRKAG2;MITF;ADIPOR1;FGFR4;CX3CR1;SIRT1;NR1H4;SIRPA;AVIL;C3;NOS1AP;CD47
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3355754420145709,-1.0557227766051673,0.3925233644859813,0.7133207874518929,1.0,4/23,7.11%,PARP14;STAT1;NR1H3;NLRC5
prerank,central nervous system development (GO:0007417),0.3588073569373088,1.0556896679150758,0.35835835835835833,0.8396348563992393,1.0,36/250,13.47%,DCLK1;SLC23A1;WWP1;PKD1;ZFHX3;ECRG4;PBX3;NFIB;GSN;VIT;ADGRL2;GLIS2;HES5;STAT3;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;SOX9;S100B;CDK5RAP3;HAPLN4;ZIC1;SYNJ1;ZIC4;ATN1;PHF8;POU6F1;SMO;LIG4;PAFAH1B2;NPAS1;ALDH3A2
prerank,regulation of T cell cytokine production (GO:0002724),0.4826869403776146,1.0549047320313805,0.4279661016949153,0.8412637734363101,1.0,4/15,11.75%,TNFRSF1B;FZD5;TRPM4;SMAD7
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.453508262420058,1.0547136689294554,0.41792929292929293,0.8412573657712177,1.0,13/21,33.16%,RAB34;ARMC9;TEDC1;EVC;PDCL;SMO;UCHL5;TXNDC15;DLG5;TUBD1;GLI1;ULK3;GAS8
prerank,defense response to bacterium (GO:0042742),0.3682130713478948,1.054670973040091,0.39747634069400634,0.8408082769033149,1.0,10/105,9.28%,PRKCD;LBP;SPN;SHC1;RNASE7;MAVS;RNASE3;GBP6;FCER1G;RNASE6
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.36590400508233356,1.054249323676114,0.39161554192229037,0.8414556245287657,1.0,27/124,15.43%,MYOC;NEDD4;CTTN;STMND1;EHD1;LRP12;LIMA1;DOCK7;PPP1R9B;MNS1;ODF2;BLOC1S2;HMGB1;GPRIN1;TBC1D23;TBC1D24;CYFIP1;ARFIP2;UHMK1;NLGN1;BLOC1S3;MANF;TTC17;MARK4;PLP1;IL6;MICALL2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.4493560170974643,1.0540209831800647,0.4167741935483871,0.8415450882106476,1.0,13/22,36.51%,PSMA8;NFE2L2;PSMA4;PSMA6;PSMA3;PSMB1;PSMA5;PSMA7;PSMA1;PSMB2;PSMB4;PSMB10;PSME4
prerank,maturation of SSU-rRNA (GO:0030490),0.42332018973540875,1.0539786228895789,0.42193087008343266,0.8410940165839215,1.0,12/34,24.72%,HELB;TSR1;SRFBP1;WDR3;RIOK1;DCAF13;TSR2;NOB1;TSR3;NGDN;WDR46;RIOK2
prerank,polarized epithelial cell differentiation (GO:0030859),0.4912713920272854,1.0535234393074877,0.42955801104972374,0.8418330109667505,1.0,4/13,12.28%,RHOA;SYNE4;MYO9A;EZR
prerank,mitotic spindle organization (GO:0007052),0.3629629877627846,1.053507312782177,0.3971631205673759,0.8413101734172284,1.0,37/153,21.34%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;MISP;VCP;WDR62;SEH1L;CENPC;MAD1L1;SMC3;RHOA;DCTN2;SPAST;CENPT;CKAP5;INTS13;RCC1;CHEK2;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;RANBP2;NDEL1;RMDN1;CDC20;BIRC5;DYNC1I2;DLGAP5;STAG1;CCDC61;ARHGEF10;SBDS
prerank,regulation of wound healing (GO:0061041),0.40692273011381713,1.0534448663874805,0.4009163802978236,0.8409248956113284,1.0,4/42,2.85%,SRSF6;FGF2;PRKCE;EPHB2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4094601704710472,1.0533205753637218,0.4002333722287048,0.8407024982842737,1.0,17/40,31.69%,TONSL;WRN;RAD51;TRAIP;DONSON;PRIMPOL;BOD1L1;POLD1;ZRANB3;FBH1;RTEL1;CDK9;ATR;SMARCAL1;DDX11;TIMELESS;BLM
prerank,positive regulation of cell motility (GO:2000147),0.35762920063933734,1.0532032769004667,0.3591549295774648,0.8404447206018957,1.0,24/205,7.57%,THBS1;MYOC;EGFR;NTN1;VEGFA;F3;ADAM9;COL1A1;TWIST2;TIAM1;NTRK3;DRD1;RDX;EPHB2;TWIST1;STAT3;SEMA3E;PRKCA;ACVR1;ADAM10;MMP14;SEMA4B;CXCL16;ELP5
prerank,phospholipid biosynthetic process (GO:0008654),0.4132445436472941,1.052954090413018,0.41705607476635514,0.8405808659670907,1.0,16/36,30.73%,DHDDS;LPCAT1;DOLPP1;FADS1;FAR1;HDHD5;PIP5K1A;AGPAT5;CLN3;MBOAT1;FITM2;PCYT2;SPHK2;AGPAT3;SGMS2;SRD5A3
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4231642785262356,1.0528948209140907,0.39952153110047844,0.8401769525593938,1.0,8/31,22.41%,CYP19A1;LIAS;NFS1;FDXR;LSS;PRLR;NOXRED1;PYCR1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.517053436986008,1.0528933931453508,0.41605839416058393,0.8396143518208962,1.0,6/10,26.02%,EMC2;EMC9;EMC1;EMC8;EMC4;MMGT1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.38468972679266555,1.0528668125192253,0.3965702036441586,0.8391324087084658,1.0,40/72,34.68%,ERCC8;GPS1;ERCC5;HMGN1;ERCC4;CUL4A;ERCC3;XAB2;USP7;ERCC2;POLR2F;ISY1;RPS27A;UBC;AQR;COPS4;POLR2B;COPS7A;UVSSA;POLD1;GTF2H4;POLR2H;COPS3;XPA;DDB1;POLR2I;RBX1;POLR2L;COPS5;XRCC1;ERCC1;ERCC6;POLR2K;POLK;RPA3;CUL4B;CCNH;COPS2;COPS7B;RFC4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5161087272705686,1.052709542384884,0.41874084919472915,0.839000686871587,1.0,1/10,0.64%,BMP1
prerank,sulfur amino acid catabolic process (GO:0000098),0.5243108704721364,1.0522925013509605,0.42377622377622376,0.839627489472398,1.0,2/10,7.73%,MPST;MTRR
prerank,negative regulation of response to stimulus (GO:0048585),0.392791696526594,1.0522383420558632,0.4017857142857143,0.8392108367583188,1.0,9/60,11.07%,SLIT2;COL3A1;UBASH3B;VPS13C;TWIST1;ACVR1;DDAH1;LPCAT3;TERT
prerank,superoxide metabolic process (GO:0006801),0.42706996129655406,1.0520334830528568,0.41566265060240964,0.8392105711698273,1.0,4/29,11.85%,SH3PXD2A;NOX4;SH3PXD2B;SOD1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.37191548348491976,1.0520061859995626,0.3909378292939937,0.8387412266369918,1.0,32/88,28.90%,IGFBP5;SAMD4A;RIC1;CST3;CDK5RAP3;ILF3;RGP1;NELL1;SERPINE2;RBM4;CAMK2N1;CNOT8;HDAC6;CNOT10;EPRS1;DAPK3;CLN3;CNOT9;SHMT1;AKT1;SYNCRIP;CDK5;CALR;FXR2;EIF2AK3;YBX1;DNAJC1;MRPL13;RIDA;FXR1;LARP1;ATRAID
prerank,hippo signaling (GO:0035329),-0.3273373965662981,-1.0518830149102547,0.319047619047619,0.7212230474986521,1.0,3/26,4.47%,TJP1;TEAD4;AMOTL2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.49384844223657026,1.051817098019877,0.4198047419804742,0.8387091790366492,1.0,5/13,19.78%,EDEM2;BCAP31;YOD1;ERLEC1;UBE2G2
prerank,negative regulation of cartilage development (GO:0061037),0.4921806004003793,1.0517980343073623,0.44505494505494503,0.8382047156887694,1.0,3/13,12.61%,WNT9A;SOX9;TGFBR1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3818066943986119,1.0517141530994105,0.39672131147540984,0.837878566946784,1.0,14/72,13.07%,MYOC;FGF2;NEDD4;NTRK3;NTRK1;FSHR;TGFB2;FGFR1;SOX9;CBL;ROR1;MAZ;PIK3CB;F2R
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.42732236099598053,1.0514619989386114,0.4231227651966627,0.8380393627080034,1.0,9/32,19.84%,ID2;BRD4;ESRRB;CDC6;CDC45;TFDP1;CDT1;E2F1;CDK5
prerank,regulation of fat cell differentiation (GO:0045598),0.38593432288394136,1.0514326815166135,0.4228694714131607,0.8375623723148861,1.0,19/74,18.70%,CMKLR1;ID2;ZFPM2;LRP5;WWTR1;FTO;CARM1;TRPM4;RORA;SYAP1;WDFY2;IL6;SIRT2;CREB1;TRIO;ANKRD26;E2F1;CDS1;AKT1
prerank,regulation of macrophage migration (GO:1905521),0.5250587271214169,1.0513558620170795,0.43191800878477304,0.83720865103409,1.0,2/10,10.12%,EMILIN1;MTUS1
prerank,positive regulation of cell population proliferation (GO:0008284),0.3508311594310168,1.051097161743202,0.34,0.8373802286696557,1.0,89/423,18.74%,THBS1;PGF;EGFR;IRS1;FOXP1;PID1;ID2;ZFPM2;VEGFA;GAS6;DDR2;FGF2;TCF7L2;TIAM1;ACER3;NTRK3;PROK2;FGF17;GAB2;LRP5;MAPK15;TGFB3;SHC1;HDAC4;PKHD1;WWTR1;HES5;CSNK2A1;TGFB2;TCIRG1;DNAJA2;FXN;FAM98A;ADAM10;IL12RB2;TGFBR2;FGFR1;MEIS3;SOX9;RARA;S100B;AKT2;TRPM4;EDN3;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;CDC123;TMEM119;FAM98B;VIP;FOXM1;CTF1;CHTOP;TERT;BMPR1A;MAZ;PHIP;TGFBR1;HDAC1;LIG4;F2R;KMT2D;NACC1;BMP5;CLCF1;PRDX3;STX4;IL6;MAP3K3;SLC35F6;CNOT8;ERBB2;FGF5;CCN4;SSR1;GAREM1;UFL1;PRLR;HMOX1;E2F1;KIF20B;BIRC5;SAAL1;AKT1;OSMR;GDNF
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.28474454021775103,-1.0509085268710265,0.36363636363636365,0.721885656327654,1.0,10/47,10.39%,GRM5;APOE;APP;WDR91;NR1H3;AGTR1;CSF1;EDNRB;EDN1;MTPN
prerank,regulation of cytoskeleton organization (GO:0051493),0.3689664430539811,1.0508881300687876,0.4096133751306165,0.8374257827974824,1.0,18/108,13.08%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;PHLDB1;SORBS3;CLIC4;ARHGAP17;CDK10;CAPN2;RHOA;PAK2;ABL1;KATNBL1;EZR;ARHGAP44
prerank,cellular macromolecule catabolic process (GO:0044265),0.4022641669195046,1.05079640818156,0.4075342465753425,0.8371054536057709,1.0,22/49,28.41%,SIDT2;PPP1R8;RNASE3;RNASE6;CHEK2;SUPV3L1;SND1;NGLY1;FBXO17;IDE;NCBP1;DFFB;UBE2G2;MTREX;PABPC4;OGA;ADAMTS9;HTRA2;RIPK1;DNASE1L2;MANBA;STT3B
prerank,calcium ion transport into cytosol (GO:0060402),-0.3486082655835383,-1.050701455882512,0.3524229074889868,0.7205590596233769,1.0,10/21,14.19%,SLC8A1;RYR2;CACNA2D1;ITPR3;GRIN2B;GRIN2A;ADRA1A;JPH1;JPH2;GRIN1
prerank,positive regulation of kinase activity (GO:0033674),0.36676780596705066,1.0506001144225146,0.4106029106029106,0.8371311898027193,1.0,20/107,13.18%,RASSF2;EGFR;GAS6;DDR2;NTRK3;NTRK1;EPHB2;CAMKK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;TAB2;LMO4;SNX9;DDR1;RAD50;MAPRE3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.46888011768184984,1.0503977638848996,0.41845764854614415,0.837170840755435,1.0,9/19,29.91%,CSNK2A2;FZD5;SREBF1;USP36;HDAC6;PINK1;HTRA2;SREBF2;PRKN
prerank,protein ubiquitination (GO:0016567),0.34930197018344744,1.0502250674435685,0.327,0.8371128601286726,1.0,179/471,30.24%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXL7;PSMD7;FBXW8;TOPORS;CDC16;UBE2B;VCP;RNF182;DTX3;LRSAM1;PSMA8;UBE2R2;ERCC8;NFX1;PRKDC;KLHL7;UBE3C;NFE2L2;RNF115;TRIM41;PEX5;TRPC4AP;HUWE1;TRIM27;SYVN1;CBL;RBBP6;LZTR1;WWP2;PEX13;PSMA4;ITCH;CUL4A;FBXO25;UCHL3;FBXL4;RNF114;UBR5;RNF25;UBE2C;FBXO22;NEUROD2;RNF14;FBXL12;SDE2;ATG3;PSMD12;MYLIP;CUL1;FBXL19;RNF38;PSMA6;DTX2;PEX10;USP7;RNF103-CHMP3;TRIM26;TNKS2;FBXL14;RNF11;LNPEP;PSMD1;DDA1;UBE2L6;ARRB1;FBXO17;STUB1;FBXL20;PSMC5;PSMD11;KLHL22;UBE2V2;PSMC4;PSMD14;RPS27A;UBC;OTULIN;RC3H2;BIRC6;TRIM13;VPS11;UBE4A;FBXL18;TRIM6;TPP2;UHRF2;RNF7;FBXW2;NPEPPS;UBR2;CDC27;RNF141;ASB5;MYCBP2;FBXW4;RUSC1;CBFB;UBE2G2;PCNP;TRAIP;PSMA3;TRIM47;USP5;UBOX5;SMURF2;TRIM43;MUL1;SH3RF1;RNF4;PSMB1;PEX2;PAF1;PSMD4;KCTD13;KLHL12;CUL9;AREL1;PEX14;DERL1;RNF20;PSMA5;RNF146;FBXO11;DET1;UBE2Z;PSMA7;TAF1;FBXO9;RNF122;AMFR;ANKRD9;PINK1;RCHY1;SELENOS;RNF138;RNFT1;UBE2W;RTF1;UVSSA;UBR3;RNF111;SHPRH;PSMC1;CUL7;RNF126;RNF166;FBXW10;FBH1;CAND1;PSMA1;RNF167;UBE2V1;USP22;TRIM7;DDB1;UBE4B;FBXL8;FBXO41;RBX1;BTRC;RNF135;UBE2Q2;UBR1;TRIM39;KLHL9;VPS18;PRKN;UBE2H;BLMH;TRIP12;ANAPC11;UBE2S;PSMD2;CTNNB1
prerank,renal water homeostasis (GO:0003091),-0.34338340508302717,-1.0498132398534894,0.3466666666666667,0.7210649163185026,1.0,6/23,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,anion transmembrane transport (GO:0098656),0.38462739080072855,1.0497900593131333,0.4039301310043668,0.8377382155341478,1.0,6/67,5.41%,SLC23A1;SLC23A2;SLC5A6;ABCC1;SFXN3;LRRC8D
prerank,regulation of feeding behavior (GO:0060259),-0.4132144493398562,-1.0496188942378293,0.4117647058823529,0.7196887423323469,1.0,2/11,2.51%,LEPR;SGIP1
prerank,negative regulation of interferon-gamma production (GO:0032689),0.4414973490871106,1.049441758298888,0.4221938775510204,0.8381154700045671,1.0,4/23,13.03%,GAS6;HMGB1;RARA;INHBA
prerank,positive regulation of protein metabolic process (GO:0051247),0.3677692074527572,1.049374699876881,0.41286307053941906,0.8377336886237962,1.0,32/110,23.28%,WWP1;GPC3;NEDD4;LDB1;STX5;CSNK2A1;RILP;VCP;DACT1;HUWE1;WWP2;NSF;MAPK8;ITCH;VIP;AXIN1;EIF4G1;INHBA;CD80;SEC22B;IDE;AKT1;ASB5;NFKBIA;CLU;SMURF2;RAB1A;AREL1;SLC25A37;RAB1B;PRMT1;ABCB10
prerank,positive regulation of ruffle assembly (GO:1900029),0.49583275278918537,1.0493600102129714,0.41440217391304346,0.8372153742479244,1.0,5/13,14.67%,EPS8L1;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,organonitrogen compound catabolic process (GO:1901565),0.39020085086748296,1.048868370204083,0.4076147816349384,0.8380288757151542,1.0,15/57,19.40%,PLA2G4A;PDXDC1;LRSAM1;MPST;CPQ;GNPDA1;PLA2G5;UCHL3;LNPEP;IDE;PLA2G15;RENBP;BCKDK;NPEPPS;LVRN
prerank,regulation of necroptotic process (GO:0060544),0.44833939691914093,1.048862592199102,0.42385786802030456,0.8374879135967165,1.0,10/23,30.57%,YBX3;OGT;RIPK3;STUB1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,metal ion homeostasis (GO:0055065),0.4110870155665691,1.0486207715823799,0.4066820276497696,0.8376156528785195,1.0,8/40,14.77%,SLC12A7;SLC12A2;CNNM2;SLC12A4;SELENON;SCNN1A;LETM1;CYP27B1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3818901265915001,-1.048445289319848,0.3709677419354839,0.720861604166261,1.0,3/16,3.71%,SOX5;PTN;SOX6
prerank,recombinational repair (GO:0000725),0.37505500336739755,1.0484311620637634,0.4146079484425349,0.8375933398228855,1.0,40/77,35.51%,REV3L;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SPIDR;SWI5;SFPQ;RAD50;PARP1;PSMD14;HUS1;SMC5;RAD51;XRCC3;RNF138;RECQL5;SMC6;SLX4;YY1;FBH1;SWSAP1;NSMCE2;RAD52;RHNO1;AP5Z1;UBE2N;ZFYVE26;BLM;XRCC1;POLQ;RPA3;MMS22L;FAN1;MRE11;NSMCE1;SEM1
prerank,synaptic vesicle localization (GO:0097479),0.4883518412265386,1.048284516724016,0.4194915254237288,0.8374371090746945,1.0,5/13,19.84%,DNM2;SYNJ1;NLGN1;SNAPIN;CDK5
prerank,double-strand break repair via homologous recombination (GO:0000724),0.3683596624435187,1.0482103563965819,0.40818467995802726,0.8370740332969983,1.0,41/95,32.95%,REV3L;MCMDC2;TONSL;MCM2;ERCC5;MORF4L1;RBBP8;ERCC4;SFR1;WRN;SPIDR;SWI5;SFPQ;RAD50;CDC45;GINS4;PARP1;PSMD14;HUS1;MCM4;SMC5;NIPBL;RAD51;XRCC3;RNF138;RECQL5;SMC6;SLX4;MCM7;YY1;FBH1;SWSAP1;NSMCE2;RAD52;AP5Z1;UBE2N;ZFYVE26;BLM;XRCC1;POLQ;RPA3
prerank,presynapse assembly (GO:0099054),-0.3583624062143361,-1.0481365158762415,0.396,0.7198033855887082,1.0,4/16,4.80%,IL1RAPL1;WNT5A;PTPRD;BSN
prerank,N-glycan processing (GO:0006491),0.4619497014653824,1.0480825653476202,0.4453227931488801,0.836896607547321,1.0,4/18,9.51%,ST8SIA2;PRKCSH;MGAT4B;FUT8
prerank,positive regulation of interleukin-6 production (GO:0032755),0.38058088823187003,1.0480301708084967,0.4152173913043478,0.8364797121693123,1.0,12/68,15.25%,LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;C1QTNF4;HSPD1;F2R;SETD4;IL6
prerank,DNA biosynthetic process (GO:0071897),-0.37600328556031426,-1.0479172590755015,0.34959349593495936,0.7184305951434891,1.0,10/16,22.74%,PPIA;TYMS;RFC3;SIRT1;POLD2;WRNIP1;POLE;CDKN2D;POLD4;POLL
prerank,response to growth factor (GO:0070848),0.40898674994919254,1.047762580580488,0.42159090909090907,0.8366484131299237,1.0,11/41,18.70%,ACVR1B;SHC1;ACVR1;TGFBR2;URI1;BMPR1A;TGFBR1;LRP2;HDAC6;ERBB2;AKT1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5088465179330318,1.0475380957358342,0.45241379310344826,0.8367379720949939,1.0,5/11,12.61%,TGFB2;ACVR1;TGFBR2;SMAD7;TGFBR1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5126157943651269,1.047447950937138,0.4306784660766962,0.8364567384752606,1.0,5/10,23.95%,TBX21;SMAD7;RC3H2;IL4;NFKBID
prerank,regulation of axon guidance (GO:1902667),0.5117708035192725,1.0471259083058608,0.4426705370101596,0.836797856330899,1.0,3/10,19.10%,VEGFA;NRP1;MYCBP2
prerank,regulation of macrophage differentiation (GO:0045649),0.4763445188326062,1.04674783925837,0.42396907216494845,0.8372606065362428,1.0,4/15,13.03%,ID2;PRKCA;PTPN2;INHBA
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.3913654734915364,1.0465221542911562,0.42967032967032964,0.8373619883578134,1.0,28/58,32.75%,ERCC8;PRKDC;HMGB1;ERCC4;KDM2A;ATM;RAD50;LIG4;PIAS4;DCLRE1B;UBE2V2;PSMD14;SMC5;SUMO1;POLB;XRCC6;BRCC3;UVRAG;IFFO1;ATP23;NSMCE2;SMARCAL1;ZBTB7A;UBE2N;ERCC1;ERCC6;HERC2;POLQ
prerank,ncRNA catabolic process (GO:0034661),0.42616394732272556,1.0464564716714866,0.41304347826086957,0.8369945597691413,1.0,9/28,20.93%,TENT4B;ERN2;DIS3L2;SND1;XRN1;EXOSC4;DIS3;MTREX;ZCCHC8
prerank,serine family amino acid catabolic process (GO:0009071),0.5188876759288149,1.0462964226738671,0.4446043165467626,0.836902740389054,1.0,4/10,18.59%,GCSH;SHMT2;SHMT1;DAO
prerank,negative regulation of nervous system development (GO:0051961),0.46914562842308366,1.0462124977056357,0.4404283801874163,0.8365727566529485,1.0,1/17,0.27%,SLIT1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.41020938095424087,-1.0459623015785247,0.4103448275862069,0.721528812633639,1.0,6/11,17.41%,CACNB2;CACNA2D1;SESTD1;NOS1;CACNB1;NOS1AP
prerank,glucose transmembrane transport (GO:1904659),-0.36648477903760085,-1.0457935079314966,0.3672566371681416,0.7201875973689199,1.0,4/18,6.84%,SLC2A1;SLC5A3;SORT1;PPARD
prerank,regulation of cellular localization (GO:0060341),0.39484846521467215,1.0457869171738088,0.4144960362400906,0.8371898330577404,1.0,7/46,8.05%,EFNA5;GSN;LRP5;CAMK2D;DYNC1H1;DVL1;MAD1L1
prerank,positive regulation of vascular permeability (GO:0043117),-0.417753956545688,-1.0455595853938757,0.41924398625429554,0.7189188948736656,1.0,5/12,9.54%,TJP1;OCLN;BMP6;PDE2A;ANGPT1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.515367944775194,1.044535692476922,0.43607954545454547,0.8401354788442569,1.0,1/10,3.32%,HSPA2
prerank,regulation of programmed cell death (GO:0043067),0.3575620635016131,1.0443657135942235,0.4040609137055838,0.8400339982131599,1.0,72/161,30.44%,ACER3;NTRK1;FBXO10;GAS1;CRADD;CD3E;ACTN3;VCP;RAF1;SOX9;NDRG1;IKZF3;SRA1;AKT1S1;RBM25;WRN;ANP32B;MADD;RIPK3;ABL1;LCMT1;ATM;TNFRSF10B;CIDEA;CASP1;MARK4;USP36;TOMM70;PSMC5;PLSCR3;CREBBP;HIP1;PERP;MAGED1;DAPK3;BID;BIRC5;AKT1;PRDX2;ASAH1;IRF3;STEAP3;CDK5;RTKN;CALR;CLU;NUP62;CTSB;LRRK2;HS1BP3;BIRC3;TRIAP1;FBXO11;TP53;PINK1;ANP32E;FANK1;DAXX;RIPK1;SGK1;RABGGTB;OSGIN1;NOP53;KANK2;BCL6;BCAR1;CASP2;PRKN;ZBTB7A;DFFA;CASP6;HSP90AA1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3828842938468208,1.0441731874518103,0.4154013015184382,0.8399842307595603,1.0,29/62,29.94%,ELOF1;CDK12;GTF2F1;CCNT2;ERCC3;ERCC2;POLR2F;AFF4;MLLT3;NCBP1;SSRP1;ELP4;NCBP2;PAF1;POLR2B;SETD2;NELFB;CDK13;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;NELFA;POLR2I;CDK9;MLLT1;ADRM1;POLR2L
prerank,protein phosphorylation (GO:0006468),0.34831328140498374,1.0439674054377026,0.339,0.8399880322024095,1.0,144/478,22.62%,DCLK1;EGFR;PKD1;PKDCC;PRKCD;GAS6;CIT;DDR2;ULK2;NTRK1;MARK1;PRKCE;ACVR1B;MAPK15;EPHB2;CLK3;CSNK1D;CAMK2D;MAP3K5;STRADA;TNK1;CSNK2A2;CSNK2A1;TGFB2;LIMK2;MORC3;ERC1;FASTK;PRKCA;DYRK4;NRBP2;ACVR1;EPHB3;ILK;NEK7;PRKDC;ERN2;ADAM10;TGFBR2;TLK1;STK39;ABI1;BCR;FGFR1;IRAK3;CDK10;RPS6KA4;RARA;PAK4;AKT2;DGKQ;CDK12;GMFB;PKN2;PAK2;ILF3;MAPK8;BMP4;FGFR2;CDC25B;SMG1;CSNK1G1;CHUK;MUSK;TNNI3K;RIPK3;ABL1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;MAPK12;PDPK1;GRK6;DDR1;SMAD7;NRBP1;UHMK1;CSNK1E;TGFBR1;STK25;SRMS;MAP3K10;PICK1;DMPK;MARK4;WNK1;FRK;SRPK1;TBCK;BRD2;EEF2K;MAP3K3;LATS2;CAMK4;CDC42BPB;TLK2;CREB1;COQ8B;ERBB2;TP53RK;STK16;HASPIN;MKNK2;BIRC6;SIK2;PRKAG1;DAPK3;BCKDK;CAD;VRK2;CLK2;BIRC5;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;CDK5;PRKAB1;EIF2AK4;SGK3;FGFR3;MAPK9;GRK4;PRKACA;VRK3;NEK4;ABI2;LRRK2;CSNK1G3;MAST4;JAK1;CAMK1;CDKL3;STK38;EIF2AK3;PRKCI;TOP1;FAM20A
prerank,establishment of vesicle localization (GO:0051650),0.4616039220845547,1.0438492337107117,0.43070652173913043,0.8397753461750717,1.0,6/18,19.84%,LIMK2;DNM2;SYNJ1;CCDC186;SNAPIN;CDK5
prerank,DNA conformation change (GO:0071103),0.4581903105100953,1.043798668068429,0.41546526867627787,0.8393505077687564,1.0,7/17,24.81%,HMGB1;ABL1;ERCC3;TOP3B;TOP1;TOP1MT;TOP3A
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3488050550301858,1.0437438793355736,0.37975951903807614,0.8389542271287088,1.0,77/348,18.70%,RASSF2;PGF;EGFR;GDF10;SLCO3A1;VEGFA;EFNA5;GAS6;DDR2;FGF2;CARD14;NTRK3;NTRK1;FGF17;GHR;INHBC;TGFB3;CAMKK1;DOCK7;CSNK1D;TGFB2;CSPG4;LIMK2;IL5;CALM2;MAVS;ACVR1;TOM1L1;ILK;PFN2;SMAD4;RSPO1;RAF1;SOX9;RPS6KA4;AKT2;DGKQ;ANGPT4;PAK2;BMP4;TMEM119;MUSK;ABL1;TAB2;NIBAN1;BMPR1A;AXIN1;SNX9;TENM1;AKAP9;RAD50;NRP1;TGFBR1;EIF4G1;INHBA;CD80;MAPRE3;ERP29;WDFY2;DAB2;BMP5;HGF;IL6;ARRB1;IQGAP1;HDAC6;ERBB2;FGF5;CALM3;EFNA1;FLCN;PRKAG1;ARAF;TRIM6;CNOT9;RB1CC1;AKT1
prerank,nuclear transport (GO:0051169),0.4701640239274911,1.0437112396034443,0.4315068493150685,0.8384829747894189,1.0,2/16,9.12%,XPO1;PSIP1
prerank,positive regulation of cyclase activity (GO:0031281),0.4874201684716468,1.0436334945540056,0.4320652173913043,0.8381541149768171,1.0,3/14,9.65%,CACNA1C;STIM1;MAPK8
prerank,regulation of establishment of planar polarity (GO:0090175),0.3717469260350663,1.0433526521476757,0.40768409818569906,0.8383612239358073,1.0,22/88,16.38%,TIAM1;PRICKLE1;PSMD7;PKHD1;AP2A1;PSMA8;DACT1;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD1;PSMC5;PSMD11;NPHP3;PSMC4;PSMD14
prerank,keratan sulfate biosynthetic process (GO:0018146),0.43807141444835007,1.0429912336083484,0.40359897172236503,0.8388330593106018,1.0,5/26,9.01%,ST3GAL4;B3GNT7;B4GALT1;ST3GAL2;B4GALT5
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3680379046567322,-1.0428512642320726,0.34649122807017546,0.7238848075223547,1.0,3/18,2.72%,FLT1;COL4A3;AKT3
prerank,positive regulation of dendrite development (GO:1900006),-0.429864521505318,-1.0424832770317576,0.41414141414141414,0.723098832568203,1.0,4/10,13.76%,PTN;BMP7;VLDLR;LRP8
prerank,cell-matrix adhesion (GO:0007160),0.3680493892349624,1.04243954567583,0.42555438225976766,0.8397722645420321,1.0,12/95,6.78%,PKD1;ITGA11;COL3A1;ADAM9;TIAM1;CTTN;EMILIN1;ACTN3;PPFIA1;THBS3;ILK;BCR
prerank,cellular response to calcium ion (GO:0071277),-0.26341257839558707,-1.0423749069498798,0.35294117647058826,0.7215146522483068,1.0,25/67,20.86%,ADGRV1;WNT5A;ITPKB;CPNE4;PRKAA2;ADCY1;KCNH1;RASGRP2;BRAF;PRKAA1;MCOLN1;SYT10;SYT13;SLC25A24;SYT3;SYT2;CPNE7;SYT11;SYT12;HPCA;ECT2;SYT7;SYT15;PPIF;SCN5A
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4545359757237327,1.0421761204700917,0.4266666666666667,0.8399435348854656,1.0,3/18,10.12%,SLIT2;EDN3;MTUS1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.37295177359569637,1.0421459472133825,0.4218916046758767,0.8394767212374905,1.0,30/82,26.63%,CSNK1D;DYNC1H1;SFI1;ODF2;ALMS1;DCTN2;CKAP5;SDCCAG8;AKAP9;CEP164;CSNK1E;YWHAE;CEP41;CEP63;PCM1;HAUS5;CDK2;DYNC1I2;DCTN1;PRKACA;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL;TP53;TUBB4B;CCP110;PPP2R1A;ATF5
prerank,maturation of 5.8S rRNA (GO:0000460),0.4693808388837804,1.0419756814451884,0.4316353887399464,0.8394225229183938,1.0,9/17,26.99%,C1D;PRKDC;LAS1L;EXOSC4;EIF6;MTREX;WDR12;RRP15;MAK16
prerank,myeloid leukocyte differentiation (GO:0002573),0.37688381374854074,1.0419190057495074,0.4150326797385621,0.8390252789248795,1.0,15/65,19.14%,FOXP1;VEGFA;GAB2;RXRA;GLO1;TGFBR2;RARA;SBNO2;BMP4;RUNX1;FARP2;CAMK4;PARP1;E2F1;CDK2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.35232201563581905,1.0419004647836858,0.3847695390781563,0.8385243896352446,1.0,51/234,20.48%,ESR1;LRP6;SLCO3A1;VEGFA;DDR2;CARD14;NTRK1;PLPP3;RAB7B;HDAC4;CARD16;STAT3;ERC1;MAVS;ADCY8;IRAK3;TRIM41;JUP;RPS6KA4;TRIM27;ROR1;FOXA1;CHUK;RIPK3;NFKBIB;IRAK1;TAB2;RNF25;NEUROD2;SRF;MID2;PSMA6;SMO;TRIM26;PRDX3;TFDP1;IL6;CRTC2;RPS27A;UBC;NFKB2;TRIM13;TRIM6;AKT1;ATF2;HIPK2;IKBKE;NFKBIA;TCF3;TNFSF18;CLU
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.412359158849894,-1.041603496214621,0.3888888888888889,0.7218324526752322,1.0,4/11,19.07%,EFNB2;MYOCD;GPER1;TGFB1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4028527165890589,1.0415240088581168,0.42739079102715466,0.8390062572967543,1.0,24/42,32.30%,CHD3;SMARCC2;INO80B;SPTY2D1;ACTR6;PBRM1;ZNHIT1;HDAC1;HNRNPC;VPS72;SMARCAD1;CHD8;ACTR8;CHD4;SMARCA4;SRCAP;HDAC2;ANP32E;ARID1A;SMARCD2;SMARCC1;MBD3;GATAD2B;ERCC6
prerank,cellular response to alcohol (GO:0097306),0.3999715515744027,1.041516951217502,0.41359447004608296,0.8384808318759985,1.0,14/42,20.86%,LRP6;GRAMD1A;OSBPL7;ADCY2;ADCY8;JUP;SPIDR;SMO;GRAMD1C;GOLPH3;ADCY7;RAD51;KLF9;GNB1
prerank,neurotransmitter transport (GO:0006836),0.37737917939653265,1.0411266763673244,0.4058127018299246,0.8389924507123244,1.0,9/73,9.82%,SLC38A2;SLC38A1;UNC13B;PPFIA1;DVL1;SLC6A2;SLC28A2;SYNJ1;NRXN2
prerank,megakaryocyte differentiation (GO:0030219),-0.42459132711501807,-1.0411231682719682,0.3737704918032787,0.7212105624077281,1.0,3/11,9.77%,KIT;SH2B3;TAL1
prerank,regulation of interleukin-8 production (GO:0032677),0.3793270515141938,1.0411020657104968,0.42036836403033584,0.8385135313115736,1.0,11/69,15.27%,LBP;F3;STAT3;ANXA4;MAVS;HMGB1;ANXA1;MAPKBP1;F2R;IL6;ARRB1
prerank,proton transmembrane transport (GO:1902600),-0.29344267478644087,-1.0409769043401575,0.3333333333333333,0.7197336627527161,1.0,1/36,0.01%,ATP1A2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5123171225499392,1.0409532550127931,0.4194008559201141,0.8383847531167549,1.0,2/10,3.46%,MUC1;CYP1B1
prerank,protein K48-linked deubiquitination (GO:0071108),0.4401377504399122,1.040942718934172,0.4298245614035088,0.8378720471483858,1.0,8/23,21.03%,OTUB1;USP50;OTUB2;USP34;USP33;OTUD5;YOD1;USP5
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.49003101456267434,1.0408853806945053,0.43419267299864317,0.8374823718840383,1.0,5/13,17.10%,IL33;SOAT1;RAMP1;CHP1;SLC2A10
prerank,activation of phospholipase C activity (GO:0007202),0.4166934846411357,1.0405627790683438,0.4213759213759214,0.8378462364738433,1.0,2/29,3.20%,EGFR;EDNRA
prerank,spindle assembly checkpoint signaling (GO:0071173),0.44845882696139805,1.040478776507457,0.45430809399477806,0.8364515943935894,1.0,7/20,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.44845882696139805,1.040478776507457,0.45430809399477806,0.8364515943935894,1.0,7/20,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.44845882696139805,1.040478776507457,0.45430809399477806,0.8364515943935894,1.0,7/20,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4313734366750537,1.0403801041321252,0.43309002433090027,0.8361757934926021,1.0,13/26,30.04%,ANAPC5;CDC16;CDC6;UBE2C;LCMT1;ANAPC4;CDC27;DLGAP5;CDK5RAP2;RIOK2;NEK6;NSMCE2;ANAPC11
prerank,inositol lipid-mediated signaling (GO:0048017),0.3954396584726284,1.0403024551933648,0.41816143497757846,0.8358470999627609,1.0,11/50,12.37%,IRS1;PLCE1;TNFAIP8L3;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;EZR;PIK3CB
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.4131622525183185,-1.040279458911973,0.42857142857142855,0.7197518935231447,1.0,3/10,3.54%,LYN;RAPGEF2;CXCL12
prerank,cytosolic calcium ion transport (GO:0060401),0.4206230676041425,1.0402681045075208,0.44550898203592815,0.8354220190639866,1.0,3/28,5.91%,CACNA1C;SLC35G1;MCU
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3481752826494816,1.0401438711264641,0.382,0.8352018750343085,1.0,84/390,17.48%,PGF;EGFR;IRS1;SLC39A14;VEGFA;EFNA5;DDR2;FGF2;ARHGEF28;COL1A1;TIAM1;UBASH3B;GRB10;NTRK3;RHOQ;ATP6V1C2;NTRK1;FGF17;GHR;HNRNPH1;VAV2;EPHB2;SIPA1L1;SHC1;SPRED2;RBFOX2;TNK1;STAT3;CD3E;TCIRG1;ARPC1B;CLNK;AP2A1;EPHB3;EPHB6;FOXC2;ATP6V0A1;GIGYF1;SULF1;ABI1;FGFR1;CYFIP1;CBL;SOCS2;AKT2;KALRN;RHOA;ROR1;PAK2;ZNF106;FGFR2;ITGAV;MUSK;GTF2F1;FLRT2;ATP6V0D1;GIT1;SHOC2;DDR1;PHIP;PIK3CB;NRP1;PTPN2;AP2A2;HNRNPM;ATP6V1B2;PTBP1;SRMS;TIAL1;FRK;ATP6V1E1;POLR2F;PSEN2;HGF;SOS1;SIRT2;IDE;GALNT3;ERBB2;FGF5;NCBP1;NGEF;EFNA1;PRLR
prerank,neuromuscular junction development (GO:0007528),-0.3403548516277344,-1.0401062068029376,0.36764705882352944,0.718409554419356,1.0,6/24,4.19%,UNC13C;PPFIBP1;PDZRN3;CACNB2;CACNB4;PPFIBP2
prerank,plasma membrane invagination (GO:0099024),0.42190023773908547,1.039851214948364,0.42929936305732486,0.8354692879081969,1.0,5/29,15.30%,GSN;SNX18;RHOA;SNX9;SPIRE2
prerank,heart process (GO:0003015),0.4832835797874504,1.0397576178108168,0.435933147632312,0.8351879666883896,1.0,3/14,11.85%,SGCD;NOX4;SOD1
prerank,glycoprotein metabolic process (GO:0009100),0.38993059532858076,1.0393212019822786,0.43521594684385384,0.8357946107433796,1.0,17/53,24.59%,ST3GAL4;ST8SIA2;PRKCSH;ST3GAL2;B4GALT5;MGAT4B;FUT8;GAL3ST4;NGLY1;FBXO17;B3GNT6;GOLPH3;GANAB;MAN2B1;B4GALT7;OGA;ADAMTS9
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.48428365954656327,1.0390687376943966,0.43443708609271525,0.8358930514274899,1.0,3/13,15.89%,PTGIS;NNMT;NAPRT
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.36149251020553425,1.0389554998405766,0.4117647058823529,0.8356515970194685,1.0,22/125,14.16%,XPO1;TUBG2;PPP1CC;TBCE;SEC13;DYNC1H1;WDR62;SEH1L;CENPC;MAD1L1;DCTN2;CENPT;CKAP5;INTS13;RCC1;NUP37;MIS12;RCC2;ZW10;DYNC1LI2;RANBP2;NDEL1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3586000785006429,1.0388958054995057,0.4131979695431472,0.8352668453624522,1.0,35/140,17.28%,SLIT2;RHOJ;PLCE1;SRGAP2;SRGAP3;TIAM1;ARAP1;RHOQ;TIAM2;VAV2;ARHGAP17;BCR;RHOT2;ARHGAP21;KALRN;RHOA;RHOT1;ITGAV;INPP5B;FOXM1;MYO9A;ARHGAP20;ARHGAP8;ARHGAP44;OCRL;SOS2;SQSTM1;ARHGEF1;RHOB;AKAP13;SOS1;TAGAP;TRIO;NGEF;FLCN
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.35381422511230964,1.0387667367212627,0.41289023162134947,0.8350752159301801,1.0,30/214,13.07%,BMPER;EGFR;TNFAIP8L3;GAS6;FGF2;EMILIN1;NTRK3;NTRK1;FSHR;TIMP3;EPHB2;CCL13;SHC1;SPRED2;PKHD1;CCL15;PRKCA;SMAD4;HMGB1;DLG1;ROR1;FGFR2;PLA2G5;MAP3K12;P2RY6;ARHGAP8;EZR;NRP1;PTPN2;F2R
prerank,tRNA wobble uridine modification (GO:0002098),0.47985728852142007,1.0385218432420178,0.43519781718963163,0.8352146610977333,1.0,7/14,24.88%,TRMU;CTU2;ELP1;ELP4;ALKBH8;ELP3;MTO1
prerank,positive regulation of insulin secretion (GO:0032024),0.40782354327604076,1.038188405493878,0.43508771929824563,0.8355431248901664,1.0,6/36,8.87%,TCF7L2;ADCY8;MCU;AACS;CAPN10;TRPM4
prerank,regulation of myoblast differentiation (GO:0045661),0.41528014357462717,1.0377631816848845,0.42284325637910086,0.836162103699398,1.0,5/32,9.70%,BOC;SOX9;SRA1;EID2B;BMP4
prerank,positive regulation of monooxygenase activity (GO:0032770),0.43302597016319444,1.0376587461653637,0.4503067484662577,0.8359245846232594,1.0,8/26,18.74%,NPR3;TERT;PIK3CB;S100A1;VDR;CYP27B1;AKT1;GDNF
prerank,positive regulation of protein transport (GO:0051222),0.38175962984169687,1.0376447319242572,0.44171122994652406,0.835439404599403,1.0,18/67,18.37%,ADAM9;UNC13B;TGFB3;APBB3;TGFB2;BCAS3;TENM1;EZR;CHP1;ACSL3;PCM1;APBB1;CNST;SYTL4;IER3IP1;GOLPH3;KIF20B;CLN3
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3458104778406389,-1.037481867334395,0.3786008230452675,0.723284625469251,1.0,2/20,6.20%,WNT4;C1QTNF3
prerank,cholesterol homeostasis (GO:0042632),0.3785549945810531,1.0372858530421063,0.432967032967033,0.835883164157009,1.0,12/64,13.71%,EHD1;LRP5;LIMA1;HDAC9;SOAT1;LAMTOR1;TSKU;AKR1C1;RORA;NPC1;RALY;ABCA1
prerank,carbohydrate homeostasis (GO:0033500),0.37822762874257604,1.0368470535545322,0.42857142857142855,0.8365555904854252,1.0,9/67,8.46%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;TENT4B;MCU;BACE2;ADIPOR2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3481152192836152,1.0367279686879816,0.401,0.8363368294844613,1.0,131/336,30.17%,FOXP1;HELB;MAPK15;PARP3;TOPORS;CHD1L;UBE2B;TRIM28;POLE2;VCP;CBX1;TNFRSF1B;PHF1;GNL1;DCUN1D5;ERCC8;PRKDC;RMI2;INTS3;OTUB1;TRRAP;KMT5C;SLF2;RBBP6;FAAP20;RBBP8;ERCC4;RAD1;OGG1;WRN;CUL4A;SPIDR;ABL1;UBR5;WDR48;BCL2L2;ATM;USP45;CHEK2;MAPK12;ZDHHC16;TDP1;ERCC3;RAD50;CSNK1E;TANK;ALKBH1;MMS19;CEP63;TLK2;ATRIP;PARP1;AATF;HUS1;APBB1;SMC5;SUMO1;POLB;NIPBL;CBX5;UFL1;MEN1;ALKBH8;E2F1;BID;USP10;ATF2;RAD51;IKBKE;IRF3;MTREX;TRAIP;FANCG;XRCC3;SUV39H1;ENDOV;SLF1;NEK4;SFN;UPF1;ZBTB40;USP47;TOPBP1;PDS5A;UVRAG;ALKBH3;BOD1L1;TAOK3;SMC1A;TAF1;TP53;RBM24;TAOK2;XIAP;RECQL5;POLD1;GTF2H4;SMC6;SLX4;SHPRH;TAOK1;HTRA2;MCM7;CGAS;SETD7;XPA;YY1;PARP4;USP16;ZRANB3;FBH1;RTEL1;RPAIN;NOP53;PNKP;ADPRS;SETX;DDB1;ATR;SMARCAL1;IGHMBP2;GRB2;BCL6;HMCES;MBD4;DDX11;RAD52;PDS5B;CASP2;TRIP12;TIMELESS
prerank,metal ion transport (GO:0030001),-0.25463600666907105,-1.0365681179873312,0.4225352112676056,0.723918191337585,1.0,22/86,14.24%,ITPR1;SLC8A1;CALCRL;CACNA1D;RYR2;TRPC3;CACNA1E;CACNA2D1;CACNG7;SLC39A8;TUSC3;SLC41A1;CACNG8;SLC8A3;ATP2A3;CAV1;CACNG3;NDFIP2;SLC30A1;TRPC4;TPT1;NIPAL4
prerank,snRNA processing (GO:0016180),0.4652901213487741,1.036445231754969,0.43905635648754915,0.8365939864282579,1.0,3/16,9.08%,INTS14;INTS3;INTS4
prerank,regulation of neuroinflammatory response (GO:0150077),0.4578462807126042,1.036405856988255,0.44155844155844154,0.8361625290588405,1.0,3/19,8.00%,IL33;TNFRSF1B;DAGLA
prerank,regulation of axon regeneration (GO:0048679),-0.4114097676676087,-1.0361770603546827,0.40892193308550184,0.723134502338288,1.0,7/12,25.05%,PTN;EPHA4;INPP5F;SCARF1;RTN4R;RTN4RL1;GRN
prerank,synaptic vesicle endocytosis (GO:0048488),0.4184191533084675,1.036028044507104,0.43146603098927294,0.8367057564676214,1.0,10/33,15.34%,STON2;SYT8;CEL;DNM2;FCHO2;STON1;SYNJ1;NLGN1;SNAP91;STX1A
prerank,protein insertion into membrane (GO:0051205),0.41867435014569665,1.035957710018359,0.4423076923076923,0.836354531797885,1.0,11/32,27.76%,EGFR;STX5;TRAM2;ALDH3A2;STX1A;HMOX1;COX18;VAMP2;GET4;SEC61B;CCDC47
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.27187598792323675,-1.0358921494929156,0.3763440860215054,0.7220160856139639,1.0,13/66,8.97%,FLT1;ROBO1;IL34;PDGFD;KIT;FGF1;TPD52L1;PDGFRB;SASH1;ADRA2A;PIK3R6;PDGFC;PAK1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3674797699787512,-1.0352310485260616,0.42805755395683454,0.7218048638048093,1.0,7/17,21.04%,ITGA1;PDGFRB;CD300A;PTPA;PPP1R12A;PPP1R15B;PPP1R15A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.42633076553719773,1.035188853574508,0.4280442804428044,0.8379033697432682,1.0,11/29,25.01%,LDLRAD4;SPRED2;FOXA1;SMAD7;FUZ;BMP5;IL17RD;EFNA1;MAD2L2;ZNF750;PPP2CA
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.4472241565740571,1.035137055936075,0.42670157068062825,0.8375170610851496,1.0,9/20,24.81%,SCD5;CBR4;FAR1;PPT2;ACACA;ACSL3;HSD17B8;GCDH;FITM2
prerank,negative regulation of programmed cell death (GO:0043069),0.3474304225370555,1.0351064545281892,0.4114114114114114,0.8370598530231125,1.0,83/355,19.83%,THBS1;EGFR;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;NOL3;SHC1;TOPORS;PKHD1;SIX4;ANXA4;ERC1;BAG3;TAX1BP1;HYPK;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;RAF1;SOX9;ARF4;ERCC5;PA2G4;CBL;SOCS2;AKT2;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;ITCH;VIP;RIPK3;IRAK1;BCL2L2;NAA16;PHIP;HSPA5;CD27;MIEN1;SERPINB9;HDAC1;VTCN1;HSPD1;LRP2;SUPV3L1;SQSTM1;DAB2;PRDX3;HNRNPK;CAT;PSEN2;HGF;IL6;PSMC5;AATF;RPS27A;UBC;HIGD1A;BIRC6;PRLR;CITED2;ARAF;GOLPH3;BNIP1;BID;CLN3;BIRC5;AKT1;GDNF;DNAJA1;PRDX2;NFKBIA;TAF9B
prerank,cellular response to osmotic stress (GO:0071470),0.4333902181617763,1.03473073420297,0.4322250639386189,0.8375496467667871,1.0,4/21,6.67%,YBX3;LRRC8D;SLC4A11;STK39
prerank,positive regulation of signal transduction (GO:0009967),0.35026075851478217,1.0347003801142003,0.3921765295887663,0.8371056172526242,1.0,43/238,13.12%,SMOC2;ADAMTS3;IRS1;SLC39A14;GAS6;F3;RSPO3;PTGIS;CCN3;GRB10;NTRK3;ATP6V1C2;ZMIZ1;RAB34;CSNK2A1;CRADD;TGFB2;STAT3;PRKCA;ARMC9;DACT1;ILK;POGLUT1;JAG1;SULF1;SKI;RSPO1;DLG4;TEDC1;EVC;FGFR2;ITGAV;ING5;TERT;P2RY6;SHANK1;PHIP;PDCL;NRP1;TGFBR1;SMO;NLGN1;CD80
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.30464598855209996,-1.0346044537306698,0.41353383458646614,0.7215313526825681,1.0,16/35,18.53%,SEMA6A;PLXNA2;SEMA3D;SEMA7A;SEMA5A;PLXND1;NRP2;ARHGDIA;PLXNB2;SEMA4D;SEMA3G;SEMA4A;PLXNB1;SEMA4G;SEMA5B;PLXNA3
prerank,response to reactive oxygen species (GO:0000302),0.3846997194872518,1.0343890100452544,0.43770672546857775,0.8374276605838616,1.0,12/54,18.70%,EGFR;ADAM9;COA8;MAPK8;CHUK;SOD1;STK25;PRDX3;CAT;TXNRD2;HMOX1;AKT1
prerank,regulation of viral release from host cell (GO:1902186),0.44772950414404333,1.0341942569130795,0.4330708661417323,0.837429170114358,1.0,9/21,28.34%,TRIM28;MID2;CHMP3;TRIM26;TRIM13;TRIM8;CHMP2A;VPS37B;DDB1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5087888671797733,1.0339724973949516,0.451063829787234,0.8374766509615104,1.0,3/11,15.61%,MAVS;STX4;CAMK4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4225563395307604,1.0334712539367001,0.4533001245330012,0.8382623249859112,1.0,11/29,24.32%,HELB;TSR1;RRS1;DCAF13;RPP40;TSR2;ABT1;NGDN;WDR46;TBL3;KRI1
prerank,positive regulation of binding (GO:0051099),0.3683427943417057,1.0332554306113182,0.45320715036803366,0.8383431837598864,1.0,20/84,19.01%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;HMGB1;SKI;RARA;BMP4;NVL;TERT;MED25;ADD1;USP33;SIRT2;IDE;NCBP1;MEN1;CDT1;HIPK2
prerank,cellular response to unfolded protein (GO:0034620),0.4227944669679735,1.0331715280022438,0.44095477386934673,0.8380530800989707,1.0,12/26,29.91%,HSPA2;BAG3;HSPA14;HSPA5;HSPD1;OPTN;ABCB10;DAXX;HSPB8;ERN1;HSF1;PRKN
prerank,response to glucagon (GO:0033762),-0.35152815414505884,-1.0327272293671108,0.4015444015444015,0.7246709579192977,1.0,6/19,7.53%,ADCY5;ADCY1;PRKAR2B;PRKACB;PRKAR1B;ADCY4
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4980538128075652,1.0327157379799947,0.4428969359331476,0.8382492836853483,1.0,8/11,29.40%,CCT4;LARP7;CCT6A;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4980538128075652,1.0327157379799947,0.4428969359331476,0.8382492836853483,1.0,8/11,29.40%,CCT4;LARP7;CCT6A;CCT8;TCP1;DKC1;CCT5;MEPCE
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.413763841350101,-1.032657310065407,0.42474916387959866,0.72305559531097,1.0,2/11,1.32%,NEDD4L;ACTN2
prerank,diterpenoid metabolic process (GO:0016101),0.3855002786731292,1.0325941086748112,0.4401805869074492,0.8380513865879962,1.0,8/55,13.50%,GPC6;LRP1;GPC3;SDC1;AKR1C1;LRP2;ALDH3A2;OPN1MW
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.44758048686416574,1.0325498637362318,0.4231770833333333,0.8376173627443146,1.0,11/18,35.53%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;UBTF;POLR2L;POLR2K;SIRT7;LYAR;UTP15
prerank,cellular response to ketone (GO:1901655),-0.29406518919941166,-1.032446515806751,0.37012987012987014,0.7218052891908108,1.0,4/35,4.23%,ADCY5;ROCK2;ADCY1;AHR
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.36799928642330504,1.0323755445295806,0.4402116402116402,0.8375372865726417,1.0,18/94,12.55%,PRKCD;DDX5;FHIT;CYP1B1;TOPORS;MAP3K5;ATF4;TNFRSF1B;PRKDC;ERN2;CUL4A;ABL1;BCL2L2;ATM;CHEK2;AIFM1;TNFRSF10B;CUL1
prerank,lipid biosynthetic process (GO:0008610),0.3768402284751067,1.0316979176800374,0.4313304721030043,0.8388174246665823,1.0,20/77,18.78%,ABCD3;CYP19A1;ACSF3;LPCAT1;SCD5;DOLPP1;GPAT4;SREBF1;OLAH;FADS1;CBR4;FDXR;ACACA;PIP5K1A;LSS;HSD17B8;PRLR;AGPAT5;AGPS;ACSL6
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5210675529256346,1.03145922735394,0.4460431654676259,0.8388818822491633,1.0,3/10,12.31%,DLGAP3;DLGAP4;AKAP9
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.41282241624058297,1.0314562999554229,0.43580683156654887,0.8383664981010355,1.0,13/31,22.64%,DLG2;CRB1;DLG1;RHOA;SYNE4;MYO9A;EZR;CRB2;WDR1;ERBIN;PDCD6IP;PRKCI;CAMSAP3
prerank,cardiac muscle contraction (GO:0060048),0.41105309745554375,1.0311651953652927,0.43509615384615385,0.8386124146879842,1.0,6/34,6.20%,ATP1B1;GSN;CAMK2D;DMD;GAA;KCNE5
prerank,synaptic vesicle transport (GO:0048489),0.4971845005866655,1.0307732172716493,0.4482758620689655,0.8391509744070109,1.0,4/11,19.84%,DNM2;SYNJ1;SNAPIN;CDK5
prerank,hyaluronan metabolic process (GO:0030212),0.43749863763457186,1.0306488914782523,0.4417098445595855,0.8389528806026824,1.0,5/23,13.28%,FGF2;SLC9A1;ABCC5;CHP1;HEXA
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.49602025338465827,1.030501592970247,0.42547033285094066,0.8388180438029702,1.0,1/11,0.97%,GAS6
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.47210524899380657,1.0303231729498639,0.44037940379403795,0.8387650488063202,1.0,4/15,14.77%,SFRP4;BMP4;VDR;CYP27B1
prerank,connective tissue development (GO:0061448),0.40687623279803115,1.03021522550231,0.43243243243243246,0.838539530795989,1.0,8/35,12.96%,PKD1;LRP5;HES5;SULF1;SOX9;SH3PXD2B;SLC39A13;TRIP11
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3607732317476676,1.0301756306802177,0.43737166324435317,0.8381306054812637,1.0,22/112,12.82%,GDF10;COL3A1;ADAM9;COL1A2;LTBP2;SMAD9;SMAD6;ZMIZ1;TGFB3;TGFB2;PDE3A;ACVR1;SMAD4;TGFBR2;SKI;SOX9;CBL;RHOA;BMPR1A;SMAD7;TGFBR1;ZMIZ2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.37069314193780306,1.0298273690532227,0.4596340150699677,0.8385361430918373,1.0,17/74,18.74%,THBS1;EYA2;TCF7L2;NOL3;ACVR1;BMP4;ITGAV;TERT;PHIP;TNFRSF10B;TGFBR1;BMP5;BIRC6;HMOX1;ZMYND11;AKT1;GDNF
prerank,glutathione metabolic process (GO:0006749),0.404533916936967,1.0294141673830302,0.4490521327014218,0.8390829665497298,1.0,10/38,23.50%,GCLC;GSTT1;GSTM5;SOD1;GSR;GSTZ1;GCLM;CHAC2;HAGH;DPEP1
prerank,potassium ion transport (GO:0006813),0.36372600899742175,1.0292314957165176,0.44455958549222796,0.839036186682383,1.0,12/120,7.45%,KCNJ2;KCNJ15;KCNK5;KCNB1;SLC24A3;HCN4;KCNN1;SLC9A8;SLC9A4;SLC9A1;KCNIP2;KCND1
prerank,clathrin coat assembly (GO:0048268),-0.3757248851625312,-1.0291283474984931,0.41603053435114506,0.7284582097171295,1.0,5/15,12.54%,SGIP1;PICALM;HIP1R;NSG1;PIK3C2A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.38002541055010297,-1.0290692193715074,0.4244604316546763,0.7268154128400931,1.0,6/14,11.99%,NOS3;ENPEP;ACE;AGTR1;EDN1;ACE2
prerank,establishment of spindle localization (GO:0051293),0.4689392033486055,1.028946859562944,0.4613333333333333,0.8392714544727402,1.0,3/14,7.48%,DYNC1H1;TLE6;LLGL1
prerank,positive regulation of cell projection organization (GO:0031346),0.3567732923450651,1.0288968074338887,0.44895833333333335,0.8388751420123347,1.0,16/115,9.47%,SLIT2;PLXNA4;TIAM1;NTRK3;NTRK1;TIAM2;DPYSL3;CUX1;ARSB;FBXW8;KIDINS220;P3H1;DVL1;DLG4;RHOA;ROR1
prerank,macrophage differentiation (GO:0030225),0.4729472532197847,1.0288114547005753,0.45714285714285713,0.8385934675998288,1.0,3/13,16.21%,VEGFA;BMP4;PARP1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.3808160203331281,-1.028784093240979,0.3917910447761194,0.7258871123206165,1.0,8/14,12.44%,ADGRV1;WNT5A;DGKD;DGKG;GPD1L;FLT4;ADRA1A;CD40
prerank,ribosome assembly (GO:0042255),0.3944727453577843,1.0286811253701786,0.4428251121076233,0.8384224971940939,1.0,13/47,21.34%,RPSA;MRPS2;RRS1;MPV17L2;RRP7A;NLE1;DHX29;EIF6;PPAN;EFL1;BOP1;EIF2A;SBDS
prerank,regulation of cell motility (GO:2000145),0.36168965104721484,1.0285420088136266,0.4528301886792453,0.8382926316335301,1.0,20/121,12.02%,EGFR;PLXNA4;NTN1;FGF2;SRCIN1;FGF17;LDB2;LDB1;TWIST1;LMNA;MEAK7;RAF1;BEX4;AKT2;RHOA;PKN2;ABL1;LMO4;CCDC25;RCC2
prerank,regulation of translational initiation (GO:0006446),0.3798637289812003,1.028398597302838,0.46271929824561403,0.8381654044544422,1.0,24/63,28.60%,EIF4A2;ATF4;EIF4G2;EIF4G3;IMPACT;CDC123;KHDRBS1;UHMK1;AGO2;EIF4G1;ALKBH1;RBM4;NCBP1;NCBP2;GLE1;EIF2AK4;EIF2AK3;EIF4B;RPS6KB1;NCK1;TPR;YTHDF1;EIF4H;LARP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3729079428664006,1.0283536149023802,0.44017094017094016,0.8377728685632243,1.0,24/70,23.60%,PSMD7;PSMA8;FCER1G;PSMA4;ITGAV;PDIA3;CHUK;PSMD12;PSMA6;SEC22B;LNPEP;SNAP23;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;CALR;PSMB1;PSMD4;PSMA5;PSMA7;ITGB5
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.376217230749992,1.028343718247681,0.44396551724137934,0.8372744524430482,1.0,27/73,25.78%,LDB1;PSMD7;PSMA8;PRKDC;PSMA4;ITCH;ABL1;PSMD12;PSMA6;PDCD2;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;PSMA5;PSMA7;METTL14;PSMC1
prerank,regulation of organelle organization (GO:0033043),0.37353792879208464,1.0281563784632575,0.4602332979851538,0.8372636673605881,1.0,35/80,28.51%,RDX;MAPK15;STX5;CLIC4;MAVS;MIEF2;RHOT2;CLEC16A;CAPN2;RHOT1;PAK2;TMED9;EZR;AKAP9;TBC1D25;PREB;SQSTM1;VPS11;CDT1;GOLPH3;CLN3;TMEM33;ARMH3;MUL1;LMAN1;CAMSAP3;CAPN6;MTM1;PINK1;SCARB2;TAOK1;SAR1A;SURF4;MYO5A;FIS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3418982921025381,-1.0281108170875313,0.386046511627907,0.7258971829058283,1.0,10/20,15.96%,TGFBR3;ENG;TBX3;NOTCH1;RBPJ;ACVRL1;SPRY1;HEY2;OLFM1;BMP2
prerank,mammary gland epithelium development (GO:0061180),0.4763810898791652,1.028099766441257,0.45395590142671854,0.8368866281765437,1.0,2/14,8.56%,ID2;AKT2
prerank,triglyceride catabolic process (GO:0019433),-0.3541483723381915,-1.027966853356936,0.40969162995594716,0.724481280289289,1.0,9/19,36.69%,LPL;FABP5;FABP7;FABP3;LIPH;LIPC;FABP4;FABP12;PNPLA2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37065598206502676,1.0278497169048135,0.42857142857142855,0.837017451569481,1.0,20/80,15.89%,PLCE1;ARAP1;RHOQ;DPYSL3;TGFB3;BCAS3;EPS8L1;CDC42EP2;FAM98A;CYFIP1;TENM1;NRP1;MIEN1;CDC42EP5;NLGN1;MARK4;NDEL1;FUZ;PLEKHM1;PALM
prerank,response to organonitrogen compound (GO:0010243),0.40464425227171674,1.027713332950011,0.4448356807511737,0.8368779167212226,1.0,12/38,25.07%,MEAK7;VCP;IRAK3;SYVN1;IL6;ERLEC1;GLRB;KAT7;RCN3;DRD2;DERL1;DNAJB12
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3634834653261927,1.0276700832538865,0.43854166666666666,0.8359672242816081,1.0,29/104,23.82%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,cellular response to lectin (GO:1990858),0.3634834653261927,1.0276700832538865,0.43854166666666666,0.8359672242816081,1.0,29/104,23.82%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,pyruvate metabolic process (GO:0006090),0.386937330276995,1.0275538305372542,0.43526785714285715,0.8357436261467782,1.0,4/52,6.10%,ME1;SLC16A1;LDHC;GLO1
prerank,translesion synthesis (GO:0019985),0.3921284375958692,1.0275526143163116,0.44495944380069524,0.8352310854125157,1.0,14/42,25.47%,REV3L;POLE2;VCP;FAAP20;UBE2L6;RPS27A;UBC;REV1;NPLOC4;USP10;MAD2L2;PRIMPOL;RCHY1;POLD1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.37794141906102974,1.027182087055698,0.44820065430752454,0.8357092953677946,1.0,36/73,33.07%,HDAC4;GLMN;PHF1;TRIM27;SF3B1;TDG;KAT2A;RBBP7;POLR2F;HDAC6;POLR1G;MPHOSPH8;POLR1C;TASOR;TAF1C;TBP;KAT2B;DNMT1;H3-3A;POLR2H;IGF2;DNMT3A;SPHK2;MECP2;TAF1D;POLR2L;SUZ12;TAF1B;MTF2;CTCF;SPI1;MTA1;ERCC6;POLR2K;CREBZF;TAF1A
prerank,negative regulation of apoptotic process (GO:0043066),0.3435668216421671,1.0267946912438493,0.422,0.8361942897726246,1.0,96/444,18.74%,THBS1;EGFR;SIX1;PRKCD;VEGFA;FSTL1;GAS6;GCLC;CARD14;PROK2;NTRK1;SMAD6;COMP;TGFB3;NOL3;SHC1;TOPORS;PKHD1;CSNK2A2;CSNK2A1;SIX4;CARD16;ANXA4;ERC1;BAG3;TAX1BP1;PRKCA;HYPK;NRBP2;FXN;GLO1;PRKDC;ADAM10;ANGPTL4;RAF1;SOX9;ARF4;TRIM27;ERCC5;PA2G4;CBL;SOCS2;AKT2;ANGPT4;PAK2;MAPK8;ANXA1;BMP4;ITCH;VIP;IRAK1;BCL2L2;MAZ;NAA16;SFPQ;SOD1;PHIP;HSPA5;CD27;CIDEA;PTRH2;MIEN1;SERPINB9;HDAC1;VTCN1;HSPD1;LIG4;F2R;LRP2;YWHAE;SUPV3L1;NDNF;SQSTM1;DAB2;CLCF1;PRDX3;HNRNPK;CAT;PSEN2;HGF;IL6;AATF;RPS27A;UBC;HIGD1A;BIRC6;PRLR;CITED2;ARAF;GOLPH3;BNIP1;BID;CLN3;BIRC5;AKT1;GDNF
prerank,positive regulation of neuron migration (GO:2001224),-0.410823529173522,-1.0266025641563454,0.4206896551724138,0.7262294254401394,1.0,3/11,9.31%,SEMA6A;RAPGEF2;ARHGEF2
prerank,actin filament capping (GO:0051693),0.4629706606741052,1.0263967837753285,0.45703611457036114,0.8362318997884975,1.0,8/18,25.88%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL;TWF1
prerank,barbed-end actin filament capping (GO:0051016),0.4629706606741052,1.0263967837753285,0.45703611457036114,0.8362318997884975,1.0,8/18,25.88%,GSN;VILL;ADD1;SCIN;CAPZA1;ADD3;SVIL;TWF1
prerank,regulation of cell migration (GO:0030334),0.3427845725735489,1.0260026961395585,0.42242242242242245,0.83678806359884,1.0,48/382,8.56%,THBS1;MYOC;SLIT2;EGFR;PLXNA4;IGFBP5;VEGFA;F3;FGF2;SRGAP2;SRGAP3;ADAM9;COL1A1;TWIST2;SRCIN1;TIAM1;NTRK3;FGF17;DRD1;TMEFF2;LDB2;LDB1;DPYSL3;RDX;MAPK15;EPHB2;LDLRAD4;CYP1B1;SLURP1;ARSB;LMNA;CLIC4;PTPRU;STAT3;SEMA3E;PRKCA;MEAK7;ACVR1;ADAM10;JAG1;SULF1;MMP14;SEMA4B;CXCL16;ELP5;BEX4;NOG;AKT2
prerank,cellular response to interleukin-4 (GO:0071353),-0.4186377165234729,-1.025777856035434,0.4205298013245033,0.7266143621241926,1.0,2/10,3.71%,LEF1;TCF7
prerank,glucose metabolic process (GO:0006006),0.3844442446560821,1.0257416324193562,0.4501108647450111,0.8369787564730187,1.0,13/58,18.38%,SLC39A14;LRP5;ATF4;SORD;GAA;ADPGK;CRTC2;AKR1A1;HECTD4;PGK1;SLC37A4;ENO2;GDPGP1
prerank,regulation of endocytic recycling (GO:2001135),0.5046475342958293,1.0255523539789402,0.46685472496473907,0.8369645701992151,1.0,4/11,13.45%,EHD1;EHD2;ATP9A;RAB11B
prerank,apoptotic mitochondrial changes (GO:0008637),-0.31248905483293127,-1.0255038601819058,0.3783783783783784,0.725544854991355,1.0,12/32,19.67%,BCL2;BCL2L1;DNM1L;ERBB4;HK2;IFIT2;BOK;MFF;CAMK2A;SOD2;BIK;NDUFS1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.4914097602223851,1.0254713117423861,0.45492957746478874,0.8366485224746465,1.0,1/12,0.43%,IRS1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.47587738424815423,1.0254687783502234,0.458950201884253,0.8361382621649108,1.0,4/14,12.31%,ATP1B1;ANK2;KCNIP2;AKAP9
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.48694758202118177,1.0253693594975863,0.44755244755244755,0.8359032274996976,1.0,4/12,18.28%,ADCY8;TRPM4;STX4;C2CD2L
prerank,pre-miRNA processing (GO:0031054),0.47416286277847564,1.0249300808296502,0.45188284518828453,0.8365773390600828,1.0,4/14,16.62%,PRKRA;AGO1;AGO2;TUT7
prerank,regulation of lymphocyte migration (GO:2000401),0.4987976181962618,1.0248900081975227,0.4822485207100592,0.8361615186655974,1.0,4/10,23.25%,SPN;MIA3;AKT1;SLC8B1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.3519513525499261,1.0248544256945082,0.45121951219512196,0.8357523130015209,1.0,56/148,26.71%,CSNK2A2;CSNK2A1;KMT5A;RRS1;CHD3;USP2;RMI2;MDM4;EHMT1;CDK5RAP3;RBBP8;RAD1;WRN;ING5;PIP4K2B;ATM;CHEK2;PDPK1;TAF15;TAF6;RAD50;HDAC1;TAF13;RBBP7;USP7;HEXIM1;ATRIP;TTC5;PPP2R5C;TP53RK;HUS1;SSRP1;BOP1;PRKAG1;AKT1;HIPK2;CDK2;TAF9B;CDK5;PRKAB1;NOC2L;MAPKAP1;PAK1IP1;TOPBP1;TBP;MEAF6;TAF1;SMYD2;TP53;CHD4;TOP3A;HDAC2;DAXX;EHMT2;SGK1;TAF10
prerank,regulation of cell aging (GO:0090342),0.49233064614801747,1.0248066352391263,0.4474820143884892,0.8353533703680835,1.0,5/11,27.28%,LMNA;FOXM1;NEK4;VASH1;NEK6
prerank,lipoprotein localization (GO:0044872),0.49081016140659856,1.0243406921065248,0.4591549295774648,0.836077381755076,1.0,1/11,1.02%,LRP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.42949480295338227,1.0241895360827526,0.452,0.8359620674199706,1.0,6/21,20.11%,SAMD4A;CNOT8;TUT7;CNOT10;CNOT9;TNKS1BP1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.38403989839548625,1.0239388600332695,0.45685840707964603,0.836119707304395,1.0,17/54,26.25%,GAS6;CARD16;TAX1BP1;SHARPIN;MADD;CHUK;PTPN2;CASP1;OTULIN;TRAIP;CCDC3;GPS2;BIRC3;CYLD;SPPL2A;TRADD;RIPK1
prerank,cellular response to oxidative stress (GO:0034599),0.3591058344892888,1.0237746694484804,0.45962732919254656,0.8360318944782319,1.0,39/118,24.91%,EGFR;PRKCD;VKORC1L1;ATF4;SLC4A11;NOX4;NFE2L2;MAPK8;STX2;CHUK;ABL1;SOD1;LONP1;SESN2;SRXN1;PRDX3;CAT;STX4;SIRT2;GSR;TXNRD2;FOXO3;PARP1;HMOX1;VRK2;AKT1;PRDX2;EIF2S1;MAPK9;LRRK2;PYCR1;PRDX1;GPX7;FOS;PYROXD1;PXN;TP53;PINK1;SELENOS
prerank,protein localization to kinetochore (GO:0034501),0.47157459627894327,1.0234449633278226,0.44010767160161507,0.8364289350120535,1.0,5/14,16.57%,CENPT;MIS12;RCC2;ZW10;IK
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.41131268569825263,-1.0233969745415255,0.3979591836734694,0.7292607571928719,1.0,3/11,12.41%,NOS3;GCH1;SPR
prerank,regulation of catecholamine secretion (GO:0050433),0.4191776585608469,1.0233498107843928,0.46096654275092935,0.8361726684015915,1.0,3/29,6.91%,KCNB1;SYT8;CHRNB2
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.3299130233928904,-1.0232960224621703,0.4292929292929293,0.7278366068082885,1.0,9/25,17.19%,VCAM1;CTNNA3;CXADR;CD200;ITGA7;ITGA4;PKP2;DSP;NINJ1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.3379618903441277,-1.0231888928508845,0.41509433962264153,0.7263703179856609,1.0,6/21,10.31%,PLTP;APOE;PTCH1;NR1H3;CAV1;EEPD1
prerank,receptor internalization (GO:0031623),0.3941737533795976,1.0231219168783978,0.45576707726763716,0.8362708701008124,1.0,10/44,15.27%,LRP1;NEDD4;RAMP2;DNM2;CD9;FCER1G;SNX1;RAMP1;CLTC;ARRB1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3432173410635654,1.0231123643390976,0.4245472837022133,0.8357812791228646,1.0,58/248,16.61%,EGFR;LRP6;CTNND2;TCF7L2;GPC3;COL1A1;SFRP4;PLEKHA4;PRICKLE1;DKK3;PSMD7;TLE2;CSNK1D;WWTR1;PTPRU;UBE2B;VCP;TLE6;PSMA8;DACT1;DVL1;ILK;CCAR2;FZD7;RSPO1;JUP;SOX9;NOG;DACT3;TRPM4;TLE3;PSMA4;FGFR2;CSNK1G1;TPBG;UBR5;AXIN1;INVS;PSMD12;USP34;CSNK1E;HDAC1;PSMA6;WNK1;LIMD1;TNKS2;DAB2;FUZ;PSMD1;PSMC5;LATS2;GSKIP;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14;OTULIN
prerank,regulation of chemokine production (GO:0032642),0.4027733053650516,1.0226880001734608,0.4502994011976048,0.8364110950772116,1.0,2/36,1.30%,FOXP1;IL33
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3623114751702693,1.0226212139227928,0.4424686192468619,0.8360681481386433,1.0,29/105,23.82%,PRKCD;MUC1;PSMD7;PSMA8;RAF1;MUC13;FCER1G;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;PSMA3;PRKACA;PSMB1;PSMD4;PSMA5;PSMA7;NRAS;KRAS
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.40663227244129707,1.0219644128775716,0.45913461538461536,0.8373139209397902,1.0,14/32,30.24%,MAPK15;NEK7;ATM;TNKS2;CCT4;CCT6A;CCT8;MAP2K7;HNRNPA1;TCP1;PNKP;CCT5;ATR;CTNNB1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4793894031766753,1.0218012604678122,0.46544428772919605,0.8372373156556548,1.0,3/12,13.94%,GSN;MID2;TRIM26
prerank,secretion (GO:0046903),-0.3863215199555684,-1.0217472974868356,0.4312977099236641,0.728394174321582,1.0,5/14,13.06%,SLC22A6;RIMS1;NPR1;SLC22A2;SLC22A4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.26454140760906636,-1.0213978084796578,0.4,0.7276012253876766,1.0,19/55,19.03%,BCL2;BCL2L1;WWOX;TPD52L1;DNM1L;FAS;TNFSF12;NUPR1;BOK;CAV1;BCL2L11;STYXL1;TRAF7;GPER1;HYAL2;PML;PYCARD;RACK1;RPS3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.38170398457134164,1.0213687946353542,0.4682981090100111,0.8378223457895676,1.0,22/50,29.58%,PRR7;NXN;OGT;ABL1;SMAD7;CHP1;U2AF2;SQSTM1;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;TAF1;CAMLG;GTPBP4;SVBP;PER2;SPOPL;PRMT3
prerank,histone exchange (GO:0043486),0.4010119524983128,1.0211382727975846,0.4602803738317757,0.8379481612794575,1.0,8/37,16.11%,HJURP;CENPC;CENPT;SPTY2D1;ACTR6;ZNHIT1;RBBP7;VPS72
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4655679126837617,1.0209968368684292,0.46603260869565216,0.8378175081730203,1.0,1/15,0.75%,PRKCD
prerank,peptidyl-proline modification (GO:0018208),0.42177988777407516,1.0209739000230778,0.46503067484662575,0.8373788966255087,1.0,12/25,30.69%,FKBP5;FKBP10;P3H2;PPIL3;NKTR;NTMT1;FKBP4;PPIG;FKBP1B;PPID;PPIC;PPIH
prerank,cellular response to leucine (GO:0071233),0.497567062582752,1.0208422300198006,0.45626822157434405,0.8367084317122482,1.0,5/10,23.02%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,response to leucine (GO:0043201),0.497567062582752,1.0208422300198006,0.45626822157434405,0.8367084317122482,1.0,5/10,23.02%,SESN3;SESN2;KLHL22;UBR2;RPTOR
prerank,striated muscle contraction (GO:0006941),-0.27442682628307963,-1.020681760873412,0.4017094017094017,0.727696920343206,1.0,4/53,3.25%,ATP1A2;SLC8A1;TPM1;RYR2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.48280769810695706,1.0206526137377556,0.463448275862069,0.8366910144966341,1.0,1/13,0.43%,IRS1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.38542716083535383,1.0205598515475405,0.44215349369988544,0.8364210923390126,1.0,9/48,13.07%,UBASH3B;DRD1;CAMK2D;CALM2;DMD;ANK2;SELENON;PDPK1;F2R
prerank,mitotic cytokinetic process (GO:1902410),0.4429977102035212,1.0200988512004905,0.4461538461538462,0.8371362944567963,1.0,7/20,24.56%,RHOA;CHMP3;MITD1;CHMP4A;CHMP4B;PDCD6IP;CHMP2A
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.46912750613212556,1.0198071819518095,0.458950201884253,0.8373901331794016,1.0,8/15,27.28%,CDC16;CDC6;UBE2C;ANAPC1;CDC27;RIOK2;TPR;NEK6
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4866366980970524,1.01968627052962,0.4618585298196949,0.8371816405378156,1.0,4/13,11.28%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5105710738857777,1.0196138596701538,0.46511627906976744,0.8368603684602552,1.0,2/10,11.51%,ADAM9;IQSEC1
prerank,immunoglobulin mediated immune response (GO:0016064),0.5109162059416059,1.0195963179462706,0.4731494920174166,0.836397078738023,1.0,2/10,11.94%,FCER1G;CD27
prerank,regulation of cell development (GO:0060284),0.4016552864652832,1.0195655887235509,0.4569377990430622,0.8359649739676985,1.0,7/36,12.12%,DOCK7;HDAC9;HES5;BHLHE40;HEYL;FBXO22;HEY1
prerank,regulation of synapse organization (GO:0050807),-0.3157546313584556,-1.01867385454408,0.430622009569378,0.7311534624480216,1.0,8/26,10.58%,IL1RAPL1;WNT5A;EPHA4;ARHGAP22;CTNNA2;ABHD17C;PDLIM5;YWHAZ
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.4540672762336033,1.0184448572990856,0.4498044328552803,0.8384188776404732,1.0,7/19,13.69%,ZFPM2;FGF2;NOG;FGFR2;BMPR1A;TGFBR1;RUNX1
prerank,GPI anchor metabolic process (GO:0006505),0.41140590478594646,1.0180992461072222,0.4609571788413098,0.8388311667895676,1.0,12/26,32.31%,PIGW;PIGF;PIGL;PGAP2;DPM3;PIGV;PGAP1;PIGQ;PIGB;PIGN;PIGC;PIGO
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5086224253458806,1.0178518611213614,0.4637883008356546,0.8389828109828484,1.0,3/10,16.48%,PLA2G4A;PLA2G5;PLA2G15
prerank,negative regulation of cell motility (GO:2000146),0.3574825082929076,1.0177913113867338,0.45855194123819515,0.8386322611509891,1.0,14/108,6.57%,SLIT2;IGFBP5;SRGAP2;SRGAP3;TMEFF2;DPYSL3;MAPK15;LDLRAD4;CYP1B1;SLURP1;CLIC4;PTPRU;JAG1;SULF1
prerank,microtubule anchoring at centrosome (GO:0034454),0.5072447266711173,1.0171308931180811,0.47982708933717577,0.8398483285474753,1.0,3/10,20.23%,NIN;PCM1;DCTN1
prerank,myotube differentiation (GO:0014902),-0.35284815805278136,-1.017075692681221,0.3798449612403101,0.7334831022786314,1.0,9/17,17.40%,JAM2;KCNH1;SORT1;ADGRB3;NOS1;ADAMTS15;IGF1;PLD3;ADAMTS5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.38873127878545044,-1.0168557097084332,0.42105263157894735,0.7323573558686716,1.0,3/12,4.47%,PODXL;PROM1;PTPRO
prerank,alanine transport (GO:0032328),0.5003590576516326,1.0166919088329713,0.46372688477951635,0.8404544231591237,1.0,3/10,13.62%,SLC7A10;SLC38A3;SLC1A4
prerank,signal release from synapse (GO:0099643),-0.2895056525882716,-1.0162335322442453,0.3937007874015748,0.7323036734794146,1.0,16/43,22.23%,NRXN1;LIN7A;RIMS1;PIP5K1C;SYN2;SYN1;STXBP3;SYT10;SNCA;GAD1;SNAP25;SLC32A1;PTPRN2;GRM4;CPLX2;PDZD11
prerank,RNA biosynthetic process (GO:0032774),0.4142805560441297,1.0161804917913653,0.46601941747572817,0.8412882172517125,1.0,12/31,30.88%,HELB;TCEA2;TERT;TAF6;TAF13;SMN1;TBP;PRIM1;TAF10;SETX;PRMT5;TTF2
prerank,regulation of neuron projection arborization (GO:0150011),-0.36568155202327274,-1.0160671782887518,0.42913385826771655,0.7310010183830996,1.0,5/15,9.28%,WNT5A;GRIP1;NTNG1;MACF1;MFSD2A
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.368803666036762,1.0159286234797664,0.4579741379310345,0.841405658881493,1.0,14/76,12.99%,CTTN;NTRK3;PRKCE;SORBS3;DYNC1H1;BCAS3;CDC42EP2;PFN2;ABL1;KATNBL1;SNX9;TENM1;NRP1;CDC42EP5
prerank,regulation of macromolecule metabolic process (GO:0060255),0.34849780276284875,1.0158749826667275,0.48216106014271154,0.8410559013516842,1.0,45/170,23.95%,FOXP1;ATP1B1;C1D;AFF3;YBX3;COQ7;PRDM5;PRDM11;PRDM10;PRDM6;LAMTOR1;ANKRA2;HNRNPDL;RSPO1;TRIM27;TSKU;EDN3;PCBP4;PRDM4;ARF1;FUBP1;MARF1;NELL1;PCBP2;TRIM26;HNRNPK;AFF4;UBAP2;ZNF462;HMG20A;KDM6B;PRDM2;RFXANK;TRIM6;GDNF;CDK2;MTMR1;AFF2;TRIM43;POGZ;LDLR;ZNF711;CAVIN4;YBX1;NFKBID
prerank,mononuclear cell differentiation (GO:1903131),0.42091244232853664,1.015559892422412,0.4427860696517413,0.8413792729094619,1.0,2/24,0.97%,VEGFA;GAS6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.3735909237479618,1.0153277285399578,0.4588364434687157,0.8414940625437639,1.0,24/70,23.58%,LDB1;PSMD7;PSMA8;PRKDC;PSMA4;ITCH;ABL1;PSMD12;PSMA6;RUNX1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;SETD1A;CBFB;TCF3;PSMA3;PSMB1;PSMD4;KMT2A;PSMA5;PSMA7
prerank,sterol homeostasis (GO:0055092),0.3705862903181218,1.0153133379484949,0.45704845814977973,0.8410220660993396,1.0,12/65,13.71%,EHD1;LRP5;LIMA1;HDAC9;SOAT1;LAMTOR1;TSKU;AKR1C1;RORA;NPC1;RALY;ABCA1
prerank,autophagosome maturation (GO:0097352),0.41062964108075933,1.0152751738648793,0.4634146341463415,0.8406322637021268,1.0,17/32,36.62%,VCP;LIX1L;WIPI2;VIPAS39;CHMP3;UBQLN1;CLN3;LAMP2;UVRAG;VTI1B;VPS16;STX17;MAP1LC3B;GABARAPL2;TSG101;EPG5;ATG14
prerank,mitotic recombination (GO:0006312),0.46676779504295884,1.0152380671241328,0.4555112881806109,0.8402173224747227,1.0,9/15,31.99%,RAD50;TPRKB;SMC5;RAD51;XRCC3;SMC6;NSMCE2;RAD52;ERCC1
prerank,cardiac cell development (GO:0055006),0.48651265889981543,1.0151492610505408,0.46846846846846846,0.8399451107450112,1.0,3/11,9.62%,VEGFA;JAG1;ALPK3
prerank,double-strand break repair (GO:0006302),0.3487582961174184,1.0150538546214807,0.4684317718940937,0.8396732244327888,1.0,42/158,20.81%,REV3L;PARP3;VCP;PRKDC;HMGB1;TONSL;ERCC5;MORF4L1;RBBP8;ERCC4;MAPK8;SFR1;WRN;SPIDR;KDM2A;SWI5;KPNA2;ATM;CHEK2;SFPQ;TDP1;KDM4A;RAD50;LIG4;PIAS4;DCLRE1B;UBE2V2;PARP1;PSMD14;HUS1;APBB1;SMC5;SUMO1;POLB;SMARCAD1;ACTR8;RAD51;XRCC6;TNKS1BP1;BRCC3;XRCC3;MAD2L2
prerank,acute-phase response (GO:0006953),0.47851033415476973,1.0147527790651039,0.45454545454545453,0.8399520836486665,1.0,1/12,1.06%,LBP
prerank,regulation of secretion by cell (GO:1903530),0.38269953715411187,1.0146819231423854,0.4346846846846847,0.8396419044386326,1.0,13/54,15.40%,SNCAIP;P3H1;RAB21;RIC1;RAB8A;DISP1;LLGL1;NSF;ANXA1;RAB3D;STXBP5;STX4;RAB3B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.37914072888742156,1.0146181209258682,0.4581447963800905,0.839298848311931,1.0,15/53,24.51%,PKD1;XPO1;GLMN;OSBPL7;PSMC5;USP19;DNAAF4;PSMD14;UFL1;ARAF;UCHL5;PRKACA;DESI1;USP14;PINK1
prerank,regulation of neuron apoptotic process (GO:0043523),0.35981113873744214,1.014152465823776,0.4632352941176471,0.8399957390530328,1.0,22/96,19.93%,SIX1;KCNB1;NTRK1;TGFB3;SIX4;TGFB2;ATF4;NRBP2;AKT1S1;BACE1;SOD1;LIG4;F2R;NDNF;CLCF1;FOXO3;NSMF;NF1;CLN3;GDNF;CDK5;NFATC4
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.39799914496915195,-1.014028976366377,0.42258064516129035,0.734524277065561,1.0,2/12,4.77%,AXIN2;RB1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.35915986344516104,-1.0139576366595477,0.43272727272727274,0.7329881947148689,1.0,5/17,10.90%,APOE;FGF1;ABCG1;PRKAA1;KPNB1
prerank,dendrite morphogenesis (GO:0048813),0.40282342043576336,1.0139070271067545,0.4642857142857143,0.8401225289120481,1.0,10/35,13.48%,CTNND2;FARP1;EPHB2;ARC;DVL1;EPHB3;DLG4;TMEM106B;SHANK1;MEF2A
prerank,error-prone translesion synthesis (GO:0042276),0.4290976304497611,1.013826620525621,0.45751633986928103,0.8398556569884802,1.0,7/21,23.63%,REV3L;POLE2;RPS27A;UBC;REV1;MAD2L2;PRIMPOL
prerank,ameboidal-type cell migration (GO:0001667),0.38308326112834334,1.0138006248996811,0.46524663677130046,0.8394244478411187,1.0,8/51,9.52%,SRGAP2;GPC3;CCN3;PDXDC1;SEMA3E;FAT2;SEMA4B;PKN2
prerank,protein localization to cell surface (GO:0034394),0.4277916802417019,1.0137907946076743,0.458808618504436,0.8389493568644663,1.0,12/26,30.24%,PTPRU;RIC3;GGA2;ANK2;GGA1;FBLN5;UNC50;USP4;PRRT1;WNT11;GGA3;CTNNB1
prerank,regulation of kinase activity (GO:0043549),0.35867033911546253,1.0137218641033336,0.4783068783068783,0.8386369236249498,1.0,18/89,12.34%,EGFR;PLCE1;DDR2;NTRK3;NTRK1;LDB2;LDB1;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;LMO4;DDR1;SOD1;RAD50
prerank,regulation of oxidoreductase activity (GO:0051341),0.47200280514923987,1.0136771020808368,0.47730398899587345,0.8382562792012725,1.0,3/13,15.82%,ECSIT;ABL1;HDAC6
prerank,cellular amide metabolic process (GO:0043603),0.3586307128366843,1.013676587779509,0.45445134575569357,0.8377602749445813,1.0,27/102,21.30%,SLC5A6;PLPP3;CPZ;ATF4;ACSF2;SLC25A32;ACOT11;PLPP1;MTRR;DNPEP;GPAT4;NNMT;MTHFD2;NLN;CPXM2;GLYAT;PLA2G15;ALDH1L2;MTHFD1;ORMDL3;SHMT2;ACOT13;SHMT1;ACSL6;MTHFR;ORMDL1;PCCB
prerank,respiratory electron transport chain (GO:0022904),0.4664394974053411,1.0136244923307824,0.4605809128630705,0.8373865078546167,1.0,4/14,10.20%,ETFRF1;ETFDH;ETFB;ETFA
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.4727815236356989,1.0136176207759218,0.46787709497206703,0.8369075426123144,1.0,6/13,28.73%,TGFBR2;RUNX1;CBFB;GLI3;SOCS1;NKAP
prerank,detection of calcium ion (GO:0005513),0.4737391530107104,1.0134447569666365,0.46174863387978143,0.83688213180357,1.0,4/13,16.85%,CALM2;KCNIP2;STIM1;CALM3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3612924097386542,1.013432228735611,0.4726315789473684,0.836411696056082,1.0,33/88,28.94%,FBXL7;PSMD7;PSMA8;PSMA4;CUL4A;FBXL4;FBXL12;PSMD12;CUL1;PSMA6;FBXL14;PSMD1;FBXO17;FBXL20;PSMC5;PSMD11;PSMC4;PSMD14;FBXL18;FBXW4;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;FBXO9;PSMC1;FBXO38;PSMA1;DMAC2;FBXL8;RBX1;BTRC
prerank,DNA methylation (GO:0006306),0.4370120654184668,1.0134313935209707,0.4512040557667934,0.8359200196356027,1.0,9/23,26.54%,BAZ2A;TEX15;EHMT1;MTRR;PICK1;FOS;DNMT1;EHMT2;DNMT3A
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.39874488969916444,1.0133655871310934,0.4606205250596659,0.8356043813051925,1.0,4/34,4.73%,PGF;VEGFA;GAS1;RAMP2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.36006787033872506,1.0132391030904422,0.4673684210526316,0.8354444620988459,1.0,17/100,13.07%,MYOC;EGFR;FGF2;NEDD4;NTRK3;NTRK1;FSHR;TWIST1;TGFB2;FGFR1;SOX9;CBL;ROR1;PIP4K2B;MAZ;PIK3CB;F2R
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.45977382490441426,1.0131997646892785,0.4776902887139108,0.8350524390108173,1.0,5/16,6.98%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,DNA damage checkpoint signaling (GO:0000077),0.4129011169082995,1.0126844442652752,0.4745762711864407,0.8359409679509981,1.0,15/28,32.30%,TIPRL;RAD1;ATM;CHEK2;CEP63;ATRIP;HUS1;E2F1;DONSON;ATR;INTS7;RAD17;RHNO1;HINFP;ERCC6
prerank,embryonic axis specification (GO:0000578),0.45917470668634514,1.012530612969942,0.46056338028169014,0.835834585660797,1.0,3/15,8.14%,SMAD6;COBL;FZD5
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.342216118137211,1.0125268212132137,0.48234106962663975,0.8353473383357924,1.0,42/186,16.38%,LRP6;TRABD2B;LRP1;TCF7L2;SFRP4;GRB10;PRICKLE1;NXN;DKK3;PSMD7;TLE2;WWTR1;PTPRU;TLE6;PSMA8;DACT1;DVL1;SOX9;NOG;DACT3;TSKU;NFATC1;TLE3;PSMA4;TPBG;AXIN1;INVS;PSMD12;HDAC1;PSMA6;LIMD1;DAB2;FUZ;WIF1;PSMD1;PSMC5;LATS2;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.41750436804226615,-1.0125154994752905,0.44299674267100975,0.7333146723967726,1.0,4/10,8.39%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,regulation of pseudopodium assembly (GO:0031272),-0.41750436804226615,-1.0125154994752905,0.44299674267100975,0.7333146723967726,1.0,4/10,8.39%,CDC42EP4;APC;CDC42EP3;CDC42
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4929961070167844,1.0124527459478923,0.47950819672131145,0.8350360877979356,1.0,2/11,14.06%,P4HB;UBQLN1
prerank,negative regulation of transport (GO:0051051),-0.2682314115224348,-1.0121740119230644,0.4339622641509434,0.7324807023216866,1.0,16/51,18.91%,MCTP1;NR1H3;CTTNBP2NL;BST2;DYSF;PACSIN3;NDFIP2;YRDC;PRKD1;SNCA;SIRPA;CRYAB;ERBB3;SYT11;PXK;RACK1
prerank,protein localization to phagophore assembly site (GO:0034497),0.49111872121296807,1.0120810224181214,0.46285714285714286,0.8354980141827523,1.0,5/11,29.79%,PACS2;WIPI2;ATG9A;ATG13;STX17
prerank,dendritic cell chemotaxis (GO:0002407),0.46516929334252516,1.012021018665432,0.4722222222222222,0.8351659453257136,1.0,3/14,15.84%,HMGB1;TRPM4;CXCR4
prerank,response to unfolded protein (GO:0006986),0.38449602873744354,1.0119728242304853,0.4640820980615735,0.8347950281227088,1.0,19/48,31.19%,SERPINH1;HSPA2;BAG3;HSPA14;HSPA5;HSPD1;DNAJA1;OPTN;DERL1;HERPUD1;DAXX;HSPB8;ERN1;HSF1;STT3B;DNAJB1;PRKN;HSP90AA1;HSPH1
prerank,motile cilium assembly (GO:0044458),0.48137204548571566,1.0116429686680914,0.47368421052631576,0.8351280969677545,1.0,3/12,13.29%,DNAAF3;CCDC39;BBS5
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.32934262622882937,-1.0116052300969893,0.4252336448598131,0.7322001899764892,1.0,2/23,3.43%,ATP1A2;CACNA2D1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4262081573470997,1.0114028528646148,0.4583333333333333,0.8352513543044332,1.0,6/24,16.23%,KCNB1;C2CD5;MIEF2;AKT2;CHP1;ERBB2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3586042747678123,-1.0113398625569867,0.43478260869565216,0.7311788594891159,1.0,2/16,0.76%,AUTS2;ARHGAP24
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4488286245171748,1.0112020040456016,0.4642857142857143,0.8352581258166412,1.0,8/16,28.37%,PID1;VCP;PARP1;FLCN;IL4;PINK1;DNAJC30;SPHK2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3656484597927603,-1.0109152209733234,0.42657342657342656,0.7305442377763117,1.0,1/15,0.50%,LEF1
prerank,regulation of autophagy (GO:0010506),0.34466153385042825,1.0109022932513636,0.47047047047047047,0.8354997718573511,1.0,95/216,28.89%,NEDD4;ATP6V1C2;EXOC4;MAPK15;CSNK2A2;STAT3;OSBPL7;EIF4G2;LAMTOR1;ATP6V0A1;HMGB1;RAB8A;EIF4G3;TRIM27;FZD5;DAP;FOXK1;MAPK8;PIP4K2B;VPS26A;SREBF1;ABL1;TAB2;ATP6V0D1;ATM;MID2;KDM4A;PIK3CB;SNX32;EIF4G1;ATP6V1B2;USP33;WDR41;UBQLN1;USP36;TRIM65;ATP6V1E1;USP13;HGF;SIRT2;FOXO3;TLK2;HDAC6;KLHL22;ORMDL3;FLCN;UFL1;PRKAG1;DAPK3;TRIM6;USP10;RB1CC1;AKT1;ATP6V1C1;DCAF12;CDK5;PRKAB1;RHEB;ATF6;UCHL1;PRKACA;OPTN;CAPNS1;LRRK2;TRIM8;RUBCN;ZKSCAN3;KAT8;RPTOR;NPRL2;ATP6V0E1;SMCR8;BAD;ROCK1;PINK1;ATP6V0B;LAMTOR2;EXOC7;ATG13;MET;HTRA2;GOLGA2;ERN1;EIF4E;PIP4K2C;CAPN1;LAMTOR3;ABL2;SNX5;TFEB;ULK1;SREBF2;PLEKHF1;CISD2;DRAM1
prerank,nuclear pore complex assembly (GO:0051292),0.5011791161811604,1.0108148719942924,0.47531734837799716,0.8352342727168487,1.0,5/10,27.35%,NUP93;TMEM170A;NDC1;TPR;AHCTF1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3963487257105373,1.01074621831886,0.4506172839506173,0.8349188954638497,1.0,7/34,11.75%,ATP1B1;HCN4;CALM2;SLC9A1;ANK2;TNNI3K;SMAD7
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4356152866670663,1.010437896652777,0.4756554307116105,0.8352291397786554,1.0,6/22,14.77%,VKORC1L1;UBIAD1;LRP2;PIAS4;VDR;CYP27B1
prerank,anion transport (GO:0006820),0.40451252957394784,1.0104107590613234,0.47417840375586856,0.8348068785675629,1.0,6/33,12.01%,SLC26A7;LRRC8D;SLC4A2;SLC26A4;VDAC2;SLC17A5
prerank,L-amino acid transport (GO:0015807),0.4112399369650837,1.0103697784285848,0.45443499392466585,0.8344247268628581,1.0,1/28,0.09%,SLC38A2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3598241068876985,1.0103685573993608,0.48025613660619,0.8339399670588813,1.0,33/88,25.43%,VPS13A;EXOC4;VPS13C;DOP1B;AP2A1;GOPC;DNM2;GOLGB1;PUM1;GBF1;MON2;LLGL1;SCFD1;STEAP2;ARF1;BLOC1S3;CLTC;SNAP23;STX4;ARRB1;SCAMP2;NAPA;SH3D19;SCAMP3;CORO7;CLTA;ARFGEF2;CLINT1;SCAMP1;CHMP2A;ACBD3;VPS35L;VAMP2
prerank,regulation of protein dephosphorylation (GO:0035304),0.4068794630521637,1.0103357397849846,0.4675324675324675,0.8335349116692817,1.0,13/37,18.29%,PRKCD;CALM2;PPP1R8;PPP6R1;SYMPK;TIPRL;PPP6R3;CNEP1R1;PTBP1;ARPP19;NSMF;CALM3;PPP6R2
prerank,wound healing (GO:0042060),0.370633839009594,1.0099731660846127,0.4725877192982456,0.8340183609996316,1.0,16/62,17.54%,FGF2;COL3A1;AHNAK2;TGFB2;FZD7;RAF1;NOG;TSKU;DCBLD2;SRF;TGFBR1;MIA3;ERBB2;NF1;SYTL4;HMOX1
prerank,nervous system development (GO:0007399),0.338752803515315,1.009825942613823,0.48348348348348347,0.8339153826592731,1.0,67/429,13.89%,DCLK1;PCDHB16;NAV2;WWP1;PKD1;ST8SIA2;VEGFA;EFNA5;ECRG4;FGF13;FGF2;GSN;CRIM1;FARP1;FGF17;DRD1;LDB2;LDB1;CNTFR;ACVR1B;GLIS2;EPHB2;NAV1;PMP22;RBFOX2;MBNL1;HDAC4;WWTR1;HES5;STAT3;PCDHB12;DACT1;DVL1;WDR62;SPG7;JAG1;SCD5;DLG4;DAGLA;S100B;FZD5;CHERP;NOG;RBM45;HAPLN4;KALRN;ZIC1;GMFB;NRXN2;ZIC4;ATN1;NEUROD2;BPNT1;TENM1;MYLIP;NELL1;TGFBR1;SMO;RAPGEFL1;LIG4;NLGN1;INHBA;DCHS1;NPAS1;ALDH3A2;MARK4;NDP
prerank,reticulophagy (GO:0061709),0.4908018782302034,1.0098003413419592,0.4745042492917847,0.8334872351707123,1.0,8/12,28.38%,ULK2;UBA5;UFL1;RB1CC1;TEX264;ATG2B;UFC1;ULK1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4590007265138927,1.009713015482146,0.46390374331550804,0.8332401336536005,1.0,3/16,8.32%,SIX1;FTO;TFE3
prerank,DNA dealkylation (GO:0035510),0.5058266080491017,1.0096786053688327,0.47262247838616717,0.8323664075142988,1.0,3/10,13.50%,MPG;FTO;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5058266080491017,1.0096786053688327,0.47262247838616717,0.8323664075142988,1.0,3/10,13.50%,MPG;FTO;ALKBH1
prerank,regulation of centrosome cycle (GO:0046605),0.4393423081739102,1.009623690420346,0.4784876140808344,0.8320270876971213,1.0,8/21,26.63%,PKHD1;CHMP3;MARK4;CHMP4B;PDCD6IP;XRCC3;CHMP2A;ATF5
prerank,DNA recombination (GO:0006310),0.3978315753542413,1.009438596522091,0.47820965842167257,0.8320015010840227,1.0,18/37,31.99%,HMGB1;WRN;RAD50;LIG4;SUPV3L1;TSN;RAD51;XRCC3;RECQL5;FBH1;RTEL1;RPAIN;IGHMBP2;RAD52;RHNO1;MSH2;BLM;ERCC1
prerank,protein targeting to membrane (GO:0006612),0.3629343588584117,1.0090138762498788,0.4722814498933902,0.8326155695225017,1.0,33/83,30.33%,ABCD3;PXMP2;SEC61A1;RABGEF1;PEX5;SSR2;PEX16;PEX13;ATG3;ALDH3A2;SIL1;SSR1;ZDHHC4;ZDHHC20;CHMP4A;CHMP4B;PEX2;ABCD1;ACBD5;PRKCI;PEX14;ZDHHC9;SGTB;TAOK2;GET3;PARD3;VPS37B;SEC62;FIS1;SRPRA;PIKFYVE;ATAD1;SRP14
prerank,ncRNA transcription (GO:0098781),0.46781043833308383,1.0089888001918448,0.4600280504908836,0.8321980193381536,1.0,10/13,36.12%,USPL1;POLR1G;CAVIN1;GTF3C1;GTF3A;NIFK;RPAP2;SIRT7;BRF1;SNAPC3
prerank,lipid oxidation (GO:0034440),-0.38196025347312,-1.008693006553066,0.41496598639455784,0.7342906137184347,1.0,4/12,19.41%,PPARGC1A;ADIPOR1;ALOX12;PLA2G7
prerank,long-term memory (GO:0007616),0.4484159571303685,1.0083185584028946,0.474034620505992,0.8334397348072572,1.0,8/19,21.93%,ARC;SHANK1;KAT2A;CAMK4;EIF2AK4;NFATC4;RASGRF1;LDLR
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.3354899642086262,-1.008138075187573,0.45754716981132076,0.7339099406288075,1.0,4/21,7.04%,PDE4D;NT5C2;NUDT4;PDE2A
prerank,protein K63-linked ubiquitination (GO:0070534),0.3854440813881289,1.0080993226902548,0.47980997624703087,0.8334908175637078,1.0,19/41,30.07%,NEDD4;UBE2B;RNF115;TRIM27;WWP2;ITCH;TRAF3;STUB1;UBE2V2;TRAF3IP2;HECTD1;RNF4;ZFP91;RNF126;UBE2V1;RNF135;TRAF5;PRKN;UBE2S
prerank,ganglioside biosynthetic process (GO:0001574),0.4658024166199661,1.0080329315941217,0.4852941176470588,0.8331629993201988,1.0,4/15,9.01%,ST8SIA2;ST6GALNAC5;ST3GAL2;B4GALT5
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4566872311194767,1.0076887355805066,0.45652173913043476,0.8335524035609574,1.0,9/15,30.33%,SEC61A1;RAB3GAP1;SPCS2;ZFAND2B;RAB3GAP2;SPCS1;SRPRA;ZFAND2A;SRP14
prerank,negative regulation of cell death (GO:0060548),0.3622485332492416,1.0075092886087471,0.48520084566596194,0.8335231523713598,1.0,27/88,26.38%,SRSF6;FGF2;SRGAP2;CCN5;CCN3;LRPAP1;AGR2;TNFRSF1B;IMPACT;BMP4;EIF4G1;PSMC5;CCN4;AKT1;CDK5;CLU;CHMP4A;CHMP4B;NUP62;LRRK2;GPNMB;PINK1;CHMP2A;NENF;HTRA2;NCK1;WNT11
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4368386443895553,1.0073989549709765,0.46296296296296297,0.8333238679221658,1.0,5/17,13.74%,CYFIP1;GMFB;ARFIP2;ARF1;PICK1
prerank,prostanoid metabolic process (GO:0006692),-0.3769606762211588,-1.0072059372872648,0.44642857142857145,0.7346386598380062,1.0,5/13,16.50%,PTGS1;HPGD;GSTM1;PTGR2;CYP2S1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5029582385507346,1.0066719279990535,0.45710059171597633,0.8346712411552146,1.0,3/10,10.20%,ETFDH;ETFB;ETFA
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.4646167874945414,1.0066235867264737,0.4965612104539202,0.8342964701544424,1.0,3/14,12.61%,WNT9A;SOX9;TGFBR1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.4564992936346114,1.0063689141329772,0.47979139504563234,0.834487847731547,1.0,5/16,21.66%,SRSF1;PSIP1;RBM22;NCBP2;SFSWAP
prerank,negative regulation of viral transcription (GO:0032897),0.46672726886253574,1.00575054516195,0.4812760055478502,0.8355935178170335,1.0,6/13,19.46%,TRIM27;UBP1;MID2;HEXIM1;TRIM13;LARP7
prerank,positive regulation of bone resorption (GO:0045780),0.48411369588112235,1.0056832142525254,0.45584045584045585,0.8352769217273502,1.0,3/11,14.67%,PRKCA;MC4R;PLEKHM1
prerank,membrane lipid biosynthetic process (GO:0046467),0.3755529775929598,1.0049145881438621,0.48026315789473684,0.8367238369984958,1.0,7/58,8.59%,ST3GAL4;ACER3;PLPP3;KDSR;ELOVL5;PLPP1;ST3GAL2
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.36766259519343175,1.0047468725089257,0.47502656748140276,0.8366607372834073,1.0,8/72,8.29%,SLIT2;PRKCD;FGF13;EMILIN1;LIMA1;PFN2;SMAD4;IAPP
prerank,negative regulation of multicellular organismal process (GO:0051241),0.34169696858975185,1.0045314731579944,0.4783047426841574,0.8367354317286962,1.0,34/199,12.27%,EGFR;SRSF6;GAS6;ZNF423;NFIB;NPR3;SMAD6;DOCK7;LDLRAD4;HDAC9;SPRED2;PARP3;TRPV3;LRPAP1;ATF4;ACTN3;FOXC2;ACOT11;PFN2;SOX9;RPS6KA4;PGAM5;TFE3;TLE3;BMP4;FOXA1;IP6K1;PCTP;RAB11FIP5;ABHD6;SMAD7;SRF;HEY1;CIDEA
prerank,protein insertion into ER membrane (GO:0045048),0.3984956388609064,1.0042561993259902,0.48375451263537905,0.836978651524172,1.0,17/37,27.76%,STX5;TRAM2;EMC2;ALDH3A2;STX1A;EMC9;EMC1;HMOX1;CAMLG;EMC8;VAMP2;GET4;EMC4;MMGT1;GET3;SEC61B;CCDC47
prerank,liver development (GO:0001889),-0.30281777446816116,-1.004029008138702,0.4624277456647399,0.7411489401581501,1.0,5/32,5.88%,TGFBR3;WNT4;ARID5B;LSR;PROX1
prerank,carboxylic acid catabolic process (GO:0046395),0.467571642296383,1.0040090864597566,0.4791666666666667,0.8370909065324802,1.0,6/12,31.48%,GNPDA1;RENBP;BCKDK;ACOT8;PON3;NAGK
prerank,lymphocyte differentiation (GO:0030098),-0.24641340056737052,-1.0039811461005324,0.4186046511627907,0.7395663788088606,1.0,20/68,20.76%,LEPR;CHD7;KIT;VCAM1;KLF6;JAG2;RHOH;IKZF1;HHEX;PIK3CD;ITGA4;LFNG;AXL;CR2;PTPN22;DLL4;ADGRG3;TOX;SOX4;NHEJ1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.32887386362817617,-1.0037413345342259,0.4386792452830189,0.7384910621955886,1.0,4/23,3.97%,CEMIP;BMP7;APP;PRKAG2
prerank,negative regulation of hydrolase activity (GO:0051346),0.38171402318997083,1.0032571925061373,0.49714937286202965,0.838446112451407,1.0,11/49,13.92%,SLC39A14;RDX;KLRK1;BCAS3;CST3;ZCCHC9;URI1;RCC2;CHP1;ARL2;WNK1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.4149309390133732,1.0031906284209413,0.4934131736526946,0.8381320127730486,1.0,4/27,5.28%,MYOC;ARAP1;TMEFF2;PPFIA1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.41656356602904976,1.0028314831086707,0.4752116082224909,0.8385449545904488,1.0,7/27,17.74%,ZC3H12D;RNASE6;ZC3H12C;LACTB2;XRN1;PCF11;KHNYN
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4802709321277018,1.0028242609371658,0.49719887955182074,0.8380796161523828,1.0,3/12,20.23%,NIN;PCM1;DCTN1
prerank,regulation of lymphocyte activation (GO:0051249),0.47414643520376454,1.002587566065497,0.4786931818181818,0.8381737704432856,1.0,3/12,12.33%,IKZF3;CRTAM;KAT2A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4711769713108901,1.0023414132483088,0.48599439775910364,0.8383232234013881,1.0,2/13,5.17%,PID1;VCP
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3899669328925528,1.0022766495531987,0.4839476813317479,0.838005528250637,1.0,7/39,13.17%,EGFR;PTPN3;RNF115;CBL;PTPN18;PTPN2;STAM2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3715124560673396,-1.0021570794665624,0.4329501915708812,0.7409268452571991,1.0,5/15,15.94%,PRKCH;AGTR1;CSF1;LPL;MSR1
prerank,negative regulation of neurogenesis (GO:0050768),-0.2946590763556322,-1.0020591241186632,0.44021739130434784,0.7394828890323806,1.0,5/34,6.92%,PTN;B2M;RAPGEF2;NOTCH1;ARHGDIA
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.45256419436344175,1.0018651744237248,0.48221343873517786,0.8385873822210252,1.0,3/15,7.40%,ADAM9;EHD1;EHD2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2893442525013044,-1.0017720728166526,0.4319526627218935,0.738505148204204,1.0,8/33,10.47%,TGFA;AFAP1L2;CCDC88A;DGKD;HIP1R;ADRA2A;HBEGF;SHKBP1
prerank,cell cycle G1/S phase transition (GO:0044843),0.37020914751204387,1.0014643242739987,0.49281767955801103,0.8390921595937275,1.0,18/61,21.05%,ACVR1B;ACVR1;E2F3;GSPT1;CUL4A;PHF8;RCC1;CUL1;KHDRBS1;INHBA;CCNE2;LATS2;CDC25A;E2F1;DBF4;CDK2;MAX;BCAT1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.39991085497092466,1.0014241074971564,0.48856799037304455,0.8387118814428076,1.0,4/35,6.57%,THBS1;SPARC;XDH;SULF1
prerank,negative regulation of ossification (GO:0030279),-0.32094023114400694,-1.000987689183428,0.45454545454545453,0.73885474445595,1.0,5/23,7.38%,ENPP1;NOTCH1;SRGN;BCOR;RBPJ
prerank,positive regulation of cellular process (GO:0048522),0.33320346015978125,1.0006485015828215,0.509,0.8401563680292081,1.0,115/565,18.74%,THBS1;PGF;EGFR;LRP6;IRS1;ZFHX3;PRKCD;VEGFA;GAS6;LRP1;LBP;FGF2;P4HB;TIAM1;ACER3;NTRK3;PROK2;FGF17;PRR7;GAB2;LRP5;MAPK15;TGFB3;SHC1;HDAC4;PKHD1;LMNA;WWTR1;HES5;CSNK2A1;TGFB2;TCIRG1;DYNC1H1;PRKCA;DNAJA2;EIF4G2;TNFRSF1B;FXN;FAM98A;ADAM10;IL12RB2;TGFBR2;FZD7;MMP14;FGFR1;MEIS3;CXCL16;SOX9;CAPN10;RARA;S100B;PA2G4;TFE3;AKT2;FCER1G;CDC6;TRPM4;EDN3;MAPK8;BMP4;FGFR2;ITGAV;CDC25B;TBRG4;PLA2G5;CDC123;FAM98B;VIP;FOXM1;CTF1;CHTOP;ATM;MAZ;PHIP;SRF;TGFBR1;HDAC1;NCMAP;EIF4G1;F2R;KMT2D;ACACA;NACC1;SUPV3L1;LMAN2;COLEC12;BMP5;CLCF1;PRDX3;CSPP1;STX4;IL6;EXOSC4;SIRT2;SLC35F6;CNOT8;KLHL22;ERBB2;SMC5;FGF5;NCBP1;SSR1;FLCN;GAREM1;UFL1;PRLR;TRIM13;HDGFL2;CITED2;KIF20B;HCFC1;BIRC5;AKT1;OSMR;GDNF
prerank,regulation of viral entry into host cell (GO:0046596),0.40030495991563686,1.0001028663617673,0.49280575539568344,0.8410299587626667,1.0,5/30,13.94%,GSN;P4HB;TRIM27;MID2;TRIM26
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.49698852314096276,1.0000362012913204,0.5071428571428571,0.8407066856260627,1.0,2/10,12.91%,LRP1;PTPN2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4296514363365699,0.9999784527155168,0.4895833333333333,0.8403798017965609,1.0,7/21,20.81%,MAD1L1;ATM;ZW10;KLHL22;IK;CDC20;MAD2L2
prerank,cardiac muscle tissue development (GO:0048738),0.3769046923794889,0.999925127478486,0.48031496062992124,0.8400328336931924,1.0,11/50,16.74%,CACNA1G;SGCD;HCN4;SMAD4;BMP4;CSRP3;BMPR1A;HEY1;BMP5;AKAP13;KDM6B
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4258225134694619,0.9998558395602591,0.4627594627594628,0.839738512472336,1.0,6/23,22.48%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.46415278214823313,0.9992913246764081,0.4742547425474255,0.8407330233005268,1.0,1/13,0.51%,PLXNA4
prerank,central nervous system neuron development (GO:0021954),-0.3478039903062804,-0.9992007194817762,0.42857142857142855,0.7416724857259172,1.0,2/15,2.55%,MAP2;RAPGEF2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3575031958911029,-0.9991610161287101,0.4772727272727273,0.7401342915611726,1.0,6/17,14.89%,SLC7A5;SYK;PRKCQ;HAVCR2;LGALS9;PRKCZ
prerank,regulation of microtubule-based movement (GO:0060632),0.4974093232775162,0.999156636604624,0.5043731778425656,0.8405691165367523,1.0,2/11,4.94%,CFAP298;DYNLT2B
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.35966774801393386,0.9991469424303779,0.47761194029850745,0.8401156735438539,1.0,24/83,21.05%,ACVR1B;ACVR1;BRD4;E2F3;GSPT1;CDC6;CUL4A;PHF8;RCC1;CUL1;KHDRBS1;CDC45;INHBA;CCNE2;TFDP1;LATS2;CDC25A;CDT1;E2F1;DBF4;CDK2;CDK5;MAX;BCAT1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4273610830256673,0.998992667047002,0.4918238993710692,0.8400033035063227,1.0,14/23,33.90%,MTMR11;SYNJ1;INPP5B;MTMR10;PIP4P2;OCRL;MTMR1;SYNJ2;MTM1;SACM1L;MTMR2;MTMR12;MTMR9;MTMR4
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.3341438364616316,-0.9988177451366804,0.44715447154471544,0.7393538661655836,1.0,2/18,1.64%,BCL2;BCL2L1
prerank,negative regulation of lyase activity (GO:0051350),-0.35930245735977434,-0.9988165220418608,0.46586345381526106,0.7376998306708059,1.0,2/16,1.93%,GRM3;ADGRV1
prerank,regulation of establishment of protein localization (GO:0070201),0.47110230057311886,0.9980301614012356,0.4876373626373626,0.841882267990086,1.0,5/13,24.21%,SCFD1;SPIDR;GAPVD1;DNAJA1;PTP4A3
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3556359274515071,0.9977044422667937,0.48824786324786323,0.8422025808141026,1.0,13/85,13.61%,PIEZO2;COL11A1;COL1A1;LRTOMT;LHFPL5;CDC14A;CHRNB2;TIMM9;ROR1;SLC26A4;SOD1;LRP2;GSDME
prerank,regulation of immune response (GO:0050776),0.3422335097276972,0.997284396548986,0.49896907216494846,0.8427736928379382,1.0,24/135,21.29%,FOXP1;COL3A1;COL1A2;COL1A1;SPN;TGFB2;CD3E;KLRK1;NPDC1;RAET1E;CRTAM;RIPK3;TRAF3;LAG3;COLEC12;N4BP1;DENND1B;ADCY7;CLEC2D;APPL2;APPL1;LAIR1;IL4;CD300LB
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3996752547878333,-0.9971214214321621,0.44954128440366975,0.7403491341160349,1.0,5/10,28.09%,ANO6;CD300A;C3;TREM2;NCKAP1L
prerank,tricarboxylic acid metabolic process (GO:0072350),0.47110465074958063,0.9970005892404237,0.4895977808599168,0.8429749745376084,1.0,8/12,34.22%,ACO1;IREB2;IDH3B;ACLY;IDH3G;IDH2;IDH1;GLUD1
prerank,regulation of keratinocyte migration (GO:0051547),0.4826271436063374,0.996855718791608,0.4914772727272727,0.8428771210160179,1.0,2/12,11.51%,ADAM9;IQSEC1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2896414586201978,-0.9967580706062594,0.47019867549668876,0.7396030059426372,1.0,13/37,19.72%,BCL2;BCL2L1;DNM1L;NUPR1;BOK;CAV1;RPS7;BCL2L11;STYXL1;EIF5A;RACK1;RPS3;MSX1
prerank,signal transduction in response to DNA damage (GO:0042770),0.3751674009797206,0.9967578002722828,0.4983089064261556,0.842639892678045,1.0,24/49,30.66%,MDM4;NDRG1;TIPRL;RAD1;ABL1;ATM;CHEK2;SESN2;CEP63;ATRIP;HUS1;E2F1;BID;USP10;MAD2L2;TRIAP1;DONSON;TP53;ATR;GRB2;INTS7;RAD17;RHNO1;HINFP
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.39085078673915635,0.9962064812335854,0.4777911164465786,0.8435283468076553,1.0,14/33,30.51%,PPP6R3;TERT;TELO2;RAD50;DCLRE1B;RAD51;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1;CTC1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4480790636438268,0.9960019944030419,0.4987012987012987,0.8435775708594735,1.0,5/18,17.73%,DDR2;EMILIN1;RUNX1;IL6;IER3IP1
prerank,neuron cell-cell adhesion (GO:0007158),-0.3602453336305341,-0.9958973207390345,0.45555555555555555,0.7401194290428706,1.0,6/14,15.19%,NRXN1;ASTN2;NCAM2;CNTN4;NRXN3;ASTN1
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.34061746281929683,-0.9958312393022237,0.44047619047619047,0.7386277808568142,1.0,4/18,7.69%,APOE;ABCG1;TMCC2;NSG1
prerank,positive regulation of cell cycle process (GO:0090068),0.3571310591590786,0.9956376095549228,0.5005246589716684,0.8439661228503931,1.0,23/91,21.33%,CIT;PRKCE;LRP5;DYNC1H1;CDC14A;GIPC1;CDC6;RHOA;EDN3;PKN2;CDC25B;SPAST;PHIP;RCC2;OPN1MW;CSPP1;SIRT2;USP19;KIF20B;DBF4;XRCC3;NUP62;DRD2
prerank,DNA double-strand break processing (GO:0000729),0.4345946136420537,0.9952699506283073,0.4778523489932886,0.8444488929094233,1.0,10/18,31.69%,RBBP8;ATM;RAD50;UBE2V2;SMARCAD1;RNF138;SLX4;RAD52;UBE2N;BLM
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.39738913365861633,0.995245174769548,0.5087924970691676,0.8440222372626024,1.0,6/35,13.08%,MYOC;EPHB2;TGFB2;LZTR1;SCAI;ARHGAP44
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.36369909556048047,-0.9947637055059436,0.4388185654008439,0.7397133073857003,1.0,8/17,17.08%,BMP6;SASH1;LY86;CD180;CACTIN;CX3CL1;SIGIRR;CD55
prerank,protein-DNA complex disassembly (GO:0032986),0.45095142306546104,0.9944960707545448,0.4905149051490515,0.8453722727996819,1.0,7/16,29.70%,SMARCC2;NFE2;HMGA1;SMARCA4;ARID1A;SMARCD2;SMARCC1
prerank,neutrophil degranulation (GO:0043312),0.3326445132385914,0.9943241147998749,0.528,0.8453241303340043,1.0,122/425,28.49%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2;ACTR2;CYSTM1;CAND1;CAPN1;PLAUR;LAMTOR3;NPC2;SURF4;CANT1;QPCT;ABCA13;MANBA;ACLY;RAB3A
prerank,positive regulation of lipid localization (GO:1905954),0.4759109350356078,0.994246437800453,0.5084745762711864,0.8450528616563251,1.0,1/11,1.02%,LRP1
prerank,epithelial structure maintenance (GO:0010669),-0.3992373936786082,-0.9941920411307669,0.46254071661237783,0.739606253718918,1.0,2/11,5.80%,RBP4;CXADR
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.45416405456072023,0.9939411330884022,0.4896640826873385,0.8453735277471083,1.0,5/15,13.52%,EGFR;NTRK1;ABL1;DDR1;SRMS
prerank,cellular protein catabolic process (GO:0044257),0.369313007836565,0.9939092138997275,0.4760312151616499,0.844972823176696,1.0,18/59,22.57%,FAP;TCIRG1;AP2A1;CLPP;CAPN2;CHEK2;MYLIP;LONP1;PSMA6;AP2A2;CLTC;IDE;CTSZ;UBE2G2;CLTA;CTSB;CTSK;CTSO
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.47225528567792613,0.9938760487016407,0.4924554183813443,0.8445832337285165,1.0,7/12,27.67%,GNL3;CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3753489364494797,0.9935690115999368,0.5056689342403629,0.8448565066533035,1.0,18/50,27.30%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;PSMA1
prerank,glial cell differentiation (GO:0010001),0.4061519025440993,0.993490035985345,0.4963680387409201,0.8445885078995565,1.0,9/28,23.14%,NFIB;HES5;STAT3;SOX9;PICK1;GPR157;CDK5;GPC1;SOX8
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.49626661540252,0.9933431350221282,0.48625180897250364,0.8445045790366972,1.0,4/10,16.02%,PLS1;TSKU;SOD1;IFT88
prerank,regulation of interleukin-6 production (GO:0032675),0.35284838522996154,0.9928947201064321,0.5184404636459431,0.8451156466550636,1.0,15/96,15.27%,GAS6;LBP;IL33;TWIST1;RAB7B;STAT3;MAVS;HMGB1;IRAK3;C1QTNF4;HSPD1;F2R;SETD4;IL6;ARRB1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.40333691447246767,0.9927447558290293,0.48721071863581,0.8450152862098728,1.0,6/27,8.10%,AHNAK;CAMK2D;CALM2;DMD;ANK2;SELENON
prerank,regulation of chemotaxis (GO:0050920),0.39829328995225055,0.9927140835829271,0.49876543209876545,0.8446191563209777,1.0,1/30,0.08%,THBS1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.4325623397578048,0.9925907323749238,0.49550706033376124,0.8444470753370745,1.0,10/20,30.57%,OGT;RIPK3;STUB1;ASAH1;PDCD6IP;BIRC3;CYLD;RIPK1;HSP90AA1;SPATA2
prerank,receptor catabolic process (GO:0032801),0.42145163530787144,0.9922807448858207,0.5068836045056321,0.8447333180385951,1.0,9/24,23.07%,NEDD4;AP2A1;MYLIP;AP2A2;CLTC;GPRASP1;CLTA;MVB12A;UVRAG
prerank,positive regulation of actin nucleation (GO:0051127),0.4880927044798945,0.9921230004834212,0.5043227665706052,0.8446791847553428,1.0,4/11,21.51%,GSN;CYFIP1;SCIN;ABI2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.48189711108718136,0.9919595703229621,0.49714285714285716,0.8446072539865481,1.0,4/11,15.40%,PTGIS;FAP;CIDEA;SIRT2
prerank,positive regulation of cell migration (GO:0030335),0.334783397268933,0.9918441317074069,0.5255767301905717,0.8443875984769621,1.0,28/253,7.68%,THBS1;MYOC;EGFR;VEGFA;F3;DDR2;ADAM9;COL1A1;TWIST2;TIAM1;NTRK3;DRD1;PRKCE;RDX;ACVR1B;EPHB2;TGFB2;STAT3;SEMA3E;PRKCA;ACVR1;ADAM10;MMP14;DOCK5;SEMA4B;CXCL16;ELP5;SOX9
prerank,cellular transition metal ion homeostasis (GO:0046916),0.356685291218131,0.9916906170666191,0.52,0.8442947287964926,1.0,20/91,17.54%,SCARA5;SLC39A14;FLVCR1;HMOX2;FXN;SLC39A7;SMAD4;ACO1;SLC30A5;SLC39A13;ATP6V0D1;ARF1;SOD1;CUL1;CYBRD1;ABCB6;FRRS1;IREB2;SLC30A9;HMOX1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4760860073125661,0.9916519490990923,0.4887005649717514,0.8439144832251116,1.0,5/12,24.64%,PRKDC;SDE2;CDK2;TP53;RPS27L
prerank,positive regulation of protein binding (GO:0032092),0.36969302127282805,0.9915974867058669,0.5055066079295154,0.8435736406081717,1.0,11/56,13.73%,PKD1;LRP1;TCF7L2;TIAM1;DACT1;BMP4;ABL1;NVL;TERT;ADD1;USP33
prerank,negative regulation of DNA recombination (GO:0045910),0.38056124393098856,0.9909538173647148,0.509090909090909,0.8446316847979266,1.0,21/43,32.75%,HELB;PARP3;RMI2;POLR2F;MAD2L2;POLR2B;DAXX;POLR2H;CGAS;ZRANB3;FBH1;RTEL1;SHLD3;SHLD1;POLR2I;POLR2L;PARPBP;MSH2;BLM;POLR2K;POLQ
prerank,steroid catabolic process (GO:0006706),0.49647660590859494,0.9909116377961191,0.5,0.8442596752793131,1.0,2/10,14.77%,CYP19A1;CYP27B1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.40185636095225447,-0.9903232517909092,0.4825174825174825,0.7476834257411421,1.0,2/10,2.55%,ZEB2;RAPGEF2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.4122178265030625,0.9898329525003601,0.4840686274509804,0.8463567737145062,1.0,4/26,8.87%,EFNA5;LRP5;ADCY8;TRPM4
prerank,cellular protein modification process (GO:0006464),0.327673082792057,0.9891730847847698,0.567,0.8474964948400081,1.0,276/982,24.73%,PLOD2;THBS1;DCLK1;ST3GAL4;ST8SIA2;IGFBP5;CHRDL1;PRKCD;FSTL1;GAS6;COL3A1;GPC3;P4HB;NTRK1;MARK1;PRKCE;PTPN3;FBXO10;PPP1CC;LOXL1;DMP1;ACVR1B;TGM5;TGM6;FBXL7;PSMD7;CLK3;CSNK1D;PARP3;CAMK2D;RAB2A;FBXW8;CEL;MAP3K5;STRADA;PTPRS;PTPRF;PTP4A2;DUSP11;TNK1;PTPRU;CSNK2A1;COP1;TGFB2;DCAF6;LIMK2;MORC3;GGCX;P3H1;FASTK;PRKCA;PSMA8;NRBP2;ACVR1;B3GNT7;PRKCSH;ILK;ERCC8;NEK7;GPAA1;PRKDC;PPM1H;ERN2;ADAM10;TGFBR2;SIRT5;TLK1;STK39;BCR;RAB8A;LOX;QSOX1;FGFR1;IRAK3;CKAP4;WIPI2;CDK10;ARF4;RPS6KA4;GPS1;MBTPS1;NAGPA;RARA;SOCS6;PAK4;PMM2;SOCS2;AKT2;ST3GAL2;CST3;WWP2;PPM1M;B4GALT5;DAPP1;CDK12;PTPN18;GMFB;PPP3CC;PKN2;PAK2;ILF3;CALU;MAPK8;PSMA4;ANXA1;BMP4;CDC25B;CUL4A;NPC1;CHUK;TNNI3K;RIPK3;UCHL3;RAB38;RCN1;FBXL4;ABL1;IRAK1;MAP4K5;MAP3K12;LCMT1;FUT4;ATM;BMPR1A;CHEK2;FBXO22;FBXL12;PDPK1;GRK6;ATG3;PSMD12;NRBP1;WDR5;TULP4;CUL1;CSNK1E;TGFBR1;FBXL19;PSMA6;PPEF2;STK25;RBBP7;B3GNT9;RAB11B;PICK1;DMPK;MARK4;NUCB1;WNK1;DCAF13;TNKS2;FRK;SRPK1;FBXL14;TBCK;ATE1;BRD2;PSMD1;MIA3;NGLY1;DDA1;UBE2L6;IL6;FBXO17;SIRT2;FBXL20;PSMC5;LATS2;CAMK4;CDC42BPB;TLK2;PSMD11;KLHL22;CREB1;COQ8B;PPP2R5C;B3GNT6;PARP1;ILKAP;ERBB2;TP53RK;PSMC4;PSMD14;VCAN;LIPT1;HASPIN;STT3A;MKNK2;GNMT;BIRC6;NTAQ1;UFL1;SIK2;ALG1;MEN1;PRKAG1;CHST5;DAPK3;ARAF;FBXL18;BCKDK;SUMF2;SENP8;VRK2;CLK2;BIRC5;RNF7;CDK20;MAST2;CDKL2;FBXW2;AKT1;ASB5;HIPK2;ALG3;CDK2;IKBKE;FBXW4;PPM1J;CDK5;PRKAB1;APLP2;EIF2AK4;PSMA3;PIGT;SGK3;MAPK9;GRK4;PRKACA;DCAF11;PENK;PSMB1;NEK4;METAP1D;PSMD4;LRRK2;CSNK1G3;RAB1A;COPS4;B3GNT2;JAK1;LOXL2;CAMK1;CDKL3;CUL9;STK38;UBA3;EIF2AK3;PRKCI;ASB6;FAM20A;RAB1B;PSMA5;MTM1;MAN2B1;B4GALT7;FBXO11;PSMA7;PGAP1;PLK4;TAOK3;VGF;COPS7A;PHEX;PHKA2;TAF1;FBXO9;CSK;ANKRD9;TBK1;METAP2;ROCK1;PINK1;OGA;LMTK2;CDK13
prerank,axoneme assembly (GO:0035082),0.399279256672497,0.9889290366652769,0.5096852300242131,0.8476404622437259,1.0,8/30,22.72%,CFAP206;DNAAF3;CCDC39;LRGUK;TTLL3;SPAG17;TTC12;SPAG16
prerank,cellular response to radiation (GO:0071478),0.3862565093165465,0.9888722289079055,0.4970484061393152,0.8472992370911815,1.0,19/40,31.69%,RAD1;SPIDR;SWI5;LIG4;TANK;OPN1MW;OPN1MW3;RHOB;HUS1;RAD51;TNKS1BP1;OPN3;TP53;RRH;GPR52;GRB2;INTS7;RHNO1;BLM
prerank,neutrophil activation involved in immune response (GO:0002283),0.330714142449353,0.9887727510813593,0.545,0.8470837426004437,1.0,122/428,28.49%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2;ACTR2;CYSTM1;CAND1;CAPN1;PLAUR;LAMTOR3;NPC2;SURF4;CANT1;QPCT;ABCA13;MANBA;ACLY;RAB3A
prerank,neutrophil mediated immunity (GO:0002446),0.3303870715974234,0.9886685070300472,0.538,0.8468585101283028,1.0,109/432,25.64%,PRKCD;PYGB;GSN;TIMP2;IGF2R;CRACR2A;PSMD7;ARSB;CEACAM3;ANXA2;TCIRG1;HMOX2;DNAJC13;COPB1;RAB24;DYNC1H1;UBR4;LPCAT1;VCP;STBD1;TNFRSF1B;GAA;LAMTOR1;ATP6V0A1;ADAM10;HMGB1;ARSA;QSOX1;PTGES2;CREG1;CKAP4;FAF2;RNASE3;B4GALT1;JUP;HUWE1;GDI2;PA2G4;CYFIP1;FCER1G;CST3;RHOA;ATP8A1;ITGAV;COMMD9;PLAC8;GHDC;GLIPR1;RAB3D;PSMD12;CAP1;AMPD3;AP2A2;PAFAH1B2;DERA;TOM1;FRK;SNAP23;MLEC;PSMD1;CAT;IL6;RAB4B;IQGAP1;NAPRT;PSMD11;STOM;PSMD14;ACP3;ORMDL3;ACTR1B;GLB1;RAB5B;IST1;AOC1;ACTR10;CTSZ;PTAFR;ASAH1;XRCC6;HVCN1;DOK3;SLC27A2;LAIR1;LAMP1;CCT8;CTSB;PSMB1;LAMP2;RAB18;SLC11A1;MAGT1;VNN1;PSMA5;MAN2B1;PYGL;BST1;NRAS;SCAMP1;ROCK1;CDK13;GNS;KCMF1;S100A11;TUBB4B;VPS35L;VAMP2;GUSB;LAMTOR2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4462373234840596,0.9885046978954257,0.47989276139410186,0.8467792382297131,1.0,7/16,28.67%,NAA60;NAA40;NAA16;CREBBP;KAT2B;NAA15;NAA25
prerank,secretory granule organization (GO:0033363),0.4851974248912809,0.9883248044741408,0.5211678832116788,0.8467698234279492,1.0,4/10,13.71%,BLOC1S2;F2R;BLOC1S3;ABCA1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.31457882989809566,-0.9882077258803519,0.47572815533980584,0.7512753224613813,1.0,12/25,25.72%,DNM1L;PDCD5;FAM162A;BCL2L11;MFF;GPER1;PYCARD;BIK;PPIF;BNIP3;HRK;PMAIP1
prerank,phosphorylation (GO:0016310),0.33041452049906994,0.9881434390845697,0.5455455455455456,0.8467183596936454,1.0,144/384,27.52%,DCLK1;PRKCD;GAS6;NTRK1;MARK1;PRKCE;ACVR1B;EPHB2;CLK3;CSNK1D;CAMK2D;MAP3K5;NADK;STRADA;TNK1;CSNK2A1;TGFB2;STAT3;LIMK2;MORC3;SHPK;FASTK;PRKCA;NRBP2;ACVR1;ILK;NEK7;PRKDC;ERN2;ADAM10;TGFBR2;TLK1;STK39;BCR;FGFR1;IRAK3;CDK10;RPS6KA4;RARA;PAK4;DGKQ;CDK12;GMFB;PKN2;PAK2;ILF3;MAPK8;CDC25B;CHUK;TNNI3K;ABL1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;PDPK1;GRK6;NRBP1;PIK3CB;CSNK1E;TGFBR1;STK25;PICK1;DMPK;MARK4;WNK1;LIMD1;FRK;SRPK1;TBCK;BRD2;LATS2;CAMK4;CDC42BPB;TLK2;CREB1;COQ8B;ERBB2;TP53RK;HASPIN;PGK1;MKNK2;BIRC6;SIK2;PRKAG1;DAPK3;BCKDK;VRK2;CLK2;BIRC5;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;CDK5;PRKAB1;EIF2AK4;SGK3;MAPK9;GRK4;PRKACA;NEK4;LRRK2;PANK3;JAK1;CAMK1;CDKL3;STK38;EIF2AK3;PRKCI;TOP1;FAM20A;PLK4;TAOK3;TAF1;CSK;TBK1;ROCK1;PINK1;LMTK2;CDK13;TAOK2;TYK2;STK3;STK24;TKFC;PRRT1;TAOK1;NIM1K;WNT11;SGK1;ERN1;CCL2;NEK6;MAP3K11;MEX3B;PNKP;CSNK1A1;PI4KA
prerank,fat cell differentiation (GO:0045444),0.36489839845103744,0.9880950914681355,0.49445676274944567,0.8463749134152648,1.0,5/57,8.56%,PID1;TCF7L2;SMAD6;BBS9;AKT2
prerank,lipoprotein biosynthetic process (GO:0042158),-0.3889800855812199,-0.9876026637426639,0.4642857142857143,0.7510764466493665,1.0,1/11,1.38%,APOE
prerank,regulation of protein neddylation (GO:2000434),0.4896114182425886,0.9876026344481067,0.524517087667162,0.8470882463352594,1.0,2/10,12.60%,DCUN1D5;DCUN1D2
prerank,translational termination (GO:0006415),0.3496599008058284,0.9874575228257954,0.5163329820864068,0.8469726025225961,1.0,30/95,28.46%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;GSPT1;MRPS18B;MTRF1L;MRPL39;ABCE1;MRPS14;MRPL35;ETF1;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;TRMT112;MRPL30;MRPL4;MRPL11
prerank,positive regulation of TOR signaling (GO:0032008),0.38053234319062684,0.9865334054873156,0.5099415204678363,0.8487185019617014,1.0,18/40,32.53%,GAS6;SEC13;LAMTOR1;SEH1L;CLEC16A;TELO2;KLHL22;FLCN;GOLPH3;RHEB;RPTOR;SMCR8;LAMTOR2;LAMTOR3;GPR137B;HTR6;HDAC3;PIK3CA
prerank,regulation of gluconeogenesis (GO:0006111),0.4006670978885906,0.986072286275434,0.48116646415552855,0.8493691933853659,1.0,8/27,18.34%,DGKQ;OGT;NNMT;PTPN2;USP7;ARPP19;GNMT;CLK2
prerank,negative regulation of T cell proliferation (GO:0042130),0.402516251093893,0.9856920011789444,0.4955300127713921,0.8498465211965639,1.0,5/28,13.12%,SPN;GLMN;CRTAM;VTCN1;CD80
prerank,regulation of primary metabolic process (GO:0080090),0.34122020761761224,0.9854332804292052,0.5268041237113402,0.850005239040008,1.0,35/126,23.75%,ID2;TNFAIP8L3;CHD9;NCOR2;PSMD7;RXRA;PSMA8;PLPP1;CARM1;PSMA4;SREBF1;PSMD12;NR1D2;PSMA6;ACACA;PSMD1;PSMC5;PSMD11;CREBBP;PSMC4;PSMD14;SIN3B;AZIN1;NFYA;LSS;PRKAB1;PSMA3;SC5D;GPS2;PSMB1;PSMD4;LDLR;PSMA5;PSMA7;TM6SF2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3971972071610113,0.9853628873465797,0.5200471698113207,0.849698218410638,1.0,12/33,21.75%,SYMPK;MAZ;PABPN1;CLP1;CPSF4;PCF11;NCBP1;CPSF7;NCBP2;CSTF2;CSTF2T;SNRPB
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.45821551864107113,0.9851670333510638,0.5063291139240507,0.849709817269043,1.0,2/13,5.15%,GAS6;MAVS
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.35984425692943944,0.9849067871530185,0.505933117583603,0.8498749515915418,1.0,22/67,23.60%,PSMD7;PSMA8;PSMA4;ITGAV;PDIA3;CHUK;PSMD12;PSMA6;SEC22B;SNAP23;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;CALR;PSMB1;PSMD4;PSMA5;PSMA7;ITGB5
prerank,intermediate filament organization (GO:0045109),-0.355569461094764,-0.984684358543698,0.4493927125506073,0.7567050754101925,1.0,6/17,16.84%,DES;VIM;PKP2;KLHL24;DSP;GFAP
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4569768501249677,0.98459397470634,0.5006915629322268,0.8501812657010176,1.0,8/14,32.30%,FUS;WDR48;MMS19;PARP1;ACTR2;WAS;TIMELESS;ERCC6
prerank,neuron projection morphogenesis (GO:0048812),0.3426868300403075,0.984401804508701,0.534288638689867,0.8501507978996569,1.0,24/137,13.48%,DCLK1;CTNND2;SRGAP2;MAP1B;FARP1;CTTN;ANKRD27;EPHB2;ARC;DOCK7;DNM2;DVL1;EPHB3;RAB8A;LLGL1;DLG4;S100B;IMPACT;FGFR2;TMEM106B;SHANK1;NLGN1;LRP2;MEF2A
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3551071081171647,0.9842918882595844,0.5015940488841658,0.8499352022540633,1.0,12/76,17.16%,ESR1;CMKLR1;PLCE1;DRD1;FPR3;GPR20;VIP;P2RY6;F2R;GNA11;GPR157;CALCA
prerank,cranial nerve development (GO:0021545),-0.3811306671887296,-0.9839540488268437,0.46006389776357826,0.756981191562159,1.0,2/11,8.86%,CHD7;SALL1
prerank,regulation of myelination (GO:0031641),0.4032779402159317,0.98391947616618,0.49133663366336633,0.8503381732907325,1.0,7/25,15.94%,LGI4;HES5;TMEM98;TNFRSF1B;NCMAP;SIRT2;NKX6-2
prerank,pseudouridine synthesis (GO:0001522),0.4572656255463954,0.9835359565360808,0.49173553719008267,0.8507851553881443,1.0,8/13,34.70%,PUS3;TRUB1;PUS1;PUS10;DKC1;NOP10;PUS7;PUS7L
prerank,regulation of oxidative phosphorylation (GO:0002082),0.44836941001529385,0.9834826712829413,0.5054054054054054,0.8504357247959533,1.0,7/16,24.51%,ACTN3;VCP;SHMT2;MLXIPL;ABCD1;COX7A2L;PINK1
prerank,cellular response to growth factor stimulus (GO:0071363),0.33923229376878006,0.9834041796671137,0.5335365853658537,0.8501524668200251,1.0,32/151,15.54%,EGFR;TMEM100;VEGFA;SMAD9;NTRK3;NTRK1;EHD1;ACVR1B;SHC1;GAS1;KIDINS220;PDE3A;RAMP2;ACVR1;SMAD4;TGFBR2;SOX9;ANXA1;BMP4;SYAP1;RUNX2;URI1;BMPR1A;PDPK1;SMAD7;NRP1;TGFBR1;LRP2;NDNF;HGF;SIRT2;IQGAP1
prerank,regulation of GTPase activity (GO:0043087),0.3349524427395236,0.9830769383695073,0.5278622087132725,0.85049306269688,1.0,33/177,14.16%,PLXNA4;SGSM2;EFNA5;SRGAP2;ASAP3;ARAP1;NTRK1;RDX;VAV2;CCL13;SIPA1L1;FGD6;CCL15;KLRK1;BCAS3;SNX18;RAB3GAP1;EPHB3;S100A10;RIC1;ADAP1;RGP1;ZC3H15;SNX9;SOD1;RCC2;EVI5L;F2R;ARHGAP44;OCRL;ARL2;WNK1;NDEL1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36817734750917946,0.9828087881988432,0.5186020293122886,0.8507095201319462,1.0,17/53,23.58%,PSMD7;PSMA8;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;BCKDK;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.2370738290690287,-0.9828038476772334,0.5172413793103449,0.7583215941468813,1.0,19/86,12.97%,OCLN;APOE;APP;EVL;SEMA5A;NAV3;RB1;PROX1;CDC42EP4;BAIAP2;SYNPO2;CDC42EP3;LMOD1;PAK1;CLIP1;EDN1;PLEK;GPX1;CX3CL1
prerank,ceramide biosynthetic process (GO:0046513),-0.2847944499176196,-0.9819472310695162,0.4701492537313433,0.7588304894432608,1.0,6/40,5.41%,ST6GALNAC3;CERS4;SGMS1;ST8SIA4;DEGS2;ST8SIA6
prerank,regulation of histone deacetylation (GO:0031063),0.4530419871562592,0.9818107223051824,0.4907801418439716,0.8525803031274792,1.0,5/13,28.37%,CAMK2D;NIPBL;AKAP8;SAP30BP;SPHK2
prerank,post-translational protein modification (GO:0043687),0.3305191963414553,0.9814531353118845,0.561,0.8529682347404866,1.0,113/332,29.04%,IGFBP5;CHRDL1;FSTL1;GAS6;GPC3;P4HB;FBXO10;DMP1;FBXL7;PSMD7;RAB2A;FBXW8;PTP4A2;COP1;DCAF6;PSMA8;PRKCSH;ERCC8;ADAM10;RAB8A;QSOX1;CKAP4;GPS1;MBTPS1;SOCS6;SOCS2;CST3;CALU;PSMA4;BMP4;CUL4A;UCHL3;RAB38;RCN1;FBXL4;FBXO22;FBXL12;PSMD12;WDR5;TULP4;CUL1;FBXL19;PSMA6;RBBP7;RAB11B;NUCB1;DCAF13;FBXL14;PSMD1;MIA3;DDA1;IL6;FBXO17;FBXL20;PSMC5;PSMD11;KLHL22;PSMC4;PSMD14;VCAN;STT3A;MEN1;FBXL18;SUMF2;SENP8;RNF7;FBXW2;ASB5;FBXW4;APLP2;PSMA3;DCAF11;PENK;PSMB1;PSMD4;RAB1A;COPS4;CUL9;UBA3;ASB6;RAB1B;PSMA5;FBXO11;PSMA7;VGF;COPS7A;FBXO9;ANKRD9;PSMC1;CCDC8;CUL7;COPS3;RAB5A;DCAF5;FBXW10;ESCO1;DCAF4;RABGGTB;SDC2;DCAF17;CAND1;PSMA1;SCG2;KCTD7;DDB1;STT3B;RAB3A;FBXL8;FBXO41;RBX1;BTRC;ANO8;WDTC1
prerank,cellular response to cadmium ion (GO:0071276),0.4070706946676439,0.9814483489083707,0.4784217016029593,0.8525137856892125,1.0,9/24,27.84%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX;HSF1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.46621398604719394,0.9802969557308266,0.5007112375533428,0.8547526101824489,1.0,5/12,22.07%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,response to histamine (GO:0034776),-0.4150409695334958,-0.9801169654955069,0.4750830564784053,0.7618974322682294,1.0,3/10,8.61%,GABRB1;GABRB3;GABRB2
prerank,cellular response to amino acid stimulus (GO:0071230),0.3848945177610965,0.9798907088730409,0.5029797377830751,0.8552299134054416,1.0,9/33,18.72%,IPO5;SESN3;LAMTOR1;CASTOR2;CAPN2;SESN2;NSMF;KLHL22;UBR2
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2813728715165973,-0.9797575027247041,0.5031847133757962,0.7611389174648145,1.0,5/41,5.22%,TJP1;PODXL;GCNT2;BMP7;PIEZO1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.31527406668772995,-0.9797200091103936,0.4577114427860697,0.7595743756408748,1.0,5/24,10.40%,ITPR1;RYR2;ITPR3;HTR2C;ITPR2
prerank,keratan sulfate catabolic process (GO:0042340),-0.38923631199413383,-0.9794561762146017,0.48322147651006714,0.7585666860832502,1.0,3/11,9.20%,FMOD;LUM;OGN
prerank,regulation of cell communication (GO:0010646),0.3870001867081684,0.9792490829463136,0.5287221570926143,0.856344215302921,1.0,7/35,11.94%,MGLL;CAMK2D;ANK2;SOCS2;ANXA1;GRK6;NCLN
prerank,heme catabolic process (GO:0042167),0.44218749854318407,0.9790266181570995,0.4900398406374502,0.8559493459529106,1.0,2/14,4.28%,ABCC1;HMOX2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.44218749854318407,0.9790266181570995,0.4900398406374502,0.8559493459529106,1.0,2/14,4.28%,ABCC1;HMOX2
prerank,amide transport (GO:0042886),0.401029425228282,0.9789865548771269,0.5080745341614907,0.8555666879553941,1.0,3/26,7.03%,SLC5A6;SLC25A32;DISP1
prerank,protein oxidation (GO:0018158),0.48542116275218505,0.9788442981474672,0.5173913043478261,0.8554480492316793,1.0,4/11,22.20%,LOXL1;LOX;PRDX3;LOXL2
prerank,cellular response to insulin stimulus (GO:0032869),0.34135916539710703,0.9785241748135384,0.5215605749486653,0.855729079227401,1.0,26/124,16.21%,IRS1;SLC39A14;GRB10;RHOQ;ATP6V1C2;SHC1;HDAC9;TCIRG1;C2CD5;FOXC2;ATP6V0A1;PRKDC;RAB8A;CAPN10;AKT2;ZNF106;SYAP1;ATP6V0D1;PDPK1;PHIP;PTPN2;ATP6V1B2;ATP6V1E1;SOS1;IDE;PARP1
prerank,regulation of cellular senescence (GO:2000772),-0.28877447213561114,-0.9784666179527628,0.5135135135135135,0.7594252860462863,1.0,6/28,9.41%,CDK6;B2M;SLC30A10;AKT3;NUAK1;ABI3
prerank,regulation of telomerase activity (GO:0051972),0.3729869423536541,0.9784150704347904,0.5244186046511627,0.8555174517464291,1.0,16/45,30.44%,MAPK15;NEK7;SMG6;ERCC4;NVL;ATM;MEN1;CCT4;MAP2K7;TCP1;TP53;PARP4;DKC1;PNKP;CTNNB1;HSP90AA1
prerank,membrane raft organization (GO:0031579),0.43478380959610863,0.9780302877764053,0.5034578146611342,0.8559960566041195,1.0,3/15,9.93%,ANXA2;S100A10;NPC1
prerank,positive regulation of histone acetylation (GO:0035066),0.41320000603549445,0.9779841371103252,0.5044472681067345,0.855645937505591,1.0,4/23,7.77%,MUC1;SMAD4;TADA2A;RPS6KA4
prerank,midbody abscission (GO:0061952),0.44375567616912714,0.977653079870477,0.508519003931848,0.8559762149869559,1.0,6/17,24.56%,CHMP3;MITD1;CHMP4A;CHMP4B;PDCD6IP;CHMP2A
prerank,positive regulation of cellular respiration (GO:1901857),0.47418816358335086,0.9776016862859342,0.5273492286115007,0.8556389741919204,1.0,5/11,24.51%,VCP;IFNLR1;IL4;ISCU;PINK1
prerank,positive regulation of organelle assembly (GO:1902117),0.3777237478988378,0.9770872998216135,0.5110081112398609,0.8563714675107208,1.0,18/44,27.18%,SDC1;IL5;DYNC1H1;LRSAM1;RAB3GAP1;PIP4K2B;MARK4;G3BP2;FUZ;KCTD17;RAB3GAP2;PDCD6IP;NUP62;PLK4;ARHGAP35;CCP110;TAPT1;PIP4K2C
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4642803387118747,0.9769285206943359,0.5118549511854951,0.8562686328211147,1.0,4/13,20.99%,GAB2;STX4;IL4;LAMP1
prerank,regulation of aerobic respiration (GO:1903715),0.4422169712368114,0.9767090631323645,0.5195681511470985,0.8562938125084875,1.0,8/15,27.36%,ACTN3;VCP;IDE;SHMT2;ABCD1;COX7A2L;PINK1;NOP53
prerank,organic hydroxy compound transport (GO:0015850),-0.28014007804487684,-0.9766573652911946,0.4965034965034965,0.7623616417994046,1.0,4/36,2.34%,ABCC4;SLCO2B1;SLCO1C1;RBP4
prerank,negative regulation of TOR signaling (GO:0032007),0.38662153745749395,0.9765085593394027,0.5311004784688995,0.8563205897742807,1.0,14/36,23.77%,NPRL3;SESN3;CASTOR2;AKT1S1;ATM;DEPTOR;SESN2;TMEM127;MINAR1;FLCN;UBR2;KPTN;TSC2;NPRL2
prerank,regulation of acute inflammatory response (GO:0002673),0.4341278372587083,0.9764703603126524,0.5228758169934641,0.8559478072772196,1.0,4/18,20.97%,IL6;PTGES;OSMR;IL4
prerank,cytoskeleton organization (GO:0007010),0.3402019451712642,0.9764518019146325,0.5283213182286303,0.8555229459210781,1.0,13/114,9.03%,MICAL2;RHOBTB1;PLCE1;FMNL2;MARK1;RND3;ARC;CCL13;FGD6;BRWD1;PAK4;PALLD;RHOA
prerank,vacuolar acidification (GO:0007035),0.41193227718909237,0.9763958032837352,0.5229357798165137,0.8551866936682455,1.0,8/21,30.40%,TCIRG1;ATP6V0A1;ATP6V0D1;CLN3;SLC11A1;ATP6V0E1;CLN5;ATP6V1H
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4547930728253149,0.976243593757148,0.5084033613445378,0.8550837567016297,1.0,5/13,22.07%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.37488085317253184,0.9760881526769506,0.5159817351598174,0.8549895746023194,1.0,11/45,18.91%,EGFR;PLCE1;SHC1;SOX9;CBL;PDPK1;SOS1;IQGAP1;GAREM1;AKT1;ERBIN
prerank,positive regulation of catalytic activity (GO:0043085),0.38190770372822586,0.9760490923868421,0.49765258215962443,0.854622844858096,1.0,9/37,15.15%,BCAS3;FXN;MAPK8;WRN;ABL1;CHTOP;SOD1;PSEN2;STX4
prerank,cGMP metabolic process (GO:0046068),-0.38050223544966433,-0.9760479218778761,0.47686832740213525,0.7621721328690302,1.0,5/12,21.18%,GUCY1B1;PDE2A;NPR1;PDE9A;NPPC
prerank,positive regulation of cholesterol transport (GO:0032376),-0.30720301199637967,-0.9758178898375773,0.48520710059171596,0.7611086013483003,1.0,7/27,10.31%,PLTP;APOE;PTCH1;NR1H3;ABCA5;CAV1;EEPD1
prerank,hyaluronan catabolic process (GO:0030214),0.43553549559467797,0.9757249218551833,0.5040760869565217,0.8549256266713147,1.0,4/18,13.28%,FGF2;SLC9A1;CHP1;HEXA
prerank,protein localization to synapse (GO:0035418),0.47036693291922493,0.9756803031554824,0.5034867503486751,0.8545647222805857,1.0,5/12,13.02%,DLG4;MPP4;NRXN2;SHANK1;NLGN1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.40540663373723956,0.9756784839107864,0.5156054931335831,0.8541055676416712,1.0,6/26,11.52%,ASAP3;RDX;PFN2;ALMS1;SLC9A1;SHANK1
prerank,response to insulin (GO:0032868),0.35523520910355577,0.9754699453089474,0.538543897216274,0.854135000881012,1.0,12/80,9.74%,IRS1;SLC39A14;RHOQ;HDAC9;C2CD5;MEAK7;PRKDC;RAB8A;CAPN10;AKT2;OGT;SYAP1
prerank,regulation of multicellular organism growth (GO:0040014),0.45052455208983794,0.9753408393909536,0.49226441631504925,0.8539802558125192,1.0,3/15,11.85%,GHR;STAT5A;SOD1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3835503373599123,0.9751902714409283,0.5255041518386714,0.8538827218904738,1.0,5/35,6.18%,HOXA5;LDB1;ACVR1B;STAT3;PRKDC
prerank,peptidyl-lysine acetylation (GO:0018394),0.49112216976094714,0.9747433425775516,0.5142428785607196,0.8544597671240863,1.0,5/10,26.59%,KAT2A;CREBBP;KAT7;KAT2B;ESCO1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4763102595192642,0.9744353137850574,0.5261669024045261,0.854771168208316,1.0,4/11,9.71%,LRP5;TGFBR2;SOX9;FGFR2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.46482925233268657,0.9741818547211071,0.5206258890469416,0.8549194380795689,1.0,3/12,8.29%,HES5;JAG1;ESRRB
prerank,cellular response to oxygen levels (GO:0071453),0.4783088286234721,0.9740207950080032,0.5161290322580645,0.8548355695190145,1.0,2/10,13.74%,ATP6V0D1;PICK1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.414077359738533,0.9739894720987832,0.5075757575757576,0.8544431904271244,1.0,7/22,21.83%,MDFIC;GDI1;CHP1;RAB23;SUFU;LRRK2;LMAN1
prerank,translational elongation (GO:0006414),0.3433891362916776,0.9739758817913555,0.5313152400835073,0.8540136858202692,1.0,49/101,37.68%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MRPL39;MRPS14;EEF1G;MRPL35;LTN1;MRPS17;EEF2K;EEF1B2;MRPL45;TUFM;EEFSEC;PTCD3;MRPL12;MRPL47;GTPBP2;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;EEF1D;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2;NEMF
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4133155192153027,0.9739127708927379,0.5152998776009792,0.8537122403782431,1.0,9/25,29.94%,SF3B1;SRRM1;WDR83;SRSF10;TRA2B;GEMIN2;SRSF4;SF3B4;KHSRP
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.4747614472019636,0.973785014269386,0.5211062590975255,0.8535509713185983,1.0,1/10,0.78%,VEGFA
prerank,response to cadmium ion (GO:0046686),0.39784403821194664,0.9736656918501607,0.5147058823529411,0.8533888047692676,1.0,9/26,27.84%,EGFR;MAPK8;CHUK;SUMO1;AKT1;MAPK9;FOS;DAXX;HSF1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.34626064402498163,0.9734434207920558,0.530031612223393,0.8534355617026852,1.0,8/87,4.62%,PRKCD;RHOBTB1;EFNA5;LRP1;RHOQ;RND3;ARHGAP17;SEMA3E
prerank,protein tetramerization (GO:0051262),0.3613257672118025,0.9729418114847144,0.5225321888412017,0.8541493711078298,1.0,16/67,19.91%,KCNJ2;PKD1;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;SHMT2;GNMT;ACOT13;HSD17B8;CPSF7;CPSF6;SHMT1;TK1;APPL2
prerank,positive regulation of JNK cascade (GO:0046330),0.3574179767785176,0.972181983805813,0.5333333333333333,0.8554644615544355,1.0,11/70,13.67%,RASSF2;SH3RF3;GADD45G;MAP3K5;HMGB1;FZD7;LTBR;AXIN1;CD27;TRAF3;MAP3K10
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3375512310150015,0.9721472311018023,0.5435005117707267,0.8550910654705828,1.0,39/132,24.47%,SLC4A4;IRS1;PRKCD;ADAM9;RDX;TWIST1;TNFRSF1B;DACT1;HMGB1;TRIM27;AKT2;ITCH;SNX9;MID2;EZR;PIK3CB;SUPV3L1;TRIM65;FOXO3;CNOT8;ORMDL3;FLCN;UFL1;VPS11;SH3D19;TRIM6;MLXIPL;ATF6;DAGLB;OPTN;LRRK2;UPF1;ABCD1;TRIM8;PFKFB4;NPRL2;ENTPD5;BAD;ROCK1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.45895071169798984,0.9721035912761261,0.491869918699187,0.8547383662183582,1.0,7/13,23.04%,IPO5;RGPD1;KPNA2;RANBP2;KPNA3;KPNA4;NUP35
prerank,positive regulation of growth (GO:0045927),0.35251275260031184,0.9720177649183266,0.5204741379310345,0.8544992148404856,1.0,22/64,23.02%,EGFR;CSNK2A1;TGFB2;AGR2;EIF4G2;FXN;ADAM10;MMP14;CXCL16;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;USP47;RPTOR
prerank,peptidyl-amino acid modification (GO:0018193),0.48042759828848686,0.9719113994398783,0.4956896551724138,0.8542768594138548,1.0,6/10,34.33%,FKBP10;METAP1D;METAP2;ATP7A;METAP1;FKBP7
prerank,positive regulation of chromosome organization (GO:2001252),0.448169123384636,0.9715694289044955,0.5074024226110363,0.8546434458598455,1.0,6/15,29.21%,GNL3;RAD50;LIG4;PPP1R10;RTEL1;DDX11
prerank,regulation of cell cycle process (GO:0010564),0.3403023514896155,0.9713691494395107,0.5458333333333333,0.8546690779396405,1.0,33/104,27.35%,KIF13A;CSNK2A2;CSNK2A1;DYNC1H1;CALM2;HORMAD1;RMI2;SOX9;MAD1L1;RCC1;GIT1;MARK4;SND1;USP19;CALM3;BIRC6;FLCN;E4F1;DAPK3;KIF20B;DBF4;CUL9;SETD2;UVRAG;TXLNG;PLK4;RAB11FIP4;CDK13;CCP110;CCDC8;CUL7;ATF5;AHCTF1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.318635612681525,-0.9711644552679168,0.5,0.7694983964020308,1.0,4/21,5.73%,EYA1;BCL2;BCL2L1;EYA4
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.318635612681525,-0.9711644552679168,0.5,0.7694983964020308,1.0,4/21,5.73%,EYA1;BCL2;BCL2L1;EYA4
prerank,protein N-linked glycosylation (GO:0006487),0.35810376869443505,0.9704566349401809,0.5355969331872946,0.8563305276289496,1.0,23/66,25.48%,PGM3;GFPT1;B4GALT1;GFPT2;PMM2;MGAT4B;UGGT2;ALG13;FUT8;DOLPP1;UGGT1;TMEM165;STT3A;ALG1;ALG3;DPM3;LMAN1;ALG14;MAGT1;B4GALT7;ENTPD5;ALG12;MGAT5
prerank,growth hormone receptor signaling pathway (GO:0060396),0.45164534399074174,0.9703919727617727,0.5142083897158322,0.8560315364725688,1.0,4/14,8.51%,GHR;STAT5A;STAT3;SOCS2
prerank,regulation of microtubule depolymerization (GO:0031114),0.4125413850376781,0.9701560823184462,0.5373317013463892,0.8561404577799764,1.0,2/25,1.28%,FGF13;MAP1B
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.41828749563742823,0.9700055257657443,0.5380774032459426,0.856016325084777,1.0,1/23,0.21%,SLC4A4
prerank,TOR signaling (GO:0031929),0.40591835721465075,0.9700044037148062,0.5114045618247299,0.8555601144805413,1.0,11/26,24.51%,NPRL3;MEAK7;TIPRL;SYAP1;SMG1;FLCN;AKT1;MAPKAP1;RPTOR;RPS6KB1;PINK1
prerank,phospholipid homeostasis (GO:0055091),0.4626092567250428,0.9699641148740941,0.5253521126760563,0.8551835477262235,1.0,5/11,26.43%,TLCD2;ABCA1;TLCD1;RCN3;ANGPTL3
prerank,regulation of transport (GO:0051049),-0.2818959967671223,-0.9697727078614263,0.5035971223021583,0.7713503538756477,1.0,4/36,2.87%,LEPR;EPB41;ICA1;MYO6
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.45858146339661654,0.9694978514333799,0.5088676671214188,0.855329009913553,1.0,3/13,4.21%,SHC1;STAT5A;STAT3
prerank,cellular response to interleukin-15 (GO:0071350),0.45858146339661654,0.9694978514333799,0.5088676671214188,0.855329009913553,1.0,3/13,4.21%,SHC1;STAT5A;STAT3
prerank,negative regulation of cellular senescence (GO:2000773),-0.35451001579893227,-0.9691957562104005,0.4844961240310077,0.7711676030994348,1.0,3/13,2.72%,CDK6;SLC30A10;AKT3
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2932836476036476,-0.9691571001456459,0.5051546391752577,0.7696127774089689,1.0,4/26,5.05%,DNAJC6;SGIP1;PICALM;PIP5K1C
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.37141860620622075,0.9691491192081951,0.5376470588235294,0.8556655004438699,1.0,10/40,16.45%,VEGFA;SFRP4;ANXA2;RAB21;CBL;PICK1;DAB2;HNRNPK;ARRB1;HIP1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.40091631625879665,0.9687493281471734,0.5320754716981132,0.8561755120970683,1.0,2/27,1.10%,GAS6;DDR2
prerank,glucose homeostasis (GO:0042593),0.34709511374214014,0.9686519321727552,0.5422832980972516,0.8559580419841286,1.0,10/83,8.58%,IRS1;KCNB1;TCF7L2;STAT3;ADCY8;LRRC8D;MCU;BACE2;ADIPOR2;FOXK1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3369628393386455,0.9685735078263032,0.5606995884773662,0.8556851998954361,1.0,19/141,12.31%,ESR1;EGFR;IGFBP5;DRD1;HCN4;SLC26A6;CYP1B1;PDE3A;ADCY2;ADCY8;JUP;NRIP1;IMPACT;RORA;SPIDR;URI1;P2RY6;EZR;AKAP9
prerank,positive regulation of glycolytic process (GO:0045821),0.43200782039069613,0.9685343811082682,0.5449804432855281,0.854865838344882,1.0,1/20,0.21%,SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.43200782039069613,0.9685343811082682,0.5449804432855281,0.854865838344882,1.0,1/20,0.21%,SLC4A4
prerank,regulation of DNA repair (GO:0006282),0.37500565664085383,0.9683887381859908,0.5303370786516854,0.8547700727936509,1.0,4/44,6.13%,EGFR;EYA2;TRIM28;ERCC8
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4084124228422543,0.967972444379026,0.5283251231527094,0.855283690761523,1.0,4/24,7.68%,PKDCC;WNT9A;MBOAT2;SOX9
prerank,regulation of type I interferon production (GO:0032479),0.3451477354770826,0.9679724409389124,0.5535331905781584,0.8548297185265116,1.0,38/84,32.37%,TAX1BP1;MAVS;PRKDC;GPATCH3;POLR3H;ITCH;IRAK1;TRAF3;CRCP;PCBP2;POLR3GL;POLR2F;UBE2L6;CREBBP;OTUD5;NFKB2;ACOD1;NPLOC4;IKBKE;XRCC6;IRF3;POLR3K;POLR1C;RNF216;CYLD;TBK1;ILRUN;POLR2H;CGAS;DDX41;POLR3E;RNF135;POLR2L;CTNNB1;NFKB1;POLR3F;POLR2K;IFIH1
prerank,regulation of endocytosis (GO:0030100),0.35573785050505397,0.9678348416255494,0.5471698113207547,0.8547045637687642,1.0,18/61,22.77%,STON2;LRP1;GPC3;ARFGAP1;LRPAP1;LRSAM1;STON1;ABL1;DAB2;RAB4B;HIP1;CD151;RAB5B;RUFY2;ZFYVE16;RAB4A;RUBCN;TSC2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.35947485435347476,0.967728282250784,0.5322222222222223,0.8545146480148609,1.0,12/56,22.12%,LBP;HMGB1;ALPK1;IRAK1;TAB2;TRAF3;S100A1;RPS27A;UBC;CTSB;TLR1;CTSK
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.39483853847738015,0.9671962843475842,0.5489949748743719,0.8552809494693334,1.0,13/29,34.14%,NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT6
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3562657941829682,-0.9670717516437219,0.47413793103448276,0.773061818945716,1.0,3/16,1.91%,ROCK2;CDH5;RIPOR2
prerank,oligodendrocyte development (GO:0014003),0.4368162501631122,0.9670511140722023,0.5172872340425532,0.8551583897424225,1.0,3/15,14.28%,HES5;B4GALT5;PLP1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.33200093952219,-0.9669609710882934,0.4959016393442623,0.7716643143952423,1.0,9/17,29.31%,CXCL12;ANO6;SERPINE1;PLA2G7;CREB3;CCR2;CXCL10;LGMN;CCL5
prerank,cardiac muscle cell differentiation (GO:0055007),0.414076976795485,0.9665432015458664,0.5158730158730159,0.8558829790783535,1.0,5/21,16.74%,VEGFA;ACVR1;ALPK3;AKAP13;KDM6B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.4735878570537281,0.9662680986152686,0.5454545454545454,0.8560713769936155,1.0,2/11,6.36%,STAT3;IL12RB2
prerank,cilium movement (GO:0003341),0.3667838725694354,0.9660565386344533,0.5528735632183908,0.8561064525628376,1.0,12/47,24.63%,CFAP251;CFAP206;ODAD2;CCDC39;ROPN1L;DNAAF4;TEKT2;TTC29;CFAP73;SPAG17;CAMSAP3;DNAAF5
prerank,regulated exocytosis (GO:0045055),0.32844240734128566,0.9660103710080626,0.5845213849287169,0.8557780816718181,1.0,38/173,21.50%,THBS1;VEGFA;GAS6;SYT8;CHID1;TIMP3;TGFB3;SPARC;PCDH7;TOR4A;ARHGAP17;TGFB2;CD9;MAGED2;QSOX1;FAM3C;BRPF3;STEAP2;RAB11FIP5;SOD1;RAB11B;MANF;SCIN;HGF;STX1A;CD109;WDR1;SYTL4;LHFPL2;SERPING1;PCYOX1L;SNAPIN;TEX264;CDK5;APLP2;CLU;LAMP2;GTPBP2
prerank,negative regulation of B cell activation (GO:0050869),0.4174917565230806,0.965796263801315,0.5172855313700384,0.8558064417964931,1.0,4/21,13.03%,ID2;PARP3;ATM;INHBA
prerank,regulation of stem cell population maintenance (GO:2000036),-0.3273800519934812,-0.9657392303510854,0.48148148148148145,0.7730160869275223,1.0,3/18,6.99%,PTN;ELAVL1;CNOT1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.4093764879632292,0.9654811128912358,0.5147247119078106,0.856121620014945,1.0,1/20,0.38%,PSTPIP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3489726450009795,-0.9654026165217287,0.4907749077490775,0.7721746371345816,1.0,4/15,12.81%,SAMHD1;USP18;NLRC5;CACTIN
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.41743463334545905,0.9652829830893435,0.5126162018592297,0.8561387421263611,1.0,3/19,8.43%,RIC3;CHRNB2;CHRNA5
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4122921082089869,0.9652584907306538,0.5167095115681234,0.8557548924575878,1.0,5/22,14.29%,DDX5;SPRED2;CDK5RAP3;ATM;HEXIM1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.38052022619715553,0.9651165323044528,0.5385514018691588,0.8556421059305473,1.0,7/39,10.42%,RPSA;LTV1;RRP7A;EMG1;SRFBP1;WDR3;RIOK1
prerank,aerobic electron transport chain (GO:0019646),-0.24654861779026968,-0.9650896822639008,0.5833333333333334,0.7713388440384138,1.0,21/68,24.19%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFAF1;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,negative regulation of response to wounding (GO:1903035),0.4195607612587182,0.9649533146972445,0.5091623036649214,0.8555734757149853,1.0,5/19,19.12%,FGF2;PTPRS;GIT1;CD109;CRK
prerank,protein deacylation (GO:0035601),0.3996200863966745,0.964861471253025,0.5229813664596273,0.8553283367047543,1.0,5/23,15.82%,HDAC4;SIRT5;HDAC1;SIRT2;HDAC6
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4245323097723628,0.9645570565601155,0.5145502645502645,0.8555626445959335,1.0,3/16,7.59%,PARP3;PRKDC;KMT5C
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4086673212340794,0.9645554427862012,0.5095541401273885,0.855117819622331,1.0,12/22,35.53%,ATF4;PHF8;ERBB2;EIF2AK3;WDR75;SMARCA4;UBTF;PWP1;DDX11;NCL;LYAR;UTP15
prerank,ERBB signaling pathway (GO:0038127),0.35615012215150077,0.9644441307067785,0.5427631578947368,0.8549261452850115,1.0,15/64,18.91%,EGFR;PLCE1;SHC1;PRKCA;SOX9;CBL;PTPN18;PDPK1;SOS1;STUB1;IQGAP1;ERBB2;GAREM1;AKT1;ERBIN
prerank,regulation of intracellular signal transduction (GO:1902531),0.32378520526813703,0.9641489308969936,0.619,0.8551425172910104,1.0,108/420,20.97%,MYOC;RASSF2;EGFR;CMKLR1;RHOJ;VEGFA;SRGAP2;SRGAP3;TIAM1;ARAP1;NTRK3;RHOQ;NTRK1;TIAM2;TCP11;FSHR;VAV2;PRDM11;PKHD1;ARHGAP17;CSNK2A2;CSNK2A1;KMT5A;RRS1;CHD3;USP2;RMI2;MOB3B;BCR;RHOT2;MDM4;EHMT1;ARHGAP21;PAK4;CASTOR2;DLG1;KALRN;RHOA;RHOT1;RBBP8;RAD1;PAK2;ITGAV;WRN;ING5;PIP4K2B;INPP5B;MYO9A;ARHGAP20;ULK4;ATM;TELO2;CHEK2;PDPK1;TAF15;TAF6;ARHGAP8;EZR;RAD50;TRAF3;HDAC1;TAF13;NLGN1;ARHGAP44;OCRL;RBBP7;USP7;SOS2;SQSTM1;ARHGEF1;TMEM127;TBCK;RHOB;AKAP13;SOS1;WDR54;PIP5K1A;ATRIP;TTC5;TAGAP;PPP2R5C;TRIO;TP53RK;HUS1;SSRP1;NGEF;FLCN;UFL1;BOP1;PRKAG1;ARAF;TRIM6;VRK2;AKT1;HIPK2;CRK;CDK2;NFKBIA;WWC2;TAF9B;CDK5;PRKAB1;NOC2L;MAPKAP1;DEPDC1B;RCN3;OPTN;PRKAR2A
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4123488752490913,0.9641372567027789,0.5435630689206762,0.854719517990379,1.0,7/22,23.51%,FXN;NFS1;GLRX5;ISCA2;MMS19;ISCU;NUBP2
prerank,ephrin receptor signaling pathway (GO:0048013),0.3457147361032668,0.9638212799836089,0.5480043149946062,0.8549561421357037,1.0,12/82,9.03%,EFNA5;ARHGEF28;TIAM1;VAV2;EPHB2;SIPA1L1;ARPC1B;AP2A1;EPHB3;EPHB6;KALRN;RHOA
prerank,positive regulation of metabolic process (GO:0009893),0.3408996139034637,0.963760065522591,0.5549738219895288,0.8546511468716697,1.0,11/103,9.02%,GNAS;CMKLR1;VEGFA;GADD45G;GRB10;PEMT;DYNC1H1;ALMS1;EHMT1;ADIPOR2;OGT
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.38567532122117376,0.9635818008257955,0.5474452554744526,0.8546084056995961,1.0,14/31,34.14%,NT5C3B;DIS3L2;PATL1;LSM2;EXOSC4;CNOT8;DIS3;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT6
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4571511189957419,0.9635512587688692,0.5098039215686274,0.8542340303369996,1.0,6/12,26.31%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,nuclear membrane organization (GO:0071763),0.4213360979599873,0.9633591714607397,0.5278858625162127,0.8541988497288692,1.0,8/19,28.98%,SPAST;TMEM43;DCTN1;CHMP4B;NEMP1;CHMP2A;UBXN2A;TOR1AIP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.45464602657845343,0.963173475572879,0.523943661971831,0.854161622111998,1.0,3/13,14.66%,GLRX5;ISCA2;MMS19
prerank,microvillus organization (GO:0032528),-0.3675152137051149,-0.963139403452259,0.4931972789115646,0.774460523418603,1.0,3/13,2.55%,MAP4K4;TNIK;RAPGEF2
prerank,long-chain fatty acid metabolic process (GO:0001676),0.35472157281648364,0.9631104639393964,0.5473801560758083,0.8538573199193223,1.0,20/64,27.55%,MGLL;PLA2G4A;CYP1B1;ELOVL5;DAGLA;FADS1;ACAD9;ACSL3;PNPLA3;HACL1;ACSL6;ACSBG1;SLC27A2;DAGLB;ABCD1;ACOT8;FAAH;ALOXE3;ELOVL1;SLC27A3
prerank,glycerophospholipid catabolic process (GO:0046475),0.39508432273509303,0.9628637784548714,0.534629404617254,0.853990486171057,1.0,7/27,16.48%,PLA2G4F;PLA2G4A;SMPD4;PLA2G5;ENPP6;GDPD3;PLA2G15
prerank,cellular response to tumor necrosis factor (GO:0071356),0.32678636821490525,0.9625059498294484,0.590030518819939,0.8543659006711642,1.0,42/175,23.58%,PID1;CARD14;YBX3;CCL13;PSMD7;CCL15;PSMA8;SMPD4;TNFRSF1B;ILK;TNFSF15;NFE2L2;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;CD27;PSMD12;TRAF3;PSMA6;TANK;GSDME;PSMD1;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;ACOD1;AKT1;ERBIN;ASAH1;NFKBIA;PSMA3;TNFSF18;PSMB1;PSMD4;BIRC3;MAP3K14;PSMA5;PSMA7
prerank,regulation of lysosomal lumen pH (GO:0035751),0.4546201136055953,0.9623124873508007,0.5431918008784773,0.8543333424337735,1.0,4/12,27.89%,TMEM165;CLN3;LRRK2;CLN5
prerank,regulation of potassium ion transport (GO:0043266),0.3913308925044727,0.9622262432875365,0.5320987654320988,0.8540773895311259,1.0,7/31,10.43%,FHL1;DRD1;KCNE5;ANK2;KCNIP2;DLG1;VIP
prerank,cellular response to cAMP (GO:0071320),0.3924961368413878,0.9622221828110945,0.5379901960784313,0.8536414961663276,1.0,3/30,2.99%,IGFBP5;HCN4;SLC26A6
prerank,regulation of stress fiber assembly (GO:0051492),0.3510736168999083,0.9621348924448733,0.5709711846318036,0.8534017429827234,1.0,16/74,12.61%,MYOC;ASAP3;ARAP1;TMEFF2;TGFB3;SORBS3;PPFIA1;S100A10;PFN2;ALMS1;SLC9A1;RHOA;PAK2;ABL1;NRP1;TGFBR1
prerank,granulocyte chemotaxis (GO:0071621),0.35725446735120486,0.9618789266652472,0.5380249716231555,0.8535233168287828,1.0,7/55,9.70%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3;ANXA1
prerank,acylglycerol homeostasis (GO:0055090),-0.33305799442147366,-0.9615860677388176,0.5151515151515151,0.7767609029696212,1.0,5/20,11.93%,APOE;NR1H3;PNPLA8;SCARB1;LPL
prerank,integrin-mediated signaling pathway (GO:0007229),0.3461096652719682,0.9614921653521943,0.5568669527896996,0.8539595046914208,1.0,12/73,12.40%,ITGA11;COL3A1;ADAM9;PLPP3;COL16A1;ILK;PRAM1;ADAM10;ITGAV;ABL1;RCC2;NRP1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.39710502349460375,-0.9614456758327186,0.5138461538461538,0.7755068683484517,1.0,3/10,10.27%,CACNB2;CACNA2D1;PDE4B
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.3262979064272252,-0.9612609529656795,0.5258620689655172,0.7743893693299524,1.0,7/18,15.10%,LTBP1;SMAD3;CD200;FN1;LGALS9;CD34;ITGB8
prerank,regulation of small molecule metabolic process (GO:0062012),-0.29378832124520826,-0.9605326888047163,0.5229885057471264,0.7745110004512115,1.0,5/28,7.50%,APOE;PDK1;PPARA;FMO5;ADIPOR1
prerank,regulation of chromatin binding (GO:0035561),0.470666158397411,0.9604234124340335,0.5259365994236311,0.8558743191992829,1.0,5/10,29.21%,BTAF1;MED25;CDT1;WAPL;DDX11
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.30335402446139365,-0.9604110054141716,0.5138121546961326,0.7732187591586812,1.0,3/24,2.56%,AUTS2;OCLN;PIK3R1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3935217861626698,0.9597419679370423,0.5475896168108776,0.8569609642076348,1.0,13/31,32.06%,TOPORS;DCUN1D5;UBE2C;AXIN1;DCUN1D2;CDC20;RAB1A;PINK1;GOLGA2;BTRC;UBE2S;UBE2N;GORASP1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3725191849670078,0.9597312315867232,0.544589774078478,0.8565451219498321,1.0,9/36,19.33%,FHIT;CCAR2;GIPC1;OGT;USP7;TLK2;N4BP1;RYBP;UCHL5
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.34675974559735107,0.9596058269910263,0.574761399787911,0.8563817054292574,1.0,24/87,22.06%,FGF2;FGF17;HNRNPH1;SPRED2;RBFOX2;FGFR1;CBL;FGFR2;GTF2F1;FLRT2;SHOC2;HNRNPM;PTBP1;TIAL1;NDNF;POLR2F;GALNT3;FGF5;NCBP1;NCBP2;FGF18;FGFR3;HNRNPA1;POLR2B
prerank,regulation of biomineral tissue development (GO:0070167),0.399440249302518,0.9594664750149204,0.5365551425030979,0.8562644869981122,1.0,5/26,7.68%,GAS6;DDR2;TWIST1;NBR1;SOX9
prerank,negative regulation of JNK cascade (GO:0046329),0.38526091450175826,0.9594508038988596,0.5397796817625459,0.8558543067334434,1.0,15/31,25.15%,PDCD4;DACT1;ITCH;PER1;MEN1;ZMYND11;DNAJA1;AIDA;DUSP19;GPS2;CYLD;TAOK3;PINK1;NCOR1;MAPK8IP1
prerank,microvillus assembly (GO:0030033),-0.35657412059912436,-0.959436284651481,0.4842105263157895,0.7740812126809535,1.0,3/14,2.55%,MAP4K4;TNIK;RAPGEF2
prerank,homocysteine metabolic process (GO:0050667),0.4660572797999485,0.959180059837609,0.5454545454545454,0.8560262822307154,1.0,3/11,7.73%,MPST;NOX4;MTRR
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32934143662755644,0.9589567744833422,0.6014127144298688,0.8560932569716401,1.0,37/182,18.31%,ESR1;FOXP1;ID2;VEGFA;FGF2;SLC24A3;EMILIN1;ANXA7;LRPAP1;TGFB2;CD3E;XDH;ADAM10;DLG4;DGKQ;WWP2;BMP4;AGO1;TERT;BMPR1A;KDM4A;PTRH2;HDAC1;AGO2;SMO;SETDB1;ERP29;RUNX1;ZNF148;VDR;WDR54;RBL2;SLC2A10;FLCN;CITED2;TRIM6;TRAT1
prerank,anterograde axonal transport (GO:0008089),0.3787200731440783,0.9583926549452485,0.5391923990498813,0.8569451473213333,1.0,11/37,22.20%,DLG2;RAB21;BLOC1S2;SPAST;AP3D1;SOD1;BLOC1S3;SNAPIN;KIF1B;MAPK8IP3;NEFL
prerank,positive regulation of viral life cycle (GO:1903902),0.4141668974613677,0.9580047817166336,0.5486381322957199,0.857355119373104,1.0,7/22,28.34%,P4HB;KPNA2;CHMP3;CHMP2A;VPS37B;KPNA6;DDB1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.30715641015961465,-0.9578895128792242,0.5227272727272727,0.7762594357858926,1.0,7/22,14.31%,AEBP1;APOE;MAP2;CAMSAP1;PRUNE1;GPX1;EFEMP2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.4514453144923295,0.9576196260393943,0.5305555555555556,0.8577693066521787,1.0,2/13,8.32%,SIX1;TFE3
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4142222957328119,0.9575874913724445,0.5419354838709678,0.8573915699683258,1.0,3/20,7.79%,HOXA5;LDB1;HOXA9
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3425972019572332,0.9571666482811214,0.5675965665236051,0.8578897744519556,1.0,31/85,28.11%,TIAM1;PRICKLE1;PSMD7;AP2A1;PSMA8;DVL1;FZD7;FZD5;RHOA;PSMA4;PSMD12;PSMA6;AP2A2;CLTC;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;SMURF2;PSMB1;PSMD4;PSMA5;PSMA7;PSMC1;DVL2;WNT11;CELSR3;PSMA1;FZD1
prerank,mitotic cell cycle phase transition (GO:0044772),0.32688145696204707,0.9564501244072148,0.6038500506585613,0.859105043155991,1.0,66/203,25.58%,ACVR1B;FBXL7;CSNK1D;PPP1R12B;CDC16;DYNC1H1;SFI1;DNM2;ACVR1;ODF2;ALMS1;E2F3;GSPT1;DCTN2;CDC25B;CUL4A;SPAST;CKAP5;FOXM1;PHF8;UBE2C;RCC1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;INHBA;YWHAE;CCNG2;CCNE2;PPP2R2D;ARPP19;CEP41;CEP63;PCM1;LATS2;HAUS5;ANAPC1;CDC25A;E2F1;CCDC57;DBF4;CDC27;CDK2;DYNC1I2;MAX;DCTN1;CHMP4B;PRKACA;OPTN;BCAT1;ACTR1A;CDK5RAP2;NEDD1;PLK4;RPS6KB1;CNTRL;CHMP2A;CTDP1;TUBB4B;CCP110
prerank,regulation of lipid metabolic process (GO:0019216),0.3424102264326264,0.9563290712477391,0.5502136752136753,0.8589494644079937,1.0,15/88,17.15%,ID2;TNFAIP8L3;CHD9;NCOR2;RXRA;PLPP1;CARM1;RORA;SREBF1;NR1D2;ACACA;CREBBP;SIN3B;NFYA;LSS
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.28095698472103103,-0.9561606744688125,0.5459770114942529,0.7788333402826716,1.0,11/32,18.88%,CEMIP;TRPC3;AKAP6;CAV1;CX3CL1;GRIN1;APLNR;SNCA;GPER1;THY1;P2RX7
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.36929083327212897,0.9561393741565992,0.5455580865603644,0.858937002681865,1.0,12/43,16.81%,DDR2;LRP5;WWTR1;ACVR1;BMP4;TMEM119;RUNX2;BMPR1A;NELL1;HGF;IL6;CCN4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.33424317799711,-0.9557082941079282,0.5336322869955157,0.7783546137367683,1.0,6/18,14.42%,VCAM1;JAM2;SLC39A8;CX3CR1;ITGA4;GCNT1
prerank,vasoconstriction (GO:0042310),-0.37669538714771167,-0.9555699091248503,0.49830508474576274,0.77708025302094,1.0,6/11,16.74%,SLC8A1;EDNRB;EDN1;ACTA2;PIK3C2A;HTR2B
prerank,regulation of actin filament-based movement (GO:1903115),-0.3953957119833366,-0.9549116711757625,0.50625,0.7770383792199202,1.0,5/10,23.28%,PDE4D;PDE4B;SCN5A;STC1;SRI
prerank,phospholipid translocation (GO:0045332),0.3924450125438066,0.9547442143695621,0.5592185592185592,0.8616290396646608,1.0,7/28,15.86%,TMEM30B;ABCC1;ATP8B2;ATP8A1;ATP9A;ABCA1;PLSCR3
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4469730970016731,0.954540344134348,0.527891156462585,0.8616301047431532,1.0,5/14,27.98%,ETNK1;ETNPPL;CHKB;PCYT2;SELENOI
prerank,positive regulation of cell growth (GO:0030307),0.33454175897522936,0.9544700039261669,0.5661764705882353,0.8613467257474238,1.0,24/96,23.02%,EGFR;NTN1;CSNK2A1;TGFB2;EIF4G2;FXN;ADAM10;MMP14;CXCL16;GOLGA4;TGFBR1;EIF4G1;SUPV3L1;EXOSC4;KLHL22;ERBB2;NCBP1;HDGFL2;AKT1;TAF9B;DDX49;SHTN1;USP47;RPTOR
prerank,telomere organization (GO:0032200),0.36472025359959304,0.9541659916181214,0.5605536332179931,0.861572190693397,1.0,11/43,19.46%,PARP3;PRKDC;ERCC4;WRN;TERT;ATM;RAD50;DCLRE1B;PARP1;HUS1;XRCC6
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.28819916658472167,-0.9540740039980095,0.5321637426900585,0.7774333568581201,1.0,4/31,13.02%,PLCB1;SYK;CD40;LGALS9
prerank,organelle fusion (GO:0048284),0.40175446209391724,0.9538298391389346,0.5256410256410257,0.8618517912010981,1.0,11/22,30.35%,MIEF2;SPG7;EEA1;STX4;VPS11;MFN1;AFG3L2;FIS1;USP30;VPS18;MIEF1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3440818922649763,0.9537168870073232,0.586096256684492,0.861659473511703,1.0,22/80,25.65%,THBS1;PRKCD;SLC2A13;SAMD4A;PRKDC;NIBAN1;IL6;EIF6;ERBB2;EIF3D;EFNA1;PYM1;CLU;CIRBP;FXR2;UPF3A;NSMAF;RPS6KB1;RPS27L;UPF3B;RBM3;METTL14
prerank,gene expression (GO:0010467),0.3231199786284297,0.9536967763582633,0.65,0.8612649647971583,1.0,118/348,28.79%,SRSF6;RRBP1;RPSA;NUP93;DDX17;HNRNPH1;SRSF1;SRSF5;SEC13;TOPORS;RBM39;BAZ2A;DUSP11;RAE1;M1AP;SRSF2;CASC3;NOX4;SEH1L;ABCF1;TASP1;HNRNPA2B1;SMG6;SRSF11;SYMPK;HARS2;LMF1;GSPT1;HNRNPL;MRPS18B;NXF1;ZC3H11A;SMG1;SRRM1;U2AF1;NFKBIB;RBM6;CHTOP;RBM5;PABPN1;NUP37;MRPS14;XAB2;AGO2;EIF4G1;MRPL35;HSPD1;MEF2A;RBM4;RANBP2;U2AF2;CLP1;CPSF4;HNRNPK;MMS19;NUP88;YTHDC1;POLR2F;MRPS17;SARNP;TFIP11;STUB1;THOC2;SRSF3;FYTTD1;RPS27A;YARS2;NCBP1;SRSF7;GOLPH3;E2F1;POM121;NUP210;NCBP2;SARS1;GLE1;SYNCRIP;RPL7A;HNRNPH3;DARS1;NUP62;DHX8;MED20;UPF1;SRSF4;POLR2B;MRPS21;ASMT;NDC1;NUP35;GALNT2;HNRNPU;MRPS18A;RPS9;MRPL37;PABPC4;UPF3B;RBM3;DDX39B;NUP85;POLR2H;DDX20;MRPL13;NUP160;TPR;DKC1;SRBD1;EIF4E;DRG1;RPL41;RPL30;SETX;DEDD2;MRPL11;POLR2I;PWP1;WARS1;IGHMBP2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.32392847953455683,0.953677236093065,0.6164658634538153,0.8608734227333177,1.0,13/190,4.67%,THBS1;SLIT2;ESR1;PDE11A;CIT;CCN3;NPRL3;TWIST1;PKHD1;PHLPP2;UBE2B;XDH;PDE3A
prerank,long-chain fatty acid transport (GO:0015909),-0.2884766604581611,-0.9535771509917075,0.5434782608695652,0.7770672034111279,1.0,8/30,10.23%,APOE;ACSL1;PRKAA2;PRKAG2;CPT1A;SLC27A4;MFSD2A;MID1IP1
prerank,macroautophagy (GO:0016236),0.33183216690768313,0.9535633493752934,0.5823045267489712,0.8606854880585213,1.0,41/118,27.29%,CSNK2A2;CSNK2A1;TCIRG1;VCP;LIX1L;TOMM40;NBR1;WIPI2;PGAM5;PIP4K2B;ATG3;STAM2;VIPAS39;CHMP3;UBQLN1;SQSTM1;PLEKHM1;VPS41;TOMM70;YOD1;PRKAG1;CLN3;RB1CC1;VTA1;PRKAB1;CHMP4A;CHMP4B;ATG16L1;LAMP2;MFN1;ACBD5;MVB12A;UVRAG;PINK1;CHMP2A;ILRUN;ATG13;VTI1B;AMBRA1;VPS16;VPS37B
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.44659734344229524,0.9533809383539925,0.5408022130013831,0.8606573618188993,1.0,1/13,1.30%,IL33
prerank,monocarboxylic acid metabolic process (GO:0032787),0.3333271289662274,0.9529734328359474,0.5910973084886129,0.8611329188658048,1.0,18/117,15.66%,ME1;SLC5A6;SLC16A1;AGXT2;LDHC;ACSF3;CPT1C;ACSF2;ACOT11;GLO1;AKR1C1;NPC1;DLAT;ACSL3;GLYAT;CKB;SCPEP1;HACL1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.45134058310457636,0.9529537899392054,0.5332409972299169,0.8607310056672317,1.0,3/13,15.15%,TM9SF4;RIC3;STX4
prerank,negative regulation of cell development (GO:0010721),-0.3099702300018835,-0.9528351106976065,0.5369458128078818,0.7771912906420515,1.0,5/25,13.95%,B2M;NOTCH1;RFLNA;RFLNB;IGF1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.3924867787179299,0.9525009837611222,0.5601965601965602,0.8612693757671667,1.0,8/26,22.45%,CYP1B1;ATF4;SULF1;RORA;IL6;SARS1;SULF2;EIF2AK3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.37132429374673404,0.9524967576890726,0.5431235431235432,0.860833598993419,1.0,6/38,13.25%,HJURP;IPO4;CENPC;CENPT;CABIN1;RBBP7
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4327197771469987,0.9524623083707976,0.5326842837273992,0.8604707282732054,1.0,3/15,11.47%,ADAM9;TNFRSF1B;SNX9
prerank,iron-sulfur cluster assembly (GO:0016226),0.39826683802123103,0.9524273013015212,0.5428211586901763,0.8601163897585706,1.0,7/24,23.51%,FXN;NFS1;GLRX5;ISCA2;MMS19;ISCU;NUBP2
prerank,regulation of platelet aggregation (GO:0090330),0.4310974287961664,0.9524229152585316,0.5396825396825397,0.8596828928978792,1.0,4/17,6.03%,PRKCD;C1QTNF1;PRKCA;CD9
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4522421136260783,0.9523049995425648,0.536986301369863,0.8590743918351134,1.0,1/12,0.86%,EFNA5
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4522421136260783,0.9523049995425648,0.536986301369863,0.8590743918351134,1.0,1/12,0.86%,EFNA5
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3442641310651776,0.952211868826054,0.5786637931034483,0.8588278673454661,1.0,11/75,14.03%,MGLL;SLC39A14;PLCE1;PPP1R9B;PDE6A;DGKQ;RPGRIP1L;GIT1;GRK6;USP33;GUCY2D
prerank,regulation of viral life cycle (GO:1903900),-0.3184206937324936,-0.9519640928839945,0.5,0.7777633720934096,1.0,6/21,14.58%,PPIA;TRIM14;NECTIN2;TRIM21;TRIM68;AXL
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4492709775191913,0.9518344839880988,0.541782729805014,0.859273440677264,1.0,2/13,7.26%,TWIST1;YJU2
prerank,response to cAMP (GO:0051591),0.3710047977657002,0.951831857449862,0.5373831775700935,0.8588394483058284,1.0,6/37,12.31%,IGFBP5;HCN4;SLC26A6;DGKQ;EZR;AKAP9
prerank,B cell mediated immunity (GO:0019724),0.46955618325810644,0.9517146991068559,0.5450643776824035,0.8586457651469822,1.0,2/10,11.94%,FCER1G;CD27
prerank,positive regulation of hydrolase activity (GO:0051345),0.3281354603860587,0.9516016019374638,0.5936213991769548,0.8584629462774933,1.0,29/137,17.72%,SGSM2;SRGAP2;ASAP3;ARAP1;NTRK1;CCL13;CCL15;CALM2;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;RHOA;MAPK8;WRN;RGP1;RIPK3;ZC3H15;MAPK12;SNX9;EVI5L;F2R;NDEL1;ERBB2;CALM3;NF1;FLCN;SNX13
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.33777307712108245,0.9513627927841121,0.5810526315789474,0.8585620718775969,1.0,14/102,9.74%,IRS1;SLC39A14;PRKCD;RHOQ;HDAC9;C2CD5;ADCY2;ADCY8;PRKDC;RAB8A;ADCY9;CAPN10;AKT2;SYAP1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3836701155936466,-0.951331362224249,0.49050632911392406,0.7777494180308472,1.0,4/10,15.34%,PARP14;SH2B3;INPP5F;SOCS3
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31585378810335607,-0.9511097845150857,0.5288888888888889,0.7767104018215593,1.0,8/21,21.04%,ITGA1;PDGFRB;CD300A;PLEK;BMP2;PTPA;PPP1R15B;PPP1R15A
prerank,polyol biosynthetic process (GO:0046173),0.4333282681861703,0.9507889965635201,0.5480378890392422,0.8594014120107786,1.0,2/16,1.74%,FGF2;ACER3
prerank,cell chemotaxis (GO:0060326),0.3541095863348082,0.9507827374524381,0.547486033519553,0.8589765748799996,1.0,11/60,15.88%,PRKCD;VEGFA;CCN3;DOCK4;ABCC1;ACKR4;NRP1;PARVA;HGF;CXCR4;PIP5K1A
prerank,RNA modification (GO:0009451),0.35553878113377096,0.9507087146871971,0.5399325084364455,0.858701704933481,1.0,23/54,35.07%,SSB;ANKRD16;ELP5;TRMT1;PUS3;TRUB1;ALKBH1;CTU2;TRMT6;TSR3;TRMT61A;METTL1;NSUN6;DTWD1;NSUN3;MEPCE;NOP10;RBM15;THUMPD1;PUS7;PUS7L;AARS1;MRM2
prerank,cell cycle G2/M phase transition (GO:0044839),0.3320471454732566,0.9506219391144208,0.6004140786749482,0.858459539725491,1.0,40/129,24.00%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;CKAP5;FOXM1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;YWHAE;ARPP19;CEP41;CEP63;PCM1;HAUS5;CDC25A;CCDC57;CDK2;AKAP8;DYNC1I2;DCTN1;PRKACA;OPTN;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3840351640467674,0.9504414899866713,0.558858501783591,0.8584130837306491,1.0,3/33,2.90%,IGFBP5;PDCD4;TGFB3
prerank,sympathetic nervous system development (GO:0048485),0.4376120833035987,0.9503673956897243,0.5396174863387978,0.858146511676122,1.0,4/15,18.74%,NTRK1;NRP1;NF1;GDNF
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.33873343916871806,-0.9501113850499026,0.532,0.7775347344337942,1.0,8/17,20.86%,NEDD4L;RYR2;GPD1L;KCNJ8;PKP2;SCN3B;KCNQ1;SCN5A
prerank,snRNA transcription (GO:0009301),0.3479088700788141,0.9498612243146733,0.5725108225108225,0.8588413546708437,1.0,33/70,34.40%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;USPL1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;POLR2I;CDK9;INTS7;POLR2L;INTS6;SNAPC1;GTF2A2;RPAP2;POLR2K;RPRD2;ZC3H8;GTF2E2;INTS10
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.38358512469247946,0.9497832244172238,0.5542021924482339,0.8585834312452756,1.0,9/31,13.14%,ZFPM2;TGFB2;SMAD4;NOG;FGFR2;BMPR1A;SMAD7;TGFBR1;LRP2
prerank,cellular metal ion homeostasis (GO:0006875),0.3351027004798013,0.94957238341511,0.5768025078369906,0.8586193789882881,1.0,15/102,11.18%,KCNJ2;ATP1B1;SLC12A2;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;SLC9A1;ANK2;CHERP;STIM1;EDN3;CSRP3;TMEM165
prerank,diacylglycerol metabolic process (GO:0046339),0.39589153290889756,0.9495249142992869,0.5314769975786925,0.8582971779431157,1.0,4/23,9.36%,PLCE1;DAGLA;DGKQ;PGS1
prerank,early endosome to late endosome transport (GO:0045022),0.40697727256245975,0.9492644095043303,0.5412234042553191,0.8584387457197,1.0,3/20,8.53%,ANKRD27;RILP;EEA1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.36278383456047614,0.9490971179609395,0.5369047619047619,0.8583702635377116,1.0,7/43,13.17%,EGFR;PTPN3;SOCS4;RNF115;CBL;PTPN2;STAM2
prerank,glycogen biosynthetic process (GO:0005978),0.45136789152178936,0.949090711548111,0.5535211267605634,0.8575126851995106,1.0,1/12,2.87%,PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),0.45136789152178936,0.949090711548111,0.5535211267605634,0.8575126851995106,1.0,1/12,2.87%,PPP1R3C
prerank,mitotic nuclear division (GO:0140014),0.34871275220082804,0.9485272634152697,0.5806451612903226,0.8583199046567388,1.0,24/71,26.49%,TUBG2;SMC4;MISP;SMC3;RHOA;SPAST;UBE2C;CHEK2;MIS12;ZW10;NDEL1;PPP2R2D;KLHL22;STAG1;CCDC61;CHMP4B;NUP62;ARHGEF10;WRAP73;SMC1A;CHMP2A;CTDP1;SPICE1;GOLGA2
prerank,mesoderm development (GO:0007498),0.4210657885895481,0.9484988092289477,0.5508365508365508,0.857942434653617,1.0,3/18,8.03%,VEGFA;FOXC2;IKZF3
prerank,negative regulation of receptor internalization (GO:0002091),0.4543451821774586,0.9481848377400314,0.5356125356125356,0.8582035391713946,1.0,4/12,21.61%,LRPAP1;DLG4;WDR54;ATXN2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4609773689975173,0.9475210594740499,0.5525179856115108,0.8591998417945639,1.0,2/11,10.46%,YBX3;RIPK3
prerank,regulation of cellular component organization (GO:0051128),0.32454749382571213,0.9472683124123231,0.6038894575230297,0.8593137328829795,1.0,48/135,26.63%,PLCE1;STON2;NEDD4;ARFGAP1;HJURP;CAMK2D;SNCAIP;DCUN1D5;LAMTOR1;ANKRA2;IRAK3;TMC8;PAK4;SOCS2;STON1;ITCH;URI1;ABL1;SETD5;NCLN;MARK4;RAB4B;MLLT3;HIP1;SSRP1;SLC2A10;RAB5B;RUFY2;HCFC1;SLITRK2;SETD1A;ZFYVE16;SGK3;MAD2L2;RAB4A;CAMSAP3;TSC2;RPTOR;HNRNPU;ROCK1;PINK1;IL17RB;TAOK2;PTPN11;LAMTOR2;RAB5A;SGK1;ATF5
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3281505209742083,0.946655744164585,0.5894519131334023,0.8602044418428374,1.0,35/114,26.51%,CARD14;PSMD7;PSMA8;TNFRSF1B;ILK;TNFSF15;TXNDC17;PSMA4;LTBR;CHUK;COMMD7;CD27;PSMD12;TRAF3;PSMA6;PSMD1;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;NFKBIA;PSMA3;TNFSF18;PSMB1;PSMD4;BIRC3;MAP3K14;PSMA5;PSMA7;TP53;TRADD;PSMC1;RIPK1;CDIP1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.24838795681756382,-0.9466186573342227,0.5625,0.7843977069493271,1.0,19/57,17.20%,ACTN2;APP;GRIA1;CACNG7;GRIN2B;CACNG8;GRIA4;OPRM1;GRIN2A;CACNG3;GRIA3;CACNG4;SHISA6;RELN;GRIN1;DLGAP1;DLGAP2;CAMK2A;CNIH3
prerank,homeostasis of number of cells (GO:0048872),0.4498397895850995,0.9465657383402576,0.5401974612129761,0.8599661076578236,1.0,4/12,13.07%,CCN3;UBAP2L;LPCAT3;F2R
prerank,membrane assembly (GO:0071709),0.37767484677140517,0.9461484925580805,0.5446859903381642,0.8604484368085664,1.0,11/34,17.37%,CEL;ANXA2;TLCD2;S100A10;NRXN2;SPAST;STX2;NLGN1;STX4;SPTBN1;TLCD1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3032766575169424,-0.9460892259368071,0.5416666666666666,0.7841639138742471,1.0,6/25,12.06%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,neurotransmitter uptake (GO:0001504),0.44725362094818044,0.9458414065234634,0.5324137931034483,0.8606798894539089,1.0,1/12,0.11%,SLC38A1
prerank,tRNA 5'-end processing (GO:0099116),0.4374348240824114,0.9440033005288161,0.5592991913746631,0.8642297376519799,1.0,6/15,30.83%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,epithelium development (GO:0060429),0.33270056781279134,0.9437317931966654,0.6049638055842813,0.8643928834523857,1.0,13/107,10.26%,SIX1;PKD1;VEGFA;ANXA7;MEOX2;HES5;ANXA4;DACT1;DVL1;SOX9;AKR1C1;FGFR2;EHF
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4532109771368978,0.9435736051378925,0.5513888888888889,0.8642998408402832,1.0,2/12,6.98%,UBASH3B;ANK2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4216260752843635,0.9434808833068353,0.5490445859872611,0.8640771915386899,1.0,8/17,28.54%,NCBP1;CPSF7;CPSF6;NCBP2;RNF20;ZC3H14;HSF1;CDK9
prerank,copper ion transport (GO:0006825),0.4544362587627504,0.9433977030771254,0.5431400282885431,0.8638297401494279,1.0,4/11,31.56%,STEAP2;STEAP3;SLC31A2;ATP7A
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3851499375770813,0.9431570718174196,0.5705445544554455,0.8638786974045191,1.0,6/27,16.53%,IRAK3;IRAK1;TAB2;HSPD1;RPS27A;UBC
prerank,striated muscle cell differentiation (GO:0051146),0.4322977013568038,0.9427864489473672,0.5591397849462365,0.864235616902724,1.0,5/16,16.74%,SDC1;SKI;MYEF2;AKAP13;KDM6B
prerank,membrane organization (GO:0061024),0.31793968131720585,0.9425520208478779,0.6445115810674723,0.8643023127514546,1.0,68/227,26.29%,EGFR;STON2;NUP93;CTTN;IGF2R;TLCD2;STX11;AP2A1;DNM2;ANK2;FCHO2;HUWE1;CBL;SYNJ1;NPC1;SPAST;LPCAT3;SNX9;AP3D1;USO1;TMEM43;CHP1;REPS1;OCRL;LRP2;AP2A2;STAM2;GAPVD1;PICK1;CHMP3;DMPK;REEP3;CLTC;DAB2;SNAP23;MITD1;ARRB1;HIP1;RPS27A;UBC;SPTBN1;TLCD1;TMEM170A;NAPA;CLN3;TMEM33;COX18;CLTA;CHMP4A;CHMP4B;SYNJ2;PDCD6IP;ARPC1A;MTCH1;LDLR;REPS2;PRKCI;VAMP4;NEMP1;SNX3;CHMP2A;PLEKHA3;SCARB2;VAMP2;VTI1B;DVL2;RAB5A;ACTR2
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3494840970242573,0.94251399415922,0.5633484162895928,0.8639448520811972,1.0,24/52,37.01%,SAMD4A;NT5C3B;PATL1;LSM2;EXOSC4;CNOT8;TUT7;CNOT10;RC3H2;DIS3;CNOT9;TNKS1BP1;DCP1A;LSM5;EDC4;EXOSC2;DCPS;EXOSC3;CNOT4;CNOT6;PAN2;RC3H1;DCP1B;PNLDC1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.362745013823634,0.9422523314926083,0.5618615209988649,0.8640845197171224,1.0,9/44,12.61%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.4693764897001399,0.9421723762917136,0.5596590909090909,0.8638413023494258,1.0,4/10,13.74%,PLPP1;GAP43;F2R;PICK1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.395703989532394,-0.9420737732300822,0.5146579804560261,0.7921419498067888,1.0,2/10,2.19%,VTN;PRKCB
prerank,tRNA 5'-leader removal (GO:0001682),0.4478185035911616,0.9415771920340714,0.5723951285520974,0.864702595409558,1.0,6/13,30.83%,SSB;RPP40;RPP14;RPP21;POP5;PRORP
prerank,negative regulation of phosphatase activity (GO:0010923),0.3931809848262018,0.9411217767228246,0.5538656527249683,0.8652669072317565,1.0,10/25,24.17%,TGFB2;TIPRL;ZCCHC9;URI1;CHP1;PPP1R35;CRY2;PPP1R36;BOD1L1;FKBP1B
prerank,prostanoid biosynthetic process (GO:0046457),0.42970182587521244,0.940451525368132,0.5544827586206896,0.8662686296096962,1.0,2/15,1.79%,PTGIS;PLA2G4A
prerank,peptidyl-tyrosine modification (GO:0018212),0.350564563229086,0.9399730884592559,0.5788888888888889,0.8669048011805872,1.0,9/56,10.59%,EGFR;PKDCC;DDR2;NTRK1;EPHB2;ABI1;FGFR1;FGFR2;ABL1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3861651170334995,0.939779639385667,0.5296251511487303,0.8668887587709666,1.0,8/28,23.32%,MAP1B;STMND1;ABL1;MAPRE3;ARL2;STMN2;CAMSAP3;FKBP4
prerank,negative regulation of endopeptidase activity (GO:0010951),0.35781547842455785,0.9396555857131009,0.5689851767388826,0.8667279545234902,1.0,9/47,18.73%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINB9;SERPINE2;CRB2;AKT1;SERPING1
prerank,prostaglandin biosynthetic process (GO:0001516),0.41246844447492875,0.9395604484757827,0.5524193548387096,0.8664922232519514,1.0,3/18,7.02%,PTGIS;PLA2G4A;PTGES2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.380480524884801,-0.9393029660003885,0.5287356321839081,0.7974979319621216,1.0,5/13,16.01%,CNOT1;PRR5L;ZC3H12A;ZC3HAV1;GTPBP1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.2883628628714312,-0.9390286171040624,0.5664739884393064,0.796615042676691,1.0,3/34,1.46%,LYN;MFHAS1;LGR4
prerank,regulation of fatty acid oxidation (GO:0046320),-0.3344511078292493,-0.9389341301836023,0.5353159851301115,0.7952627148935814,1.0,3/16,6.44%,PPARA;PRKAG2;PPARGC1A
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3899290636642531,0.9388078123998644,0.5430038510911425,0.8676672744007196,1.0,6/25,18.85%,EXT1;B3GNT7;B3GNT9;B4GAT1;B3GNT6;EXT2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3826376616462147,0.9387593349062751,0.565483476132191,0.8673379161650497,1.0,2/30,1.46%,PRKCD;SRCIN1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.32282309669307646,0.9384867096785813,0.6292929292929293,0.867472641389314,1.0,51/166,25.86%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;POLR3H;MED27;RARA;ESRRB;RORA;GTF2F1;MAZ;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;CRCP;ERCC2;VDR;POLR2F;NRBF2;CREBBP;MED26;NR3C1;TFB2M;POLR1G;TEAD2;CAVIN1;GTF3C1;NR3C2;TAF9B;NR2F6;POLR1C;POLR2B;TAF1C;NR2C2;TBP;KAT2B;NR5A1;TAF1;NCOR1;MED23;GTF2H4;POLR2H
prerank,phospholipid catabolic process (GO:0009395),0.396679413772548,0.9381274138997799,0.5708812260536399,0.8677784480633952,1.0,6/24,16.32%,PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;ENPP6;GDPD3
prerank,positive regulation of response to stimulus (GO:0048584),0.36367718601761856,0.9380718373336384,0.5620525059665871,0.8674658959699539,1.0,5/40,8.10%,PRKCD;TGFB2;MAVS;ILK;SELENON
prerank,negative regulation of developmental growth (GO:0048640),0.3839635205814031,0.9379502090468238,0.5742092457420924,0.8672756180173787,1.0,3/30,3.93%,FGF13;ULK2;PTPRS
prerank,embryonic heart tube morphogenesis (GO:0003143),0.35837454163563465,0.9377107064353059,0.5527522935779816,0.8673422174106155,1.0,8/43,13.29%,MICAL2;ACVR1;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5
prerank,hydrogen peroxide catabolic process (GO:0042744),0.46102267754589404,0.9376991565680785,0.5849858356940509,0.8669367394327216,1.0,6/11,30.51%,PRDX3;CAT;PRDX2;PRDX1;PXDN;PRDX5
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.39389284182281237,0.9376225216530472,0.580964153275649,0.8666638414692657,1.0,7/25,13.92%,ATP1B1;DMD;STK39;ANK2;COA8;AKAP9;WNK1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.36891516817491554,-0.9376049450101471,0.5258064516129032,0.7969909126850545,1.0,4/11,22.81%,C1QTNF3;C1QTNF12;SIK1;EP300
prerank,regulation of DNA binding (GO:0051101),0.3590739986363096,0.937539480562091,0.5660592255125285,0.8664179339547041,1.0,11/44,19.73%,HJURP;HMGB1;SKI;MAPK8;SMO;SIRT2;SUMO1;MDFI;CDT1;E2F1;NFKBIA
prerank,small GTPase mediated signal transduction (GO:0007264),0.3312497026682081,0.9373802809919503,0.6197478991596639,0.8663236035426409,1.0,19/103,15.25%,NTN1;PLCE1;FGF2;TIAM1;MRAS;TIAM2;SHC1;TRIM28;BCR;USP50;RRAD;ARFIP2;RAB38;SHOC2;CHP1;SETDB1;NUCB1;G3BP2;SOS1
prerank,actin filament organization (GO:0007015),0.31839929047649085,0.9373402191048781,0.6399594320486816,0.8659861685442695,1.0,20/151,9.03%,RHOBTB1;GSN;RND3;DPYSL3;VILL;PLS1;PPP1R9B;COBL;ARHGAP17;CORO6;FAT1;TLE6;MYO1E;CDC42EP2;MCU;ABI1;ELMO3;DLG1;GAS2;RHOA
prerank,negative regulation of MAP kinase activity (GO:0043407),0.3589116591661975,0.9372258846600054,0.5530921820303384,0.8658056856769554,1.0,12/44,20.28%,PRKCD;PDCD4;IRAK3;CDK5RAP3;BMP4;PAQR3;PIK3CB;NF1;DNAJA1;AIDA;DUSP19;UCHL1
prerank,mitochondrial translational elongation (GO:0070125),0.33476024731463405,0.9367254377558148,0.5972369819341127,0.8664406703113945,1.0,41/88,37.65%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.39154549108434056,-0.9367098576388668,0.5335365853658537,0.797432476165316,1.0,3/10,5.22%,PODXL;DPP4;PIEZO1
prerank,positive regulation of developmental process (GO:0051094),0.31980905559404266,0.9363961945185945,0.6461071789686552,0.8666989247145196,1.0,31/164,13.02%,BMP1;VEGFA;FOXD1;ACVR1B;PHLDB1;LMNA;COBL;AGR2;TLE6;ACVR1;DVL1;MIEF2;MCU;FGFR1;KMT5C;SOX9;DLG4;PA2G4;ESRRB;TRPM4;B4GALT5;EDN3;BMP4;TMEM119;BMPR1A;NEUROD2;SHANK1;FOXO6;SRF;AGO2;NLGN1
prerank,tryptophan catabolic process (GO:0006569),0.44958624095592103,0.9362838169801226,0.5655853314527504,0.8664941839793427,1.0,3/11,20.64%,IDO2;AFMID;KYAT1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3276154273476881,0.936231980722441,0.640124095139607,0.8661787029872148,1.0,39/128,24.00%,FBXL7;CSNK1D;PPP1R12B;DYNC1H1;SFI1;DNM2;ODF2;ALMS1;DCTN2;CDC25B;CKAP5;FOXM1;LCMT1;CHEK2;FBXL12;SDCCAG8;AKAP9;CUL1;CEP164;KHDRBS1;CSNK1E;YWHAE;ARPP19;CEP41;CEP63;PCM1;HAUS5;CDC25A;CCDC57;CDK2;DYNC1I2;DCTN1;PRKACA;OPTN;ACTR1A;CDK5RAP2;NEDD1;PLK4;CNTRL
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3614198360672216,-0.9356137523534493,0.5208333333333334,0.7984978090709984,1.0,3/12,4.13%,APP;CXCL12;JAM2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3246084882663511,0.9354270169853948,0.6077235772357723,0.8674874309122419,1.0,43/138,25.86%,ESR1;RARB;NCOR2;HDAC9;RXRA;WWTR1;NR2F1;RXRB;E2F3;MED27;RARA;ESRRB;RORA;GTF2F1;MAZ;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;ERCC2;VDR;POLR2F;NRBF2;CREBBP;MED26;NR3C1;TEAD2;NR3C2;TAF9B;NR2F6;POLR2B;NR2C2;TBP;KAT2B;NR5A1;TAF1;NCOR1;MED23;GTF2H4;POLR2H
prerank,regulation of NMDA receptor activity (GO:2000310),-0.2845612575902811,-0.9350254051273066,0.5823529411764706,0.7983828746684409,1.0,11/32,14.19%,ACTN2;APP;GRIA1;SLC6A9;GRIN2B;GRIA4;OPRM1;GRIN2A;GRIA3;RELN;GRIN1
prerank,mitochondrial translational termination (GO:0070126),0.3350398291297248,0.9349875944485729,0.6064171122994653,0.8679722334864145,1.0,41/88,37.65%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;MRPS18B;MTRF1L;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,C4-dicarboxylate transport (GO:0015740),-0.3496451398926934,-0.9349398540737728,0.5068493150684932,0.7970524362864218,1.0,6/14,16.41%,SLC25A13;SLC1A1;SLC1A2;SLC25A14;SLC13A5;SLC25A30
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.31965408027033293,0.9348993463153094,0.6535353535353535,0.8677367423116272,1.0,42/172,18.37%,FGF2;PLEKHA4;PLA2G4A;PEMT;PIK3C2B;CSNK2A2;CSNK2A1;PITPNM1;LPCAT1;GPD1;TAMM41;LPCAT4;DGKQ;ETNK1;PGS1;STARD7;SYNJ1;GPAT4;PLA2G5;PIP4K2B;LPCAT3;PCTP;FAR1;ARF1;INPP4A;ETNPPL;PIK3CB;OCRL;PI4K2A;PLA2G12A;CDIPT;PNPLA3;HDHD5;CHKB;PIP5K1A;PI4KB;INPP5E;PTDSS1;VAC14;AGPAT5;CDS1;CLN3
prerank,regulation of mitotic spindle assembly (GO:1901673),0.4123532673974861,0.9348618679873533,0.5745501285347043,0.8673912524718196,1.0,12/19,38.61%,EML3;CHMP3;CHMP4B;PDCD6IP;HNRNPU;CHMP2A;TPR;DRG1;CHMP4C;CCSAP;VPS4B;CHMP1B
prerank,regulation of mast cell degranulation (GO:0043304),-0.35127014281513913,-0.9348284773003734,0.5220588235294118,0.7957733611865495,1.0,5/14,13.02%,LYN;CD300A;SYK;CD84;LGALS9
prerank,regulation of synapse maturation (GO:0090128),-0.36661495261260135,-0.9347446398103435,0.5298013245033113,0.7943931979929523,1.0,4/10,13.90%,NRXN1;ARHGEF15;YWHAZ;RELN
prerank,cellular response to cytokine stimulus (GO:0071345),0.3121133622295309,0.934630650420623,0.726,0.8674509066816338,1.0,86/416,19.78%,PID1;VEGFA;GAS6;LBP;F3;FGF2;SLC12A2;COL1A2;PTGIS;YBX3;GRB10;GHR;MUC1;GAB2;CNTFR;DPYSL3;SLC26A6;TWIST1;CCL13;SDC1;SHC1;NFAT5;STAT5A;CCL15;STAT3;IL5;SHPK;SMPD4;TNFRSF1B;TXLNA;IL12RB2;NFE2L2;STK39;IFNLR1;IRAK3;SOX9;SOCS6;CBL;GBP6;SOCS2;RHOA;SBNO2;PTPN18;RORA;MAPK8;ANXA1;CHUK;CTF1;IRAK1;IL20RB;PIK3CB;PTPN2;TANK;CD80;GSDME;CASP1;WNK1;CLCF1;STX4;HGF;IL6;SOS1;STX1A;FOXO3;CXCR4;RPS27A;UBC;PRLR;HMOX1;EPRS1;DAPK3;TRIM6;ACOD1;USP10;SHMT1;BIRC5;AKT1;OSMR;ERBIN;CRK;PLP2;SYNCRIP;PTAFR;ASAH1;PTPN23;UBE2G2
prerank,cellular response to chemokine (GO:1990869),0.3510339839190642,0.934614061226109,0.5789473684210527,0.86705772079019,1.0,5/46,9.03%,SLC12A2;CCL13;CCL15;STK39;RHOA
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.32831679541680553,0.9345379561834749,0.6060924369747899,0.866807422353233,1.0,32/109,23.95%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PAK2;MAPK8;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;PSMA6;NFATC3;PSMD1;SOS1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;MAPK9;MAP2K7;PSMB1;PSMD4;PSMA5;PSMA7;FOS
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3339385705659666,0.9344191895867514,0.6086021505376344,0.8666384080713633,1.0,11/71,13.13%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,fatty acid biosynthetic process (GO:0006633),0.34498862294346216,0.9343953174910318,0.5915032679738562,0.8662570045527835,1.0,8/63,10.36%,ABCD3;ACSF3;ELOVL5;SCD5;LIAS;OLAH;FADS1;CBR4
prerank,JNK cascade (GO:0007254),0.35688958696671336,0.9340567647069179,0.5831408775981525,0.8665839842521326,1.0,16/40,28.98%,MAP3K5;GPS1;MAPK8;IRAK1;TAB2;MAP3K12;MAP3K10;RPS27A;UBC;MAPK9;GPS2;MAP2K7;RIPK2;MAP3K11;UBE2V1;MAP2K4
prerank,dendritic spine organization (GO:0097061),0.391685655088763,0.9339202325439208,0.5835380835380836,0.8664423024072878,1.0,8/26,13.74%,CTNND2;EPHB2;ARC;EPHB3;DLG4;ARF1;SHANK1;PICK1
prerank,positive regulation of cell death (GO:0010942),-0.25429319034385195,-0.9338111294420882,0.6296296296296297,0.7950864141527506,1.0,16/59,15.02%,SLC6A13;EFNB2;WNT5A;ACER2;PICALM;AXIN2;FAF1;GRIN2B;APC;PRODH;ZC3H12A;EGR1;SARM1;C1QA;SNCA;TYROBP
prerank,Golgi to plasma membrane transport (GO:0006893),0.35521032373040384,0.9336485847207897,0.5833333333333334,0.8665943695838093,1.0,21/47,28.27%,KIF13A;EXOC4;RAB34;GOPC;GGA2;LLGL1;GOLGA4;NSF;STEAP2;GGA1;SPTBN1;GOLPH3;BLZF1;OPTN;ARFGEF2;VAMP4;VPS35L;VAMP2;GCC2;OSBPL5;GGA3
prerank,defense response to tumor cell (GO:0002357),-0.3860152315566575,-0.933647083708543,0.5358255451713395,0.7939363279869858,1.0,2/10,9.41%,RBMS3;ABI3
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4485729153340863,0.933567452276088,0.5645390070921986,0.8663509178162576,1.0,3/12,21.97%,STARD3NL;FDXR;STARD3
prerank,mesenchymal to epithelial transition (GO:0060231),0.4611298361357701,0.9331662192093798,0.5724962630792227,0.8667844483355231,1.0,2/10,9.70%,FZD7;BMP4
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.43812133880675713,0.9331350159824777,0.564625850340136,0.8659913463579614,1.0,4/12,13.52%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.43812133880675713,0.9331350159824777,0.564625850340136,0.8659913463579614,1.0,4/12,13.52%,SLC9A1;CHERP;STIMATE;PTBP1
prerank,response to hydroxyurea (GO:0072710),0.45259127556611556,0.9331296886020238,0.5647382920110193,0.8655745990946895,1.0,6/11,31.69%,DDI2;SPIDR;KAT7;DDX11;TIMELESS;BLM
prerank,axonogenesis (GO:0007409),0.3145746822596551,0.9327296729378813,0.6746987951807228,0.8659573208653963,1.0,25/237,8.25%,SLIT3;SLIT2;SLIT1;EMB;EFNA5;MAP1B;ULK2;GRB10;GAB2;GLI2;PDLIM7;EPHB2;DOCK7;SHC1;NTN4;SEMA3E;PRKCA;EPHB3;EPHB6;RAB8A;SEMA4B;LLGL1;S100B;PALLD;CYFIP1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.4164259253966806,0.932695482894816,0.5517693315858454,0.8655961979018334,1.0,5/16,19.01%,IGFBP5;PHIP;BMP5;IGFBP6;ZFAND2B
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.36722592252437525,0.9326361050022731,0.5881670533642691,0.8652886476941608,1.0,7/38,17.54%,THBS1;TMC8;MADD;TNFRSF10B;BMP5;STX4;HMOX1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.3879011283347411,0.9321919760622083,0.5851851851851851,0.8657890431944942,1.0,7/24,22.45%,CYP1B1;ATF4;SULF1;RORA;IL6;SULF2;EIF2AK3
prerank,transcription by RNA polymerase II (GO:0006366),0.31575366339041794,0.9321876421689484,0.6926926926926927,0.8653739043020349,1.0,97/305,25.90%,ESR1;PRRX1;NFIX;RARB;DDX5;NCOR2;DEAF1;HDAC9;ELOF1;RXRA;WWTR1;ATF4;INTS14;NR2F1;TCFL5;RXRB;NFX1;INTS3;E2F3;MED27;RARA;ESRRB;SYMPK;INTS4;HSF2BP;CDK12;RORA;GTF2F1;CCNT2;INTS13;MAZ;PABPN1;TAF15;TAF6;NRBP1;ERCC3;NR1D2;HDAC1;TAF13;TRIP11;ERCC2;CLP1;CPSF4;VDR;SNAPC4;POLR2F;MBD1;TFDP1;AFF4;NRBF2;PCF11;MLLT3;CREBBP;MED26;PARP1;RPRD1A;NCBP1;SSRP1;NFYA;NR3C1;ELP4;CPSF7;NCBP2;TEAD2;CSTF2;CBFB;NR3C2;TAF9B;ABT1;CSTF2T;MED20;PAF1;NFIC;CEBPD;NR2F6;SNRPB;POLR2B;TAF1C;NR2C2;MNT;SETD2;TBP;ICE1;TFCP2;NELFB;KAT2B;NR5A1;TAF1;CDK13;EAF1;NCOR1;CTDP1;MED23;RTF1;GTF2H4;POLR2H;RNMT
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.37672659834381406,0.9319939628648409,0.5774309723889556,0.8653530917965542,1.0,8/33,14.32%,GAS6;TCF7L2;PKHD1;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,DNA replication checkpoint signaling (GO:0000076),0.422370439321766,0.9315177847863909,0.5697368421052632,0.8659014491319382,1.0,7/16,30.53%,CDC6;CDC45;HUS1;CDT1;TOPBP1;TIMELESS;RAD17
prerank,heart looping (GO:0001947),0.363153565030601,0.9307938564725972,0.5692488262910798,0.8669743062947162,1.0,8/39,16.20%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.4276512115989751,0.9307930695342496,0.5788770053475936,0.866550150567566,1.0,4/16,11.28%,ZFPM2;FGF2;FGFR2;BMPR1A
prerank,membrane lipid metabolic process (GO:0006643),-0.3074288409719332,-0.9305837390131375,0.5408163265306123,0.7997048759049992,1.0,5/22,9.48%,ST3GAL6;CERK;SERINC1;GAL3ST1;SPHK1
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4251089113293631,0.930564949585131,0.5868673050615595,0.8665886517794553,1.0,2/16,2.57%,PDCD4;CHID1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.30939313918517936,0.9305260871444032,0.749,0.8662346447589481,1.0,88/532,16.53%,IRS1;PRKCD;VEGFA;LBP;F3;FGF2;COL1A2;PDCD4;IL33;P4HB;CARD14;GRB10;GHR;MUC1;GAB2;CNTFR;TWIST1;CCL13;SDC1;PSMD7;SHC1;CAMK2D;STAT5A;ANXA2;CCL15;STAT3;PITPNA;IL5;MID1;PSMA8;TNFRSF1B;ILK;TXLNA;TNFSF15;SMAD4;IL12RB2;IFNLR1;IRAK3;BRWD1;HNRNPA2B1;HNRNPDL;RPS6KA4;SOCS6;CBL;ADIPOR2;SOCS2;FCER1G;JAGN1;TXNDC17;RORA;PAK2;PSMA4;ANXA1;LTBR;CHUK;CTF1;IRAK1;TAB2;ARF1;COMMD7;SOD1;CD27;PSMD12;IL20RB;PIK3CB;TRAF3;CUL1;PSMA6;CD80;CASP1;TRIM26;SQSTM1;CLCF1;PSMD1;STX4;HGF;IL6;SOS1;STX1A;MAP3K3;PSMC5;FOXO3;PSMD11;PSMC4;PSMD14;TRAF3IP2;RPS27A;UBC
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.410037929872847,0.930206038617679,0.5842245989304813,0.8664545760128955,1.0,9/18,33.68%,FXN;EDN3;ABL1;GDNF;RFK;ABL2;PDP2;ATP7A;PDP1
prerank,muscle tissue development (GO:0060537),-0.3529222796288767,-0.9301766351397672,0.5209125475285171,0.7991303036308927,1.0,3/13,3.22%,ENG;PTCH1;PGM5
prerank,peptide catabolic process (GO:0043171),0.3943080203867826,0.9300668702642801,0.5783289817232375,0.8663288475238244,1.0,9/23,23.50%,ECE1;CPQ;XPNPEP1;LNPEP;IDE;NPEPPS;LVRN;CHAC2;DPEP1
prerank,stem cell differentiation (GO:0048863),0.36536095656795314,0.9296606350042663,0.5921658986175116,0.866756363824728,1.0,8/39,17.35%,LRP6;TGFB2;PUM1;FGFR2;HOXB4;PSMD11;MLLT3;UFL1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4311446086023194,0.929204879383969,0.5618915159944368,0.8672684052175866,1.0,4/14,18.57%,AGR2;HSPA5;UFL1;TMEM33
prerank,negative regulation of protein kinase activity (GO:0006469),0.3317974655591075,0.929057036855543,0.6125,0.8671337311852013,1.0,21/88,20.31%,LRP6;SRCIN1;UBASH3B;LRP5;WWTR1;DVL1;TRIM27;AKT1S1;CDK5RAP3;PAK2;ABL1;PDPK1;DEPTOR;CHP1;CAMK2N1;GSKIP;NF1;CDKN1C;AKT1;DUSP19;RTRAF
prerank,DNA replication initiation (GO:0006270),0.3666911628550447,0.9287807657280227,0.5770142180094787,0.8672770423069713,1.0,12/37,26.11%,POLE2;MCM2;CDC6;CDC45;MCM4;ORC2;CDT1;DBF4;CDK2;TOPBP1;PRIM1;MCM7
prerank,second-messenger-mediated signaling (GO:0019932),-0.22951362012578463,-0.9286935705987538,0.6794871794871795,0.8011134401753397,1.0,18/82,12.06%,APOE;MCTP1;NOS3;CCR9;RYR2;GUCY1B1;DGKD;NUDT4;MCTP2;AGTR1;SPHK1;KSR2;EDNRB;EDN1;CX3CR1;NOS1;CHRM3;DDAH2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.4642138730447251,0.9285992157084313,0.5631349782293179,0.8672210125519237,1.0,5/11,36.40%,ATF4;PINK1;PRKN;NR4A3;NONO
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.33270144513905103,0.9282553151132742,0.62486602357985,0.8674959089484472,1.0,23/87,23.58%,FHL1;FBXL7;PSMD7;PSMA8;DACT1;DLG1;PSMA4;PSMD12;CUL1;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RBL2;PSMA3;PSMB1;PSMD4;USP47;GPNMB;PSMA5;PSMA7
prerank,negative regulation of potassium ion transport (GO:0043267),-0.35674070186396856,-0.9281085002851931,0.5590277777777778,0.8008688055486166,1.0,5/13,15.30%,NEDD4L;ACTN2;CAV1;NOS1;CASQ2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.37307232860616274,0.9278461528112979,0.5658536585365853,0.8679375878094657,1.0,10/29,26.25%,CHUK;TRAF3;TANK;RPS27A;UBC;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3404404831349742,0.9278313274712346,0.6043243243243244,0.8675449611887628,1.0,32/69,34.40%,INTS14;INTS3;INTS4;GTF2F1;CCNT2;INTS13;TAF6;TAF13;SNAPC4;POLR2F;RPRD1A;NCBP1;NCBP2;POLR2B;TBP;ICE1;POLR2H;INTS9;SRRT;POLR2I;CDK9;INTS7;POLR2L;INTS6;SNAPC1;GTF2A2;RPAP2;POLR2K;RPRD2;ZC3H8;GTF2E2;INTS10
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3933612831406783,0.9278228222617865,0.5835380835380836,0.8671415904760579,1.0,13/26,31.55%,NOL3;ATF4;NFE2L2;AKT1;LRRK2;PYCR1;VNN1;PINK1;HTRA2;NME5;PRKN;GPR37;GPR37L1
prerank,spindle assembly (GO:0051225),0.3398444611306876,0.9277624378816552,0.5945652173913043,0.866842563636845,1.0,27/67,32.66%,CSNK1D;GOLGA8B;MISP;TUBGCP3;NEK7;SMC3;RHOA;RCC1;CHEK2;MAPRE3;CEP63;HAUS5;STAG1;CCDC61;ARHGEF10;WRAP73;SMC1A;NCOR1;SPICE1;GOLGA2;NEK6;TOGARAM1;TUBGCP2;KIF2A;BCCIP;HDAC3;PIBF1
prerank,negative regulation of developmental process (GO:0051093),0.3376218004749027,0.9276707732421777,0.6131465517241379,0.8666003689394861,1.0,13/69,12.12%,GAS6;NFIB;GRIN3A;PARP3;PTPRS;SOX9;HUWE1;CST3;BMP4;ANP32B;FOXM1;NEUROD2;HEY1
prerank,negative regulation of blood pressure (GO:0045776),-0.3484683835991681,-0.9272919457987815,0.5659722222222222,0.8011484545954932,1.0,7/13,29.23%,NOS3;BMPR2;NOS1;APLN;PRCP;NOS2;DRD3
prerank,histone H2A ubiquitination (GO:0033522),0.41383031986596436,0.9272915827281801,0.582562747688243,0.8669583297352267,1.0,5/17,18.72%,UBE2B;RNF2;RING1;RYBP;UBR2
prerank,neuropeptide signaling pathway (GO:0007218),-0.23891766440376405,-0.9272029160953387,0.5833333333333334,0.7998028825791165,1.0,15/58,23.92%,SORCS1;RAPGEF2;GLRA2;SORT1;OPRM1;CYSLTR1;NMU;NTS;GLRA1;NXPH2;PNOC;NMUR2;CYSLTR2;NXPH4;KISS1R
prerank,cell proliferation in forebrain (GO:0021846),0.4566406059590223,0.9271968437631687,0.5779310344827586,0.8667356256261295,1.0,2/10,15.08%,DOCK7;PCM1
prerank,positive regulation of neuron death (GO:1901216),-0.25710070558708936,-0.9271072279999709,0.6551724137931034,0.7984880700293382,1.0,11/46,15.02%,EFNB2;WNT5A;PICALM;EPHA7;GRIN2B;NUPR1;EGR1;SARM1;C1QA;SNCA;TYROBP
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.42617666906664203,0.9270276451917251,0.5898491083676269,0.8666550099164902,1.0,6/15,21.85%,ATL2;REEP3;TMEM170A;TMEM33;ATL1;RAB18
prerank,epithelial cell development (GO:0002064),0.39735173986262484,0.9269458830751177,0.5606060606060606,0.8663926357438358,1.0,2/20,3.83%,LRTOMT;PKHD1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.2951989136487249,-0.9267195189894496,0.5816326530612245,0.7978537461937147,1.0,4/26,7.03%,ITPR1;RYR2;ITPR3;HTR2C
prerank,steroid hormone biosynthetic process (GO:0120178),0.3784467316795198,0.926620309684291,0.5816203143893591,0.866657923975264,1.0,5/29,21.97%,CYP19A1;STARD3NL;FDXR;HSD17B8;STARD3
prerank,female gamete generation (GO:0007292),-0.28061066042313665,-0.9264533517491023,0.608433734939759,0.7968651927608242,1.0,13/29,22.56%,DIAPH2;PTN;FMN2;TOB2;SPO11;MEI4;MCM8;PRDM9;DMC1;MDK;NANOS3;NANOS1;TRIP13
prerank,purine-containing compound catabolic process (GO:0072523),-0.3502759903616445,-0.9262548207833805,0.5371024734982333,0.7958530437077463,1.0,4/13,12.80%,NT5C2;DPYD;GDA;GPX1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4526123750330678,0.9262332462982811,0.57,0.8670304096253745,1.0,5/10,19.88%,MTHFD2;MTHFD1;SHMT2;SHMT1;MTHFR
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.39259193261494973,0.9261851150292926,0.5749039692701664,0.8667109213784001,1.0,7/23,20.97%,GHR;CYP1B1;HES5;F2R;IL6;PRLR;IL4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.32928726588843127,-0.9260416385913041,0.5720164609053497,0.7948135299788731,1.0,6/16,18.51%,AUTS2;BCOR;PIH1D1;CTR9;BRCA1;KDM1A
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3932336793682414,0.9259420542470191,0.5935897435897436,0.8667744487936516,1.0,3/22,14.76%,SRSF6;FGFR2;VDR
prerank,transcription by RNA polymerase III (GO:0006383),0.3782477793227409,0.9258887843770156,0.5745992601726264,0.8664688657559145,1.0,10/27,22.66%,POLR3H;CRCP;POLR3GL;SNAPC4;GTF3C1;GTF3C4;POLR3K;GTF3A;TBP;ICE1
prerank,stabilization of membrane potential (GO:0030322),0.4225399568345992,0.9256943939874506,0.5852047556142669,0.8664530958775267,1.0,1/16,0.40%,KCNK5
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.37290669584496383,0.9254813438581518,0.5780487804878048,0.8664546462266539,1.0,11/31,21.66%,SRCIN1;ARC;SIPA1L1;TANC2;NLGN1;ARHGAP44;NGEF;EFNA1;CDK5;ABI2;LRRK2
prerank,melanosome transport (GO:0032402),0.4026671995341989,0.9254669165210332,0.5510752688172043,0.865653837077958,1.0,7/18,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,pigment granule transport (GO:0051904),0.4026671995341989,0.9254669165210332,0.5510752688172043,0.865653837077958,1.0,7/18,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,nucleoside phosphate catabolic process (GO:1901292),0.43045473164546055,0.9251642085726549,0.5944444444444444,0.8658664901000196,1.0,4/13,9.61%,ENTPD2;ENTPD6;DCTPP1;SMPDL3A
prerank,defense response to Gram-negative bacterium (GO:0050829),0.36161581322988284,0.9250775066860719,0.6129032258064516,0.8656164425663366,1.0,9/42,22.65%,LBP;RNASE7;RNASE3;RNASE6;DEFB1;IL6;DMBT1;OPTN;SLC11A1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.40499922287427365,0.9248241842786485,0.5482166446499339,0.8657181358518213,1.0,2/18,2.58%,GRIK4;UNC13B
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.44424423110211847,0.9247250965010161,0.5668073136427567,0.8654914073086244,1.0,2/11,6.33%,LMNA;SMAD4
prerank,regulation of biosynthetic process (GO:0009889),-0.3647474821028606,-0.9246611011129456,0.5261194029850746,0.7965857379067963,1.0,3/11,15.01%,SLC25A33;MID1IP1;SNCA
prerank,negative regulation of translation (GO:0017148),0.3280951243757524,0.9246061464732965,0.6194968553459119,0.8653238232070989,1.0,30/87,28.60%,IGFBP5;SAMD4A;FTO;PUM1;ILF3;METTL16;AGO2;RBM4;CNOT8;CNOT10;EPRS1;DAPK3;CNOT9;SHMT1;SYNCRIP;EIF2AK4;UNK;CALR;FXR2;EIF2AK3;YBX1;RBM24;ROCK1;METTL14;MRPL13;TPR;RIDA;FXR1;YTHDF1;LARP1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.3899963801290429,0.9239958600528666,0.5592783505154639,0.8661523950641704,1.0,5/22,15.25%,GHR;CYP1B1;HES5;F2R;IL6
prerank,oligodendrocyte differentiation (GO:0048709),-0.30444500783146955,-0.9239450779056522,0.6052631578947368,0.7967642665647123,1.0,4/19,8.51%,SOX13;SOX6;SLC8A3;EIF2B3
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.41444022683838855,0.9238241549025943,0.5723860589812333,0.8660832485758573,1.0,2/17,0.96%,CACNA1C;ATP1B1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3198785835965366,0.9236991148413538,0.6317948717948718,0.8659285379884843,1.0,36/133,24.42%,SLC35G1;ATP1B1;SLC24A3;CCL13;CAMK2D;PKHD1;CCL15;PACS2;ADCY8;SLC10A7;MCU;ANK2;CHERP;STIM1;EDN3;CSRP3;TMEM165;MICU2;LETM1;YWHAE;DMPK;MICU1;CALB2;CALCA;KCTD17;CLN3;CALR;PRKACA;ATP2B4;ANXA6;AFG3L2;SLC8B1;STOML2;FKBP1B;HERPUD1;STIM2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4507910012152385,0.9236682716616981,0.5863570391872278,0.865574108018347,1.0,5/11,30.27%,NRP1;HGF;SIRT2;BCAR1;RAC1
prerank,negative regulation of cell aging (GO:0090344),-0.3143614893113439,-0.9234585885116466,0.5537190082644629,0.7963267980290136,1.0,3/16,2.72%,CDK6;SLC30A10;AKT3
prerank,regulation of rRNA processing (GO:2000232),0.40797085612499173,0.9234136769060891,0.5794270833333334,0.8656730901110653,1.0,12/16,38.90%,RIOK1;USP36;KAT2B;WDR75;BUD23;RIOK2;TRMT112;SIRT7;UTP15;DIMT1;YTHDF2;WDR43
prerank,organophosphate biosynthetic process (GO:0090407),0.3615253882779709,0.923262578961351,0.5892857142857143,0.8655613140322129,1.0,12/37,26.44%,FGF2;LPCAT1;TKT;NFS1;FADS1;IP6K1;PIP5K1A;AGPAT5;MBOAT1;PPIP5K1;FITM2;PCYT2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.2892696798180631,-0.9232006235138357,0.5979381443298969,0.7954415165818154,1.0,6/26,12.06%,INSR;SMAD3;KLF2;ASS1;EDN1;DDAH2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3278620397707682,-0.9226566490386727,0.539568345323741,0.7951319680863486,1.0,12/14,43.80%,PAEP;IL17D;CD84;RASGRP1;IL18;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,SNARE complex assembly (GO:0035493),-0.37013581341368607,-0.9222740492975969,0.5415162454873647,0.7945263607446641,1.0,1/10,1.48%,STXBP6
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3383273585606605,0.9222477173634644,0.5895439377085651,0.8672434810808268,1.0,15/57,21.82%,XPO1;LTV1;RRS1;EMG1;CUL4A;RIOK1;NVL;MRTO4;BYSL;BOP1;METTL17;NOC2L;WDR12;GTF3A;PAK1IP1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3859147920330068,0.9221797024763313,0.5835411471321695,0.8669721394612505,1.0,9/23,21.66%,DRD1;ATF4;SLC9A1;ABL1;SIRT2;PRKACA;GNB1;ATP2B4;LRRK2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.43491473957686927,0.9211573814663021,0.5744089012517385,0.8686572644423808,1.0,4/13,15.25%,NFAT5;RHOA;IRAK1;IL6
prerank,regulation of TORC1 signaling (GO:1903432),0.36822513332405066,0.9211468974146635,0.6050420168067226,0.8682658339959992,1.0,11/33,19.27%,SESN3;SEH1L;CLEC16A;CASTOR2;DGKQ;ATM;TELO2;SESN2;KLHL22;FLCN;KPTN
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3927914297184465,0.9211202916892113,0.5626566416040101,0.8678995590973843,1.0,1/21,0.44%,FOXP1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32867092223477984,0.921045287165672,0.6148068669527897,0.8676393783868316,1.0,11/73,13.13%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;FCER1G;WIPF1;ABL1;PIK3CB;MYH2
prerank,brain development (GO:0007420),0.3186948647622731,0.9209741484208981,0.6459816887080366,0.8673632594486126,1.0,31/136,20.91%,SLC23A1;ZFHX3;PBX3;NFIB;ADGRL2;HES5;PITPNM1;RAB3GAP1;AMIGO3;TGFBR2;PBX1;MEIS3;TBC1D23;CDK5RAP3;ZIC1;SYNJ1;PHF8;POU6F1;PAFAH1B2;ABCB6;CXCR4;PHGDH;NF1;NIPBL;IER3IP1;CHD8;PAFAH1B3;SETD1A;BPTF;SYNJ2;AFF2
prerank,heterochromatin assembly (GO:0031507),0.39423662256367076,0.9208244990852837,0.5721854304635762,0.8672373025791997,1.0,6/20,20.79%,BAZ2A;EZH1;HDAC1;SIRT2;HMGA1;SUV39H1
prerank,myelin assembly (GO:0032288),0.45182572902234,0.9207547252176578,0.5798561151079137,0.8669597372575069,1.0,3/10,12.75%,PMP22;CD9;NCMAP
prerank,retinoid metabolic process (GO:0001523),0.3346613947495404,0.9203882697360113,0.6375545851528385,0.8673156857365941,1.0,5/71,3.46%,GPC6;LRP1;GPC3;SDC1;CYP1B1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.45184432895305154,0.9203336506929712,0.5821325648414986,0.8661868101194767,1.0,6/10,31.99%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.45184432895305154,0.9203336506929712,0.5821325648414986,0.8661868101194767,1.0,6/10,31.99%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,t-circle formation (GO:0090656),0.45184432895305154,0.9203336506929712,0.5821325648414986,0.8661868101194767,1.0,6/10,31.99%,WRN;XRCC3;SLX4;SMARCAL1;BLM;ERCC1
prerank,regulation of monocyte differentiation (GO:0045655),0.42808076687281515,0.9202838087218201,0.581267217630854,0.8658814627584058,1.0,1/14,0.44%,FOXP1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.39094944353507183,0.9202542559655739,0.5969773299748111,0.8655266072047973,1.0,4/24,10.05%,IRS1;PPP1R3C;AKT2;PPP1R3F
prerank,negative regulation of MAPK cascade (GO:0043409),0.3304285686998634,0.9198369000921693,0.6385026737967915,0.8659466921622815,1.0,16/87,12.91%,PRKCD;EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;IRAK3;CDK5RAP3;DLG1;BMP4;PAQR3;FOXM1;EZR;PIK3CB;PPEF2;PTPN2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.4499039703668799,0.9195440385454209,0.5841874084919473,0.8661455735952153,1.0,3/10,13.92%,ADAM10;STK39;WNK1
prerank,positive regulation of dephosphorylation (GO:0035306),0.38891237804052325,0.9195266836676462,0.5883069427527405,0.8657683661524547,1.0,8/27,16.85%,PRKCD;CALM2;SYMPK;RIPK3;CNEP1R1;PTBP1;NSMF;CALM3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.33425906906585456,0.9189653770809549,0.6167209554831705,0.8664850168607566,1.0,11/67,12.40%,PGF;VEGFA;VAV2;SULF1;ABI1;CYFIP1;RHOA;PAK2;ITGAV;PIK3CB;NRP1
prerank,regulation of protein secretion (GO:0050708),0.3207917205612524,0.9186173200019225,0.643378519290928,0.8667548044347488,1.0,25/119,17.96%,CACNA1C;KCNB1;SLC12A2;ADAM9;UNC13B;TGFB3;APBB3;TGFB2;P3H1;PRKCA;DISP1;LLGL1;CACNA2D2;EZR;STXBP5;GLP1R;ERP29;PICK1;IL6;STX1A;APBB1;SLC2A2;SYTL4;IER3IP1;GOLPH3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.30229243351794166,-0.9182218834731081,0.5454545454545454,0.8023819395857509,1.0,5/21,9.39%,ADCY5;GUCY1B1;ADCY1;ADCY4;NPR1
prerank,signal transduction by p53 class mediator (GO:0072331),0.37433407612578584,0.9181734837149982,0.587088915956151,0.8672272209480546,1.0,5/30,12.59%,DDX5;FHIT;MDM4;NDRG1;SESN2
prerank,miRNA mediated inhibition of translation (GO:0035278),0.4508605673449391,0.9176855089102429,0.5881481481481482,0.8673897032513355,1.0,4/11,15.73%,AGO1;AGO2;RBM4;EIF6
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.4508605673449391,0.9176855089102429,0.5881481481481482,0.8673897032513355,1.0,4/11,15.73%,AGO1;AGO2;RBM4;EIF6
prerank,"phototransduction, visible light (GO:0007603)",0.424731773830601,0.9172602079510679,0.5885558583106267,0.8678545342563141,1.0,4/14,20.86%,PDE6A;GNA11;SAG;GNB1
prerank,blood circulation (GO:0008015),0.3459821913179759,0.9166949823852094,0.5952649379932357,0.8685856205888209,1.0,5/49,3.90%,ELN;SGCD;GCLC;HCN4;MEOX2
prerank,positive regulation of nuclear division (GO:0051785),-0.28873680882425723,-0.9166448044867525,0.6173469387755102,0.8044184099730955,1.0,3/25,4.51%,INSR;TGFA;PDGFRB
prerank,epidermis development (GO:0008544),0.3366519954712494,0.9166038491489631,0.5882352941176471,0.8683591928560922,1.0,9/56,16.37%,KRTDAP;TGM5;PLOD1;FGFR2;CRABP2;HDAC1;ALDH3A2;GRHL1;EMP1
prerank,male meiosis I (GO:0007141),0.41857591421576235,0.9165765714689809,0.5818908122503329,0.8680047095771604,1.0,3/16,18.60%,FOXJ3;HSF2BP;BRDT
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3329757520249362,0.9165586427967193,0.6281352235550709,0.8676298223851714,1.0,37/72,37.43%,CHD1L;HORMAD1;PNRC2;ERCC5;ERCC4;RNASE6;OGG1;CUL4A;ERCC3;RAD50;ERCC2;PARP1;RPS27A;UBC;DCP1A;POLD1;GTF2H4;XPA;FBH1;DNASE1L2;DDB1;EDC4;DXO;RBX1;RNASE1;IHO1;ERCC1;POLK;RPA3;CUL4B;FAN1;RFC4;MRE11;DCP1B;POLD3;REXO4;MUS81
prerank,regulation of microtubule-based process (GO:0032886),0.3619345479432123,0.9164767417657805,0.5966981132075472,0.8673744873379551,1.0,10/36,26.63%,EFNA5;PHLDB1;MARK4;HDAC6;ERBB2;CAMSAP3;CYLD;ROCK1;TAOK1;ATF5
prerank,determination of heart left/right asymmetry (GO:0061371),0.3529110805720684,0.9164215733966797,0.5861271676300578,0.8670755991583021,1.0,8/42,16.20%,MICAL2;TGFBR2;TBX21;CCDC39;SRF;SMO;BBS5;NPHP3
prerank,receptor metabolic process (GO:0043112),0.3492477991714967,0.916389812822628,0.6152149944873209,0.8667266300040695,1.0,16/53,23.07%,LRP1;NEDD4;RAMP2;DNM2;CD9;FCER1G;SNX1;RAMP1;RAB11B;CLTC;PHETA2;GRK4;ARFGEF2;ACKR3;MVB12A;UVRAG
prerank,regulation of response to biotic stimulus (GO:0002831),0.3716250242953732,0.916162309151593,0.5826296743063932,0.8668056450347543,1.0,8/28,25.60%,FOXP1;TRAF3;N4BP1;APPL2;APPL1;BIRC3;XIAP;TKFC
prerank,neutrophil chemotaxis (GO:0030593),0.34182610489894094,0.9160196090426508,0.6146788990825688,0.8666757969046684,1.0,6/53,9.29%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.2160739424431149,-0.9156881113744445,0.6666666666666666,0.8051978410768987,1.0,48/110,23.31%,RPS14;RPS15;RPS25;RPL8;SMG7;RPS8;RPL4;RPS20;CTIF;RPS27;RPL24;RPS10;RPS29;RPL26;RPS7;RPS16;RPS24;RPL35;RPL36;GSPT2;RPL11;RPL18A;RPS12;RPL12;SMG8;RPS11;UBA52;RPL18;RPS15A;RPS28;EIF4A3;RPL21;RPL7;RPL10;RPL15;RPS3;RPS18;RPS19;RPL38;RPS5;RPL28;RPL35A;RPS4X;RPL9;RPL17;RPL23;RPL31;RPL37
prerank,monocyte differentiation (GO:0030224),0.4475426777330676,0.9155713416221605,0.5804093567251462,0.8671881217589446,1.0,2/10,9.70%,VEGFA;BMP4
prerank,amyloid precursor protein catabolic process (GO:0042987),0.41739185825114455,0.9152495765472655,0.5796703296703297,0.8674241900713604,1.0,4/14,18.37%,ADAM10;BACE1;PSEN2;CLN3
prerank,response to interferon-alpha (GO:0035455),0.41203695683264385,0.9152347604376668,0.573170731707317,0.8670430093392203,1.0,1/16,0.97%,GAS6
prerank,establishment of spindle orientation (GO:0051294),0.3777280730298343,0.9151781585106982,0.5908558030480656,0.8667480805544366,1.0,7/28,22.48%,PKHD1;MISP;LLGL1;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,base-excision repair (GO:0006284),0.35132857474700524,0.914954924086502,0.6285714285714286,0.8667930841739317,1.0,24/48,34.68%,MPG;HUWE1;ERCC5;OGG1;WRN;TDG;SMUG1;PARP1;POLB;APEX2;USP47;PARG;POLD1;POLG;XPA;PNKP;ADPRS;MBD4;XRCC1;ERCC6;POLQ;RPA3;PRMT6;RFC4
prerank,membrane depolarization (GO:0051899),0.3671417722116093,0.914937629166023,0.568986568986569,0.8664136775803633,1.0,4/32,10.59%,CACNA1G;SCN11A;CHRNB2;ABL1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.42715817696980496,0.9139990476305067,0.5529891304347826,0.8678480047975246,1.0,4/13,14.77%,DKK3;SOD1;BMP5;CYP27B1
prerank,regulation of double-strand break repair (GO:2000779),0.36037452767512684,0.9139587244709834,0.6087962962962963,0.8675064051190987,1.0,17/39,30.17%,TWIST1;OTUB1;SLF2;SPIDR;FOXM1;UBR5;OTUB2;SPIRE2;RAD51;SLF1;SETD2;ACTR2;WAS;RTEL1;DDX11;TRIP12;TIMELESS
prerank,protein K63-linked deubiquitination (GO:0070536),0.36928492848632477,0.9138596201333473,0.6,0.8672854678889759,1.0,12/31,23.23%,USP50;OTUB2;USP7;USP33;USP13;PSMD14;OTUD5;SHMT2;YOD1;ZRANB1;BRCC3;CYLD
prerank,cellular response to drug (GO:0035690),-0.29022544678602075,-0.9136659967305675,0.5953488372093023,0.8084818351529964,1.0,5/25,10.27%,PPM1E;ACER2;TFRC;AIM2;PDE4B
prerank,response to nitric oxide (GO:0071731),-0.3506521571469833,-0.9132836171899992,0.5578947368421052,0.8077918909566386,1.0,6/13,27.33%,GUCY1B1;KCNC2;FOXO1;MT3;MMP3;AQP1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.32959597452892647,0.912886772818395,0.6146179401993356,0.8687576118550214,1.0,9/66,15.25%,FOXP1;CARD16;STAT3;USP50;FZD5;GIT1;F2R;CASP1;IL6
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3205064255105915,-0.9127830504588279,0.5860805860805861,0.8074957508539047,1.0,5/15,15.92%,DGKD;HIP1R;AAK1;TNK2;BMP2K
prerank,response to cytokine (GO:0034097),0.3128529699427217,0.9123689542848871,0.6817713697219362,0.8693741461316735,1.0,20/141,10.69%,PID1;COL3A1;ADAM9;AFF3;TIMP2;TIMP3;DPYSL3;NFAT5;HDAC4;STAT3;PRKCA;ADAM10;IFNLR1;IRAK3;CXCL16;RHOA;PTPN18;MAPK8;ANXA1;IRAK1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.42533042032076585,0.9121730329296565,0.574792243767313,0.8693406148863914,1.0,6/13,26.31%,HEXIM1;LARP7;NELFB;HNRNPU;RECQL5;NELFA
prerank,hexose metabolic process (GO:0019318),0.3592922942091033,0.9119824726217166,0.6,0.8692935613255318,1.0,11/39,20.88%,FUOM;SORD;GAA;PMM2;ADPGK;AKR1A1;HECTD4;SLC37A4;SLC35A2;GDPGP1;FPGT
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.345682381029735,0.9117319987075206,0.6208853575482406,0.8693834279250516,1.0,10/46,12.71%,SRGAP2;SRCIN1;TMEFF2;NTN4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA
prerank,pancreas development (GO:0031016),0.4286959768094166,0.911642360393568,0.6047819971870605,0.869155227929048,1.0,3/12,16.20%,TCF7L2;CCDC39;NPHP3
prerank,regulation of actomyosin structure organization (GO:0110020),0.42507237023524197,0.9112025957214048,0.5932203389830508,0.8695876441260728,1.0,3/13,6.94%,ASAP3;ALMS1;SLC9A1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.4210041969721734,0.9110199755077572,0.5691868758915835,0.8695676197868326,1.0,2/12,7.71%,SOX9;MUC13
prerank,negative regulation of receptor binding (GO:1900121),0.45142369302406854,0.9108693854566978,0.5916083916083916,0.8694702120878778,1.0,2/10,8.27%,PTPRF;NOG
prerank,cytoplasmic microtubule organization (GO:0031122),0.3435699669566369,0.9108630089903316,0.625414364640884,0.8690760157521821,1.0,16/54,22.64%,LIMK2;DYNC1H1;CLIP4;TUBGCP3;DLG1;RHOA;SPAST;EZR;CHP1;PCM1;KATNA1;SLAIN2;DCTN1;CLIP2;CRIPT;CAMSAP3
prerank,regulation of macrophage cytokine production (GO:0010935),0.4207739371548326,0.9097675721287937,0.5781466113416321,0.8708031638698842,1.0,3/13,7.14%,TGFB3;TGFB2;IRAK3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.36445956608736874,0.909683623267727,0.5878048780487805,0.870552124684419,1.0,10/30,26.25%,CHUK;TRAF3;TANK;RPS27A;UBC;IKBKE;IRF3;BIRC3;TBK1;RIPK1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3071248202603787,0.9094954254226696,0.7324649298597194,0.8704977214591922,1.0,73/306,22.96%,ST3GAL4;EXT1;RRBP1;RPSA;HELB;TOPORS;BAZ2A;POLE2;EIF4G2;RMI2;ABCF1;MCM2;HARS2;ST3GAL2;GSPT1;CDC6;B4GALT5;RBBP8;RAD1;WRN;MRPS18B;ING5;NFKBIB;TERT;ATM;GAL3ST4;RAD50;MRPS14;EEF1G;XAB2;AGO2;EIF4G1;CDC45;MRPL35;INHBA;MEF2A;MMS19;POLR2F;MRPS17;ING4;EEF2K;ATRIP;B3GNT6;RPS27A;HUS1;MCM4;EEF1B2;YARS2;REV1;TUFM;ORC2;GOLPH3;E2F1;EEFSEC;DBF4;EXT2;SARS1;CDK2;RPL7A;DARS1;KAT7;TBRG1;MED20;GTPBP2;UPF1;POLR2B;TOPBP1;MRPS21;ASMT;PTMS;TOP1;DONSON;TOP1MT
prerank,regulation of dendritic spine development (GO:0060998),0.3988706277627735,0.9092334597102909,0.6007802340702211,0.870601532997356,1.0,6/19,13.02%,GRIN3A;PTPRS;TANC2;SHANK1;FOXO6;NLGN1
prerank,alcohol catabolic process (GO:0046164),-0.3843954422038336,-0.9090093456065127,0.5770491803278689,0.8145877375933622,1.0,5/10,20.71%,APOE;CYP27A1;SCARF1;MT3;CYP46A1
prerank,positive regulation of transferase activity (GO:0051347),0.313608145266516,0.9087915885786579,0.6783505154639176,0.8710642047802684,1.0,23/142,12.60%,EGFR;DDR2;NTRK3;NTRK1;MAPK15;EPHB2;TOPORS;EPHB3;EPHB6;DCUN1D5;NEK7;FGFR1;HNRNPA2B1;ROR1;FGFR2;MUSK;NVL;LMO4;AXIN1;PABPN1;DDR1;RAD50;DCUN1D2
prerank,proteasome assembly (GO:0043248),0.4494224061547186,0.9084861333380715,0.5897058823529412,0.8712889553865313,1.0,5/11,29.86%,PSMD11;OTUD6B;PSMD4;PSMG2;ADRM1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4129249729742755,0.9084107360935882,0.6034712950600801,0.8710257329172244,1.0,5/16,18.70%,NPR3;TERT;PIK3CB;S100A1;AKT1
prerank,regulation of protein ubiquitination (GO:0031396),0.31623337211003993,0.9080741290284652,0.6614583333333334,0.8712716504257869,1.0,40/108,30.44%,PRR7;PRICKLE1;NXN;HUWE1;CDK5RAP3;OGT;AXIN1;SMAD7;CHP1;TGFBR1;PHF23;UBQLN1;U2AF2;SQSTM1;ARRB1;STUB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;MYCBP2;LRRK2;BIRC3;DERL1;USP4;CAMLG;GTPBP4;PINK1;RCHY1;XIAP;DAXX;NDFIP1;RIPK2;SVBP;PER2;SPOPL;PRMT3;PRKN;HSP90AA1
prerank,positive regulation of protein secretion (GO:0050714),0.33210029937429714,0.907792593406063,0.6546448087431694,0.8714268384354307,1.0,9/69,7.97%,ADAM9;TCF7L2;UNC13B;TGFB3;APBB3;TGFB2;MCU;AACS;CAPN10
prerank,negative regulation of gene expression (GO:0010629),0.3056943053990828,0.9076848413364748,0.7597597597597597,0.8712423166810895,1.0,57/302,18.44%,ESR1;FOXP1;ID2;IGFBP5;VEGFA;FGF2;SLC24A3;EMILIN1;NCOR2;ANXA7;SAMD4A;HDAC9;TGFB2;CD3E;XDH;PHF1;ADAM10;RPS6KA4;TRIM27;DGKQ;ZC3H12D;WWP2;ILF3;BMP4;AGO1;DIS3L2;TERT;BMPR1A;METTL16;KDM4A;CIDEA;PTRH2;HDAC1;AGO2;SMO;RBBP7;SETDB1;LSM2;ERP29;PTBP1;RBM4;RUNX1;ZNF148;VDR;CNOT8;N4BP1;ZC3H10;CNOT10;RBL2;SLC2A10;FLCN;EPRS1;CITED2;DAPK3;TRIM6;CNOT9;SHMT1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.35489671598318373,0.907543202080493,0.6131301289566237,0.87110711597202,1.0,4/39,7.97%,TCF7L2;MCU;AACS;CAPN10
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.39871126299597137,0.907365530264089,0.6153846153846154,0.8710499015757976,1.0,3/18,7.77%,VEGFA;ADCY8;RPS6KA4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.2523239408951962,-0.9072686478853097,0.625,0.8170711628425984,1.0,14/45,18.88%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;LGALS9;TRIM16;TYROBP;NOD2;PYCARD;MYD88;P2RX7
prerank,genitalia development (GO:0048806),0.4308917522397248,0.9071494188480077,0.5947075208913649,0.8710978956631631,1.0,1/12,0.46%,PKD1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.22975065868523545,-0.9069790837870536,0.7586206896551724,0.8161844013690477,1.0,21/69,24.19%,COX8A;COX6C;NDUFC2;COX4I1;CYC1;UQCRC2;UQCR11;COX10;NDUFA13;NDUFB2;UQCRB;NDUFAF1;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA8;NDUFB11;UQCRQ;NDUFS6;NDUFA4
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.30835564979382035,0.9066601635097045,0.7055837563451777,0.8717084183404848,1.0,35/161,16.38%,LRP6;TCF7L2;SFRP4;PRICKLE1;DKK3;PSMD7;TLE2;WWTR1;PTPRU;TLE6;PSMA8;DACT1;DVL1;SOX9;NOG;DACT3;TLE3;PSMA4;TPBG;AXIN1;INVS;PSMD12;HDAC1;PSMA6;LIMD1;DAB2;FUZ;PSMD1;PSMC5;LATS2;PSMD11;MLLT3;NPHP3;PSMC4;PSMD14
prerank,regulation of Notch signaling pathway (GO:0008593),0.32928198684366694,0.906373757142326,0.6453362255965293,0.8718689866220997,1.0,10/76,8.96%,EGFR;CCN3;ZMIZ1;TGFB2;STAT3;POGLUT1;JAG1;MMP14;LLGL1;WWP2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.348944705594345,0.905908882926411,0.6189917936694022,0.8723717242328576,1.0,4/39,6.53%,VEGFA;FXYD5;RDX;JAG1
prerank,regulation of cell adhesion (GO:0030155),0.3155377955509047,0.9058721674401704,0.6813524590163934,0.8720407898598037,1.0,12/129,6.35%,PLXNA4;ZFHX3;VEGFA;EFNA5;P4HB;TGFBI;EPHB2;SPN;PKHD1;PRKCA;EPHB3;ADAM10
prerank,apoptotic process (GO:0006915),0.30954262558839707,0.905859493306629,0.7303822937625755,0.8716639466019236,1.0,43/203,20.16%,PLAGL1;PRKCD;EFNA5;CIT;PDCD4;PRKCE;MAGI3;FAP;RELT;TGFBR2;RAF1;MCM2;PAK4;IAPP;DAP;OGT;CSRNP1;ATN1;YARS1;AIFM1;TNFRSF10B;ERCC3;HSPD1;LIG4;ERCC2;MAP3K10;CASP1;DMPK;RHOB;ING4;CXCR4;PLSCR3;PARP1;HIP1;DAPK3;BNIP1;BID;AKT1;RFK;IRF3;NFKBIA;CDK5;TRAIP
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3922296198975884,0.9055815746074908,0.5997425997425997,0.8718052974659544,1.0,5/21,6.98%,CACNA1C;CAMK2D;CALM2;DMD;ANK2
prerank,cellular protein metabolic process (GO:0044267),0.3049289012388213,0.905458029960594,0.766,0.8716325379603278,1.0,94/396,24.20%,PLOD2;ST8SIA2;IGFBP5;CHRDL1;FSTL1;PCSK5;GAS6;RRBP1;RPSA;GPC3;P4HB;DMP1;TGM5;PAPPA;GGCX;HM13;PRKCSH;PRKDC;ADAM10;SPG7;LOX;ABCF1;QSOX1;CKAP4;MBTPS1;NAGPA;HARS2;AKT2;GSPT1;CST3;WWP2;CALU;BMP4;MRPS18B;RIPK3;RCN1;ABL1;LCMT1;FDXR;CHEK2;FBXO22;ATG3;MRPS14;AGO2;EIF4G1;CCDC59;MRPL35;SPCS2;NUCB1;MIA3;MRPS17;UBE2L6;PSEN2;IL6;IDE;VCAN;LIPT1;RPS27A;YARS2;GNMT;NTAQ1;PCMT1;MEN1;NAPSA;ARAF;IGFBP6;DMBT1;FBXW2;SARS1;UBE2G2;RPL7A;APLP2;SEC11A;DARS1;PENK;CSNK1G3;MRPS21;LOXL2;ASMT;CDKL3;STK38;UBA3;MMP2;AFG3L2;MAN2B1;B4GALT7;STOML2;FBXO11;MRPS18A;VGF;RPS9;PHEX;PHKA2;MRPL37
prerank,glycerolipid metabolic process (GO:0046486),-0.34932201590634043,-0.9053407983078949,0.5877862595419847,0.8184037139837593,1.0,5/11,14.58%,DGKB;DGKG;GAL3ST1;DGKZ;DGKA
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.39209273063429806,0.9050355845104349,0.5894039735099338,0.8720737602262435,1.0,4/19,9.84%,VEGFA;PTPRU;DENND6A;FOXA1
prerank,regulation of Golgi organization (GO:1903358),0.4012844179487487,0.9050165998239372,0.5923984272608126,0.8716994457354362,1.0,7/17,33.63%,STX5;AKAP9;ARMH3;CAMSAP3;MYO5A;EHD3;STX18
prerank,regulation of myoblast fusion (GO:1901739),0.4327866597597954,0.904762158456986,0.6104815864022662,0.8717838038048166,1.0,2/11,7.40%,EHD1;EHD2
prerank,actin filament network formation (GO:0051639),0.43967944852024377,0.9047487653171646,0.5959302325581395,0.8714035180623716,1.0,2/11,4.04%,PLS1;COBL
prerank,negative regulation of protein transport (GO:0051224),0.3761977248077481,0.9046259221052714,0.6075,0.8712658943670527,1.0,8/25,26.37%,PKDCC;WWP2;ERP29;DRD2;CSK;SNX3;HMGCR;NDFIP1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.44249106556556383,0.9045705723400109,0.6046195652173914,0.870972304781834,1.0,3/11,6.23%,IRS1;GHR;GIGYF1
prerank,cholesterol transport (GO:0030301),0.3493558808382951,0.9041006900570954,0.6332945285215367,0.871454489704808,1.0,16/45,28.04%,LIMA1;SOAT1;CEL;TSKU;AKR1C1;NPC1;OSBP;ABCA1;CLU;STARD5;LDLR;STARD3;SERAC1;SOAT2;NPC2;OSBPL5
prerank,response to interleukin-1 (GO:0070555),0.3214425239174104,0.9039525536283141,0.6377440347071583,0.8713460149826942,1.0,10/73,13.03%,PTGIS;CCL13;HDAC4;CCL15;PRKCA;IRAK3;SOX9;ANXA1;IRAK1;TANK
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3138491507494247,0.9034226162881236,0.6804550155118925,0.8719751817863599,1.0,26/124,16.38%,TCF7L2;SFRP4;TIAM1;PRICKLE1;PSMD7;PDE6A;AP2A1;PSMA8;DVL1;FZD7;FZD5;NFATC1;RHOA;PSMA4;AGO1;PSMD12;AGO2;PSMA6;AP2A2;CLTC;GNAO1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14
prerank,positive chemotaxis (GO:0050918),0.4012449184585982,0.9031356907894775,0.5948717948717949,0.8721308375582788,1.0,1/17,0.78%,VEGFA
prerank,regulation of lipid storage (GO:0010883),0.37793227265494544,0.9029711695800874,0.5947302383939774,0.8720369012755009,1.0,7/22,19.73%,FTO;ITGAV;PTPN2;IL6;MEST;IKBKE;NFKBIA
prerank,sulfur compound catabolic process (GO:0044273),0.35229579796207056,0.9024526225352543,0.6198547215496368,0.8726322766568663,1.0,12/38,25.11%,BGN;ARSB;CSPG4;MPST;ACAT1;HEXA;VCAN;GLB1;CHAC2;DPEP1;FITM2;GNS
prerank,Fc receptor signaling pathway (GO:0038093),0.3175374967007054,0.9023958378809499,0.6656151419558359,0.8723376278621795,1.0,32/110,23.95%,GAB2;VAV2;PSMD7;SHC1;PSMA8;FCER1G;NFATC1;PAK2;MAPK8;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;PSMA6;NFATC3;PSMD1;SOS1;PSMC5;PSMD11;PSMC4;PSMD14;PSMA3;MAPK9;MAP2K7;PSMB1;PSMD4;PSMA5;PSMA7;FOS
prerank,ether lipid metabolic process (GO:0046485),0.4160367255398202,0.9019028976406875,0.5934515688949522,0.8729070841512779,1.0,6/14,27.70%,PEX7;FAR1;AGMO;AGPS;NCEH1;TMEM86B
prerank,leukotriene biosynthetic process (GO:0019370),0.4151055907093929,0.9018500478579835,0.5952380952380952,0.8726024923504088,1.0,2/14,9.99%,PLA2G4A;PLA2G5
prerank,isotype switching (GO:0045190),0.44415497606933824,0.9017313404321795,0.5972789115646259,0.8724411804761474,1.0,6/10,38.42%,HSPD1;LIG4;MSH2;EXOSC3;RNF8;RNF168
prerank,eosinophil migration (GO:0072677),0.408632900771739,0.9016349854144469,0.5893108298171589,0.8718300613471706,1.0,1/14,3.10%,CCL13
prerank,eosinophil chemotaxis (GO:0048245),0.408632900771739,0.9016349854144469,0.5893108298171589,0.8718300613471706,1.0,1/14,3.10%,CCL13
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.41209413787630295,0.9015845606747849,0.5900537634408602,0.8715210329990493,1.0,5/15,16.21%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,protein neddylation (GO:0045116),0.42899319513186834,0.9014886463200119,0.6286509040333796,0.8713129362333676,1.0,5/13,28.91%,DCUN1D5;DCUN1D2;RNF7;UBA3;RBX1
prerank,regulation of T cell proliferation (GO:0042129),0.33261309939507855,0.9012038626624969,0.6569832402234637,0.8714516474744325,1.0,13/61,23.45%,SPN;GLMN;CD3E;TNFRSF1B;ANXA1;RIPK3;VTCN1;CD80;IL6;TNFSF18;IL4;GPNMB;DLG5
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.30959905981879154,0.901153661136357,0.6912065439672802,0.8711413905323776,1.0,16/159,6.39%,PCDHB16;PKD1;CDH11;GPC6;EMB;HMCN1;PTPRS;PTPRF;TGFB2;NECTIN3;LRFN4;CRB1;ACVR1;AMIGO3;FAT2;TGFBR2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4047152437555142,0.9011346540118648,0.5775749674054759,0.8707697426453663,1.0,4/17,15.27%,ANXA4;ANXA1;MAPKBP1;ARRB1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3437847953319504,-0.9010544681130938,0.5972696245733788,0.8267181268306596,1.0,10/13,36.62%,UNC93B1;MYD88;PIK3R4;TLR7;PIK3AP1;IRAK2;TNIP2;TRAF6;IRAK4;PIK3C3
prerank,protein homotetramerization (GO:0051289),0.34499070151804645,0.9009772491156485,0.6117908787541713,0.8706760781352517,1.0,12/49,19.91%,KCNJ2;CRYZ;TRPM4;CBR4;ACACA;PKD2L1;SHMT2;GNMT;ACOT13;SHMT1;TK1;APPL2
prerank,heterocycle biosynthetic process (GO:0018130),0.4166536458796043,0.9009530941673883,0.628133704735376,0.8703218728979417,1.0,4/14,22.41%,LIAS;NFS1;NOXRED1;PYCR1
prerank,positive regulation of cellular protein localization (GO:1903829),0.32757391230721666,0.9009224594330842,0.6508287292817679,0.869971642308177,1.0,16/69,20.87%,GNL3;WWTR1;LIMK2;TM9SF4;MEAK7;RIC3;CDK5RAP3;TRAPPC12;SESN2;MARK4;STX4;ORMDL3;CDT1;AKT1;KAT7;NUP62
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.43496301710288193,0.9009019390783961,0.5887323943661972,0.869610332221041,1.0,4/10,27.84%,NCBP1;NCBP2;PAF1;HSF1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3685350206383651,-0.9005166010505469,0.5445205479452054,0.8262978121117145,1.0,4/10,18.25%,MTMR3;MFSD2A;DNAJC19;PHB2
prerank,neuron projection extension (GO:1990138),-0.266094088002208,-0.9004189814787941,0.6324324324324324,0.8249842592569495,1.0,6/32,7.63%,ALCAM;AUTS2;SEMA5A;NRP2;FLRT1;SH3GL2
prerank,regulation of cartilage development (GO:0061035),0.4012062753072495,0.9003721598932228,0.6091503267973856,0.8702329948403646,1.0,6/18,14.92%,BMP1;MBOAT2;SOX9;BMP4;KAT2A;SCIN
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.41960729185413975,0.9003448328706848,0.6097902097902098,0.8698923980918922,1.0,3/14,13.12%,RARA;ANXA1;CD80
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.36944591005863303,0.9002828175015657,0.598531211750306,0.869611769781674,1.0,5/26,8.56%,IRS1;RHOQ;C2CD5;CAPN10;AKT2
prerank,rRNA methylation (GO:0031167),0.38723772853432537,0.9001272687524299,0.6348808030112923,0.8695116519471268,1.0,12/22,38.20%,EMG1;METTL16;TFB2M;FBL;BUD23;TRMT112;NSUN3;METTL15;MRM2;ZCCHC4;NSUN5;DIMT1
prerank,regulation of ruffle assembly (GO:1900027),0.38331049622165564,0.9000638909527829,0.6078184110970997,0.869244193750371,1.0,7/23,14.67%,RDX;EPS8L1;PFN2;FAM98A;NLGN1;NDEL1;PLEKHM1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.42791926124037755,0.8995871825026824,0.6027210884353742,0.8697660061536263,1.0,4/12,22.13%,CDC6;CHEK2;HUS1;TOPBP1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.30153821991839885,-0.8994611693362976,0.5974025974025974,0.8255990887433395,1.0,2/20,2.11%,IL1R1;B2M
prerank,lysine catabolic process (GO:0006554),0.43115774750313207,0.8991058856531372,0.5934515688949522,0.8698840437057062,1.0,4/12,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,lysine metabolic process (GO:0006553),0.43115774750313207,0.8991058856531372,0.5934515688949522,0.8698840437057062,1.0,4/12,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,negative regulation of neuron death (GO:1901215),0.3192605657543641,0.8988599960853288,0.6746611053180396,0.8699788593164862,1.0,23/93,22.98%,SIX1;NTRK1;TGFB3;SIX4;ATF4;TNFRSF1B;NRBP2;SOD1;EIF4G1;LIG4;F2R;NDNF;CLCF1;CLN3;AKT1;GDNF;CDK5;NFATC4;CHMP4A;CHMP4B;LRRK2;PRKCI;GPNMB
prerank,negative regulation of interleukin-6 production (GO:0032715),0.368473088653237,0.8987266977933687,0.5958485958485958,0.8698384473790426,1.0,2/27,7.14%,GAS6;IRAK3
prerank,T cell proliferation (GO:0042098),-0.3341034680393088,-0.8980946703553786,0.5878378378378378,0.8271238025243399,1.0,1/13,0.49%,CADM1
prerank,regulation of store-operated calcium entry (GO:2001256),0.4394374885133305,0.8978215270816512,0.597997138769671,0.8711537397045085,1.0,5/10,23.25%,STIM1;EFHB;SARAF;HOMER2;SLC8B1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.231989313919113,-0.8975046809746717,0.6697247706422018,0.8268613202922428,1.0,12/49,13.59%,SGMS1;BCL2;BCL2L1;DNM1L;DAPK2;DDX3X;NUPR1;BOK;CAV1;BCL2L11;STYXL1;NDUFA13
prerank,regulation of centriole replication (GO:0046599),0.40766767079791705,0.8972510533021315,0.6122177954847278,0.8718342566231397,1.0,8/17,28.53%,ALMS1;KAT2A;NUP62;CDK5RAP2;KAT2B;PLK4;SPICE1;STIL
prerank,calcium import into the mitochondrion (GO:0036444),0.44741441427976175,0.8971297649970245,0.6171428571428571,0.8716591923235881,1.0,4/10,23.18%,MCU;MICU2;MICU1;AFG3L2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.366677864531514,0.8970068559920226,0.6083231334149327,0.8715169116264948,1.0,11/29,22.72%,ACSF3;ELOVL5;SCD5;CBR4;PPT2;ACACA;ACSL3;HSD17B8;ACSL6;ACSBG1;GCDH
prerank,outer dynein arm assembly (GO:0036158),0.41519431859168354,0.8968805054717336,0.6125511596180082,0.871366608123664,1.0,5/14,26.04%,DNAH8;ODAD2;DNAAF4;DNAAF5;DNAL1
prerank,modified amino acid transport (GO:0072337),0.40801911020585246,0.8966167909237688,0.6229729729729729,0.8714568256591412,1.0,2/15,5.93%,SLC5A6;SLC25A32
prerank,glycolipid metabolic process (GO:0006664),0.34382553405994176,0.8964451735332012,0.6460481099656358,0.8714021626725823,1.0,10/47,19.42%,ST3GAL4;PIGW;SMPD4;ARSA;ST3GAL2;GALC;HEXA;GLB1;SUMF2;ASAH1
prerank,positive regulation of telomere capping (GO:1904355),0.39743663109868893,0.895683228316241,0.603448275862069,0.8724656091110328,1.0,6/17,27.40%,MAPK15;NEK7;TNKS2;MAP2K7;RTEL1;PNKP
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.42845854866856004,0.8956123717704246,0.6,0.872212524655259,1.0,4/12,21.41%,RDX;BRD8;KLF9;CTSB
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4157881061997786,0.895333834323545,0.6022566995768688,0.8723428632358434,1.0,6/13,23.14%,UBA5;SAE1;DESI2;DESI1;UBA3;SENP6
prerank,toll-like receptor signaling pathway (GO:0002224),0.31920044903048883,0.8951650607874726,0.6535600425079703,0.8722662169716798,1.0,17/84,22.34%,LBP;SCARA3;HMGB1;IRAK3;CHUK;IRAK1;TAB2;TRAF3;HSPD1;S100A1;COLEC12;RPS27A;UBC;CTSB;TLR1;CTSK;BIRC3
prerank,positive regulation of protein depolymerization (GO:1901881),-0.342734035085386,-0.8950002907195458,0.5743243243243243,0.8308315327394422,1.0,4/11,17.38%,SEMA5A;NES;PLEK;TRPV4
prerank,nucleocytoplasmic transport (GO:0006913),0.3487907220480533,0.8945192866659407,0.6288056206088993,0.8731083790297893,1.0,12/40,25.89%,XPO1;SNUPN;GEMIN7;NCBP1;SMN1;NCBP2;RITA1;SNRPB;GEMIN2;HNRNPA1;NUTF2;DDX20
prerank,ganglioside metabolic process (GO:0001573),0.3865748388509253,0.8942170991071008,0.6129032258064516,0.8732769426942613,1.0,2/20,4.40%,ST8SIA2;ST6GALNAC5
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3077246303615609,-0.8940811323833914,0.611353711790393,0.8314834398305476,1.0,4/18,8.78%,PPARA;PAG1;DUSP3;ASS1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.3621458776640488,-0.8940795214064611,0.6086956521739131,0.829969860566155,1.0,5/10,16.31%,LPGAT1;NR1H3;SLC45A3;MID1IP1;ABCD2
prerank,cellular lipid catabolic process (GO:0044242),0.3727792293382477,0.894060534340955,0.6278511404561825,0.8731711094367869,1.0,9/27,26.43%,CYP1B1;CEL;SIRT2;PLA2G15;ACBD5;ABHD12;ACOT8;FAAH;ANGPTL3
prerank,positive regulation of cellular senescence (GO:2000774),-0.3593154304638432,-0.8938251841759275,0.5808580858085809,0.8289546283846881,1.0,3/10,14.06%,B2M;ABI3;SIRT1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.28995723921074773,-0.8933323720439642,0.6607929515418502,0.8285705397701192,1.0,6/23,17.83%,CECR2;KPNA1;H1-0;KPNB1;DNASE1L1;FOXL2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.3081867477507181,0.8930525133609303,0.6983640081799591,0.874703328289305,1.0,57/119,32.53%,FGF2;PLEKHA4;TTC7A;PIK3C2B;PITPNM1;PIGW;SOCS4;SOCS7;SOCS6;SOCS2;PIGF;SYNJ1;SMG1;PIP4K2B;IP6K1;ARF1;INPP4A;PIK3CB;OCRL;PIGL;PI4K2A;PGAP2;TTC7B;CDIPT;PIP5K1A;PI4KB;INPP5E;VAC14;CDS1;MTMR1;SYNJ2;DPM3;RAB4A;PIGV;MTM1;TMEM150A;PLEKHA3;PIGQ;SOCS1;RAB5A;PIGB;PIP4K2C;PI4KA;PIK3C2G;SACM1L;RUFY1;FIG4;PIKFYVE;SBF1;PIGN;PLEKHA1;MTMR2;PIGC;MTMR12;MTMR9;PIGO;PIK3CA
prerank,synapse organization (GO:0050808),0.3105426002986217,0.8930219792488342,0.6959669079627715,0.874364859722668,1.0,13/125,5.70%,PCDHB16;GPC6;CTNND2;NEDD4;FARP1;DRD1;UNC13B;PTPRS;PTPRF;SEMA3E;LRFN4;PPFIA1;DVL1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.32529592657518086,0.8930098226709968,0.6890308839190629,0.8739911123040115,1.0,16/70,17.25%,SRGAP2;SRCIN1;TMEFF2;PKHD1;NTN4;ATF4;EPHB3;ILK;RHOA;ITGAV;NRP1;PARVA;SIPA1L3;MICALL2;TBCD;EFNA1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.28497482024243115,-0.891853200332976,0.627906976744186,0.8303058211362567,1.0,5/27,8.00%,IL1RAPL1;CCDC88A;CTNNA2;NTNG1;HOMER1
prerank,negative regulation of wound healing (GO:0061045),0.3618932618219332,0.8914038077522518,0.6294919454770755,0.8765816526317339,1.0,2/28,1.21%,FGF2;SLC12A2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.4106071939089138,0.8913128571793805,0.6229050279329609,0.8763449527106469,1.0,3/15,12.70%,PABPC1;TENT4B;AGO2
prerank,autonomic nervous system development (GO:0048483),0.3920275234124794,0.8908847025841921,0.6327077747989276,0.8767832206315567,1.0,5/17,23.14%,NTRK1;NRP1;NF1;GDNF;SOX8
prerank,positive regulation of cation channel activity (GO:2001259),0.34863338516053244,0.8907152377465577,0.6306620209059234,0.8766882778183955,1.0,8/40,16.85%,EPHB2;ARC;CALM2;ANK2;KCNIP2;P2RY6;STAC3;CALM3
prerank,neuromuscular process (GO:0050905),0.3984738515982589,0.8906407301631344,0.611185086551265,0.8764307272815097,1.0,6/16,20.23%,PRRT2;SHANK1;UBA5;CLN3;MYCBP2;DCTN1
prerank,positive regulation of cellular component organization (GO:0051130),0.3144348274705052,0.890321354603651,0.6993801652892562,0.8766491402933969,1.0,31/107,22.66%,TRABD2B;VEGFA;LRP1;MPP7;GPC3;TGFB3;TGFB2;VCP;CDC42EP2;SLF2;PLEKHM2;SPIDR;NEUROD2;TMED9;TGFBR1;ADD1;RUNX1;DAB2;ANAPC2;SUMO1;CD151;CDT1;BID;CDC20;PTPN23;DCTN1;CLU;SLF1;LMAN1;CAMK1;ICE1
prerank,defense response to fungus (GO:0050832),0.39365723457082735,0.8900032927436872,0.612565445026178,0.8768220047670264,1.0,1/17,4.60%,RNASE7
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.3467172094730467,0.8898221410664141,0.6261792452830188,0.8767797278598265,1.0,10/37,22.00%,PDCD4;CHID1;STAT3;PER1;IL6;ADCY7;APPL2;APPL1;IL17RA;ABCD1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.2979966272615567,-0.889790306964561,0.6306306306306306,0.8333795037835275,1.0,5/20,13.90%,APOE;SHANK3;CUX2;LRP8;RELN
prerank,axonal transport of mitochondrion (GO:0019896),0.43510599768079,0.8892870549094126,0.6241426611796982,0.8773619667447234,1.0,4/11,22.20%,SYBU;SPAST;ACTR10;NEFL
prerank,negative regulation of cation channel activity (GO:2001258),0.36949388807585476,0.8892594220767627,0.6239103362391034,0.8770208389878804,1.0,7/26,24.26%,EPHB2;CALM2;UBQLN1;CALM3;DRD2;FKBP1B;CBARP
prerank,regulation of Rho protein signal transduction (GO:0035023),0.32432349403610045,0.8890422159162567,0.6723952738990333,0.8770426243709155,1.0,14/72,15.27%,MYOC;COL3A1;ARHGEF28;EPS8L1;BCR;RAF1;GPR20;ABL1;NRP1;SCAI;F2R;ABCA1;AKAP13;ARRB1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.36455149514807966,-0.8890188457437486,0.589041095890411,0.8335858507309845,1.0,5/10,17.21%,PRKAA2;PRKAA1;MYOCD;SIRT1;KLF15
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3175464655064335,0.8889650478445361,0.6591397849462366,0.8767991664123903,1.0,10/70,13.13%,PRKCD;PRKCE;VAV2;ARPC1B;ABI1;CYFIP1;WIPF1;ABL1;PIK3CB;MYH2
prerank,telomere maintenance via telomerase (GO:0007004),0.35782879633509057,0.8889427546517695,0.6044499381953028,0.876442631298393,1.0,11/28,30.44%,PPP6R3;TERT;TELO2;RAD50;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1
prerank,protein autophosphorylation (GO:0046777),0.3057682935668221,0.8886382234648542,0.7164634146341463,0.8766208632656758,1.0,40/157,18.70%,EGFR;DDR2;ULK2;NTRK1;ACVR1B;MAPK15;CAMK2D;TNK1;EPHB3;STK39;FGFR1;CDK12;PAK2;FGFR2;SMG1;MUSK;RIPK3;ABL1;IRAK1;MAP3K12;ATM;CHEK2;PDPK1;DDR1;UHMK1;STK25;SRMS;MAP3K10;EEF2K;MAP3K3;CAMK4;ERBB2;STK16;MKNK2;SIK2;DAPK3;CAD;VRK2;CLK2;AKT1
prerank,tRNA wobble base modification (GO:0002097),0.40817209185457276,0.888607968854515,0.60778859527121,0.8762839675237193,1.0,6/14,24.88%,ALKBH1;CTU2;ELP4;ALKBH8;ELP3;MTO1
prerank,regulation of defense response (GO:0031347),0.31888151092234346,0.8885392355586655,0.6655773420479303,0.8760256359447263,1.0,22/76,25.60%,MGLL;FOXP1;SHPK;BRD4;SBNO2;ANXA1;NR1D2;TRAF3;PSMA6;CASP1;N4BP1;PTGES;UFL1;APPL2;APPL1;DAGLB;BIRC3;AREL1;CYLD;BST1;XIAP;TKFC
prerank,regulation of T cell chemotaxis (GO:0010819),0.4238702315343465,0.8883163150324817,0.6095100864553314,0.8760464686681979,1.0,3/11,13.92%,ADAM10;STK39;WNK1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3561490007189442,0.88818653219958,0.6275946275946276,0.8759028580718374,1.0,4/30,6.33%,FSTL1;SFRP4;DKK3;SMAD4
prerank,retrograde axonal transport (GO:0008090),0.4033372936652497,0.8881129800878812,0.6505376344086021,0.8756495114452532,1.0,5/16,22.20%,DLG2;DYNC1H1;SOD1;ACTR10;NEFL
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.3023623583192444,-0.8879049370952735,0.6188340807174888,0.8345286379217275,1.0,14/18,41.07%,IGFBP2;IGF1;PYCARD;RPS3;AGER;FADD;IL27RA;IL18;IL12RB1;TNFSF9;IL23A;IL23R;IL12B;IL2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.35577446770047355,-0.8876012379096611,0.5876288659793815,0.8337222071466796,1.0,9/11,42.08%,PRKCQ;NFKBIZ;MALT1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,catecholamine biosynthetic process (GO:0042423),-0.3489282677349988,-0.8873665151456879,0.5919732441471572,0.8327736068487658,1.0,3/11,15.01%,MOXD1;GCH1;SNCA
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3360721118808983,0.887352796569602,0.6611111111111111,0.8767007878524493,1.0,9/51,12.61%,MYOC;TGFB3;SORBS3;S100A10;PFN2;RHOA;ABL1;NRP1;TGFBR1
prerank,protein catabolic process (GO:0030163),0.3280017752056982,0.8873472160499043,0.6655555555555556,0.8763179111989232,1.0,25/59,30.44%,VCP;LRSAM1;PSMA8;SOCS6;DDI2;UCHL3;CHEK2;ATE1;NGLY1;FBXO17;IDE;UBE2G2;LAMP2;USE1;OGA;ADAMTS9;HTRA2;RIPK1;CLN5;MANBA;DDB1;STT3B;NR1D1;PRKN;HSP90AA1
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3621384152496333,-0.8871323421675541,0.583596214511041,0.8317807537004605,1.0,2/10,11.30%,RB1;EGR1
prerank,positive regulation of T cell migration (GO:2000406),0.3793521871183302,0.887113025158129,0.6193548387096774,0.8763622044875898,1.0,5/20,13.92%,SPN;ADAM10;STK39;RHOA;WNK1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3113933819844278,0.8869821090493694,0.6965589155370178,0.8762036167675368,1.0,25/105,21.33%,PRKCD;FGF2;PTGIS;CCN3;DRD1;PTPRS;CARD16;TRAFD1;IRAK3;SHARPIN;RORA;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2;SIRT2;CD109;OTULIN;ACOD1;CRK;GPS2;IL4;MUL1;DRD2
prerank,negative regulation of ATPase activity (GO:0032780),-0.3160939560100262,-0.8863598955990265,0.6370967741935484,0.831914926734796,1.0,5/16,20.67%,IFIT1;SIRT1;VCPKMT;PXK;PPIF
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.26002785195173395,-0.8856954599852956,0.6225165562913907,0.8318860631375589,1.0,6/38,8.74%,BMP6;SASH1;LY86;CD180;DDX60;GBP5
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.32678626206856,-0.8856903485991774,0.5923344947735192,0.8304096683950961,1.0,6/14,17.88%,GMPS;ADK;IMPDH1;ADSS1;LHPP;PPAT
prerank,positive regulation of type I interferon production (GO:0032481),0.32002921048617394,0.8853205761103355,0.6637837837837838,0.8788533766557894,1.0,33/73,32.37%,MAVS;PRKDC;POLR3H;CHUK;IRAK1;CRCP;HSPD1;POLR3GL;POLR2F;TOMM70;CREBBP;NFKB2;XRCC6;IRF3;POLR3K;POLR1C;SETD2;TBK1;PTPN11;POLR2H;CGAS;DDX41;RIPK2;POLR3E;RNF135;POLR2L;CTNNB1;HSP90AA1;RIOK3;NFKB1;POLR3F;POLR2K;IFIH1
prerank,regulation of centrosome duplication (GO:0010824),0.36484464970389474,0.8852958802190054,0.6311274509803921,0.8785062998737985,1.0,10/29,28.53%,PKHD1;ALMS1;CHMP3;CHMP4B;PDCD6IP;XRCC3;TMEM67;CHMP2A;SPICE1;STIL
prerank,positive regulation of DNA recombination (GO:0045911),0.36556635429931816,0.8848146450092413,0.6163682864450127,0.878993405826898,1.0,13/27,30.17%,FUS;KMT5C;WDR48;ERCC2;MMS19;PARP1;MAD2L2;ACTR2;WAS;SHLD3;SHLD1;HMCES;TIMELESS
prerank,sensory perception (GO:0007600),0.3346503000568202,0.8845355825592507,0.6295871559633027,0.8791307451255004,1.0,2/45,1.92%,GNAS;PROK2
prerank,protein localization to mitochondrion (GO:0070585),0.4307860229294912,0.8845270400460886,0.6262203626220363,0.878755097247542,1.0,6/11,27.27%,AKT1;DNAJA1;COX18;LRRK2;PINK1;RALA
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.34738641360590194,0.8840447066727652,0.6542056074766355,0.8792418836839949,1.0,7/38,18.49%,ESR1;RORA;MAPKBP1;TANK;PER1;USP10;ZMYND11
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3132679734740639,0.8838718408101677,0.7178683385579937,0.8791847202335851,1.0,16/107,11.18%,SLC39A14;ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC39A7;SLC10A7;ANK2;CHERP;STIM1;EDN3;SLC30A5;SLC39A13;CSRP3;TMEM165
prerank,aggrephagy (GO:0035973),0.3678338361972805,0.8838578320599937,0.6127450980392157,0.8788193240440363,1.0,10/27,22.03%,DYNC1H1;DYNC1LI2;UBQLN1;SQSTM1;HDAC6;IFT88;RPS27A;UBC;DYNC1I2;ACBD5
prerank,protein acetylation (GO:0006473),0.3639911433397228,0.8837481138220393,0.631578947368421,0.8786336359006266,1.0,9/30,26.59%,NAA60;NAA40;ING5;NAA16;ING4;CREBBP;KAT2B;NAA15;ESCO1
prerank,regulation of RNA export from nucleus (GO:0046831),0.43158905621680094,0.8835889790095935,0.628005657708628,0.8785266689531811,1.0,5/11,26.42%,KHDRBS1;CPSF6;NCBP2;SETD2;TPR
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3486151859709601,-0.883451670104903,0.6285714285714286,0.8338269683806923,1.0,2/12,3.61%,SEMA6A;ADAMTS12
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.34119339898395634,0.8834445056037514,0.6526195899772209,0.8784091505328997,1.0,19/43,32.51%,INTS3;CDC6;CDK5RAP3;ATM;RINT1;FOXN3;HUS1;BRCC3;TOPBP1;DONSON;TAOK3;TAOK2;TAOK1;NOP53;TRIM39;PABIR1;RAD17;BLM;CHFR
prerank,androgen metabolic process (GO:0008209),0.38882905034798143,0.8824243793218903,0.6318607764390897,0.8798605607508494,1.0,2/18,13.20%,CYP19A1;DHRS9
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3436177385493263,-0.8822102593041333,0.5871886120996441,0.835151952912454,1.0,3/11,6.40%,PARP14;PARP16;PARP11
prerank,lipid droplet organization (GO:0034389),0.3740055097281804,0.8817611483113529,0.6226650062266501,0.8806923810336431,1.0,10/22,29.51%,RAB3GAP1;FAF2;CIDEA;PNPLA3;CDS1;RAB18;FITM2;PPID;ZFYVE1;SQLE
prerank,lipid modification (GO:0030258),0.34703436756680095,0.8817575673723564,0.6560659599528857,0.8803091256278203,1.0,6/37,10.45%,PLPP3;PLPP5;PLPP1;MBOAT2;DGKQ;LPCAT3
prerank,macromolecule catabolic process (GO:0009057),0.3699057639525161,0.8817035885513731,0.6586294416243654,0.8800196482874717,1.0,7/26,23.52%,NEDD4;LRSAM1;UCHL3;IDE;MVB12A;UVRAG;USE1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3603627978307507,0.8816732576832554,0.6291309669522643,0.8796764273721202,1.0,11/28,27.84%,PARP3;PRKDC;KMT5C;TFIP11;MAD2L2;ACTR2;WAS;SHLD3;PNKP;SHLD1;HSF1
prerank,negative regulation of neuron projection development (GO:0010977),-0.23350843136268326,-0.8804633487222796,0.6875,0.8374079974625602,1.0,20/56,20.00%,EFNB2;LPAR1;APOE;EPHA4;PTPRO;PTPN9;ARHGDIA;DCC;PRAG1;BAG5;MCF2;DENND5A;SPOCK1;MAG;TRPV4;MT3;LRP4;THY1;RTN4R;BCL11A
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.32302808022871443,0.8802402259236201,0.6799568965517241,0.8818624718221592,1.0,11/67,11.74%,EGFR;PKDCC;DDR2;NTRK1;GHR;EPHB2;ABI1;FGFR1;FGFR2;ABL1;DDR1
prerank,cognition (GO:0050890),0.3369853249071525,0.8802222977973304,0.660069848661234,0.8815037008450527,1.0,9/42,16.94%,ST3GAL4;DOP1B;SOBP;CHRNB2;CYFIP1;SETD5;SLC1A4;NF1;NIPBL
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.30789049520159634,0.8785047837542675,0.7324380165289256,0.8842002022337049,1.0,22/121,15.25%,VEGFA;EFNA5;GAS6;SRCIN1;GHR;HES5;STAT3;CSPG4;IL5;ACVR1;NOX4;DLG4;DGKQ;ANGPT4;PAK2;ABL1;CTF1;NRP1;CD80;CLCF1;HGF;IL6
prerank,steroid metabolic process (GO:0008202),0.3208122832371634,0.8781803891139309,0.6752411575562701,0.8844098093378197,1.0,13/72,17.48%,CYP19A1;CYP1B1;AKR1C1;NPC1;FDXR;DHRS4;LRP2;DHRS9;PIAS4;VDR;CYP27B1;LSS;PRLR
prerank,vesicle organization (GO:0016050),0.3351432323961495,0.8781508430328153,0.6555299539170507,0.8840667264848115,1.0,12/46,21.10%,DNAJC13;LAMTOR1;USP50;LAPTM4B;WASHC4;PI4K2A;SQSTM1;VPS11;PHETA2;ZFYVE16;SNX11;ARFGEF2
prerank,negative regulation of JUN kinase activity (GO:0043508),0.43516986165341054,0.8779528440886907,0.6037735849056604,0.8840201635864571,1.0,5/10,25.15%,PDCD4;DNAJA1;AIDA;DUSP19;MAPK8IP1
prerank,microtubule bundle formation (GO:0001578),0.3386644320667501,0.8777632978318988,0.6390465380249716,0.8839754070179064,1.0,11/42,22.75%,NAV1;CFAP206;SPAST;CCDC66;CHP1;MARK4;LRGUK;TTLL3;CDK5RAP2;SPAG16;CAPN6
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.3567105173927595,0.877531786867233,0.6461352657004831,0.883619729151004,1.0,4/29,13.25%,HJURP;CENPC;CENPT;RBBP7
prerank,CENP-A containing chromatin organization (GO:0061641),0.3567105173927595,0.877531786867233,0.6461352657004831,0.883619729151004,1.0,4/29,13.25%,HJURP;CENPC;CENPT;RBBP7
prerank,mitochondrial translation (GO:0032543),0.30954668362127596,0.8772851652697916,0.7138397502601457,0.883654530315022,1.0,44/104,37.65%,MRPS2;MRPL33;MRPS35;MRPS28;DAP3;MRPL19;NOA1;MRPS18B;MTRF1L;MRPL39;MRPS14;MRPL35;MRPS17;MRPL45;TUFM;PTCD3;MRPL12;MRPL47;MRPS24;MRPS21;MRPS26;MRPS18A;MRPL37;MRPL17;MRPL13;MRPL30;MRPL4;MRPL11;NDUFA7;MRPL28;MRPL24;MRPS10;CHCHD1;MRPS31;MRPL15;MRPS33;MRPL50;AURKAIP1;MRPL41;MRPL14;MRPL32;MRPL38;MRPL46;MRPL2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3161820304155745,0.8772666714594933,0.7018299246501615,0.8832955144536063,1.0,18/75,20.97%,LRP6;PRKCD;LRP5;IPO5;IRAK3;CDK5RAP3;BMP4;PAQR3;ABL1;PIK3CB;HEXIM1;LATS2;NF1;CDKN1C;MEN1;AKT1;UCHL1;PRKAR2A
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.40408689158056343,0.8770794634491555,0.6388140161725068,0.8832252009161562,1.0,2/14,5.56%,ENTPD2;ENTPD6
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4233729014562401,0.876870621845188,0.640625,0.8832174419465604,1.0,2/11,10.98%,FGF2;IP6K1
prerank,negative regulation of transposition (GO:0010529),0.39776114490532544,0.8767308471087616,0.6446499339498019,0.8830684843244777,1.0,6/16,34.00%,TEX15;TUT7;UBR2;MOV10;SIRT7;DDX4
prerank,regulation of cell-substrate adhesion (GO:0010810),0.33737033561212243,0.8764731482033931,0.6581395348837209,0.8831342310596183,1.0,10/42,16.86%,VIT;PKHD1;AGR2;FZD7;RHOA;PIK3CB;ARL2;NDNF;TBCD;NF1
prerank,negative regulation of T cell differentiation (GO:0045581),0.4465209689744588,0.8763200605769077,0.6384839650145773,0.8830153280491166,1.0,3/10,24.24%,BMP4;LAG3;GLI3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.28640940309111923,-0.875703596785836,0.6699029126213593,0.8463703937314491,1.0,5/23,7.32%,ACSL1;ELOVL7;HACD1;FAR2;HSD17B12
prerank,positive regulation of B cell proliferation (GO:0030890),-0.26849609329748125,-0.8755420239729201,0.7150837988826816,0.8452175457444776,1.0,7/29,12.44%,BCL2;TFRC;NFATC2;CD38;VAV3;CD74;CD40
prerank,protein polyglutamylation (GO:0018095),0.42402185415859023,0.8744279731185389,0.6396011396011396,0.886088116627807,1.0,3/11,14.97%,TTLL2;TPGS1;CEP41
prerank,dendritic cell differentiation (GO:0097028),0.37558021261157226,0.8744130944896152,0.6386010362694301,0.8857295749772012,1.0,2/22,6.39%,GAS6;TGFBR2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.3464711752676426,0.8743958570243678,0.6470588235294118,0.8853700328732949,1.0,16/36,25.20%,DACT1;DLG1;ITCH;FOXM1;EZR;PER1;MEN1;ZMYND11;AIDA;DUSP19;GPS2;CYLD;TAOK3;PINK1;NCOR1;QARS1
prerank,negative regulation of cell adhesion (GO:0007162),0.31509165972119885,0.8742955529497509,0.6993534482758621,0.8851547108809038,1.0,9/72,6.70%,PLXNA4;TGFBI;MUC1;EPHB2;SPN;CYP1B1;ADAM10;JAG1;FZD7
prerank,cellular response to virus (GO:0098586),0.3496714465462202,0.8739579720528184,0.6394052044609665,0.885357502984502,1.0,8/30,19.54%,GBF1;LGALS8;CHUK;ARF1;GSDME;IL6;TOMM70;IRF3
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32282513143790775,0.8738711476186979,0.6611111111111111,0.8851239658470919,1.0,21/54,30.24%,PRR7;NXN;OGT;SMAD7;CHP1;U2AF2;SQSTM1;ARRB1;N4BP1;MINAR1;UFL1;AKT1;DNAJA1;USP4;CAMLG;GTPBP4;SVBP;PER2;SPOPL;PRMT3;CTNNB1
prerank,dicarboxylic acid catabolic process (GO:0043649),0.4093400986627683,0.8735286237915391,0.6213183730715287,0.8853485003591951,1.0,3/13,7.23%,ACSF3;PM20D2;QPRT
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.39928407879774663,0.8729312404192346,0.6422018348623854,0.886023056413606,1.0,2/17,2.90%,PDCD4;TGFB3
prerank,organelle transport along microtubule (GO:0072384),0.3520106098409049,0.8725729783978508,0.6464155528554071,0.8862675727023765,1.0,9/31,22.68%,COPG1;RHOT2;ARHGAP21;RHOT1;TMEM201;NDEL1;CLN3;RAB1A;PEX14
prerank,oogenesis (GO:0048477),-0.304101485927167,-0.8724196493023683,0.6443514644351465,0.8502543086097937,1.0,7/15,22.56%,PTN;FMN2;MEI4;MDK;NANOS3;NANOS1;TRIP13
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3974988128953389,0.8715960209072747,0.6538969616908851,0.8876158661513649,1.0,2/16,4.40%,ST8SIA2;ST6GALNAC5
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2621625042628919,-0.8708299750319889,0.6870748299319728,0.8522030978684784,1.0,9/34,18.25%,WNT5A;RBP4;SLC7A5;LACC1;GPI;NOD2;PTPN22;XBP1;PHB2
prerank,retinal metabolic process (GO:0042574),0.4167446723979619,0.8704017797039815,0.613933236574746,0.8893579274262999,1.0,2/12,8.81%,CYP1B1;AKR1C1
prerank,positive regulation of GTPase activity (GO:0043547),0.2951215843717029,0.8703689748007407,0.7663645518630413,0.8890279415794123,1.0,38/188,17.72%,SGSM2;SRGAP2;ASAP3;TIAM1;ARAP1;NTRK3;NTRK1;TIAM2;TBC1D8B;TBC1D2B;CCL13;DOCK7;SIPA1L1;CCL15;BCAS3;SNX18;RAB3GAP1;S100A10;RIC1;BCR;RGP1;ZC3H15;SNX9;EVI5L;TBC1D9B;F2R;TBC1D25;NDEL1;TBCK;TBC1D10A;SIPA1L3;TBC1D17;PIP5K1A;ERBB2;NF1;NGEF;FLCN;SNX13
prerank,regulation of viral transcription (GO:0046782),0.3417137611677404,0.8697703421196571,0.6788665879574971,0.8897208132203048,1.0,17/39,29.94%,MDFIC;TRIM27;UBP1;GTF2F1;MID2;HEXIM1;POLR2F;TRIM13;LARP7;POLR2B;NELFB;CTDP1;POLR2H;NELFA;POLR2I;CDK9;POLR2L
prerank,central nervous system neuron differentiation (GO:0021953),0.3465023059486067,0.8696822454217658,0.6593673965936739,0.8894783183661539,1.0,1/33,0.33%,LRP6
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3716163817096594,0.8696419511994712,0.6486486486486487,0.8891543900213775,1.0,4/21,12.31%,KCNE5;ANK2;SNTA1;AKAP9
prerank,negative regulation of immune system process (GO:0002683),0.3882691434127659,0.8696052474491888,0.6438172043010753,0.888826381627001,1.0,2/16,7.68%,COL3A1;SOX9
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.36587603487301085,0.8695803469594767,0.6352040816326531,0.8884742320428105,1.0,4/21,16.24%,SHPK;TKT;DERA;PGD
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.42204674979762946,0.8694704270590642,0.6432664756446992,0.8878776406961809,1.0,3/11,24.17%,CALM2;CALM3;FKBP1B
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.42204674979762946,0.8694704270590642,0.6432664756446992,0.8878776406961809,1.0,3/11,24.17%,CALM2;CALM3;FKBP1B
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.336738300575821,-0.8690285086659039,0.6241379310344828,0.8545081278292118,1.0,3/12,9.62%,LYN;ELF2;CD300A
prerank,anterograde trans-synaptic signaling (GO:0098916),0.2942047576995792,0.8687089293125374,0.7867203219315896,0.888820701291779,1.0,20/224,8.78%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CAMKK1;PMP22;CEL;KCNN1;GABRA3;CHRNB2;KCNIP2;SLC6A2;GIPC1;SLC12A4;DLG4;CHRNA5;DLG1
prerank,negative regulation of cell population proliferation (GO:0008285),0.2906635751698284,0.8681633162600394,0.8545636910732196,0.8893906140811698,1.0,74/351,18.03%,ZBTB7C;WNT9A;IGFBP5;SFRP4;CCN3;NTRK1;SMAD6;TGFB3;P3H3;CYP1B1;SLURP1;GLMN;FAP;LMNA;PTPRU;TGFB2;MORC3;P3H1;CLMN;TMEM115;NOX4;PLPP1;PRKRA;ABI1;IFNLR1;E2F3;SKI;CDK10;MDM4;RAF1;SOX9;TES;P3H2;CHERP;NOG;DDAH1;CDC6;BMP4;ING5;VIP;DIS3L2;RBM5;MED25;PBRM1;TENM1;NELL1;TGFB1I1;PTPN2;INHBA;F2R;CGRRF1;GSDME;FRK;FUZ;BMP5;TMEM127;VDR;CYP27B1;SCIN;TFDP1;CAMK2N1;IL6;ING4;SIRT2;PPP2R5C;MINAR1;NF1;FLCN;MAGED1;HMOX1;CDKN1C;MEN1;HMGA1;E2F1
prerank,positive regulation of proteolysis (GO:0045862),0.31974818802411625,0.8680401342295335,0.6795016987542469,0.8892161445343454,1.0,17/55,25.00%,ADAM9;TNFRSF1B;OGT;WDR48;MAPK12;SNX9;TANK;TBC1D10A;STUB1;PERP;SH3D19;IST1;RCN3;CYFIP2;BAD;PINK1;HDAC2
prerank,gluconeogenesis (GO:0006094),0.3403366596664421,0.8678820278926006,0.6705744431418523,0.8891097006576678,1.0,12/39,29.33%,SLC39A14;ATF4;CRTC2;PGK1;SLC37A4;ENO2;SLC25A11;SLC25A12;PFKFB1;PER2;MDH2;GAPDHS
prerank,secondary alcohol metabolic process (GO:1902652),0.3351667168434138,0.8676546996768916,0.6662763466042154,0.8891138128474706,1.0,19/42,33.41%,SOAT1;RXRA;TSKU;NSDHL;ABCA1;EBP;IL4;IDH3B;STARD3;APOF;ANGPTL3;SOAT2;OSBPL5;SQLE;OSBPL1A;IDH3G;IDH2;IDH1;GBA2
prerank,embryonic heart tube development (GO:0035050),-0.3257166347412416,-0.8658098964136934,0.6227758007117438,0.8599183027696616,1.0,5/14,17.06%,RYR2;SOX17;TBX2;SOX18;NDRG4
prerank,cell cycle checkpoint signaling (GO:0000075),-0.332219176681446,-0.865315725270856,0.6448275862068965,0.8594503791771729,1.0,4/12,11.65%,PRCC;ZWILCH;NABP2;PLK2
prerank,cellular response to chemical stress (GO:0062197),0.30690993263602717,0.8652522625226633,0.7159329140461216,0.8930076509668083,1.0,41/96,31.02%,VKORC1L1;ATF4;LRRC8D;SLC4A11;NOX4;NFE2L2;STX2;ABL1;ATM;SOD1;LONP1;SESN2;SRXN1;PRDX3;CAT;STX4;SIRT2;GSR;TXNRD2;FOXO3;PARP1;VRK2;PRDX2;EIF2S1;LRRK2;PYCR1;PRDX1;GPX7;PYROXD1;PINK1;SELENOS;HTRA2;AIF1;SETX;NOX1;RAD52;PRDX5;PRDX6;KEAP1;ADNP2;CYBA
prerank,activation of GTPase activity (GO:0090630),0.3098008186754163,0.8652444794113877,0.7364505844845909,0.8926324647686762,1.0,18/89,15.88%,SGSM2;TIAM1;NTRK3;TIAM2;TBC1D8B;TBC1D2B;DOCK7;SIPA1L1;BCAS3;BCR;EVI5L;TBC1D9B;TBC1D25;TBCK;TBC1D10A;SIPA1L3;TBC1D17;PIP5K1A
prerank,regulation of cellular component movement (GO:0051270),0.32836607434128967,0.8650145684875312,0.677564825253664,0.8926780320261869,1.0,9/49,10.59%,EGFR;VEGFA;ARAP1;PKHD1;CD9;RAF1;RHOA;PKN2;ABL1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4298105183161205,0.8649547756120564,0.648068669527897,0.8923862367766109,1.0,4/10,30.39%,RPUSD1;TSR3;DKC1;NOP10
prerank,response to amino acid (GO:0043200),0.3454446167326421,0.8648487618796488,0.6452004860267315,0.8921945034962396,1.0,10/31,27.42%,IPO5;MEAK7;LAMTOR1;CAPN2;SESN2;NSMF;GLRB;RPTOR;LAMTOR2;LAMTOR3
prerank,T cell differentiation in thymus (GO:0033077),0.4068146430337558,0.8647408763343539,0.6551724137931034,0.8920094437211985,1.0,5/14,31.07%,RIPK3;LIG4;GLI3;ZFP36L1;PTPRC
prerank,chloride transmembrane transport (GO:1902476),0.331326238032161,0.8644671557751431,0.678082191780822,0.8920799163642212,1.0,5/48,7.65%,SLC12A7;SLC12A2;SLC4A8;GABRA3;SLC12A4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3124452502794693,0.8643709956579138,0.7158234660925726,0.8918712318822571,1.0,24/72,26.25%,GAS6;ELF1;TAX1BP1;IRAK3;SHARPIN;MADD;CHUK;IRAK1;ABCE1;PTPN2;RUNX1;OTULIN;SUMO1;VRK2;CBFB;JAK1;BIRC3;CYLD;SPPL2A;TRADD;PTPN11;SOCS1;IFNGR2;RIPK1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.31832213986980856,0.8639119444138708,0.6850220264317181,0.8923073155291068,1.0,18/61,23.58%,NCOR2;PSMD7;PSMA8;SIRT5;PSMA4;PSMD12;PSMA6;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;AZIN1;PSMA3;PSMB1;PSMD4;PSMA5;PSMA7
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.29272008858924503,-0.863708992121734,0.6742081447963801,0.8611834497306778,1.0,1/20,0.15%,PLCB1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3147910383993365,0.8637015288535455,0.7105831533477321,0.8922810072601279,1.0,25/67,28.43%,RDX;MAPK15;TBC1D2B;DYNLT2B;GAP43;IFT20;TBC1D24;ATG3;SDCCAG8;TBC1D9B;TBC1D10A;TBC1D17;IFT88;EVI5;TBC1D22B;FXR2;ATP8B1;CYLD;RABGAP1;TBC1D20;TWF1;RAB5A;WAS;FXR1;IFT140
prerank,erythrocyte differentiation (GO:0030218),0.3285563009327378,0.863510055684932,0.6812933025404158,0.8922451999929009,1.0,10/44,19.01%,ID2;VEGFA;FLVCR1;CDK5RAP3;PTPN2;INHBA;UBA5;UFL1;ACIN1;HIPK2
prerank,neuron projection organization (GO:0106027),-0.3138831667152042,-0.8630474626113075,0.6705426356589147,0.8610130400297906,1.0,2/15,2.33%,INSR;APP
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.20030311888742236,-0.8629618290249345,0.7647058823529411,0.8596778936045008,1.0,29/163,11.76%,PDE4D;BCL2;TEC;PRKCB;PIK3R1;RFTN1;INPP5D;PSMC6;FYB1;PAG1;TNFRSF21;BMX;PAK3;NFATC2;CD38;SKP1;THEMIS;EIF2B3;VAV3;PAK1;PSME3;ZC3H12A;PSME1;SPPL3;PDE4B;SYK;PRKCQ;PIK3CD;SH2B2
prerank,"transcription, DNA-templated (GO:0006351)",0.29555738556671646,0.8629124163565116,0.8020100502512563,0.8928869142568571,1.0,80/207,29.56%,NFIX;DDX5;DEAF1;TOPORS;BAZ2A;TCEA2;ATF4;TCFL5;NFX1;POLR3H;HSF2BP;GTF2F1;NFKBIB;CCNT2;TAF15;TAF6;ERCC3;XAB2;TAF13;CRCP;TRIP11;MEF2A;ERCC2;POLR3GL;MMS19;POLR2F;MBD1;TFDP1;AFF4;FOXO3;MLLT3;PARP1;NCBP1;SSRP1;NFYA;SMN1;E2F1;TFB2M;NCBP2;GTF3C1;GTF3C4;CBFB;TAF9B;POLR3K;TWNK;MRPL12;ABT1;MED20;PAF1;NFIC;CEBPD;GTF3A;POLR1C;POLR2B;TAF1C;MNT;TBP;NELFB;TAF1;TP53;EAF1;CTDP1;RTF1;GTF2H4;POLR2H;RNMT;NELFA;TAF10;UBTF;DRG1;HSF1;TAF5L;SETX;TAF3;POLR2I;CDK9;PWP1;NFE2L3;MLLT1;PRMT5
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.38372217259130303,0.8628149623976561,0.6557161629434954,0.8926740081559185,1.0,8/18,29.23%,GPATCH3;PUM1;NPLOC4;BIRC3;SEC14L1;C1QBP;NOP53;PUM2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.25164218081710804,-0.8627773688614161,0.7658227848101266,0.8585999815029572,1.0,18/36,22.43%,PARP14;WNT5A;TRIM44;NLRC5;CASP4;CSF1;EDN1;CD74;AGPAT2;AXL;HSPA1A;AGPAT1;ZBP1;TXK;HSPA1B;IL7;CD300LF;PARP9
prerank,regulation of cation channel activity (GO:2001257),0.3073423421656047,0.8626946668362115,0.7178947368421053,0.8925174793874349,1.0,13/89,8.78%,FGF13;DLG2;AHNAK;CAMK2D;CALM2;DMD;CNIH2;KCNE5;SLMAP;ANK2;DLG4;SELENON;DLG1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.36923525802242985,0.8624016229588795,0.6458333333333334,0.892628964506817,1.0,4/21,9.03%,EFNA5;LDB1;SLC9A1;RHOA
prerank,ESCRT III complex disassembly (GO:1904903),0.42839298143110827,0.8623131053674098,0.6428571428571429,0.8920232384891572,1.0,3/10,24.56%,IST1;VTA1;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),0.42839298143110827,0.8623131053674098,0.6428571428571429,0.8920232384891572,1.0,3/10,24.56%,IST1;VTA1;CHMP2A
prerank,hydrogen peroxide metabolic process (GO:0042743),0.3774825768778468,0.8620060532287765,0.6645077720207254,0.8921563678559065,1.0,9/19,31.02%,SOD1;PRDX3;CAT;PRDX2;PRDX1;PXDN;NOX1;PRDX5;CYBA
prerank,plasma membrane organization (GO:0007009),0.316987176543543,0.8618189029929806,0.6982182628062361,0.8921168569756502,1.0,18/61,22.15%,AHNAK2;TLCD2;ANK2;EHD2;NSF;STX2;SNX9;STX4;CXCR4;PLSCR3;SPTBN1;SYTL4;TLCD1;CLN3;CHMP4A;ANXA6;ABCD1;PLSCR4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.29934364089467774,-0.86180459253677,0.6557377049180327,0.8590919461357314,1.0,4/18,7.32%,ACSL1;ELOVL7;HACD1;HSD17B12
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.3964139604346625,0.8610343580556993,0.6568627450980392,0.8930629325568075,1.0,3/14,13.92%,ADAM10;STK39;WNK1
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3160867669036689,-0.8604252692217164,0.6382978723404256,0.8604401274057134,1.0,2/15,2.33%,APOE;APP
prerank,organophosphate catabolic process (GO:0046434),-0.33580881762542114,-0.8604174238732543,0.632996632996633,0.8589612831819632,1.0,2/11,8.98%,ENPP2;PLBD2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3445518791587982,0.8602810889751644,0.659952606635071,0.8940142218090462,1.0,2/33,2.63%,EGFR;RDX
prerank,endothelial tube morphogenesis (GO:0061154),0.42702539429490016,0.8602452974115868,0.6458333333333334,0.8936801851538326,1.0,6/10,30.24%,RHOA;BMP4;RHOB;PRKD2;CCM2;CTNNB1
prerank,heart contraction (GO:0060047),0.33155048303493806,0.8601449566647951,0.6724941724941725,0.8934669959356965,1.0,7/41,11.85%,SGCD;ATP1B1;DMD;GAA;KCNE5;CSRP3;SOD1
prerank,regulation of exosomal secretion (GO:1903541),0.37610427128080054,0.8598621898067618,0.6492346938775511,0.8935621427273006,1.0,5/19,24.56%,SDC1;ATP9A;CHMP3;PDCD6IP;CHMP2A
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.32156435441721853,0.859861194331709,0.7097130242825607,0.8931775417783961,1.0,23/57,32.81%,PRKDC;CDK5RAP3;ATM;CHEK2;SDE2;RINT1;FOXN3;HUS1;ATF2;CDK2;BRCC3;TOPBP1;DONSON;TAOK3;TP53;RPS27L;TAOK2;TAOK1;NOP53;TRIM39;RAD17;BLM;WAC
prerank,cellular component assembly (GO:0022607),0.2900399042252282,0.8598302632665233,0.8209255533199196,0.8928491741955279,1.0,62/253,23.54%,RHOJ;GAS6;CHAF1B;GSN;RHOQ;DPYSL3;PLS1;LIMA1;CFAP206;TLCD2;HES5;CD3E;M1AP;HORMAD1;DVL1;ILK;GPAA1;SPG7;QSOX1;LLGL1;MDM4;SOX9;DLG4;CYFIP1;RHOA;CDAN1;ST13;WIPF1;MYO9A;SNX9;SHANK1;EZR;ZW10;PARVA;STK25;NLGN1;ADD1;SCIN;LRGUK;CREBBP;TTLL3;KPNA3;SPTBN1;TLCD1;EPRS1;TEAD2;NOC2L;DARS1;CAPZA1;TEX11;CALD1;SPAG17;REPS2;KMT2A;BAIAP2L1;PEX14;SPAG16;AFG3L2;NIFK;GORASP2;DET1;GPM6B
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.3525081786254485,-0.8598203131543312,0.6276595744680851,0.8587187637232901,1.0,2/11,8.10%,ABCG1;AGTR1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.373227306033398,0.8596418270827628,0.6653992395437263,0.8927776937879919,1.0,1/21,0.78%,VEGFA
prerank,chromatin remodeling at centromere (GO:0031055),0.3471716056253322,0.8596105066898456,0.6765755053507729,0.8924472045994629,1.0,4/31,13.25%,HJURP;CENPC;CENPT;RBBP7
prerank,regulation of water loss via skin (GO:0033561),-0.3101894735160058,-0.8592824149778993,0.6504065040650406,0.856981105956699,1.0,3/15,12.66%,LSR;CLDN1;ALOX12
prerank,establishment of skin barrier (GO:0061436),-0.3101894735160058,-0.8592824149778993,0.6504065040650406,0.856981105956699,1.0,3/15,12.66%,LSR;CLDN1;ALOX12
prerank,regulation of pH (GO:0006885),0.4163863103587503,0.8592159915149438,0.6384839650145773,0.8927650415990356,1.0,2/11,10.27%,SLC9A1;SLC26A4
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.32305649184344687,-0.8587766135039215,0.6629213483146067,0.8565481847290822,1.0,6/13,21.72%,NOTCH1;RYR2;RBPJ;HEY2;FOXF1;NPY5R
prerank,Notch signaling pathway (GO:0007219),0.3192537640697734,0.8581781059501113,0.7017738359201774,0.8941695041178982,1.0,14/59,16.11%,ZNF423;HES5;GMDS;DTX3;ADAM10;JAG1;PBX1;HEYL;NLE1;ITCH;HEY1;DTX2;PSEN2;CREBBP
prerank,response to thyroid hormone (GO:0097066),0.4060197259936071,0.8581102417183766,0.64822695035461,0.8939109277665839,1.0,4/13,21.41%,RDX;BRD8;KLF9;CTSB
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3409407063692349,-0.8580950178809873,0.6729559748427673,0.8564974338825854,1.0,5/11,27.06%,ENPP2;CORO1C;CD44;CORO1B;SRC
prerank,regulation of MAP kinase activity (GO:0043405),0.3037889437115648,0.857747542363795,0.7319915254237288,0.8941406571193233,1.0,15/92,12.79%,EGFR;PRKCD;VEGFA;FGF2;FGFR1;IRAK3;CDK5RAP3;EDN3;CDK12;BMP4;PAQR3;IRAK1;TENM1;PIK3CB;PPEF2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.40007609364337404,0.8576455181955309,0.6497326203208557,0.8939213286631742,1.0,2/13,8.56%,IRS1;AKT2
prerank,positive regulation of innate immune response (GO:0045089),0.3475803108714861,0.857447339872441,0.6634382566585957,0.8938950257440227,1.0,3/30,9.99%,LBP;MAVS;PLA2G5
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.3803882413527464,0.8574384908100884,0.6520584329349269,0.8935277857484757,1.0,4/17,12.40%,NTRK3;BCAS3;ABL1;NRP1
prerank,regulation of isotype switching (GO:0045191),0.39238703525742524,0.8573852544823868,0.640495867768595,0.8932375019056878,1.0,7/14,29.08%,PARP3;KMT5C;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,triglyceride biosynthetic process (GO:0019432),-0.29426116273073155,-0.8571457343975613,0.6425531914893617,0.8568881819598596,1.0,6/18,18.30%,LPGAT1;GK;MOGAT3;LPIN2;DGAT2;DGAT1
prerank,response to ethanol (GO:0045471),0.39335707005884174,0.8569928411985795,0.6638772663877266,0.893537214416901,1.0,4/14,18.48%,GRIN3A;CHRNB2;SOD1;ADCY7
prerank,interstrand cross-link repair (GO:0036297),0.3246948000365603,0.8567282313101997,0.6986607142857143,0.8935958240719204,1.0,14/53,20.74%,VCP;FAAP20;ERCC4;WDR48;DCLRE1B;FANCE;ATRIP;FAAP24;RPS27A;UBC;RAD51;USP1;FANCG;XRCC3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.30169067543759065,-0.8567016284520913,0.6792452830188679,0.8563475014770432,1.0,9/16,20.35%,PPARA;SLC30A10;ASXL3;TRAP1;CEACAM1;GPER1;ABCD2;ABCB7;SLC18A2
prerank,positive regulation of response to external stimulus (GO:0032103),0.29795705176864384,0.8564908215143645,0.7618556701030927,0.8936141884775971,1.0,7/128,6.37%,THBS1;PDCD4;IL33;ABCC1;PRKCA;LRSAM1;PUM1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3624455130194444,0.8563069518028521,0.6708229426433915,0.8935397866663546,1.0,6/22,16.21%,CAMK2D;PRKCA;SMAD4;SLC9A1;MEF2A;PARP1
prerank,cellular response to ionizing radiation (GO:0071479),0.3239370365230381,0.8562466505800218,0.6910935738444194,0.8932655014279016,1.0,22/47,31.81%,RAD1;WRN;SPIDR;SWI5;ATM;LIG4;TANK;RHOB;TLK2;HUS1;NIPBL;RAD51;XRCC6;TNKS1BP1;TP53;HSF1;ATR;GRB2;INTS7;RHNO1;BLM;YAP1
prerank,regulation of striated muscle contraction (GO:0006942),0.34956851055024357,0.8562330034206271,0.6728395061728395,0.8929043325100544,1.0,7/27,11.75%,HCN4;CALM2;TNNT3;DMD;ANK2;TNNI3K;SMAD7
prerank,mesenchymal cell differentiation (GO:0048762),0.32173305078300485,0.8561967517888605,0.6929133858267716,0.8925784769212562,1.0,10/51,9.71%,LRP6;DDX5;DDX17;TGFB2;TRIM28;FGFR1;HEYL;SOX9;NOG;FGFR2
prerank,hexose biosynthetic process (GO:0019319),0.3318710764365783,0.8557210616527836,0.6935483870967742,0.8930260598894462,1.0,13/42,29.33%,SLC39A14;ATF4;SORD;CRTC2;PGK1;SLC37A4;ENO2;SLC25A11;SLC25A12;PFKFB1;PER2;MDH2;GAPDHS
prerank,positive regulation of signaling (GO:0023056),0.3368446449009106,0.8555509649619666,0.66507747318236,0.8929230672608682,1.0,7/37,9.50%,ECE1;CLSTN2;ANXA2;ILK;DLG4;EDN3;NSF
prerank,regulation of p38MAPK cascade (GO:1900744),0.33583239301427287,0.8552187253955913,0.6880093131548312,0.8931130465213156,1.0,7/35,15.24%,VEGFA;GADD45G;XDH;DLG1;ULK4;EZR;PER1
prerank,defense response to protozoan (GO:0042832),-0.32563145478763067,-0.8552085145210252,0.6587837837837838,0.8578506724178874,1.0,5/12,18.15%,GBP7;GBP4;CD40;BATF;MYD88
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3775119755462619,0.8549996671562105,0.6562905317769131,0.8930974635625741,1.0,4/18,16.78%,BRD4;CDC25B;RCC2;CDC25A
prerank,positive regulation of developmental growth (GO:0048639),0.32334850524692743,0.8549643456785712,0.6966932725199544,0.89276625935614,1.0,5/49,7.80%,NTN1;GHR;ACTN3;AGR2;GOLGA4
prerank,pore complex assembly (GO:0046931),0.3744720656461917,0.8546239677376083,0.6736020806241872,0.8929603195921547,1.0,8/19,27.35%,NUP93;ADAM10;TMEM170A;NDC1;BAD;AFDN;TPR;AHCTF1
prerank,regulation of catabolic process (GO:0009894),-0.2896163723940505,-0.8545123301081472,0.6533333333333333,0.8577562295583815,1.0,3/18,8.32%,NEDD4L;FAF1;HPGD
prerank,zinc ion homeostasis (GO:0055069),0.3590891853133667,0.8542739686347833,0.6760736196319018,0.8931912404340694,1.0,5/28,9.85%,SLC39A14;SLC39A7;TMC8;SLC30A5;SLC39A13
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3836944835623045,0.8540654704240671,0.6596026490066225,0.8931654408231073,1.0,5/16,17.28%,SEH1L;CLEC16A;TELO2;KLHL22;FLCN
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.37676534791592703,0.8538313318694463,0.6446499339498019,0.8931715554739205,1.0,5/20,15.73%,AGO1;AGO2;LIMD1;CNOT8;EIF6
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.4229586393020774,0.8538252120529665,0.6642547033285094,0.8924181599583625,1.0,10/10,57.73%,CEP250;TULP1;GRM6;RPE65;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.4229586393020774,0.8538252120529665,0.6642547033285094,0.8924181599583625,1.0,10/10,57.73%,CEP250;TULP1;GRM6;RPE65;CACNA2D4;CNGB1;CACNA1F;GNAT2;REEP6;GNAT1
prerank,negative regulation of centrosome duplication (GO:0010826),0.4127332592435493,0.8534416104209522,0.6694101508916324,0.8926832188927327,1.0,4/11,24.46%,KAT2A;CDK5RAP2;KAT2B;TMEM67
prerank,response to ATP (GO:0033198),-0.29696349685868983,-0.8533097733210452,0.7077625570776256,0.8587579022233779,1.0,5/18,18.88%,TRPC3;ABCC9;CIB2;P2RY1;P2RX7
prerank,positive regulation of MAPK cascade (GO:0043410),0.28872147720122915,0.8529666380060392,0.8335005015045135,0.8930762518242951,1.0,31/245,13.07%,BMPER;EGFR;VEGFA;TNFAIP8L3;GAS6;FGF2;NTRK3;NTRK1;FSHR;CCL13;SHC1;CCL15;TGFB2;MID1;PRKCA;LAMTOR1;HMGB1;FGFR1;IAPP;EDN3;ROR1;FGFR2;PLA2G5;IRAK1;MAP3K12;P2RY6;ARHGAP8;TENM1;NRP1;STK25;F2R
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.33197292793321037,0.852447162946519,0.7001166861143524,0.8935610275952232,1.0,5/38,7.83%,GAS6;SRCIN1;SHC1;NOX4;DLG4
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3616108064678697,0.8523489992931519,0.65375,0.8933311350702831,1.0,6/24,19.84%,TGFB2;ATF4;BACE1;FOXO3;NF1;CDK5
prerank,manganese ion transport (GO:0006828),0.3915032182128697,0.8519960277099418,0.6707152496626181,0.8935351507742774,1.0,1/14,0.72%,SLC39A14
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3272459520835772,0.851650653278711,0.6922209695603156,0.8937461969711227,1.0,9/46,14.82%,PLA2G4A;LPCAT1;GPD1;LPCAT4;DGKQ;GPAT4;PLA2G5;PLA2G12A;PNPLA3
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.30996477363160335,0.8511065358311284,0.7141304347826087,0.894294672873753,1.0,10/69,14.53%,SIX1;NTRK1;TGFB3;SIX4;NRBP2;SOD1;LIG4;F2R;NDNF;CLCF1
prerank,regulation of dephosphorylation (GO:0035303),-0.3057496818658504,-0.8510902579545963,0.672,0.861758233649475,1.0,3/15,6.61%,PPP1R16B;SMG7;MTMR3
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.31433304551320457,0.8508624128853282,0.7386117136659436,0.8943125601602242,1.0,17/69,20.26%,IRS1;PLCE1;NTRK1;GAB2;PIK3C2B;FGFR1;OGT;RHOA;EZR;PIK3CB;SIRT2;PI4KB;ERBB2;NF1;AKT1;PTAFR;PLCB2
prerank,cellular response to hydroxyurea (GO:0072711),0.42294457284386355,0.8499957969331299,0.6652719665271967,0.8954101171854103,1.0,6/10,36.14%,DDI2;SPIDR;DDX11;TIMELESS;BLM;RTF2
prerank,positive regulation of glucose import (GO:0046326),0.35714359804915574,0.8497523778169846,0.6670807453416149,0.8954478218851677,1.0,4/21,8.56%,IRS1;RHOQ;CAPN10;AKT2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.29298930809461377,-0.8493274402109164,0.6739130434782609,0.8639631247877498,1.0,9/20,21.05%,PRKAA2;RPS6KA5;PPARGC1A;PRKAA1;NOS1;BRCA1;MAPK3;SOX4;GLYR1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.28385726439017356,0.8492630360739919,0.917,0.8958555146623363,1.0,62/509,13.14%,THBS1;MYOC;ESR1;EGFR;IRS1;VEGFA;TNFAIP8L3;GAS6;F3;FGF2;TCF7L2;PDCD4;NEDD4;NTRK3;NTRK1;FGF17;GAB2;FSHR;SHC1;SEC13;NFAT5;CARD16;TGFB2;MAVS;BRD4;ILK;LAMTOR1;SEH1L;PUM1;HMGB1;FGFR1;SOX9;TRIM27;S100B;IAPP;CBL;AKT2;CDK5RAP3;RHOA;SHARPIN;ROR1;FGFR2;ITGAV;LTBR;CHUK;ALPK1;IRAK1;TAB2;BCAP31;MAZ;C1QTNF4;NEUROD2;PDPK1;TNFRSF10B;CD27;MID2;PIK3CB;TGFBR1;NLGN1;F2R;CD80;LRP2
prerank,amyloid-beta metabolic process (GO:0050435),0.386982235843451,0.8488178179759934,0.677376171352075,0.896206219189473,1.0,4/16,15.93%,BACE2;BACE1;PSEN2;IDE
prerank,regulation of fibroblast proliferation (GO:0048145),0.3271547765395055,0.8481184265924049,0.6926658905704307,0.8970205539469863,1.0,8/45,18.03%,GAS6;DDR2;MORC3;SKI;MED25;LIG4;NF1;E2F1
prerank,mitochondrial transcription (GO:0006390),0.4249738275384872,0.8479904923654534,0.6642228739002932,0.8968649232828115,1.0,4/10,20.44%,FOXO3;TFB2M;TWNK;MRPL12
prerank,negative regulation of cellular metabolic process (GO:0031324),0.332895332473686,0.8478787362217611,0.6916666666666667,0.8966807176279029,1.0,12/37,24.97%,LRPAP1;SIRT5;DLG4;ITGAV;SIRT2;WDR54;AATF;TRAT1;OPTN;ATXN2;PINK1;NCOR1
prerank,negative regulation of cell activation (GO:0050866),0.39057940734655616,0.8478087945690789,0.6543715846994536,0.8964333706942175,1.0,2/14,2.99%,EMILIN1;C1QTNF1
prerank,mRNA destabilization (GO:0061157),0.3349123946783806,0.8476575013713212,0.7033603707995365,0.8963165710771908,1.0,18/38,31.78%,FTO;PUM1;ZC3H12D;DIS3L2;METTL16;TUT7;RC3H2;UPF1;RBM24;ROCK1;METTL14;RIDA;YTHDF1;ZFP36L1;KHSRP;PLEKHN1;MOV10;DCPS
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.4017749785814547,0.8476117095607275,0.6607387140902873,0.8960084523124212,1.0,2/12,8.56%,IRS1;AKT2
prerank,error-free translesion synthesis (GO:0070987),0.3604065443198758,0.8472254787133501,0.6730279898218829,0.896266598223075,1.0,7/22,25.47%,VCP;RPS27A;UBC;REV1;NPLOC4;RCHY1;POLD1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.31546468899563107,-0.8465856147882475,0.6591760299625468,0.8678945137096785,1.0,3/13,4.15%,SHANK3;APP;ADCY1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3548753967879149,0.8463634659305489,0.6741854636591479,0.8973375743942176,1.0,4/24,8.10%,CAMK2D;CALM2;DMD;SELENON
prerank,ruffle organization (GO:0031529),0.38223789755962667,0.8454235576363321,0.6912928759894459,0.8985129167490674,1.0,4/16,15.88%,LIMA1;CYFIP1;ARFIP2;PIP5K1A
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28916625313295763,0.8450480409943836,0.798984771573604,0.8987599946594432,1.0,29/149,20.48%,SLCO3A1;CARD14;NTRK1;RAB7B;CARD16;STAT3;ERC1;IRAK3;RPS6KA4;TRIM27;ROR1;CHUK;RIPK3;NFKBIB;IRAK1;TAB2;RNF25;MID2;PSMA6;PRDX3;IL6;RPS27A;UBC;NFKB2;TRIM13;TRIM6;NFKBIA;TNFSF18;CLU
prerank,regulation of muscle contraction (GO:0006937),0.35012273851234593,0.8450395318479637,0.7073791348600509,0.8983946949975244,1.0,3/26,5.10%,PLCE1;PPP1R12B;TNNT3
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3773509942555883,0.8449289119350042,0.6811023622047244,0.8981895156445139,1.0,6/17,25.87%,TGFB2;MID1;STK25;TAOK3;TAOK2;TAOK1
prerank,regulation of protein localization to nucleus (GO:1900180),0.328562125539856,0.8447507300818546,0.7058139534883721,0.8981118844803375,1.0,17/43,28.80%,WWTR1;LIMK2;CDK5RAP3;BMP4;NVL;SESN2;LATS2;BYSL;ORMDL3;FLCN;AKT1;KAT7;EIF2AK3;ILRUN;TPR;LIF;TESK1
prerank,negative regulation of viral life cycle (GO:1903901),0.3830161095587217,0.8446743788937469,0.6726519337016574,0.8978603554924834,1.0,3/15,13.94%,GSN;MID2;TRIM26
prerank,regulation of protein kinase A signaling (GO:0010738),-0.28818617530378243,-0.8442952677960144,0.6855895196506551,0.8709971793279168,1.0,4/20,6.41%,ADGRV1;AKAP6;PRKAR2B;PRKAR1B
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.36543120159604037,0.8441643963514285,0.6924034869240349,0.8983319002474399,1.0,1/22,0.58%,ID2
prerank,regulation of interferon-gamma production (GO:0032649),0.303887774644147,0.8439999211443427,0.7289416846652268,0.8982223989138874,1.0,10/71,13.03%,GAS6;IL12RB2;HMGB1;TRIM27;RARA;FZD5;CRTAM;RIPK3;HSPD1;INHBA
prerank,negative regulation of nuclear division (GO:0051784),0.408894022894952,0.8438687146823969,0.6614509246088194,0.8980672459447764,1.0,2/11,9.70%,TOM1L1;BMP4
prerank,phosphatidic acid metabolic process (GO:0046473),0.3237313591946773,0.8438641893469383,0.7099322799097065,0.8976957654990249,1.0,9/48,14.82%,PLA2G4A;LPCAT1;GPD1;LPCAT4;DGKQ;GPAT4;PLA2G5;PLA2G12A;PNPLA3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3355186449716356,0.8436571679075076,0.6981351981351981,0.8976571157672484,1.0,19/37,34.27%,IFT20;IFT80;TRIP11;IFT46;PCM1;IFT88;DYNC2I1;IFT43;TNPO1;IFT27;DYNC2H1;KIF17;DYNC2I2;IFT140;KIFAP3;DYNLL2;IFT52;WDR35;DYNLRB1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2978112847310044,0.8431206607556312,0.7663551401869159,0.8981135022487028,1.0,18/108,13.71%,F3;GSN;PRR7;MAP3K5;CRADD;XDH;VCP;TNFSF15;HMGB1;DAP;ANP32B;BCAP31;AIFM1;TNFRSF10B;PDCD2;HSPD1;F2R;CASP1
prerank,lipid catabolic process (GO:0016042),-0.2922951729395247,-0.8427655372731895,0.7231404958677686,0.8723164077094445,1.0,8/18,26.88%,PLA1A;PLAAT3;LPL;LIPE;MT3;LIPH;LIPC;HSD17B14
prerank,monocarboxylic acid catabolic process (GO:0072329),0.36374266634605634,0.8427338491207611,0.68875,0.8983927020448595,1.0,2/21,3.76%,AGXT2;CEL
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.40609146394632967,0.8423858922358702,0.6855524079320113,0.8985954476619142,1.0,6/11,31.69%,DONSON;ZRANB3;FBH1;SMARCAL1;TIMELESS;BLM
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.35411719585400503,0.8423083971953237,0.7016645326504481,0.8983358767814124,1.0,12/24,32.45%,PHF1;TRIM27;RBBP7;MPHOSPH8;TASOR;DNMT1;H3-3A;DNMT3A;SUZ12;MTF2;SPI1;CREBZF
prerank,muscle cell development (GO:0055001),0.340338048995728,0.8419753614153446,0.6743341404358354,0.8985259227452695,1.0,6/30,9.62%,VEGFA;SDC1;RAMP2;DMD;ANK2;ALPK3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.35975672237369793,0.8419258526202799,0.6818757921419518,0.8982256099744172,1.0,2/21,3.72%,FOXP1;ELF1
prerank,placenta development (GO:0001890),0.39663202028300937,0.8419182455033174,0.6801675977653632,0.8978632552354362,1.0,4/12,27.82%,SOD1;PLAC1;CUL7;E2F8
prerank,mitochondrial RNA metabolic process (GO:0000959),0.389115889079904,0.8417272522657158,0.6740027510316369,0.8978079487329782,1.0,4/14,20.44%,FOXO3;TFB2M;TWNK;MRPL12
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.31351553771461027,-0.8417186470735946,0.6632653061224489,0.8728718922363725,1.0,3/14,9.05%,TFRC;RIF1;NECTIN2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3295253124895576,-0.8416632199771255,0.657243816254417,0.8715106989711874,1.0,1/11,1.25%,CDH13
prerank,fibrinolysis (GO:0042730),-0.31192646822477355,-0.8415586402592081,0.6875,0.8702862107477675,1.0,2/13,10.56%,PLAT;SERPINE1
prerank,positive regulation of viral process (GO:0048524),0.31323163614169836,0.8415093911161686,0.7216035634743875,0.8977702334001555,1.0,24/60,30.69%,MDFIC;PABPC1;TMEM39A;PKN2;GTF2F1;KPNA2;SRPK1;POLR2F;POLR2B;NELFB;STAU1;CTDP1;TBC1D20;POLR2H;PPID;NELFA;KPNA6;HACD3;DDB1;POLR2I;CDK9;LARP1;POLR2L;PPIH
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.3990730835313868,0.8414207708121428,0.6774647887323944,0.8975396386493453,1.0,2/12,5.71%,ATP1B1;DMD
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.34078983229881826,0.841069678974701,0.7083333333333334,0.8977049148064326,1.0,3/31,8.78%,FHL1;DACT1;DLG1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4028000776058261,0.8407332985316239,0.6661991584852734,0.8979142762328404,1.0,2/12,2.58%,SYT8;UNC13B
prerank,endothelial cell differentiation (GO:0045446),0.3938347200753809,0.8402411499291083,0.6558988764044944,0.8983474080424039,1.0,2/12,6.53%,FSTL1;JAG1
prerank,positive regulation of immune effector process (GO:0002699),0.3507074021783131,0.8402346935058409,0.6975308641975309,0.8979785614808444,1.0,2/27,9.99%,LBP;PLA2G5
prerank,cellular response to nutrient levels (GO:0031669),0.31042781480538173,0.8399918716707009,0.7475083056478405,0.8980087886549837,1.0,20/62,29.19%,KCNB1;WIPI2;CLEC16A;WRN;SREBF1;FADS1;EIF4G1;USP33;VPS41;FLCN;KLF10;LAMP2;LRRK2;RPTOR;STK24;EHMT2;TFEB;ULK1;SREBF2;ZFYVE1
prerank,positive regulation of cilium assembly (GO:0045724),0.37052571329929557,0.8398881969861542,0.6813922356091031,0.8977924179449924,1.0,8/18,29.61%,MARK4;FUZ;KCTD17;WRAP73;ARHGAP35;CCP110;TAPT1;SEPTIN9
prerank,positive regulation of protein polymerization (GO:0032273),0.3085394550648131,0.8398168010110679,0.738562091503268,0.8975445869551307,1.0,22/65,30.44%,CTTN;PRKCE;CDC42EP2;PFN2;SNX9;TENM1;AKAP9;CDC42EP5;ARL2;SLAIN2;DCTN1;CDK5RAP2;BAIAP2L1;PINK1;MET;NCK1;DRG1;FES;TOGARAM1;VASP;RAC1;HSP90AA1
prerank,transition metal ion homeostasis (GO:0055076),0.3503142365304206,0.8394310251271352,0.6906211936662606,0.8977988514304176,1.0,8/28,17.54%,SLC39A14;NEO1;HMOX2;TMC8;CYBRD1;BDH2;IREB2;HMOX1
prerank,protein localization to lysosome (GO:0061462),0.342019307217932,0.8388815396740378,0.6934487021013597,0.8983178859834171,1.0,7/28,28.27%,NEDD4;NAGPA;KPTN;ZFYVE16;SCARB2;GCC2;GGA3
prerank,intraciliary retrograde transport (GO:0035721),0.40255039274772103,0.8384933743642641,0.6898016997167139,0.8985491609790639,1.0,7/12,32.89%,DYNLT2B;DYNC2I1;IFT43;DYNC2H1;DYNC2I2;IFT140;WDR35
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32517201236034715,0.8383295448974755,0.7144495412844036,0.8984414979267268,1.0,10/46,17.28%,EMILIN1;TIMP3;EPHB2;SPRED2;SMAD4;DLG1;EZR;PTPN2;CAMK2N1;FLCN
prerank,sterol transport (GO:0015918),0.3686787668017692,0.8380034626231041,0.6829896907216495,0.8985890198557906,1.0,6/19,28.04%,NPC1;OSBP;LDLR;STARD3;NPC2;OSBPL5
prerank,mesenchyme development (GO:0060485),0.38726554723065487,0.8377906061296443,0.7033426183844012,0.8985524447794244,1.0,4/15,12.61%,CRELD1;BMP4;FGFR2;TGFBR1
prerank,cAMP biosynthetic process (GO:0006171),0.4070486876792802,0.8374589521319511,0.6882352941176471,0.8987301009215323,1.0,3/10,7.53%,ADCY2;ADCY8;ADCY9
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.401968752408543,0.8367432849916493,0.6862210095497954,0.8995196520719497,1.0,7/12,32.06%,UBE2C;CDC20;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,epithelial cell migration (GO:0010631),0.33106494544162895,0.8365616958671117,0.7035714285714286,0.8994412576522054,1.0,9/37,12.40%,FSTL1;CYP1B1;FAP;FAT2;GIPC1;RHOA;PKN2;ABL1;NRP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.35261475921317037,0.8349476184583839,0.6854942233632862,0.9016473676226078,1.0,10/22,32.29%,ERI3;RRS1;RPP40;WDR12;ABT1;KRI1;ERI1;EXOSC2;NOP14;EXOSC3
prerank,negative regulation of immune response (GO:0050777),0.2840337980688562,0.8341227404555389,0.7916241062308478,0.902577279789352,1.0,31/154,21.21%,COL3A1;GPR27;DRD1;FSHR;RAMP2;TRAFD1;ADCY2;ADCY8;IRAK3;ADCY9;TRIM27;GPR20;IAPP;ITCH;MAPKBP1;RAMP1;VIP;GLP1R;MC4R;PCBP2;PTGDR;IL6;SIRT2;CREB1;CALCA;ACOD1;ADCY7;PRKACA;GNB1;PRKAR2A;MUL1
prerank,positive regulation of DNA binding (GO:0043388),0.33377741870633293,0.8338748785576953,0.683649289099526,0.902599616698531,1.0,5/31,18.06%,TWIST1;HMGB1;SKI;SIRT2;TRIM6
prerank,synapse assembly (GO:0007416),0.30636454737203916,0.833494899846714,0.75,0.9028074433672696,1.0,8/67,9.82%,PCDHB16;FGF13;FARP1;DRD1;LGI2;DVL1;FZD5;NRXN2
prerank,regulation of JNK cascade (GO:0046328),0.2922225727027797,0.8330159520260045,0.7642782969885774,0.9031976309569149,1.0,14/101,12.52%,RASSF2;EGFR;SH3RF3;GADD45G;MAP3K5;DACT1;HMGB1;FZD7;ITCH;LTBR;ULK4;AXIN1;CD27;TRAF3
prerank,regulation of protein localization to cell surface (GO:2000008),0.3342599793780394,0.8326086010912829,0.7142857142857143,0.9034468235579444,1.0,7/33,15.15%,TM9SF4;RIC3;GOPC;GBF1;RAB11FIP5;RAB11B;STX4
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3537927745001367,0.8325784553160033,0.6853503184713375,0.9027420273208926,1.0,13/23,28.53%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1;BBC3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3537927745001367,0.8325784553160033,0.6853503184713375,0.9027420273208926,1.0,13/23,28.53%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1;BBC3
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2890549674715136,-0.8318349247605865,0.7131474103585658,0.8877008214932695,1.0,6/18,17.07%,SLC25A13;ASPG;ASS1;SMS;MSRA;FOLH1
prerank,positive regulation of endocytosis (GO:0045807),0.314495187292361,0.8315183741285483,0.7262180974477959,0.9040762178992712,1.0,13/45,20.97%,LRP1;GPC3;RAB21;CBL;NLGN1;DAB2;HNRNPK;HIP1;CD151;CLN3;APPL2;CLU;IL4
prerank,negative regulation of platelet activation (GO:0010544),0.37624744308296854,0.8313827143450028,0.6849673202614379,0.9039053864696724,1.0,3/16,6.03%,PRKCD;C1QTNF1;CD9
prerank,synaptonemal complex assembly (GO:0007130),0.37737842210074823,0.8309276252516847,0.6970108695652174,0.9038823459656963,1.0,4/15,28.83%,HORMAD1;TEX11;P3H4;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.37737842210074823,0.8309276252516847,0.6970108695652174,0.9038823459656963,1.0,4/15,28.83%,HORMAD1;TEX11;P3H4;SYCP2
prerank,regulation of histone methylation (GO:0031060),0.3926955947894445,0.8307328826206838,0.6846361185983828,0.9038149414061909,1.0,5/13,21.58%,NSD1;NNMT;CHTOP;MTHFR;PAF1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.30280567953035076,0.8306952174382225,0.7556756756756757,0.9034968747358836,1.0,24/73,25.17%,F3;CRADD;XDH;VCP;TNFSF15;DAP;ANP32B;AIFM1;TNFRSF10B;PDCD2;HSPD1;F2R;CASP1;HIP1;BID;MUL1;SENP1;DIABLO;MTCH1;EIF2AK3;BAD;RPS27L;BCL2L13;TRADD
prerank,negative regulation of cilium assembly (GO:1902018),0.4052583276548628,0.8306514000793654,0.6896067415730337,0.9031972081320062,1.0,3/12,12.05%,LIMK2;CDK10;EVI5L
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.22633979326326353,-0.830529093486191,0.8064516129032258,0.888673182121067,1.0,15/51,18.88%,WNT5A;APP;AIM2;GBP5;HSPB1;EGR1;LPL;LGALS9;TRIM16;TYROBP;S100A13;NOD2;PYCARD;MYD88;P2RX7
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3677523678375965,0.8299557306270416,0.6770428015564203,0.9039381492722603,1.0,5/17,15.84%,ID2;TNFRSF1B;SERPINE2;CLCF1;CXCR4
prerank,neutrophil migration (GO:1990266),0.30494858235474115,0.8297525706720228,0.7511210762331838,0.9038704213592589,1.0,6/58,9.29%,CCL13;CCL15;TGFB2;GBF1;FCER1G;EDN3
prerank,neuron projection fasciculation (GO:0106030),0.4082069252869409,0.8296596905627878,0.7013177159590044,0.9036380764271091,1.0,2/10,5.74%,EPHB2;EPHB3
prerank,protein kinase B signaling (GO:0043491),0.35450103471188804,0.8294194869460021,0.6903553299492385,0.90364418935269,1.0,7/23,29.77%,GAS6;SIRT2;AKT1;TSC2;CCL2;SETX;ZFP36L1
prerank,negative regulation of complement activation (GO:0045916),-0.337806368650909,-0.8287642141806623,0.6816816816816816,0.8905471916765226,1.0,4/10,23.39%,A2M;CR2;CD55;SUSD4
prerank,phosphatidylinositol metabolic process (GO:0046488),0.29109187704906847,0.8285694598713674,0.7931392931392931,0.9046194196382439,1.0,30/109,21.26%,FGF2;PLA2G4F;PLEKHA4;PLA2G4A;PIK3C2B;PITPNM1;PIGW;MTMR11;SYNJ1;PLA2G5;PIP4K2B;INPP5B;ARF1;MTMR10;INPP4A;PIK3CB;PIP4P2;OCRL;PI4K2A;PLA2G12A;CDIPT;PIP5K1A;PI4KB;INPP5E;VAC14;CDS1;PLCB2;MTMR1;SYNJ2;RAB4A
prerank,cellular protein-containing complex assembly (GO:0034622),0.28743269859308834,0.8284823560178388,0.8187311178247734,0.9043923984735437,1.0,55/159,27.84%,NUP93;TIAM1;TBCE;CD3E;DNAJB14;DMD;DNAAF3;SMAD4;FCHO2;CENPC;CCDC39;CENPT;AXIN1;SNX9;AIFM1;MIS12;LONP1;HSPD1;ARL2;CHMP3;CLTC;PTGES3L;PSMD11;TBCD;HIP1;HIGD1A;VBP1;PRLR;TMEM170A;DLGAP5;OTUD6B;CLTA;CLU;CHMP4A;CHMP4B;POGZ;PSMD4;TTC12;NDC1;COX7A2L;EIF4B;UVRAG;VAMP4;TCP1;PSMG2;PXN;CHMP2A;DNAJB12;VAMP2;NCK1;TPR;EID2;AHCTF1;RAB5IF;HSF1
prerank,tetrapyrrole metabolic process (GO:0033013),0.36935903830534444,0.8284633222654654,0.7037037037037037,0.9040488401509099,1.0,4/18,14.15%,ABCC1;MTRR;MMAB;ABCB6
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3271678659507588,0.8283068317638776,0.7012048192771084,0.9039389185417438,1.0,6/32,16.85%,DRD1;CALM2;P2RY6;PDPK1;F2R;CALM3
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.29303445467629635,-0.8278196586484394,0.7346938775510204,0.890807591203742,1.0,8/17,30.36%,ADRA2A;PRKAA1;MFSD2A;BSCL2;ALK;APOC1;GPLD1;PDE3B
prerank,protein prenylation (GO:0018342),0.4132339545895767,0.8274368095741423,0.6848306332842415,0.904963339473155,1.0,7/10,41.92%,RABGGTB;PTAR1;FNTB;RABGGTA;CHM;FNTA;PGGT1B
prerank,regulation of peptidase activity (GO:0052547),0.35594265270373177,0.8272483271990783,0.6746835443037975,0.9048761189426403,1.0,7/19,27.77%,CST3;MAPK12;HDAC1;PSMA3;RCN3;PINK1;SVBP
prerank,rRNA 3'-end processing (GO:0031125),0.40153355971493515,0.8268536591160733,0.6828908554572272,0.905128308730343,1.0,1/10,2.56%,ERI3
prerank,ATP transport (GO:0015867),-0.3413656612933096,-0.826841179065614,0.7181208053691275,0.891107962791405,1.0,3/10,28.50%,SLC25A24;CD47;SLC17A9
prerank,negative regulation of GTPase activity (GO:0034260),0.3511822053462695,0.8268157932284579,0.6929824561403509,0.9048228894362793,1.0,6/22,13.92%,RDX;KLRK1;BCAS3;RCC2;ARL2;WNK1
prerank,sister chromatid segregation (GO:0000819),0.333886566027986,0.8267341721765534,0.730909090909091,0.9045775798403379,1.0,5/31,15.96%,TUBG2;SMC4;MIS12;ZW10;KLHL22
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.37731812689350785,0.8266213388459764,0.6852103120759837,0.9040187455991797,1.0,5/15,24.98%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.37731812689350785,0.8266213388459764,0.6852103120759837,0.9040187455991797,1.0,5/15,24.98%,BLOC1S2;AP3D1;BLOC1S3;SNAPIN;AP3B1
prerank,positive regulation of viral transcription (GO:0050434),0.3454974792156913,0.8261692982987191,0.7183622828784119,0.904348570551566,1.0,14/25,35.34%,MDFIC;GTF2F1;POLR2F;POLR2B;NELFB;CTDP1;POLR2H;NELFA;POLR2I;CDK9;POLR2L;POLR2K;DHX9;SUPT4H1
prerank,replication fork processing (GO:0031297),0.3246641909049955,0.82600679007085,0.7329411764705882,0.9042397512204902,1.0,16/38,35.18%,TONSL;WRN;RAD51;TRAIP;PRIMPOL;BOD1L1;ZRANB3;FBH1;RTEL1;CDK9;ATR;SMARCAL1;DDX11;BLM;MMS22L;MRE11
prerank,T cell mediated immunity (GO:0002456),0.3883480752403828,0.8257196424139507,0.7089871611982882,0.9043327291216112,1.0,3/13,9.77%,GNL1;JAG1;CRTAM
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.33281867696550516,0.8254949046558971,0.7335766423357665,0.9043135713516628,1.0,3/33,8.78%,FHL1;DACT1;DLG1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.40813439777752203,0.8253721827492669,0.6738197424892703,0.9037522445653905,1.0,3/10,11.17%,HDAC4;ACTN3;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.40813439777752203,0.8253721827492669,0.6738197424892703,0.9037522445653905,1.0,3/10,11.17%,HDAC4;ACTN3;GIT1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.38737626824639604,0.8253333370466615,0.6935933147632312,0.9034482354602135,1.0,6/13,32.32%,PGM3;RENBP;CHST5;OGA;NAGK;CHST7
prerank,regulation of inflammatory response (GO:0050727),0.2809661868393872,0.8247827489964555,0.832995951417004,0.9039472016182724,1.0,27/190,17.35%,MGLL;FOXP1;PRKCD;PDCD4;IL33;PTGIS;CCN3;ABCC1;SHPK;TNFRSF1B;BRD4;DAGLA;SBNO2;SHARPIN;RORA;ANXA1;LPCAT3;NR1D2;PSMA6;PTPN2;CASP1;SETD4;IL6;PTGES;OTULIN;CCN4;UFL1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.32946778674581484,0.8243103694107047,0.7375455650060754,0.9043012781034657,1.0,5/32,6.91%,NEDD4;CUX1;FBXW8;LZTS1;CHRNB2
prerank,axonal fasciculation (GO:0007413),0.38902271332796146,0.8241677962988312,0.7101865136298422,0.904145102692315,1.0,2/12,5.74%,EPHB2;EPHB3
prerank,regulation of response to external stimulus (GO:0032101),0.2863028543870963,0.824119985708699,0.8183738120380147,0.903851626006293,1.0,34/121,26.02%,MGLL;FOXP1;EPHB2;SHPK;PDE6A;BRD4;SBNO2;ANXA1;NR1D2;TRAF3;PSMA6;F2R;CASP1;GUCY2D;CXCR4;N4BP1;PTGES;UFL1;SAG;APPL2;APPL1;GRK4;DAGLB;BIRC3;AREL1;CYLD;BST1;USP14;METAP2;XIAP;STK24;TKFC;NMT1;CYRIB
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.37184099389265574,0.8240837232234718,0.7034482758620689,0.9035335240428142,1.0,4/15,20.27%,STAT3;IL6;APPL1;IL17RA
prerank,regulation of regulated secretory pathway (GO:1903305),-0.24352524085621263,-0.8236519837211326,0.7483443708609272,0.8955406069871269,1.0,14/34,20.12%,RIMS2;RIMS1;SYN1;DTNBP1;SYT10;SYT13;SYT3;SYT2;PREPL;RAB15;SYT11;SYT12;SYT7;SYT15
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2938645597533936,0.8231420377378892,0.7770700636942676,0.9046454879920797,1.0,32/84,34.38%,IGFBP5;SAMD4A;ILF3;RBM4;CNOT8;CNOT10;ORMDL3;EPRS1;DAPK3;CNOT9;SHMT1;SYNCRIP;CALR;CLU;ORMDL1;FXR2;EIF2AK3;YBX1;ROCK1;MRPL13;RIDA;FXR1;GGA3;LARP1;CAPRIN1;DAPK1;PRNP;NCL;PCIF1;PUS7;DHFR;RTN3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.3312945110225651,0.8226017501371562,0.7151370679380215,0.9051297049758577,1.0,9/34,18.03%,ZFPM2;WWTR1;RORA;IL6;SIRT2;TRIO;ANKRD26;FLCN;E2F1
prerank,regulation of neurogenesis (GO:0050767),0.30990450881354914,0.8225245467715518,0.7425629290617849,0.9048729478612184,1.0,10/55,15.25%,DOCK7;HES5;SERPINF1;BHLHE40;HEYL;HEY1;LIG4;LRP2;PCM1;IL6
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.33912836534742585,-0.8223219565053618,0.7102803738317757,0.8965037407406206,1.0,3/10,13.56%,PRKCH;NME2;TRIM16
prerank,centromere complex assembly (GO:0034508),0.3231129479806402,0.8218031882123381,0.734338747099768,0.9056203910485784,1.0,5/36,13.25%,HJURP;CENPC;CENPT;MIS12;RBBP7
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3921563605949956,0.8217881798070789,0.7047244094488189,0.9052684516671193,1.0,8/13,39.84%,LCMT1;XRCC3;CDK5RAP2;TPR;DYNC1LI1;PCID2;NDC80;DUSP1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2935300851503143,0.8214099891377388,0.7734627831715211,0.9054840564061146,1.0,20/80,27.13%,PRICKLE1;TOPORS;DCUN1D5;HUWE1;CDK5RAP3;AXIN1;SMAD7;DCUN1D2;PHF23;UBQLN1;STUB1;MYCBP2;LRRK2;BIRC3;DERL1;PINK1;RCHY1;XIAP;NDFIP1;RIPK2
prerank,neurotrophin signaling pathway (GO:0038179),0.34917600586026976,0.8204904866449843,0.6970474967907574,0.9065636388433376,1.0,2/21,4.64%,NTRK1;KIDINS220
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3008174085305759,0.8197846234164673,0.7669256381798002,0.9073063267336063,1.0,7/65,8.39%,EGFR;ARAP1;PTPN3;MVB12B;AGR2;RNF115;CBL
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3935894794065797,0.8194616515104971,0.7187060478199718,0.9074436695480875,1.0,8/13,33.73%,ALG13;ALG1;ALG3;ALG14;ALG12;ALG9;SRD5A3;ALG8
prerank,regulation of cell-cell adhesion (GO:0022407),0.3203386792841974,0.8187782537856967,0.7464622641509434,0.9081378936550499,1.0,7/39,11.75%,EFNA5;PKHD1;ADA;EPHB3;JAG1;FUT4;SMAD7
prerank,positive regulation of ion transport (GO:0043270),0.3063103828807118,0.8185912079560546,0.7448979591836735,0.9080369828310629,1.0,8/48,13.07%,FHL1;DRD1;CRACR2A;CHRNB2;ANK2;DLG1;PRSS8;F2R
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.31861249959726606,-0.8183264558987439,0.6594202898550725,0.9023502641786695,1.0,9/12,43.80%,PRKCQ;CCR2;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.38658760942524684,0.8182004193592477,0.6980337078651685,0.9082484977284503,1.0,6/12,28.84%,ELOVL5;FADS1;ABCD1;ACOT8;ELOVL1;SCP2
prerank,cobalamin metabolic process (GO:0009235),0.36892558223791994,0.8179974459611759,0.6958762886597938,0.9081869552029224,1.0,3/17,9.57%,ABCC1;MTRR;MMAB
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.32093181323473036,0.8179631451368805,0.7344300822561692,0.9078729544484333,1.0,11/35,20.97%,LRPAP1;RAB21;RSPO1;CBL;ARF1;PIK3CB;SNAP91;HNRNPK;HIP1;CLU;IL4
prerank,nucleic acid-templated transcription (GO:0097659),0.3200237383588314,0.8177092227870711,0.760644418872267,0.907908444685942,1.0,17/42,30.90%,TOPORS;BAZ2A;NFKBIB;TERT;XAB2;MEF2A;MMS19;POLR2F;E2F1;MED20;POLR2B;POLR2H;DRG1;POLR2I;PWP1;POLR2L;TAF1B
prerank,rRNA transcription (GO:0009303),0.3626698491779113,0.8176591503126319,0.7142857142857143,0.9076195166899674,1.0,10/17,35.74%,POLR1G;CAVIN1;GTF3C1;GTF3C4;GTF3A;NIFK;TAF1B;SIRT7;TCOF1;BRF1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.35772197875870726,0.8176429457087842,0.7189973614775725,0.9072786025613075,1.0,6/18,21.66%,SLC4A8;RAB3GAP1;RIMS4;NLGN1;SNAPIN;LRRK2
prerank,L-serine metabolic process (GO:0006563),0.4012116570570285,0.817170201240925,0.7071428571428572,0.9076198027619683,1.0,5/10,19.03%,SRR;PHGDH;SHMT2;SHMT1;PSAT1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.3525213170419684,0.8168748576262279,0.7341115434500648,0.9076913375042568,1.0,4/20,10.45%,MBTPS1;DGKQ;SREBF1;LPCAT3
prerank,regulation of interferon-alpha production (GO:0032647),0.3445363826380349,0.8166685811042242,0.6909323116219668,0.9076386871910148,1.0,8/23,27.13%,PTPRS;MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,regulation of calcium ion import (GO:0090279),-0.27381943566712097,-0.8162446462883209,0.7543103448275862,0.9047087279035039,1.0,4/21,11.89%,CXCL12;PDGFRB;PLPP4;SLC30A1
prerank,7-methylguanosine RNA capping (GO:0009452),0.33117973292483466,0.81601061478659,0.7302158273381295,0.9078724657063212,1.0,15/31,33.42%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;POLR2H;RNMT;POLR2I;POLR2L;POLR2K;CCNH
prerank,7-methylguanosine mRNA capping (GO:0006370),0.33117973292483466,0.81601061478659,0.7302158273381295,0.9078724657063212,1.0,15/31,33.42%,GTF2F1;ERCC3;ERCC2;POLR2F;NCBP1;NCBP2;RAMAC;POLR2B;GTF2H4;POLR2H;RNMT;POLR2I;POLR2L;POLR2K;CCNH
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3385014471859011,-0.8159890967632905,0.6776315789473685,0.9036858711831226,1.0,5/10,20.15%,SIRT1;SNCA;KLF15;BRCA1;TAF7
prerank,regulation of protein processing (GO:0070613),0.353771051010309,0.8159339498545355,0.721419185282523,0.9076239484647185,1.0,5/21,21.66%,GAS1;SERPINE2;RUNX1;CLN3;LRRK2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.35328270715051024,0.8154331540000195,0.7070967741935484,0.9080097923292255,1.0,9/20,30.69%,FKBP5;PPIL3;NKTR;FKBP4;PPIG;FKBP1B;PPID;PPIC;PPIH
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3338373989412323,-0.814640592391854,0.7094594594594594,0.9047370351263492,1.0,5/10,19.56%,APC;CDC42;RACGAP1;ECT2;KNSTRN
prerank,Notch signaling involved in heart development (GO:0061314),0.3902545155811272,0.8145570799409911,0.7060478199718706,0.9090013839037411,1.0,3/11,12.12%,JAG1;HEYL;HEY1
prerank,synaptic vesicle exocytosis (GO:0016079),0.3159413374730029,0.8144121791593908,0.7304550758459744,0.9088458825419085,1.0,15/40,26.91%,SYT8;UNC13B;STX11;PRRT2;STX2;SNAP23;STX4;STX1A;SNAPIN;CDK5;STX1B;VAMP2;STX19;PCLO;SNPH
prerank,multivesicular body assembly (GO:0036258),0.3325746319856789,0.8142726920088191,0.7274969173859432,0.9086957484748224,1.0,12/30,32.86%,STAM2;CHMP3;IST1;VTA1;CHMP4A;CHMP4B;PDCD6IP;MVB12A;CHMP2A;VPS37B;CHMP4C;VPS37C
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.29345823492856093,-0.8141212555209338,0.7228915662650602,0.9041413773797463,1.0,9/15,34.49%,KLHL18;STXBP4;PHB2;CUL3;CRNN;DYRK3;ATAD5;CDC73;NPM1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3936413528469078,0.8138659408660289,0.7204610951008645,0.9089535843103841,1.0,3/11,19.65%,HMGB1;RUNX1;CBFB
prerank,positive regulation of autophagy (GO:0010508),0.2928636300300423,0.8135196374066502,0.7810839532412327,0.9091342672170287,1.0,37/81,31.58%,SESN3;HMGB1;TRIM27;MID2;PIK3CB;SESN2;PAFAH1B2;TRIM65;FOXO3;ORMDL3;FLCN;UFL1;TRIM13;TRIM6;EIF2AK4;ATF6;OPTN;IL4;RUFY4;LRRK2;TRIM8;TSC2;NPRL2;BAD;TBK1;ROCK1;PINK1;GPSM1;TFEB;ULK1;LARP1;PLEKHF1;PRKN;IRGM;MTDH;PIM2;DAPK1
prerank,activation of protein kinase A activity (GO:0034199),0.36240089047539314,0.8134170709876172,0.7129120879120879,0.9089362790897125,1.0,4/16,7.53%,PRRC1;ADCY2;ADCY8;ADCY9
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.34659310194137194,0.8128597550925732,0.7341772151898734,0.9094171050080173,1.0,6/24,14.32%,GAS6;RAMP2;NFE2L2;PAK4;PDPK1;NDNF
prerank,mitotic cytokinesis (GO:0000281),0.3087299256599552,0.8127448615920961,0.7534403669724771,0.9092457184088033,1.0,16/47,27.72%,CIT;SNX18;SPAST;SNX9;RHOB;MITD1;SPTBN1;TTC19;RTKN;CHMP4B;PDCD6IP;ROCK1;JTB;CUL7;EFHC1;SON
prerank,regulation of blood circulation (GO:1903522),0.32066894167532767,0.8125388376916608,0.7177615571776156,0.9091890966890812,1.0,6/34,13.87%,ECE1;CAMK2D;KCNE5;KCNIP2;S100A1;DMPK
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.3419011911582978,0.8124128249132391,0.7155727155727156,0.9090115081463815,1.0,3/23,11.75%,ID2;FGFR2;SMAD7
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.29989538589831694,0.8123662556499295,0.7619047619047619,0.9087147068390162,1.0,19/56,27.72%,CIT;SNX18;RHOA;SPAST;SNX9;RHOB;MITD1;SPIRE2;SPTBN1;IST1;TTC19;RTKN;CHMP4B;PDCD6IP;ROCK1;JTB;CUL7;EFHC1;SON
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.28442992535281914,0.8121074766052614,0.794392523364486,0.9087479495208973,1.0,16/104,16.85%,LRP6;LRP5;CALM2;CDC6;CDK5RAP3;RHOA;CDK12;SYAP1;ABL1;CCNT2;TELO2;PPEF2;CCNG2;CCNE2;CDC25A;CALM3
prerank,glycerophospholipid metabolic process (GO:0006650),0.2908703712490715,0.8114807493970226,0.7790948275862069,0.9093658198679399,1.0,20/75,22.84%,PLA2G4F;PLA2G4A;PIGW;SMPD4;PIGF;SYNJ1;FAR1;ABHD6;PIGL;ENPP6;PNPLA3;HDHD5;PIP5K1A;GDPD3;PLA2G15;CLN3;PLCB2;PIGX;ABHD12;PIGV
prerank,cardiac ventricle morphogenesis (GO:0003208),0.31270771676245973,0.8113516395069256,0.7456242707117853,0.9091920590637604,1.0,9/41,12.12%,TGFB2;TGFBR2;JAG1;HEYL;BMP4;FGFR2;BMPR1A;SMAD7;HEY1
prerank,membrane fusion (GO:0061025),0.3229433637828742,0.8112733025072646,0.7342995169082126,0.9089385946962877,1.0,8/33,17.80%,STX11;DNM2;HUWE1;NSF;USO1;CHP1;SNAP23;NAPA
prerank,response to UV-B (GO:0010224),-0.3137279517921034,-0.8110644375517045,0.7064846416382252,0.9080682973918266,1.0,12/12,68.66%,CRIP1;HYAL2;MME;STK11;CDKN1A;IL12A;IL12B;MFAP4;HYAL1;HYAL3;RELA;MSH2
prerank,regulation of neuroblast proliferation (GO:1902692),0.3764103295719202,0.8108056061391811,0.7197802197802198,0.9092765013219497,1.0,1/15,0.78%,VEGFA
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.36616729794742214,0.8107238434904751,0.711051930758988,0.9090428513373888,1.0,3/15,7.13%,TGFB2;CELF4;FGFR1
prerank,regulation of immunoglobulin production (GO:0002637),0.3471458999547974,0.8106807959075393,0.7110552763819096,0.908739260083742,1.0,5/23,20.97%,EPHB2;CLCF1;STX4;IL6;IL4
prerank,peripheral nervous system development (GO:0007422),0.34252726059973987,0.8106233110083455,0.7204968944099379,0.9084583456631314,1.0,8/23,23.14%,PMP22;ALDH3A2;GFRA3;NF1;SCN8A;GDNF;GPC1;SOX8
prerank,maintenance of protein location in nucleus (GO:0051457),0.3486113285554697,0.8103588429472088,0.7241813602015114,0.9084959890800132,1.0,3/20,13.59%,TOPORS;MORC3;ARL2
prerank,RNA destabilization (GO:0050779),0.36281734579667163,0.8102970415081804,0.7275132275132276,0.9082230033812139,1.0,10/18,28.86%,FTO;PUM1;METTL16;RBM24;ROCK1;METTL14;RIDA;YTHDF1;ZC3H18;DXO
prerank,Ras protein signal transduction (GO:0007265),0.28018178464048454,0.8102533946955425,0.8245614035087719,0.9079174293990291,1.0,22/137,15.25%,NTN1;PLCE1;FGF2;COL1A2;TIAM1;MRAS;GDI1;SHC1;TRIM28;EPS8L1;CDC42EP2;USP50;CYFIP1;RHOA;SHOC2;CDC42EP5;SETDB1;ARHGEF1;G3BP2;RHOB;FARP2;SOS1
prerank,response to chemokine (GO:1990868),0.38747813576468637,0.8098483603857352,0.7345767575322812,0.9081676100430851,1.0,4/13,13.92%,SLC12A2;STK39;RHOA;WNK1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3176392185188034,0.8092140130107633,0.7502944640753828,0.9087545989679654,1.0,15/37,27.13%,SPRED2;CALM2;DGKQ;AXIN1;SMAD7;PPEF2;EIF4G1;SIRT2;CALM3;TRIM6;TNKS1BP1;RPTOR;S1PR2;PARD3;RIPK2
prerank,positive regulation of protein deacetylation (GO:0090312),0.3705089310961975,0.8091706346754225,0.6914446002805049,0.9084455831358046,1.0,4/14,24.33%,NNMT;NIPBL;AKAP8;SAP30BP
prerank,regulation of presynapse organization (GO:0099174),0.3566396326232585,0.8087726750515529,0.7161803713527851,0.9083246161016441,1.0,2/18,4.90%,GPC6;LRFN4
prerank,regulation of presynapse assembly (GO:1905606),0.3566396326232585,0.8087726750515529,0.7161803713527851,0.9083246161016441,1.0,2/18,4.90%,GPC6;LRFN4
prerank,necroptotic process (GO:0070266),0.3585741581128591,0.808715653076441,0.7133333333333334,0.9080325090326008,1.0,7/16,32.21%,PGAM5;TRPM7;RIPK3;CYLD;RIPK1;ITPK1;IPMK
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2738982081660722,0.8083262133039797,0.857429718875502,0.9082481290084096,1.0,28/198,14.36%,ALPL;PLCE1;TNFAIP8L3;PLA2G4F;PLA2G4A;PLPP3;EPHB2;NADK;GFPT1;STAT3;LIMK2;SHPK;PLPP1;LPCAT4;GFPT2;PAK2;SYNJ1;PLA2G5;PIP4K2B;PPA2;INPP5B;IP6K1;LGALS13;INPP4A;PIK3CB;OCRL;LIMD1;DUSP18
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.2644783155760734,-0.8078518063334411,0.7634854771784232,0.9121047071697677,1.0,4/22,10.60%,WNT5A;SLC7A5;LACC1;TRIL
prerank,regulation of adenylate cyclase activity (GO:0045761),0.34443432686422215,0.8076336781482446,0.7273869346733668,0.9089106448608228,1.0,5/22,16.86%,CACNA1C;STIM1;CAP1;PALM;NF1
prerank,granulocyte differentiation (GO:0030851),-0.2814873221654719,-0.8074541231278912,0.7431906614785992,0.911300721760977,1.0,3/18,4.58%,LEF1;CBFA2T3;DEK
prerank,arachidonic acid secretion (GO:0050482),-0.32474823510122613,-0.8074179008330269,0.660377358490566,0.9083843420402752,1.0,3/10,7.77%,BDKRB2;PNPLA8;ACE
prerank,arachidonate transport (GO:1903963),-0.32474823510122613,-0.8074179008330269,0.660377358490566,0.9083843420402752,1.0,3/10,7.77%,BDKRB2;PNPLA8;ACE
prerank,regulation of cytoplasmic translation (GO:2000765),0.376147827367594,0.8073222476619709,0.7212205270457698,0.908986610477248,1.0,1/14,1.81%,YBX3
prerank,purine-containing compound salvage (GO:0043101),0.3875542873741663,0.80727511008104,0.71671388101983,0.9086939092391798,1.0,3/12,12.98%,ADA;AMPD3;DGUOK
prerank,regulation of cell division (GO:0051302),0.28865792561991294,0.8071399607115114,0.7882096069868996,0.908540460726379,1.0,25/72,31.74%,KIF13A;CALM2;TLE6;ESRRB;FGFR2;GIT1;CSPP1;SIRT2;MLLT3;CALM3;BIRC6;FLCN;SFN;SETD2;UVRAG;PLK4;RAB11FIP4;CCP110;EFHC1;AHCTF1;PRDM15;KLHL9;ZFYVE26;BLM;RAB11FIP3
prerank,multivesicular body organization (GO:0036257),0.32645930106558946,0.8052821946851993,0.7358722358722358,0.9109501814504452,1.0,10/31,27.29%,STAM2;CHMP3;IST1;VTA1;CHMP4A;CHMP4B;PDCD6IP;MVB12A;CHMP2A;VPS37B
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3267069674304721,0.8051159814709977,0.7415865384615384,0.910829784444814,1.0,2/32,2.83%,DDX5;FHIT
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.32383127297192593,0.8049003731055,0.7310924369747899,0.910790646270641,1.0,9/30,24.29%,TENT4B;ERCC4;TEN1;HNRNPC;XRN1;MEN1;HNRNPA1;HNRNPU;TP53
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.35830309563199053,0.8047936898322469,0.7197875166002656,0.9105733712900361,1.0,6/18,18.53%,MDFIC;CHP1;RAB23;LATS2;FLCN;SUFU
prerank,regulation of chromosome organization (GO:0033044),0.3456081390965641,0.8047018759460509,0.7477707006369426,0.9103459339396907,1.0,6/22,21.97%,RMI2;SMG6;SMG1;LIG4;CDT1;UPF1
prerank,ribosome biogenesis (GO:0042254),0.2745279108000791,0.8046791919617726,0.8742393509127789,0.9100209230183264,1.0,54/187,27.93%,XPO1;C1D;LTV1;RRS1;RRP7A;LAS1L;EMG1;CUL4A;WDR3;RIOK1;NVL;ABCE1;WDR55;ESF1;RRP12;DHX29;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;EIF6;BYSL;DIS3;BOP1;METTL17;NOB1;RPL7A;NOC2L;MTREX;EIF2A;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;GTF3A;PAK1IP1;WDR46;WDR75;RPS9;TBL3;SENP3;RIOK2;UTP11;NOP58;DKC1;POP5;FCF1;NOP53;RPL41;RPL30
prerank,cellular response to glucose starvation (GO:0042149),0.31043452169305935,0.8044633877902165,0.7638888888888888,0.9099607203400908,1.0,14/41,26.33%,SESN3;ATF4;IMPACT;HSPA5;SESN2;PICK1;FOXO3;SIK2;PRKAG1;KPTN;HNRNPA1;EIF2AK3;TP53;NIM1K
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.27850087786445527,-0.8041581394749981,0.7623318385650224,0.9123455956576303,1.0,9/21,25.70%,PAG1;DUSP3;TNFAIP3;PTPN22;SOX11;SAMSN1;LST1;LAX1;IL4I1
prerank,negative regulation of ion transport (GO:0043271),-0.2670530470307983,-0.8038953975371916,0.7623318385650224,0.9113003510230046,1.0,10/24,18.75%,ACTN2;WNK2;ADRA2A;PACSIN3;NOS1;WNK4;SNCA;CASQ2;SYT11;PXK
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.33875259862418783,0.8035863076145909,0.7269230769230769,0.9109091027891069,1.0,3/23,8.39%,SRCIN1;SOCS4;CBL
prerank,positive regulation of chemokine production (GO:0032722),0.30762233872327116,0.8035098486088967,0.7650397275822929,0.9106509359348267,1.0,4/44,6.48%,IL33;TWIST1;MAVS;HMGB1
prerank,cilium-dependent cell motility (GO:0060285),0.3412831976883266,0.8032194823557458,0.7139240506329114,0.9107016427258473,1.0,4/22,18.64%,DNAH8;CCDC39;DNAH2;TEKT2
prerank,mRNA polyadenylation (GO:0006378),0.33233741545814266,0.8028332750479991,0.7466504263093788,0.9105512026339319,1.0,7/26,21.58%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,RNA polyadenylation (GO:0043631),0.33233741545814266,0.8028332750479991,0.7466504263093788,0.9105512026339319,1.0,7/26,21.58%,PABPC1;TENT4B;SYMPK;CLP1;PCF11;TENT2;PAF1
prerank,protein monoubiquitination (GO:0006513),0.3156374907602547,0.8027460750492285,0.7553699284009546,0.9103189509266648,1.0,12/36,29.91%,TOPORS;UBE2B;UBE2R2;HUWE1;KLHL22;PAF1;KLHL12;RNF20;UBE2W;RNF126;RBX1;PRKN
prerank,negative regulation of defense response (GO:0031348),0.28925642594003514,0.8027117909327214,0.7903225806451613,0.9100175642800287,1.0,18/77,21.21%,PRKCD;PTGIS;CCN3;TRAFD1;IRAK3;SHARPIN;RORA;ITCH;MAPKBP1;LPCAT3;PTPN2;PCBP2;SIRT2;OTULIN;ACOD1;GPS2;IL4;MUL1
prerank,cardiocyte differentiation (GO:0035051),0.39376661962448956,0.8024250846663478,0.7132459970887919,0.9100707979550787,1.0,3/10,16.74%,TGFB2;AKAP13;KDM6B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3571139811949934,0.8021609177279877,0.7137150466045273,0.910081243061732,1.0,2/17,7.26%,TWIST1;YJU2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2723518461676754,-0.8017858333974078,0.7227272727272728,0.9134958272974235,1.0,5/20,13.95%,RB1;LAMTOR5;NIBAN2;H1-0;IGF1
prerank,retina homeostasis (GO:0001895),-0.2556209471258736,-0.8017711900576466,0.75,0.912042713984425,1.0,4/23,9.30%,B2M;WHRN;ATP1B2;HSPB1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.32931856694170203,-0.8012833144994698,0.7049180327868853,0.9114217027175698,1.0,3/11,15.61%,FAS;CAV1;FOXO1
prerank,toxin transport (GO:1901998),0.39683190131401685,0.8005639872773546,0.7110157367668097,0.9120366507498976,1.0,4/10,30.20%,ADAM10;SLC22A3;ANTXR1;RAB40B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3436027669314067,0.7999436761886023,0.7126865671641791,0.9125719040443285,1.0,2/22,3.26%,LBP;RAB7B
prerank,cardiac ventricle development (GO:0003231),-0.264253239154907,-0.7996998454076364,0.7587939698492462,0.912550629281751,1.0,9/20,21.71%,ENG;NOTCH1;PDE2A;SALL1;HEY2;STRA6;DLL4;SCN5A;GJA5
prerank,mitochondrion organization (GO:0007005),0.276038663172182,0.7995156138689192,0.8564154786150713,0.9128252595100897,1.0,44/165,24.88%,PID1;VPS13C;DNM2;MIEF2;SPG7;TOMM40;SIRT5;RHOT2;TIMM9;RHOT1;RAB38;TERT;NRF1;BCAP31;AIFM1;LONP1;HSPD1;MEF2A;SUPV3L1;MTFR1;PRDX3;TOMM70;PARP1;HIGD1A;POLG2;BCS1L;TFB2M;BID;HCFC1;CLUH;TWNK;NIPSNAP2;FANCG;MUL1;LRRK2;MFN1;COX7A2L;AFG3L2;MTM1;STOML2;VPS13D;PINK1;TIMM17B;TIMM22
prerank,positive regulation of transmembrane transport (GO:0034764),0.37026423649281426,0.7994092103333517,0.719225449515906,0.912612113647535,1.0,2/13,4.38%,SLC26A6;C2CD5
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.3126658393061499,-0.7991143121620179,0.6866666666666666,0.9120462645581182,1.0,5/12,17.88%,GMPS;IMPDH1;ADSS1;LHPP;PPAT
prerank,lymphocyte proliferation (GO:0046651),0.342205782355395,0.7989524512418382,0.7490196078431373,0.9129304290897938,1.0,1/22,1.42%,ELF4
prerank,calcium ion homeostasis (GO:0055074),0.2831616545464665,0.7985530558116322,0.8216159496327388,0.9131426705078753,1.0,13/95,11.18%,ATP1B1;SLC24A3;CCL13;PKHD1;CCL15;SLC10A7;ANK2;SELENON;CHERP;STIM1;EDN3;CSRP3;TMEM165
prerank,cochlea morphogenesis (GO:0090103),-0.32120530341507264,-0.7984785110705692,0.7333333333333333,0.9116637415068732,1.0,2/10,5.37%,TBX18;TBX1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.35107403149294986,0.7984639653134913,0.7291399229781772,0.912917811403455,1.0,5/18,21.82%,CCDC39;ROPN1L;NPHP3;DNAAF4;SPAG17
prerank,cyclooxygenase pathway (GO:0019371),0.3925335816288932,0.7984398215838109,0.7317784256559767,0.9125889713141326,1.0,2/10,7.02%,PTGIS;PTGES2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.344978611805319,0.798423106733436,0.7516339869281046,0.9122517153970925,1.0,13/20,35.95%,CAMK2D;PACS2;BCAP31;THADA;KCTD17;HERPUD1;CCDC47;FIS1;TMCO1;SELENOK;RAP1GDS1;WFS1;BAK1
prerank,regulation of protein localization (GO:0032880),0.2949562299865971,0.7982182458498456,0.7711386696730552,0.9121725532579031,1.0,15/58,22.43%,DVL1;TRIM27;DLG1;PLEKHM2;MAPK8;SLC26A4;VIP;CSNK1E;PARP1;SUMO1;UFL1;TRIM6;TRIM46;CAMK1;TMEM231
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.2548247367112913,-0.7973118266115514,0.7867298578199052,0.9122080926499331,1.0,10/24,20.60%,BCL2;BCL2L1;CXCL12;CD74;TPT1;SIRT1;CD44;KDM1A;CDKN2D;TAF9
prerank,blood vessel diameter maintenance (GO:0097746),0.3171487025395132,0.7967120823809672,0.7455197132616488,0.9140019544484635,1.0,3/34,3.20%,GCLC;ECE1;EDNRA
prerank,histone H2B ubiquitination (GO:0033523),-0.3189414157976719,-0.7964797953321253,0.7425742574257426,0.912107232733205,1.0,4/10,16.69%,RNF40;UBE2E1;LEO1;CTR9
prerank,extracellular transport (GO:0006858),0.3824134657564705,0.7963294317228395,0.7149059334298119,0.9141809662521175,1.0,4/12,21.82%,WWP2;ROPN1L;DNAAF4;SPAG17
prerank,regulation of JUN kinase activity (GO:0043506),0.3199830730850073,0.7959313476979714,0.7466827503015682,0.9143889747762888,1.0,11/33,27.37%,PDCD4;MAP3K5;PPEF2;MAP3K10;DNAJA1;AIDA;DUSP19;TAOK3;MAPK8IP1;DVL2;MAP3K11
prerank,epithelial cell morphogenesis (GO:0003382),0.3590012061857074,0.7954288621846144,0.7377483443708609,0.9147097837733921,1.0,2/17,3.83%,COL15A1;PKHD1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.32050805738601973,0.7952475223070807,0.7690504103165299,0.9146195764704611,1.0,12/33,24.51%,NOL3;FXN;HUWE1;IAPP;HGF;SLC35F6;FLCN;AKT1;CLU;MUL1;TRIAP1;PINK1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.30430898836757003,0.7951818425796198,0.7640047675804529,0.9143599302257069,1.0,3/42,6.67%,CCL13;CCL15;STK39
prerank,carbohydrate derivative transport (GO:1901264),0.3463305860196376,0.794741768060942,0.7444005270092227,0.9146434152961602,1.0,2/18,5.76%,LBP;SLC10A7
prerank,cellular respiration (GO:0045333),0.3093475702693284,0.7947272262799765,0.768235294117647,0.9143120485485355,1.0,8/41,14.02%,ETFRF1;COQ10B;ETFDH;ETFB;ETFA;NDUFS7;SURF1;MTFR1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.30279038051812257,0.7945973360416198,0.7832957110609481,0.9141325756054566,1.0,4/49,4.21%,VEGFA;GHR;HES5;STAT3
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.346712856264869,0.7945000006824895,0.7576142131979695,0.9139033746630523,1.0,8/21,23.25%,MCU;BCAP31;MICU2;LETM1;MICU1;ANXA6;AFG3L2;SLC8B1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.33327289441500935,0.7942456780982191,0.7469733656174334,0.9139314548339909,1.0,3/24,6.96%,VEGFA;SEMA3E;SEMA4B
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3121668006406871,-0.7941995876320356,0.7538461538461538,0.9144698831403639,1.0,5/13,21.17%,ELOVL7;HACD1;TECRL;ELOVL6;HACD4
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3708468940975995,0.7938537797259653,0.7272727272727273,0.914115281661015,1.0,4/13,12.59%,SESN3;CASTOR2;ATM;SESN2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3921806038379221,0.7938212309517507,0.7317415730337079,0.9138032100278279,1.0,6/10,27.67%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.293197107934153,-0.7933416627375875,0.7319587628865979,0.9144508052843264,1.0,9/12,40.32%,PAEP;IL17D;RASGRP1;IL18;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.39534218641182917,0.793269270735878,0.7274052478134111,0.9142433468527297,1.0,5/10,30.83%,CDT1;DBF4;STOML2;E2F8;SSBP1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.34220795025182726,0.7928232155823464,0.7531969309462916,0.9144946325315279,1.0,4/21,16.78%,BRD4;CDC25B;RCC2;CDC25A
prerank,response to ionizing radiation (GO:0010212),0.2903850670670954,0.7919175075521049,0.8045112781954887,0.9154199166620521,1.0,19/70,22.13%,COP1;INTS3;RAD1;ANXA1;SPIDR;SWI5;ATM;LIG4;TANK;RHOB;AEN;HUS1;TRIM13;MEN1;CLK2;RAD51;TNKS1BP1;BRCC3;TOPBP1
prerank,gonad development (GO:0008406),0.30583868853467333,0.7918602926896332,0.7883720930232558,0.9151368007108355,1.0,7/41,13.14%,FSHR;CYP19A1;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.25174294224741045,-0.7916042178000169,0.7904761904761904,0.9158971297895958,1.0,9/24,19.49%,BCL2L1;NR1H3;AQP11;UBXN1;OPA1;HSPA1A;XBP1;RACK1;CREB3
prerank,fatty acid metabolic process (GO:0006631),0.27999446903960923,0.7914092445779151,0.8352331606217617,0.9154297137235063,1.0,32/115,28.48%,ABCD3;CEL;ACSF3;CPT1C;ACSF2;ACOT11;ADIPOR2;CBR4;SLC27A6;ACAD9;ACACA;ACSL3;PNPLA3;CRAT;HACL1;PLA2G15;HSD17B8;ACSL6;ACSBG1;SLC27A2;PEX2;ACBD5;MCAT;ACOT8;FA2H;FAAH;ANGPTL3;ALOXE3;SLC27A3;PON3;PER2;ACLY
prerank,male gonad development (GO:0008584),0.3151313676866324,0.791174677895375,0.7824019024970273,0.9153988039258583,1.0,6/34,13.14%,FSHR;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,establishment of protein localization to membrane (GO:0090150),0.2895089843921883,0.7911322085519779,0.8169014084507042,0.9151027316866487,1.0,19/66,27.29%,EGFR;NECTIN3;RABGEF1;RAB3GAP1;NPC1;ATG3;RAB11B;ZDHHC4;BID;RAB3GAP2;COX18;ZDHHC20;PRKCI;ZDHHC9;GORASP2;TAOK2;AFDN;PARD3;VPS37B
prerank,MAPK cascade (GO:0000165),0.2657033466804298,0.7906038176882616,0.93,0.9154828916985364,1.0,74/295,23.87%,EGFR;IRS1;FGF13;FGF2;DLG2;FGF17;MRAS;PTPN3;PPP1CC;PSMD7;SHC1;MAP3K5;IL5;PSMA8;FGFR1;RAF1;SOX9;DLG4;PDE6D;DLG1;MAPK8;PSMA4;FGFR2;ITGAV;CHUK;PAQR3;SHOC2;PABPN1;MAPK12;PSMD12;PIK3CB;CUL1;PSMA6;MEF2A;YWHAE;ARL2;PSMD1;HGF;SOS1;MAP3K3;PSMC5;PSMD11;IL17RD;ERBB2;PSMC4;PSMD14;GFRA3;RPS27A;UBC;FGF5;NF1;SPTBN1;WDR83;MEN1;ARAF;GDNF;PEBP1;RASGRF1;PSMA3;FGF18;FGFR3;MAP2K7;PSMB1;PSMD4;LRRK2;JAK1;NEFL;SYNGAP1;PSMA5;ZDHHC9;PSMA7;NRAS;KRAS;TAOK3
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.38635879422878405,0.7904908694298307,0.7298850574712644,0.9152843340956859,1.0,2/11,4.91%,RDX;PRKCA
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.39584073592065727,0.7903872189582265,0.7542613636363636,0.9150839790567604,1.0,2/10,7.68%,PKDCC;SOX9
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.31612553332953053,0.7892197407199837,0.757396449704142,0.916393910008068,1.0,12/32,29.22%,CDK5RAP3;ATM;RINT1;FOXN3;BRCC3;TOPBP1;DONSON;TAOK3;TAOK2;TAOK1;NOP53;TRIM39
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.3366855515190151,0.7891677479124841,0.7437908496732026,0.916103493230923,1.0,6/22,17.61%,IPO5;HEXIM1;CAMK2N1;LATS2;CDKN1C;MEN1
prerank,positive regulation of leukocyte migration (GO:0002687),0.3254291039879726,0.7884566637319391,0.7590511860174781,0.9167513704648027,1.0,6/27,20.97%,VEGFA;EDN3;MIA3;IL6;TNFSF18;IL4
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.21306559314476142,-0.7872976657857845,0.8632478632478633,0.9214766620978426,1.0,20/48,29.79%,IL1R1;PDE4D;SLC7A5;PDE4B;LGALS9;PTPN22;PYCARD;TXK;CD276;ISG15;TLR7;CCR2;TLR3;RASGRP1;FADD;ZFPM1;CD14;SLAMF6;IL18;TLR8
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.32954586901542177,0.7869683057730515,0.7659574468085106,0.9184905110253427,1.0,9/24,26.53%,PKD1;DNAAF4;PSMD14;EFNA1;UCHL5;PRKACA;USP14;PINK1;TMF1
prerank,negative regulation of viral process (GO:0048525),0.29245678076865983,0.7865904738494973,0.801354401805869,0.918661261344982,1.0,16/57,22.10%,TRIM28;MAVS;TRIM27;ILF3;UBP1;MID2;CHMP3;TRIM26;SRPK1;HEXIM1;N4BP1;TRIM13;TRIM6;LARP7;SHFL;TRIM8
prerank,sphingoid biosynthetic process (GO:0046520),0.3830640219078586,0.7863927453879715,0.7349926793557833,0.9182138115751282,1.0,1/11,1.74%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.3830640219078586,0.7863927453879715,0.7349926793557833,0.9182138115751282,1.0,1/11,1.74%,ACER3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.35691612758825947,0.7858314604138802,0.7529107373868047,0.9186072333623901,1.0,4/17,13.69%,TGFB3;BMP4;F2R;RUNX1
prerank,prostaglandin metabolic process (GO:0006693),0.3259403201143936,0.7855031031967864,0.7509481668773704,0.9187208337906485,1.0,2/26,1.79%,PTGIS;PLA2G4A
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3475464731082343,0.7854681162110261,0.7532981530343008,0.9184097910653659,1.0,4/19,13.69%,ELF1;MAVS;IRAK1;RUNX1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3541944214877433,0.784956277353714,0.7388963660834454,0.9187661097561609,1.0,10/16,22.07%,IRAK3;CLEC16A;GSPT1;TBC1D25;ETF1;HDAC6;CLN3;GLE1;UPF1;SHFL
prerank,regulation of cholesterol efflux (GO:0010874),0.31737262329592913,0.784947486531179,0.7784577723378213,0.9184214635109172,1.0,3/30,5.94%,LRP1;RXRA;LAMTOR1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.273784453459223,0.7845921786899608,0.8252118644067796,0.918554782007146,1.0,13/101,13.18%,EGFR;PKD1;VEGFA;FGF2;CALM2;FGFR1;RHOA;EDN3;SYAP1;IRAK1;TELO2;TENM1;MAPRE3
prerank,mitochondrion distribution (GO:0048311),-0.3107128014951684,-0.7843923201691261,0.722972972972973,0.9246935130921368,1.0,4/12,13.09%,DNM1L;TRAK2;TRAK1;ARMC1
prerank,sphingolipid biosynthetic process (GO:0030148),0.2874631425277801,0.7840955580450178,0.8242229367631297,0.9188725502993329,1.0,7/71,6.19%,ACER3;PLPP3;ST6GALNAC5;KDSR;SMPD4;ELOVL5;PLPP1
prerank,positive regulation of inflammatory response (GO:0050729),0.2808902024416652,0.7838041930465892,0.8226652675760755,0.9189100464613259,1.0,4/86,3.97%,LBP;PDCD4;IL33;ABCC1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.28408113133505875,0.7836034683112585,0.8096809680968097,0.9188322086495686,1.0,22/70,26.25%,ACVR1B;CRADD;TGFB2;BAG3;TNFRSF1B;BLOC1S2;ITGAV;BCL2L2;PDPK1;TNFRSF10B;CD27;INHBA;DEDD;BID;APPL1;FGFR3;IL4;DIABLO;BAD;TRADD;DAXX;RIPK1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.37375811244501467,0.7825013490919707,0.7219020172910663,0.9200044370550582,1.0,2/12,5.06%,CAMK2D;CALM2
prerank,regulation of T cell activation (GO:0050863),0.3034268125046184,0.7818994102338446,0.7747641509433962,0.9204472214445387,1.0,7/42,12.92%,TNFRSF1B;TBX21;CRTAM;ABL1;KAT2A;VTCN1;HSPD1
prerank,cellular zinc ion homeostasis (GO:0006882),0.3308383978506379,0.7815272915074318,0.7669543773119606,0.9206065831673977,1.0,4/26,9.85%,SLC39A14;SLC39A7;SLC30A5;SLC39A13
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3413606862030182,0.7815140054778713,0.7565104166666666,0.9202657826679079,1.0,8/19,33.57%,ZNF76;TENM1;CHD8;ICE1;RPTOR;PRDX5;POLR3F;ZC3H8
prerank,translation (GO:0006412),0.26720504248057,0.7810512945259077,0.9094567404426559,0.9205262220257081,1.0,58/208,28.79%,RRBP1;RPSA;VARS1;MRPS2;MRPS28;WARS2;ABCF1;HARS2;GSPT1;NOA1;MRPS18B;PPA2;ZC3H15;YARS1;ABCE1;DARS2;MRPS14;EEF1G;AGO2;EIF4G1;MRPL35;ETF1;MRPS17;EEF2K;RPS27A;EEF1B2;YARS2;TUFM;EPRS1;PPA1;EEFSEC;SARS2;SARS1;DRG2;PTCD3;RPL7A;DARS1;MRPL47;GTPBP2;MRPS24;MRPS21;ASMT;MRPS18A;RPS9;MRPL37;PABPC4;TMA7;QARS1;CARS1;MRPL13;TRMT112;SRBD1;DRG1;RPL41;RPL30;MRPL11;WARS1;IGHMBP2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.36062001278665395,0.7810373527030657,0.758575197889182,0.9201892040466314,1.0,4/16,13.69%,TGFB3;BMP4;F2R;RUNX1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3162239420994259,-0.7809931472236243,0.7593984962406015,0.928594335306849,1.0,2/13,1.29%,SLC8A1;PDE4D
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.35183319418307324,0.7808943036179538,0.7372654155495979,0.9200270637768667,1.0,3/16,9.77%,KLRK1;RAET1E;CRTAM
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2958533874232927,0.7808370817874033,0.7690557451649602,0.9197551350119069,1.0,16/48,26.51%,TOPORS;TNFRSF1B;PRKDC;ABL1;BCL2L2;ATM;CHEK2;AEN;E2F1;HIPK2;IKBKE;SFN;TP53;RPS27L;HTRA2;CDIP1
prerank,protein auto-ADP-ribosylation (GO:0070213),0.3701580941450805,0.7805908416164004,0.7406380027739251,0.9197302425802856,1.0,4/12,20.30%,PARP3;TNKS2;PARP1;PARP12
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3784790182094415,0.7796561804895781,0.7430555555555556,0.9206636678384339,1.0,6/11,27.67%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.20489620959516242,-0.7791749281210035,0.91,0.9299489175505983,1.0,15/57,17.84%,UACA;DDX3X;GRIN2B;PDCD5;AIM2;GRIN2A;SOX7;SYK;ACVR1C;NDUFA13;SIRT1;GRIN1;GPER1;FOXL2;PYCARD
prerank,respiratory chain complex IV assembly (GO:0008535),0.3344674388679162,0.7788407287040998,0.7761006289308177,0.9214521763742729,1.0,10/21,32.50%,COA8;SURF1;BCS1L;COA6;FASTKD3;COX18;COX15;COA5;COX16;TIMM21
prerank,positive regulation of transporter activity (GO:0032411),0.36675590568010175,0.7781360910962161,0.7311827956989247,0.9220395193922345,1.0,2/13,6.67%,RXRA;STK39
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.35307751095814877,0.7766463157291008,0.7645502645502645,0.9233564753923107,1.0,2/15,12.70%,PABPC1;AGO2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.35307751095814877,0.7766463157291008,0.7645502645502645,0.9233564753923107,1.0,2/15,12.70%,PABPC1;AGO2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.34619477941904175,0.7766312677552649,0.746684350132626,0.9230183782035798,1.0,3/17,9.77%,KLRK1;RAET1E;CRTAM
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3225970997925457,0.7762561389450144,0.7574257425742574,0.9231732389113164,1.0,1/25,0.51%,CMKLR1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.2758153065086317,-0.7759169490573515,0.7786561264822134,0.9335616091435383,1.0,2/16,9.00%,CLDN5;CLDN1
prerank,basement membrane organization (GO:0071711),0.3627293001660342,0.7759121906391596,0.7350543478260869,0.9232955830192281,1.0,3/14,10.91%,NTN4;RAMP2;FLRT2
prerank,regulation of exocytosis (GO:0017157),0.297773375718064,0.7758037673643534,0.7901376146788991,0.923097462029603,1.0,11/46,17.30%,RAB2B;RAB21;RAB8A;NSF;ANXA1;RAB3D;STXBP5;CHMP3;STX4;RAB3B;SYTL4
prerank,positive regulation of telomerase activity (GO:0051973),0.30956153781058393,0.7757913936589826,0.7654171704957679,0.9227557498119652,1.0,10/33,30.44%,MAPK15;NEK7;NVL;CCT4;MAP2K7;TCP1;DKC1;PNKP;CTNNB1;HSP90AA1
prerank,histone ubiquitination (GO:0016574),0.3337734628440857,0.7757557217613037,0.7651515151515151,0.9224393418250628,1.0,12/21,37.66%,UBE2B;HUWE1;UBR2;PAF1;RNF20;USP22;UBE2A;UBE2N;WAC;DTX3L;ATXN7L3;RNF8
prerank,chemical synaptic transmission (GO:0007268),0.26105837030525986,0.7756819657913754,0.928928928928929,0.9221790147893025,1.0,24/284,8.78%,PCDHB16;LRP6;GRIK4;SLC12A7;DLG2;EXOC4;UNC13B;CAMKK1;PMP22;CEL;KCNN1;ERC1;RIC3;GABRA3;DVL1;CHRNB2;KCNIP2;SLC6A2;GIPC1;SLC12A4;TBC1D24;DLG4;CHRNA5;DLG1
prerank,pinocytosis (GO:0006907),0.3835781242937196,0.775222600339139,0.7277936962750716,0.9224439299553796,1.0,1/10,4.00%,RAB34
prerank,establishment of mitotic spindle localization (GO:0040001),0.3207813245283329,0.7751806887817809,0.7983193277310925,0.9221553288784693,1.0,6/28,22.48%,PKHD1;MISP;ZW10;NDEL1;DCTN1;CDK5RAP2
prerank,positive regulation of myelination (GO:0031643),0.3727059196428305,0.7751499124681451,0.7627840909090909,0.9218388729514533,1.0,2/11,12.75%,TNFRSF1B;NCMAP
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.34926035664104155,0.7745816635964756,0.7516778523489933,0.922220110219773,1.0,4/16,20.79%,DPYSL3;UPP2;TET2;NT5C
prerank,postsynaptic membrane organization (GO:0001941),0.3396814457113322,0.7742970899355953,0.7526455026455027,0.9222455453718417,1.0,5/17,13.02%,CEL;DLG4;NRXN2;MUSK;NLGN1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3456000916262823,0.7741046982887609,0.7480106100795756,0.9221453326621207,1.0,5/17,25.57%,DRD1;ADCY9;AKAP13;DRD2;ADRB1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.33208689962808846,0.7736433129134296,0.7503201024327785,0.922417328079331,1.0,8/21,24.47%,SFRP4;BMP4;RUNX1;MAFG;CBFB;SFN;CTSK;ROCK1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.34761182679923697,0.7733610036767291,0.7605633802816901,0.9224315249614649,1.0,9/16,35.55%,ZC3H12D;UPF1;RBM24;ZFP36L1;KHSRP;PLEKHN1;MOV10;TARDBP;RC3H1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.31809494512260167,-0.7730152656912598,0.712280701754386,0.936531803181574,1.0,2/10,5.46%,DPYD;UPB1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3102130355981272,0.7722873994518378,0.7746305418719212,0.9235466600215615,1.0,11/29,30.44%,PPP6R3;TERT;TELO2;RAD50;CDK2;TNKS1BP1;ANKRD28;DKC1;RTEL1;NOP10;HSP90AA1
prerank,cellular response to superoxide (GO:0071451),-0.3163833228529691,-0.77121450146239,0.7411003236245954,0.9378076223413703,1.0,2/10,4.82%,NOS3;SOD3
prerank,negative regulation of cell communication (GO:0010648),0.3322695604443465,0.7711867804067657,0.77735368956743,0.9246682235444406,1.0,3/21,13.52%,UBASH3B;ACVR1;SRMS
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.30203556819719696,-0.770838061799899,0.7395833333333334,0.9369277264908149,1.0,7/12,20.60%,BCL2;RPL26;CD74;SIRT1;CD44;KDM1A;TAF9
prerank,myoblast fusion (GO:0007520),0.36552288253818743,0.7707332783025606,0.7424892703862661,0.9249334592736971,1.0,2/12,6.03%,PTGFRN;CD9
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3469973080323497,0.7703343860022175,0.7661822985468957,0.925115315382139,1.0,6/15,22.51%,NOL3;FXN;HGF;AKT1;CLU;TRIAP1
prerank,acylglycerol metabolic process (GO:0006639),0.30593631533148735,0.7702489299771129,0.8049645390070922,0.9248636903453847,1.0,6/37,14.82%,MGLL;LMF1;DGKQ;PGS1;ABHD6;PNPLA3
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3793666774442785,0.7697930476759878,0.7563025210084033,0.9251113095088258,1.0,5/10,25.60%,GPATCH3;NPLOC4;SEC14L1;C1QBP;TKFC
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3129955766238462,0.7694821908915139,0.7944711538461539,0.9251898996051168,1.0,8/30,22.00%,ABCD3;ELOVL5;SLC27A6;ACSL6;ACSBG1;SLC27A2;PEX2;ABCD1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.31262643327158435,0.7694424590996547,0.7825552825552825,0.9248861054241059,1.0,11/27,29.14%,MAP3K5;MAPK8;CHUK;CUL1;RPS27A;UBC;KAT7;MAP2K7;TAOK2;BTRC;CCM2
prerank,regulation of hormone secretion (GO:0046883),0.35324447595280994,0.7689237397912585,0.7760814249363868,0.9252309830099853,1.0,5/15,27.32%,EDN3;ANXA1;NMB;VAMP2;LIF
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.29468849722834706,0.7685216064911959,0.7986425339366516,0.925419188851407,1.0,10/45,16.21%,ZC3H7A;PUM1;MATR3;CYFIP1;METTL16;NOLC1;YTHDC1;PER1;FOXO3;ZC3H10
prerank,regulation of DNA recombination (GO:0000018),0.3094689292340659,0.7683046697737094,0.7831325301204819,0.9253690987078751,1.0,12/32,31.69%,SPIDR;KPNA2;RAD50;SMARCAD1;RAD51;IL4;SETD2;ZRANB3;RTEL1;IL7R;MSH2;BLM
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2992230298522961,-0.7680699377271204,0.7585034013605442,0.939603176126453,1.0,3/10,12.75%,RIF1;DCLRE1C;TERF2IP
prerank,homologous chromosome segregation (GO:0045143),-0.25795487408371087,-0.7678242167832064,0.7962962962962963,0.9385238472923177,1.0,14/20,40.84%,FMN2;MEI4;FANCD2;PRDM9;SGO1;MAJIN;MEIOB;TERB1;PTTG1;RNF212B;MEIKIN;ANKRD31;TERB2;ZCWPW1
prerank,postreplication repair (GO:0006301),0.29321780747678505,0.7677364088708207,0.8145161290322581,0.9257932562869623,1.0,20/45,35.30%,UBE2B;VCP;FAAP20;UBE2L6;UBE2V2;RPS27A;UBC;REV1;USP10;PRIMPOL;POLD1;UBE2V1;UBE2A;MSH2;UBE2N;POLK;RPA3;PARP10;RFC4;NSMCE1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3100294934281824,0.7676384868894338,0.790834312573443,0.9255704096746779,1.0,2/33,4.91%,ID2;PRKCA
prerank,transport along microtubule (GO:0010970),0.3629169185610592,0.7670417872112748,0.7739251040221914,0.9260144012267875,1.0,3/13,8.01%,BAG3;COPG1;ARHGAP21
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.32305316275556056,0.7661043608164401,0.7753530166880617,0.9268908760737522,1.0,7/23,28.45%,PDE6A;GUCY2D;SAG;GRK4;METAP2;NMT1;PDE6G
prerank,hexose transmembrane transport (GO:0008645),0.32640102109621383,0.7659007820543179,0.7643312101910829,0.9268181887748463,1.0,5/21,17.10%,SLC5A2;SLC2A9;SLC50A1;SLC2A2;SLC2A10
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.336203292781391,0.7651072927423478,0.7789072426937739,0.9275148134570675,1.0,5/18,19.49%,COA8;SURF1;BCS1L;FASTKD3;COX18
prerank,positive regulation of nervous system process (GO:0031646),0.336105594457534,0.7650224128158294,0.7685060565275909,0.9272612349358443,1.0,3/18,12.75%,UNC13B;TNFRSF1B;NCMAP
prerank,leukocyte tethering or rolling (GO:0050901),-0.273225070124983,-0.764853621098413,0.8197424892703863,0.9413665675934977,1.0,5/17,14.42%,VCAM1;JAM2;CX3CR1;ITGA4;GCNT1
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.33471226928785885,0.7647583695805407,0.7522464698331194,0.9272281231056182,1.0,4/19,12.98%,ADA;TERT;AMPD3;DGUOK
prerank,actin nucleation (GO:0045010),0.32621336097194925,0.7644510421825417,0.7931034482758621,0.9272708453420985,1.0,4/21,15.30%,ARPC1B;TRIM27;SCIN;SPIRE2
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.32059248101424714,-0.7644455375091215,0.7639344262295082,0.9405362976201362,1.0,10/10,67.97%,NCKAP1L;IL12A;FOXP3;TLR4;IL12B;VSIR;IFNG;TNFSF4;DDIT3;PRNP
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3740737598978865,0.7642804218589992,0.7667638483965015,0.9271398889309184,1.0,3/10,16.89%,GNPDA1;NANP;RENBP
prerank,ketone body metabolic process (GO:1902224),0.378042768945244,0.7641769550584897,0.765379113018598,0.9269287141228422,1.0,4/10,14.02%,AACS;HMGCL;ACAT1;BDH2
prerank,cellular response to interferon-gamma (GO:0071346),0.2727609932128675,0.7635188877296971,0.837037037037037,0.9274307789499309,1.0,15/88,19.54%,PRKCD;SLC26A6;CCL13;CAMK2D;CCL15;MID1;GBP6;CASP1;TRIM26;EPRS1;DAPK3;ACOD1;SYNCRIP;PTAFR;IRF3
prerank,negative regulation of interferon-beta production (GO:0032688),0.36873935627619886,0.7634322615190879,0.7606461086637298,0.9271888447628016,1.0,1/10,3.93%,PTPRS
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.30254370101272743,0.7632074281450223,0.781433607520564,0.927117054021388,1.0,6/34,11.99%,LRP5;ANAPC5;CDC16;EDN3;PHIP;ANAPC4
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.30813436940165295,0.7630099839361656,0.8,0.9270107312771116,1.0,7/33,18.70%,IRS1;PIK3C2B;PIK3CB;SIRT2;ERBB2;NF1;AKT1
prerank,cGMP biosynthetic process (GO:0006182),-0.3131992397584249,-0.76292407849806,0.7777777777777778,0.941304145212951,1.0,2/10,9.39%,GUCY1B1;NPR1
prerank,nucleotide catabolic process (GO:0009166),0.349795881133933,0.7628868719105604,0.7779255319148937,0.926802288524614,1.0,3/16,13.67%,XDH;VCP;DERA
prerank,mitochondrial protein processing (GO:0034982),0.3649208085042399,0.7623180008213385,0.763046544428773,0.9272012812732457,1.0,6/11,27.81%,SPG7;PMPCA;AFG3L2;STOML2;PMPCB;ATP23
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2836386778001854,-0.7613641065240551,0.7881040892193308,0.942170251643842,1.0,1/14,0.35%,AUTS2
prerank,Golgi to lysosome transport (GO:0090160),-0.3112313532831479,-0.7610128109896358,0.7762711864406779,0.9411990394726959,1.0,2/11,6.74%,ANKFY1;SORT1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.34536376488838905,0.7609981218875621,0.7803234501347709,0.9285483107959991,1.0,2/15,7.94%,ARPC1B;TRIM27
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3781405426559953,0.7609339952886625,0.7779433681073026,0.9282939806718029,1.0,2/10,8.71%,LAPTM4B;TSKU
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.267749737795588,0.7608388310229275,0.8639667705088265,0.9280622261640522,1.0,15/110,13.81%,GNAS;DRD1;FSHR;ADGRL2;RAMP2;ADCY2;ADCY8;ADCY9;IAPP;RAMP1;VIP;GLP1R;MC4R;ABCA1;GPR12
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.2953818851770972,0.760424577934085,0.806146572104019,0.92826446015157,1.0,3/35,4.11%,GHR;CYP1B1;HES5
prerank,regulation of endopeptidase activity (GO:0052548),0.2847749199561831,0.7596395310813163,0.8342602892102335,0.9289255837817941,1.0,11/59,20.20%,SERPINH1;TIMP2;TIMP3;SERPINF1;SERPINB9;HDAC1;SERPINE2;CRB2;AKT1;SERPING1;PSMA3
prerank,stress-activated MAPK cascade (GO:0051403),0.2769196628997142,0.7593109853223435,0.8475138121546961,0.9289818307072188,1.0,23/61,29.77%,MAP3K5;GPS1;MAPK8;CHUK;IRAK1;TAB2;MAP3K12;CUL1;MAP3K10;RPS27A;UBC;MAP2K3;MAPK9;GPS2;MAP2K7;TAOK2;RIPK2;MAP3K11;UBE2V1;BTRC;MAP2K4;CCM2;ZFP36L1
prerank,dendrite self-avoidance (GO:0070593),0.3469021038672439,0.7592008768650871,0.7991858887381276,0.9287766813598944,1.0,3/16,14.31%,EMB;PALLD;IGSF9
prerank,C-terminal protein amino acid modification (GO:0018410),-0.30164172183133003,-0.7588310637733657,0.772189349112426,0.9428590205193793,1.0,3/11,17.07%,AGBL4;TTL;FOLH1
prerank,long-term synaptic potentiation (GO:0060291),0.3324307453230728,0.7584328570704607,0.7632600258732212,0.9293993711039321,1.0,2/21,3.05%,MPP2;ARC
prerank,epithelial cell-cell adhesion (GO:0090136),0.363470023805469,0.7584285288255748,0.7517146776406035,0.9290503947146698,1.0,2/11,7.66%,CCN3;JUP
prerank,positive regulation of type 2 immune response (GO:0002830),0.34771520343918205,0.7582261792052579,0.7537212449255751,0.9289650090817978,1.0,4/14,20.97%,RARA;IL6;DENND1B;IL4
prerank,copper ion homeostasis (GO:0055070),0.3373739322650617,0.7578229121402174,0.7795484727755644,0.9291576633386734,1.0,8/17,33.20%,ARF1;ABCB6;ANKRD9;XIAP;SLC31A2;ATP7A;PRNP;MT2A
prerank,mitochondrial fusion (GO:0008053),0.33112087429979314,0.757682140785333,0.7865612648221344,0.928985727567022,1.0,8/18,30.35%,MIEF2;SPG7;MFN1;AFG3L2;STOML2;FIS1;USP30;MIEF1
prerank,regulation of embryonic development (GO:0045995),0.2991489263856548,0.7576327718058105,0.8023809523809524,0.9286884562826183,1.0,9/34,16.94%,PHLDB1;TLE6;POGLUT1;EHMT1;B4GALT5;TDG;CRB2;NPHP3;NIPBL
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.266350082071314,-0.7574911067209077,0.7769516728624535,0.9432129280988745,1.0,4/16,11.88%,NR1H3;ABHD5;MFSD2A;SCARB1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.3449920829200696,0.7564455860229738,0.7728494623655914,0.9298590335939644,1.0,1/15,2.03%,NTRK1
prerank,positive regulation of protein processing (GO:0010954),0.32553786263875273,0.7561629699716023,0.7649301143583227,0.9298626221607277,1.0,2/19,10.45%,GSN;LPCAT3
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.27266235048427045,-0.7557871102246301,0.8284518828451883,0.9441500716448121,1.0,2/16,3.54%,BCL2L1;CXCL12
prerank,cholesterol efflux (GO:0033344),0.33046949092411826,0.7556457299006023,0.7970430107526881,0.9301825361486735,1.0,4/20,13.71%,SOAT1;TSKU;NPC1;ABCA1
prerank,development of primary male sexual characteristics (GO:0046546),0.3021060747967278,0.7548088419885797,0.8257211538461539,0.9308987884133203,1.0,6/34,13.14%,FSHR;SIX4;TGFB2;SOX9;INHBA;LRP2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.3388757943866384,0.7538403185194941,0.795601552393273,0.9317797084913613,1.0,3/17,12.91%,UBASH3A;EZR;PTPN2
prerank,embryonic digit morphogenesis (GO:0042733),0.3403264323257616,0.7536154633844285,0.7783572359843546,0.9317165799303205,1.0,5/18,16.11%,ECE1;TWIST1;NOG;HDAC1;CREBBP
prerank,protein destabilization (GO:0031648),0.30245638602756975,0.7534391942138584,0.8028673835125448,0.9315849019477527,1.0,12/32,32.05%,GSN;CREBBP;SERF1A;MUL1;PEX2;DERL1;GGA3;NR1D1;BTRC;PRKN;IRGM;PRNP
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.30130663162399624,0.75308144730253,0.8275449101796407,0.9316963372581142,1.0,3/34,5.58%,MPP2;GABRA3;RAB3GAP1
prerank,positive regulation of hormone secretion (GO:0046887),0.3370193038762992,0.7526619995754377,0.7843915343915344,0.9318811296237537,1.0,2/17,9.29%,CYP19A1;EDN3
prerank,negative regulation of catalytic activity (GO:0043086),-0.2303432710898186,-0.7523248370862671,0.8786407766990292,0.9476051003660501,1.0,8/24,18.42%,NOTCH1;NES;IFIT1;NOS1;SIRT1;CAMK2A;MT3;PPP1R12A
prerank,actin crosslink formation (GO:0051764),0.35870247368978014,0.7519634793222296,0.7804195804195804,0.9324520507652013,1.0,2/12,8.83%,DPYSL3;GAS2
prerank,skeletal muscle contraction (GO:0003009),0.3294332833387198,0.7507045101792446,0.7738095238095238,0.9336769913703625,1.0,2/19,14.73%,TNNT3;STAC3
prerank,protein palmitoylation (GO:0018345),-0.21921196864987488,-0.7496338338479264,0.8914285714285715,0.9498542900662528,1.0,13/30,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,cellular response to interleukin-1 (GO:0071347),0.2546539398326453,0.7492004662566796,0.9114954221770092,0.9352252862264226,1.0,32/143,21.97%,PTGIS;CCL13;PSMD7;CCL15;PSMA8;IRAK3;SOX9;RPS6KA4;PSMA4;CHUK;IRAK1;TAB2;PSMD12;CUL1;PSMA6;TANK;SQSTM1;PSMD1;MAP3K3;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC;ACOD1;USP10;NFKBIA;PSMA3;PSMB1;PSMD4;UPF1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3093823711875793,0.7491916121209159,0.8055207026348808,0.9348842472748127,1.0,11/26,32.37%,ITCH;ALPK1;IRAK1;TAB2;RPS27A;UBC;CYLD;RIPK2;UBE2V1;UBE2N;IFIH1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.3055949739222954,0.7482831678541659,0.8089330024813896,0.9356700719047213,1.0,8/25,25.33%,ACVR1B;STAT3;PRKDC;INHBA;FOXO3;PRMT1;ABCB10;BRD1
prerank,regulation of cellular component size (GO:0032535),0.3056255261934986,0.7482374258971675,0.8200734394124847,0.9353764694906581,1.0,3/30,4.64%,RDX;VAV2;PEX11A
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.2748097962721381,-0.7478327711920224,0.8052434456928839,0.9507926057826421,1.0,4/14,14.49%,DPYD;UPB1;ERH;UMPS
prerank,cellular copper ion homeostasis (GO:0006878),0.3431577354776284,0.7476247656057033,0.7789613848202397,0.9358084252528508,1.0,7/14,33.20%,ARF1;ABCB6;ANKRD9;SLC31A2;ATP7A;PRNP;MT2A
prerank,adipose tissue development (GO:0060612),0.35662825829023687,0.7475374212081073,0.7689075630252101,0.9355502878679917,1.0,2/11,9.26%,LRP5;SH3PXD2B
prerank,modulation by symbiont of host process (GO:0044003),-0.30963132866941445,-0.7472701641475821,0.7827586206896552,0.9500978903526831,1.0,3/10,14.75%,B2M;MRC1;UBA52
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2573390436470919,-0.7471552695213042,0.8047808764940239,0.9488128861534415,1.0,1/17,1.38%,APOE
prerank,programmed necrotic cell death (GO:0097300),0.3264956660918179,0.7465372005564914,0.7888446215139442,0.9364393965332397,1.0,3/18,10.46%,PGAM5;TRPM7;RIPK3
prerank,positive regulation of secretion (GO:0051047),0.360390224437062,0.746518165801223,0.7912552891396333,0.9361148050603051,1.0,2/11,14.92%,ACSL3;SCIN
prerank,ceramide catabolic process (GO:0046514),0.34781010177855687,0.7460276376079291,0.7759336099585062,0.9363894307891965,1.0,3/14,19.42%,ACER3;HEXA;ASAH1
prerank,regulation of cytokine production (GO:0001817),0.2562464008021705,0.7455722099092481,0.8946830265848671,0.9366184842777834,1.0,19/126,16.81%,FOXP1;IL33;HDAC9;GLMN;TNFRSF1B;RPS6KA4;BTNL9;ANXA1;CRTAM;RIPK3;SOD1;CIDEA;KAT2A;TRAF3;VTCN1;PER1;IL6;N4BP1;CCN4
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.30544338806613097,0.7455028470849606,0.8204182041820418,0.9363459115579962,1.0,2/29,6.48%,GAS6;HMGB1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.300669255271979,0.745251248034915,0.8059701492537313,0.9362953294392178,1.0,5/31,13.12%,SPN;GLMN;ATM;VTCN1;CD80
prerank,amino sugar metabolic process (GO:0006040),0.3683480661851466,0.7451233575751535,0.7771345875542692,0.9361054727282329,1.0,2/10,7.90%,GFPT1;GFPT2
prerank,modulation by host of symbiont process (GO:0051851),-0.21968966569184634,-0.7450102101664827,0.8688524590163934,0.9503761726617683,1.0,13/31,31.67%,LEF1;NAPEPLD;CX3CR1;EP300;NUCKS1;HMGA2;POU2F3;AQP1;HPN;CCL5;JUN;SAP30;CCL4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.29338573060821826,0.7444611341335288,0.8219653179190751,0.9365738758819362,1.0,12/35,29.12%,MPG;OGG1;TDG;SMUG1;PARP1;POLB;PARG;POLD1;POLG;PNKP;ADPRS;MBD4
prerank,exit from mitosis (GO:0010458),0.36746008797561974,0.7444335632518496,0.7983651226158038,0.9362609405704596,1.0,8/12,33.14%,SPAST;UBE2C;PPP2R2D;CHMP4B;CHMP2A;CTDP1;UBE2S;SIRT7
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.31295247997635006,0.7442801653851437,0.8018018018018018,0.9361064738725995,1.0,5/23,17.93%,INTS3;CDK5RAP3;ZW10;ZFYVE19;WEE2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.26992955788662276,-0.7437408788563532,0.8093385214007782,0.9505492285992548,1.0,11/15,40.32%,SYK;CD55;CCR2;SHH;IL12A;IL23A;PNP;EBI3;IHH;IL23R;IL12B
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.281831308258794,0.7428361164313696,0.8298850574712644,0.9375181566660195,1.0,8/47,15.24%,EGFR;TGFB2;MID1;NBR1;FOXM1;ULK4;STK25;PER1
prerank,regulation of sodium ion transport (GO:0002028),0.2914668820778701,0.7428348627657057,0.8341346153846154,0.9371663448254153,1.0,7/34,15.24%,NEDD4;SLMAP;SNTA1;DLG1;PRSS8;WNK1;PER1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.31027088125948266,0.7415649032197095,0.8177339901477833,0.9383669502695793,1.0,2/26,6.48%,LBP;HMGB1
prerank,regulation of tissue remodeling (GO:0034103),0.3324504021173229,0.7414616649145337,0.7987261146496816,0.938154404053144,1.0,3/18,13.69%,DDR2;CST3;RUNX1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3481641846296254,0.7414413801237908,0.7838214783821479,0.9378255252120815,1.0,5/13,27.13%,TBC1D10A;PERP;CYFIP2;BAD;RIPK2
prerank,protein K48-linked ubiquitination (GO:0070936),0.2754373074289621,0.7390324304849949,0.851063829787234,0.940406611125849,1.0,20/54,30.01%,TOPORS;UBE2B;UBE2R2;RNF115;SYVN1;ITCH;UBR5;UBE2C;UBE2G2;RNF4;TTC3;RNF216;RNF146;AMFR;RNF126;FBXO38;RBX1;UBE2Q2;PRKN;UBE2H
prerank,regulation of neuron migration (GO:2001222),0.3128223302323181,0.7382391569849011,0.8197530864197531,0.9410281465356097,1.0,2/26,1.17%,COL3A1;SRGAP2
prerank,regulation of interleukin-2 production (GO:0032663),0.28296199065931016,0.7376752139051316,0.8484500574052812,0.9413609238289401,1.0,9/43,19.83%,GLMN;TBX21;TRIM27;ANXA1;EZR;CD80;RUNX1;SPTBN1;HOMER2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.29820965767049934,0.7349973147204,0.8090575275397797,0.9442647406430995,1.0,7/29,20.03%,NTRK1;SHC1;ITGAV;SHOC2;LRRC59;ERBIN;RASGRF1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.2726160531245388,0.7349715928462641,0.8411111111111111,0.9439420152979728,1.0,17/59,27.13%,ERC1;SHARPIN;CHUK;TAB2;TANK;RPS27A;UBC;NKIRAS1;AKT1;NFKBIA;BIRC3;MAP3K14;TBK1;ROCK1;TRADD;RIPK1;RIPK2
prerank,regulation of lymphocyte proliferation (GO:0050670),0.32867681398360427,0.7348105283085108,0.8010540184453228,0.9437860540785495,1.0,2/16,8.03%,TNFRSF1B;IKZF3
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2888032496700466,0.7345017137501222,0.8378995433789954,0.9437851255332247,1.0,11/38,22.77%,PKHD1;PHLPP2;XDH;PIK3CB;PPP2R5C;FLCN;AKT1;MUL1;BANK1;DRD2;TSC2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.2939628445021751,-0.7343070605070183,0.8032258064516129,0.9612313240911369,1.0,2/10,9.04%,RAPGEF3;PIH1D1
prerank,regulation of transposition (GO:0010528),0.35141605852463337,0.733679448433159,0.8024861878453039,0.9444155417583405,1.0,2/13,18.72%,TEX15;UBR2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3013258653754442,0.7334880875051211,0.8393524283935243,0.9442904640192284,1.0,9/28,25.58%,CRADD;BAG3;BLOC1S2;TNFRSF10B;DEDD;BID;DIABLO;TRADD;DAXX
prerank,neuromuscular process controlling balance (GO:0050885),-0.277631272920372,-0.7330451555658573,0.8245033112582781,0.9613182982371224,1.0,1/12,1.57%,NRXN1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.3054705155053357,0.7323562632282447,0.81375,0.9452977760804193,1.0,5/25,17.10%,GLMN;ANXA1;CD80;RUNX1;SPTBN1
prerank,negative regulation of signaling (GO:0023057),0.306841804395573,0.7312199171928938,0.8117942283563363,0.9462983858935659,1.0,5/25,20.95%,UBASH3B;ACVR1;SRMS;TRAT1;OPTN
prerank,macrophage migration (GO:1905517),-0.2698681732580038,-0.7304004359223837,0.782312925170068,0.9630451752858792,1.0,13/13,73.04%,EDNRB;TAFA4;CCR2;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;P2RX4;P2RY12;CKLF;CCL2
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3423687452720223,0.7302710508438641,0.8197831978319783,0.9470748573267099,1.0,2/14,18.72%,IL6;OSMR
prerank,regulation of complement activation (GO:0030449),0.28721382559441067,0.7294327678977567,0.8544819557625145,0.9477069552522878,1.0,7/40,20.48%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,protein autoprocessing (GO:0016540),0.32627898387376164,0.7289124110885444,0.8071519795657727,0.9479478463482777,1.0,7/17,37.13%,FXN;CASP1;AFG3L2;HTRA2;PIDD1;MYRF;CTSL
prerank,fatty acid elongation (GO:0030497),-0.27832968681884807,-0.7285301956827706,0.791970802919708,0.963901886326359,1.0,2/13,4.87%,ELOVL7;HACD1
prerank,diol metabolic process (GO:0034311),0.319355980588108,0.7281600027687715,0.8194622279129321,0.9484818708137628,1.0,2/19,6.19%,PLPP3;PLPP1
prerank,negative regulation of histone modification (GO:0031057),0.335268789706801,0.7278023518495439,0.7948016415868673,0.9485601032536398,1.0,3/14,19.97%,TWIST1;THAP7;NOC2L
prerank,intestinal absorption (GO:0050892),0.3429583498097022,0.7266111232524831,0.8157181571815718,0.9495724694165388,1.0,1/13,2.99%,SLC26A6
prerank,excitatory postsynaptic potential (GO:0060079),0.3222563432772994,0.7265628959299438,0.8224543080939948,0.9492715815367047,1.0,5/19,21.66%,MPP2;RAB3GAP1;AKT1;DRD2;LRRK2
prerank,negative regulation of inflammatory response (GO:0050728),0.2476206255144641,0.7265018679518351,0.934077079107505,0.9489853763013907,1.0,34/182,20.97%,PRKCD;PTGIS;GPR27;CCN3;DRD1;FSHR;RAMP2;ADCY2;ADCY8;TNFRSF1B;ADCY9;GPR20;IAPP;SHARPIN;RORA;RAMP1;VIP;LPCAT3;GIT1;GLP1R;PTPN2;MC4R;PTGDR;IL6;CREB1;OTULIN;CALCA;ACOD1;ADCY7;PRKACA;GNB1;GPS2;IL4;PRKAR2A
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2690995877613674,0.7250852142622156,0.8975770925110133,0.9503507379872737,1.0,21/62,27.23%,YBX3;NOL3;CCAR2;NFE2L2;SYVN1;HYOU1;URI1;BCL2L2;AKT1;DNAJA1;NOC2L;CLU;ACKR3;LRRK2;VNN1;HERPUD1;CREB3L1;PINK1;SELENOS;HTRA2;PLAUR
prerank,regulation of immune effector process (GO:0002697),0.2835944351166713,0.7250587666972428,0.8623853211009175,0.9500247056102615,1.0,7/41,20.48%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,positive regulation of cell killing (GO:0031343),0.3400210687097826,0.7241180234465062,0.8143053645116919,0.9507524626885933,1.0,7/13,31.82%,FZD7;MAPK8;DVL2;NOX1;RAC1;CYBA;NOXO1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.2785011490460447,-0.7237025615910015,0.8037735849056604,0.9683084430643925,1.0,5/11,23.35%,AKAP6;NOS1AP;LRRC38;LRRC55;TREM2
prerank,pyroptosis (GO:0070269),-0.25561473328597956,-0.7232919327853681,0.849624060150376,0.9673413074518588,1.0,6/15,26.38%,CASP4;AIM2;ZBP1;TREM2;NLRC4;APIP
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3286135907850849,0.7231996636837489,0.8298153034300791,0.951479678281004,1.0,5/16,16.21%,CAMK2D;PRKCA;SLC9A1;MEF2A;PARP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3576386927464555,0.7231619930184238,0.8216292134831461,0.9511780124333225,1.0,6/10,36.22%,YOD1;ERLEC1;UBE2G2;INSIG1;OS9;UBAC2
prerank,negative regulation of innate immune response (GO:0045824),-0.2104982770604896,-0.7219800735243578,0.8956043956043956,0.9674758191935244,1.0,8/34,13.39%,SAMHD1;USP18;NLRC5;TRIM21;A2M;DHX58;CACTIN;TNFAIP3
prerank,cellular response to metal ion (GO:0071248),0.2501607524571983,0.721314192777335,0.9201637666325486,0.9529487631213892,1.0,14/123,13.48%,EGFR;SLC12A2;DLG2;SYT8;CAMK2D;CLIC4;ADCY8;DLG4;MAPK8;CHUK;NEUROD2;NLGN1;ADD1;MEF2A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3208468480429382,0.7200133458643131,0.8136246786632391,0.9541376670772096,1.0,8/18,29.91%,NOL3;NFE2L2;AKT1;VNN1;PINK1;HTRA2;NME5;PRKN
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2781976227579741,0.7200021072116677,0.8573059360730594,0.9537969087938144,1.0,13/46,28.51%,TOMM40;TIMM9;BCAP31;AIFM1;HSPD1;TOMM70;GRPEL1;AKT1;PINK1;TIMM17B;TIMM22;RALA;FIS1
prerank,response to axon injury (GO:0048678),0.3112792503766878,0.7196464710437249,0.8166449934980494,0.9538443682390585,1.0,3/18,11.85%,DPYSL3;GAP43;SOD1
prerank,glutamate metabolic process (GO:0006536),0.31217328595457494,0.7195217778122156,0.8242343541944075,0.9536362001759479,1.0,1/19,1.56%,GCLC
prerank,positive regulation of ATPase activity (GO:0032781),0.27812978949737616,0.7192504955249449,0.872852233676976,0.9536091024116253,1.0,4/41,11.00%,ATP1B1;TNNT3;PFN2;CHTOP
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.261894023513378,0.7190454590215999,0.8905419766206164,0.9534864332891002,1.0,18/75,21.39%,MAP1B;FARP1;DOCK7;DVL1;RAB8A;LLGL1;S100B;FGFR2;TMEM106B;MEF2A;TBCD;APBB1;SLITRK2;CDK5;UNK;DRD2;SHTN1;ATL1
prerank,regulation of stem cell proliferation (GO:0072091),-0.2459902874187636,-0.7183544775447805,0.8653846153846154,0.9702400094625898,1.0,4/17,18.51%,FBLN1;ACE;SOX11;KDM1A
prerank,glucose import (GO:0046323),0.34430096424487405,0.7183150243396091,0.8186889818688982,0.9539803574658329,1.0,3/13,17.10%,SLC5A2;RAB4B;SLC2A10
prerank,sarcomere organization (GO:0045214),0.29130545376338607,0.7183098238468149,0.8351783517835178,0.953629719933719,1.0,5/27,20.47%,SIX4;TNNT3;CSRP3;WDR1;CSRP2
prerank,positive regulation of cell development (GO:0010720),0.29083496019414945,0.7180789456857819,0.8567990373044525,0.9535226636096051,1.0,5/31,13.14%,SERPINF1;PDE3A;BMP4;LIG4;LRP2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3143106246086972,0.7179714731748074,0.8028909329829172,0.9532925968269997,1.0,7/19,27.13%,MAVS;CHUK;HSPD1;IRF3;SETD2;TBK1;RIPK2
prerank,neuron apoptotic process (GO:0051402),0.31238358529211485,0.71787598430478,0.8177215189873418,0.9530531221110894,1.0,6/19,21.69%,CIT;ATN1;LIG4;BID;CDK5;DIABLO
prerank,axon development (GO:0061564),0.25917877858377253,0.7177684869399484,0.8983050847457628,0.9528178755062772,1.0,21/78,25.05%,MAP1B;EPHB2;DOCK7;EPHB3;GAP43;RAB8A;LLGL1;S100B;FGFR2;PLP1;APBB1;SLITRK2;CDK5;MAPK8IP3;DRD2;SHTN1;ATL1;AFG3L2;LMTK2;TAOK2;ARHGAP35
prerank,magnesium ion transport (GO:0015693),0.34190794649014566,0.7176551858709983,0.8122392211404729,0.9525853798271232,1.0,7/12,28.20%,NIPA2;MRS2;CNNM4;MAGT1;MMGT1;NIPAL2;NIPAL1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3146025229122976,0.7176432267180926,0.8125,0.9522470758424073,1.0,2/19,11.17%,CARD16;GIT1
prerank,rRNA catabolic process (GO:0016075),0.3214259527434429,0.7176149924446976,0.8103448275862069,0.9519340358585999,1.0,4/16,17.07%,ERN2;XRN1;EXOSC4;DIS3
prerank,nuclear body organization (GO:0030575),-0.2777325145753087,-0.7173267992125855,0.8309859154929577,0.970007173602026,1.0,1/12,0.62%,ETS1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3080570889269014,0.7170317741988602,0.8090909090909091,0.9522544325916025,1.0,5/20,17.61%,IPO5;HEXIM1;LATS2;CDKN1C;MEN1
prerank,regulation of ERAD pathway (GO:1904292),0.3456496685372024,0.7169524053953851,0.8258426966292135,0.9519864658381263,1.0,7/11,37.20%,USP13;USP19;HERPUD1;RNFT1;TMEM259;USP25;RNF185
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.28912562311565443,0.7167994424191337,0.8617886178861789,0.951812395082744,1.0,8/36,12.61%,CSNK2A2;CSNK2A1;CRADD;ING5;MADD;MAZ;DEPTOR;TGFBR1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.26712657221415054,0.7164384778562475,0.8721058434399118,0.9518893241048912,1.0,4/57,4.21%,VEGFA;GHR;HES5;STAT3
prerank,dephosphorylation (GO:0016311),0.24564061601137363,0.7162974790489589,0.9389623601220752,0.951693387321678,1.0,15/147,9.49%,ALPL;PLPP3;PTPN3;PPP1CC;PLPP5;PTPRS;PTPRF;DUSP11;PTPRU;PLPP1;PPM1H;PPM1M;DAPP1;PTPN18;PPP3CC
prerank,positive regulation of peptidase activity (GO:0010952),0.31255238365626004,0.715978776190073,0.8389610389610389,0.9516965290760956,1.0,5/20,24.51%,VCP;MAPK12;TANK;RCN3;PINK1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.279707526686896,0.7156244815845892,0.856156501726122,0.9517433297969019,1.0,3/45,4.58%,PRKCD;CAMK2D;MID1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.32885642639910273,0.7152803764827896,0.8359046283309958,0.9517787262612568,1.0,6/15,32.32%,GNPDA1;RENBP;CHST5;OGA;NAGK;CHST7
prerank,regulation of cellular catabolic process (GO:0031329),0.26392316588380405,0.7150947088486468,0.8848684210526315,0.9516549787162967,1.0,29/62,30.62%,MAPK15;OSBPL7;RAB8A;PIP4K2B;ABL1;ATM;USP33;WDR41;USP13;HDAC6;DAPK3;USP10;DCAF12;LRRK2;ABCD1;KAT8;RPTOR;SMCR8;ROCK1;SCARB2;LONP2;PIP4K2C;ABL2;CISD2;DRAM1;GPR137B;DRAM2;PRKN;KEAP1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.2921595773614803,0.7149074684681238,0.8409638554216867,0.9515118980351555,1.0,13/28,30.27%,CKAP5;GIT1;AKAP9;ARL2;SLAIN2;DCTN1;CDK5RAP2;MET;DRG1;FES;TOGARAM1;MECP2;RAC1
prerank,positive regulation of exocytosis (GO:0045921),0.28376628272271814,0.7138426087388543,0.8556085918854416,0.9523309871864833,1.0,9/35,28.49%,SDC1;RAB2B;RAB3D;STXBP5;SYTL4;PDCD6IP;CHMP2A;RAB5A;RAB3A
prerank,positive regulation of T cell differentiation (GO:0045582),0.2822890178579236,0.7137026075014529,0.8569753810082064,0.9521405198225154,1.0,2/36,2.48%,ZMIZ1;GLI2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3404815495510508,0.7135219554674409,0.810320781032078,0.9519893644126861,1.0,4/12,18.70%,FUT4;WNK1;MIA3;AKT1
prerank,negative regulation of protein depolymerization (GO:1901880),0.30253399351763677,0.7134800401669708,0.8464373464373465,0.9516838863497494,1.0,2/24,3.12%,FGF13;LIMA1
prerank,peptide hormone secretion (GO:0030072),0.2968523309146338,0.7129145009696997,0.8335329341317366,0.9519708993982596,1.0,6/26,23.62%,EDN3;ANXA1;VIP;IL6;RAB1A;FAM3B
prerank,protein targeting (GO:0006605),0.24978381135948566,0.7127572980253648,0.9105858170606372,0.9517841355587474,1.0,36/118,30.33%,LTBP2;SEC61A1;RABGEF1;TOMM40;GIPC1;TIMM9;PEX16;PEX1;BCAP31;ATG3;NLGN1;SPCS2;HPS4;TOMM70;HACL1;ZDHHC4;PEX6;ZFAND2B;ZDHHC20;LAMP2;PRKCI;ZDHHC9;TAOK2;TIMM17B;TIMM22;LONP2;KATNB1;PARD3;VPS37B;KIF13B;FIS1;SPCS1;SRPRA;ZFAND2A;PIKFYVE;SRP14
prerank,regulation of intracellular protein transport (GO:0033157),0.2916483366202236,0.7125935223824075,0.8440797186400938,0.951620904376934,1.0,12/32,28.34%,BCAS3;BMP4;TENM1;UHMK1;NDEL1;PCM1;KIF20B;ICE1;VAMP2;TPR;GCC2;B3GAT3
prerank,somite development (GO:0061053),0.33835136912006913,0.7118553468165215,0.8321775312066574,0.9520665817765853,1.0,3/11,16.73%,MEOX2;SMO;MTHFD1
prerank,lipid droplet formation (GO:0140042),-0.28467262806844124,-0.7117561510334653,0.8181818181818182,0.9748862385508271,1.0,1/10,2.46%,CDS2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.3298745908603963,0.7116006971535581,0.8175765645805593,0.9519972450585872,1.0,4/13,18.53%,MDFIC;CHP1;RAB23;SUFU
prerank,dendritic cell migration (GO:0036336),0.31788627016472826,0.7112284509284361,0.8235294117647058,0.9520510151791007,1.0,3/16,15.84%,HMGB1;TRPM4;CXCR4
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.23150313752327997,-0.7109970746612889,0.9342105263157895,0.9743211608326331,1.0,6/22,21.04%,ROCK2;PPP4R4;STYXL1;PTPA;PPP1R11;PPP1R15A
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.35121932493453784,0.7106785127559158,0.8128571428571428,0.9523098855348548,1.0,2/10,15.82%,AOC3;HDAC6
prerank,regulation of DNA damage checkpoint (GO:2000001),0.34852222202236693,0.7100508301086975,0.8194842406876791,0.9526521243274251,1.0,1/10,6.09%,CCAR2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.26784582518619454,0.7099795092383594,0.8825503355704698,0.9523827918398168,1.0,29/54,39.26%,RRS1;LAS1L;NLE1;NVL;MRTO4;EIF6;PPAN;BOP1;RPL7A;NOC2L;WDR12;GTF3A;PAK1IP1;RRP15;MAK16;NOP53;RPF2;RSL1D1;HEATR3;RPLP0;MALSU1;RPL3;RPL10A;MDN1;LTO1;RSL24D1;RPL5;PES1;MRPL20
prerank,glycolytic process (GO:0006096),-0.21600388581459162,-0.7091307655160937,0.9050279329608939,0.9748327722099128,1.0,5/28,11.13%,HK2;PGAM4;PGAM1;GPI;ALDOC
prerank,ncRNA processing (GO:0034470),0.2425386461670574,0.7089033086678126,0.9506545820745217,0.9532220892816314,1.0,56/200,27.93%,C1D;RRP7A;SSB;INTS3;PRKRA;HNRNPA2B1;LAS1L;EMG1;INTS4;WDR3;AGO1;NVL;DGCR8;WDR55;ESF1;RRP12;AGO2;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;BYSL;TUT7;ADAT1;DIS3;BOP1;SARS1;NOB1;RPL7A;MTREX;WDR12;ZCCHC8;NOP56;DDX49;FBL;SBDS;WDR36;WDR46;WDR75;RPP21;RPS9;TBL3;SENP3;UTP11;NOP58;PUS10;DKC1;INTS9;POP5;FCF1;NOP53;SRRT;RPL41;RPL30
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.3468401128352311,0.7075642839386808,0.8312236286919831,0.9543221057410936,1.0,2/10,12.37%,XDH;PIK3CB
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.3236153589144948,0.7066584663918054,0.8335607094133697,0.9549367325215542,1.0,6/16,34.35%,VTA1;CHMP4A;CHMP4B;TMEM50B;CHMP4C;TMEM50A
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.2700964396040516,-0.706324009470638,0.8378378378378378,0.9763700016246916,1.0,4/12,12.94%,PIK3R1;BOK;BCL2L11;PTPN1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.238597020291066,-0.7058723071791174,0.9023255813953488,0.9739448188981095,1.0,6/19,17.18%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.238597020291066,-0.7058723071791174,0.9023255813953488,0.9739448188981095,1.0,6/19,17.18%,POLR2G;POLR2E;POLR2C;TERF2IP;POLR2D;POLR2A
prerank,protein localization to condensed chromosome (GO:1903083),0.3341537787202831,0.7053369658256518,0.8354080221300139,0.9560466067665772,1.0,3/12,16.57%,MIS12;ZW10;IK
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.1979417887121514,-0.7049668343702339,0.9548387096774194,0.9734329211406755,1.0,16/40,22.04%,BCL2L1;DNM1L;PDCD5;GHITM;FAM162A;BCL2L11;MFF;GPX1;IGF1;OPA1;GPER1;PYCARD;BIK;PRELID1;PPIF;BNIP3
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.27974708688093014,0.7043139843410547,0.8720095693779905,0.9568330918748296,1.0,9/35,14.02%,SCD5;AACS;HMGCL;CBR4;FAR1;PPT2;ACAT1;ACACA;BDH2
prerank,"wound healing, spreading of cells (GO:0044319)",0.2916553545903726,0.7042547833005476,0.8381430363864492,0.9565482632454022,1.0,4/24,17.44%,TMEFF2;RHOA;DDR1;CD151
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3099459639543854,0.7041452899755622,0.8369426751592357,0.9563247640015414,1.0,8/18,27.67%,CHP1;CCT4;CCT6A;CCT8;TCP1;PTP4A3;DKC1;CCT5
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.32732338157489343,0.704087251026553,0.8270571827057183,0.9560381472738926,1.0,5/13,22.45%,LPCAT3;MANF;USP19;CLU;EIF2AK3
prerank,regulation of lamellipodium organization (GO:1902743),-0.25896164228765145,-0.7019200225262204,0.861003861003861,0.9752140713572038,1.0,14/14,74.13%,CDC42;CAPZB;CD44;CARMIL2;VIL1;PDPN;EPHA2;DMTN;FER;TWF2;CARMIL1;RAC1;WAS;TWF1
prerank,apical junction assembly (GO:0043297),0.26657540171617217,0.7018896928179517,0.876265466816648,0.9580613745919973,1.0,17/53,26.52%,MPP7;RAMP2;DLG1;RHOA;PKN2;PAK2;CLDN11;ARL2;MICALL2;TBCD;WDR1;CLDN15;PDCD6IP;PRKCI;AFDN;FBF1;PARD3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.31030757484711174,0.7011500325543589,0.8440721649484536,0.9585106167174627,1.0,10/18,40.59%,ANXA1;NR3C1;KLF9;HNRNPU;ZFP36L1;SSTR2;FAM107A;PCK2;UBE2L3;REST
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2307172465237952,-0.7007092220145538,0.8737864077669902,0.9750105521032681,1.0,7/21,19.49%,BCL2L1;BOK;BCL2L11;OPA1;HSPA1A;XBP1;CREB3
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2840645201782464,-0.7005548586271709,0.843558282208589,0.9737164364162241,1.0,10/10,71.62%,APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;ABCA2;NFKB1;SREBF2
prerank,positive regulation of exosomal secretion (GO:1903543),0.3245172091222812,0.7004502253386747,0.8446866485013624,0.9588963192597286,1.0,1/15,3.15%,SDC1
prerank,protein ADP-ribosylation (GO:0006471),0.2848887670321435,0.7001376013613765,0.8623629719853837,0.9588946200416344,1.0,6/28,16.21%,PARP3;SIRT5;ARF4;TNKS2;SIRT2;PARP1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.2883043867343667,0.6990081811014777,0.8633004926108374,0.9597300454748258,1.0,5/25,20.81%,TWIST1;NSD1;HEY1;TRIM6;MAD2L2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.18466030247332438,-0.6986526951235226,0.9693877551020408,0.9742426520510112,1.0,9/57,12.44%,KDR;DNM1L;HIP1R;PDCD5;PPARGC1A;BOK;FAM162A;BCL2L11;MFF
prerank,regulation of interferon-beta production (GO:0032648),0.2646456612871622,0.6986178656254058,0.8708189158016147,0.9597734043509846,1.0,17/46,32.37%,PTPRS;MAVS;TRAF3;TOMM70;IRF3;RNF216;TBK1;PTPN11;YY1;RIPK2;PPM1B;RNF135;HSP90AA1;LILRB1;RIOK3;POLR3F;IFIH1
prerank,positive regulation of cytokine production (GO:0001819),0.23450788050587573,0.6984430418834583,0.985985985985986,0.9596233831954617,1.0,54/292,22.65%,FOXP1;LBP;F3;IL33;TWIST1;RAB7B;CYP1B1;GLMN;STAT3;ATF4;MAVS;PRKDC;IL12RB2;HMGB1;SULF1;POLR3H;TRIM27;RARA;FZD5;FCER1G;RORA;ANXA1;CRTAM;IRAK1;C1QTNF4;SOD1;KAT2A;CRCP;HSPD1;F2R;CD80;RUNX1;POLR3GL;SETD4;POLR2F;IL6;CREBBP;SPTBN1;NFKB2;HMOX1;TRIM6;SULF2;XRCC6;IRF3;POLR3K;APPL1;IL17RA;IL4;DRD2;RAB1A;TLR1;POLR1C;EIF2AK3;SLC11A1
prerank,innate immune response (GO:0045087),0.23647103127237468,0.6981635875165241,0.9728370221327968,0.9595771815071227,1.0,40/217,23.23%,LBP;COLEC11;TNK1;TRIM28;RNASE7;MAVS;HMGB1;IFNLR1;CXCL16;RNASE3;TRIM27;S100B;FCER1G;RNASE6;CHUK;ALPK1;IRAK1;MID2;DEFB1;SRMS;TRIM26;FRK;SRPK1;COLEC12;CYP27B1;OTULIN;SHMT2;TRIM13;TRIM6;DMBT1;CAPZA1;IL4;TRIM43;CD300LB;SHFL;TRIM8;SETD2;SLC11A1;VNN1;CYLD
prerank,glycoprotein catabolic process (GO:0006516),0.3136372417669719,0.6977736933302767,0.8498659517426274,0.9596317858964509,1.0,7/17,28.41%,EDEM2;NGLY1;FBXO17;OGA;ADAMTS9;MANBA;STT3B
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.29634982316116387,0.6971024075204184,0.8716049382716049,0.9599874705915872,1.0,7/25,20.87%,ARAP1;AGR2;CBL;HIP1;CNOT9;AKT1;NUP62
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3123122261428064,0.6969913324301296,0.8392857142857143,0.9597477577170596,1.0,7/16,29.83%,HASPIN;NIPBL;POGZ;PDS5A;SMC1A;MAU2;PDS5B
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.26059170941868964,0.6969857957165253,0.8896174863387978,0.9594039359546686,1.0,16/59,28.84%,ABCD3;ACSF3;OSBPL7;CBR4;OSBP;ACACA;SRR;HSD17B8;SLC27A2;HSD3B7;MCAT;ACOT8;HOGA1;PER2;ACLY;SCP2
prerank,positive regulation of vasoconstriction (GO:0045907),0.32892489996901997,0.6962076939562154,0.8202247191011236,0.9598686282755388,1.0,2/13,13.07%,TRPM4;F2R
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.2862323892225791,0.6959856540234045,0.8609022556390977,0.9597562230228791,1.0,4/25,13.07%,DRD1;ANK2;PDPK1;F2R
prerank,protein-containing complex subunit organization (GO:0043933),0.24543848955552158,0.6957316570365534,0.9367219917012448,0.9596789843995721,1.0,35/109,26.88%,HES5;CD3E;GPAA1;SEH1L;SPG7;LLGL1;MDM4;SOX9;DLG4;ST13;WIPF1;SNX9;SHANK1;ZW10;CREBBP;KPNA3;EPRS1;TEAD2;DARS1;CAPZA1;REPS2;NDC1;KMT2A;PEX14;NUP35;AFG3L2;NIFK;DET1;TP53;VAMP2;PPID;TPR;PARD3;PPP2R1A;WAS
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.23771582966308832,0.6955627709429419,0.954728370221328,0.9595023705249424,1.0,32/168,21.06%,RPSA;DDX5;PABPC1;SAMD4A;CASC3;TENT4B;THRAP3;PNRC2;SMG6;GSPT1;SMG1;AGO1;DIS3L2;ATM;PATL1;EIF4G1;ETF1;XRN1;EXOSC4;MRTO4;CNOT8;RPS27A;TUT7;CNOT10;RC3H2;NCBP1;NCBP2;CNOT9;RPL7A;TNKS1BP1;PYM1;TENT2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3190572264439275,0.6953315408793188,0.8358413132694938,0.9594007024847288,1.0,1/14,1.81%,YBX3
prerank,negative regulation of cell cycle (GO:0045786),0.250234611364879,0.6952388942836322,0.9078947368421053,0.9591567536772091,1.0,15/73,19.69%,PDCD4;PTPN3;GAS1;IPO5;BMP4;TAF6;INHBA;HEXIM1;RHOB;CAMK2N1;LATS2;CDKN1C;MEN1;HECA;GMNC
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.24166067671542044,0.6951117320891324,0.9427083333333334,0.9589415147857905,1.0,21/117,20.97%,GPR27;DRD1;FSHR;RAMP2;ADCY2;ADCY8;ADCY9;GPR20;IAPP;RAMP1;VIP;GLP1R;MC4R;PTGDR;IL6;CREB1;CALCA;ADCY7;PRKACA;GNB1;PRKAR2A
prerank,regulation of secretion (GO:0051046),-0.25924459740151407,-0.6949561235702271,0.8380281690140845,0.9765262823951915,1.0,7/13,30.34%,MYO6;OAS2;ERBB3;KCNQ1;NRG1;OPRK1;GPLD1
prerank,indolalkylamine catabolic process (GO:0046218),0.3405391633153786,0.6937346091895344,0.8453757225433526,0.9599814206739481,1.0,2/10,20.64%,IDO2;KYAT1
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2538284030977865,-0.6921790091564344,0.8614232209737828,0.9778428886459257,1.0,6/15,20.67%,CPEB2;DDX3X;ZC3H12A;ZFAND1;ATF3;PPIF
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.22658793410780068,-0.6918832918795432,0.9140271493212669,0.9767176188528185,1.0,7/22,19.57%,BMP7;DYNLL1;PLEK;ANKLE2;SIRT1;CDKN2C;CDKN2D
prerank,positive regulation of T cell proliferation (GO:0042102),-0.17891114285806528,-0.6918611614919935,0.9807692307692307,0.9752896906655053,1.0,12/55,20.97%,IGFBP2;TFRC;VCAM1;SLC7A1;CD274;SYK;IGF1;PYCARD;RPS3;CD276;AGER;CCR2
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2437772516331973,0.6915496564954718,0.9331210191082803,0.9618845977674029,1.0,20/94,16.53%,PSMD7;PSMA8;IRAK3;RPS6KA4;PSMA4;CHUK;IRAK1;TAB2;PSMD12;CUL1;PSMA6;SQSTM1;PSMD1;MAP3K3;PSMC5;PSMD11;PSMC4;PSMD14;RPS27A;UBC
prerank,serine family amino acid biosynthetic process (GO:0009070),0.32950466693228,0.6915328895881164,0.8309037900874635,0.9615567614900075,1.0,5/12,20.13%,SRR;PHGDH;MTHFD1;PSAT1;SEPHS2
prerank,protein lipidation (GO:0006497),0.25092240392660337,0.6911476332169125,0.9097995545657016,0.9615706996564332,1.0,14/59,26.69%,PIGW;WIPI2;PIGF;ZDHHC16;HHAT;PIGL;PGAP2;ZDHHC13;ZDHHC20;DPM3;PIGV;ZDHHC9;PIGQ;PIGB
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.24044387455792515,0.6910400627589431,0.934375,0.9613301001479899,1.0,21/116,20.97%,GPR27;DRD1;FSHR;RAMP2;ADCY2;ADCY8;ADCY9;GPR20;IAPP;RAMP1;VIP;GLP1R;MC4R;PTGDR;IL6;CREB1;CALCA;ADCY7;PRKACA;GNB1;PRKAR2A
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.23439176026939842,0.6893777321500154,0.969758064516129,0.9626829594145334,1.0,59/208,28.50%,ESR1;CARD16;MAVS;BRD4;TRIM27;S100B;RHOA;SHARPIN;RORA;ROR1;LTBR;MAPKBP1;CHUK;ALPK1;IRAK1;TAB2;PDPK1;TNFRSF10B;MID2;TRAF3;TANK;F2R;CASP1;SQSTM1;AKAP13;PER1;ZDHHC13;MAP3K3;TRAF3IP2;UFL1;TRIM13;HMOX1;TRIM6;USP10;ZMYND11;IKBKE;CC2D1A;NUP62;OPTN;MUL1;MIER1;TRIM8;BIRC3;MAP3K14;TBK1;PINK1;TRADD;TFG;RIPK1;TMEM106A;NDFIP1;RIPK2;NEK6;CANT1;UBE2V1;PPM1B;GPR89A;SPHK2;NR1D1
prerank,regulation of humoral immune response (GO:0002920),0.2674016454918958,0.6891029300644371,0.8888888888888888,0.9626010059040827,1.0,7/44,20.48%,CFH;C9;C8B;SERPING1;C8G;CPB2;CLU
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2830114495339097,0.6888419542445287,0.8669950738916257,0.9625237933953446,1.0,2/27,4.14%,SYT8;ARHGAP17
prerank,positive regulation of mitochondrial fission (GO:0090141),0.30309651663578707,0.6882551488173221,0.8496042216358839,0.9627601958043543,1.0,8/18,30.35%,MIEF2;MCU;MUL1;PINK1;RALA;FIS1;PRKN;MIEF1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.30112757085007036,0.6877366444982284,0.8486005089058524,0.9629536028407881,1.0,3/18,16.62%,MCMDC2;GINS4;MCM4
prerank,rRNA processing (GO:0006364),0.23610179951333363,0.6876723526980036,0.9675785207700102,0.9626716553357516,1.0,62/172,32.65%,C1D;PRKDC;RRP7A;LAS1L;EMG1;SRFBP1;WDR3;RIOK1;NVL;WDR55;ESF1;RRP12;NOLC1;UTP14A;DCAF13;EXOSC4;NOC4L;MRTO4;EIF6;BYSL;DIS3;BOP1;NOB1;RPL7A;TSR3;MTREX;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;WDR46;WDR75;RPS9;TBL3;SENP3;RIOK2;UTP11;NOP58;RRP15;DKC1;MAK16;POP5;FCF1;NOP53;RPL41;RPL30;ERI1;PIH1D2;THUMPD1;EXOSC2;RIOK3;RPL27;RPL37A;RRP1B;NOP14;UTP3;RPL36A;EXOSC3;MPHOSPH6;UTP4
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.32727142241131846,0.6875141301364065,0.8569424964936886,0.9624884443782101,1.0,1/12,2.60%,DPYSL3
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2458689252561352,-0.6872908709792644,0.8852459016393442,0.9782434426492169,1.0,3/18,12.07%,PIK3R1;BOK;BCL2L11
prerank,diol biosynthetic process (GO:0034312),0.31454461722520083,0.6871841717859709,0.8415300546448088,0.9624750397340438,1.0,1/15,1.74%,ACER3
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.2475634750271532,-0.6871022372872302,0.875,0.9770244009030273,1.0,3/16,9.15%,KLK2;ACE;BMPR2
prerank,hematopoietic stem cell differentiation (GO:0060218),0.33800946531074383,0.6870224090493479,0.847672778561354,0.9622776581583754,1.0,4/10,24.29%,HOXB4;MLLT3;UFL1;TP53
prerank,determination of left/right symmetry (GO:0007368),0.2671563277820521,0.6869936665882553,0.8840236686390532,0.9619597214702954,1.0,11/36,28.53%,ODAD2;CCDC39;SMO;NPHP3;DNAAF4;CITED2;LEFTY1;PKD1L1;BBS7;ENKUR;STIL
prerank,negative regulation of neuron differentiation (GO:0045665),0.2921333077392594,0.6868952876361096,0.8746770025839793,0.9617019822014375,1.0,6/22,20.37%,HES5;SOX9;HEY1;NEPRO;EIF2AK4;CALR
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.29900363043731787,0.6863068765037676,0.8771241830065359,0.961940511540738,1.0,5/20,23.25%,LONP1;HSPD1;PTGES3L;CLU;PSMG2
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.2802453949115341,0.686199925032624,0.8734335839598998,0.9616958829893942,1.0,2/26,3.46%,ACER3;CYP1B1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2871772622774196,0.685556481187448,0.875,0.9620081349883756,1.0,8/24,27.75%,ITCH;IRAK1;TAB2;RPS27A;UBC;CYLD;RIPK2;UBE2V1
prerank,sterol metabolic process (GO:0016125),0.2544320052918885,0.685541331634142,0.8984198645598194,0.9616776011249563,1.0,20/60,30.60%,CYP19A1;CYP1B1;SOAT1;RXRA;TSKU;NSDHL;FDXR;ABCA1;EBP;SC5D;IL4;STARD3;APOF;HMGCR;ANGPTL3;SOAT2;OSBPL5;SQLE;INSIG1;OSBPL1A
prerank,UV-damage excision repair (GO:0070914),-0.26564559663549053,-0.6845955439520665,0.8953068592057761,0.9777966708602027,1.0,12/12,73.46%,ACTR5;SIRT1;INO80;MC1R;DDB2;POLA1;XPC;POLD3;CUL4B;ERCC1;DDB1;XPA
prerank,T cell activation involved in immune response (GO:0002286),0.32493152152236854,0.6821503815663886,0.8361581920903954,0.964685482406241,1.0,4/12,22.65%,FCER1G;EIF2AK4;TNFSF18;SLC11A1
prerank,fatty acid transmembrane transport (GO:1902001),0.29981741585086275,0.6820703233362123,0.8713910761154856,0.9644129859157647,1.0,1/19,0.93%,ABCD3
prerank,cellular response to dsRNA (GO:0071359),0.30918136992800727,0.681756350201259,0.8315789473684211,0.9643602528019458,1.0,7/15,34.60%,MAVS;COLEC12;MUL1;CGAS;RIOK3;IFIH1;DHX9
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.32117855338707546,0.681652126267388,0.8467852257181943,0.9641106269671676,1.0,3/13,13.71%,CD9;FCER1G;ABCA1
prerank,cellular response to UV-A (GO:0071492),0.3313396900782717,0.6809970353476624,0.856338028169014,0.9644252736247042,1.0,4/11,30.12%,OPN3;MMP2;PPID;TIMP1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.2782361028938509,0.6807100164213763,0.8722627737226277,0.9643432535203982,1.0,4/30,15.25%,STAT3;HMGB1;HSPD1;IL6
prerank,regulation of innate immune response (GO:0045088),-0.17756306176897935,-0.6802493253249802,0.9827586206896551,0.9803165207144108,1.0,11/57,13.76%,IFNAR2;SAMHD1;USP18;GBP5;RNASEL;TRIM21;DHX58;CACTIN;PTPN1;TNFAIP3;LRP8
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.29586908146040314,0.6799998848203409,0.8608247422680413,0.9646908536355423,1.0,2/19,3.65%,CUX1;FBXW8
prerank,regulation of nuclear division (GO:0051783),0.2938935857121333,0.6797833065448837,0.8600508905852418,0.9645551658753012,1.0,8/20,29.56%,RCC1;DAPK3;KIF20B;CUL9;CDK13;CCDC8;CUL7;PRMT5
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.33221144780090806,0.6796911532663666,0.8522895125553914,0.9642894773663575,1.0,2/10,16.78%,KCNE5;SUMO1
prerank,replicative senescence (GO:0090399),0.33085758181947933,0.6794898040728996,0.869198312236287,0.9641386679406748,1.0,3/12,11.36%,TERT;ATM;CHEK2
prerank,mitochondrial membrane organization (GO:0007006),-0.2058437753322505,-0.6789716479763818,0.9263803680981595,0.9800351033608039,1.0,10/32,22.04%,BCL2;BCL2L1;CHCHD3;GHITM;MTX2;OPA1;MFN2;PPIF;SAMM50;BNIP3
prerank,spliceosomal snRNP assembly (GO:0000387),0.2712571232992759,0.6788229769734592,0.9031877213695395,0.9644383406570666,1.0,14/38,32.69%,SNUPN;LSM2;GEMIN7;SMN1;SRSF10;SNRPB;GEMIN2;WDR77;USP4;DDX20;SNRPF;PRMT5;SART3;TGS1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.27867100254279303,0.6784691921957906,0.8736591179976162,0.9644443213242443,1.0,7/32,16.85%,PRKCD;CALM2;SYMPK;CNEP1R1;PTBP1;NSMF;CALM3
prerank,mismatch repair (GO:0006298),0.27992142550111454,0.6782482992934856,0.8813131313131313,0.9643207430300643,1.0,9/27,32.95%,ABL1;TDG;PMS2;MSH4;SETD2;POLD1;MSH2;ERCC1;RPA3
prerank,negative regulation of dephosphorylation (GO:0035305),0.29928211729453447,0.6781554288132255,0.8677248677248677,0.9640705993108146,1.0,8/18,24.66%,PPP1R8;ZCCHC9;URI1;CHP1;ARPP19;PPP1R35;PPP1R36;YWHAB
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3248807431584234,0.6778148546053541,0.844319775596073,0.9640553067094181,1.0,11/11,67.53%,PKD2L1;RTP4;LPO;RTP2;PKD1L3;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;RTP3
prerank,ribosomal large subunit assembly (GO:0000027),0.28770727693419756,0.6777365017632742,0.8689740420271941,0.9637851159160108,1.0,4/24,17.46%,RRS1;NLE1;PPAN;BOP1
prerank,protein acylation (GO:0043543),0.26307090188821103,0.6769237986483793,0.8955399061032864,0.9642068689461845,1.0,10/38,23.44%,ING5;ZDHHC16;KAT2A;HHAT;ING4;ZDHHC13;CREBBP;ZDHHC20;ZDHHC9;KAT2B
prerank,macrophage chemotaxis (GO:0048246),-0.26981736019582,-0.6767815488891316,0.8306188925081434,0.9805908340284293,1.0,10/10,73.04%,EDNRB;TAFA4;CCL5;CCL3;EDN2;SAA1;CXCL17;LGALS3;CKLF;CCL2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3307982564510461,0.6767600188273974,0.8581560283687943,0.9640151947852366,1.0,4/10,26.37%,WWP2;DNAJA1;SNX3;NDFIP1
prerank,cellular response to interferon-beta (GO:0035458),-0.24787390743603696,-0.6767056686603878,0.9074074074074074,0.9792108769430242,1.0,3/14,13.59%,STAT1;AIM2;NDUFA13
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.2603892027620841,-0.6764243006741499,0.8888888888888888,0.9780475505367255,1.0,13/13,73.99%,NECTIN2;FADD;IL12A;IL12RB1;IL23A;IL23R;IL12B;XCL1;PVR;SLC22A13;MR1;STX7;CYRIB
prerank,regulation of gastrulation (GO:0010470),0.31724605450723886,0.6761096096398548,0.8700947225981055,0.964288768169489,1.0,2/14,6.18%,PHLDB1;POGLUT1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30880825878966534,0.6759139940335778,0.8702702702702703,0.9641370745418538,1.0,4/15,27.97%,IDO2;GSTZ1;KYAT1;HGD
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2956134105233478,0.6749778221435551,0.8634590377113134,0.9646766059492989,1.0,4/18,15.25%,STAT3;SMAD4;CBL;IL6
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2768933900542233,0.6746871320353518,0.8757687576875769,0.9645953209276965,1.0,11/31,31.91%,EPHB2;KMT5C;CLCF1;STX4;IL6;MAD2L2;SHLD3;SHLD1;HMCES;PTPRC;SASH3
prerank,regulation of keratinocyte differentiation (GO:0045616),0.283920869098831,0.6746351669889721,0.8725,0.9642982300177942,1.0,7/24,24.47%,SRSF6;RUNX1;VDR;CYP27B1;CBFB;CTSK;ROCK1
prerank,snRNA 3'-end processing (GO:0034472),0.2949555261357827,0.6746240079753971,0.8604651162790697,0.9639615356924971,1.0,7/19,32.29%,INTS14;EXOSC4;TOE1;INTS7;INTS6;EXOSC2;EXOSC3
prerank,intracellular lipid transport (GO:0032365),0.29108288326051296,0.6740494790350547,0.8821192052980132,0.9641531622020629,1.0,1/21,0.93%,ABCD3
prerank,vesicle transport along microtubule (GO:0047496),0.28723104024971663,0.6739716218457874,0.8748435544430538,0.9638810591475415,1.0,2/23,4.82%,KIF13A;DYNC1H1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.3257439683639346,0.6739043105372439,0.8633879781420765,0.9635953007625332,1.0,2/12,12.01%,PRKCA;CNEP1R1
prerank,negative regulation of viral genome replication (GO:0045071),0.26171221473711814,0.673014553086785,0.9184397163120568,0.9640964041183412,1.0,10/40,22.17%,MAVS;ILF3;RESF1;SETDB1;SRPK1;N4BP1;TRIM6;MPHOSPH8;SHFL;TASOR
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.3155921657018135,0.6728571392402558,0.8684582743988685,0.9638991337430561,1.0,2/13,12.70%,PABPC1;AGO2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.2800863189689703,0.6719324143870178,0.8835192069392813,0.9644409209668604,1.0,2/25,5.58%,MPP2;RAB3GAP1
prerank,mitochondrial fission (GO:0000266),-0.24039082673016943,-0.6717111617553415,0.8894009216589862,0.9807085380608063,1.0,5/16,17.26%,DNM3;DNM1L;MFF;OPA1;MTFR2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.2797939298001066,0.6713456197981663,0.8903061224489796,0.9646482789648959,1.0,5/27,15.25%,NFAT5;RHOA;IRAK1;HSPD1;IL6
prerank,response to exogenous dsRNA (GO:0043330),0.295952824150173,0.6711193222950614,0.8633377135348226,0.9645339721054916,1.0,6/18,26.35%,MAVS;IRAK3;COLEC12;MUL1;SLC3A2;CGAS
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.27408998605165275,0.6709255155338059,0.8897058823529411,0.9643623406817426,1.0,5/28,11.90%,MAP3K5;ATF4;ERN2;AIFM1;TNFRSF10B
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.30464750221693315,0.6703937765465069,0.8773841961852861,0.9645269973871327,1.0,3/15,13.53%,SAT2;SMOX;SRM
prerank,lipid homeostasis (GO:0055088),0.2508000061454921,0.6703189450858859,0.9288888888888889,0.9642545704825656,1.0,17/57,26.43%,ACOXL;TLCD2;ACOX3;NR1D2;ABCA1;PNPLA3;THADA;ORMDL3;TLCD1;MLXIPL;RCN3;ORMDL1;ABCD1;TM6SF2;FITM2;POLD1;ANGPTL3
prerank,regulation of defense response to virus by host (GO:0050691),0.27238685843985383,0.6700278568730517,0.8833535844471446,0.9641975570736563,1.0,9/30,23.03%,MAVS;IFNLR1;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;MUL1;RNF216
prerank,histone H2A monoubiquitination (GO:0035518),0.29372934441100285,0.6695343601139909,0.8546895640686922,0.9643281267461962,1.0,4/17,18.27%,RNF2;RING1;PCGF2;RYBP
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.22079495533390145,-0.6676320121113832,0.9285714285714286,0.9829005030266998,1.0,6/21,18.53%,KDR;LGALS9;IGF1;HTR2B;MT3;MAPK3
prerank,microtubule depolymerization (GO:0007019),0.2991981286443974,0.6670021749044956,0.8683510638297872,0.9663223966307961,1.0,4/17,20.56%,STMND1;CKAP5;KIF24;STMN2
prerank,neuron maturation (GO:0042551),0.2906606209029211,0.6656872924769538,0.8834827144686299,0.9672010481583521,1.0,4/18,14.86%,LGI4;B4GALT5;PICK1;FARP2
prerank,regulation of dopamine secretion (GO:0014059),0.2781576139103671,0.6650689887073657,0.8813982521847691,0.9674364547379005,1.0,2/25,6.91%,SYT8;CHRNB2
prerank,negative regulation of reproductive process (GO:2000242),0.29723661192495254,0.6647860473645822,0.8677462887989204,0.9673282367593695,1.0,7/17,33.67%,SULF1;WEE2;CALR;WDR77;ARHGDIB;TIMP1;HYAL3
prerank,regulation of lipid catabolic process (GO:0050994),-0.2265302418304906,-0.6646723399312481,0.9453781512605042,0.9839905409683263,1.0,6/19,23.25%,ADRA2A;PRKAA1;BSCL2;TYSND1;ALK;APOC1
prerank,amide biosynthetic process (GO:0043604),0.2514792094644927,0.6644617217130778,0.9160045402951191,0.9672879149596418,1.0,4/47,8.39%,PCSK5;SMPD4;DMD;NANP
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.27527885803619506,0.6641945453286977,0.893167701863354,0.9671992470199727,1.0,4/25,15.61%,LRPAP1;DLG4;ITGAV;WDR54
prerank,sensory perception of pain (GO:0019233),0.28396599574129094,0.6633817710884912,0.8774193548387097,0.9675712745722758,1.0,2/21,6.91%,PROK2;CHRNB2
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.25389862928939994,0.6601967722786558,0.9176334106728539,0.9700943646771881,1.0,8/42,18.36%,VCP;FAAP20;WRN;UBE2L6;RPS27A;UBC;REV1;USP10
prerank,cellular response to exogenous dsRNA (GO:0071360),0.31380239679839356,0.6596356783681002,0.8636995827538247,0.9702545254274738,1.0,6/12,34.60%,MAVS;COLEC12;MUL1;CGAS;IFIH1;DHX9
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.32503585023427695,0.6595334772900561,0.8797736916548797,0.9699974469622378,1.0,3/11,24.88%,TIMM9;TOMM70;TIMM22
prerank,primary alcohol metabolic process (GO:0034308),0.2767202748655312,0.6594408501062585,0.9007444168734491,0.9697458377536781,1.0,5/25,18.75%,CYP1B1;DHRS9;ALDH3A2;GDPD3;DHRS3
prerank,receptor recycling (GO:0001881),0.33008866469822606,0.6594343099673576,0.8587896253602305,0.9694094903393019,1.0,4/10,24.66%,RAB11B;PHETA2;ARFGEF2;LMTK2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.18030088656535836,-0.6592836955550925,0.9851851851851852,0.9869601514840095,1.0,4/44,6.28%,CYP7B1;PRKAG2;CYP27A1;INSIG2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3231227751900508,0.6590424120082865,0.867816091954023,0.9694122219576491,1.0,1/11,2.13%,MUC1
prerank,acetyl-CoA metabolic process (GO:0006084),0.3053775224763492,0.6587391224727926,0.863031914893617,0.9693512213904997,1.0,5/15,28.48%,ACAT1;ACACA;HMGCS2;PPCS;ACLY
prerank,regulation of interleukin-10 production (GO:0032653),-0.1853076494560026,-0.6581884612358402,0.987012987012987,0.9864196911287612,1.0,13/44,20.77%,TNFRSF21;CD274;SYK;LGALS9;CD34;PRKCZ;TYROBP;NOD2;CD47;PYCARD;DLL1;ISG15;AGER
prerank,cholesterol metabolic process (GO:0008203),0.2414773685099016,0.6578753055972222,0.9299781181619255,0.9697928861241605,1.0,24/68,33.68%,SOAT1;CEL;RXRA;TSKU;NSDHL;ABCA1;LSS;EBP;IL4;STARD3;APOF;HMGCR;ANGPTL3;SOAT2;ACAT2;OSBPL5;ACLY;SQLE;INSIG1;OSBPL1A;GGPS1;GBA2;TM7SF2;PLPP6
prerank,regulation of histone acetylation (GO:0035065),0.2627771513790139,0.6566280479663618,0.905727923627685,0.9705333125627847,1.0,9/33,22.61%,TADA2A;RPS6KA4;SETD5;ARRB1;FLCN;THAP7;NOC2L;CAMK1;KMT2A
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.27489740759811165,-0.6562903227726723,0.8870967741935484,0.9865115077301672,1.0,4/10,17.08%,PRKCQ;ZBTB7B;LGALS9;CD55
prerank,meiosis I (GO:0007127),0.2811036634387764,0.6558977105921142,0.8938618925831202,0.970836721771897,1.0,3/23,18.60%,FOXJ3;HSF2BP;BRDT
prerank,regulation of adaptive immune response (GO:0002819),0.29146320362235056,0.6555395740881952,0.8858974358974359,0.9708108159882137,1.0,4/18,19.92%,TRIM27;RIPK3;ADCY7;EIF2AK4
prerank,positive regulation of histone methylation (GO:0031062),0.2802799247157475,0.6547154451691806,0.9,0.9711845601004301,1.0,5/24,12.23%,PHF1;SMAD4;OGT;CHTOP;WDR5
prerank,regulation of response to oxidative stress (GO:1902882),-0.2675363370390856,-0.6542650199751318,0.8782287822878229,0.9866593684864662,1.0,1/11,1.66%,MCTP1
prerank,histone monoubiquitination (GO:0010390),-0.20644568522408754,-0.6540426252064934,0.9726027397260274,0.9854099522706103,1.0,6/24,16.69%,BCOR;SKP1;RNF40;UBE2E1;LEO1;CTR9
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.26731830192420214,0.6539555786868887,0.9008894536213469,0.9715148236206657,1.0,11/28,31.49%,ITCH;IRAK1;TAB2;RPS27A;UBC;OTULIN;CYLD;RIPK2;UBE2V1;IRGM;UBE2N
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2589920465035685,0.6537910615499067,0.9085439229843562,0.9713222224921322,1.0,7/36,14.34%,TCF7L2;PDE6A;FZD5;NFATC1;AGO1;AGO2;GNAO1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.27077209505993705,0.6526600947617486,0.9010152284263959,0.9719415164570573,1.0,6/26,22.34%,IRAK3;LRRC14;APPL2;APPL1;GPS2;BIRC3
prerank,regulation of mitochondrial fission (GO:0090140),0.2726033310720779,0.6526521325481447,0.8952618453865336,0.9716046466553518,1.0,10/24,30.35%,MIEF2;MCU;MUL1;LRRK2;PINK1;CYRIB;RALA;FIS1;PRKN;MIEF1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.2834184229630103,0.6525528082121906,0.8875,0.9713371337028086,1.0,1/21,1.12%,FGF13
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.17349730345065684,-0.6524066592428261,0.9809523809523809,0.9852797183174997,1.0,7/53,11.67%,CALCRL;HTR2C;HTR4;OPRM1;CNR1;MC5R;CHRM3
prerank,mitochondrial transport (GO:0006839),0.2468437854286102,0.6522221790226155,0.9325842696629213,0.9712760418883809,1.0,14/53,24.88%,FLVCR1;SPG7;TOMM40;TIMM9;BCAP31;TOMM70;TMEM14C;BCS1L;COX18;STARD3;ABCB10;BAD;TIMM17B;TIMM22
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.22555644388707677,0.6499237192121057,0.976482617586912,0.9728467415743656,1.0,17/152,15.23%,GNAS;DRD1;FSHR;ADGRL2;RAMP2;ADCY2;ADCY8;ADCY9;IAPP;RAMP1;VIP;GLP1R;MC4R;ABCA1;GPR12;GNAO1;GNA11
prerank,retinol metabolic process (GO:0042572),0.3034558826054622,0.6489387714437849,0.8825966850828729,0.9733270163479583,1.0,3/14,18.75%,CYP1B1;DHRS9;DHRS3
prerank,negative regulation of histone acetylation (GO:0035067),-0.2625033887402669,-0.6480949856841579,0.8896551724137931,0.9870192377351055,1.0,6/11,27.72%,SIRT1;SNCA;BRCA1;TAF7;SIN3A;SET
prerank,positive regulation of translational initiation (GO:0045948),0.2874448924932308,0.64791287233166,0.8782383419689119,0.97386160986063,1.0,6/18,28.60%,CDC123;KHDRBS1;UHMK1;RPS6KB1;YTHDF1;LARP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.26306778205983805,0.6478616594186418,0.9317904993909866,0.9735601500765808,1.0,12/31,25.91%,PPP3CC;MAPK8;YWHAE;YWHAQ;TFDP1;E2F1;BID;SFN;TP53;BAD;YWHAB;NMT1
prerank,rRNA metabolic process (GO:0016072),0.2226461383944942,0.6475181282757317,0.9725888324873097,0.9735039854382063,1.0,55/160,32.65%,C1D;RRP7A;ERN2;LAS1L;EMG1;WDR3;NVL;WDR55;ESF1;RRP12;NOLC1;UTP14A;DCAF13;XRN1;EXOSC4;NOC4L;MRTO4;BYSL;DIS3;BOP1;NOB1;RPL7A;MTREX;WDR12;NOP56;DDX49;FBL;SBDS;WDR36;NIFK;WDR46;WDR75;RPS9;TBL3;SENP3;UTP11;NOP58;DKC1;POP5;FCF1;NOP53;RPL41;RPL30;DEDD2;PIH1D2;EXOSC2;RPL27;RPL37A;RRP1B;NOP14;UTP3;RPL36A;EXOSC3;MPHOSPH6;UTP4
prerank,B cell differentiation (GO:0030183),0.25098481385153154,0.6465667205924864,0.9324796274738067,0.9739413538522171,1.0,9/46,20.97%,HDAC9;HDAC4;SYVN1;PTPN2;CLCF1;TCF3;TPD52;GPS2;IL4
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.26372936672315317,-0.6447972260613614,0.8940397350993378,0.9880406565017262,1.0,10/10,73.65%,ZFP57;PCGF5;CTCFL;DNMT3L;PRMT7;KDM1B;PCGF3;MECP2;DNMT3A;IGF2
prerank,carnitine metabolic process (GO:0009437),0.31253108472753716,0.6447626622449184,0.8823529411764706,0.9750655639988274,1.0,3/12,18.44%,CPT1C;CRAT;SHMT1
prerank,synaptic vesicle cycle (GO:0099504),-0.1987942131245896,-0.6420258949531794,0.9723756906077348,0.9886883934118648,1.0,10/30,21.39%,RIMS1;PIP5K1C;SYNDIG1;SYT10;SNCA;SNAP25;SLC32A1;SYT7;SLC18A2;CPLX2
prerank,zymogen activation (GO:0031638),0.24949288298777866,0.6414941673011256,0.9225352112676056,0.9773539990145618,1.0,8/39,27.13%,PRSS12;MMP14;TBC1D10A;PGK1;PERP;CYFIP2;BAD;RIPK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3197734896003197,0.6413080098077617,0.8685714285714285,0.9771626733245813,1.0,3/10,24.26%,CALM3;DRD2;CBARP
prerank,cellular response to ATP (GO:0071318),-0.24169753280180803,-0.6403284667785599,0.9061224489795918,0.9884440118102569,1.0,14/14,75.86%,CIB2;P2RY1;P2RX7;P2RX3;P2RY2;PDXP;TRPV1;RYR3;P2RY4;HSP90B1;P2RX4;P2RY12;SSH1;TAF1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.31499815167749706,0.6387721010663062,0.8810888252148997,0.9788434237513256,1.0,1/10,5.17%,GABRA3
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.23856665426913082,-0.6379581099901925,0.9075342465753424,0.9886814940677253,1.0,4/12,24.06%,LAMA5;VANGL2;ACTB;ZDHHC7
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.22970365448023328,-0.6365735547853876,0.9266409266409267,0.9882473929126423,1.0,6/16,20.41%,GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,organelle fission (GO:0048285),0.26961608714505453,0.6362003826566338,0.9066339066339066,0.9805233432567653,1.0,10/24,31.04%,PEX11A;DNM2;MTFR1;SEC16B;MUL1;ACOT8;FIS1;PRKN;MIEF1;MTFR1L
prerank,cell junction maintenance (GO:0034331),-0.23678110807815816,-0.6357587247142072,0.9343065693430657,0.9873523057077834,1.0,7/14,29.21%,CLDN1;CBLN2;CSF1R;CBLN1;MYADM;PARD6A;NLGN2
prerank,phasic smooth muscle contraction (GO:0014821),0.30916417882432135,0.6353822013554707,0.8740849194729137,0.9808270534184031,1.0,3/10,21.33%,EDN3;GDNF;DRD2
prerank,regulation of phosphate metabolic process (GO:0019220),-0.22479905165160374,-0.6351437422855618,0.9306122448979591,0.9863706792820902,1.0,4/16,13.10%,SMG7;SRPX2;PGAM1;BARD1
prerank,positive regulation of phagocytosis (GO:0050766),0.24263199768391389,0.6347507665828107,0.9401805869074492,0.9809737884841316,1.0,8/47,22.65%,GAS6;FCER1G;PLA2G5;LMAN2;APPL2;CALR;TUB;SLC11A1
prerank,presynapse organization (GO:0099172),0.31181120201819035,0.6337853777659619,0.8897058823529411,0.9813629848719992,1.0,2/10,13.02%,DVL1;NLGN1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.27808648463481683,0.6334657934807953,0.9053876478318003,0.9812606698792653,1.0,3/18,12.28%,TBX21;TRIM27;EZR
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.26143827463466873,0.6332688634700836,0.91320293398533,0.9810534472453383,1.0,6/26,18.74%,EYA2;FGFR1;TERT;INHBA;AKT1;GDNF
prerank,bile acid metabolic process (GO:0008206),0.26444586859500996,0.6328835264700987,0.9098660170523751,0.9810036093774388,1.0,7/27,24.67%,OSBPL7;AKR1C1;NPC1;OSBP;SLC27A2;HSD3B7;ACOT8
prerank,thyroid hormone generation (GO:0006590),0.3063204011721134,0.6325047272758245,0.8930099857346647,0.9809496241302057,1.0,1/10,5.72%,CPQ
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.21640334625519456,-0.6320760052538963,0.940677966101695,0.9870444213139323,1.0,7/20,20.41%,NT5C2;GMPS;IMPDH1;ADSS1;LHPP;PPAT;AMPD2
prerank,response to gamma radiation (GO:0010332),0.26766540352920515,0.6320220596398002,0.9305210918114144,0.9809653571483956,1.0,10/24,28.72%,WRN;ATM;LIG4;TLK2;TRIM13;MEN1;XRCC6;TP53;HSF1;ATR
prerank,bile acid biosynthetic process (GO:0006699),-0.19880598754110815,-0.6317617668755208,0.9646464646464646,0.9858257134252101,1.0,2/24,5.32%,CYP7B1;CYP27A1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.26187562134025694,0.631144176816881,0.9300613496932515,0.981277117455724,1.0,12/26,30.27%,AKAP9;ARL2;SLAIN2;DCTN1;STMN2;CDK5RAP2;MET;KATNB1;DRG1;FES;TOGARAM1;RAC1
prerank,ceramide metabolic process (GO:0006672),0.23923099671600742,0.6307039580732239,0.9574944071588367,0.9812620869282856,1.0,4/49,6.19%,ACER3;PLPP3;SMPD4;PLPP1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3048509685350656,0.630302343877076,0.8732590529247911,0.9812007780318412,1.0,6/11,33.14%,SMARCA4;NOP53;PWP1;DDX11;NCL;SIRT7
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.28139282500107227,0.6297924624849156,0.9068241469816273,0.9812442344319359,1.0,4/17,16.57%,MIS12;ZW10;HASPIN;IK
prerank,regulation of cellular amide metabolic process (GO:0034248),0.2537912373788118,0.6294046460981413,0.9228028503562945,0.9811788011127566,1.0,15/32,34.34%,PRKCD;CYFIP1;NOLC1;FOXO3;EIF2A;ATXN2;ROCK1;RBM3;EIF4E;PUM3;METAP1;TMED10;PCIF1;TCOF1;SAMD8
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2899278588562758,0.6293141885893391,0.9226666666666666,0.9809037673634737,1.0,3/15,18.74%,CHEK2;HUS1;ATF2
prerank,positive regulation of lipid storage (GO:0010884),0.2668117384546675,0.6291132836018207,0.9333333333333333,0.9807154658094278,1.0,4/21,19.25%,EHD1;CIDEA;PLIN3;IKBKE
prerank,regulation of microtubule nucleation (GO:0010968),0.30955279559818494,0.628951551228166,0.8919308357348703,0.9805022808547913,1.0,3/10,20.23%,CKAP5;GIT1;DCTN1
prerank,cellular response to nitrogen compound (GO:1901699),0.27511850107992947,0.6281305014159085,0.9235668789808917,0.980775475704269,1.0,12/20,36.14%,DDI2;SPIDR;AOC1;ATP2B4;DAXX;HSF1;DDX11;TIMELESS;RIOK3;BLM;EPG5;RTF2
prerank,response to interferon-gamma (GO:0034341),0.2278182167486862,0.6281210143391613,0.9565217391304348,0.9804384729404735,1.0,13/67,22.65%,SLC26A6;CCL13;CCL15;CXCL16;GBP6;CASP1;CYP27B1;EPRS1;DAPK3;ACOD1;SYNCRIP;SHFL;SLC11A1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.17644799863630822,-0.628103397949601,0.9931506849315068,0.9867993768052469,1.0,37/38,72.68%,NDUFC2;NDUFA13;NDUFB2;NDUFAF1;NDUFB7;NDUFS1;NDUFA8;NDUFB11;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFA11;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFAB1;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,heterochromatin organization (GO:0070828),-0.23435557198794138,-0.6273386565068623,0.9541984732824428,0.9859388578487837,1.0,1/14,0.70%,MECOM
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.26707029279465605,0.6268874281687057,0.9266409266409267,0.9810106699849471,1.0,3/23,9.77%,KLRK1;RAET1E;CRTAM
prerank,nuclear membrane disassembly (GO:0051081),0.29540157837405023,0.6264741351662523,0.9248322147651007,0.9809662944817886,1.0,3/14,20.23%,PRKCA;CNEP1R1;DCTN1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2639697658345029,0.6253713054366348,0.9201995012468828,0.9814335147587685,1.0,4/25,8.21%,CNNM2;TMC8;SELENON;TRPM7
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.21526679002170385,0.62519938226953,0.9887869520897044,0.9812160181595563,1.0,44/158,28.02%,CARD16;MAVS;BRD4;TRIM27;S100B;RHOA;SHARPIN;ROR1;LTBR;CHUK;ALPK1;IRAK1;TAB2;TNFRSF10B;MID2;F2R;CASP1;AKAP13;ZDHHC13;MAP3K3;TRAF3IP2;TRIM13;HMOX1;TRIM6;IKBKE;CC2D1A;NUP62;MUL1;MIER1;TRIM8;BIRC3;MAP3K14;TBK1;PINK1;TRADD;TFG;RIPK1;TMEM106A;NDFIP1;RIPK2;NEK6;CANT1;UBE2V1;GPR89A
prerank,positive regulation of viral genome replication (GO:0045070),0.25487059085131397,0.6251782343418809,0.9217809867629362,0.9808894997370075,1.0,4/29,14.24%,PABPC1;TMEM39A;PKN2;SRPK1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.26906883187860764,0.625078771038169,0.9119496855345912,0.9806210677392959,1.0,8/21,24.66%,PPP1R8;TIPRL;YWHAE;ARPP19;CRY2;BOD1L1;FKBP1B;YWHAB
prerank,positive regulation of defense response (GO:0031349),0.22253227726561997,0.6246403912100645,0.9639448568398727,0.9805949147918651,1.0,4/89,5.43%,PDCD4;IL33;ABCC1;LRSAM1
prerank,Rac protein signal transduction (GO:0016601),0.27445311097547276,0.6245786040378237,0.9198966408268734,0.9802983820345027,1.0,3/18,14.86%,TIAM1;CYFIP1;FARP2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.2854264008780617,0.6245128114717793,0.9140518417462483,0.9800055165589812,1.0,1/15,2.13%,MUC1
prerank,nucleoside catabolic process (GO:0009164),0.30091583227418506,0.6239731906984919,0.9,0.9800764791761534,1.0,3/11,20.79%,UPP2;DERA;NT5C
prerank,positive regulation of signaling receptor activity (GO:2000273),0.24614261843064333,0.6239157653642472,0.9434416365824309,0.9797769772370427,1.0,5/36,15.82%,EPHB2;ARC;NRP1;HDAC1;HDAC6
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.23779643693494718,0.6229733259424399,0.9390103567318757,0.9801038168443599,1.0,8/45,18.82%,PTPN3;GAS1;TOM1L1;BMP4;ZW10;CDKN1C;WEE2;HECA
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.20519681260770758,-0.6216879353698183,0.9629629629629629,0.988062571937356,1.0,12/23,36.53%,HPGD;GSTM1;ALOX12;ELOVL6;ASAH2;ALOX5;CYP2E1;GSTM4;CYP1A1;ACOT7;LTC4S;GSTP1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.233411728861797,-0.6203758432940801,0.9233870967741935,0.9874286261331825,1.0,5/14,20.97%,SYK;LGALS9;PTPN22;CD55;CCR2
prerank,myelin maintenance (GO:0043217),0.30975120932915273,0.6202832561397631,0.9094890510948905,0.9816611785074687,1.0,4/10,22.00%,SOD1;CXCR4;CLU;ABCD1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.26182223752854655,0.620223699566629,0.9195402298850575,0.9813700757804866,1.0,3/23,11.17%,HDAC4;ACTN3;GIT1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.25053534011642986,0.6201035804308815,0.9315726290516206,0.9811147491778238,1.0,3/30,7.26%,TWIST1;CCAR2;YJU2
prerank,mitotic spindle assembly (GO:0090307),0.23931979314315177,0.6200533975643618,0.9409090909090909,0.980809191920911,1.0,15/42,32.66%,MISP;SMC3;RHOA;CHEK2;STAG1;CCDC61;ARHGEF10;WRAP73;SMC1A;SPICE1;GOLGA2;TOGARAM1;KIF2A;BCCIP;PIBF1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.2800336959625249,0.6191318685193762,0.9065040650406504,0.9811237170526864,1.0,5/15,23.76%,NLGN1;CLN3;USP46;DRD2;SYN3
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.2921303649822519,0.6187519952269398,0.8953804347826086,0.9810443565249961,1.0,5/12,23.13%,IAPP;VBP1;CLU;LDLR;PFDN4
prerank,cellular amino acid catabolic process (GO:0009063),0.22058679932784578,0.6179897054861911,0.972457627118644,0.981245799748072,1.0,24/87,27.97%,HYKK;MTRR;DDAH1;IDO2;HMGCL;AUH;HNMT;ACAT1;CARNMT1;GCSH;GSTZ1;SHMT2;BCKDK;SHMT1;DAO;PHYKPL;KYAT1;BCAT1;GCDH;CRYM;BCKDHB;HIBCH;HOGA1;HGD
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.23191132988095656,0.6176992628875344,0.9536199095022625,0.9811081839844555,1.0,8/50,17.59%,CDC6;CDK5RAP3;CCNT2;CCNG2;CCNE2;CAMK2N1;CDC25A;CDKN1C
prerank,phosphate ion transmembrane transport (GO:0035435),0.296174995359976,0.6175140387459994,0.8991477272727273,0.9808972507131365,1.0,5/12,30.85%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,T cell receptor signaling pathway (GO:0050852),0.21427003510507744,0.6172505444766101,0.9927835051546392,0.9807443465549779,1.0,39/138,27.30%,PSMD7;CD3E;PSMA8;PRAM1;BTNL9;PAK2;PSMA4;CHUK;TAB2;PDPK1;PSMD12;PIK3CB;CUL1;KHDRBS1;PSMA6;VTCN1;WNK1;PSMD1;PSMC5;PSMD11;PSMC4;PSMD14;RC3H2;DENND1B;TRAT1;PSMA3;PSMB1;PSMD4;PSMA5;STOML2;PSMA7;NFKBID;CSK;PSMC1;NCK1;MOG;WAS;RIPK2;PSMA1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.22729237654030857,-0.6152679661544617,0.9246031746031746,0.9890018972354307,1.0,5/14,19.49%,BCL2L1;OPA1;HSPA1A;XBP1;CREB3
prerank,positive regulation of histone modification (GO:0031058),0.2432120314847313,0.6140769616597378,0.9477521263669502,0.9826036652533261,1.0,8/33,24.33%,TADA2A;RPS6KA4;CHTOP;ARRB1;NIPBL;AKAP8;PAF1;SAP30BP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.28846926361665925,0.6137765498638577,0.9111709286675639,0.9824905599602801,1.0,2/14,14.20%,TERT;TNKS2
prerank,transcription preinitiation complex assembly (GO:0070897),0.29206995792487855,0.6135947151555462,0.921090387374462,0.9822821938466683,1.0,5/12,30.90%,BDP1;TBP;TAF1;GTF2A2;TAF1B
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.23657710089686823,-0.6133725150089713,0.921311475409836,0.9886861252503263,1.0,2/11,12.24%,AHR;CEACAM1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2360606033868722,0.6111906669132934,0.9587628865979382,0.9835613663178165,1.0,15/44,29.94%,PABPC1;FTO;PUM1;METTL16;AGO2;CNOT8;UPF1;RBM24;ROCK1;METTL14;RIDA;TNRC6A;YTHDF1;ZFP36L1;KHSRP
prerank,aerobic respiration (GO:0009060),-0.20880450400113754,-0.61055378960823,0.9555555555555556,0.9888831881047976,1.0,6/20,17.26%,ME3;UQCRC2;SLC25A14;UQCRB;UQCRC1;MTFR2
prerank,regulation of phagocytosis (GO:0050764),0.2299936147625905,0.610002210305139,0.9632925472747497,0.9840114314998489,1.0,6/53,14.04%,GAS6;FCER1G;ITGAV;PLA2G5;PIP4P2;LMAN2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.27082489117463143,0.60997754229795,0.9328165374677002,0.9836920433820764,1.0,7/18,28.41%,DERA;NGLY1;FBXO17;OGA;ADAMTS9;MANBA;STT3B
prerank,regulation of mitotic nuclear division (GO:0007088),0.22932585485039522,0.6076041153601928,0.9591160220994475,0.9849095979599326,1.0,16/55,26.36%,LRP5;TOM1L1;EDN3;BMP4;RCC1;LCMT1;PHIP;DAPK3;KIF20B;NUP62;CUL9;CDK5RAP2;CDK13;CCDC8;CUL7;IGF2
prerank,detection of visible light (GO:0009584),-0.21661103482789043,-0.6075670982205456,0.9437751004016064,0.9890696146602412,1.0,2/16,12.16%,ABCA4;RP1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.259856989973736,0.6075371744423297,0.9175126903553299,0.9846117664510603,1.0,2/20,7.53%,DRD1;ADCY9
prerank,B cell activation (GO:0042113),0.22412691144932168,0.6075370282511953,0.976998904709748,0.9842718935596378,1.0,12/68,21.23%,EPHB2;HDAC9;HDAC4;CHRNB2;PTPN2;HSPD1;CLCF1;TCF3;TPD52;GPS2;IL4;BANK1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2512174951006446,0.6049893592226485,0.9447852760736196,0.9855144258232693,1.0,5/27,17.16%,DRD1;GPR20;F2R;GPR157;CALCA
prerank,protein targeting to mitochondrion (GO:0006626),0.2309674333765862,0.6048501413313127,0.9740990990990991,0.9852757302325894,1.0,8/52,16.96%,TOMM40;TIMM9;BCAP31;AIFM1;HSPD1;TOMM70;PMPCA;GRPEL1
prerank,tryptophan metabolic process (GO:0006568),0.2920208463526095,0.6037550258476191,0.9188034188034188,0.9856098601960748,1.0,2/11,20.64%,IDO2;KYAT1
prerank,negative regulation of translational initiation (GO:0045947),0.28694091952824474,0.6037395852885818,0.9182058047493403,0.9852810878152035,1.0,5/13,28.60%,AGO2;RBM4;EIF2AK4;TPR;LARP1
prerank,apoptotic nuclear changes (GO:0030262),0.2519057123645886,0.6031504802622697,0.92,0.9853132514940759,1.0,5/24,18.12%,ERN2;HMGB1;CDK5RAP3;ACIN1;DFFB
prerank,steroid biosynthetic process (GO:0006694),0.22759007841942303,0.6029594470425195,0.9562780269058296,0.9850879790387205,1.0,16/56,30.60%,CYP19A1;OSBPL7;FDXR;OSBP;LSS;PRLR;EBP;SC5D;SLC27A2;HSD3B7;ACOT8;HMGCR;SCP2;SQLE;INSIG1;OSBPL1A
prerank,positive regulation of isotype switching (GO:0045830),0.2734691044295495,0.6027417196886775,0.9135802469135802,0.9848793086218787,1.0,7/15,29.08%,KMT5C;CLCF1;MAD2L2;IL4;SHLD3;SHLD1;HMCES
prerank,alpha-amino acid metabolic process (GO:1901605),0.2272777854251052,0.6010197234291925,0.9621993127147767,0.9856110147436987,1.0,13/45,25.29%,NOX4;MTRR;DDAH1;SRR;MTHFD1;GNMT;MTHFR;RIMKLB;KYAT1;PYCR1;DPEP1;RIMKLA;SLC25A12
prerank,glutamine family amino acid metabolic process (GO:0009064),0.23595966963674564,0.6004927524086561,0.9632701421800948,0.9856012468696006,1.0,14/33,34.22%,GCLC;DDAH1;CAD;RIMKLB;GCLM;KYAT1;PYCR1;RIMKLA;FPGS;NIT2;DGLUCY;ART4;ALDH18A1;GLUD1
prerank,entry into host (GO:0044409),0.2791248105250273,0.6003650105203512,0.9174690508940853,0.9853416140288621,1.0,6/13,30.24%,CBL;ITGAV;CXCR4;MET;GRB2;CTNNB1
prerank,covalent chromatin modification (GO:0016569),0.27389994741123797,0.5994531733432859,0.9137466307277629,0.9855612009386597,1.0,3/14,17.35%,SETD5;HDAC1;UFL1
prerank,regulation of AMPA receptor activity (GO:2000311),0.2534621406384216,0.5993498946179071,0.9389027431421446,0.985288420235934,1.0,5/25,17.67%,ARC;CNIH2;SHANK1;NLGN1;SHISA8
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.2628376948557936,0.598439761738817,0.9319371727748691,0.9855034293241725,1.0,5/17,27.40%,KCNE5;SUMO1;RNF207;VAMP2;KCNRG
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.2853809087965335,0.5964412246753191,0.9087078651685393,0.9863489479300366,1.0,2/11,14.29%,SCARA3;COLEC12
prerank,stem cell development (GO:0048864),0.26927830597159247,0.5961362897648644,0.9264305177111717,0.9861961152267319,1.0,8/16,34.91%,NOLC1;KLHL12;SOX8;TAPT1;PTPRC;SNAI2;TCOF1;PEF1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2403385185680711,0.5917439790961705,0.9429611650485437,0.9884266256951773,1.0,9/30,28.41%,UGGT2;FUT8;UGGT1;STT3A;DPM3;LMAN1;MAGT1;MGAT5;STT3B
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.27204694620661546,0.5916210151916119,0.9362549800796812,0.9881622078751485,1.0,6/15,34.03%,ANXA1;NR3C1;HNRNPU;ZFP36L1;SSTR2;FAM107A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.18514012364092555,-0.5895581547402635,0.9747474747474747,0.9969806145294893,1.0,6/26,15.93%,CDK6;TMEM178A;MAFB;CEACAM1;HOXA7;C1QC
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.25300280492263355,0.5894971309683199,0.942381562099872,0.9890206735733105,1.0,2/22,5.71%,AHNAK;DMD
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.2735639722931128,0.5883318452944603,0.9380053908355795,0.9893216573513363,1.0,6/13,35.20%,HSPA5;UFL1;NCK1;ATF6B;WFS1;DNAJB9
prerank,endochondral bone morphogenesis (GO:0060350),0.28361333360483526,0.5866180800351044,0.9280677009873061,0.9899550234007948,1.0,3/11,20.60%,BMP4;TMEM119;FGFR3
prerank,purine nucleotide catabolic process (GO:0006195),0.2747992277012466,0.5842402250220344,0.9179415855354659,0.9909620319562558,1.0,1/13,4.54%,XDH
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.2798189355942085,0.5826672333527794,0.9411764705882353,0.9914577080657385,1.0,7/13,38.99%,LSM2;SRSF10;USP4;DDX20;SART3;CD2BP2;PRPF31
prerank,microtubule-based transport (GO:0099111),0.2809314464537883,0.5824997055085973,0.9364406779661016,0.9912152860899162,1.0,4/12,21.82%,ROPN1L;DNAAF4;DYNC1I2;SPAG17
prerank,response to muramyl dipeptide (GO:0032495),-0.22759808854162258,-0.5817628023636953,0.9350180505415162,0.9991755907208407,1.0,4/12,16.36%,ARHGEF2;VIM;NOD2;PTPN22
prerank,regulation of steroid metabolic process (GO:0019218),0.242629782151363,0.58162029070122,0.946047678795483,0.9913518322630948,1.0,5/23,19.42%,LAMTOR1;DGKQ;RORA;STUB1;ASAH1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.22415676669864637,-0.5814115918804204,0.9480968858131488,0.9979142193092906,1.0,6/12,28.37%,WDR18;METTL4;WRNIP1;GMNN;TIPIN;TICRR
prerank,protein import into mitochondrial matrix (GO:0030150),0.2562231420791653,0.5813569734307465,0.9432989690721649,0.991158649180001,1.0,6/18,32.50%,TOMM40;TOMM70;GRPEL1;TIMM17B;GRPEL2;TIMM21
prerank,linoleic acid metabolic process (GO:0043651),0.25474623492920945,0.5811670883742152,0.9430051813471503,0.9909165783245389,1.0,5/17,27.15%,ELOVL5;FADS1;ABCD1;ALOXE3;ELOVL1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.29013652834037,0.5806050627654659,0.9215976331360947,0.9908924649955761,1.0,3/10,28.37%,RARA;IL4;SPHK2
prerank,plasma membrane repair (GO:0001778),0.2733551717590996,0.580250438140707,0.9354838709677419,0.9907336554558308,1.0,1/13,2.82%,AHNAK2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.21050458435987093,-0.5798680150228411,0.9527896995708155,0.9971561469951353,1.0,2/16,7.50%,PDK1;ADIPOR1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.25803905935963617,0.5789869292105406,0.9355281207133059,0.9910228231268859,1.0,6/16,37.07%,SOX9;APPL2;NCOR1;WDTC1;ACADL;ERLIN1
prerank,peptidyl-asparagine modification (GO:0018196),0.23421949320904958,0.578205971906012,0.95,0.9910598894190994,1.0,9/31,28.41%,UGGT2;FUT8;UGGT1;STT3A;DPM3;LMAN1;MAGT1;MGAT5;STT3B
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.24297441362725897,0.5779946036974895,0.9530284301606922,0.9908175859953596,1.0,2/25,4.16%,CSNK2A2;CSNK2A1
prerank,cellular response to inorganic substance (GO:0071241),0.2497949333985575,0.5769533817311432,0.9610552763819096,0.9910062117265053,1.0,9/21,31.69%,DDI2;SPIDR;AOC1;CDK2;DPEP1;DDX11;TIMELESS;MTR;BLM
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2493263079756748,0.5750043143044682,0.9518229166666666,0.9916287214187869,1.0,7/21,24.51%,SIRT5;COA8;SIRT2;HDAC6;AATF;ABCD1;PINK1
prerank,glycosphingolipid metabolic process (GO:0006687),0.22257186633390857,0.5741314508367993,0.9770378874856487,0.991717471946462,1.0,8/42,19.42%,ST6GALNAC5;SMPD4;ARSA;GALC;HEXA;GLB1;SUMF2;ASAH1
prerank,sphingolipid metabolic process (GO:0006665),0.2020837093395923,0.5732297207898892,0.9928131416837782,0.9918329722763841,1.0,8/108,6.71%,ACER3;PLPP3;PDXDC1;KDSR;SMPD4;ELOVL5;PLPP1;ARSA
prerank,negative regulation of histone methylation (GO:0031061),0.28936518610089684,0.5714201293079738,0.9495677233429395,0.9923951936083736,1.0,2/10,12.23%,PHF1;WDR5
prerank,canonical glycolysis (GO:0061621),-0.18067036736345948,-0.5709103903747208,0.9846938775510204,0.9981338946711139,1.0,4/24,11.13%,HK2;PGAM1;GPI;ALDOC
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.18067036736345948,-0.5709103903747208,0.9846938775510204,0.9981338946711139,1.0,4/24,11.13%,HK2;PGAM1;GPI;ALDOC
prerank,insulin secretion (GO:0030073),0.2507497710421369,0.5705863686044312,0.9559748427672956,0.9924527304043685,1.0,3/19,13.45%,ANXA1;RAB11FIP5;RAB11B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.2590936866258815,0.5705817718235289,0.9513513513513514,0.9921159424716621,1.0,3/15,20.81%,ABL1;SMAD7;MAD2L2
prerank,positive regulation of chromatin organization (GO:1905269),-0.2151151842320005,-0.5697235701435088,0.967741935483871,0.997194740445971,1.0,12/12,78.51%,TAL1;TERF2IP;SIN3A;TERF1;ACD;TINF2;ATRX;TERF2;UBE2N;DAXX;H3-3A;MIER1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.2354621250964829,0.5691252367571675,0.9507389162561576,0.9924938042409327,1.0,3/29,9.77%,KLRK1;RAET1E;CRTAM
prerank,phosphate ion transport (GO:0006817),0.257527693162203,0.5688446349265159,0.9390728476821192,0.9923063008748751,1.0,5/16,30.85%,SLC25A3;SLC37A4;SLC37A3;SLC25A11;SLC20A2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.25043308428271416,0.5685795359644525,0.9565217391304348,0.9917552855530283,1.0,6/20,27.11%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),0.25043308428271416,0.5685795359644525,0.9565217391304348,0.9917552855530283,1.0,6/20,27.11%,AUH;ACAT1;BCKDK;BCAT1;BCKDHB;HIBCH
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.2640997507497965,0.56853471590138,0.9459084604715673,0.9914389375962489,1.0,8/13,38.89%,IL6;MGAT5;HES1;PTPRC;IL7R;JAK3;CRLF2;JAK2
prerank,negative regulation of T cell activation (GO:0050868),0.22476738700322568,0.5678882488942387,0.9802224969097652,0.9914120793749019,1.0,4/35,13.12%,SPN;GLMN;VTCN1;CD80
prerank,primary miRNA processing (GO:0031053),0.2868003850455108,0.5668827315759216,0.938375350140056,0.9915516426047806,1.0,2/10,11.69%,HNRNPA2B1;DGCR8
prerank,positive regulation of cell aging (GO:0090343),0.27049975659902914,0.5664320303059205,0.9458333333333333,0.991426376381702,1.0,4/11,26.35%,LMNA;HMGA1;ARG2;CGAS
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26578291619561173,0.5663244953072201,0.9547325102880658,0.9911338911465476,1.0,1/13,4.21%,STAT3
prerank,negative regulation of hormone secretion (GO:0046888),0.2839669025716447,0.5652600502202568,0.9479606188466948,0.9913024637749416,1.0,3/10,31.74%,RAB11FIP5;LIF;RAB11FIP3
prerank,cellular response to gamma radiation (GO:0071480),0.2496918016968342,0.5633529445498715,0.9486521181001284,0.9918373900949928,1.0,8/17,31.81%,WRN;ATM;TLK2;XRCC6;TP53;HSF1;ATR;YAP1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.23460771618819076,0.5633415294564148,0.9618226600985221,0.9915062340724442,1.0,7/25,29.33%,FOXK1;ADPGK;PGK1;ENO2;PFKP;PFKL;GAPDHS
prerank,plasma membrane tubulation (GO:0097320),0.26672525091594584,0.5623918635615724,0.9313725490196079,0.9915921516521993,1.0,3/13,20.57%,EHD2;SNX9;CHMP4A
prerank,maturation of LSU-rRNA (GO:0000470),0.23041827603454276,0.5605375937213524,0.9537712895377128,0.9920684001740093,1.0,11/26,33.51%,LAS1L;EIF6;BOP1;RPL7A;WDR12;NIFK;RRP15;MAK16;RPF2;RSL1D1;DDX18
prerank,intracellular sterol transport (GO:0032366),0.26479472637497325,0.5600768728462356,0.9562841530054644,0.9919351608046681,1.0,3/13,13.71%,NPC1;OSBP;ABCA1
prerank,establishment of melanosome localization (GO:0032401),0.24309231665350645,0.5594830293579244,0.9693741677762983,0.9918627052830861,1.0,7/19,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.24188221536570698,0.5593361972689834,0.9521345407503234,0.9915883926345931,1.0,5/20,25.90%,ADA;RPGRIP1L;GPRASP1;YWHAB;MET
prerank,erythrocyte development (GO:0048821),-0.23291282244398417,-0.558912452983888,0.9391025641025641,0.9999192864888363,1.0,10/10,76.73%,SH2B3;NCKAP1L;ALAS2;ALAS1;GATA1;DMTN;LYAR;MED1;ZBTB7A;ABCB10
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.22168520213887405,0.5588953778917363,0.9658823529411765,0.991443994602334,1.0,9/35,24.17%,CALM2;PPP6R1;TIPRL;PPP6R3;CALM3;PPP6R2;CRY2;BOD1L1;FKBP1B
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.24036936827360209,0.5576754184957001,0.9664082687338501,0.9916409172385059,1.0,8/22,33.49%,KAT2A;LAG3;RUNX1;CBFB;SOCS1;BCL6;CD46;FANCA
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.2706887807540145,0.556670631906973,0.9276773296244785,0.9917366876111912,1.0,2/10,18.70%,MIA3;AKT1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.25939994196882615,0.5558624880877046,0.953232462173315,0.9917452096354367,1.0,1/14,6.37%,PUM1
prerank,inorganic ion transmembrane transport (GO:0098660),0.268724771110865,0.555371883657395,0.9375,0.9916113854690682,1.0,2/12,15.52%,TRPM4;PKD2L1
prerank,ganglion development (GO:0061548),-0.22038645019544778,-0.5549108954048732,0.9588607594936709,0.9999230527265934,1.0,2/11,15.74%,NRP2;UNC5C
prerank,cholesterol biosynthetic process (GO:0006695),0.225459589129858,0.5546194525890698,0.9698795180722891,0.9915903419098283,1.0,12/31,33.68%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.24840988421997334,0.5512746878328526,0.9557046979865772,0.9926211799841074,1.0,7/15,30.39%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.23923649587413964,0.5511899831657369,0.9612403100775194,0.992328527455794,1.0,10/19,37.41%,AEN;HIPK2;TP53;RPS27L;CDIP1;MSH2;SNW1;DYRK2;PHLDA3;BCL3
prerank,regulation of viral genome replication (GO:0045069),0.20472577376717255,0.550863414610477,0.9844789356984479,0.9921325182634066,1.0,19/56,33.01%,PABPC1;TMEM39A;MAVS;PKN2;ILF3;SRPK1;N4BP1;TRIM6;SHFL;STAU1;BANF1;PPID;HACD3;DDB1;LARP1;PPIH;TNIP1;IFIH1;PARP10
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.2376497853178992,0.5506211345817524,0.9695431472081218,0.9918966652553644,1.0,3/22,12.91%,UBASH3A;EZR;PTPN2
prerank,superoxide anion generation (GO:0042554),0.2552996126345358,0.550514435896556,0.9456521739130435,0.9916028744507855,1.0,1/13,6.00%,NOX4
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.276394243734109,0.5499202106658203,0.9534883720930233,0.9915026493954657,1.0,4/10,31.07%,IRAK3;TLE5;MAP2K5;PTPRC
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.22733876755986449,0.548979216755602,0.974390243902439,0.9915390788089701,1.0,5/28,20.48%,OSBPL7;CDK5RAP3;AXIN1;PSMC5;CLU
prerank,cellular biogenic amine metabolic process (GO:0006576),0.25892921415579584,0.5480604532065938,0.9587482219061166,0.9915509935366335,1.0,3/12,22.12%,HNMT;SRM;SLC22A3
prerank,regulation of response to interferon-gamma (GO:0060330),0.25856078916900355,0.5469118046463771,0.9521857923497268,0.9916574740203723,1.0,5/14,26.04%,PTPN2;SUMO1;JAK1;SOCS1;IFNGR2
prerank,regulation of osteoclast differentiation (GO:0045670),0.2194060831489764,0.5465869257381988,0.9764150943396226,0.9914406968870163,1.0,1/33,1.84%,UBASH3B
prerank,determination of bilateral symmetry (GO:0009855),0.2296621866739832,0.5457767665766505,0.9703225806451613,0.991422134778291,1.0,7/24,28.53%,ODAD2;NPHP3;DNAAF4;CITED2;LEFTY1;BBS7;STIL
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2001001228642575,0.5450971790991342,0.9816216216216216,0.9913486403664892,1.0,7/63,15.25%,EPHB2;CD3E;CHRNB2;ANXA1;CD80;CLCF1;IL6
prerank,sensory perception of taste (GO:0050909),0.263320783973018,0.5439890562125245,0.9408450704225352,0.9914118413689432,1.0,1/10,15.52%,PKD2L1
prerank,alpha-amino acid catabolic process (GO:1901606),0.220723144727137,0.5434831522563678,0.9778051787916153,0.9912784699932156,1.0,6/29,20.64%,MTRR;IDO2;ACAT1;GSTZ1;DAO;KYAT1
prerank,negative regulation of DNA binding (GO:0043392),0.22168172112298518,0.5420882303807525,0.9782082324455206,0.9914541083293054,1.0,7/28,20.81%,HEY1;SMO;SUMO1;MDFI;E2F1;NFKBIA;MAD2L2
prerank,regulation of protein localization to centrosome (GO:1904779),-0.2303663140155532,-0.5406984999914721,0.9550898203592815,1.0,1.0,3/10,16.21%,APC;CEP72;NSFL1C
prerank,positive regulation of B cell activation (GO:0050871),0.20491512206632964,0.5398091323156625,0.989749430523918,0.9919347643005848,1.0,7/50,15.25%,EPHB2;MMP14;CHRNB2;KMT5C;CD27;CLCF1;IL6
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.20401757689893282,-0.53800295447739,0.9633333333333334,1.0,1.0,13/13,79.62%,ADHFE1;D2HGDH;GOT1;AADAT;GPT2;GOT2;OGDH;TAT;DLST;IDH1;IDH2;L2HGDH;PHYH
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2265233642018294,0.537923039895526,0.9716748768472906,0.9922609082185215,1.0,9/24,30.49%,MAVS;TOMM70;TRAF3IP2;TRIM6;EIF2AK4;IL4;CGAS;HSP90AA1;LILRB1
prerank,tyrosine metabolic process (GO:0006570),-0.21392251710399265,-0.5377907791045416,0.9794520547945206,1.0,1.0,4/11,25.70%,FAH;THAP4;TYR;IL4I1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.22862137298420698,0.537357262035914,0.9749058971141782,0.9921337835233152,1.0,5/23,24.88%,TIMM9;TOMM70;COX18;BAD;TIMM22
prerank,negative regulation of cell division (GO:0051782),0.2587362075510271,0.5366955258764711,0.9655667144906743,0.9920301411384325,1.0,4/11,31.69%,ZFYVE19;E2F8;CHMP4C;BLM
prerank,melanosome localization (GO:0032400),0.22941768988952088,0.5360804541070265,0.9732262382864793,0.991900172146272,1.0,7/21,31.14%,BBS5;RAB11B;BLOC1S3;MLPH;BBS7;MYO5A;RAB27B
prerank,sensory perception of smell (GO:0007608),-0.2133442129048456,-0.5324170463201212,0.9715189873417721,1.0,1.0,11/11,78.69%,SYT10;SLC24A4;ADCY3;BEST2;OMP;BBS4;OBP2B;GFY;MKKS;UBR3;DRD2
prerank,negative regulation of phagocytosis (GO:0050765),0.23553672074102258,0.5314027073852743,0.9621409921671018,0.9931147092882195,1.0,4/17,24.37%,HMGB1;PIP4P2;APPL1;SNX3
prerank,positive regulation of JUN kinase activity (GO:0043507),0.22567141804279117,0.5290722014148139,0.97375,0.9935447562083181,1.0,6/23,27.37%,MAP3K5;MAP3K10;DUSP19;TAOK3;DVL2;MAP3K11
prerank,positive regulation of T cell activation (GO:0050870),0.19517980530939155,0.5284123078335999,0.9868421052631579,0.9934297644026332,1.0,6/62,15.25%,ZMIZ1;CD3E;ANXA1;HSPD1;CD80;IL6
prerank,modulation by host of viral genome replication (GO:0044827),-0.19930947897049592,-0.5281322358894592,0.9814814814814815,1.0,1.0,13/13,80.09%,ZC3H12A;IFI27;NUCKS1;FMR1;FBXL2;CCL8;CCNK;YTHDC2;PPIB;VAPA;PRKN;TBC1D20;EIF2AK4
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.25654973135544035,0.5267117972952765,0.9544159544159544,0.993616831097449,1.0,3/11,21.93%,SREBF1;CNEP1R1;LDLR
prerank,glycerol metabolic process (GO:0006071),-0.220834492307299,-0.5267040556002711,0.976027397260274,0.9997987684749015,1.0,5/10,29.43%,GK;GK5;TPI1;GOT1;COQ3
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.1908648331264714,0.5265332049953099,0.9978632478632479,0.9933401111571694,1.0,39/87,38.76%,ECSIT;COA8;AIFM1;ACAD9;NDUFS7;SURF1;BCS1L;TTC19;FASTKD3;COX18;NDUFAF4;UQCC3;SDHAF1;NDUFB6;DMAC2;NDUFA1;SDHAF2;COA5;SDHAF4;NDUFA7;NDUFB9;NDUFV2;COX16;NDUFA6;TIMM21;NDUFAF5;NDUFV3;SDHAF3;NDUFA9;UQCC1;NDUFAB1;UQCRFS1;NUBPL;COX14;NDUFA10;COX20;NDUFB10;NDUFS3;NDUFB3
prerank,T cell homeostasis (GO:0043029),0.2598470132787558,0.5227058004060902,0.9586305278174037,0.9941676542441271,1.0,5/10,33.57%,RIPK3;AKT1;PPP2R3C;JAK3;ZC3H8
prerank,mitochondrial genome maintenance (GO:0000002),0.25545774119871284,0.5224704782054581,0.9647390691114246,0.9939039356636018,1.0,3/11,16.21%,LONP1;MEF2A;PARP1
prerank,inner mitochondrial membrane organization (GO:0007007),0.1994733539515852,0.5220194680464691,0.992196209587514,0.9937147049207201,1.0,17/47,36.54%,SPG7;TIMM9;MICOS10;LETM1;ATP5MC3;TOMM70;UQCC3;AFG3L2;TIMM22;ATP5MC2;DNAJC11;MTX3;ATP5PD;ATP5MF;TIMM8B;ATP5F1E;ATP5F1C
prerank,negative regulation by host of viral transcription (GO:0043922),0.24442910049588853,0.5204372103626417,0.9770773638968482,0.9938643864871379,1.0,12/12,75.58%,HDAC1;TARDBP;TFAP4;INPP5K;REST;PSMC3;CCL3;CCL4;JUN;CCL5;POU2F3;HMGA2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.21580320967915537,0.5203522554782394,0.9878048780487805,0.993559740810982,1.0,4/27,16.48%,ETNK1;ETNPPL;CHKB;PLA2G15
prerank,peptide biosynthetic process (GO:0043043),0.1797196438704362,0.5203247148489786,0.9989806320081549,0.9932326618049041,1.0,12/153,12.89%,PCSK5;RRBP1;RPSA;DMD;ABCF1;HARS2;GSPT1;MRPS18B;MRPS14;AGO2;EIF4G1;MRPL35
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.22393519046091798,0.5185906015124689,0.9784263959390863,0.9934069807408107,1.0,8/21,32.06%,UBE2C;CDC20;MAD2L2;RAB1A;GOLGA2;BTRC;UBE2S;GORASP1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.24537330392669598,0.5165422704886865,0.978494623655914,0.9936440590718785,1.0,4/13,28.28%,HEY1;MAD2L2;TAF1;PER2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.20648967551622419,-0.5135441667200848,0.9862542955326461,1.0,1.0,10/10,79.37%,THAP4;IL4I1;QDPR;KYNU;PCBD1;IYD;PAH;ATP7A;ASRGL1;KYAT1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.20722668053582752,0.5125272764723361,0.9835680751173709,0.9943967885379258,1.0,5/33,18.31%,UBASH3A;EZR;PTPN2;KCNN4;TRAT1
prerank,positive regulation of behavior (GO:0048520),0.2556231067312311,0.5122060582437034,0.9569583931133429,0.9941563052159501,1.0,2/10,13.02%,AGRP;NLGN1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.23928594299323108,0.5112787568513119,0.9860724233983287,0.9940648725060935,1.0,5/14,31.07%,TNFRSF1B;IL4;LDLR;NR1D1;PTPRC
prerank,regulation of activated T cell proliferation (GO:0046006),0.20659406877549968,0.5111783177607762,0.9843373493975903,0.9937552239601851,1.0,3/30,10.46%,HMGB1;CRTAM;RIPK3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.19072049625786575,0.5094209291299335,0.9955555555555555,0.9935376160777183,1.0,25/56,40.56%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB10;NDUFS3;NDUFB3;NDUFB5;TMEM126A;NDUFS8
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.19072049625786575,0.5094209291299335,0.9955555555555555,0.9935376160777183,1.0,25/56,40.56%,ECSIT;ACAD9;NDUFS7;BCS1L;NDUFAF4;NDUFB6;DMAC2;NDUFA1;NDUFA7;NDUFB9;NDUFV2;NDUFA6;TIMM21;NDUFAF5;NDUFV3;NDUFA9;NDUFAB1;NUBPL;NDUFA10;NDUFB10;NDUFS3;NDUFB3;NDUFB5;TMEM126A;NDUFS8
prerank,microtubule anchoring (GO:0034453),0.24329107946976597,0.5076947173416511,0.970954356846473,0.9936423328798237,1.0,5/12,31.51%,PCM1;CAMSAP3;PEX14;GCC2;BCCIP
prerank,cristae formation (GO:0042407),0.21144442349988415,0.5044272912221327,0.9901356350184957,0.9941142709226051,1.0,11/27,36.54%,SPG7;LETM1;ATP5MC3;UQCC3;AFG3L2;ATP5MC2;DNAJC11;ATP5PD;ATP5MF;ATP5F1E;ATP5F1C
prerank,negative regulation by host of viral process (GO:0044793),-0.1992719512960522,-0.4963351472750774,0.9929328621908127,1.0,1.0,10/10,80.09%,ZC3H12A;CRP;CCL8;PTX3;CCNK;LTF;PSMC3;VAPA;PRKN;EIF2AK4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.2367866591394715,0.4906920947861403,0.9814285714285714,0.9968170989231773,1.0,2/11,18.51%,ARRB1;SAG
prerank,mesenchymal cell development (GO:0014031),0.2111458171613142,0.48832575511051823,0.9755469755469756,0.9969431649026359,1.0,8/18,34.91%,HEYL;NOLC1;KLHL12;SOX8;TAPT1;SNAI2;TCOF1;PEF1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.21616041365214084,0.4863174201949175,0.9828269484808454,0.9970065013282111,1.0,4/19,24.48%,HYKK;PHYKPL;GCDH;CRYM
prerank,secondary alcohol biosynthetic process (GO:1902653),0.19829020846669002,0.48540488326848374,0.9915865384615384,0.9968411656966727,1.0,11/30,33.68%,NSDHL;LSS;EBP;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,carbohydrate catabolic process (GO:0016052),0.18736085166474473,0.4827643472070216,0.9954648526077098,0.9970045275861764,1.0,11/38,30.22%,MAN2C1;DERA;PGK1;ENO2;MAN2B1;ENO4;PFKFB1;MANBA;PFKL;GAPDHS;LDHA
prerank,B cell activation involved in immune response (GO:0002312),0.22598164491132267,0.48125392047031046,0.9851752021563343,0.9969598329213313,1.0,6/13,38.42%,LIG4;MSH2;GPR183;EXOSC3;RNF8;RNF168
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.22902733914993423,0.4757603807421521,0.9765840220385675,0.9975722366564207,1.0,3/11,21.58%,NCBP1;NCBP2;PAF1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.23327308125291665,0.4746243045848848,0.9868613138686131,0.9974367144386491,1.0,3/11,26.26%,IL4;HDAC2;TMEM106A
prerank,regulation of microglial cell activation (GO:1903978),-0.1734179050376981,-0.4718371699996032,1.0,1.0,1.0,5/15,25.05%,SPHK1;CX3CL1;SYT11;TREM2;GRN
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.20596598752179163,0.4715683504724749,0.978891820580475,0.9975950299471725,1.0,7/18,30.39%,CCT4;CCT6A;CCT8;TCP1;DKC1;CCT5;NOP10
prerank,spermatid development (GO:0007286),-0.13642834115035263,-0.46988814049718236,1.0,1.0,1.0,6/32,22.73%,JAM2;NECTIN2;CEP57;TDRD5;ACRBP;SYCP3
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.16245224215572535,-0.4623907352316805,0.9960159362549801,1.0,1.0,3/17,13.53%,ATP5ME;ATP5MC1;ATP5F1B
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.21287910945952748,0.46172551518914123,0.9904891304347826,0.9987476158316141,1.0,5/16,31.96%,RIPK3;CYRIB;LILRB1;PTPRC;STX7
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.16573545106409693,-0.4599851453569807,1.0,1.0,1.0,14/14,83.45%,NECTIN2;IKBKG;RPS3;CARD11;CD226;TESPA1;LCK;BCL10;RAB29;CD81;RELA;PRKD2;TRAT1;KCNN4
prerank,positive regulation of interferon-beta production (GO:0032728),0.1845193483683844,0.4595603141223739,0.9963724304715841,0.9987146476628673,1.0,11/33,32.37%,MAVS;TOMM70;IRF3;TBK1;PTPN11;RIPK2;RNF135;HSP90AA1;RIOK3;POLR3F;IFIH1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.1633035942808292,-0.45497203629480665,1.0,1.0,1.0,3/16,13.53%,ATP5ME;ATP5MC1;ATP5F1B
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.22429544874457583,0.45359320621079824,0.9881129271916791,0.9991493125927198,1.0,1/10,9.77%,CRTAM
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18959549333332693,0.4504543945623819,0.991304347826087,0.9992093937823089,1.0,4/24,16.90%,LIG4;RPS27A;UBC;POLB
prerank,positive regulation of lymphocyte activation (GO:0051251),0.18714565619260043,0.4502173750985824,0.9925093632958801,0.9989041808929757,1.0,6/28,26.97%,PRKDC;HSPD1;IL6;XRCC6;CYRIB;CCL2
prerank,DNA catabolic process (GO:0006308),-0.1812703991965855,-0.4490359810773243,0.990909090909091,1.0,1.0,11/11,81.89%,XRN2;DNASE1L1;SETMAR;ISG20;DNASE1;DNASE1L3;MUS81;REXO4;DNASE1L2;FBH1;DFFB
prerank,regulation of B cell activation (GO:0050864),0.18485443293979456,0.44526316944562405,0.9951923076923077,0.9991369659009771,1.0,4/25,21.23%,IKZF3;IL6;IL4;BANK1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.20141184883975988,0.44317908125010824,0.9917695473251029,0.999017455709875,1.0,4/15,24.81%,SREBF1;CNEP1R1;LDLR;FITM2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.21281585993307062,0.44276881969208315,0.9890260631001372,0.9987297658641707,1.0,7/12,38.79%,YTHDC1;CDYL;HNRNPU;RBM15;RLIM;SMCHD1;PCGF3
prerank,regulation of neutrophil migration (GO:1902622),0.22032157502938882,0.44141615306793447,0.9942112879884226,0.9985435184221345,1.0,3/10,30.27%,MPP1;BST1;RAC1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.1563579277864992,-0.44129263434787536,1.0,0.99961337128252,1.0,18/18,84.39%,HIP1R;BOK;HSPA1A;TMEM14A;BAX;ZNF205;CHCHD10;TMEM102;GSK3B;FZD9;ACAA2;GSK3A;BAK1;MPV17L;SLC25A5;MUL1;BID;SLC35F6
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.1938683918419919,0.44056669524784703,0.9946018893387314,0.9983029937745159,1.0,7/18,33.74%,TCTA;IL4;GPR137B;LILRB1;LILRB3;FSTL3;FBN1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.21672001506307675,0.43274589654921264,0.9899135446685879,0.99837298750502,1.0,10/10,78.34%,WNK1;MAP2K5;KLF4;ADIPOQ;IL1RN;IL10;APOA1;MYADM;MBP;MAPK7
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.21672001506307675,0.43274589654921264,0.9899135446685879,0.99837298750502,1.0,10/10,78.34%,WNK1;MAP2K5;KLF4;ADIPOQ;IL1RN;IL10;APOA1;MYADM;MBP;MAPK7
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.1962855167721536,0.4325294649853679,0.992,0.9980573316548031,1.0,2/16,14.37%,ERCC4;MSH4
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.21662618436025216,0.43183884188482385,0.9942363112391931,0.9977853476089429,1.0,4/10,36.54%,ATP5MC3;ATP5MC2;ATP5PD;ATP5F1C
prerank,positive regulation of immune response (GO:0050778),-0.11062537374921587,-0.42946572975087477,1.0,0.9988134683169612,1.0,22/64,33.14%,GBP5;CD74;RSAD2;LGALS9;SIRT1;NOD2;PYCARD;XBP1;ITGAM;POLR3B;POLR3D;HRG;GRN;FADD;NMI;CCL5;TLR8;IL15;CD226;MYB;IL12RB1;POLR3C
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.19362613743570042,0.42371951359632903,0.9958847736625515,0.9981392680496298,1.0,7/14,39.14%,BOP1;WDR12;NIFK;RPF2;DDX18;RPL7L1;PES1
prerank,sterol biosynthetic process (GO:0016126),0.16765579504024955,0.41862173935974206,0.9964539007092199,0.998176082521245,1.0,12/33,33.68%,NSDHL;LSS;EBP;SC5D;HMGCR;ACAT2;ACLY;SQLE;INSIG1;GGPS1;TM7SF2;PLPP6
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.17558387449163496,0.41120458234168916,0.9975031210986267,0.9983444477902699,1.0,2/22,12.92%,FZD5;HSPD1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.16006799920949535,0.3910921554145931,0.9975698663426489,0.9990200851432872,1.0,1/29,5.16%,HORMAD1
prerank,negative regulation of synaptic transmission (GO:0050805),0.15610999068613757,0.3732090746836418,1.0,0.9992639947825481,1.0,7/23,31.59%,ARF1;PICK1;DRD2;LRRK2;PRRT1;ATAD1;MTMR2
